data_4crp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4crp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 108.314 -0.995 . . . . 2.01 108.314 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.524 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-85 -97.69 124.26 41.94 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.917 -1.142 . . . . 1.61 107.917 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.99 173.93 10.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.712 -1.218 . . . . 1.32 107.712 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.43 127.14 41.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.318 -0.553 . . . . 1.15 111.978 -173.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -118.17 140.82 49.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.346 -1.353 . . . . 1.67 107.346 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' HB1' ' A' ' 94' ' ' ALA . 95.5 t -115.93 121.22 66.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 121.378 0.608 . . . . 1.11 112.025 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 79.3 mt-30 -108.13 130.63 55.1 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.864 -1.161 . . . . 2.66 107.864 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.434 HD11 HG21 ' A' ' 98' ' ' ILE . 28.4 mt -122.96 156.2 35.21 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.232 -0.655 . . . . 1.08 109.232 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -132.11 151.01 52.01 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.549 -0.538 . . . . 1.34 109.549 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -60.04 132.47 54.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 124.551 1.157 . . . . 1.24 110.058 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 135.06 57.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 124.473 1.108 . . . . 1.07 109.722 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.44 127.91 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.694 -0.484 . . . . 1.21 109.694 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.3 mt-10 -77.86 109.96 12.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.126 -0.943 . . . . 2.52 112.058 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -168.9 162.39 11.25 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.807 -2.294 . . . . 1.33 104.807 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -55.63 -36.67 67.26 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.967 1.258 . . . . 3.4 113.42 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -95.5 99.22 11.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.893 -1.521 . . . . 3.18 106.893 172.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.431 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 53.3 m95 -81.0 137.59 36.07 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.203 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.07 124.04 31.88 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.765 -0.652 . . . . 0.34 110.222 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.3 mt -107.27 95.57 13.63 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.12 -1.437 . . . . 1.07 107.12 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.06 134.92 26.25 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.655 2.237 . . . . 0.32 111.912 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -129.74 155.49 45.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.112 0.482 . . . . 0.42 111.171 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 23.0 m -138.72 117.7 12.49 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.349 -0.982 . . . . 1.29 108.349 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.08 123.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.27 -1.011 . . . . 1.08 108.27 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 6.1 p-10 -108.96 156.33 19.84 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.868 -0.733 . . . . 1.39 111.013 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.57 147.25 4.57 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.652 -0.979 . . . . 0.6 110.652 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -86.31 -50.28 0.49 Allowed Pre-proline 0 C--N 1.311 -1.078 0 CA-C-O 119.126 -0.464 . . . . 3.29 111.253 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.5 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 C--N 1.366 1.453 0 N-CA-C 107.398 -1.808 . . . . 1.09 107.398 167.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.67 117.48 45.02 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 115.773 -0.649 . . . . 1.36 111.75 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -85.27 145.71 9.67 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.85 1.7 . . . . 0.56 111.642 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -78.32 120.17 22.71 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.122 -1.066 . . . . 1.74 108.122 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 56' ' ' PHE . 97.2 mt -93.17 123.3 36.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.99 -0.55 . . . . 1.14 109.891 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -134.66 131.82 38.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.029 -0.532 . . . . 4.62 110.848 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 87.6 m95 -93.02 135.07 34.52 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.359 -0.837 . . . . 0.33 109.495 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -113.11 134.51 54.51 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.894 -1.891 . . . . 1.57 105.894 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -125.34 111.42 15.16 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.489 -0.56 . . . . 1.04 109.489 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.61 34.59 24.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.165 0.986 . . . . 2.17 111.048 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.6 85.64 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.142 -0.481 . . . . 0.61 112.974 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -108.33 153.6 23.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.753 -0.832 . . . . 1.84 108.753 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.25 115.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.759 . . . . 1.31 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -89.34 122.62 32.75 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.247 -1.02 . . . . 1.33 108.247 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.57 129.92 55.54 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.374 -1.343 . . . . 2.69 107.374 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.235 0.614 . . . . 1.74 111.194 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 p -126.26 -165.69 1.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.044 -0.724 . . . . 2.07 109.044 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 m -78.62 -22.45 46.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 118.414 0.552 . . . . 1.9 110.597 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -87.21 -40.39 14.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.745 -0.382 . . . . 1.89 110.386 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -112.49 106.71 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.701 -1.222 . . . . 1.18 107.701 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -130.88 139.71 50.15 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.179 0.807 . . . . 3.62 113.179 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -84.68 119.96 25.84 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.263 -0.88 . . . . 1.15 109.749 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -94.09 125.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.44 -0.346 . . . . 2.04 110.441 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 37' ' ' LEU . 66.8 m-85 -106.78 106.74 17.41 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.582 -1.636 . . . . 0.87 106.582 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.0 154.63 17.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.397 -0.921 . . . . 1.7 108.956 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.26 113.0 14.58 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 123.479 0.711 . . . . 3.36 111.574 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.81 161.15 27.45 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.727 2.285 . . . . 1.63 110.552 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.82 142.06 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.712 -1.218 . . . . 1.88 107.712 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.82 -6.19 20.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.136 0.574 . . . . 2.29 112.243 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -104.0 -0.7 28.54 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.142 -0.481 . . . . 3.93 111.332 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.5 pt-20 -115.04 146.15 41.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.691 -1.226 . . . . 1.89 107.691 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -94.12 2.91 55.92 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.134 -0.691 . . . . 1.86 109.134 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.94 129.03 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.617 -0.72 . . . . 1.19 111.609 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -94.55 134.97 36.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.148 -1.797 . . . . 2.36 106.148 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.16 161.79 21.23 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.612 -0.435 . . . . 1.49 110.266 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.29 -165.38 35.24 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 120.674 -0.774 . . . . 0.36 111.334 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 t -156.16 141.87 17.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.502 -0.555 . . . . 0.36 109.502 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 50.3 tp -91.02 100.93 13.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.618 -2.364 . . . . 1.06 104.618 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -103.27 129.27 50.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.218 -0.593 . . . . 3.22 110.63 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.73 109.18 20.27 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.617 -0.883 . . . . 1.78 108.617 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -72.15 -43.09 65.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.599 -1.182 . . . . 2.42 109.95 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 101.0 31.9 Favored Pre-proline 0 N--CA 1.429 -1.501 0 N-CA-C 105.641 -1.985 . . . . 3.22 105.641 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.05 147.11 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.617 2.211 . . . . 1.62 112.372 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 p -130.06 141.29 50.73 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 122.039 -0.413 . . . . 1.75 110.406 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 41.8 p-80 -58.54 -6.4 0.7 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.118 1.525 . . . . 2.61 115.118 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.79 -17.06 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.152 -0.684 . . . . 1.77 109.152 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.595 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 17.5 m120 -83.34 -1.2 52.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.241 1.016 . . . . 2.19 109.625 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 39.5 t30 -77.11 81.22 3.63 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.28 -0.873 . . . . 2.08 108.883 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.88 -155.86 8.99 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.201 -0.909 . . . . 0.59 111.669 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -98.43 128.97 45.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.841 0.682 . . . . 2.28 112.841 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.595 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 76.9 m-85 -108.25 141.57 39.83 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.969 1.308 . . . . 1.03 108.021 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.1 m -142.57 134.44 27.0 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.631 -0.668 . . . . 1.13 109.353 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.8 tp -104.89 122.45 45.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.77 -0.456 . . . . 1.07 109.77 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.91 125.25 52.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.204 -1.036 . . . . 1.15 108.204 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -120.65 120.8 36.78 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.19 -1.041 . . . . 1.11 108.19 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.69 121.6 35.94 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.83 -0.348 . . . . 1.34 111.425 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -128.59 170.97 9.39 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 107.576 -1.268 . . . . 1.61 107.576 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.06 -41.26 33.74 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.602 2.201 . . . . 1.33 114.432 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -67.29 -45.65 75.91 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.509 -0.476 . . . . 1.1 112.207 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.01 178.09 47.54 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 119.103 -1.523 . . . . 0.71 113.594 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -119.86 133.53 55.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 123.202 0.601 . . . . 1.83 109.742 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -113.9 155.28 26.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.138 -0.69 . . . . 1.16 109.138 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.7 p -144.8 148.03 33.57 Favored 'General case' 0 N--CA 1.418 -2.068 0 O-C-N 123.52 0.513 . . . . 0.88 110.26 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.82 146.38 29.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.057 -1.831 . . . . 1.09 106.057 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -118.48 144.31 46.1 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.473 -0.491 . . . . 1.7 110.318 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.461 HG22 ' HB2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -134.67 122.16 37.76 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 C-N-CA 124.807 1.243 . . . . 1.38 109.505 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.19 108.6 16.82 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.777 -1.564 . . . . 1.67 106.777 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 155.84 25.22 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.313 -0.403 . . . . 1.26 110.924 -174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.38 100.65 10.07 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.385 0.612 . . . . 1.4 111.373 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 86.0 m-85 . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 108.146 -1.057 . . . . 4.75 108.146 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.403 -2.791 0 N-CA-C 109.374 -0.602 . . . . 2.01 109.374 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.601 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.9 m-85 -75.09 115.68 14.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.093 -1.447 . . . . 1.61 107.093 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -83.2 178.14 8.23 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.937 -0.764 . . . . 1.32 108.937 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 126.92 40.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 119.745 -0.782 . . . . 1.15 111.257 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -122.93 143.23 50.04 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.142 -1.429 . . . . 1.67 107.142 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.81 121.14 66.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.132 0.491 . . . . 1.11 110.901 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 118.83 37.77 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.301 -0.863 . . . . 2.66 108.858 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 mt -115.44 144.64 43.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.943 0.401 . . . . 1.08 109.984 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.95 151.27 51.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.968 -0.753 . . . . 1.34 108.968 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 m -57.49 135.1 56.58 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 124.455 1.097 . . . . 1.24 110.411 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.2 130.86 46.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.393 1.058 . . . . 1.07 110.66 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.9 136.14 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.335 0.588 . . . . 1.21 110.094 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.93 106.94 7.79 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.331 -1.304 . . . . 2.52 110.54 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.4 mtm -141.93 -163.16 1.53 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.953 -1.499 . . . . 1.33 106.953 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -67.89 -45.03 75.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.99 -0.744 . . . . 3.4 108.99 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -111.85 138.84 47.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 106.393 -1.706 . . . . 3.18 106.393 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 72.4 m95 -81.76 133.54 35.35 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 42.1 t -120.26 116.09 24.89 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.3 -0.864 . . . . 0.34 110.093 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 69.9 mt -100.08 99.37 9.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.144 -1.428 . . . . 1.07 107.144 172.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 2.9 Cg_exo -75.3 125.89 9.41 Favored 'Trans proline' 0 C--O 1.252 1.207 0 C-N-CA 122.502 2.135 . . . . 0.32 111.804 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -120.98 153.57 37.14 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.092 -0.707 . . . . 0.42 109.092 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.5 m -140.54 114.3 8.87 Favored 'General case' 0 C--N 1.267 -3.02 0 N-CA-C 108.715 -0.846 . . . . 1.29 108.715 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -110.43 116.31 52.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.596 -0.89 . . . . 1.08 108.596 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 8.5 t70 -101.22 137.06 40.07 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.634 -0.876 . . . . 1.39 108.634 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.46 145.17 4.27 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 110.326 -1.11 . . . . 0.6 110.326 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -84.05 -55.53 0.46 Allowed Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.739 -0.467 . . . . 3.29 109.739 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.1 Cg_endo -62.4 120.78 8.48 Favored 'Trans proline' 0 C--N 1.387 2.56 0 N-CA-C 108.643 -1.329 . . . . 1.09 108.643 170.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.1 111.59 8.99 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 116.15 -0.477 . . . . 1.36 111.531 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -83.97 162.13 13.79 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 122.547 2.165 . . . . 0.56 112.344 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -94.37 130.01 40.86 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.516 -0.92 . . . . 1.74 108.516 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.2 mt -98.54 140.67 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.995 -0.372 . . . . 1.14 109.995 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -143.88 133.71 23.89 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.162 -0.681 . . . . 4.62 109.162 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.3 m95 -96.64 117.46 31.04 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.33 109.862 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -100.72 127.23 47.21 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.336 -1.727 . . . . 1.57 106.336 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' HZ ' ' O ' ' A' ' 78' ' ' VAL . 88.7 t80 -122.97 108.05 12.51 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 109.213 -0.662 . . . . 1.04 109.213 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.58 17.7 6.39 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.679 0.791 . . . . 2.17 112.835 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.1 -12.16 40.7 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.973 -0.632 . . . . 0.61 112.685 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 m -108.62 151.99 25.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.851 -0.796 . . . . 1.84 108.851 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.41 123.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.379 -0.373 . . . . 1.31 110.017 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.2 tp -82.65 113.38 20.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.845 -0.616 . . . . 1.33 109.552 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.01 140.78 30.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.374 -0.602 . . . . 2.69 109.374 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.77 137.59 36.25 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.785 -0.643 . . . . 1.74 110.084 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 p -127.16 -165.97 1.54 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.773 0.829 . . . . 2.07 110.068 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 m -75.64 -31.91 60.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.023 0.44 . . . . 1.9 110.546 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -89.84 -28.41 19.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.071 0.397 . . . . 1.89 112.071 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.9 mt -125.53 106.64 16.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.091 -0.707 . . . . 1.18 109.091 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -145.91 156.27 43.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.61 -0.436 . . . . 3.62 110.547 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -85.23 109.79 18.58 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.666 -0.864 . . . . 1.15 108.666 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.54 108.77 21.55 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.37 -0.974 . . . . 2.04 108.37 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -85.95 145.74 27.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.53 -0.915 . . . . 0.87 108.53 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.2 pp -109.42 157.96 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.376 -1.713 . . . . 1.7 106.376 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.07 109.0 5.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 O-C-N 123.485 0.491 . . . . 3.36 110.15 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.63 140.92 19.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.393 2.062 . . . . 1.63 111.705 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.61 134.66 51.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.069 -1.085 . . . . 1.88 108.069 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.17 -18.28 63.31 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.832 0.678 . . . . 2.29 112.832 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.65 -23.2 59.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.256 -0.429 . . . . 3.93 110.478 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.83 152.31 18.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.515 -0.55 . . . . 1.89 109.515 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 11.12 38.26 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.496 -1.298 . . . . 1.86 107.496 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -104.74 127.88 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.037 -0.983 . . . . 1.19 110.617 -173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HB2' HG12 ' A' ' 29' ' ' VAL . 66.5 mtp180 -92.43 115.06 27.75 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.574 -1.639 . . . . 2.36 106.574 176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.429 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 90.5 m-70 -101.97 142.73 32.8 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.263 -0.643 . . . . 1.49 109.263 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.78 -178.79 38.4 Favored Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 120.21 -0.995 . . . . 0.36 111.327 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 t -144.33 132.81 22.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 120.547 0.213 . . . . 0.36 111.278 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 54.4 tp -87.16 114.01 23.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.433 -2.062 . . . . 1.06 105.433 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 16.4 ptm180 -106.76 119.58 39.71 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 112.338 0.495 . . . . 3.22 112.338 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.85 108.2 19.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.75 -2.315 . . . . 1.78 104.75 171.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.35 -52.53 11.93 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 108.982 -0.747 . . . . 2.42 108.982 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -128.26 100.23 23.44 Favored Pre-proline 0 N--CA 1.397 -3.111 0 N-CA-C 105.843 -1.91 . . . . 3.22 105.843 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.447 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 25.2 Cg_exo -67.09 150.39 82.36 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.11 1.873 . . . . 1.62 109.897 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -112.62 178.14 4.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.577 -0.283 . . . . 1.75 111.073 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -52.63 -37.02 57.69 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.469 0.708 . . . . 2.61 112.626 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.492 ' O ' ' HZ ' ' A' ' 41' ' ' PHE . 14.6 m -77.17 -10.44 13.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 112.825 0.676 . . . . 1.77 112.825 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.58 26.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.701 1.0 . . . . 2.19 113.701 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 78' ' ' VAL . 74.6 m-20 -110.86 53.47 0.7 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.755 -1.943 . . . . 2.08 105.755 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -133.78 -168.23 11.78 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.38 -1.39 . . . . 0.59 114.061 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 15.0 m120 -102.43 114.59 28.91 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.517 0.727 . . . . 2.28 109.989 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.09 116.2 31.56 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.738 -0.838 . . . . 1.03 108.738 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 77.8 m -116.62 122.75 45.53 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.694 -0.484 . . . . 1.13 109.694 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.1 tp -96.84 118.32 33.02 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.765 -0.457 . . . . 1.07 109.765 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.6 136.33 41.63 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.748 -0.834 . . . . 1.15 108.748 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.49 120.42 26.77 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.86 -1.163 . . . . 1.11 107.86 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.07 134.4 54.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 123.16 0.288 . . . . 1.34 110.599 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -153.2 171.93 6.24 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.67 -1.233 . . . . 1.61 107.67 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -55.94 -39.32 91.9 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.284 1.989 . . . . 1.33 113.408 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.55 -15.74 61.77 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.045 0.387 . . . . 1.1 112.045 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.27 -161.46 29.72 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 119.02 -1.562 . . . . 0.71 113.252 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.72 124.29 25.0 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.814 -0.81 . . . . 1.83 108.814 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -102.38 151.15 22.6 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.66 -0.867 . . . . 1.16 108.66 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 6.4 p -152.23 135.31 15.72 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.719 0.637 . . . . 0.88 110.775 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.44 47.08 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.175 -1.417 . . . . 1.09 107.175 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -129.54 145.24 51.49 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.875 0.369 . . . . 1.7 111.318 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 126.37 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.947 -1.131 . . . . 1.38 107.947 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -106.67 137.19 45.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.221 -0.659 . . . . 1.67 109.221 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.46 145.86 47.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.765 -0.828 . . . . 1.26 108.765 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -127.64 104.08 7.67 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.272 0.558 . . . . 1.4 110.433 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 58.2 t80 . . . . . 0 C--N 1.302 -1.484 0 N-CA-C 114.389 1.255 . . . . 4.75 114.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.379 -3.976 0 CA-C-O 122.193 0.997 . . . . 2.01 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.469 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 95.1 m-85 -96.61 127.26 42.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.323 -1.732 . . . . 1.61 106.323 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.2 m -92.4 -159.39 0.66 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 119.145 -0.455 . . . . 1.32 110.227 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.58 106.84 18.78 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 119.369 0.986 . . . . 1.15 112.123 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 39.4 m -112.81 126.68 55.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.399 -0.819 . . . . 1.67 108.882 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.55 124.86 72.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 120.926 0.393 . . . . 1.11 112.0 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -124.83 121.13 33.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.092 -1.077 . . . . 2.66 108.092 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.3 mt -105.0 156.12 18.33 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.982 0.42 . . . . 1.08 111.494 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -130.91 144.28 51.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.453 -1.314 . . . . 1.34 107.453 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -65.25 136.99 57.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.718 0.807 . . . . 1.24 110.089 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -51.58 138.63 22.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.403 1.064 . . . . 1.07 110.926 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.62 143.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.036 -0.529 . . . . 1.21 110.234 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.86 98.53 2.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.796 -1.093 . . . . 2.52 111.685 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -141.21 -169.59 2.88 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.395 -1.335 . . . . 1.33 107.395 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -78.93 -39.67 34.02 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.995 -0.743 . . . . 3.4 108.995 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -101.55 127.08 48.42 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.858 -1.905 . . . . 3.18 105.858 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.437 ' HB2' HD13 ' A' ' 72' ' ' LEU . 78.5 m95 -82.78 126.83 32.85 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.099 0.476 . . . . 1.0 110.991 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 43.7 t -117.73 118.13 31.23 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.51 -0.768 . . . . 0.34 109.435 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.6 mt -101.75 97.43 7.94 Favored Pre-proline 0 C--O 1.247 0.952 0 N-CA-C 107.599 -1.26 . . . . 1.07 107.599 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 9.7 Cg_exo -74.25 136.0 21.43 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.507 2.138 . . . . 0.32 111.427 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -124.41 161.32 26.25 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.283 0.563 . . . . 0.42 110.818 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -140.8 110.51 6.43 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.792 -0.818 . . . . 1.29 108.792 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.449 HG13 HD23 ' A' ' 37' ' ' LEU . 4.0 p -123.33 117.49 51.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.059 -1.089 . . . . 1.08 108.059 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 11' ' ' SER . 1.7 p-10 -103.1 165.94 10.73 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.526 -1.27 . . . . 1.39 110.715 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.58 165.54 12.5 Favored Glycine 0 N--CA 1.409 -3.111 0 O-C-N 124.823 1.327 . . . . 0.6 109.935 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -101.96 -55.22 0.13 Allowed Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.788 -0.449 . . . . 3.29 109.788 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.2 Cg_endo -66.05 119.78 6.85 Favored 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.08 -1.931 . . . . 1.09 107.08 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 115.07 27.31 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 1.36 111.508 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.01 134.59 9.45 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 121.516 1.477 . . . . 0.56 111.356 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -70.61 132.75 45.93 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.519 -1.289 . . . . 1.74 107.519 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD23 HG13 ' A' ' 29' ' ' VAL . 72.1 mt -100.04 120.45 39.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.968 0.414 . . . . 1.14 110.432 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -122.1 128.05 50.87 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.532 -0.758 . . . . 4.62 109.819 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -93.9 155.37 17.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.082 -0.508 . . . . 0.33 110.627 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 11.5 tp -137.83 141.1 40.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.185 -1.413 . . . . 1.57 107.185 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -119.12 101.96 8.39 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.348 0.659 . . . . 1.04 109.43 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 57.69 31.38 20.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.96 0.904 . . . . 2.17 111.063 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.51 -19.04 55.33 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.707 -0.759 . . . . 0.61 112.74 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.7 t -88.68 140.98 28.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.44 -0.578 . . . . 1.84 109.44 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.21 117.1 2.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.741 -0.663 . . . . 1.31 111.007 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.7 tp -91.13 126.46 36.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.011 -0.737 . . . . 1.33 109.011 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -93.99 137.39 33.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.898 -0.592 . . . . 2.69 109.441 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.76 83.31 5.73 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 1.74 108.754 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -84.48 -178.41 6.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.198 -0.91 . . . . 2.07 110.706 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -58.96 -34.82 72.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.213 0.53 . . . . 1.9 111.67 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -87.43 -13.99 41.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.643 0.609 . . . . 1.89 112.643 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.19 105.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 107.304 -1.369 . . . . 1.18 107.304 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -135.94 145.95 46.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.509 -0.877 . . . . 3.62 112.025 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 m -89.7 110.21 21.12 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.912 -1.144 . . . . 1.15 107.912 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.33 113.38 26.63 Favored 'General case' 0 N--CA 1.418 -2.025 0 C-N-CA 119.325 -0.95 . . . . 2.04 109.047 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -87.74 133.84 33.78 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.831 -1.544 . . . . 0.87 106.831 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.16 164.19 19.31 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.234 -0.986 . . . . 1.7 108.949 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.82 120.5 50.36 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.779 -0.823 . . . . 3.36 108.779 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.12 128.34 30.11 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 122.635 2.223 . . . . 1.63 111.253 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.91 125.45 29.32 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.282 -0.872 . . . . 1.88 108.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.22 -27.81 62.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.0 -1.0 . . . . 2.29 113.006 -173.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.3 -9.16 42.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.047 0.388 . . . . 3.93 112.047 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -102.3 150.28 23.48 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.693 0.759 . . . . 1.89 112.248 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.5 p -105.07 7.99 34.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.991 -1.004 . . . . 1.86 108.701 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 18.1 t -112.0 133.26 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.922 -1.035 . . . . 1.19 109.668 -176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -87.56 134.86 33.55 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.685 -1.598 . . . . 2.36 106.685 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -124.3 155.68 38.25 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.009 0.433 . . . . 1.49 109.891 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.03 -171.63 43.03 Favored Glycine 0 N--CA 1.411 -3.028 0 N-CA-C 109.516 -1.434 . . . . 0.36 109.516 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 71' ' ' ARG . 39.3 t -148.03 141.26 25.12 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.004 0.43 . . . . 0.36 110.793 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.0 tp -88.65 102.23 14.76 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.282 -2.118 . . . . 1.06 105.282 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HG2' ' SG ' ' A' ' 69' ' ' CYS . 85.2 mtm-85 -102.37 129.2 48.77 Favored 'General case' 0 CA--C 1.48 -1.745 0 C-N-CA 119.203 -0.999 . . . . 3.22 110.857 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 23' ' ' TRP . 62.8 mt -86.24 108.47 18.39 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.561 -1.644 . . . . 1.78 106.561 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -67.64 -47.07 70.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 114.691 -1.141 . . . . 2.42 109.011 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -128.12 110.07 19.87 Favored Pre-proline 0 N--CA 1.421 -1.882 0 N-CA-C 106.439 -1.689 . . . . 3.22 106.439 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 35.1 Cg_endo -68.83 130.54 20.69 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 121.607 1.538 . . . . 1.62 111.275 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.6 p -123.96 171.99 9.29 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.57 -0.741 . . . . 1.75 109.632 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -72.46 -8.54 55.59 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.452 0.538 . . . . 2.61 112.452 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.89 -9.54 11.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.394 0.616 . . . . 1.77 110.422 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.647 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.1 m120 -90.12 27.12 1.69 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.711 0.767 . . . . 2.19 110.467 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -126.57 64.96 1.26 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.016 -1.105 . . . . 2.08 108.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.06 -158.55 11.52 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.525 -0.845 . . . . 0.59 112.234 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -96.55 129.22 43.98 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.377 -0.231 . . . . 2.28 110.377 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.647 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 52.6 m-85 -116.64 117.75 30.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.035 0.445 . . . . 1.03 110.427 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.1 m -100.47 136.07 40.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.238 -0.653 . . . . 1.13 109.238 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' SER . 49.3 tp -103.29 114.21 28.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.187 -0.672 . . . . 1.07 109.187 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' A' ' 95' ' ' SER . 2.8 mm? -100.63 116.41 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.145 -1.057 . . . . 1.15 108.145 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -113.72 120.98 42.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.948 -1.13 . . . . 1.11 107.948 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.64 50.67 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.872 -0.331 . . . . 1.34 111.549 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -141.12 175.25 3.18 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.34 -1.355 . . . . 1.61 107.34 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -47.08 -29.77 9.23 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.851 2.368 . . . . 1.33 115.035 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.6 m -71.6 -41.23 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.073 0.463 . . . . 1.1 111.769 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.21 -162.76 35.05 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.571 -0.824 . . . . 0.71 111.051 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 62.4 tt0 -132.47 131.32 41.57 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.857 -0.423 . . . . 1.83 109.857 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.76 150.19 27.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.734 -0.839 . . . . 1.16 108.734 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.0 p -142.8 120.78 12.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.771 0.32 . . . . 0.88 111.831 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.34 147.92 45.04 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.542 -1.281 . . . . 1.09 107.542 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -118.46 123.88 46.25 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 118.002 0.364 . . . . 1.7 111.164 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.92 120.22 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.974 -1.121 . . . . 1.38 107.974 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.53 128.74 39.79 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.288 -1.004 . . . . 1.67 108.288 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.75 116.91 30.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.875 0.369 . . . . 1.26 110.583 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.11 101.4 12.86 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.355 0.598 . . . . 1.4 109.414 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 20.3 t80 . . . . . 0 C--N 1.303 -1.413 0 CA-C-N 115.29 -0.868 . . . . 4.75 112.501 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.397 -3.077 0 CA-C-O 122.2 1.0 . . . . 2.01 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.479 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 67.1 m-85 -81.48 109.96 16.43 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 105.775 -1.935 . . . . 1.61 105.775 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.3 t -84.0 175.59 9.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.228 -1.027 . . . . 1.32 108.228 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.71 126.37 39.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 112.852 0.686 . . . . 1.15 112.852 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -123.82 139.13 54.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.515 -1.291 . . . . 1.67 107.515 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.36 114.41 46.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.583 -0.525 . . . . 1.11 109.583 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -111.42 116.72 31.4 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.967 -0.56 . . . . 2.66 110.791 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.7 mt -102.71 156.34 17.7 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.277 -0.874 . . . . 1.08 109.16 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -131.82 153.01 50.59 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.344 -0.613 . . . . 1.34 109.344 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -58.85 137.38 57.8 Favored 'General case' 0 N--CA 1.425 -1.724 0 O-C-N 124.909 1.38 . . . . 1.24 108.728 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 143.03 56.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.19 -0.67 . . . . 1.07 109.19 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.62 129.85 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.52 0.676 . . . . 1.21 110.146 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.73 91.75 4.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.724 -1.125 . . . . 2.52 112.514 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -154.43 -178.32 7.07 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.084 -1.821 . . . . 1.33 106.084 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -71.93 -28.64 63.61 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 120.554 1.525 . . . . 3.4 110.499 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.43 100.96 13.44 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.554 -1.276 . . . . 3.18 107.554 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -81.89 99.55 9.12 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.837 0.827 . . . . 1.0 110.22 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.6 t -103.05 123.05 45.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.717 -1.583 . . . . 0.34 109.123 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.87 99.97 25.23 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.426 -1.324 . . . . 1.07 107.426 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.29 132.72 18.23 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.361 2.041 . . . . 0.32 112.58 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -128.35 149.9 50.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.232 0.539 . . . . 0.42 109.869 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -136.61 112.68 9.7 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.229 -1.026 . . . . 1.29 108.229 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 66' ' ' ARG . 2.7 p -110.83 119.23 59.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.825 -0.805 . . . . 1.08 108.825 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 25.0 t70 -101.0 132.05 46.59 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.243 -1.021 . . . . 1.39 108.243 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.83 131.66 1.28 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 109.387 -1.485 . . . . 0.6 109.387 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -75.64 -54.77 2.19 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.629 -0.508 . . . . 3.29 109.629 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 19.7 Cg_endo -63.11 120.42 7.89 Favored 'Trans proline' 0 C--N 1.379 2.163 0 N-CA-C 107.384 -1.814 . . . . 1.09 107.384 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.0 12.52 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.193 -0.458 . . . . 1.36 111.807 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.436 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 87.4 Cg_endo -76.64 149.69 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.11 1.874 . . . . 0.56 111.698 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -76.13 109.37 9.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.567 -0.901 . . . . 1.74 108.567 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.36 125.68 34.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.876 0.37 . . . . 1.14 110.953 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -135.52 130.95 35.39 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.223 -0.444 . . . . 4.62 110.11 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -90.97 131.56 36.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.749 -0.659 . . . . 0.33 109.734 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -104.88 127.03 52.55 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 105.247 -2.131 . . . . 1.57 105.247 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.29 109.54 16.97 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 122.662 0.385 . . . . 1.04 110.254 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.8 t30 51.35 52.36 14.96 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.344 1.028 . . . . 2.17 110.58 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.73 51.01 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 114.541 -1.209 . . . . 0.61 114.179 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -122.7 161.27 24.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.862 -0.792 . . . . 1.84 108.862 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.78 117.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 115.338 -0.846 . . . . 1.31 110.416 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.64 98.53 9.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.076 -0.65 . . . . 1.33 110.085 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -84.62 95.64 8.94 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 103.951 -2.611 . . . . 2.69 103.951 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.99 125.54 23.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.875 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.5 p -103.9 -165.44 1.15 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.14 -0.936 . . . . 2.07 111.852 -172.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -84.49 -9.93 57.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.906 0.86 . . . . 1.9 108.876 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -89.02 -39.7 13.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.417 -0.81 . . . . 1.89 109.094 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mt -127.48 106.38 15.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.755 -1.572 . . . . 1.18 106.755 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -131.39 150.37 52.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 119.608 -0.837 . . . . 3.62 112.728 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 m -92.55 110.51 21.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.716 -1.129 . . . . 1.15 110.105 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.48 113.11 23.73 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.693 -0.854 . . . . 2.04 108.693 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.54 138.03 31.81 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.544 0.687 . . . . 0.87 110.687 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.71 136.67 40.21 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.055 -0.975 . . . . 1.7 109.606 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -68.52 112.84 12.36 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 124.802 1.314 . . . . 3.36 111.983 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.33 155.06 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.197 2.598 . . . . 1.63 110.172 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.09 19.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 119.097 -0.478 . . . . 1.88 109.74 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.03 85.09 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 118.724 0.693 . . . . 2.29 112.695 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.07 -2.67 58.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.173 1.175 . . . . 3.93 114.173 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -101.17 157.59 16.66 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.592 -0.843 . . . . 1.89 108.825 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 p -112.4 15.93 20.08 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.834 0.349 . . . . 1.86 111.697 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.12 124.57 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 119.967 -0.693 . . . . 1.19 110.363 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HB2' HG12 ' A' ' 29' ' ' VAL . 78.0 mtp180 -95.73 116.59 29.1 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 105.665 -1.976 . . . . 2.36 105.665 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -98.73 149.5 22.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.181 -1.044 . . . . 1.49 108.181 -174.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.01 174.96 46.01 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 119.338 -1.41 . . . . 0.36 112.388 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -144.76 132.66 21.3 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.471 0.708 . . . . 0.36 109.929 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -88.44 113.18 23.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.644 -1.984 . . . . 1.06 105.644 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -107.34 123.37 48.24 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.131 0.491 . . . . 3.22 111.596 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.79 108.37 17.44 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 106.567 -1.642 . . . . 1.78 106.567 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -73.4 -52.94 12.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.071 -0.968 . . . . 2.42 109.059 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.0 101.23 51.25 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.56 -1.274 . . . . 3.22 107.56 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.04 129.47 18.41 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.688 1.592 . . . . 1.62 110.331 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 p -138.62 168.88 18.83 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.138 -1.06 . . . . 1.75 108.138 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -76.13 -6.01 49.24 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 122.243 -0.286 . . . . 2.61 111.479 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.44 -21.41 10.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 109.212 -0.662 . . . . 1.77 109.212 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.27 -10.6 59.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.657 0.741 . . . . 2.19 109.799 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 11.2 t30 -83.57 75.97 9.99 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.23 -1.396 . . . . 2.08 107.23 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.55 -171.58 27.78 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.21 -0.905 . . . . 0.59 111.533 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.29 128.23 38.06 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.42 0.526 . . . . 2.28 112.42 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.47 123.09 48.54 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 61.7 m -115.42 128.99 56.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.19 -0.671 . . . . 1.13 109.19 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.1 tp -99.61 114.59 27.73 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.1 -0.704 . . . . 1.07 109.1 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.14 131.01 50.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.157 -1.053 . . . . 1.15 108.157 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -121.14 119.04 31.23 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.916 -1.142 . . . . 1.11 107.916 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.16 130.4 46.29 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.235 -0.439 . . . . 1.34 110.045 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 42.9 t-20 -155.63 136.36 8.92 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.411 -1.329 . . . . 1.61 107.411 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.12 -17.11 23.81 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.968 3.112 . . . . 1.33 113.352 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.87 -22.49 45.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 1.1 109.537 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.46 146.9 4.51 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.971 -1.252 . . . . 0.71 109.971 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -90.94 135.34 33.8 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.639 -0.504 . . . . 1.83 109.639 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -114.85 151.67 33.5 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.06 -1.089 . . . . 1.16 108.06 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.9 p -160.33 148.96 16.9 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.103 0.478 . . . . 0.88 111.824 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.04 156.97 44.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.365 -1.346 . . . . 1.09 107.365 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -133.4 132.38 41.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.175 -0.676 . . . . 1.7 109.175 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 133.14 41.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.808 -0.812 . . . . 1.38 108.808 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 48.2 ttm -108.95 125.78 52.39 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.877 -0.514 . . . . 1.67 109.7 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -98.05 113.67 25.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.524 -0.917 . . . . 1.26 108.524 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.26 100.16 12.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.014 -0.735 . . . . 1.4 109.014 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 36.0 t80 . . . . . 0 C--N 1.3 -1.552 0 CA-C-N 114.828 -1.078 . . . . 4.75 111.831 177.626 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.414 -2.273 0 CA-C-O 121.494 0.664 . . . . 2.01 109.257 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -87.13 129.2 35.03 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.272 -1.01 . . . . 1.61 108.272 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.84 -179.94 7.41 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.322 -0.992 . . . . 1.32 108.322 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.22 117.64 30.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 CA-C-O 121.217 0.532 . . . . 1.15 110.345 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -118.44 134.48 55.03 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 107.039 -1.467 . . . . 1.67 107.039 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.4 t -122.99 119.16 57.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 120.939 -0.305 . . . . 1.11 110.906 -173.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -119.15 117.74 29.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.547 0.689 . . . . 2.66 110.505 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 98' ' ' ILE . 40.8 mt -100.37 157.15 16.83 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.048 -0.978 . . . . 1.08 111.053 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -130.93 144.52 51.53 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.178 -1.045 . . . . 1.34 108.178 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -67.91 137.77 55.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.631 -0.878 . . . . 1.24 108.631 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -47.25 137.82 7.78 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.27 1.028 . . . . 1.07 111.884 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.65 138.35 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.574 -0.739 . . . . 1.21 111.06 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.54 89.43 0.36 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.205 -1.362 . . . . 2.52 112.316 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -150.17 178.52 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.376 -1.342 . . . . 1.33 107.376 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -66.19 -46.46 77.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 119.028 0.831 . . . . 3.4 111.091 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -91.7 128.84 37.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.707 -0.849 . . . . 3.18 108.707 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -82.6 120.37 25.45 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.918 0.866 . . . . 1.0 112.545 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 40.5 t -120.51 121.4 38.37 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.263 -1.335 . . . . 0.34 109.684 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 68.5 mt -102.43 97.64 9.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 107.844 -1.169 . . . . 1.07 107.844 174.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.04 135.54 32.44 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.345 2.03 . . . . 0.32 111.913 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -128.7 149.34 50.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.311 0.577 . . . . 0.42 110.575 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.0 m -131.49 112.21 12.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.318 -0.856 . . . . 1.29 108.76 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.9 124.74 71.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.837 -0.62 . . . . 1.08 109.721 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t0 -101.17 144.07 30.49 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.22 -1.029 . . . . 1.39 108.22 -176.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 158.52 8.67 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 111.43 -0.668 . . . . 0.6 111.43 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -99.94 -58.02 0.13 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-O 118.916 -0.564 . . . . 3.29 110.902 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.0 125.07 17.48 Favored 'Trans proline' 0 C--N 1.366 1.49 0 N-CA-C 108.064 -1.552 . . . . 1.09 108.064 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 115.69 19.73 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-O 120.988 0.423 . . . . 1.36 111.768 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.63 142.45 10.34 Favored 'Trans proline' 0 N--CA 1.424 -2.585 0 C-N-CA 121.515 1.477 . . . . 0.56 110.748 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 m -75.28 105.39 6.28 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.919 -1.141 . . . . 1.74 107.919 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.06 116.92 18.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.327 0.584 . . . . 1.14 110.019 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -129.3 130.2 45.85 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.222 -0.899 . . . . 4.62 109.735 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 90.3 m95 -100.09 140.29 34.53 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.091 -0.707 . . . . 0.33 109.091 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 tp -119.56 127.72 53.26 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 105.957 -1.868 . . . . 1.57 105.957 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -121.82 109.41 14.63 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.983 -0.377 . . . . 1.04 109.983 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.08 29.62 17.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.005 0.907 . . . . 2.17 109.967 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.41 60.14 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.309 -0.859 . . . . 0.61 112.62 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.0 t -93.18 142.59 27.13 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.969 -0.752 . . . . 1.84 108.969 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.45 111.01 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.685 -0.688 . . . . 1.31 110.3 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.42 97.53 9.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.374 -0.83 . . . . 1.33 109.23 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.59 127.43 34.06 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.174 -1.417 . . . . 2.69 107.174 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.32 120.45 10.45 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 123.923 0.764 . . . . 1.74 110.659 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.0 p -106.67 -167.39 1.28 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.878 -0.601 . . . . 2.07 109.827 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -80.96 -16.86 52.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.789 -0.819 . . . . 1.9 108.789 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.75 -41.7 11.11 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.102 -0.499 . . . . 1.89 110.438 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.405 HD12 ' ND2' ' A' ' 79' ' ' ASN . 22.6 mt -124.41 106.29 16.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.382 -1.71 . . . . 1.18 106.382 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -130.39 141.93 50.53 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.901 -0.72 . . . . 3.62 111.248 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -83.31 109.97 17.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.896 -0.779 . . . . 1.15 108.896 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 71' ' ' ARG . 42.3 mt-10 -109.9 155.33 21.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.3 0.571 . . . . 2.04 110.222 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.88 151.31 40.82 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 107.749 -1.204 . . . . 0.87 107.749 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -108.82 166.15 11.03 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.251 -1.759 . . . . 1.7 106.251 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -50.94 102.88 0.33 Allowed Pre-proline 0 N--CA 1.473 0.725 0 O-C-N 123.957 0.785 . . . . 3.36 110.367 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.04 129.45 2.01 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.571 2.181 . . . . 1.63 113.411 -173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 121.11 15.26 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.347 -0.842 . . . . 1.88 109.828 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.08 -4.83 59.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.061 0.457 . . . . 2.29 109.896 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -63.72 -39.33 94.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.697 -1.224 . . . . 3.93 107.697 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.99 163.74 12.03 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.84 -1.073 . . . . 1.89 108.375 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.2 p -94.96 23.63 5.43 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.655 0.264 . . . . 1.86 111.383 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.1 t -116.88 129.47 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-O 121.178 0.514 . . . . 1.19 110.749 -175.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -91.74 132.4 36.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.906 -1.516 . . . . 2.36 106.906 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.19 128.05 56.36 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.451 -0.574 . . . . 1.49 109.451 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.58 -169.06 17.45 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 111.068 -0.813 . . . . 0.36 111.068 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.1 t -152.0 133.3 14.48 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 120.92 0.391 . . . . 0.36 110.81 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 46.3 tp -84.61 90.78 7.75 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 104.747 -2.316 . . . . 1.06 104.747 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 55' ' ' GLU . 50.1 ttp180 -95.87 120.94 37.03 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 115.595 -0.729 . . . . 3.22 109.734 -176.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.35 108.6 17.9 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.862 -1.532 . . . . 1.78 106.862 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.74 -40.18 91.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.759 -1.564 . . . . 2.42 110.64 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -128.69 101.42 20.69 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.813 -0.81 . . . . 3.22 108.813 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.59 130.41 14.81 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.357 2.038 . . . . 1.62 112.458 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 p -139.39 165.13 28.03 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.958 -1.127 . . . . 1.75 107.958 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -76.82 -5.66 49.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.285 0.846 . . . . 2.61 113.285 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.54 -11.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.089 0.471 . . . . 1.77 109.791 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' ND2' HD12 ' A' ' 52' ' ' ILE . 12.6 m120 -92.52 26.49 2.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.571 0.701 . . . . 2.19 110.038 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.606 ' OD1' ' HA ' ' A' ' 101' ' ' ALA . 17.6 t30 -117.51 114.8 23.99 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.344 -0.984 . . . . 2.08 108.344 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.76 -159.2 32.19 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.521 -0.847 . . . . 0.59 112.378 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -88.3 118.01 27.61 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.671 0.388 . . . . 2.28 111.657 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 98' ' ' ILE . 57.0 m-85 -106.8 137.56 44.6 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.588 -0.893 . . . . 1.03 108.588 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 m -137.72 133.89 34.7 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.792 -0.818 . . . . 1.13 108.792 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 39' ' ' TRP . 53.0 tp -106.11 120.68 42.42 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 109.736 -0.468 . . . . 1.07 109.736 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.42 133.41 51.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.339 -0.986 . . . . 1.15 108.339 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.66 121.18 25.09 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.999 -1.111 . . . . 1.11 107.999 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.59 132.53 53.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.024 0.202 . . . . 1.34 110.507 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 31.9 p30 -148.33 173.61 4.07 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-O 117.965 -1.017 . . . . 1.61 108.722 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 17.3 Cg_exo -41.57 -32.29 1.4 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.742 2.961 . . . . 1.33 116.318 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.8 t -81.85 -33.41 30.67 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.698 -0.626 . . . . 1.1 111.735 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.15 -161.94 35.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.563 -1.303 . . . . 0.71 112.825 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.25 133.38 47.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.805 -0.813 . . . . 1.83 108.805 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.27 154.35 29.25 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.656 -0.868 . . . . 1.16 108.656 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 p -149.5 123.77 9.57 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 123.72 0.637 . . . . 0.88 111.256 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.22 149.8 48.8 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.229 -1.397 . . . . 1.09 107.229 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.8 p -118.63 147.99 43.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.638 . . . . 1.7 112.598 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -140.59 118.88 10.28 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 C-N-CA 124.767 1.227 . . . . 1.38 109.041 177.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.435 ' N ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -101.88 100.75 11.1 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.389 -1.708 . . . . 1.67 106.389 179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.77 113.47 26.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.656 0.741 . . . . 1.26 111.007 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.606 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -105.13 104.98 14.82 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.566 -1.197 . . . . 1.4 108.611 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 C--N 1.308 -1.225 0 C-N-CA 120.304 -0.558 . . . . 4.75 110.791 179.676 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.413 -2.283 0 N-CA-C 108.49 -0.929 . . . . 2.01 108.49 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.549 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 27.6 m-85 -75.06 121.4 21.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.3 -1.371 . . . . 1.61 107.3 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -83.95 -174.16 5.13 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.154 -1.054 . . . . 1.32 108.154 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.36 118.35 30.83 Favored 'General case' 0 CA--C 1.474 -1.942 0 C-N-CA 119.128 -1.029 . . . . 1.15 109.652 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.1 m -116.67 130.66 56.86 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.789 -1.096 . . . . 1.67 108.569 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.68 119.5 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.331 -0.395 . . . . 1.11 111.379 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -115.11 120.41 39.71 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.162 -0.681 . . . . 2.66 109.162 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 27' ' ' PHE . 33.5 mt -98.41 155.13 17.39 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 109.589 -0.522 . . . . 1.08 109.589 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.67 147.18 52.49 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.917 -1.142 . . . . 1.34 107.917 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 m -60.96 131.72 51.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 124.118 0.886 . . . . 1.24 109.41 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.36 139.27 19.74 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.403 1.064 . . . . 1.07 111.44 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.9 140.98 15.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.515 0.674 . . . . 1.21 110.137 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.72 102.33 11.46 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.346 -1.297 . . . . 2.52 111.731 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -145.12 -167.47 2.68 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.106 -1.442 . . . . 1.33 107.106 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -77.93 -49.46 14.12 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.843 -1.54 . . . . 3.4 106.843 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -89.82 120.13 30.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.554 -1.276 . . . . 3.18 107.554 172.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.62 134.25 35.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.106 0.479 . . . . 1.0 111.05 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.7 t -125.99 126.07 43.71 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.214 -0.903 . . . . 0.34 110.555 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.33 102.75 22.64 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.149 -1.426 . . . . 1.07 107.149 173.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.14 138.8 23.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.251 1.967 . . . . 0.32 111.558 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 50.3 p90 -133.29 144.27 49.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.871 0.367 . . . . 0.42 110.731 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -121.59 106.24 11.18 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.447 -0.945 . . . . 1.29 108.447 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 66' ' ' ARG . 3.0 p -114.33 117.86 56.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.684 -0.858 . . . . 1.08 108.684 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -117.79 156.92 27.49 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.301 -0.56 . . . . 1.39 109.491 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 149.38 5.31 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 108.323 -1.911 . . . . 0.6 108.323 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -86.47 -53.54 0.42 Allowed Pre-proline 0 C--N 1.311 -1.095 0 C-N-CA 118.857 -1.137 . . . . 3.29 110.857 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 14.2 Cg_endo -62.75 119.31 6.34 Favored 'Trans proline' 0 C--N 1.373 1.824 0 N-CA-C 107.439 -1.793 . . . . 1.09 107.439 167.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.11 118.7 61.28 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 115.475 -0.784 . . . . 1.36 112.156 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -86.84 160.33 8.98 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.108 1.872 . . . . 0.56 112.398 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -96.99 138.19 34.9 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.235 -1.024 . . . . 1.74 108.235 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 29' ' ' VAL . 95.1 mt -101.33 134.63 44.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.185 0.517 . . . . 1.14 111.526 -175.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -136.75 131.34 33.3 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.483 -0.781 . . . . 4.62 110.248 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -97.34 138.54 34.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.873 -0.603 . . . . 0.33 110.647 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -129.8 137.04 50.28 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.716 -1.957 . . . . 1.57 105.716 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.45 119.68 20.94 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.962 -0.385 . . . . 1.04 109.962 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 60.06 26.34 15.67 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.24 1.019 . . . . 2.17 110.885 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.28 82.15 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.61 112.252 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 p -108.26 150.86 26.72 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.012 0.434 . . . . 1.84 110.391 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.45 114.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.436 -0.802 . . . . 1.31 112.148 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.38 122.1 32.95 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.936 -1.135 . . . . 1.33 107.936 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.41 137.11 40.18 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.01 -0.541 . . . . 2.69 110.029 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.52 121.03 12.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -138.09 -163.99 1.55 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 120.455 -0.498 . . . . 2.07 110.715 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -64.56 -49.89 69.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.631 0.604 . . . . 1.9 112.631 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -84.87 -31.76 23.58 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 1.89 112.013 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 79' ' ' ASN . 21.0 mt -114.42 106.66 21.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.705 -1.591 . . . . 1.18 106.705 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.23 154.21 50.22 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.542 0.687 . . . . 3.62 111.369 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -95.14 129.3 42.29 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.311 -0.859 . . . . 1.15 109.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -123.13 129.39 51.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.032 -1.47 . . . . 2.04 107.032 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.58 120.84 37.63 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.625 -0.509 . . . . 0.87 109.625 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.15 153.84 27.03 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.548 . . . . 1.7 106.822 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.56 102.05 0.29 Allowed Pre-proline 0 C--N 1.313 -0.998 0 C-N-CA 125.901 1.68 . . . . 3.36 114.0 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -88.91 146.71 5.62 Favored 'Trans proline' 0 C--O 1.264 1.79 0 C-N-CA 122.135 1.89 . . . . 1.63 110.383 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.464 ' HB1' ' HG3' ' A' ' 63' ' ' GLU . . . -84.97 155.08 21.76 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.255 -1.017 . . . . 1.88 108.255 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.54 -22.1 61.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.417 -0.811 . . . . 2.29 112.448 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.17 -2.29 43.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.425 0.528 . . . . 3.93 112.425 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 54.8 mt-10 -83.04 136.84 34.35 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 109.112 -0.699 . . . . 1.89 109.112 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -103.72 27.83 7.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.827 1.298 . . . . 1.86 108.157 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 129.42 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.2 -1.364 . . . . 1.19 108.087 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HB3' HG12 ' A' ' 29' ' ' VAL . 37.2 ttm180 -93.86 119.12 32.38 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.934 -1.506 . . . . 2.36 106.934 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -98.39 115.41 28.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.345 -0.983 . . . . 1.49 108.345 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 27' ' ' PHE . . . -133.22 166.0 23.88 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.157 -1.497 . . . . 0.36 113.517 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 t -139.88 131.93 27.91 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.541 0.736 . . . . 0.36 109.748 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.0 tp -96.39 103.44 15.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.518 -2.03 . . . . 1.06 105.518 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -108.12 127.91 54.22 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.783 0.801 . . . . 3.22 111.539 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.67 109.43 21.12 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.462 -1.245 . . . . 1.78 108.744 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -66.42 -36.39 82.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.554 -1.203 . . . . 2.42 109.677 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -134.48 101.35 12.09 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 108.021 -1.103 . . . . 3.22 108.021 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.21 130.75 11.32 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.257 1.971 . . . . 1.62 110.329 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -117.56 169.94 9.15 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.684 -0.487 . . . . 1.75 109.684 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -76.27 -7.01 53.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.655 0.613 . . . . 2.61 112.655 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.59 -9.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.503 -0.555 . . . . 1.77 109.503 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.433 HD22 HD12 ' A' ' 52' ' ' ILE . 10.8 m120 -99.59 26.85 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.401 0.68 . . . . 2.19 110.105 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -111.42 100.21 8.84 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.785 -0.82 . . . . 2.08 108.785 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.81 -157.61 30.17 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.335 -1.412 . . . . 0.59 113.85 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.53 118.73 30.21 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.355 0.662 . . . . 2.28 112.293 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.13 127.29 46.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.828 -1.078 . . . . 1.03 108.316 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 29.4 m -117.69 127.22 53.72 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 108.886 -0.783 . . . . 1.13 108.886 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.2 tp -103.39 125.71 50.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.645 -0.502 . . . . 1.07 109.645 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -108.45 129.34 55.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 124.178 0.924 . . . . 1.15 108.794 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.78 121.6 35.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.288 -1.375 . . . . 1.11 107.288 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.49 54.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 112.508 0.558 . . . . 1.34 112.508 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -141.25 162.96 44.87 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.986 -1.487 . . . . 1.61 106.986 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -47.55 -29.68 10.84 Favored 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 122.716 2.278 . . . . 1.33 114.775 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.63 -29.26 64.45 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.008 -0.432 . . . . 1.1 111.804 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.93 165.88 21.86 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.787 -1.197 . . . . 0.71 112.557 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.34 122.5 47.12 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.713 -1.217 . . . . 1.83 107.713 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.64 145.94 28.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.944 -0.762 . . . . 1.16 108.944 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 35.0 p -138.05 138.82 39.17 Favored 'General case' 0 N--CA 1.416 -2.161 0 O-C-N 123.669 0.606 . . . . 0.88 109.837 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.34 155.7 47.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.246 -1.391 . . . . 1.09 107.246 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 p -127.75 143.1 51.15 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.654 0.264 . . . . 1.7 111.686 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.58 131.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.804 -1.924 . . . . 1.38 105.804 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 ttt -112.32 107.5 16.35 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.81 -0.756 . . . . 1.67 109.202 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.37 126.48 55.41 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.292 0.568 . . . . 1.26 111.575 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.05 103.39 15.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.188 -0.915 . . . . 1.4 108.689 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 C--N 1.314 -0.974 0 C-N-CA 120.381 -0.528 . . . . 4.75 110.795 177.872 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.392 -3.337 0 N-CA-C 107.037 -1.468 . . . . 2.01 107.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.489 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 65.2 m-85 -68.1 134.52 50.71 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.67 -1.233 . . . . 1.61 107.67 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.58 -174.81 5.5 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.572 -1.27 . . . . 1.32 107.572 -174.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.17 121.89 34.99 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 119.788 -0.765 . . . . 1.15 109.462 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -125.13 135.05 52.28 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.764 -1.199 . . . . 1.67 107.764 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.54 119.11 57.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.94 0.4 . . . . 1.11 111.435 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -118.08 116.56 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.952 -0.759 . . . . 2.66 108.952 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.7 mt -98.13 155.95 16.9 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.263 -0.643 . . . . 1.08 109.263 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -130.86 153.92 48.61 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.783 -1.192 . . . . 1.34 107.783 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.0 m -59.32 133.64 56.28 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 124.729 1.268 . . . . 1.24 110.62 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 151.78 45.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.417 -0.81 . . . . 1.07 109.152 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.98 126.73 44.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.689 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HA ' ' CZ3' ' A' ' 23' ' ' TRP . 28.0 mm-40 -72.24 88.83 1.16 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.998 -1.001 . . . . 2.52 110.565 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.28 -178.86 7.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.674 -0.862 . . . . 1.33 108.674 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -61.82 -42.52 99.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.577 0.626 . . . . 3.4 112.067 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.08 109.11 21.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.992 -1.114 . . . . 3.18 107.992 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 92.1 m95 -82.27 106.97 14.59 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.306 0.574 . . . . 1.0 111.602 -174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.0 t -104.48 116.97 33.03 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.574 -1.194 . . . . 0.34 109.023 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.1 mt -102.84 100.14 15.75 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 107.858 -1.164 . . . . 1.07 107.858 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -73.41 130.02 14.53 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.258 1.972 . . . . 0.32 111.738 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -122.3 155.75 35.28 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.209 0.528 . . . . 0.42 110.522 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -138.24 106.98 5.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.462 -0.94 . . . . 1.29 108.462 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.28 117.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.059 0.457 . . . . 1.08 110.008 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.9 t70 -101.91 136.97 40.83 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.946 -0.57 . . . . 1.39 110.461 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.08 150.6 7.95 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.363 -1.095 . . . . 0.6 110.363 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -58.79 0.41 Allowed Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 107.322 -1.362 . . . . 3.29 107.322 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 38.0 Cg_endo -71.97 120.98 7.19 Favored 'Trans proline' 0 C--N 1.369 1.607 0 N-CA-C 108.173 -1.51 . . . . 1.09 108.173 168.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.7 113.63 8.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 1.36 111.065 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.48 142.43 14.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.452 2.101 . . . . 0.56 111.734 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 p -69.47 127.77 34.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.631 -0.713 . . . . 1.74 110.019 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.3 mt -98.94 126.16 44.55 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.88 -0.6 . . . . 1.14 111.069 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -131.85 127.59 36.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.88 -0.6 . . . . 4.62 110.176 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.0 m95 -92.91 126.95 38.24 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.33 110.312 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.94 126.92 54.52 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.677 -1.601 . . . . 1.57 106.677 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -115.74 102.97 10.21 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.177 -0.675 . . . . 1.04 109.177 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 54.15 40.42 31.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.055 0.942 . . . . 2.17 112.101 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.1 84.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.671 -0.695 . . . . 0.61 113.689 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -114.04 136.94 52.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 117.449 0.624 . . . . 1.84 109.716 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.77 121.06 13.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.217 -0.447 . . . . 1.31 110.266 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 tp -82.27 137.82 34.75 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.451 -1.315 . . . . 1.33 107.451 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -109.21 121.22 44.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 123.354 0.409 . . . . 2.69 110.229 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 119.64 13.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.868 -0.79 . . . . 1.74 108.868 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -150.06 -174.03 4.61 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.828 -0.804 . . . . 2.07 108.828 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 t -70.73 3.68 3.02 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 112.932 0.715 . . . . 1.9 112.932 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.16 -28.39 9.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.871 -0.518 . . . . 1.89 109.921 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -149.02 108.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.894 -1.15 . . . . 1.18 107.894 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -135.59 156.28 49.12 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.785 0.661 . . . . 3.62 112.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -100.31 110.43 22.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.293 -0.867 . . . . 1.15 110.421 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.34 146.26 24.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.78 -0.822 . . . . 2.04 108.78 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.07 156.88 32.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.314 -0.624 . . . . 0.87 109.314 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.26 160.35 29.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.422 -1.325 . . . . 1.7 107.422 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -71.68 120.28 79.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 113.916 1.08 . . . . 3.36 113.916 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.53 145.1 29.31 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 123.198 2.599 . . . . 1.63 111.071 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.54 162.0 16.65 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.485 -0.932 . . . . 1.88 108.485 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.75 -11.38 60.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.931 0.715 . . . . 2.29 112.931 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -91.19 3.31 55.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.167 0.984 . . . . 3.93 108.517 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 151.7 48.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.062 -0.972 . . . . 1.89 108.956 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -120.29 23.88 10.69 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.498 -1.667 . . . . 1.86 106.498 165.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 15.1 t -99.76 123.48 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 113.303 -1.771 . . . . 1.19 109.526 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -89.01 116.32 27.21 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.173 -1.788 . . . . 2.36 106.173 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -101.2 137.88 38.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.45 -170.39 30.33 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 120.19 -1.005 . . . . 0.36 111.046 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.9 t -150.41 132.48 15.29 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 120.874 0.368 . . . . 0.36 110.841 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.6 tp -90.13 111.82 23.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.301 -2.111 . . . . 1.06 105.301 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 10.1 ptp180 -114.09 128.91 56.59 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.046 -1.062 . . . . 3.22 112.49 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.84 107.09 18.79 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 105.455 -2.054 . . . . 1.78 105.455 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -80.81 -35.26 33.25 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.234 -0.439 . . . . 2.42 110.524 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.47 99.79 51.48 Favored Pre-proline 0 N--CA 1.421 -1.909 0 N-CA-C 108.172 -1.048 . . . . 3.22 108.172 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -84.13 143.09 10.1 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 122.229 1.953 . . . . 1.62 111.411 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -136.82 160.93 37.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.108 -1.071 . . . . 1.75 108.108 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.71 -6.89 2.89 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.963 1.097 . . . . 2.61 113.963 -173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.86 -9.93 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.797 0.332 . . . . 1.77 110.572 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -77.86 8.92 3.98 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.643 0.979 . . . . 2.19 113.643 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -91.4 88.56 6.88 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.393 -1.706 . . . . 2.08 106.393 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.65 -171.29 27.51 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.458 -1.83 . . . . 0.59 114.536 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -98.88 103.79 15.78 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.051 0.94 . . . . 2.28 110.611 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -93.3 105.96 17.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.0 m -103.93 125.94 50.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.239 -0.652 . . . . 1.13 109.239 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.5 tp -100.6 118.28 36.45 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.009 -0.737 . . . . 1.07 109.009 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 130.38 47.21 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.46 -0.941 . . . . 1.15 108.46 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 121.11 28.74 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.557 -1.275 . . . . 1.11 107.557 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.47 130.78 44.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 123.399 0.437 . . . . 1.34 110.504 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -134.9 171.27 9.28 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.415 -1.328 . . . . 1.61 107.415 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.41 -30.11 19.76 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.448 2.099 . . . . 1.33 114.145 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.83 -50.99 37.41 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 111.747 0.277 . . . . 1.1 111.747 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.92 45.22 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.452 -1.356 . . . . 0.71 112.933 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -123.55 133.09 54.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.928 0.428 . . . . 1.83 110.345 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.244 -1.021 . . . . 1.16 108.244 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 31.9 p -144.96 138.84 27.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 109.583 -0.525 . . . . 0.88 109.583 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.72 152.36 47.92 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.384 -1.339 . . . . 1.09 107.384 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 m -131.48 141.32 49.75 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.597 -0.441 . . . . 1.7 111.134 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.34 123.96 39.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 106.441 -1.689 . . . . 1.38 106.441 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -103.88 98.87 8.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.243 -0.651 . . . . 1.67 109.243 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.89 27.28 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.416 -0.811 . . . . 1.26 110.645 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.17 143.33 42.08 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.935 -1.135 . . . . 1.4 107.935 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 75' ' ' PRO . 19.3 t80 . . . . . 0 C--N 1.29 -1.988 0 N-CA-C 112.662 0.616 . . . . 4.75 112.662 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.401 -2.896 0 CA-C-O 121.662 0.744 . . . . 2.01 111.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.454 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 p90 -130.38 134.54 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.721 -1.127 . . . . 1.61 108.993 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 73.0 m -84.17 -166.19 1.36 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.57 -0.741 . . . . 1.32 111.93 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.72 39.74 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.69 0.757 . . . . 1.15 112.018 -172.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -111.72 137.48 49.57 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.954 -1.499 . . . . 1.67 106.954 173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -115.6 114.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.116 -0.698 . . . . 1.11 109.116 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -108.44 116.03 31.2 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.033 -0.728 . . . . 2.66 109.033 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -98.97 151.22 21.15 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.539 -0.541 . . . . 1.08 109.539 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -131.32 148.8 52.72 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.43 -0.952 . . . . 1.34 108.43 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -56.59 136.39 54.54 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.224 1.41 . . . . 1.24 109.617 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.96 143.2 57.94 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.952 0.783 . . . . 1.07 110.61 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.81 127.58 44.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 109.485 -0.561 . . . . 1.21 109.485 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.73 116.48 16.48 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.522 -0.763 . . . . 2.52 110.567 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.2 ptt? -168.2 -177.06 3.14 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.966 -1.494 . . . . 1.33 106.966 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -71.34 -39.46 71.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 119.517 1.053 . . . . 3.4 112.208 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.409 ' O ' ' HG3' ' A' ' 20' ' ' MET . 37.5 m80 -98.59 115.14 27.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.42 -1.326 . . . . 3.18 107.42 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -81.77 137.94 35.25 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 1.0 111.953 -172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.81 120.62 21.83 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.46 -1.245 . . . . 0.34 109.144 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.9 100.0 15.46 Favored Pre-proline 0 C--O 1.247 0.96 0 N-CA-C 106.88 -1.526 . . . . 1.07 106.88 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.54 135.57 20.19 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.338 2.026 . . . . 0.32 112.084 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.33 155.85 42.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.16 -0.473 . . . . 0.42 109.833 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 m -132.58 106.32 7.75 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.768 -1.197 . . . . 1.29 107.768 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 66' ' ' ARG . 3.4 p -110.74 119.28 59.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.67 -0.863 . . . . 1.08 108.67 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -121.22 128.15 52.15 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.624 -0.716 . . . . 1.39 111.303 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.71 147.85 9.35 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.776 -1.73 . . . . 0.6 108.776 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.16 -55.96 1.69 Allowed Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.091 -0.707 . . . . 3.29 109.091 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HB2' HD22 ' A' ' 89' ' ' ASN . 25.2 Cg_endo -63.77 122.01 9.93 Favored 'Trans proline' 0 C--N 1.376 2.0 0 N-CA-C 108.283 -1.468 . . . . 1.09 108.283 169.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.35 121.76 84.31 Favored Pre-proline 0 C--N 1.298 -1.652 0 CA-C-N 115.818 -0.628 . . . . 1.36 112.166 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -90.97 167.77 3.7 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.713 2.276 . . . . 0.56 112.464 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -105.62 126.73 52.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.12 -1.067 . . . . 1.74 108.12 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.99 143.92 26.36 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.883 0.373 . . . . 1.14 111.843 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -144.54 137.99 27.21 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.595 1.158 . . . . 4.62 109.221 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -102.93 146.0 28.99 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.67 0.748 . . . . 0.33 110.871 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 19.2 tp -131.59 127.75 37.75 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.667 -1.605 . . . . 1.57 106.667 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -111.95 106.16 14.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 110.228 -0.286 . . . . 1.04 110.228 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 57.0 30.02 17.44 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.514 0.725 . . . . 2.17 111.883 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.34 64.52 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.741 -0.742 . . . . 0.61 112.086 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 m -90.48 129.85 36.6 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.629 -0.508 . . . . 1.84 109.629 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.37 117.22 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.572 -0.74 . . . . 1.31 110.342 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.0 tp -97.58 101.3 12.79 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.409 -0.814 . . . . 1.33 109.744 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -84.31 130.71 34.78 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.898 -1.519 . . . . 2.69 106.898 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.09 138.22 56.25 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.614 0.765 . . . . 1.74 111.808 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -108.21 -163.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.654 -0.703 . . . . 2.07 109.391 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -85.76 -34.65 21.13 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.849 -0.797 . . . . 1.9 108.849 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -85.2 -28.98 25.08 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.52 -0.309 . . . . 1.89 111.67 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.7 mt -117.93 106.46 19.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.911 -1.144 . . . . 1.18 107.911 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.186 0.517 . . . . 3.62 110.983 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 m -84.54 112.53 20.49 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.114 -1.069 . . . . 1.15 108.114 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.91 127.01 46.13 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.354 -0.98 . . . . 2.04 108.354 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.01 137.14 44.44 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 4.4 pp -96.47 165.79 12.01 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.675 -1.232 . . . . 1.7 107.675 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.61 107.67 2.48 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 117.783 0.265 . . . . 3.36 111.383 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 44.1 Cg_endo -89.41 169.39 4.91 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.662 2.908 . . . . 1.63 111.238 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.95 139.48 30.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.274 -1.38 . . . . 1.88 107.274 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.94 65.51 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.532 0.733 . . . . 2.29 111.824 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -76.07 -13.17 60.22 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.55 -0.295 . . . . 3.93 111.763 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.77 134.78 35.75 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.807 0.336 . . . . 1.89 110.826 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -95.03 -2.94 49.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.073 0.94 . . . . 1.86 108.83 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.01 129.65 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 107.64 -1.244 . . . . 1.19 107.64 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.434 ' HB2' HG12 ' A' ' 29' ' ' VAL . 60.1 mtp85 -97.22 117.13 30.74 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.154 -1.425 . . . . 2.36 107.154 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.7 112.31 24.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.516 -0.766 . . . . 1.49 110.312 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 178.96 31.62 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 111.083 -0.807 . . . . 0.36 111.083 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 t -150.43 145.19 25.9 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.127 -0.323 . . . . 0.36 110.127 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 51.2 tp -80.66 109.93 15.66 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.43 -1.693 . . . . 1.06 106.43 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -97.86 122.81 41.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.76 -0.655 . . . . 3.22 110.986 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.4 mt -99.19 108.45 21.05 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.159 -1.422 . . . . 1.78 107.159 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.4 -54.99 7.78 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.165 -0.925 . . . . 2.42 109.329 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -110.43 106.17 57.72 Favored Pre-proline 0 N--CA 1.427 -1.61 0 N-CA-C 108.307 -0.998 . . . . 3.22 108.307 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.4 135.76 55.49 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.265 2.643 . . . . 1.62 111.343 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 p -142.02 155.34 45.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.939 -0.393 . . . . 1.75 109.939 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -72.88 -5.08 35.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.563 0.579 . . . . 2.61 112.563 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 80' ' ' ASN . 27.3 m -78.66 -9.72 12.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 CA-C-O 120.981 0.42 . . . . 1.77 110.285 171.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.782 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 16.1 m120 -87.81 26.53 1.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.195 0.997 . . . . 2.19 109.407 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 78' ' ' VAL . 66.3 t30 -120.68 87.83 2.82 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.273 -1.38 . . . . 2.08 107.273 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.24 -167.41 39.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.219 -0.991 . . . . 0.59 112.013 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.78 106.45 18.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.94 0.4 . . . . 2.28 111.201 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.782 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 69.7 m-85 -95.42 117.14 29.83 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.078 -1.082 . . . . 1.03 108.078 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 88.1 m -106.83 131.35 54.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.512 -0.551 . . . . 1.13 109.512 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.41 120.53 40.66 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.961 -0.755 . . . . 1.07 108.961 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.52 136.28 44.38 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.537 -1.283 . . . . 1.15 107.537 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.09 119.37 30.11 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.679 -1.601 . . . . 1.11 106.679 171.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.12 127.28 47.73 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 123.378 0.424 . . . . 1.34 109.896 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.511 HD22 ' HB2' ' A' ' 33' ' ' PRO . 25.5 t-20 -150.98 136.95 10.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.16 -1.422 . . . . 1.61 107.16 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -43.13 -34.84 4.43 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 125.252 3.968 . . . . 1.33 115.532 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.0 p -91.33 -33.69 15.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.678 -0.809 . . . . 1.1 111.526 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.86 131.55 2.58 Favored Glycine 0 C--N 1.299 -1.493 0 C-N-CA 120.075 -1.06 . . . . 0.71 112.526 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -103.92 126.58 51.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.903 -0.777 . . . . 1.83 108.903 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.4 152.89 22.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.098 -0.501 . . . . 1.16 109.813 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.7 p -151.2 120.76 6.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.246 -0.433 . . . . 0.88 110.362 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.89 144.32 49.83 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.763 -0.829 . . . . 1.09 108.763 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m -113.89 140.18 48.58 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.084 -0.339 . . . . 1.7 110.084 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.85 118.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.247 -1.019 . . . . 1.38 108.247 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.5 ttm -95.25 108.77 20.93 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.241 -0.583 . . . . 1.67 109.493 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 113.59 25.68 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.287 -0.87 . . . . 1.26 108.759 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.68 101.06 13.29 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.338 -1.356 . . . . 1.4 107.338 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 114.073 -1.421 . . . . 4.75 111.39 -175.235 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.407 -2.604 0 CA-C-O 121.258 0.551 . . . . 2.01 110.783 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.457 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 98.8 m-85 -98.84 134.02 42.31 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.997 -0.547 . . . . 1.61 109.83 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.3 m -84.09 176.33 8.89 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.52 -0.918 . . . . 1.32 108.52 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.8 130.49 39.8 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.487 -0.485 . . . . 1.15 110.57 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 5.7 m -126.98 144.4 51.03 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.674 -1.602 . . . . 1.67 106.674 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.79 116.47 43.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 1.11 111.673 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -110.31 126.4 54.17 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.229 -0.656 . . . . 2.66 109.229 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.6 mt -111.78 156.32 22.14 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.225 -0.657 . . . . 1.08 109.225 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -131.57 145.76 51.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.053 -0.721 . . . . 1.34 109.053 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -52.98 133.54 38.23 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.914 1.384 . . . . 1.24 110.075 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.22 141.53 58.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.214 -0.903 . . . . 1.07 110.004 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.21 130.75 39.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 120.508 -0.477 . . . . 1.21 110.907 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.01 96.46 2.15 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.946 -1.024 . . . . 2.52 112.845 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -167.13 150.73 6.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.848 -1.908 . . . . 1.33 105.848 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -52.33 -30.85 30.53 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.726 1.266 . . . . 3.4 114.068 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -98.73 100.65 11.89 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.212 -1.774 . . . . 3.18 106.212 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -80.63 141.05 35.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.547 0.689 . . . . 1.0 111.672 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.0 t -135.59 124.54 24.17 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.669 -1.15 . . . . 0.34 109.614 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.02 99.39 42.74 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.556 -1.275 . . . . 1.07 107.556 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 135.76 24.03 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.411 2.074 . . . . 0.32 111.647 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.34 157.17 40.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.808 0.337 . . . . 0.42 110.305 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -142.85 106.74 4.68 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.571 0.701 . . . . 1.29 109.37 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.82 131.61 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.486 -0.779 . . . . 1.08 109.028 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.2 p30 -122.62 150.74 42.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.591 -0.444 . . . . 1.39 111.142 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.17 169.84 30.3 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.697 -1.761 . . . . 0.6 108.697 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -93.99 -56.87 0.22 Allowed Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 118.491 1.145 . . . . 3.29 108.52 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.7 Cg_endo -70.4 121.55 8.1 Favored 'Trans proline' 0 C--N 1.368 1.562 0 N-CA-C 107.681 -1.7 . . . . 1.09 107.681 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.63 114.34 9.98 Favored Pre-proline 0 C--N 1.32 -0.69 0 O-C-N 123.546 0.529 . . . . 1.36 109.941 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.22 141.53 20.67 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.203 1.935 . . . . 0.56 111.923 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -71.5 110.95 6.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.807 -0.633 . . . . 1.74 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.7 130.8 34.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.648 -0.705 . . . . 1.14 111.082 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -138.28 136.79 36.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.849 -0.797 . . . . 4.62 108.849 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -100.49 118.77 37.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.097 0.475 . . . . 0.33 109.921 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.01 126.14 50.91 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.376 -2.083 . . . . 1.57 105.376 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -109.92 98.8 8.03 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 121.082 0.467 . . . . 1.04 110.276 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 60.17 25.53 14.89 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.872 1.269 . . . . 2.17 111.221 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.54 -15.17 32.39 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.825 -0.702 . . . . 0.61 113.387 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -109.52 142.44 40.56 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.667 -0.864 . . . . 1.84 108.667 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.12 122.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.517 -0.549 . . . . 1.31 109.517 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.4 tp -77.09 121.4 23.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.717 -0.846 . . . . 1.33 108.717 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -93.49 124.11 37.26 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.166 -1.05 . . . . 2.69 108.166 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 129.54 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.701 -0.481 . . . . 1.74 109.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -166.96 1.4 Allowed 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.883 -0.598 . . . . 2.07 111.035 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -81.82 -12.83 58.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.923 -0.769 . . . . 1.9 108.923 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -103.29 -40.77 6.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.938 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -113.59 106.79 21.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 106.959 -1.497 . . . . 1.18 106.959 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.086 0.47 . . . . 3.62 112.194 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.3 m -84.97 113.05 21.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.982 -0.554 . . . . 1.15 109.822 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -87.49 136.67 32.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.076 -0.511 . . . . 2.04 109.635 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.59 144.0 49.39 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.992 -0.744 . . . . 0.87 108.992 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.45 166.85 15.28 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.087 -0.709 . . . . 1.7 109.087 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.54 124.79 9.7 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 114.234 1.198 . . . . 3.36 114.234 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.81 128.42 2.4 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 121.714 1.609 . . . . 1.63 108.927 169.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.071 -1.085 . . . . 1.88 108.071 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.22 61.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.497 0.665 . . . . 2.29 110.284 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.11 -14.82 60.18 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.56 -1.2 . . . . 3.93 110.056 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.21 161.04 21.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.464 -0.939 . . . . 1.89 108.464 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 3.3 p -112.12 8.13 19.89 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.514 -0.921 . . . . 1.86 108.514 172.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.1 t -95.96 129.72 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 114.511 -1.222 . . . . 1.19 110.366 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -89.68 140.4 29.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.309 -2.108 . . . . 2.36 105.309 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -115.87 133.18 56.29 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.015 -0.735 . . . . 1.49 109.015 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.17 179.83 44.33 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 119.439 -1.363 . . . . 0.36 113.461 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.29 136.71 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.652 0.781 . . . . 0.36 110.285 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 tp -84.88 110.63 18.99 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.682 -1.599 . . . . 1.06 106.682 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -102.06 132.99 47.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.967 0.413 . . . . 3.22 111.813 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.51 109.55 19.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 107.453 -1.314 . . . . 1.78 107.453 172.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -59.09 -37.7 77.75 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.218 -1.356 . . . . 2.42 110.851 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -128.27 135.22 27.21 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 107.929 -1.137 . . . . 3.22 107.929 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.26 130.25 13.89 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 121.473 1.449 . . . . 1.62 109.672 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -115.19 139.97 49.48 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.355 -0.609 . . . . 1.75 109.355 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -75.61 -14.48 60.38 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 112.233 0.457 . . . . 2.61 112.233 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.56 -10.53 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.68 -0.808 . . . . 1.77 113.088 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.263 20.2 m-80 -92.19 26.95 2.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 116.17 1.915 . . . . 2.19 116.17 -171.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.87 74.25 7.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.998 -0.741 . . . . 2.08 108.998 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.09 -174.9 15.03 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.134 -1.032 . . . . 0.59 112.42 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -93.97 112.04 23.83 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.525 -0.337 . . . . 2.28 110.997 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -86.52 108.09 18.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.414 -0.958 . . . . 1.03 108.414 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 m -102.16 117.99 35.95 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.725 -0.842 . . . . 1.13 108.725 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.8 tp -94.73 118.91 32.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.712 -0.848 . . . . 1.07 108.712 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.0 134.5 46.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.917 . . . . 1.15 108.523 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 120.98 19.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.552 -0.907 . . . . 1.11 108.552 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.38 135.34 49.41 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 123.218 0.324 . . . . 1.34 110.4 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -143.91 169.74 9.75 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-O 117.432 -1.27 . . . . 1.61 107.663 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -42.77 -30.99 1.92 Allowed 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 123.317 2.678 . . . . 1.33 115.966 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.0 t -74.97 -47.46 29.23 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.33 -0.548 . . . . 1.1 111.649 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.45 31.36 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.825 -1.178 . . . . 0.71 112.48 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.96 129.31 43.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.093 0.473 . . . . 1.83 109.796 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.6 159.33 21.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.424 -0.954 . . . . 1.16 108.424 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 30.8 p -155.93 153.21 29.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.977 -0.556 . . . . 0.88 110.328 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 158.71 43.52 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.713 -1.588 . . . . 1.09 106.713 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 m -133.72 127.12 32.17 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 120.944 0.402 . . . . 1.7 110.615 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 118.49 45.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.697 -1.223 . . . . 1.38 107.697 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.0 ttm -96.75 114.79 26.46 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.933 -0.707 . . . . 1.67 109.659 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.73 29.72 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.331 -0.618 . . . . 1.26 109.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.83 123.03 36.4 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.667 -0.864 . . . . 1.4 108.667 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 122.003 0.906 . . . . 4.75 110.873 -178.332 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.388 -3.567 0 N-CA-C 106.192 -1.781 . . . . 2.01 106.192 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.434 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 46.6 m-85 -74.31 142.78 45.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.95 -1.023 . . . . 1.61 110.341 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.28 173.42 11.61 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.42 -1.326 . . . . 1.32 107.42 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.24 116.06 28.65 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 121.234 0.54 . . . . 1.15 110.192 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 t -117.02 132.03 56.8 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 107.283 -1.377 . . . . 1.67 107.283 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.86 115.77 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 110.242 -0.281 . . . . 1.11 110.242 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -112.31 117.9 33.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.597 -0.52 . . . . 2.66 109.597 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -100.41 151.53 21.41 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 108.654 -0.869 . . . . 1.08 108.654 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -131.24 146.13 52.19 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.238 -1.393 . . . . 1.34 107.238 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.47 132.68 54.22 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 124.087 0.867 . . . . 1.24 110.498 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.88 139.51 39.94 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.596 1.185 . . . . 1.07 111.165 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -91.92 131.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.961 -0.563 . . . . 1.21 110.076 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.08 120.4 21.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.268 -0.878 . . . . 2.52 111.053 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -169.7 -169.84 0.96 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.185 -1.413 . . . . 1.33 107.185 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -72.88 -39.26 66.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.286 0.948 . . . . 3.4 111.968 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -104.89 121.45 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.518 -1.66 . . . . 3.18 106.518 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -82.06 129.48 34.81 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.188 0.518 . . . . 1.0 110.988 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -121.11 118.59 30.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.076 -0.966 . . . . 0.34 110.013 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -101.38 102.23 20.56 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 107.476 -1.305 . . . . 1.07 107.476 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.89 138.15 18.35 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.459 2.106 . . . . 0.32 111.976 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.28 149.01 51.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.323 0.582 . . . . 0.42 110.677 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 m -133.28 106.66 7.67 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.973 -1.121 . . . . 1.29 107.973 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 66' ' ' ARG . 3.6 p -110.93 119.33 59.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 120.933 0.397 . . . . 1.08 109.953 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.59 140.54 35.74 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.838 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.1 134.84 1.74 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.79 -1.724 . . . . 0.6 108.79 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.434 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -71.73 -57.23 4.31 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 106.846 -1.539 . . . . 3.29 106.846 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.51 120.45 7.75 Favored 'Trans proline' 0 C--N 1.373 1.829 0 N-CA-C 108.316 -1.455 . . . . 1.09 108.316 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.4 119.73 59.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.407 -0.815 . . . . 1.36 110.947 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.04 149.46 9.46 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.344 2.029 . . . . 0.56 112.992 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 t -80.97 132.41 35.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.858 -1.534 . . . . 1.74 106.858 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 82.2 mt -103.2 148.24 26.03 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.065 0.46 . . . . 1.14 111.19 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.6 tpm_? -141.72 141.4 33.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.174 -0.676 . . . . 4.62 109.174 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -106.91 125.59 51.21 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.158 0.504 . . . . 0.33 109.952 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 22.4 tp -121.97 128.92 52.04 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.227 -1.398 . . . . 1.57 107.227 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -118.4 106.56 12.85 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.17 -0.678 . . . . 1.04 109.17 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.06 31.77 20.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.121 0.969 . . . . 2.17 111.446 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.93 85.49 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.853 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -107.43 150.53 26.66 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.008 -0.738 . . . . 1.84 109.008 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.3 120.29 24.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.373 -0.376 . . . . 1.31 110.756 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -87.23 128.88 35.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.82 -1.178 . . . . 1.33 107.82 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -104.09 123.96 48.21 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 110.221 -0.289 . . . . 2.69 110.221 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.94 120.96 19.28 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.996 -1.113 . . . . 1.74 107.996 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -136.89 -163.94 1.5 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.889 -0.596 . . . . 2.07 110.117 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 t -58.86 -44.8 91.11 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.505 1.122 . . . . 1.9 111.98 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 72.4 m-85 -92.26 -23.1 19.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.874 0.694 . . . . 1.89 112.874 -174.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mt -124.74 106.3 16.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.974 -1.491 . . . . 1.18 106.974 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -132.9 148.31 52.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.309 0.485 . . . . 3.62 112.309 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 m -101.22 116.96 34.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.442 -0.947 . . . . 1.15 108.442 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.662 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 42.4 mt-10 -96.21 119.85 35.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.458 -0.497 . . . . 2.04 110.513 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -103.38 112.74 25.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.409 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.46 165.57 18.01 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.723 -0.843 . . . . 1.7 108.723 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.4 115.84 43.19 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.945 -0.761 . . . . 3.36 108.945 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.26 134.32 28.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.794 1.663 . . . . 1.63 110.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.33 23.09 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.712 -1.218 . . . . 1.88 107.712 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -23.52 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.256 1.022 . . . . 2.29 113.453 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.99 -24.99 47.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.828 0.347 . . . . 3.93 111.213 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -96.48 152.25 18.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.227 -1.027 . . . . 1.89 108.227 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 p -108.44 16.1 23.35 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.977 0.894 . . . . 1.86 109.399 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 t -109.52 127.22 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.735 -1.121 . . . . 1.19 109.86 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HB3' HG12 ' A' ' 29' ' ' VAL . 21.5 ttm180 -89.59 118.01 28.9 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 2.36 107.165 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -103.85 152.29 22.09 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.426 -0.953 . . . . 1.49 108.426 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.67 -178.72 48.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.661 -1.376 . . . . 0.36 109.661 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.4 t -146.16 142.34 28.37 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 120.939 0.4 . . . . 0.36 111.297 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -92.25 100.99 13.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.936 -1.876 . . . . 1.06 105.936 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.662 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 70.8 mtt85 -99.83 131.7 45.64 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.563 0.697 . . . . 3.22 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.0 109.66 19.88 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.749 -1.204 . . . . 1.78 107.749 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.63 -45.35 83.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.775 -1.102 . . . . 2.42 108.539 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 12.9 mm-40 -130.16 100.85 18.29 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 114.969 -1.014 . . . . 3.22 109.18 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.16 154.25 12.71 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.07 1.847 . . . . 1.62 108.352 173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.52 ' OG1' HG23 ' A' ' 78' ' ' VAL . 21.5 p -125.38 -177.85 4.02 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 118.862 -0.589 . . . . 1.75 109.769 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -67.0 -18.18 65.26 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.32 0.963 . . . . 2.61 110.812 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 HG23 ' OG1' ' A' ' 76' ' ' THR . 13.0 m -72.77 -10.89 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.791 -0.641 . . . . 1.77 109.913 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.525 HD21 ' HH ' ' A' ' 83' ' ' TYR . 23.9 m120 -96.58 26.1 4.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 113.223 0.823 . . . . 2.19 113.223 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -113.6 98.27 6.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.46 -0.941 . . . . 2.08 108.46 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.1 -161.95 29.18 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.392 -0.909 . . . . 0.59 112.247 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.84 116.78 23.49 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.418 -0.216 . . . . 2.28 110.418 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.525 ' HH ' HD21 ' A' ' 79' ' ' ASN . 53.6 m-85 -97.1 105.73 17.93 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.239 -0.652 . . . . 1.03 109.239 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 90.1 m -101.76 124.8 48.0 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.587 -0.733 . . . . 1.13 110.365 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -106.56 123.72 48.53 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.655 -0.869 . . . . 1.07 108.655 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 1.9 mm? -105.48 141.98 36.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.997 -1.112 . . . . 1.15 107.997 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -135.54 121.24 19.58 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.024 -0.732 . . . . 1.11 109.024 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.47 124.14 42.91 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.309 0.485 . . . . 1.34 112.309 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -138.65 177.04 2.25 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 116.87 -1.538 . . . . 1.61 107.366 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 18.3 Cg_exo -42.64 -26.25 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.53 2.82 . . . . 1.33 116.271 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.63 -34.54 58.32 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.865 -0.522 . . . . 1.1 110.998 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.25 -167.26 29.02 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.951 -0.86 . . . . 0.71 110.951 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 61.8 tt0 -115.36 127.34 55.33 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 122.939 0.496 . . . . 1.83 110.265 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.81 161.77 13.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.182 -0.673 . . . . 1.16 109.182 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.7 p -143.69 136.72 27.61 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.602 -0.518 . . . . 0.88 109.602 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.6 155.03 50.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.954 -1.498 . . . . 1.09 106.954 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -140.07 126.8 20.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.09 0.471 . . . . 1.7 111.452 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.71 65.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.532 -1.284 . . . . 1.38 107.532 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 tpt -90.5 106.57 18.59 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.633 -0.506 . . . . 1.67 109.633 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.93 132.72 55.61 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.341 0.591 . . . . 1.26 110.686 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.17 119.7 19.16 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.023 -1.473 . . . . 1.4 107.023 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 C--N 1.306 -1.318 0 C-N-CA 120.384 -0.526 . . . . 4.75 112.315 -174.84 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.406 -2.672 0 N-CA-C 108.403 -0.962 . . . . 2.01 108.403 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -92.88 130.65 38.41 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.074 -0.713 . . . . 1.61 109.074 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -84.64 167.26 16.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.79 -1.096 . . . . 1.32 109.045 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.45 127.16 40.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.75 0.31 . . . . 1.15 111.436 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 m -120.74 135.88 55.02 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.834 -1.913 . . . . 1.67 105.834 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.0 t -115.22 114.71 47.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 120.927 0.394 . . . . 1.11 110.342 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.98 123.71 47.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.505 -0.924 . . . . 2.66 108.505 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 98' ' ' ILE . 72.9 mt -104.05 155.95 18.26 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.887 -0.412 . . . . 1.08 109.887 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -132.08 142.95 49.7 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -53.82 135.89 41.11 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 125.119 1.368 . . . . 1.24 110.858 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.87 57.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 1.07 110.789 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.33 139.07 18.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 121.223 0.535 . . . . 1.21 109.776 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.71 113.34 23.29 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.079 -0.964 . . . . 2.52 111.829 -171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -170.3 -177.65 2.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.191 -2.151 . . . . 1.33 105.191 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.72 -38.45 86.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 120.193 1.361 . . . . 3.4 113.755 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -94.29 115.74 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.465 -0.939 . . . . 3.18 108.465 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.422 ' HB2' HD13 ' A' ' 72' ' ' LEU . 94.0 m95 -82.1 117.52 22.34 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.594 0.711 . . . . 1.0 109.932 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -110.84 122.54 48.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.34 109.305 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.95 101.71 38.94 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.383 -0.969 . . . . 1.07 108.383 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.59 132.15 15.65 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.416 2.077 . . . . 0.32 111.918 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -122.71 155.34 36.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.117 0.484 . . . . 0.42 110.326 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -136.81 107.7 6.66 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.862 -0.608 . . . . 1.29 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 11' ' ' SER . 3.6 p -119.82 121.49 66.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.827 -0.805 . . . . 1.08 108.827 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.6 p-10 -104.91 161.19 14.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.644 -0.822 . . . . 1.39 110.797 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.77 177.94 24.28 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.396 -1.082 . . . . 0.6 110.396 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.406 ' HA ' ' NE2' ' A' ' 32' ' ' GLN 0.303 17.2 mm-40 -109.85 -54.82 0.05 OUTLIER Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.626 0.602 . . . . 3.29 112.626 175.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -68.93 119.17 6.18 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 N-CA-C 105.819 -2.416 . . . . 1.09 105.819 168.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 109.4 2.47 Favored Pre-proline 0 C--N 1.32 -0.695 0 O-C-N 123.826 0.704 . . . . 1.36 110.727 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 73.9 Cg_endo -72.46 135.03 23.58 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.642 1.561 . . . . 0.56 111.15 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -65.0 108.71 1.89 Allowed 'General case' 0 N--CA 1.433 -1.318 0 O-C-N 123.865 0.728 . . . . 1.74 109.98 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.421 HD22 HG13 ' A' ' 29' ' ' VAL . 87.8 mt -85.57 126.25 33.73 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.288 -0.869 . . . . 1.14 110.128 -176.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -136.77 127.2 26.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.049 -0.523 . . . . 4.62 109.726 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' THR . 85.3 m95 -90.77 134.58 34.32 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.623 -0.717 . . . . 0.33 109.756 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 tp -113.7 126.86 55.71 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 105.447 -2.057 . . . . 1.57 105.447 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -119.8 103.5 9.41 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.45 -0.574 . . . . 1.04 109.45 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 61.39 32.88 19.0 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.208 -0.906 . . . . 2.17 110.783 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.97 -14.48 64.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.807 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -98.88 138.63 35.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.223 -0.658 . . . . 1.84 109.223 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.07 123.79 24.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.941 -0.572 . . . . 1.31 110.395 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.04 120.38 24.13 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.237 -1.023 . . . . 1.33 108.237 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.79 127.62 45.93 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.833 -1.914 . . . . 2.69 105.833 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -57.79 126.73 28.67 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.705 0.628 . . . . 1.74 109.89 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.5 p -128.63 173.77 10.0 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.74 -0.837 . . . . 2.07 108.74 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -77.1 -1.29 28.38 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.738 0.78 . . . . 1.9 110.36 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -105.19 -40.68 5.78 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.305 -0.861 . . . . 1.89 109.002 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -128.58 109.22 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.835 -1.172 . . . . 1.18 107.835 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -143.81 147.07 33.6 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.464 0.65 . . . . 3.62 111.446 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 109.73 11.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.74 -1.118 . . . . 1.15 108.983 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -104.56 108.8 20.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.526 -1.287 . . . . 2.04 107.526 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.02 147.54 24.94 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.937 0.398 . . . . 0.87 111.513 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.81 165.55 13.52 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.428 -1.323 . . . . 1.7 107.428 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -81.58 126.36 76.16 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 113.638 0.977 . . . . 3.36 113.638 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.92 140.4 16.08 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.7 2.267 . . . . 1.63 111.124 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.15 161.15 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.029 -1.1 . . . . 1.88 108.029 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.39 -15.29 63.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.997 0.74 . . . . 2.29 112.997 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.54 -7.73 49.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.381 -0.6 . . . . 3.93 109.381 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.2 134.27 46.89 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.718 -0.475 . . . . 1.89 109.718 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -106.1 20.68 18.57 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.851 -1.537 . . . . 1.86 106.851 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 21.9 t -112.88 132.57 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 114.466 -1.243 . . . . 1.19 110.402 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -84.11 122.86 29.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.985 -1.857 . . . . 2.36 105.985 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -108.56 139.09 43.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.049 -0.352 . . . . 1.49 110.049 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.81 176.21 41.3 Favored Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 110.707 -0.957 . . . . 0.36 110.707 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 t -138.36 132.66 31.85 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.671 -0.492 . . . . 0.36 109.671 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.41 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 53.3 tp -80.26 105.15 11.3 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 104.593 -2.373 . . . . 1.06 104.593 170.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -99.57 116.16 31.06 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.885 -0.598 . . . . 3.22 110.521 -171.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 23' ' ' TRP . 53.9 mt -83.23 107.54 15.84 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 106.651 -1.611 . . . . 1.78 106.651 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -72.85 -49.43 30.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.329 -1.305 . . . . 2.42 109.912 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -122.2 101.46 41.27 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.004 -1.48 . . . . 3.22 107.004 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.46 129.87 29.72 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 121.989 1.793 . . . . 1.62 110.593 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -129.63 157.08 43.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.257 -0.883 . . . . 1.75 108.665 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.38 -5.09 17.03 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 113.639 0.978 . . . . 2.61 113.639 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -82.91 -10.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.406 0.146 . . . . 1.77 110.943 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.03 26.87 0.19 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.396 1.258 . . . . 2.19 114.396 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.9 p30 -113.62 123.56 50.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.069 -1.086 . . . . 2.08 108.069 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -170.81 33.0 Favored Glycine 0 C--N 1.289 -2.072 0 C-N-CA 119.458 -1.353 . . . . 0.59 111.745 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.05 104.91 16.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.616 0.245 . . . . 2.28 110.697 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -85.95 110.78 19.69 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.549 -0.908 . . . . 1.03 108.549 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' TRP . 24.5 m -102.11 133.24 47.26 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.527 -0.546 . . . . 1.13 109.527 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 95' ' ' SER . 47.5 tp -107.99 115.47 30.19 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.828 -0.434 . . . . 1.07 109.828 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.088 -1.079 . . . . 1.15 108.088 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -130.23 124.06 31.61 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.101 -0.703 . . . . 1.11 109.101 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 132.3 53.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.967 -0.293 . . . . 1.34 111.236 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -149.89 176.91 2.03 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.775 -1.565 . . . . 1.61 106.775 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -45.19 -30.31 4.98 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.197 2.598 . . . . 1.33 115.803 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.14 -21.16 59.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.538 0.57 . . . . 1.1 112.538 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -161.14 23.57 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 119.988 -1.101 . . . . 0.71 112.383 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -100.31 133.78 44.22 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.196 0.598 . . . . 1.83 111.173 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.45 42.77 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.625 -1.621 . . . . 1.16 106.625 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 49.7 p -162.06 141.38 9.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.208 0.528 . . . . 0.88 111.751 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.78 164.65 32.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.282 -1.747 . . . . 1.09 106.282 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 p -135.42 139.97 44.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.454 -0.499 . . . . 1.7 111.152 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.13 127.22 70.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.559 -1.274 . . . . 1.38 107.559 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.0 ttt -100.71 128.4 46.77 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.808 -0.757 . . . . 1.67 110.248 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -117.88 135.93 53.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.083 -1.451 . . . . 1.26 107.083 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.44 100.95 9.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.26 0.552 . . . . 1.4 110.666 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 N--CA 1.425 -1.714 0 CA-C-O 121.939 0.876 . . . . 4.75 108.782 174.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.408 -2.534 0 N-CA-C 108.674 -0.861 . . . . 2.01 108.674 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 19.3 m-85 -78.56 124.73 28.46 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.085 -1.82 . . . . 1.61 106.085 174.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.9 m -83.54 -171.34 3.53 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.082 -0.71 . . . . 1.32 109.082 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 94' ' ' ALA . . . -92.68 119.67 32.32 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 119.093 -1.043 . . . . 1.15 109.746 -172.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.5 m -118.14 128.74 55.02 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.069 -1.086 . . . . 1.67 108.069 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -115.92 119.53 62.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 116.546 -0.297 . . . . 1.11 110.261 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.62 116.85 30.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.255 -0.646 . . . . 2.66 109.255 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 27' ' ' PHE . 37.1 mt -104.46 146.56 28.68 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.156 -0.475 . . . . 1.08 109.769 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -131.25 145.85 52.07 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.612 -0.884 . . . . 1.34 108.612 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -56.3 132.95 52.25 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.589 1.181 . . . . 1.24 111.674 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB1' HG12 ' A' ' 25' ' ' ILE . . . -57.71 140.57 51.04 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.814 -1.085 . . . . 1.07 110.949 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.9 131.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.668 -0.493 . . . . 1.21 109.668 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.1 mt-10 -84.78 104.04 14.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.703 -0.681 . . . . 2.52 111.904 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -155.3 -168.51 2.87 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.497 -1.668 . . . . 1.33 106.497 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -68.5 -40.29 80.91 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.292 0.951 . . . . 3.4 111.124 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -97.89 113.86 25.8 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.21 -1.404 . . . . 3.18 107.21 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.449 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 54.6 m95 -81.45 124.6 29.58 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.82 124.73 42.73 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.639 -0.71 . . . . 0.34 110.72 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 66.7 mt -106.68 103.15 45.46 Favored Pre-proline 0 C--O 1.242 0.676 0 N-CA-C 108.365 -0.976 . . . . 1.07 108.365 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.79 131.24 14.33 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.608 2.205 . . . . 0.32 111.789 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.402 ' HB3' HD21 ' A' ' 14' ' ' LEU . 47.9 p90 -135.66 155.05 51.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.107 0.48 . . . . 0.42 110.289 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -142.45 114.98 8.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.653 0.739 . . . . 1.29 109.536 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.821 -1.081 . . . . 1.08 108.502 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -121.16 151.06 40.35 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.717 -0.793 . . . . 1.39 110.338 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.21 138.73 2.59 Favored Glycine 0 N--CA 1.42 -2.431 0 N-CA-C 108.274 -1.93 . . . . 0.6 108.274 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.42 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 24.0 tt0 -79.91 -50.97 1.17 Allowed Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.776 -0.77 . . . . 3.29 109.936 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.7 Cg_exo -61.72 120.0 7.41 Favored 'Trans proline' 0 C--N 1.375 1.923 0 N-CA-C 106.273 -2.241 . . . . 1.09 106.273 162.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB2' ' NH2' ' A' ' 66' ' ' ARG . . . -65.43 116.29 29.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.349 -0.841 . . . . 1.36 111.114 -174.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.21 159.56 8.41 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.928 1.752 . . . . 0.56 112.703 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -102.11 131.84 48.35 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.249 -1.019 . . . . 1.74 108.249 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 80.4 mt -97.97 154.05 17.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.788 0.327 . . . . 1.14 110.999 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -155.07 135.64 13.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.798 -0.816 . . . . 4.62 108.798 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.413 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.4 m95 -96.82 121.9 39.19 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.754 -0.461 . . . . 0.33 109.754 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.7 tp -109.88 127.47 54.74 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.791 -1.559 . . . . 1.57 106.791 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -118.29 98.98 6.56 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 109.625 -0.509 . . . . 1.04 109.625 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.86 43.41 21.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.752 1.221 . . . . 2.17 113.284 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.9 61.87 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.53 -0.843 . . . . 0.61 113.742 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 t -107.54 144.85 33.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.004 -1.11 . . . . 1.84 108.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -78.86 129.15 37.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.573 -0.899 . . . . 1.31 108.573 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.66 120.02 24.03 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.992 -0.744 . . . . 1.33 108.992 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -95.57 126.05 40.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.031 -0.729 . . . . 2.69 109.031 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -58.72 122.63 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.968 0.793 . . . . 1.74 109.292 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.6 p -124.73 -172.03 2.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.85 -0.426 . . . . 2.07 109.85 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 t -74.95 -30.69 61.3 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.393 -0.965 . . . . 1.9 108.393 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 43.1 m-85 -82.98 -41.49 18.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.302 -0.863 . . . . 1.89 110.362 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.447 HG22 ' HG ' ' A' ' 72' ' ' LEU . 33.7 mt -124.94 106.9 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.287 -1.005 . . . . 1.18 108.287 -176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -146.04 156.13 43.26 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 118.255 0.48 . . . . 3.62 110.413 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.9 m -92.27 121.41 33.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.629 -0.714 . . . . 1.15 110.792 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.0 134.05 40.88 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.301 -1.37 . . . . 2.04 107.301 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.78 144.27 46.4 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.84 0.352 . . . . 0.87 111.648 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.94 165.68 11.16 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.341 -2.096 . . . . 1.7 105.341 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.58 128.11 28.11 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 113.399 0.889 . . . . 3.36 113.399 -172.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 159.78 27.23 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.185 2.59 . . . . 1.63 110.494 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.51 176.16 6.65 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.124 -0.695 . . . . 1.88 109.124 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.86 77.71 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.59 0.589 . . . . 2.29 112.59 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.74 19.2 11.62 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.14 0.495 . . . . 3.93 112.067 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -111.21 113.08 25.32 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.407 -1.331 . . . . 1.89 107.407 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -93.76 2.62 56.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.8 0.81 . . . . 1.86 108.961 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.41 127.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.677 -1.147 . . . . 1.19 109.473 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' NH2' ' HB2' ' A' ' 34' ' ' ALA . 48.1 mtt180 -103.53 139.31 39.03 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.755 -1.572 . . . . 2.36 106.755 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.9 145.41 49.84 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.896 -1.149 . . . . 1.49 107.896 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.49 -167.98 33.97 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 120.032 -1.08 . . . . 0.36 111.447 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 10.0 t -150.81 132.34 14.77 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 122.069 0.148 . . . . 0.36 110.969 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.413 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 60.0 tp -84.36 112.32 20.23 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.606 -2.368 . . . . 1.06 104.606 169.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -116.69 125.97 52.49 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 119.652 -0.819 . . . . 3.22 112.262 -171.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.6 mp -107.11 109.62 21.51 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.567 -1.197 . . . . 1.78 108.616 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -70.72 -40.01 73.04 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.962 -1.017 . . . . 2.42 110.094 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -135.09 102.1 11.1 Favored Pre-proline 0 N--CA 1.419 -2.005 0 N-CA-C 107.341 -1.355 . . . . 3.22 107.341 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' ' CD1' ' A' ' 23' ' ' TRP . 73.9 Cg_endo -74.98 141.45 26.71 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.14 1.893 . . . . 1.62 111.21 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 p -104.25 171.58 7.26 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.299 -0.63 . . . . 1.75 109.299 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -68.93 -37.35 78.84 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.011 -1.075 . . . . 2.61 111.699 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.24 -10.36 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.46 0.911 . . . . 1.77 113.46 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.15 -8.7 58.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.052 0.76 . . . . 2.19 113.052 -171.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 17.7 p30 -77.65 77.25 4.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.883 0.849 . . . . 2.08 111.804 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -152.34 -153.03 6.13 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.134 -0.939 . . . . 0.59 111.499 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.17 118.66 37.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 122.977 0.511 . . . . 2.28 111.154 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -96.88 112.64 24.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.562 -0.903 . . . . 1.03 108.562 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 60.9 m -102.93 123.41 46.51 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.917 -0.771 . . . . 1.13 108.917 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -98.49 119.24 36.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.947 -0.76 . . . . 1.07 108.947 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 2.9 mm? -102.18 131.72 48.54 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.431 -0.804 . . . . 1.15 109.104 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.74 120.61 31.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.706 -1.22 . . . . 1.11 107.706 173.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.21 132.04 55.89 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 123.448 0.468 . . . . 1.34 111.526 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -145.06 174.03 3.81 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 107.8 -1.185 . . . . 1.61 107.8 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -48.05 -32.98 19.66 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.979 2.453 . . . . 1.33 115.277 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.38 -36.47 63.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.796 0.331 . . . . 1.1 111.1 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.17 -166.42 38.26 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 119.761 -1.209 . . . . 0.71 112.253 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 60.8 tt0 -128.41 135.59 49.73 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.707 -0.849 . . . . 1.83 108.707 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -106.04 154.87 20.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.743 -0.836 . . . . 1.16 108.743 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 p -146.84 119.48 8.55 Favored 'General case' 0 N--CA 1.426 -1.649 0 O-C-N 123.618 0.574 . . . . 0.88 111.149 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -126.03 148.34 49.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.416 -1.327 . . . . 1.09 107.416 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.2 m -127.83 139.77 52.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 117.934 0.334 . . . . 1.7 111.465 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.64 123.9 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 109.149 -0.686 . . . . 1.38 109.149 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 51.0 ttm -98.17 123.31 42.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.622 -0.51 . . . . 1.67 109.622 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -120.42 125.84 48.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.699 0.285 . . . . 1.26 110.972 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 113.11 24.51 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.703 -0.851 . . . . 1.4 108.703 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.308 -1.219 0 CA-C-N 116.308 -0.406 . . . . 4.75 111.471 -178.291 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.41 -2.436 0 N-CA-C 108.121 -1.066 . . . . 2.01 108.121 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.27 132.59 50.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.118 -1.067 . . . . 1.61 108.118 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 m -83.76 175.48 9.63 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.138 -1.06 . . . . 1.32 108.138 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 124.19 38.31 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.869 -0.732 . . . . 1.15 111.404 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 67.5 m -121.57 135.61 54.99 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.456 -1.313 . . . . 1.67 107.456 172.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.7 t -115.44 118.23 58.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.028 0.442 . . . . 1.11 110.695 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 28' ' ' SER . 33.4 mt-30 -113.09 116.46 29.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.651 -1.24 . . . . 2.66 107.651 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.39 156.63 17.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.16 0.505 . . . . 1.08 111.841 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -131.31 144.49 51.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.693 -1.225 . . . . 1.34 107.693 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -63.73 139.3 58.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 124.241 0.963 . . . . 1.24 108.97 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.42 141.78 29.41 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.045 0.841 . . . . 1.07 111.072 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.04 130.69 39.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.542 0.687 . . . . 1.21 109.978 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -76.89 111.19 12.17 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.433 -1.258 . . . . 2.52 112.385 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.0 ptt? -166.72 -172.89 2.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.538 -1.282 . . . . 1.33 107.538 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -75.78 -32.86 60.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.661 1.119 . . . . 3.4 111.063 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.419 ' O ' ' HG3' ' A' ' 20' ' ' MET . 61.3 m80 -99.0 122.07 41.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.448 -1.316 . . . . 3.18 107.448 176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -86.97 126.26 34.6 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.425 -0.91 . . . . 1.0 113.365 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.65 121.66 32.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.17 -1.377 . . . . 0.34 109.617 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.8 mt -106.18 97.95 17.6 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.467 -1.308 . . . . 1.07 107.467 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.3 138.66 27.9 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.631 2.221 . . . . 0.32 112.141 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -134.29 159.14 41.89 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.964 0.411 . . . . 0.42 110.595 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.407 ' HG ' ' HB2' ' A' ' 13' ' ' GLN . 3.1 p -139.86 116.71 10.95 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.36 -0.836 . . . . 1.29 109.265 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 HG13 HD22 ' A' ' 37' ' ' LEU . 2.4 p -126.39 122.75 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.428 -0.953 . . . . 1.08 108.428 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.2 p-10 -105.63 158.7 16.51 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.951 -1.1 . . . . 1.39 111.13 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.11 165.64 13.34 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.752 -1.113 . . . . 0.6 110.471 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.4 ' H ' ' HD2' ' A' ' 33' ' ' PRO 0.261 20.9 mm-40 -107.34 -52.1 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 118.942 -0.551 . . . . 3.29 111.877 175.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.2 Cg_endo -61.55 120.47 8.12 Favored 'Trans proline' 0 C--N 1.367 1.51 0 N-CA-C 106.703 -2.076 . . . . 1.09 106.703 165.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.19 114.18 11.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 O-C-N 123.55 0.531 . . . . 1.36 112.115 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 86.6 Cg_endo -81.18 142.79 13.71 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.413 1.409 . . . . 0.56 111.731 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 4.3 p -77.28 120.97 23.06 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.935 -0.765 . . . . 1.74 108.935 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 29' ' ' VAL . 93.6 mt -95.8 117.08 29.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.466 0.651 . . . . 1.14 110.477 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -125.95 134.81 51.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.926 -1.034 . . . . 4.62 109.577 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -98.64 115.86 29.61 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.627 -0.508 . . . . 0.33 109.627 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 20.8 tp -101.87 126.89 48.86 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 105.001 -2.222 . . . . 1.57 105.001 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -122.78 108.88 13.53 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 108.995 -0.743 . . . . 1.04 108.995 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.97 34.44 21.53 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 123.94 0.775 . . . . 2.17 111.466 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.3 6.9 88.97 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.849 -0.614 . . . . 0.61 112.586 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -116.24 147.15 41.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.024 -1.102 . . . . 1.84 108.024 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.5 t -76.89 114.75 17.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.142 -1.058 . . . . 1.31 108.142 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.96 118.24 18.53 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.702 -0.851 . . . . 1.33 108.702 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.08 115.04 20.33 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.442 -0.577 . . . . 2.69 109.442 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.26 108.01 5.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.51 -0.922 . . . . 1.74 108.51 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.2 p -104.13 -162.89 0.93 Allowed 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.553 -1.203 . . . . 2.07 109.655 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -81.41 -26.59 35.27 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.857 -0.794 . . . . 1.9 108.857 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -79.04 -40.31 31.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.884 -0.598 . . . . 1.89 110.268 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.6 mt -120.26 105.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.79 -1.93 . . . . 1.18 105.79 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -139.29 140.51 37.64 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.328 -0.549 . . . . 3.62 111.435 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -86.82 112.2 21.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.005 -0.543 . . . . 1.15 110.285 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -110.75 152.52 26.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.993 -0.743 . . . . 2.04 108.993 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -118.64 163.13 17.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 120.768 0.318 . . . . 0.87 110.815 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.92 140.9 52.52 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.873 -1.899 . . . . 1.7 105.873 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.21 116.75 30.29 Favored Pre-proline 0 C--N 1.296 -1.752 0 O-C-N 124.026 0.829 . . . . 3.36 111.394 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.87 169.04 16.91 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.573 2.182 . . . . 1.63 110.609 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.81 142.31 33.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.176 -1.046 . . . . 1.88 108.176 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.76 -15.24 61.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.559 0.577 . . . . 2.29 112.559 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -98.49 8.11 45.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.27 -0.423 . . . . 3.93 111.324 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.8 pt-20 -117.92 155.47 30.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.347 -0.983 . . . . 1.89 108.347 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 p -106.51 8.35 31.36 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.201 0.524 . . . . 1.86 110.887 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 t -100.08 134.62 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.456 -0.793 . . . . 1.19 109.824 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -93.67 141.96 27.9 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.286 -1.376 . . . . 2.36 107.286 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -124.29 139.58 53.78 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.927 -0.398 . . . . 1.49 109.927 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.41 -179.44 42.49 Favored Glycine 0 N--CA 1.425 -2.079 0 C-N-CA 120.498 -0.858 . . . . 0.36 111.516 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 t -149.66 138.07 20.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.927 0.394 . . . . 0.36 110.897 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -80.32 106.91 12.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.25 -1.759 . . . . 1.06 106.25 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -94.18 103.96 15.99 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.535 -0.757 . . . . 3.22 109.809 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' A' ' 52' ' ' ILE . 4.9 mp -94.64 109.51 21.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.601 -1.259 . . . . 1.78 107.601 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.66 -51.16 11.06 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.67 -1.15 . . . . 2.42 109.469 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.64 101.84 52.01 Favored Pre-proline 0 N--CA 1.423 -1.778 0 N-CA-C 107.477 -1.305 . . . . 3.22 107.477 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.9 130.65 6.71 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.288 1.992 . . . . 1.62 109.917 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -110.53 154.64 23.42 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.796 -1.187 . . . . 1.75 107.796 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -74.07 -5.4 41.38 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.694 -0.629 . . . . 2.61 112.118 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.7 -10.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.77 110.24 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.608 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 16.6 m120 -83.77 -1.62 54.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 2.19 109.545 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -79.45 83.35 5.47 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.799 -1.186 . . . . 2.08 107.799 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.33 -150.64 6.7 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.924 -0.58 . . . . 0.59 111.816 -176.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -107.72 124.13 49.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.701 0.286 . . . . 2.28 111.45 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.608 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 63.4 m-85 -100.27 113.39 26.06 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.742 -0.836 . . . . 1.03 108.742 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.4 m -103.5 121.97 43.96 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.928 -1.138 . . . . 1.13 107.928 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -99.9 119.9 38.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.734 -0.469 . . . . 1.07 109.734 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.56 136.16 44.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.388 -0.967 . . . . 1.15 108.388 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . . . -129.4 120.73 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.438 -1.319 . . . . 1.11 107.438 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 114.05 20.55 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.322 0.582 . . . . 1.34 112.507 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 39.5 p30 -127.0 161.7 52.19 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 106.538 -1.652 . . . . 1.61 106.538 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 4.5 Cg_exo -40.68 -38.65 2.72 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.895 3.063 . . . . 1.33 115.349 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.63 -34.35 75.6 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 112.488 0.551 . . . . 1.1 112.488 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.21 170.95 36.67 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.816 -1.183 . . . . 0.71 112.508 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -110.67 126.91 55.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.52 -0.918 . . . . 1.83 108.52 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -102.64 155.27 18.41 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.449 -0.575 . . . . 1.16 109.449 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 p -150.95 128.69 11.58 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.651 0.594 . . . . 0.88 110.68 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.77 159.88 41.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.586 -1.635 . . . . 1.09 106.586 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 p -136.69 146.75 46.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.586 0.708 . . . . 1.7 112.653 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 122.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.713 -1.217 . . . . 1.38 107.713 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -100.61 123.41 44.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.94 -0.763 . . . . 1.67 108.94 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.93 140.92 51.45 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.189 -0.3 . . . . 1.26 110.189 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.15 142.69 28.77 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.741 -0.663 . . . . 1.4 109.668 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--N 1.315 -0.931 0 N-CA-C 109.411 -0.588 . . . . 4.75 109.411 -178.681 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.404 -2.774 0 N-CA-C 107.704 -1.221 . . . . 2.01 107.704 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.31 135.09 34.05 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.183 -0.917 . . . . 1.61 109.39 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.7 m -84.71 176.65 8.42 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.97 -1.492 . . . . 1.32 106.97 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 128.41 40.89 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.728 -0.789 . . . . 1.15 111.408 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -115.33 136.58 52.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 106.464 -1.68 . . . . 1.67 106.464 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.5 t -115.69 116.14 51.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.025 0.44 . . . . 1.11 110.129 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -117.0 116.29 27.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.656 -0.868 . . . . 2.66 108.656 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.9 mt -97.41 156.18 16.58 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.725 -0.472 . . . . 1.08 109.725 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -131.91 146.39 52.08 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.758 -1.571 . . . . 1.34 106.758 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.33 132.21 50.83 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.812 0.695 . . . . 1.24 109.615 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.33 142.74 30.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.648 -1.16 . . . . 1.07 112.107 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.21 130.4 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.543 -0.753 . . . . 1.21 110.117 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.45 ' HG2' ' CH2' ' A' ' 23' ' ' TRP . 36.2 mt-10 -80.64 107.17 13.22 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.837 -1.074 . . . . 2.52 110.263 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 59.8 mtm -134.76 -165.81 1.72 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.41 -1.7 . . . . 1.33 106.41 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -66.02 -39.01 89.86 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.254 -1.017 . . . . 3.4 108.254 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 20' ' ' MET . 66.9 m170 -117.56 153.55 33.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.452 -1.684 . . . . 3.18 106.452 176.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.45 ' CH2' ' HG2' ' A' ' 19' ' ' GLU . 68.6 m95 -98.63 144.85 27.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -136.23 121.01 18.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.788 -1.096 . . . . 0.34 109.384 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 58.8 mt -103.38 100.31 17.94 Favored Pre-proline 0 C--O 1.24 0.562 0 N-CA-C 108.468 -0.938 . . . . 1.07 108.468 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.66 132.91 16.45 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.324 2.016 . . . . 0.32 111.85 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -128.47 152.26 48.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.993 0.425 . . . . 0.42 111.094 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 m -127.31 114.3 17.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.372 -0.973 . . . . 1.29 108.372 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.29 112.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.308 -0.627 . . . . 1.08 109.308 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.2 p-10 -112.02 144.79 40.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.995 -0.682 . . . . 1.39 110.316 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.24 165.48 32.57 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.637 -1.785 . . . . 0.6 108.637 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 19.5 tm0? -91.4 -53.31 0.28 Allowed Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 117.519 0.659 . . . . 3.29 109.999 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 3.2 Cg_exo -80.36 120.63 4.09 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 107.6 -1.731 . . . . 1.09 107.6 170.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.5 115.67 10.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 123.779 0.674 . . . . 1.36 111.763 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 87.7 Cg_endo -81.51 153.2 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.749 2.299 . . . . 0.56 113.204 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 m -79.56 119.31 22.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.531 -1.285 . . . . 1.74 107.531 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 127.41 39.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.927 0.394 . . . . 1.14 110.053 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -123.79 130.67 52.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.941 -0.763 . . . . 4.62 108.941 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -94.57 119.86 33.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.127 0.489 . . . . 0.33 109.948 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 26.3 tp -110.66 126.91 55.0 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.169 -1.419 . . . . 1.57 107.169 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -116.48 106.9 14.11 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 110.204 -0.295 . . . . 1.04 110.204 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 56.39 35.2 25.51 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.227 1.011 . . . . 2.17 111.18 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.49 -18.17 57.96 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.777 -0.647 . . . . 0.61 113.25 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.5 p -106.02 139.71 40.15 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.179 -0.6 . . . . 1.84 110.375 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.14 128.12 28.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.904 -0.589 . . . . 1.31 109.785 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -91.1 111.65 23.21 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.684 -0.689 . . . . 1.33 109.269 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -85.04 135.13 34.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.115 -1.069 . . . . 2.69 108.115 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.61 141.08 48.35 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.8 -0.445 . . . . 1.74 109.8 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -123.87 -163.79 1.17 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.284 -0.635 . . . . 2.07 109.284 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -81.98 -17.44 46.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.831 -0.433 . . . . 1.9 109.831 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.11 -31.46 9.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.409 -0.36 . . . . 1.89 111.405 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.3 mt -113.84 106.73 21.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 106.511 -1.663 . . . . 1.18 106.511 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.42 145.91 33.02 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.273 0.558 . . . . 3.62 111.813 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -85.92 112.95 21.64 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.539 -0.755 . . . . 1.15 110.422 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -96.83 112.54 24.25 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.858 -0.61 . . . . 2.04 110.947 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.52 142.6 27.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.203 -1.036 . . . . 0.87 108.203 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.31 161.68 19.54 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.408 -1.33 . . . . 1.7 107.408 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -67.13 113.67 14.68 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 113.973 1.101 . . . . 3.36 113.973 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.56 157.72 21.98 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.085 2.524 . . . . 1.63 109.61 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.6 145.57 31.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.737 -0.838 . . . . 1.88 108.737 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.03 0.76 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.689 0.756 . . . . 2.29 111.236 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 60' ' ' ALA . 15.4 m120 -123.01 9.55 9.36 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.307 -0.86 . . . . 3.93 109.034 177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.6 pt-20 -135.56 160.77 37.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.268 -1.382 . . . . 1.89 107.268 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 p -118.71 34.71 5.09 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.936 0.875 . . . . 1.86 109.778 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' OE1' ' A' ' 63' ' ' GLU . 18.7 t -109.43 127.18 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.196 -0.911 . . . . 1.19 109.401 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.32 129.17 37.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.6 -1.629 . . . . 2.36 106.6 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -114.06 134.99 54.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.386 -0.968 . . . . 1.49 108.386 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.62 179.08 36.34 Favored Glycine 0 N--CA 1.408 -3.176 0 C-N-CA 119.73 -1.224 . . . . 0.36 111.714 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 4.7 t -144.61 132.79 21.66 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.83 0.852 . . . . 0.36 109.932 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.1 tp -84.45 105.66 15.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.224 -2.139 . . . . 1.06 105.224 170.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -100.46 123.83 45.19 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.045 -0.525 . . . . 3.22 110.029 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.02 108.26 19.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.894 -1.15 . . . . 1.78 107.894 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -72.9 -35.46 67.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.514 -1.221 . . . . 2.42 109.805 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.59 108.37 58.19 Favored Pre-proline 0 N--CA 1.423 -1.814 0 N-CA-C 107.243 -1.392 . . . . 3.22 107.243 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.39 129.89 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.475 1.45 . . . . 1.62 109.915 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -126.19 141.11 52.06 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.114 0.483 . . . . 1.75 109.828 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.46 -18.39 48.84 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.144 -0.687 . . . . 2.61 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.7 -12.01 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.238 -0.585 . . . . 1.77 111.491 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 51.7 m-80 -111.62 25.99 11.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.47 0.652 . . . . 2.19 111.386 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.18 104.37 16.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.304 -0.999 . . . . 2.08 108.304 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.05 26.29 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.039 -0.824 . . . . 0.59 111.039 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -96.17 123.48 39.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.117 0.484 . . . . 2.28 111.361 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 97' ' ' SER . 8.0 m-85 -95.97 121.18 37.44 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.158 0.983 . . . . 1.03 108.978 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 53.7 m -107.77 120.9 43.55 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.582 -0.896 . . . . 1.13 108.582 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 95' ' ' SER . 54.0 tp -96.88 118.75 33.99 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.538 -0.912 . . . . 1.07 108.538 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.85 133.62 49.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.415 -0.957 . . . . 1.15 108.415 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -122.07 119.7 32.16 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.417 -0.957 . . . . 1.11 108.417 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.98 131.38 54.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.42 -0.585 . . . . 1.34 109.42 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 8.0 p30 -151.58 165.31 17.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 107.042 -1.466 . . . . 1.61 107.042 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -44.69 -40.58 14.33 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.473 2.782 . . . . 1.33 114.337 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.63 -27.28 61.19 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.85 0.685 . . . . 1.1 112.85 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.48 -156.1 27.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.121 -1.038 . . . . 0.71 112.178 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 28.7 tt0 -138.12 126.81 23.65 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.957 0.408 . . . . 1.83 110.674 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.79 157.75 16.74 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.862 -0.792 . . . . 1.16 108.862 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.2 p -153.7 142.62 21.14 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 123.255 0.347 . . . . 0.88 110.952 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -147.19 152.32 38.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.439 -1.319 . . . . 1.09 107.439 175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 37.8 m -128.77 141.16 51.4 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.103 0.411 . . . . 1.7 111.034 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 134.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.407 -0.96 . . . . 1.38 108.407 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.9 ttm -99.42 119.96 38.84 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.929 -0.482 . . . . 1.67 109.782 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.9 116.58 30.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.503 -0.554 . . . . 1.26 109.503 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.49 100.11 11.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.397 -0.964 . . . . 1.4 108.397 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 114.718 -1.128 . . . . 4.75 110.104 -179.19 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.396 -3.15 0 N-CA-C 108.598 -0.889 . . . . 2.01 108.598 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.2 m-85 -86.0 117.71 25.02 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 105.397 -2.075 . . . . 1.61 105.397 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.7 m -83.22 -179.31 7.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.797 -0.816 . . . . 1.32 108.797 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.31 126.01 38.21 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 119.606 -0.837 . . . . 1.15 110.817 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 20.8 t -118.41 131.43 56.29 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.673 -1.232 . . . . 1.67 107.673 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.5 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.886 -0.783 . . . . 1.11 108.886 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.82 116.05 27.97 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.665 -1.235 . . . . 2.66 107.665 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.479 HD11 HG21 ' A' ' 98' ' ' ILE . 38.3 mt -99.48 156.82 16.83 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.511 -0.768 . . . . 1.08 109.924 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -131.6 153.94 49.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.063 -0.517 . . . . 1.34 109.695 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -57.32 133.59 55.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.175 -1.375 . . . . 1.24 110.36 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.59 141.4 58.78 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.649 -0.705 . . . . 1.07 110.311 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -91.37 124.91 44.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.647 0.736 . . . . 1.21 111.535 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.49 111.95 20.46 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.47 -1.241 . . . . 2.52 109.92 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -162.46 0.53 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.215 -1.402 . . . . 1.33 107.215 176.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -60.85 -28.93 69.2 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.618 1.099 . . . . 3.4 112.793 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -120.86 165.16 15.57 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.884 -1.524 . . . . 3.18 106.884 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -118.19 135.83 54.01 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.76 131.69 35.85 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.552 -0.749 . . . . 0.34 110.002 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.65 106.24 53.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.383 -1.339 . . . . 1.07 107.383 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.09 137.8 19.77 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.644 2.229 . . . . 0.32 111.35 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 14' ' ' LEU . 55.1 p90 -140.01 146.47 39.1 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.227 0.537 . . . . 0.42 111.853 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.5 p -126.63 118.87 25.67 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 115.137 -0.938 . . . . 1.29 109.31 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -120.12 110.46 28.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.529 -0.915 . . . . 1.08 108.529 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.8 p-10 -108.49 150.94 26.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.395 -0.522 . . . . 1.39 110.504 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.36 144.35 3.91 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 108.493 -1.843 . . . . 0.6 108.493 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.51 -53.25 2.06 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.472 -0.936 . . . . 3.29 108.472 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 23.7 Cg_exo -67.26 120.96 8.04 Favored 'Trans proline' 0 C--N 1.379 2.168 0 N-CA-C 108.978 -1.201 . . . . 1.09 108.978 171.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.95 87.88 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.735 -0.666 . . . . 1.36 112.041 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -90.55 159.78 4.37 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.474 2.116 . . . . 0.56 111.714 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -96.36 120.6 36.95 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.995 -1.483 . . . . 1.74 106.995 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.56 159.08 19.97 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.667 0.27 . . . . 1.14 110.901 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -159.43 138.03 10.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.723 -0.843 . . . . 4.62 108.723 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -105.72 129.89 53.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.215 0.531 . . . . 0.33 111.361 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -109.33 137.35 47.32 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.839 -1.171 . . . . 1.57 107.839 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -124.82 103.89 8.32 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.982 -1.118 . . . . 1.04 107.982 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 64.36 28.0 13.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.093 0.957 . . . . 2.17 110.358 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.8 71.53 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.12 -0.945 . . . . 0.61 112.201 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -93.16 150.08 20.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.897 -0.779 . . . . 1.84 108.897 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.89 115.82 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 116.164 -0.471 . . . . 1.31 109.925 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -85.75 124.22 32.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.483 -1.303 . . . . 1.33 107.483 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -102.15 126.14 49.04 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.625 -0.879 . . . . 2.69 108.625 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 114.41 3.28 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.818 -0.808 . . . . 1.74 108.818 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -130.06 -170.8 2.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.451 -0.795 . . . . 2.07 109.588 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -60.15 -32.72 71.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.173 0.589 . . . . 1.9 112.113 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -84.7 -36.8 21.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.399 0.518 . . . . 1.89 112.399 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.52 114.63 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.955 -1.128 . . . . 1.18 107.955 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.74 155.54 48.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 118.895 0.771 . . . . 3.62 111.518 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -98.62 110.37 22.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 1.15 109.87 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.82 120.76 43.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.559 -0.534 . . . . 2.04 109.559 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -97.01 153.56 17.84 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 116.09 -0.505 . . . . 0.87 109.81 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.98 159.86 14.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.126 -1.435 . . . . 1.7 107.126 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -72.91 115.14 37.21 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 123.576 0.547 . . . . 3.36 110.273 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.17 153.95 32.28 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.546 2.164 . . . . 1.63 110.551 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.12 146.84 27.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.702 -1.221 . . . . 1.88 107.702 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.84 60.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.073 1.138 . . . . 2.29 114.073 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.18 -0.42 46.89 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.526 -0.469 . . . . 3.93 111.833 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -88.81 138.84 31.05 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.963 0.411 . . . . 1.89 110.693 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -104.45 -2.06 25.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.431 -0.952 . . . . 1.86 108.431 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.0 128.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.351 -0.84 . . . . 1.19 109.399 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -108.88 124.18 50.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.004 -1.11 . . . . 2.36 108.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -111.04 146.53 36.56 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.949 0.404 . . . . 1.49 110.097 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.39 32.37 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.614 -0.994 . . . . 0.36 110.614 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 71' ' ' ARG . 4.6 t -138.05 131.67 30.98 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.65 -0.5 . . . . 0.36 109.65 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.32 94.86 9.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.116 -2.179 . . . . 1.06 105.116 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . 15.5 ptm180 -99.93 126.4 46.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.498 -0.774 . . . . 3.22 110.617 -174.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.91 113.05 25.16 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.948 0.88 . . . . 1.78 109.367 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -61.81 -49.52 76.0 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.18 -1.827 . . . . 2.42 107.593 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -135.29 100.57 11.51 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 107.845 -1.168 . . . . 3.22 107.845 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.524 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -83.65 141.96 10.07 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.123 1.882 . . . . 1.62 111.163 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 p -130.31 -178.73 4.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 118.98 -0.533 . . . . 1.75 111.598 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -69.47 -19.6 63.75 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.382 0.992 . . . . 2.61 111.102 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 m -70.69 -10.67 14.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.77 110.639 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -88.15 14.29 9.55 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.625 -0.716 . . . . 2.19 112.844 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.56 93.64 9.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.301 -1.0 . . . . 2.08 108.301 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.19 -173.22 39.39 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.409 -0.9 . . . . 0.59 112.127 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.35 122.8 36.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.17 0.51 . . . . 2.28 111.13 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 98' ' ' ILE . 22.0 m-85 -102.97 130.43 50.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.72 1.208 . . . . 1.03 107.908 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -130.88 128.29 40.27 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.988 -0.445 . . . . 1.13 109.955 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.441 ' CB ' HD12 ' A' ' 14' ' ' LEU . 50.5 tp -100.37 124.54 45.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.59 -0.893 . . . . 1.07 108.59 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.58 138.27 48.33 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.098 -1.075 . . . . 1.15 108.098 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.3 119.5 34.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.818 -1.549 . . . . 1.11 106.818 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.68 125.41 40.24 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.043 -1.095 . . . . 1.34 108.043 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -151.04 144.78 17.46 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.506 -1.664 . . . . 1.61 106.506 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.62 -17.17 27.35 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 123.526 2.817 . . . . 1.33 113.986 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.3 t -89.65 -8.83 51.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 1.1 110.348 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.16 157.02 7.32 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.147 -0.781 . . . . 0.71 111.147 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 31.8 tt0 -90.65 133.66 34.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.088 -0.708 . . . . 1.83 109.088 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.63 23.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.641 -0.874 . . . . 1.16 108.641 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -151.45 143.21 23.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 123.355 0.409 . . . . 0.88 111.309 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.56 154.29 42.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.28 -1.378 . . . . 1.09 107.28 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.8 t -119.71 132.37 55.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.46 0.648 . . . . 1.7 111.655 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.479 HG21 HD11 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -136.34 119.76 23.07 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 124.267 1.027 . . . . 1.38 109.469 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -106.75 122.04 45.57 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.153 -0.684 . . . . 1.67 109.153 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.05 147.76 38.17 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.663 -0.415 . . . . 1.26 110.34 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.26 120.11 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.409 -1.33 . . . . 1.4 107.409 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 72.0 t80 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 115.632 -0.713 . . . . 4.75 111.653 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.402 -2.85 0 N-CA-C 109.11 -0.7 . . . . 2.01 109.11 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -89.16 136.35 33.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.706 -1.134 . . . . 1.61 108.55 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.2 t -83.91 169.56 14.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.025 -1.472 . . . . 1.32 107.025 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.92 112.82 24.72 Favored 'General case' 0 CA--C 1.489 -1.404 0 CA-C-O 121.068 0.461 . . . . 1.15 110.63 -173.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.1 t -106.87 131.89 53.45 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.889 -1.152 . . . . 1.67 107.889 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.08 114.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.735 -0.469 . . . . 1.11 109.735 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -113.14 116.16 29.41 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.501 -0.926 . . . . 2.66 108.501 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.9 mt -101.77 150.67 22.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.929 -0.397 . . . . 1.08 109.929 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.64 139.6 49.15 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.523 -0.917 . . . . 1.34 108.523 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -52.44 134.19 34.78 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.035 1.459 . . . . 1.24 110.64 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.76 142.47 49.98 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.908 -1.042 . . . . 1.07 111.072 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.51 125.89 44.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.491 0.662 . . . . 1.21 110.418 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 114.43 12.03 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.616 -1.175 . . . . 2.52 111.345 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 23.9 ptt? -165.68 -177.28 4.27 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.635 1.174 . . . . 1.33 107.996 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -71.63 -31.73 67.18 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.193 1.36 . . . . 3.4 114.47 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.478 ' O ' ' HG3' ' A' ' 20' ' ' MET . 90.1 m-70 -112.04 125.71 54.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.564 -2.013 . . . . 3.18 105.564 173.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 75' ' ' PRO . 60.0 m95 -93.12 143.67 26.02 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 113.838 1.051 . . . . 1.0 113.838 -168.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 t -134.66 125.6 27.44 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.001 -1.0 . . . . 0.34 109.876 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 63.5 mt -106.8 101.19 35.59 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.513 -1.292 . . . . 1.07 107.513 173.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.63 129.66 13.89 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.619 2.213 . . . . 0.32 112.304 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -127.46 143.41 51.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.083 0.468 . . . . 0.42 110.518 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 m -127.18 116.12 20.14 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.551 -0.907 . . . . 1.29 108.551 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.7 p -126.96 121.33 57.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.55 -0.537 . . . . 1.08 109.55 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 p-10 -115.69 148.09 40.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.566 -0.454 . . . . 1.39 109.953 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.37 149.65 6.25 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 108.094 -2.003 . . . . 0.6 108.094 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -75.78 -54.79 2.11 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 118.014 0.907 . . . . 3.29 109.111 -177.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 6.4 Cg_exo -75.99 120.0 5.58 Favored 'Trans proline' 0 C--N 1.369 1.651 0 N-CA-C 107.38 -1.815 . . . . 1.09 107.38 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.93 110.99 3.08 Favored Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 124.055 0.847 . . . . 1.36 110.924 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.47 146.05 34.5 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.213 1.942 . . . . 0.56 112.37 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 t -74.52 111.0 9.27 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.363 -1.347 . . . . 1.74 107.363 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 HD22 HG13 ' A' ' 29' ' ' VAL . 80.3 mt -88.75 125.48 34.9 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.637 -0.711 . . . . 1.14 109.786 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 39' ' ' TRP . 16.4 tpp180 -137.08 137.55 39.43 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.828 -0.434 . . . . 4.62 109.828 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.441 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 91.7 m95 -101.54 140.45 35.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.183 0.516 . . . . 0.33 109.868 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 45' ' ' VAL . 12.3 tp -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.421 -2.066 . . . . 1.57 105.421 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 79' ' ' ASN . 54.6 t80 -116.97 106.99 14.01 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.899 -0.408 . . . . 1.04 109.899 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 58.52 37.96 25.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.206 1.002 . . . . 2.17 110.839 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.72 -17.67 43.65 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.632 -0.713 . . . . 0.61 113.023 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -93.36 135.82 34.22 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.993 -0.743 . . . . 1.84 108.993 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 40' ' ' LEU . 5.1 p -67.35 136.52 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 121.373 0.606 . . . . 1.31 111.239 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.6 tp -92.2 124.25 36.14 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.45 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.41 104.81 13.62 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 103.916 -2.624 . . . . 2.69 103.916 167.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.35 137.63 18.26 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.188 0.93 . . . . 1.74 112.504 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -118.48 -166.87 1.28 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.174 -0.921 . . . . 2.07 110.467 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -67.17 -33.59 75.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.014 0.435 . . . . 1.9 111.58 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -88.61 -37.17 15.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.381 -0.372 . . . . 1.89 111.702 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.5 mt -110.0 109.45 28.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.787 -1.19 . . . . 1.18 107.787 -174.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -136.26 138.19 41.53 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.689 -0.804 . . . . 3.62 111.608 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -81.61 109.64 16.23 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.457 -0.792 . . . . 1.15 109.518 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -109.63 144.09 38.46 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.901 0.381 . . . . 2.04 110.914 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.13 153.76 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.041 -0.527 . . . . 0.87 109.629 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.45 155.85 38.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.904 -1.517 . . . . 1.7 106.904 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -74.58 121.68 85.8 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 114.534 1.309 . . . . 3.36 114.534 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.92 154.4 22.87 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.823 2.348 . . . . 1.63 109.622 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.64 176.26 9.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.164 -0.68 . . . . 1.88 109.164 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.12 89.9 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 119.043 0.838 . . . . 2.29 112.384 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.78 -20.14 59.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.993 -0.549 . . . . 3.93 110.531 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.0 113.15 19.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 120.376 -0.53 . . . . 1.89 109.974 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 m -92.25 0.47 57.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.487 1.137 . . . . 1.86 108.089 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 t -91.42 129.06 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.532 -1.213 . . . . 1.19 109.797 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.441 ' HB3' HG12 ' A' ' 29' ' ' VAL . 18.6 ttm180 -85.64 121.05 27.76 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.041 -1.837 . . . . 2.36 106.041 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.69 131.24 54.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.095 -0.705 . . . . 1.49 109.095 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.45 -177.52 35.54 Favored Glycine 0 N--CA 1.414 -2.791 0 C-N-CA 119.989 -1.101 . . . . 0.36 111.821 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.9 136.21 20.18 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.307 0.643 . . . . 0.36 109.527 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 56.7 tp -84.58 98.34 10.1 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 104.451 -2.426 . . . . 1.06 104.451 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -97.22 123.42 41.0 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.414 -0.812 . . . . 3.22 110.759 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.464 HD23 ' CZ ' ' A' ' 102' ' ' PHE . 6.5 mp -102.11 109.31 20.99 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.673 -1.232 . . . . 1.78 107.673 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -59.43 -42.77 92.64 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.656 -1.611 . . . . 2.42 109.965 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -133.17 124.98 18.69 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.274 -1.009 . . . . 3.22 108.274 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HB3' ' CD1' ' A' ' 23' ' ' TRP . 30.9 Cg_endo -66.02 130.52 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.803 2.336 . . . . 1.62 112.036 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.4 p -109.39 141.84 41.2 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.831 -0.803 . . . . 1.75 108.831 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -80.99 -13.16 59.13 Favored 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 120.589 -0.445 . . . . 2.61 110.038 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.32 -13.02 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 119.325 -0.95 . . . . 1.77 111.83 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.5 m-80 -108.48 23.01 15.15 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.957 1.095 . . . . 2.19 113.957 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -86.26 64.27 8.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.034 0.921 . . . . 2.08 111.761 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.02 -148.12 4.96 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.11 -0.95 . . . . 0.59 111.994 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -102.93 116.76 33.18 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.354 0.597 . . . . 2.28 112.603 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 51.4 m-85 -94.91 140.28 30.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.763 -0.828 . . . . 1.03 108.763 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.0 m -128.8 127.71 42.49 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 108.46 -0.941 . . . . 1.13 108.46 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.9 tp -101.6 122.94 44.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.067 -0.716 . . . . 1.07 109.067 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.13 131.48 55.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.686 -1.227 . . . . 1.15 107.686 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.01 120.11 36.25 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.51 -0.922 . . . . 1.11 108.51 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.28 115.51 27.55 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.594 0.559 . . . . 1.34 110.64 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -134.82 150.76 74.25 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-O 117.76 -1.114 . . . . 1.61 108.211 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.09 -42.15 21.2 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.478 2.119 . . . . 1.33 112.243 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.5 t -57.2 -32.69 66.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 1.1 112.01 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.1 178.57 26.93 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 109.867 -1.293 . . . . 0.71 109.867 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -106.36 129.82 54.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.385 -0.598 . . . . 1.83 109.385 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.83 152.86 20.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.005 -0.739 . . . . 1.16 109.005 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 24.8 p -141.05 146.35 37.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.924 0.392 . . . . 0.88 111.251 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.27 43.36 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.738 -1.208 . . . . 1.09 107.738 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 t -122.91 127.81 49.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.7 -0.481 . . . . 1.7 109.7 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.6 123.85 38.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.77 -0.826 . . . . 1.38 108.77 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.0 mtp -101.73 110.62 22.64 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.2 -0.6 . . . . 1.67 110.285 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.89 133.46 38.59 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.779 -0.646 . . . . 1.26 110.513 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.47 100.63 6.33 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.15 -1.056 . . . . 1.4 108.15 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.464 ' CZ ' HD23 ' A' ' 72' ' ' LEU . 33.0 m-85 . . . . . 0 C--N 1.3 -1.584 0 N-CA-C 107.807 -1.182 . . . . 4.75 107.807 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.381 -3.894 0 CA-C-O 122.582 1.182 . . . . 2.01 113.781 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.27 126.57 52.97 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 112.878 -1.965 . . . . 1.61 105.96 171.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.68 174.17 10.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.753 -1.573 . . . . 1.32 106.753 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.09 129.23 40.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 118.882 -1.127 . . . . 1.15 110.501 -174.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -122.03 135.83 54.87 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.798 -1.186 . . . . 1.67 107.798 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.82 123.23 70.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.001 0.429 . . . . 1.11 111.073 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -115.13 139.72 49.66 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.338 -0.986 . . . . 2.66 108.338 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.488 HD11 HG21 ' A' ' 98' ' ' ILE . 36.1 mt -129.85 156.88 43.64 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.348 -0.612 . . . . 1.08 109.348 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -130.7 143.16 50.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.185 -1.043 . . . . 1.34 108.185 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 134.59 56.14 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.496 1.122 . . . . 1.24 109.693 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.31 139.84 58.81 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 124.003 0.815 . . . . 1.07 110.638 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.32 134.04 31.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.976 0.417 . . . . 1.21 111.542 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 92.26 0.34 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.32 -0.855 . . . . 2.52 112.415 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.8 ptt? -144.93 -177.09 5.35 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.092 -0.707 . . . . 1.33 109.092 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -64.1 -41.68 97.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.205 0.817 . . . . 3.4 113.205 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.9 p-80 -112.44 129.24 56.39 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.052 -1.462 . . . . 3.18 107.052 173.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -82.74 147.79 28.23 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 120.849 0.357 . . . . 1.0 111.642 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -137.59 120.26 16.21 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.44 -0.8 . . . . 0.34 110.142 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.4 mt -106.93 97.41 17.61 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.637 -1.245 . . . . 1.07 107.637 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.76 131.8 17.69 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 123.125 2.55 . . . . 0.32 112.602 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.62 154.91 39.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.333 0.587 . . . . 0.42 110.844 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 m -140.14 121.83 15.33 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.617 -0.882 . . . . 1.29 108.617 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.07 111.7 29.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.744 -0.835 . . . . 1.08 108.744 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.7 p-10 -106.85 147.25 29.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.026 -0.534 . . . . 1.39 111.309 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 -170.77 32.64 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.06 -1.216 . . . . 0.6 110.06 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -122.55 -51.94 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.456 0.91 . . . . 3.29 113.456 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.01 121.32 9.62 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 107.854 -1.633 . . . . 1.09 107.854 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.43 111.03 6.24 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 123.765 0.666 . . . . 1.36 111.111 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 71.7 Cg_endo -84.47 146.65 10.96 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.841 1.694 . . . . 0.56 111.842 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 22.9 t -79.57 121.96 25.9 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.715 -1.587 . . . . 1.74 106.715 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -96.51 129.72 43.82 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.639 0.587 . . . . 1.14 109.734 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -136.58 134.7 37.71 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.116 -0.493 . . . . 4.62 110.968 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.85 34.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.617 -0.882 . . . . 0.33 108.617 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.86 130.91 52.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.086 -1.45 . . . . 1.57 107.086 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 87.2 t80 -120.8 103.72 9.31 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.049 -0.723 . . . . 1.04 109.049 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 56.86 33.59 23.38 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.662 0.785 . . . . 2.17 111.923 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.83 82.95 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.687 -0.768 . . . . 0.61 112.895 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 t -105.77 146.69 29.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.976 -1.12 . . . . 1.84 107.976 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.88 123.8 36.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.907 -0.775 . . . . 1.31 108.907 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.75 106.53 12.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.263 -0.643 . . . . 1.33 109.263 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.8 131.41 34.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.585 -0.895 . . . . 2.69 108.585 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.01 149.31 47.84 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.273 0.559 . . . . 1.74 111.268 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -145.6 -169.33 3.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 114.938 -1.028 . . . . 2.07 108.768 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 t -72.25 -25.18 61.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.429 0.633 . . . . 1.9 109.987 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 95.9 m-85 -101.52 -12.09 18.79 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.437 0.903 . . . . 1.89 113.437 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 HD12 ' ND2' ' A' ' 79' ' ' ASN . 44.4 mt -135.75 107.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.311 -1.737 . . . . 1.18 106.311 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -141.45 142.33 33.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 112.308 0.485 . . . . 3.62 112.308 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 m -88.79 109.49 20.22 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.644 -0.707 . . . . 1.15 109.499 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HG3' ' HE ' ' A' ' 71' ' ' ARG . 6.7 mm-40 -92.98 124.05 36.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.391 0.615 . . . . 2.04 110.883 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.31 120.5 40.03 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.148 -1.427 . . . . 0.87 107.148 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.514 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 pp -84.31 155.79 22.22 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 106.836 -1.542 . . . . 1.7 106.836 177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.0 105.97 3.4 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 124.138 0.899 . . . . 3.36 110.407 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 79.4 Cg_endo -88.25 169.68 6.05 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.137 2.558 . . . . 1.63 111.051 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.579 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -93.87 139.62 30.67 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.656 -1.238 . . . . 1.88 107.656 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.54 15.11 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.513 0.673 . . . . 2.29 111.413 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.85 -25.62 32.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.069 -0.968 . . . . 3.93 109.829 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.8 pt-20 -97.26 139.4 33.28 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.583 -0.895 . . . . 1.89 108.583 -177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -88.12 13.59 10.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.96 0.886 . . . . 1.86 109.94 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 132.05 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.724 -0.671 . . . . 1.19 110.259 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -95.39 136.23 36.02 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.654 -1.61 . . . . 2.36 106.654 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -125.41 157.74 36.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.163 -0.68 . . . . 1.49 109.163 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.2 -168.24 38.84 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 111.264 -0.734 . . . . 0.36 111.264 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.29 138.41 16.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 123.001 0.52 . . . . 0.36 111.335 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.13 109.83 20.19 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.81 -1.552 . . . . 1.06 106.81 172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.577 ' HE ' ' HG3' ' A' ' 55' ' ' GLU . 76.0 mtm180 -102.28 131.56 48.78 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.795 -0.362 . . . . 3.22 111.574 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.1 mp -119.83 109.56 15.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.777 -0.823 . . . . 1.78 108.777 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.84 -10.61 59.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.759 -0.655 . . . . 2.42 111.184 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -135.09 101.49 11.33 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 108.114 -1.069 . . . . 3.22 108.114 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -88.26 129.59 2.35 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.591 1.528 . . . . 1.62 110.368 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.7 p -136.54 173.15 12.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.842 -0.799 . . . . 1.75 108.842 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -78.79 -5.67 53.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.113 0.412 . . . . 2.61 112.113 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.02 -9.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.611 . . . . 1.77 109.349 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.416 ' ND2' HD12 ' A' ' 52' ' ' ILE . 13.4 m120 -104.81 22.06 15.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.005 -1.109 . . . . 2.19 108.005 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -114.17 117.44 31.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.799 -0.815 . . . . 2.08 108.799 -175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.27 -153.52 24.68 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.637 -1.268 . . . . 0.59 113.18 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 45.8 m-80 -87.28 120.66 28.79 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.55 -0.325 . . . . 2.28 111.406 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -105.56 118.28 36.16 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.311 -0.996 . . . . 1.03 108.311 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 m -122.96 125.02 44.49 Favored 'General case' 0 C--N 1.283 -2.3 0 O-C-N 121.611 -0.681 . . . . 1.13 109.775 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' CB ' HD12 ' A' ' 14' ' ' LEU . 59.0 tp -97.39 117.54 31.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.453 -0.943 . . . . 1.07 108.453 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.43 133.2 52.29 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.467 -0.938 . . . . 1.15 108.467 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -122.16 120.03 33.03 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.719 -1.215 . . . . 1.11 107.719 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.88 132.53 55.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.962 -0.755 . . . . 1.34 108.962 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 91' ' ' CYS . 8.7 p30 -152.62 170.43 8.1 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-O 118.474 -0.774 . . . . 1.61 109.257 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.48 -39.15 54.92 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.85 2.367 . . . . 1.33 114.465 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.427 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 27.0 t -70.0 -32.06 70.06 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-O 121.224 0.535 . . . . 1.1 111.832 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.19 -146.03 11.75 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 119.864 -1.16 . . . . 0.71 111.969 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.63 138.63 38.03 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.146 -0.687 . . . . 1.83 109.146 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -119.81 146.63 45.52 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.965 -1.124 . . . . 1.16 107.965 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 p -143.74 152.85 41.78 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 121.006 -0.277 . . . . 0.88 110.275 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.58 144.92 26.52 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.86 -1.533 . . . . 1.09 106.86 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -122.44 145.72 48.03 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.472 0.654 . . . . 1.7 112.358 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -133.64 124.76 48.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 125.475 1.51 . . . . 1.38 108.572 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 tpt -96.34 96.52 8.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.687 -1.227 . . . . 1.67 107.687 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.02 113.16 26.16 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.349 0.595 . . . . 1.26 111.44 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.31 99.62 9.01 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 107.093 -1.447 . . . . 1.4 107.093 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 114.209 1.188 . . . . 4.75 114.209 -178.577 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.411 -2.377 0 CA-C-O 121.478 0.656 . . . . 2.01 109.999 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.404 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.2 m-85 -86.52 127.92 34.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.818 -1.083 . . . . 1.61 109.587 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.2 t -84.68 176.47 8.55 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.557 -1.275 . . . . 1.32 107.557 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.11 114.57 26.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 120.357 -0.537 . . . . 1.15 110.55 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.63 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 34.1 t -117.68 131.31 56.65 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.743 -1.206 . . . . 1.67 107.743 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.53 121.26 67.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.507 -0.315 . . . . 1.11 110.936 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.1 123.42 42.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.569 -0.53 . . . . 2.66 109.569 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 27' ' ' PHE . 43.8 mt -105.87 156.02 18.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 1.08 109.937 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.53 151.92 51.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 110.455 -0.202 . . . . 1.34 110.455 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -54.05 133.16 43.68 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 124.786 1.304 . . . . 1.24 110.4 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 145.55 55.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.625 -0.716 . . . . 1.07 110.213 -177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.68 127.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.518 0.675 . . . . 1.21 112.745 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.74 108.83 4.08 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 114.281 -1.327 . . . . 2.52 110.926 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -170.61 -171.7 1.1 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.93 -1.507 . . . . 1.33 106.93 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -66.52 -50.59 62.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.393 -0.523 . . . . 3.4 111.982 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -92.39 120.13 32.6 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.797 -0.816 . . . . 3.18 108.797 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -82.32 120.11 24.99 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.271 0.557 . . . . 1.0 111.023 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.8 121.96 44.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.612 -1.176 . . . . 0.34 109.138 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.4 mt -103.73 103.74 38.45 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 108.054 -1.091 . . . . 1.07 108.054 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.25 130.48 13.06 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.456 2.104 . . . . 0.32 111.85 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD21 ' A' ' 14' ' ' LEU . 43.1 p90 -135.35 162.2 33.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.318 0.58 . . . . 0.42 110.482 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.0 m -144.62 123.48 12.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.651 -0.704 . . . . 1.29 109.157 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.7 p -123.6 114.69 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.079 -0.964 . . . . 1.08 108.495 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.63 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 4.1 p-10 -102.25 158.49 16.15 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.736 -1.186 . . . . 1.39 109.755 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.98 138.72 2.61 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.795 -1.322 . . . . 0.6 109.795 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -87.32 -49.6 0.45 Allowed Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 119.571 -0.852 . . . . 3.29 110.316 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.6 Cg_exo -64.17 119.48 6.54 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 105.255 -2.633 . . . . 1.09 105.255 164.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.17 117.79 59.78 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 116.138 -0.483 . . . . 1.36 112.296 -171.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -85.89 149.53 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.398 2.065 . . . . 0.56 111.941 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -90.91 138.81 31.31 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.77 -1.196 . . . . 1.74 107.77 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.9 mt -98.23 134.06 41.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.938 0.399 . . . . 1.14 111.094 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -130.29 126.22 36.69 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.037 -0.529 . . . . 4.62 110.064 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -96.78 124.33 40.72 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.599 -0.728 . . . . 0.33 109.702 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.97 128.8 55.61 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.492 -0.929 . . . . 1.57 108.492 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -105.01 104.64 14.41 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.169 -1.419 . . . . 1.04 107.169 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.08 30.76 19.65 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.801 0.81 . . . . 2.17 110.961 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.04 64.25 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.39 -0.823 . . . . 0.61 112.392 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -91.45 150.8 21.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.212 -1.032 . . . . 1.84 108.212 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -72.33 121.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.818 -0.628 . . . . 1.31 111.345 -175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -102.66 122.45 44.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.664 -1.235 . . . . 1.33 107.664 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.81 138.32 35.35 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.773 -0.825 . . . . 2.69 108.773 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -75.84 106.15 7.26 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.329 -0.396 . . . . 1.74 110.214 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -88.28 -170.37 2.93 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.852 -0.425 . . . . 2.07 109.852 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -80.12 -13.61 59.14 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.56 -0.713 . . . . 1.9 109.517 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -97.94 -40.1 8.64 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.695 -0.684 . . . . 1.89 110.137 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.12 104.89 17.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.972 -2.232 . . . . 1.18 104.972 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -135.09 149.52 50.07 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.378 -0.929 . . . . 3.62 112.078 -173.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.9 m -94.36 109.62 21.45 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.357 -0.979 . . . . 1.15 108.357 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -100.75 123.79 45.46 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.544 -0.91 . . . . 2.04 108.544 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -100.4 146.17 27.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.716 -0.846 . . . . 0.87 108.716 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.15 154.5 32.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.833 -1.173 . . . . 1.7 107.833 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.49 120.43 81.45 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 123.94 0.775 . . . . 3.36 110.203 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.94 169.53 16.26 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.873 2.382 . . . . 1.63 109.936 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.73 141.2 38.06 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.315 -1.735 . . . . 1.88 106.315 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.93 -25.35 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.107 1.521 . . . . 2.29 115.107 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -73.5 -32.05 64.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.087 0.47 . . . . 3.93 110.411 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -75.23 142.36 43.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.251 0.548 . . . . 1.89 110.1 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 m -111.29 18.03 19.66 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.382 -1.71 . . . . 1.86 106.382 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.81 121.36 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 113.819 -1.537 . . . . 1.19 108.45 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 77.6 ttt180 -93.14 111.39 23.01 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.173 -1.417 . . . . 2.36 107.173 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -101.61 155.65 17.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.46 -0.57 . . . . 1.49 109.46 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.28 -174.74 44.83 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.278 -0.963 . . . . 0.36 112.092 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.4 t -145.3 134.85 23.27 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.177 0.591 . . . . 0.36 111.025 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.0 tp -88.63 107.59 19.0 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.103 -2.184 . . . . 1.06 105.103 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -117.91 130.41 56.22 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.432 0.634 . . . . 3.22 111.228 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.44 114.79 29.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.928 -1.033 . . . . 1.78 110.802 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.33 -39.35 81.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.769 -1.105 . . . . 2.42 109.019 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.34 100.45 49.86 Favored Pre-proline 0 N--CA 1.435 -1.214 0 N-CA-C 107.897 -1.149 . . . . 3.22 107.897 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.6 135.45 24.05 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 122.652 2.234 . . . . 1.62 109.451 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -133.43 149.19 51.79 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.033 0.444 . . . . 1.75 111.514 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -70.14 -4.21 20.31 Favored 'General case' 0 C--O 1.208 -1.085 0 C-N-CA 123.822 0.849 . . . . 2.61 112.117 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.06 -9.78 11.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.416 -0.356 . . . . 1.77 110.178 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.6 m-80 -115.96 26.48 9.94 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.549 0.944 . . . . 2.19 113.549 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -94.32 72.81 3.88 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.075 0.941 . . . . 2.08 110.011 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.5 -153.11 5.88 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.701 -0.761 . . . . 0.59 113.206 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.35 123.84 43.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.967 -0.383 . . . . 2.28 109.967 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.578 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 27.8 m-85 -101.33 116.57 33.1 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.012 -0.736 . . . . 1.03 109.012 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.9 m -110.72 122.32 47.5 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.192 -1.04 . . . . 1.13 108.192 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.4 tp -99.01 119.2 37.4 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.135 -0.484 . . . . 1.07 109.811 -178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 129.38 53.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.554 -0.906 . . . . 1.15 108.554 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.47 120.99 33.61 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.326 -1.361 . . . . 1.11 107.326 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.04 124.8 46.77 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.457 -0.497 . . . . 1.34 111.492 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 43.9 p30 -138.47 171.1 8.8 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.181 -1.414 . . . . 1.61 107.181 174.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 38.9 Cg_exo -45.35 -37.48 14.22 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.043 2.495 . . . . 1.33 114.648 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.04 -49.62 73.84 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.671 0.272 . . . . 1.1 110.824 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.67 -177.65 48.03 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.131 -1.033 . . . . 0.71 111.816 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -108.1 122.58 47.19 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.992 -1.114 . . . . 1.83 107.992 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.88 149.09 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.397 -0.964 . . . . 1.16 108.397 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.1 p -147.42 140.84 25.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 O-C-N 123.464 0.477 . . . . 0.88 110.883 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.17 42.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.318 -1.364 . . . . 1.09 107.318 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.9 p -130.15 146.35 51.78 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.13 0.49 . . . . 1.7 111.842 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.57 138.6 21.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.621 -1.622 . . . . 1.38 106.621 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -111.12 124.1 51.52 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 1.67 110.336 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.62 115.31 25.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.493 -0.558 . . . . 1.26 109.493 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.43 111.65 23.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.982 -0.554 . . . . 1.4 110.303 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 N--CA 1.432 -1.331 0 CA-C-O 121.555 0.693 . . . . 4.75 111.636 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.417 -2.117 0 CA-C-O 121.784 0.802 . . . . 2.01 109.446 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.34 124.89 24.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.875 -1.057 . . . . 1.61 110.992 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 20.6 t -84.46 160.97 20.45 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.428 -1.693 . . . . 1.32 106.428 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.51 121.24 35.86 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.776 -0.77 . . . . 1.15 111.42 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -112.3 141.88 45.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.454 -1.313 . . . . 1.67 107.454 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.36 114.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 110.056 -0.349 . . . . 1.11 110.056 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -112.35 116.4 30.29 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.379 0.609 . . . . 2.66 109.55 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 HG21 ' A' ' 98' ' ' ILE . 70.7 mt -104.87 156.81 17.68 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.96 -1.018 . . . . 1.08 109.035 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -131.13 156.52 45.14 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.762 -0.829 . . . . 1.34 108.762 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -65.08 134.76 54.51 Favored 'General case' 0 N--CA 1.423 -1.806 0 O-C-N 124.456 1.097 . . . . 1.24 109.63 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.9 56.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.25 -0.886 . . . . 1.07 109.684 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.67 132.97 33.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.547 0.689 . . . . 1.21 110.652 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.44 102.39 2.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.427 -1.261 . . . . 2.52 112.465 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -161.37 -179.42 7.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.812 -1.551 . . . . 1.33 106.812 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -64.55 -37.66 88.34 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.468 1.031 . . . . 3.4 113.401 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -107.22 117.91 35.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.906 -1.516 . . . . 3.18 106.906 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.435 ' HB2' HD13 ' A' ' 72' ' ' LEU . 78.3 m95 -82.05 125.55 30.96 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.159 -0.616 . . . . 1.0 110.681 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -108.67 121.43 45.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.146 -1.057 . . . . 0.34 108.146 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 60.3 mt -102.89 98.11 10.77 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 107.693 -1.225 . . . . 1.07 107.693 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.92 132.08 19.33 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.392 2.061 . . . . 0.32 112.056 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -128.69 152.79 48.0 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.327 0.584 . . . . 0.42 110.481 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -142.18 120.63 12.42 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.265 -0.88 . . . . 1.29 108.927 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 37' ' ' LEU . 2.9 p -124.61 121.16 60.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.335 -0.987 . . . . 1.08 108.335 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 p-10 -111.55 145.49 39.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.737 -0.785 . . . . 1.39 110.204 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.62 4.73 Favored Glycine 0 C--N 1.298 -1.529 0 N-CA-C 107.504 -2.238 . . . . 0.6 107.504 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 33' ' ' PRO 0.278 46.1 tt0 -80.87 -57.43 0.58 Allowed Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 118.649 1.224 . . . . 3.29 113.168 -175.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 32.4 Cg_exo -63.69 119.74 6.89 Favored 'Trans proline' 0 C--N 1.367 1.509 0 N-CA-C 106.28 -2.239 . . . . 1.09 106.28 168.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.93 109.84 2.86 Favored Pre-proline 0 C--N 1.315 -0.923 0 O-C-N 123.806 0.691 . . . . 1.36 111.076 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 59.1 Cg_endo -71.16 141.67 40.14 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.162 1.908 . . . . 0.56 112.512 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -71.26 104.24 3.07 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.463 -0.79 . . . . 1.74 108.952 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 29' ' ' VAL . 96.0 mt -81.78 134.03 35.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.352 -0.84 . . . . 1.14 109.813 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -146.39 138.59 25.03 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 123.687 0.795 . . . . 4.62 108.86 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -102.78 130.67 49.84 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.378 0.609 . . . . 0.33 110.625 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 tp -114.72 126.79 55.26 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.954 -1.869 . . . . 1.57 105.954 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -116.63 98.12 6.36 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 109.077 -0.712 . . . . 1.04 109.077 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 51.92 56.6 7.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.167 0.984 . . . . 2.17 110.23 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.02 -13.95 12.54 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.089 -0.96 . . . . 0.61 113.816 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 m -96.6 140.99 30.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.853 -0.795 . . . . 1.84 108.853 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.92 123.45 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.461 -1.311 . . . . 1.31 107.461 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.4 tp -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.58 0.55 . . . . 1.33 109.587 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -82.83 125.83 31.75 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.486 -0.931 . . . . 2.69 108.486 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.36 153.19 35.99 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.222 -0.445 . . . . 1.74 110.031 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.9 t -166.05 -175.28 3.29 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.748 -0.834 . . . . 2.07 108.748 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 m -68.22 -17.67 64.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 119.594 1.088 . . . . 1.9 111.901 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -79.07 -40.17 31.94 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.729 0.3 . . . . 1.89 110.831 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 ' ND2' ' A' ' 79' ' ' ASN . 56.9 mt -136.15 115.66 16.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.929 -0.767 . . . . 1.18 108.929 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -142.39 145.69 34.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.107 0.479 . . . . 3.62 112.057 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 m -82.58 111.19 18.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.466 -0.788 . . . . 1.15 109.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 6.4 mm-40 -89.3 140.39 29.54 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.899 -0.778 . . . . 2.04 108.899 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -122.27 140.67 52.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.749 -0.834 . . . . 0.87 108.749 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.59 151.71 41.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.027 -1.101 . . . . 1.7 108.027 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -63.46 119.97 58.2 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 123.96 0.788 . . . . 3.36 112.598 -174.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.95 156.13 38.77 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.588 2.192 . . . . 1.63 110.351 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.89 146.91 33.31 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.667 -0.864 . . . . 1.88 108.667 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.69 -13.05 58.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.019 1.118 . . . . 2.29 114.019 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -90.57 -21.47 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.916 0.388 . . . . 3.93 111.424 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.4 pt-20 -99.28 162.47 13.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.689 -0.804 . . . . 1.89 110.957 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -121.49 29.71 7.09 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.966 -1.494 . . . . 1.86 106.966 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.93 128.76 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.22 -1.355 . . . . 1.19 108.807 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB2' HG12 ' A' ' 29' ' ' VAL . 78.2 mtp180 -92.59 132.59 36.73 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.003 -1.48 . . . . 2.36 107.003 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -121.97 143.73 49.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.302 -0.629 . . . . 1.49 109.302 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.7 -166.09 24.11 Favored Glycine 0 N--CA 1.416 -2.642 0 C-N-CA 120.512 -0.851 . . . . 0.36 111.035 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.0 t -156.07 137.57 14.06 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.833 0.453 . . . . 0.36 110.183 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.3 tp -90.16 107.93 19.43 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.851 -1.907 . . . . 1.06 105.851 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.419 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 70.6 mtt180 -100.18 120.35 39.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-N 116.502 -0.317 . . . . 3.22 110.873 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 23' ' ' TRP . 73.1 mt -83.7 108.0 16.49 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 105.96 -1.867 . . . . 1.78 105.96 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -66.97 -42.62 84.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.047 -0.979 . . . . 2.42 109.532 -176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -134.98 100.99 11.63 Favored Pre-proline 0 N--CA 1.412 -2.341 0 N-CA-C 106.533 -1.655 . . . . 3.22 106.533 171.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 14.3 Cg_exo -70.38 131.42 20.33 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.022 1.814 . . . . 1.62 110.367 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 p -130.27 155.74 45.8 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.312 -0.995 . . . . 1.75 108.312 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -65.41 -5.42 7.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.444 1.276 . . . . 2.61 114.444 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.49 -10.44 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 109.638 -0.504 . . . . 1.77 109.638 174.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' ND2' HD12 ' A' ' 52' ' ' ILE . 13.8 m120 -89.18 17.15 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.599 0.76 . . . . 2.19 111.882 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -92.15 121.9 34.13 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.874 -0.788 . . . . 2.08 108.874 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.53 -170.45 36.5 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.39 -1.386 . . . . 0.59 112.641 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.83 101.29 13.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.996 -0.602 . . . . 2.28 110.721 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' HB2' HG22 ' A' ' 98' ' ' ILE . 45.1 m-85 -83.97 114.13 21.49 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 m -117.32 132.46 56.6 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 121.452 -0.78 . . . . 1.13 110.683 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.3 tp -106.18 123.1 47.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.124 -0.695 . . . . 1.07 109.124 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.11 136.07 47.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.254 -1.017 . . . . 1.15 108.254 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -126.84 120.62 29.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.28 117.19 34.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.796 -0.446 . . . . 1.34 109.796 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -131.31 151.59 79.07 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-O 117.405 -1.283 . . . . 1.61 108.31 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -43.1 -38.42 7.43 Favored 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 122.799 2.332 . . . . 1.33 113.38 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.1 t -64.16 -39.66 94.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.486 0.714 . . . . 1.1 112.137 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.14 30.96 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.149 -0.78 . . . . 0.71 111.149 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 64.5 tt0 -128.83 129.91 46.23 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.729 -0.471 . . . . 1.83 109.729 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.43 150.51 23.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.747 -0.834 . . . . 1.16 108.747 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 p -148.65 123.73 10.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.977 -0.556 . . . . 0.88 110.183 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.41 51.88 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.006 -1.109 . . . . 1.09 108.006 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.4 m -121.17 132.79 55.05 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.699 0.761 . . . . 1.7 112.819 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -109.78 126.55 66.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 125.541 1.536 . . . . 1.38 108.685 175.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.51 ' N ' HD13 ' A' ' 98' ' ' ILE . 16.0 tpt -105.08 111.09 23.73 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 1.67 108.209 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.6 149.7 27.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.218 -0.447 . . . . 1.26 109.961 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.6 127.33 23.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.799 -0.637 . . . . 1.4 110.475 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 75' ' ' PRO . 55.4 t80 . . . . . 0 C--N 1.299 -1.604 0 C-N-CA 124.994 1.317 . . . . 4.75 107.876 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 105.846 -1.909 . . . . 2.01 105.846 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -72.13 131.73 43.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.262 -0.881 . . . . 1.61 110.084 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.36 157.1 21.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.61 -1.256 . . . . 1.32 107.61 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.56 127.2 41.4 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.624 0.601 . . . . 1.15 112.624 -172.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.3 m -123.87 141.05 52.38 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.933 -1.877 . . . . 1.67 105.933 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.0 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.074 0.464 . . . . 1.11 109.755 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -115.81 116.85 28.73 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.001 -0.74 . . . . 2.66 109.001 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -95.68 156.66 16.23 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.965 -0.561 . . . . 1.08 109.631 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -130.54 142.04 50.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.954 -1.499 . . . . 1.34 106.954 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -62.11 130.1 43.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 124.053 0.846 . . . . 1.24 110.558 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.56 140.63 40.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.451 1.1 . . . . 1.07 112.207 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.7 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.754 -0.657 . . . . 1.21 109.886 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.3 117.27 24.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.991 -1.004 . . . . 2.52 112.394 -171.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.0 ptt? -168.28 -174.27 2.23 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.129 -1.434 . . . . 1.33 107.129 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 8.0 t-80 -65.54 -52.65 50.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.794 0.724 . . . . 3.4 110.639 -176.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.462 ' O ' ' HG3' ' A' ' 20' ' ' MET . 7.8 p-80 -99.35 126.65 45.26 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.625 -0.879 . . . . 3.18 108.625 173.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -82.36 148.0 28.51 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.178 0.513 . . . . 1.0 112.224 -171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 44.0 t -131.55 118.89 20.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.506 -0.924 . . . . 0.34 108.506 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 78.3 mt -103.68 99.18 14.84 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.455 -1.313 . . . . 1.07 107.455 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.0 143.58 36.58 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.087 1.858 . . . . 0.32 110.887 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -137.73 154.58 49.61 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.724 -0.39 . . . . 0.42 110.349 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -132.62 114.06 13.77 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.638 -0.71 . . . . 1.29 110.208 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 37' ' ' LEU . 6.4 p -129.57 137.81 55.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.813 -1.551 . . . . 1.08 106.813 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.3 p-10 -132.34 161.88 32.45 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 119.741 -0.784 . . . . 1.39 110.744 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.94 153.74 7.34 Favored Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 109.502 -1.439 . . . . 0.6 109.502 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -81.31 -56.68 0.59 Allowed Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 107.973 -1.121 . . . . 3.29 107.973 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.83 120.85 7.73 Favored 'Trans proline' 0 C--N 1.375 1.928 0 N-CA-C 107.59 -1.734 . . . . 1.09 107.59 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HB2' HH21 ' A' ' 66' ' ' ARG . . . -61.78 114.41 11.18 Favored Pre-proline 0 C--N 1.312 -1.023 0 O-C-N 123.742 0.651 . . . . 1.36 111.694 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' ALA . 84.8 Cg_endo -79.1 135.05 12.01 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.572 1.515 . . . . 0.56 112.058 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 p -73.53 116.47 14.14 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 109.023 -0.732 . . . . 1.74 109.023 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.432 HD22 HG13 ' A' ' 29' ' ' VAL . 93.2 mt -87.22 127.53 35.16 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.434 -0.803 . . . . 1.14 109.647 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -125.7 130.21 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.127 -0.694 . . . . 4.62 109.127 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.5 m95 -95.64 128.87 42.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.277 0.561 . . . . 0.33 109.734 176.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.1 tp -118.59 127.42 53.59 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.703 -1.962 . . . . 1.57 105.703 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -119.91 110.85 17.21 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.587 -0.523 . . . . 1.04 109.587 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.0 28.5 16.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.061 0.945 . . . . 2.17 111.45 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.09 -12.27 69.4 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 121.389 -0.434 . . . . 0.61 112.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.1 p -103.18 151.31 22.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.754 0.311 . . . . 1.84 110.315 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.28 120.76 17.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.667 -0.697 . . . . 1.31 110.436 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.9 tp -94.42 104.44 16.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.05 -0.722 . . . . 1.33 109.05 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -85.74 137.31 32.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.252 -0.647 . . . . 2.69 109.252 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.42 129.18 39.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.956 -0.566 . . . . 1.74 109.536 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 p -126.64 -163.69 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.853 0.861 . . . . 2.07 109.661 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.6 m -87.19 -5.83 58.83 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.359 0.599 . . . . 1.9 109.661 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -103.0 -35.56 8.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.81 -0.632 . . . . 1.89 109.955 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -127.93 106.97 15.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.231 -1.025 . . . . 1.18 108.231 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -138.78 140.22 38.54 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.817 0.341 . . . . 3.62 110.303 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -86.83 113.81 22.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.706 -0.85 . . . . 1.15 108.706 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -105.52 115.06 29.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.397 0.618 . . . . 2.04 110.062 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -96.37 150.63 20.37 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.35 -0.841 . . . . 0.87 109.455 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.0 pp -106.91 165.15 11.55 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.743 -1.947 . . . . 1.7 105.743 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.4 104.74 21.43 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.556 -0.535 . . . . 3.36 109.556 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 86.9 Cg_endo -84.08 165.32 13.15 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.379 2.052 . . . . 1.63 111.145 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.32 137.29 54.54 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.962 -1.125 . . . . 1.88 107.962 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.03 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.012 0.525 . . . . 2.29 111.981 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.49 -26.01 65.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.755 0.788 . . . . 3.93 109.149 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -98.38 140.1 33.15 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.526 -0.761 . . . . 1.89 109.04 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -104.99 28.72 6.94 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.692 0.758 . . . . 1.86 108.993 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 130.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 115.241 -0.89 . . . . 1.19 109.318 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.431 HH21 ' HB2' ' A' ' 34' ' ' ALA . 75.9 mtt180 -82.74 117.54 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.4 -0.963 . . . . 2.36 108.4 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.505 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 96.1 m-70 -104.38 123.74 47.96 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.368 -0.975 . . . . 1.49 108.368 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.9 39.32 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.473 -0.87 . . . . 0.36 111.395 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.4 t -144.16 137.89 27.76 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 122.439 0.296 . . . . 0.36 110.897 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 58.9 tp -84.68 100.38 11.43 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.759 -2.311 . . . . 1.06 104.759 169.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -104.19 120.17 40.54 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 120.238 -0.585 . . . . 3.22 110.049 -174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.55 108.03 8.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.343 -1.725 . . . . 1.78 106.343 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.82 -49.19 66.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.16 -1.382 . . . . 2.42 109.479 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.4 99.8 18.86 Favored Pre-proline 0 N--CA 1.414 -2.234 0 N-CA-C 104.296 -2.483 . . . . 3.22 104.296 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 21' ' ' HIS . 33.5 Cg_exo -64.06 130.5 27.53 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.388 2.059 . . . . 1.62 111.73 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -135.18 166.02 24.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.56 -0.745 . . . . 1.75 109.383 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -62.54 -5.18 2.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.748 1.759 . . . . 2.61 115.748 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.17 -10.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.035 0.445 . . . . 1.77 109.834 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.7 26.74 0.39 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.113 1.153 . . . . 2.19 114.113 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.14 125.17 53.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.321 -0.992 . . . . 2.08 108.321 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.38 -165.71 30.96 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.21 -0.995 . . . . 0.59 111.744 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -99.96 124.0 44.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 110.024 -0.362 . . . . 2.28 110.024 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -102.67 105.79 16.32 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.622 -0.881 . . . . 1.03 108.622 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.6 m -97.33 129.58 44.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.948 -0.76 . . . . 1.13 108.948 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.2 tp -109.06 120.77 43.53 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.582 -0.525 . . . . 1.07 109.582 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.23 138.95 42.46 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.283 -1.006 . . . . 1.15 108.283 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.94 120.66 30.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.306 -0.998 . . . . 1.11 108.306 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -97.97 112.46 24.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.34 0.59 . . . . 1.34 110.97 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -130.61 140.92 40.13 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.13 -1.804 . . . . 1.61 106.13 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.16 -19.57 12.43 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 124.052 3.168 . . . . 1.33 113.947 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.0 t -78.93 -24.29 44.11 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.825 0.345 . . . . 1.1 110.593 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.52 163.61 11.76 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.555 -1.018 . . . . 0.71 110.555 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -98.12 127.65 44.18 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.478 -0.564 . . . . 1.83 109.478 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.27 155.35 18.28 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.05 -0.722 . . . . 1.16 109.05 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 39.6 p -146.02 151.56 37.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 123.232 0.332 . . . . 0.88 110.609 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.44 33.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.662 -1.607 . . . . 1.09 106.662 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 m -135.02 135.47 41.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 117.983 0.356 . . . . 1.7 110.157 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.79 134.68 63.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.844 -1.539 . . . . 1.38 106.844 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.9 ttt -108.69 134.27 51.64 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.177 -0.609 . . . . 1.67 110.063 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.54 45.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.018 -1.104 . . . . 1.26 108.018 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.51 121.04 34.64 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.025 0.44 . . . . 1.4 110.351 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.5 t80 . . . . . 0 N--CA 1.402 -2.847 0 N-CA-C 108.577 -0.897 . . . . 4.75 108.577 179.35 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 108.736 -0.839 . . . . 2.01 108.736 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.41 127.3 53.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.235 -0.654 . . . . 1.61 109.235 176.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 t -84.64 -177.87 6.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.276 . . . . 1.32 107.553 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.29 120.5 34.62 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.069 -0.652 . . . . 1.15 111.186 -174.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 1.5 m -114.82 131.17 56.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.803 -1.184 . . . . 1.67 107.803 177.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.1 t -119.65 115.01 46.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 110.14 -0.318 . . . . 1.11 110.14 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -120.38 121.96 39.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.335 -0.393 . . . . 2.66 110.033 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 27' ' ' PHE . 17.1 mt -104.16 155.25 18.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.917 -0.583 . . . . 1.08 110.786 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -131.96 151.56 51.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.235 -1.024 . . . . 1.34 108.235 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -64.48 135.8 56.42 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.278 0.986 . . . . 1.24 111.515 -174.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB1' HG12 ' A' ' 25' ' ' ILE . . . -61.1 128.91 38.73 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.826 -1.079 . . . . 1.07 111.332 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.64 136.81 24.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 116.053 -0.521 . . . . 1.21 110.427 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -87.37 129.73 34.91 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.271 -0.422 . . . . 2.52 111.155 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -176.86 -166.91 0.16 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.918 -1.512 . . . . 1.33 106.918 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -55.18 -38.44 68.34 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.815 0.672 . . . . 3.4 112.815 -178.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.53 132.72 54.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.102 -1.073 . . . . 3.18 108.102 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.452 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 64.5 m95 -81.94 119.25 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 -179.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.4 t -113.53 119.25 36.9 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.625 -0.716 . . . . 0.34 110.356 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.424 HG12 ' HB1' ' A' ' 17' ' ' ALA . 40.8 mt -104.15 96.27 9.39 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.8 -1.556 . . . . 1.07 106.8 171.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.05 141.58 14.89 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.644 2.229 . . . . 0.32 112.723 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.479 ' HB3' HD21 ' A' ' 14' ' ' LEU . 51.4 p90 -145.85 156.78 43.79 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.067 -0.515 . . . . 0.42 111.416 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -129.07 123.53 32.51 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 115.036 -0.984 . . . . 1.29 108.758 175.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' SER . 1.5 p -122.01 110.47 27.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.271 -0.877 . . . . 1.08 109.015 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 p30 -106.8 152.94 23.19 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.879 -0.601 . . . . 1.39 111.353 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.5 158.47 9.92 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 109.315 -1.514 . . . . 0.6 109.315 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 23.8 tm0? -84.79 -51.02 0.56 Allowed Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 117.74 0.77 . . . . 3.29 109.972 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 12.1 Cg_exo -73.57 134.81 21.0 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 N-CA-C 107.589 -1.735 . . . . 1.09 107.589 168.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.0 117.05 61.08 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 110.251 -0.277 . . . . 1.36 110.251 -177.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HB3' ' HB2' ' A' ' 89' ' ' ASN . 73.1 Cg_endo -82.97 154.62 14.9 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.442 2.095 . . . . 0.56 112.727 -177.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -83.35 125.14 31.34 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.779 -1.193 . . . . 1.74 107.779 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.13 130.95 40.13 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 120.873 0.368 . . . . 1.14 110.044 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -135.61 135.23 40.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.421 -0.808 . . . . 4.62 109.633 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.6 m95 -96.01 132.05 41.75 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.237 0.542 . . . . 0.33 110.528 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.8 tp -119.47 126.86 52.32 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.444 -1.687 . . . . 1.57 106.444 176.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -115.89 107.5 15.09 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.277 -1.008 . . . . 1.04 108.277 -177.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 62.24 19.91 11.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.616 0.766 . . . . 2.17 112.727 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.1 -8.96 50.09 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.263 -0.97 . . . . 0.61 112.213 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 m -105.97 137.88 43.12 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.384 -0.599 . . . . 1.84 109.384 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.3 127.87 28.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.178 0.513 . . . . 1.31 110.345 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.56 106.69 18.22 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.374 -0.973 . . . . 1.33 108.374 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -87.68 121.35 30.01 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.306 -1.368 . . . . 2.69 107.306 178.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.77 142.13 24.63 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.662 1.226 . . . . 1.74 112.386 -177.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 p -128.11 -172.15 2.62 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.67 -0.695 . . . . 2.07 109.982 -177.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 m -76.07 -12.81 60.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.667 0.27 . . . . 1.9 111.286 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.97 -40.84 7.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.918 0.389 . . . . 1.89 110.549 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.3 mt -115.89 106.41 20.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.046 -1.465 . . . . 1.18 107.046 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -147.46 152.57 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.179 0.514 . . . . 3.62 112.057 -175.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 m -96.07 118.7 33.18 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.264 -0.88 . . . . 1.15 111.045 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.13 143.1 33.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.327 -0.99 . . . . 2.04 108.327 173.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.49 135.8 51.55 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.2 -0.296 . . . . 0.87 110.2 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.47 165.44 13.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.747 -1.205 . . . . 1.7 107.747 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -64.23 112.64 8.05 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 113.389 0.885 . . . . 3.36 113.389 -170.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.4 132.26 7.94 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.601 2.201 . . . . 1.63 110.188 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 62' ' ' ASN . . . -90.42 146.24 24.31 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.819 -0.752 . . . . 1.88 109.492 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.37 11.69 2.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.452 0.644 . . . . 2.29 110.809 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 60' ' ' ALA . 17.5 m120 -105.8 2.24 27.63 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.466 1.106 . . . . 3.93 109.34 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.95 157.41 44.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.826 -1.176 . . . . 1.89 107.826 -178.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 p -111.4 36.24 3.3 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.213 1.006 . . . . 1.86 109.259 175.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.66 128.69 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.445 -1.252 . . . . 1.19 109.095 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HB3' HG12 ' A' ' 29' ' ' VAL . 77.3 ttt180 -99.71 133.94 43.32 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.0 -1.482 . . . . 2.36 107.0 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -126.62 132.58 51.22 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.982 -0.377 . . . . 1.49 109.982 -174.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.81 27.84 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 119.953 -1.118 . . . . 0.36 111.674 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.579 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 14.2 t -149.78 134.67 17.83 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.569 0.223 . . . . 0.36 110.773 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 38.3 tp -83.24 108.46 16.49 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.22 -1.77 . . . . 1.06 106.22 173.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.579 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 35.7 mtp85 -109.61 102.73 11.54 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.864 -0.607 . . . . 3.22 111.905 -173.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.4 109.98 17.77 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.746 -0.661 . . . . 1.78 109.986 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -69.61 -29.01 66.42 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.585 -1.189 . . . . 2.42 110.219 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -125.62 108.72 25.98 Favored Pre-proline 0 N--CA 1.425 -1.712 0 N-CA-C 108.444 -0.947 . . . . 3.22 108.444 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.65 129.76 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.253 1.302 . . . . 1.62 109.36 176.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -125.99 141.55 51.91 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.329 -0.619 . . . . 1.75 109.329 -175.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -77.83 -18.9 55.79 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 116.163 -0.471 . . . . 2.61 110.715 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.78 -23.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.41 -0.359 . . . . 1.77 111.19 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.568 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 55.5 m-80 -97.84 26.75 4.89 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.852 1.427 . . . . 2.19 114.852 -176.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -83.77 122.73 29.05 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.4 -1.333 . . . . 2.08 107.4 174.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.27 -160.19 32.89 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.622 -1.275 . . . . 0.59 113.215 -177.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.55 111.69 23.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.008 0.523 . . . . 2.28 110.929 -175.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 34.5 m-85 -94.74 115.37 27.43 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.948 -0.569 . . . . 1.03 109.896 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 83.5 m -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 109.304 -0.628 . . . . 1.13 109.304 177.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' SER . 57.3 tp -96.83 121.13 38.35 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.678 -0.86 . . . . 1.07 108.678 179.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.94 134.38 48.15 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.806 -0.813 . . . . 1.15 108.806 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.98 119.52 34.53 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.313 -1.366 . . . . 1.11 107.313 170.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.54 112.7 24.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.614 -0.884 . . . . 1.34 108.614 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 21.0 t-20 -132.94 146.46 61.38 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.761 -1.2 . . . . 1.61 107.761 -175.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.97 -16.43 38.8 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.433 2.756 . . . . 1.33 113.419 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 t -80.79 -38.69 28.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.872 0.368 . . . . 1.1 110.267 175.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 169.75 170.13 33.84 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.267 -1.533 . . . . 0.71 109.267 -177.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -110.27 121.21 44.74 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.034 0.445 . . . . 1.83 110.245 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.89 147.54 26.78 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.849 -0.614 . . . . 1.16 109.844 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 46.9 p -140.46 144.82 36.28 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.216 0.323 . . . . 0.88 110.344 177.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.3 46.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.484 . . . . 1.09 106.992 175.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -129.87 130.36 45.11 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 118.286 0.493 . . . . 1.7 111.073 -174.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 128.1 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.369 -1.345 . . . . 1.38 107.369 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.77 114.98 26.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.985 -1.116 . . . . 1.67 107.985 -178.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.43 113.84 26.23 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.448 0.642 . . . . 1.26 111.028 -175.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.01 102.78 14.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.281 -0.872 . . . . 1.4 109.154 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.409 -0.814 . . . . 4.75 110.841 179.704 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.379 -3.987 0 CA-C-O 122.143 0.973 . . . . 2.01 109.889 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -83.38 129.83 35.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.892 -1.151 . . . . 1.61 107.892 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 27.7 m -84.49 167.03 16.76 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.983 -1.118 . . . . 1.32 107.983 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.66 129.83 41.38 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.565 0.698 . . . . 1.15 112.413 -170.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 t -124.32 136.08 53.83 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.043 -1.836 . . . . 1.67 106.043 175.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -115.31 126.99 73.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.227 0.537 . . . . 1.11 111.155 -175.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -121.14 120.47 35.36 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.809 -1.087 . . . . 2.66 109.062 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.58 145.55 38.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.842 -0.799 . . . . 1.08 108.842 176.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -132.19 154.21 49.79 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.913 0.387 . . . . 1.34 110.958 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 m -58.99 134.49 57.03 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.708 -1.133 . . . . 1.24 111.684 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.412 ' HB1' HG12 ' A' ' 25' ' ' ILE . . . -60.6 145.53 48.59 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.286 1.034 . . . . 1.07 111.929 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -92.27 138.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.201 -0.454 . . . . 1.21 109.996 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -82.61 108.44 16.0 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.388 0.613 . . . . 2.52 112.618 -176.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -157.97 -178.78 7.56 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.212 -1.773 . . . . 1.33 106.212 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -63.25 -39.45 94.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 119.375 0.989 . . . . 3.4 112.867 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.32 122.42 44.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.485 -1.302 . . . . 3.18 107.485 176.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.24 126.76 32.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.112 0.482 . . . . 1.0 111.593 -173.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -120.35 117.45 27.79 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.34 109.989 -177.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.412 HG12 ' HB1' ' A' ' 17' ' ' ALA . 75.7 mt -99.41 105.04 30.7 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.682 -1.229 . . . . 1.07 107.682 173.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.88 136.74 19.03 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 122.261 1.974 . . . . 0.32 111.687 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -137.56 159.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.187 0.518 . . . . 0.42 110.018 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -141.97 119.55 11.72 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.636 -0.711 . . . . 1.29 109.77 176.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.93 125.95 67.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.044 -1.465 . . . . 1.08 107.044 176.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.4 p-10 -115.36 155.71 26.86 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.246 -0.982 . . . . 1.39 110.592 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 140.77 3.06 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.506 -1.437 . . . . 0.6 109.506 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -75.77 -54.6 2.17 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 108.169 -1.049 . . . . 3.29 108.169 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -65.76 122.8 10.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 N-CA-C 108.644 -1.329 . . . . 1.09 108.644 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.96 121.22 80.81 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 116.383 -0.371 . . . . 1.36 111.693 -175.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.76 155.54 11.77 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.898 1.732 . . . . 0.56 111.988 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -82.66 109.98 17.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.903 -0.777 . . . . 1.74 108.903 176.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.97 119.2 25.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.108 0.48 . . . . 1.14 110.472 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -126.65 126.12 43.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.602 -0.726 . . . . 4.62 110.324 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -91.81 119.67 31.83 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.181 -0.918 . . . . 0.33 109.662 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -109.92 127.71 54.91 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 1.57 105.7 173.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -118.81 106.09 12.18 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 110.298 -0.26 . . . . 1.04 110.298 -174.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 59.07 30.95 20.88 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.544 1.164 . . . . 2.17 110.603 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.08 82.61 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.521 -0.763 . . . . 0.61 113.092 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 p -104.78 140.97 37.31 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.338 -0.507 . . . . 1.84 109.872 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.61 114.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 1.31 111.031 -176.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.9 tp -90.21 112.22 23.67 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.337 -0.986 . . . . 1.33 108.337 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -93.49 136.98 33.24 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.682 -0.858 . . . . 2.69 108.682 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.14 100.46 0.61 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.368 0.667 . . . . 1.74 109.924 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.8 p -93.49 -167.1 1.64 Allowed 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.009 0.524 . . . . 2.07 111.397 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -77.09 -20.93 55.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.181 0.515 . . . . 1.9 110.563 175.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 99.6 m-85 -95.8 -36.51 11.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.03 0.443 . . . . 1.89 110.641 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 mt -112.41 105.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.213 -1.403 . . . . 1.18 107.213 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -134.61 155.42 50.49 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.098 0.475 . . . . 3.62 111.538 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -107.29 114.48 28.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.587 -0.523 . . . . 1.15 109.587 -178.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.11 132.4 34.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.358 -0.608 . . . . 2.04 109.358 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -122.13 149.49 43.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.779 -0.452 . . . . 0.87 109.779 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.01 163.43 20.47 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.804 -1.184 . . . . 1.7 107.804 173.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.54 116.63 64.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 123.58 0.55 . . . . 3.36 111.191 -177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.39 141.28 46.27 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.626 2.217 . . . . 1.63 110.35 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.76 145.12 55.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.78 -0.822 . . . . 1.88 108.78 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.17 -10.22 39.29 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.228 0.825 . . . . 2.29 113.228 -174.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -92.58 1.34 57.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.691 0.282 . . . . 3.93 110.875 178.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.23 170.69 15.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.356 -0.609 . . . . 1.89 109.356 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.7 p -132.45 26.8 4.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.401 0.62 . . . . 1.86 111.113 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.55 127.85 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.226 -0.657 . . . . 1.19 109.226 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -88.67 115.16 26.0 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.352 -1.351 . . . . 2.36 107.352 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -99.67 136.86 38.96 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.42 -0.955 . . . . 1.49 108.42 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.11 -178.26 43.91 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 119.941 -1.123 . . . . 0.36 112.22 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -148.99 136.6 20.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.69 0.396 . . . . 0.36 110.774 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 tp -85.6 103.7 14.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 105.035 -2.209 . . . . 1.06 105.035 171.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -111.44 127.4 55.67 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 119.955 -0.698 . . . . 3.22 110.39 -173.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.9 mp -108.85 109.78 20.98 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.937 -1.505 . . . . 1.78 106.937 178.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.52 -43.39 90.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.604 -0.725 . . . . 2.42 109.267 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -135.59 112.02 10.7 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 107.419 -1.326 . . . . 3.22 107.419 172.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.48 137.41 20.65 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.599 1.533 . . . . 1.62 111.654 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.8 p -83.48 148.52 27.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.553 -1.647 . . . . 1.75 106.553 174.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -58.39 -20.35 43.49 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.564 0.95 . . . . 2.61 113.564 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.69 -10.53 13.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 O-C-N 123.202 0.314 . . . . 1.77 111.433 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.63 26.22 0.24 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.041 1.126 . . . . 2.19 114.041 -174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -106.85 87.76 2.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.676 -1.231 . . . . 2.08 107.676 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.72 -161.72 24.34 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.634 -0.793 . . . . 0.59 112.053 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 52.4 t-20 -97.16 125.2 41.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.764 0.316 . . . . 2.28 110.557 -177.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -98.46 106.55 18.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.317 -0.994 . . . . 1.03 108.317 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -97.85 114.9 27.08 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.486 -0.931 . . . . 1.13 108.486 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.6 tp -95.43 116.86 29.38 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.273 -0.64 . . . . 1.07 109.273 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.37 127.75 52.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.27 -1.011 . . . . 1.15 108.27 177.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.46 120.1 37.08 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.994 -1.113 . . . . 1.11 107.994 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.24 112.65 25.42 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.967 -0.753 . . . . 1.34 108.967 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 26.8 t-20 -120.5 147.06 44.53 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 106.48 -1.674 . . . . 1.61 106.48 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.07 -19.64 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.894 2.396 . . . . 1.33 113.623 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.3 -29.2 23.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.818 0.342 . . . . 1.1 110.239 178.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 170.64 179.37 41.94 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 110.916 -0.874 . . . . 0.71 110.916 -179.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -112.55 139.99 47.68 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 109.448 -0.575 . . . . 1.83 109.448 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -120.53 153.05 37.24 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.9 -0.778 . . . . 1.16 108.9 178.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 48.5 p -150.35 155.39 39.53 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.377 0.423 . . . . 0.88 110.194 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.36 165.53 34.71 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.476 -1.676 . . . . 1.09 106.476 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 35.7 m -143.38 125.85 15.78 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 117.972 0.351 . . . . 1.7 110.625 -177.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.75 122.93 65.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.611 -1.255 . . . . 1.38 107.611 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 22.3 ttt -107.41 111.61 24.01 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.046 0.451 . . . . 1.67 110.08 -176.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.11 154.22 36.44 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.013 -0.539 . . . . 1.26 111.6 -174.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.76 123.67 28.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.994 -1.484 . . . . 1.4 106.994 176.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 116.291 -0.413 . . . . 4.75 111.959 -176.312 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.419 -1.995 0 CA-C-O 121.928 0.87 . . . . 2.01 110.136 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -104.72 133.8 48.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.695 -1.139 . . . . 1.61 108.075 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 m -84.86 -165.6 1.24 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.942 -0.762 . . . . 1.32 108.942 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' ALA . . . -94.12 124.62 38.25 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.251 -0.98 . . . . 1.15 111.06 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 t -128.12 129.89 47.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.444 -1.317 . . . . 1.67 107.444 175.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.97 132.56 69.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.673 -0.239 . . . . 1.11 110.664 -174.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -130.38 122.07 27.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.376 0.608 . . . . 2.66 109.711 173.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 48.8 mt -104.68 148.83 26.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.651 -0.704 . . . . 1.08 110.212 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -131.76 150.57 52.11 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.161 -0.681 . . . . 1.34 109.161 -176.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.5 m -49.39 135.23 17.87 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.605 1.562 . . . . 1.24 111.899 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 137.87 50.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.918 -1.037 . . . . 1.07 108.776 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.02 131.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.439 0.638 . . . . 1.21 110.064 -175.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -74.31 91.81 2.22 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.57 -1.196 . . . . 2.52 110.533 -177.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.7 mtm -130.98 -171.61 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.816 -0.439 . . . . 1.33 109.816 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.06 -25.38 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.4 109.691 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -119.84 143.82 47.69 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.456 -0.793 . . . . 3.18 109.83 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.78 124.11 29.96 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.574 0.702 . . . . 1.0 112.044 -177.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.7 121.59 19.88 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.556 -1.202 . . . . 0.34 109.131 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -107.16 100.96 35.76 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 107.738 -1.208 . . . . 1.07 107.738 174.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.14 129.07 11.88 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.545 2.163 . . . . 0.32 112.575 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -126.29 153.38 44.89 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.058 -0.519 . . . . 0.42 110.584 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.1 m -134.93 127.09 29.94 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.94 -0.763 . . . . 1.29 108.94 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 66' ' ' ARG . 2.1 p -127.29 124.99 65.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.39 -0.967 . . . . 1.08 108.39 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.49 149.89 37.39 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.83 -0.348 . . . . 1.39 111.821 -176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 -171.83 33.6 Favored Glycine 0 N--CA 1.428 -1.896 0 O-C-N 124.622 1.201 . . . . 0.6 110.851 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -119.0 -57.29 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-O 118.583 -0.722 . . . . 3.29 112.674 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.97 120.53 8.37 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 108.553 -1.364 . . . . 1.09 108.553 171.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 116.23 16.19 Favored Pre-proline 0 N--CA 1.448 -0.549 0 O-C-N 123.871 0.732 . . . . 1.36 111.53 -175.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -85.62 152.9 10.28 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 121.848 1.698 . . . . 0.56 111.842 -179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 p -82.8 106.07 14.33 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.881 -0.785 . . . . 1.74 108.881 174.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.69 119.75 23.7 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 109.405 -0.591 . . . . 1.14 109.405 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -137.82 131.52 31.26 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.696 -0.683 . . . . 4.62 110.679 -177.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 85.3 m95 -94.81 129.01 41.95 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.569 -0.741 . . . . 0.33 109.713 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.97 129.06 54.96 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 106.639 -1.615 . . . . 1.57 106.639 176.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -112.72 98.05 6.96 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.007 0.432 . . . . 1.04 110.28 -178.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.0 47.68 24.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.554 1.141 . . . . 2.17 111.294 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -22.22 36.59 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.367 -0.833 . . . . 0.61 113.57 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -96.37 143.57 27.3 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 1.84 109.332 -176.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.98 118.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.548 -0.751 . . . . 1.31 109.994 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 tp -82.45 120.67 25.76 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.491 -1.299 . . . . 1.33 107.491 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -107.77 140.09 41.36 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.298 -1.001 . . . . 2.69 108.298 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.89 92.93 0.52 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.662 0.744 . . . . 1.74 109.714 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -88.91 178.97 6.28 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.01 -0.996 . . . . 2.07 108.918 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 t -48.6 -36.91 16.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.171 0.988 . . . . 1.9 112.992 -176.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -110.72 5.59 20.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.113 0.783 . . . . 1.89 113.113 -173.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.15 106.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.472 -1.677 . . . . 1.18 106.472 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -126.72 137.84 53.31 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.414 -0.357 . . . . 3.62 110.439 -171.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 m -92.69 109.39 20.81 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.265 -1.383 . . . . 1.15 107.265 176.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.74 136.9 42.56 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.384 -0.598 . . . . 2.04 109.384 -174.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.01 152.49 36.31 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.9 0.381 . . . . 0.87 110.013 -177.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.51 165.2 11.99 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.402 -1.703 . . . . 1.7 106.402 175.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.38 109.73 11.39 Favored Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 123.169 0.293 . . . . 3.36 110.264 -178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.72 140.09 20.58 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.221 1.948 . . . . 1.63 110.651 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 31.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.236 -1.024 . . . . 1.88 108.236 177.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.73 -13.21 62.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.458 0.646 . . . . 2.29 110.877 -178.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.4 -26.39 65.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.855 -1.066 . . . . 3.93 110.551 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.08 143.42 33.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.114 0.483 . . . . 1.89 110.071 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.7 p -98.32 18.05 17.32 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.762 -1.199 . . . . 1.86 107.762 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.17 129.08 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 114.383 -1.28 . . . . 1.19 109.211 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HB3' HG12 ' A' ' 29' ' ' VAL . 15.5 ttm180 -95.11 132.46 40.01 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.76 -1.57 . . . . 2.36 106.76 177.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -119.6 141.83 48.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.102 -0.333 . . . . 1.49 110.102 -176.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.0 -173.94 34.18 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.409 -1.076 . . . . 0.36 110.409 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 26.8 t -148.27 135.45 20.32 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.064 0.459 . . . . 0.36 111.107 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.3 tp -83.58 114.35 21.46 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 1.06 106.52 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 96.7 mtt180 -114.92 125.05 53.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.506 0.67 . . . . 3.22 111.584 -175.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -111.62 109.84 19.94 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.765 -1.107 . . . . 1.78 108.782 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.46 -35.42 80.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.046 -0.979 . . . . 2.42 111.107 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -128.18 119.76 20.98 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.963 -0.755 . . . . 3.22 108.963 178.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.63 136.95 29.25 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 121.441 1.427 . . . . 1.62 109.068 175.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -128.99 161.04 30.84 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.33 -0.989 . . . . 1.75 108.33 -178.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -68.7 -5.03 17.99 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.472 0.916 . . . . 2.61 113.472 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.62 -9.02 10.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-O 121.069 0.461 . . . . 1.77 110.301 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.807 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.4 m120 -83.4 27.92 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.292 0.637 . . . . 2.19 112.355 -176.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -124.67 103.06 7.91 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.355 -0.98 . . . . 2.08 108.355 -178.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -159.12 30.61 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.684 -0.967 . . . . 0.59 110.684 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.447 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 23.4 t-20 -103.41 122.71 45.42 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 120.736 0.303 . . . . 2.28 110.379 -177.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.807 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 51.3 m-85 -100.49 115.2 29.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.439 -0.578 . . . . 1.03 109.439 178.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -103.31 127.59 50.6 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.496 -0.32 . . . . 1.13 110.183 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.405 ' CB ' HD12 ' A' ' 14' ' ' LEU . 59.9 tp -100.89 120.41 40.11 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.951 -0.759 . . . . 1.07 108.951 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.96 139.09 38.97 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.089 -1.078 . . . . 1.15 108.089 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.07 120.63 19.32 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.164 -1.421 . . . . 1.11 107.164 173.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.53 133.56 53.28 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.754 -0.378 . . . . 1.34 110.996 -178.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -142.76 171.29 7.29 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-O 117.23 -1.367 . . . . 1.61 107.541 175.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.24 -25.16 29.16 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.168 1.912 . . . . 1.33 114.753 -175.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.16 -23.23 38.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.994 0.368 . . . . 1.1 111.994 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.58 -175.63 35.62 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.518 -1.325 . . . . 0.71 113.092 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -124.43 131.19 53.5 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.819 -0.437 . . . . 1.83 109.819 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -106.62 148.46 28.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.454 -0.943 . . . . 1.16 108.454 176.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.4 p -142.57 122.83 13.84 Favored 'General case' 0 N--CA 1.425 -1.705 0 O-C-N 123.401 0.438 . . . . 0.88 110.442 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.81 155.5 43.99 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.799 -1.186 . . . . 1.09 107.799 177.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 50.9 m -130.26 144.22 51.24 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.84 0.352 . . . . 1.7 110.845 -178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -130.24 126.53 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.853 -1.166 . . . . 1.38 107.853 176.908 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 tpt -87.06 114.1 23.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.61 -0.885 . . . . 1.67 108.61 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.11 132.13 53.62 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.87 0.367 . . . . 1.26 110.779 -175.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.23 101.44 4.14 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.154 -1.054 . . . . 1.4 108.154 177.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.991 -0.55 . . . . 4.75 111.865 -179.034 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.408 -2.554 0 N-CA-C 108.085 -1.08 . . . . 2.01 108.085 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.503 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 97.2 m-85 -89.94 134.47 34.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.022 -1.473 . . . . 1.61 107.022 176.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.0 m -83.26 177.0 8.72 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.879 -1.156 . . . . 1.32 107.879 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 94' ' ' ALA . . . -93.25 124.22 37.08 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 119.37 -0.932 . . . . 1.15 111.17 -170.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -123.86 133.08 53.84 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 106.905 -1.517 . . . . 1.67 106.905 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -115.28 118.35 58.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.735 0.303 . . . . 1.11 110.266 -175.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -116.74 116.24 27.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.768 -0.827 . . . . 2.66 108.768 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.3 mt -96.51 156.99 16.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.651 -0.704 . . . . 1.08 110.72 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -129.93 144.65 51.43 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.876 -1.157 . . . . 1.34 107.876 -174.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -57.55 133.49 55.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.953 1.408 . . . . 1.24 110.652 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.28 141.35 52.4 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.074 -0.966 . . . . 1.07 110.3 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -92.65 127.59 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 113.26 0.837 . . . . 1.21 113.26 -177.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -83.97 88.33 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.891 -1.049 . . . . 2.52 108.796 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.03 -169.67 3.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.545 -1.28 . . . . 1.33 107.545 175.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -48.57 -38.18 19.9 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.103 1.149 . . . . 3.4 114.103 -171.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -133.25 139.57 47.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.417 -0.957 . . . . 3.18 108.417 175.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB2' HD13 ' A' ' 72' ' ' LEU . 73.5 m95 -81.34 127.1 32.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.294 0.569 . . . . 1.0 110.442 -175.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -120.81 121.58 38.46 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 114.563 -1.199 . . . . 0.34 108.144 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 52.3 mt -108.27 96.05 17.46 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.139 -1.43 . . . . 1.07 107.139 175.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.69 128.52 13.49 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.333 2.022 . . . . 0.32 111.8 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -120.05 146.68 45.67 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 116.03 -0.532 . . . . 0.42 109.853 178.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -132.59 106.81 8.04 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 108.689 -0.856 . . . . 1.29 108.689 176.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -110.56 111.25 35.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.169 -0.923 . . . . 1.08 108.766 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 p30 -101.3 137.53 39.53 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.396 -0.82 . . . . 1.39 110.148 -178.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.05 146.64 4.61 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 108.699 -1.761 . . . . 0.6 108.699 -176.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.45 -59.79 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 CA-C-O 117.947 -1.025 . . . . 3.29 110.199 -176.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 7.8 Cg_endo -54.81 119.43 6.46 Favored 'Trans proline' 0 C--N 1.393 2.88 0 N-CA-C 107.72 -1.685 . . . . 1.09 107.72 171.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.69 114.68 17.01 Favored Pre-proline 0 C--N 1.291 -1.936 0 CA-C-N 114.567 -1.197 . . . . 1.36 112.746 -171.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.67 150.05 11.35 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 122.134 1.89 . . . . 0.56 112.454 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -84.57 127.04 33.85 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.208 -1.405 . . . . 1.74 107.208 174.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.91 122.69 43.23 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.856 0.36 . . . . 1.14 111.714 -176.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -130.22 128.28 41.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.607 -0.724 . . . . 4.62 110.52 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.452 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 94.1 m95 -90.82 141.2 29.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.924 -0.769 . . . . 0.33 108.924 175.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.32 127.4 41.03 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.206 -1.405 . . . . 1.57 107.206 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -103.13 98.13 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.024 -0.732 . . . . 1.04 109.024 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.67 29.63 7.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.015 0.926 . . . . 2.17 113.311 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.56 -20.57 24.92 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.828 -0.701 . . . . 0.61 113.263 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 m -89.84 137.96 31.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.16 0.48 . . . . 1.84 110.735 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.41 108.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.994 -1.003 . . . . 1.31 111.16 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.8 tp -87.62 114.92 24.68 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.053 -1.091 . . . . 1.33 108.053 178.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.01 140.59 40.95 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.476 -1.305 . . . . 2.69 107.476 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.11 107.87 2.06 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.873 0.869 . . . . 1.74 110.998 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -99.37 -166.13 1.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.191 -0.459 . . . . 2.07 110.122 -178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.5 t -82.02 -13.21 57.71 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.1 -0.704 . . . . 1.9 109.1 176.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -102.03 -38.89 7.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.809 -0.632 . . . . 1.89 110.565 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.8 108.21 24.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.293 -1.373 . . . . 1.18 107.293 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -135.06 137.7 43.15 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.4 -0.92 . . . . 3.62 112.252 -174.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -81.44 111.04 17.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.665 -0.698 . . . . 1.15 110.163 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.28 111.27 23.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.211 0.529 . . . . 2.04 111.051 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -84.09 141.88 30.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.928 -0.578 . . . . 0.87 109.808 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -119.1 160.66 21.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.238 -1.023 . . . . 1.7 108.238 -179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -77.33 119.24 76.68 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 113.368 0.877 . . . . 3.36 113.368 -176.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.1 170.06 8.51 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 123.482 2.788 . . . . 1.63 109.241 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.68 143.02 34.99 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.286 -1.376 . . . . 1.88 107.286 177.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.28 14.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.716 1.747 . . . . 2.29 115.716 -170.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -93.73 -9.98 35.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.61 -0.836 . . . . 3.93 110.831 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.16 126.1 30.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.097 0.475 . . . . 1.89 110.525 178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -95.64 30.75 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.927 1.346 . . . . 1.86 108.372 171.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 33.4 t -116.11 135.48 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.771 -1.558 . . . . 1.19 107.363 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' A' ' 29' ' ' VAL . 31.6 ttm180 -99.44 122.16 42.15 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.361 -1.348 . . . . 2.36 107.361 177.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -108.55 141.13 40.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.485 -0.931 . . . . 1.49 108.485 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.81 -177.34 39.62 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.314 -0.946 . . . . 0.36 110.977 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.2 t -145.14 132.68 20.84 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.556 0.209 . . . . 0.36 110.575 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.9 tp -82.62 111.63 18.77 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.965 -2.235 . . . . 1.06 104.965 170.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -107.23 119.09 38.45 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.96 -0.564 . . . . 3.22 110.195 -172.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 23' ' ' TRP . 77.8 mt -81.05 108.01 14.35 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.695 -1.595 . . . . 1.78 106.695 173.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -69.99 -45.15 67.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.97 -1.014 . . . . 2.42 108.602 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -129.88 101.2 18.47 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.676 -1.602 . . . . 3.22 106.676 172.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -69.03 130.77 20.86 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.37 2.047 . . . . 1.62 111.297 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -128.65 168.85 15.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.361 -0.836 . . . . 1.75 108.983 -177.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.254 14.8 p-80 -68.47 -3.2 10.6 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 113.894 1.072 . . . . 2.61 113.894 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.88 -10.38 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.482 0.658 . . . . 1.77 109.937 174.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.756 HD21 ' HH ' ' A' ' 83' ' ' TYR . 15.7 m120 -85.69 28.09 0.8 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.261 1.025 . . . . 2.19 113.237 -175.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 35.8 p-10 -126.2 99.1 5.74 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.977 0.894 . . . . 2.08 111.735 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . 170.76 -158.18 29.68 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.298 -0.864 . . . . 0.59 111.269 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -97.33 105.69 17.89 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 122.654 0.382 . . . . 2.28 110.343 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.756 ' HH ' HD21 ' A' ' 79' ' ' ASN . 59.0 m-85 -93.0 106.32 18.29 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.244 -0.65 . . . . 1.03 109.244 175.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 38.3 m -92.87 131.99 37.41 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 1.13 109.855 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.2 tp -104.2 117.37 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.148 -0.686 . . . . 1.07 109.148 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.14 129.67 51.87 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.315 -0.994 . . . . 1.15 108.315 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.21 121.03 32.95 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.256 -1.016 . . . . 1.11 108.256 176.2 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.33 126.05 46.15 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.691 -0.403 . . . . 1.34 111.496 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -134.37 169.85 12.81 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 117.448 -1.263 . . . . 1.61 107.695 176.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.9 Cg_endo -43.25 -32.24 3.1 Favored 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 123.539 2.826 . . . . 1.33 115.248 178.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -77.08 -34.91 56.94 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 122.028 -0.42 . . . . 1.1 111.682 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.04 -166.59 38.79 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 120.405 -0.902 . . . . 0.71 112.044 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 27.6 tt0 -124.77 132.97 53.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.993 0.425 . . . . 1.83 110.338 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -108.25 152.26 24.84 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.147 -0.686 . . . . 1.16 109.147 178.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 p -141.54 148.88 40.07 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 123.482 0.489 . . . . 0.88 111.144 -179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.78 144.22 14.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.318 -1.364 . . . . 1.09 107.318 174.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 49.1 m -121.23 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.992 0.425 . . . . 1.7 110.684 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.11 126.27 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.725 -1.213 . . . . 1.38 107.725 178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.4 ttm -92.59 103.86 16.21 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.335 -0.546 . . . . 1.67 110.649 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -95.4 135.0 37.58 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.478 -1.675 . . . . 1.26 106.478 174.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.82 101.52 5.3 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.248 -0.649 . . . . 1.4 109.248 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 34.9 t80 . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.387 -0.824 . . . . 4.75 111.085 179.916 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.421 -1.89 0 N-CA-C 109.136 -0.69 . . . . 2.01 109.136 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 54.9 m-85 -102.33 122.45 44.28 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.387 -1.338 . . . . 1.61 107.387 174.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.25 -179.19 7.15 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.774 -0.648 . . . . 1.32 109.768 -176.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.43 128.56 39.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 119.51 -0.876 . . . . 1.15 112.373 -168.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -121.57 128.22 51.76 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.815 -1.55 . . . . 1.67 106.815 175.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.25 120.02 63.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.819 0.342 . . . . 1.11 110.466 -175.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -119.47 136.03 54.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.816 -0.629 . . . . 2.66 109.764 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 mt -123.06 149.63 44.17 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.386 0.613 . . . . 1.08 110.897 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -131.07 145.48 52.02 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.975 -1.12 . . . . 1.34 107.975 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 m -64.79 139.22 58.74 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.988 -1.006 . . . . 1.24 110.715 -175.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.96 139.31 28.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.638 -1.165 . . . . 1.07 111.951 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -92.07 142.74 12.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.788 -0.642 . . . . 1.21 109.914 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.41 111.61 20.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.57 0.582 . . . . 2.52 112.57 -173.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.1 ptt? -162.39 -173.24 3.5 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.48 -0.933 . . . . 1.33 108.48 175.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 118.634 0.652 . . . . 3.4 112.367 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.409 ' O ' ' HG3' ' A' ' 20' ' ' MET . 81.9 m-70 -110.8 124.82 52.76 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.645 -1.983 . . . . 3.18 105.645 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -82.6 133.48 35.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.295 0.569 . . . . 1.0 111.568 -173.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.7 t -126.56 120.49 29.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.021 -0.99 . . . . 0.34 110.053 -175.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -101.84 101.98 20.98 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.931 -1.137 . . . . 1.07 107.931 174.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.05 131.87 16.04 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.524 2.15 . . . . 0.32 112.504 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.53 160.22 34.8 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.053 0.454 . . . . 0.42 110.374 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -143.99 111.07 5.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.985 -0.746 . . . . 1.29 108.985 176.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG13 HD22 ' A' ' 37' ' ' LEU . 2.6 p -114.06 122.86 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.78 -0.645 . . . . 1.08 109.952 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 28.9 t70 -101.94 141.59 34.55 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.013 -0.54 . . . . 1.39 109.99 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.51 148.13 5.62 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.273 -1.131 . . . . 0.6 110.273 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -55.68 0.39 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.993 -1.114 . . . . 3.29 107.993 178.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.3 Cg_endo -73.28 119.61 6.09 Favored 'Trans proline' 0 C--N 1.382 2.296 0 N-CA-C 107.275 -1.856 . . . . 1.09 107.275 167.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.94 112.85 11.81 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 123.753 0.658 . . . . 1.36 112.512 -172.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 42.1 Cg_endo -70.7 141.49 41.54 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.679 2.253 . . . . 0.56 112.694 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -76.32 112.32 12.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.065 -1.457 . . . . 1.74 107.065 174.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 29' ' ' VAL . 94.2 mt -81.21 131.15 35.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.165 -0.47 . . . . 1.14 111.301 -177.131 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -132.28 131.95 42.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.283 -0.636 . . . . 4.62 109.283 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.482 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 92.0 m95 -98.02 135.39 39.78 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.916 0.389 . . . . 0.33 110.002 177.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.3 tp -116.56 134.44 54.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.246 -1.761 . . . . 1.57 106.246 176.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -121.29 112.52 18.7 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.572 -0.529 . . . . 1.04 109.572 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 57.26 24.82 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.853 0.861 . . . . 2.17 112.464 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.04 4.41 71.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.826 -0.702 . . . . 0.61 112.694 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -113.1 151.85 30.29 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.886 -0.783 . . . . 1.84 108.886 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.31 117.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.157 -0.683 . . . . 1.31 109.157 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.1 tp -82.04 111.33 18.1 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.886 -0.597 . . . . 1.33 109.401 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.66 117.39 23.75 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.147 -1.057 . . . . 2.69 108.147 176.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.96 122.58 18.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.345 -0.389 . . . . 1.74 110.153 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.7 p -105.78 -171.05 1.83 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.389 -0.369 . . . . 2.07 110.047 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -69.35 -21.03 63.85 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.29 0.567 . . . . 1.9 109.828 173.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 58.0 m-85 -91.53 -40.69 11.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.342 -0.39 . . . . 1.89 110.379 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.49 106.47 20.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.628 -1.249 . . . . 1.18 107.628 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.22 145.52 41.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.16 0.505 . . . . 3.62 112.276 -176.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.5 m -84.38 114.06 21.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.63 -0.878 . . . . 1.15 108.63 176.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.4 127.14 54.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.725 -0.843 . . . . 2.04 108.725 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.92 151.17 21.62 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.74 -0.467 . . . . 0.87 109.74 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -119.87 146.61 45.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.65 -1.241 . . . . 1.7 107.65 178.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -47.64 105.95 0.54 Allowed Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 125.744 1.618 . . . . 3.36 114.623 -172.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.54 136.0 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.187 2.592 . . . . 1.63 110.32 174.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.54 159.11 29.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.366 -0.605 . . . . 1.88 109.366 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.62 -3.37 21.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.524 0.564 . . . . 2.29 112.524 -175.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -103.5 9.36 37.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.12 0.486 . . . . 3.93 109.913 175.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.06 131.75 56.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 120.779 -0.369 . . . . 1.89 111.178 -179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.9 p -96.99 2.05 51.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.875 -1.157 . . . . 1.86 107.875 170.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -94.26 128.54 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.17 -1.377 . . . . 1.19 108.578 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.88 121.24 41.02 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.644 -1.613 . . . . 2.36 106.644 178.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -103.8 141.28 36.38 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.758 -0.83 . . . . 1.49 108.758 -175.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.51 -173.7 35.89 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 119.613 -1.28 . . . . 0.36 111.967 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 t -151.07 134.33 16.1 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 123.308 0.643 . . . . 0.36 110.332 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 55.3 tp -84.43 104.19 14.23 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 104.291 -2.485 . . . . 1.06 104.291 169.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -109.34 127.23 54.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.373 -0.531 . . . . 3.22 110.963 -171.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 6.6 mp -103.79 111.36 23.84 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.135 -0.939 . . . . 1.78 109.1 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -64.04 -42.84 96.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.47 -1.241 . . . . 2.42 109.027 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -128.63 113.04 19.23 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.726 -0.842 . . . . 3.22 108.726 176.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.79 130.39 8.62 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.111 1.874 . . . . 1.62 111.885 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 p -107.73 141.4 39.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.263 -1.014 . . . . 1.75 108.263 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -68.38 -14.76 63.22 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 120.965 0.412 . . . . 2.61 111.025 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.95 -15.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.91 -0.587 . . . . 1.77 111.06 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.532 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 47.3 m-80 -102.95 25.84 8.87 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 112.98 0.733 . . . . 2.19 112.98 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.701 -1.592 . . . . 2.08 106.701 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.45 -154.12 6.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.084 -1.055 . . . . 0.59 113.549 -175.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -105.53 120.16 40.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.066 0.46 . . . . 2.28 111.498 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.532 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 16.3 m-85 -101.24 133.79 45.28 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.117 -0.947 . . . . 1.03 108.788 178.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.8 m -122.78 129.16 51.4 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.909 -1.145 . . . . 1.13 107.909 176.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.5 tp -100.83 120.47 40.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.017 -0.734 . . . . 1.07 109.017 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.15 136.28 49.63 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.931 -1.137 . . . . 1.15 107.931 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.07 121.28 27.52 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.469 -0.937 . . . . 1.11 108.469 178.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.03 122.51 46.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.046 -0.262 . . . . 1.34 110.409 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 p-10 -137.22 177.24 2.26 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 107.102 -1.444 . . . . 1.61 107.102 177.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.28 -26.98 28.87 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.523 2.149 . . . . 1.33 114.589 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 92.6 m -76.94 -17.85 58.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.883 0.327 . . . . 1.1 111.883 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -158.74 22.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.463 -0.875 . . . . 0.71 111.653 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -107.6 138.23 44.2 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.899 0.381 . . . . 1.83 109.977 -176.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.48 158.26 24.83 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.385 -1.339 . . . . 1.16 107.385 174.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 42.7 p -153.84 159.11 41.71 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 112.442 0.534 . . . . 0.88 112.442 -177.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.17 153.98 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.833 -1.543 . . . . 1.09 106.833 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 p -123.48 151.45 42.74 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 118.075 0.398 . . . . 1.7 111.138 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.8 128.4 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 1.38 107.661 177.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.5 110.99 23.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.066 -1.457 . . . . 1.67 107.066 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.65 112.76 25.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.749 0.785 . . . . 1.26 111.659 -174.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.46 101.2 10.88 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.77 -1.105 . . . . 1.4 108.027 176.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.308 -1.22 0 CA-C-N 115.727 -0.67 . . . . 4.75 109.722 179.681 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.893 0.378 . . . . 7.93 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.77 126.23 51.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.948 0.404 . . . . 6.17 109.918 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.79 -27.77 9.57 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.1 0.952 . . . . 5.43 109.359 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -134.86 97.97 3.9 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.468 -1.242 . . . . 3.87 107.804 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -85.41 -26.51 26.35 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.633 -0.712 . . . . 2.55 109.571 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 16.9 m -65.9 102.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.72 -1.127 . . . . 2.51 112.036 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -107.24 97.99 7.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.314 -0.995 . . . . 2.01 108.314 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.524 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-85 -97.69 124.26 41.94 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.917 -1.142 . . . . 1.61 107.917 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.99 173.93 10.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.712 -1.218 . . . . 1.32 107.712 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.43 127.14 41.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.318 -0.553 . . . . 1.15 111.978 -173.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -118.17 140.82 49.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.346 -1.353 . . . . 1.67 107.346 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' HB1' ' A' ' 94' ' ' ALA . 95.5 t -115.93 121.22 66.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 121.378 0.608 . . . . 1.11 112.025 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 79.3 mt-30 -108.13 130.63 55.1 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.864 -1.161 . . . . 2.66 107.864 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.434 HD11 HG21 ' A' ' 98' ' ' ILE . 28.4 mt -122.96 156.2 35.21 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.232 -0.655 . . . . 1.08 109.232 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -132.11 151.01 52.01 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.549 -0.538 . . . . 1.34 109.549 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -60.04 132.47 54.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 124.551 1.157 . . . . 1.24 110.058 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 135.06 57.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 124.473 1.108 . . . . 1.07 109.722 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.44 127.91 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.694 -0.484 . . . . 1.21 109.694 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.3 mt-10 -77.86 109.96 12.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.126 -0.943 . . . . 2.52 112.058 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -168.9 162.39 11.25 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.807 -2.294 . . . . 1.33 104.807 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -55.63 -36.67 67.26 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.967 1.258 . . . . 3.4 113.42 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -95.5 99.22 11.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.893 -1.521 . . . . 3.18 106.893 172.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.431 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 53.3 m95 -81.0 137.59 36.07 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.203 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.07 124.04 31.88 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.765 -0.652 . . . . 0.34 110.222 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.3 mt -107.27 95.57 13.63 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.12 -1.437 . . . . 1.07 107.12 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.06 134.92 26.25 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.655 2.237 . . . . 0.32 111.912 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -129.74 155.49 45.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.112 0.482 . . . . 0.42 111.171 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 23.0 m -138.72 117.7 12.49 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.349 -0.982 . . . . 1.29 108.349 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.08 123.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.27 -1.011 . . . . 1.08 108.27 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 6.1 p-10 -108.96 156.33 19.84 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.868 -0.733 . . . . 1.39 111.013 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.57 147.25 4.57 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.652 -0.979 . . . . 0.6 110.652 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -86.31 -50.28 0.49 Allowed Pre-proline 0 C--N 1.311 -1.078 0 CA-C-O 119.126 -0.464 . . . . 3.29 111.253 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.5 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 C--N 1.366 1.453 0 N-CA-C 107.398 -1.808 . . . . 1.09 107.398 167.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.67 117.48 45.02 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 115.773 -0.649 . . . . 1.36 111.75 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -85.27 145.71 9.67 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.85 1.7 . . . . 0.56 111.642 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -78.32 120.17 22.71 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.122 -1.066 . . . . 1.74 108.122 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 56' ' ' PHE . 97.2 mt -93.17 123.3 36.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.99 -0.55 . . . . 1.14 109.891 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -134.66 131.82 38.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.029 -0.532 . . . . 4.62 110.848 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 87.6 m95 -93.02 135.07 34.52 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.359 -0.837 . . . . 0.33 109.495 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -113.11 134.51 54.51 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.894 -1.891 . . . . 1.57 105.894 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -125.34 111.42 15.16 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.489 -0.56 . . . . 1.04 109.489 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.61 34.59 24.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.165 0.986 . . . . 2.17 111.048 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.6 85.64 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.142 -0.481 . . . . 0.61 112.974 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -108.33 153.6 23.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.753 -0.832 . . . . 1.84 108.753 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.25 115.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.759 . . . . 1.31 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -89.34 122.62 32.75 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.247 -1.02 . . . . 1.33 108.247 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.57 129.92 55.54 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.374 -1.343 . . . . 2.69 107.374 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.235 0.614 . . . . 1.74 111.194 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 p -126.26 -165.69 1.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.044 -0.724 . . . . 2.07 109.044 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 m -78.62 -22.45 46.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 118.414 0.552 . . . . 1.9 110.597 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -87.21 -40.39 14.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.745 -0.382 . . . . 1.89 110.386 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -112.49 106.71 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.701 -1.222 . . . . 1.18 107.701 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -130.88 139.71 50.15 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.179 0.807 . . . . 3.62 113.179 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -84.68 119.96 25.84 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.263 -0.88 . . . . 1.15 109.749 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -94.09 125.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.44 -0.346 . . . . 2.04 110.441 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 37' ' ' LEU . 66.8 m-85 -106.78 106.74 17.41 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.582 -1.636 . . . . 0.87 106.582 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.0 154.63 17.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.397 -0.921 . . . . 1.7 108.956 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.26 113.0 14.58 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 123.479 0.711 . . . . 3.36 111.574 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.81 161.15 27.45 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.727 2.285 . . . . 1.63 110.552 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.82 142.06 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.712 -1.218 . . . . 1.88 107.712 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.82 -6.19 20.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.136 0.574 . . . . 2.29 112.243 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -104.0 -0.7 28.54 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.142 -0.481 . . . . 3.93 111.332 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.5 pt-20 -115.04 146.15 41.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.691 -1.226 . . . . 1.89 107.691 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -94.12 2.91 55.92 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.134 -0.691 . . . . 1.86 109.134 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.94 129.03 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.617 -0.72 . . . . 1.19 111.609 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -94.55 134.97 36.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.148 -1.797 . . . . 2.36 106.148 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -121.16 161.79 21.23 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.612 -0.435 . . . . 1.49 110.266 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.29 -165.38 35.24 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 120.674 -0.774 . . . . 0.36 111.334 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 t -156.16 141.87 17.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.502 -0.555 . . . . 0.36 109.502 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 50.3 tp -91.02 100.93 13.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.618 -2.364 . . . . 1.06 104.618 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -103.27 129.27 50.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.218 -0.593 . . . . 3.22 110.63 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.73 109.18 20.27 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.617 -0.883 . . . . 1.78 108.617 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -72.15 -43.09 65.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.599 -1.182 . . . . 2.42 109.95 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 101.0 31.9 Favored Pre-proline 0 N--CA 1.429 -1.501 0 N-CA-C 105.641 -1.985 . . . . 3.22 105.641 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.05 147.11 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.617 2.211 . . . . 1.62 112.372 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 p -130.06 141.29 50.73 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 122.039 -0.413 . . . . 1.75 110.406 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 41.8 p-80 -58.54 -6.4 0.7 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.118 1.525 . . . . 2.61 115.118 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.79 -17.06 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.152 -0.684 . . . . 1.77 109.152 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.595 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 17.5 m120 -83.34 -1.2 52.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.241 1.016 . . . . 2.19 109.625 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 39.5 t30 -77.11 81.22 3.63 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.28 -0.873 . . . . 2.08 108.883 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.88 -155.86 8.99 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.201 -0.909 . . . . 0.59 111.669 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -98.43 128.97 45.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.841 0.682 . . . . 2.28 112.841 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.595 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 76.9 m-85 -108.25 141.57 39.83 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.969 1.308 . . . . 1.03 108.021 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.1 m -142.57 134.44 27.0 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.631 -0.668 . . . . 1.13 109.353 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.8 tp -104.89 122.45 45.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.77 -0.456 . . . . 1.07 109.77 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.91 125.25 52.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.204 -1.036 . . . . 1.15 108.204 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -120.65 120.8 36.78 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.19 -1.041 . . . . 1.11 108.19 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.69 121.6 35.94 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.83 -0.348 . . . . 1.34 111.425 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -128.59 170.97 9.39 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 107.576 -1.268 . . . . 1.61 107.576 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.06 -41.26 33.74 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.602 2.201 . . . . 1.33 114.432 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -67.29 -45.65 75.91 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.509 -0.476 . . . . 1.1 112.207 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.01 178.09 47.54 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 119.103 -1.523 . . . . 0.71 113.594 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -119.86 133.53 55.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 123.202 0.601 . . . . 1.83 109.742 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -113.9 155.28 26.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.138 -0.69 . . . . 1.16 109.138 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.7 p -144.8 148.03 33.57 Favored 'General case' 0 N--CA 1.418 -2.068 0 O-C-N 123.52 0.513 . . . . 0.88 110.26 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.82 146.38 29.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.057 -1.831 . . . . 1.09 106.057 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -118.48 144.31 46.1 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.473 -0.491 . . . . 1.7 110.318 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.461 HG22 ' HB2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -134.67 122.16 37.76 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 C-N-CA 124.807 1.243 . . . . 1.38 109.505 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.19 108.6 16.82 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.777 -1.564 . . . . 1.67 106.777 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 155.84 25.22 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.313 -0.403 . . . . 1.26 110.924 -174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.38 100.65 10.07 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.385 0.612 . . . . 1.4 111.373 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 86.0 m-85 -100.07 78.43 2.08 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.146 -1.057 . . . . 4.75 108.146 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.7 mtt -101.81 113.9 27.5 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.016 -0.538 . . . . 5.12 110.572 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.422 ' H ' ' HB3' ' A' ' 77' ' ' HIS . 76.2 m-20 -98.06 159.42 14.95 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 121.516 0.674 . . . . 5.33 111.255 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -120.75 99.83 46.99 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.423 -2.066 . . . . 5.79 105.423 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.83 140.01 10.23 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.469 2.779 . . . . 5.07 113.449 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 125.223 1.409 . . . . 10.3 109.789 -175.706 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.501 -0.942 0 N-CA-C 107.926 -1.139 . . . . 7.93 107.926 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 53.3 34.01 16.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.416 0.687 . . . . 6.17 110.147 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 52.0 1.29 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.212 1.19 . . . . 5.43 114.212 -171.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t70 38.6 54.89 1.92 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.217 2.207 . . . . 3.87 113.544 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -98.05 -50.49 4.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.391 -0.966 . . . . 2.55 108.391 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 m -94.24 98.92 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-O 122.155 0.979 . . . . 2.51 109.0 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 p -89.18 98.72 11.92 Favored 'General case' 0 N--CA 1.403 -2.791 0 CA-C-N 115.291 -0.868 . . . . 2.01 109.374 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.601 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.9 m-85 -75.09 115.68 14.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.093 -1.447 . . . . 1.61 107.093 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -83.2 178.14 8.23 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.937 -0.764 . . . . 1.32 108.937 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 126.92 40.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 119.745 -0.782 . . . . 1.15 111.257 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -122.93 143.23 50.04 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.142 -1.429 . . . . 1.67 107.142 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.81 121.14 66.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.132 0.491 . . . . 1.11 110.901 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 118.83 37.77 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.301 -0.863 . . . . 2.66 108.858 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 mt -115.44 144.64 43.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.943 0.401 . . . . 1.08 109.984 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.95 151.27 51.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.968 -0.753 . . . . 1.34 108.968 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 m -57.49 135.1 56.58 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 124.455 1.097 . . . . 1.24 110.411 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.2 130.86 46.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.393 1.058 . . . . 1.07 110.66 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.9 136.14 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.335 0.588 . . . . 1.21 110.094 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.93 106.94 7.79 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.331 -1.304 . . . . 2.52 110.54 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.4 mtm -141.93 -163.16 1.53 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.953 -1.499 . . . . 1.33 106.953 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -67.89 -45.03 75.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.99 -0.744 . . . . 3.4 108.99 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -111.85 138.84 47.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 106.393 -1.706 . . . . 3.18 106.393 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 72.4 m95 -81.76 133.54 35.35 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 42.1 t -120.26 116.09 24.89 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.3 -0.864 . . . . 0.34 110.093 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 69.9 mt -100.08 99.37 9.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.144 -1.428 . . . . 1.07 107.144 172.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 2.9 Cg_exo -75.3 125.89 9.41 Favored 'Trans proline' 0 C--O 1.252 1.207 0 C-N-CA 122.502 2.135 . . . . 0.32 111.804 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -120.98 153.57 37.14 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.092 -0.707 . . . . 0.42 109.092 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.5 m -140.54 114.3 8.87 Favored 'General case' 0 C--N 1.267 -3.02 0 N-CA-C 108.715 -0.846 . . . . 1.29 108.715 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -110.43 116.31 52.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.596 -0.89 . . . . 1.08 108.596 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 8.5 t70 -101.22 137.06 40.07 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.634 -0.876 . . . . 1.39 108.634 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.46 145.17 4.27 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 110.326 -1.11 . . . . 0.6 110.326 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -84.05 -55.53 0.46 Allowed Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.739 -0.467 . . . . 3.29 109.739 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.601 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.1 Cg_endo -62.4 120.78 8.48 Favored 'Trans proline' 0 C--N 1.387 2.56 0 N-CA-C 108.643 -1.329 . . . . 1.09 108.643 170.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.1 111.59 8.99 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 116.15 -0.477 . . . . 1.36 111.531 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -83.97 162.13 13.79 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 122.547 2.165 . . . . 0.56 112.344 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 p -94.37 130.01 40.86 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.516 -0.92 . . . . 1.74 108.516 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.2 mt -98.54 140.67 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.995 -0.372 . . . . 1.14 109.995 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -143.88 133.71 23.89 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.162 -0.681 . . . . 4.62 109.162 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.3 m95 -96.64 117.46 31.04 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.33 109.862 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -100.72 127.23 47.21 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.336 -1.727 . . . . 1.57 106.336 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' HZ ' ' O ' ' A' ' 78' ' ' VAL . 88.7 t80 -122.97 108.05 12.51 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 109.213 -0.662 . . . . 1.04 109.213 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.58 17.7 6.39 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.679 0.791 . . . . 2.17 112.835 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.1 -12.16 40.7 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.973 -0.632 . . . . 0.61 112.685 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 m -108.62 151.99 25.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.851 -0.796 . . . . 1.84 108.851 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.41 123.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.379 -0.373 . . . . 1.31 110.017 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.2 tp -82.65 113.38 20.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.845 -0.616 . . . . 1.33 109.552 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.01 140.78 30.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.374 -0.602 . . . . 2.69 109.374 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.77 137.59 36.25 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.785 -0.643 . . . . 1.74 110.084 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 p -127.16 -165.97 1.54 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.773 0.829 . . . . 2.07 110.068 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 m -75.64 -31.91 60.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.023 0.44 . . . . 1.9 110.546 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -89.84 -28.41 19.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.071 0.397 . . . . 1.89 112.071 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.9 mt -125.53 106.64 16.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.091 -0.707 . . . . 1.18 109.091 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -145.91 156.27 43.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.61 -0.436 . . . . 3.62 110.547 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -85.23 109.79 18.58 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.666 -0.864 . . . . 1.15 108.666 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.54 108.77 21.55 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.37 -0.974 . . . . 2.04 108.37 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -85.95 145.74 27.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.53 -0.915 . . . . 0.87 108.53 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.2 pp -109.42 157.96 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.376 -1.713 . . . . 1.7 106.376 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.07 109.0 5.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 O-C-N 123.485 0.491 . . . . 3.36 110.15 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.63 140.92 19.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.393 2.062 . . . . 1.63 111.705 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.61 134.66 51.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.069 -1.085 . . . . 1.88 108.069 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.17 -18.28 63.31 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.832 0.678 . . . . 2.29 112.832 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.65 -23.2 59.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.256 -0.429 . . . . 3.93 110.478 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.83 152.31 18.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.515 -0.55 . . . . 1.89 109.515 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 11.12 38.26 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.496 -1.298 . . . . 1.86 107.496 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -104.74 127.88 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.037 -0.983 . . . . 1.19 110.617 -173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HB2' HG12 ' A' ' 29' ' ' VAL . 66.5 mtp180 -92.43 115.06 27.75 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.574 -1.639 . . . . 2.36 106.574 176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.429 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 90.5 m-70 -101.97 142.73 32.8 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.263 -0.643 . . . . 1.49 109.263 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.78 -178.79 38.4 Favored Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 120.21 -0.995 . . . . 0.36 111.327 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 t -144.33 132.81 22.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 120.547 0.213 . . . . 0.36 111.278 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 54.4 tp -87.16 114.01 23.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.433 -2.062 . . . . 1.06 105.433 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 16.4 ptm180 -106.76 119.58 39.71 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 112.338 0.495 . . . . 3.22 112.338 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.85 108.2 19.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.75 -2.315 . . . . 1.78 104.75 171.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -74.35 -52.53 11.93 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 108.982 -0.747 . . . . 2.42 108.982 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -128.26 100.23 23.44 Favored Pre-proline 0 N--CA 1.397 -3.111 0 N-CA-C 105.843 -1.91 . . . . 3.22 105.843 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.447 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 25.2 Cg_exo -67.09 150.39 82.36 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.11 1.873 . . . . 1.62 109.897 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -112.62 178.14 4.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.577 -0.283 . . . . 1.75 111.073 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -52.63 -37.02 57.69 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.469 0.708 . . . . 2.61 112.626 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.492 ' O ' ' HZ ' ' A' ' 41' ' ' PHE . 14.6 m -77.17 -10.44 13.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 112.825 0.676 . . . . 1.77 112.825 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.58 26.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.701 1.0 . . . . 2.19 113.701 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 78' ' ' VAL . 74.6 m-20 -110.86 53.47 0.7 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.755 -1.943 . . . . 2.08 105.755 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -133.78 -168.23 11.78 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.38 -1.39 . . . . 0.59 114.061 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 15.0 m120 -102.43 114.59 28.91 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.517 0.727 . . . . 2.28 109.989 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.09 116.2 31.56 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.738 -0.838 . . . . 1.03 108.738 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 77.8 m -116.62 122.75 45.53 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.694 -0.484 . . . . 1.13 109.694 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.1 tp -96.84 118.32 33.02 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.765 -0.457 . . . . 1.07 109.765 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.6 136.33 41.63 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.748 -0.834 . . . . 1.15 108.748 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.49 120.42 26.77 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.86 -1.163 . . . . 1.11 107.86 173.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.07 134.4 54.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 123.16 0.288 . . . . 1.34 110.599 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -153.2 171.93 6.24 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.67 -1.233 . . . . 1.61 107.67 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -55.94 -39.32 91.9 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.284 1.989 . . . . 1.33 113.408 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.55 -15.74 61.77 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.045 0.387 . . . . 1.1 112.045 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.27 -161.46 29.72 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 119.02 -1.562 . . . . 0.71 113.252 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.72 124.29 25.0 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.814 -0.81 . . . . 1.83 108.814 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -102.38 151.15 22.6 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.66 -0.867 . . . . 1.16 108.66 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 6.4 p -152.23 135.31 15.72 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.719 0.637 . . . . 0.88 110.775 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.44 47.08 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.175 -1.417 . . . . 1.09 107.175 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -129.54 145.24 51.49 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.875 0.369 . . . . 1.7 111.318 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 126.37 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.947 -1.131 . . . . 1.38 107.947 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -106.67 137.19 45.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.221 -0.659 . . . . 1.67 109.221 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.46 145.86 47.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.765 -0.828 . . . . 1.26 108.765 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -127.64 104.08 7.67 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.272 0.558 . . . . 1.4 110.433 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 58.2 t80 -72.88 -54.45 8.72 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 114.389 1.255 . . . . 4.75 114.389 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.7 ptm -145.36 -178.48 6.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.603 -0.517 . . . . 5.12 109.603 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 120.5 31.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.312 -1.736 . . . . 5.33 106.312 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.27 130.84 87.34 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 112.223 0.453 . . . . 5.79 112.223 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.69 117.08 4.81 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 121.917 1.745 . . . . 5.07 109.221 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.217 -0.897 . . . . 10.3 111.211 -178.414 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 112.084 0.402 . . . . 7.93 112.084 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -93.74 -72.3 0.62 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.551 0.614 . . . . 6.17 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -68.9 -38.22 79.48 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.659 1.219 . . . . 5.43 107.753 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.0 66.69 5.57 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.773 -1.558 . . . . 3.87 108.68 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -92.42 -31.68 15.21 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.44 -1.319 . . . . 2.55 107.44 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -50.04 99.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 C-N-CA 126.078 1.751 . . . . 2.51 110.973 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.6 m -104.99 97.74 7.55 Favored 'General case' 0 N--CA 1.379 -3.976 0 CA-C-N 114.411 -1.268 . . . . 2.01 110.259 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.469 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 95.1 m-85 -96.61 127.26 42.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.323 -1.732 . . . . 1.61 106.323 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.2 m -92.4 -159.39 0.66 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 119.145 -0.455 . . . . 1.32 110.227 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.58 106.84 18.78 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 119.369 0.986 . . . . 1.15 112.123 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 39.4 m -112.81 126.68 55.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.399 -0.819 . . . . 1.67 108.882 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.55 124.86 72.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 120.926 0.393 . . . . 1.11 112.0 -173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -124.83 121.13 33.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.092 -1.077 . . . . 2.66 108.092 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.3 mt -105.0 156.12 18.33 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.982 0.42 . . . . 1.08 111.494 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -130.91 144.28 51.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.453 -1.314 . . . . 1.34 107.453 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -65.25 136.99 57.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.718 0.807 . . . . 1.24 110.089 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -51.58 138.63 22.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.403 1.064 . . . . 1.07 110.926 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.62 143.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.036 -0.529 . . . . 1.21 110.234 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.86 98.53 2.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.796 -1.093 . . . . 2.52 111.685 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -141.21 -169.59 2.88 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.395 -1.335 . . . . 1.33 107.395 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -78.93 -39.67 34.02 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.995 -0.743 . . . . 3.4 108.995 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -101.55 127.08 48.42 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.858 -1.905 . . . . 3.18 105.858 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.437 ' HB2' HD13 ' A' ' 72' ' ' LEU . 78.5 m95 -82.78 126.83 32.85 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.099 0.476 . . . . 1.0 110.991 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 43.7 t -117.73 118.13 31.23 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.51 -0.768 . . . . 0.34 109.435 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.6 mt -101.75 97.43 7.94 Favored Pre-proline 0 C--O 1.247 0.952 0 N-CA-C 107.599 -1.26 . . . . 1.07 107.599 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 9.7 Cg_exo -74.25 136.0 21.43 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.507 2.138 . . . . 0.32 111.427 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -124.41 161.32 26.25 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.283 0.563 . . . . 0.42 110.818 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -140.8 110.51 6.43 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.792 -0.818 . . . . 1.29 108.792 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.449 HG13 HD23 ' A' ' 37' ' ' LEU . 4.0 p -123.33 117.49 51.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.059 -1.089 . . . . 1.08 108.059 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 11' ' ' SER . 1.7 p-10 -103.1 165.94 10.73 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.526 -1.27 . . . . 1.39 110.715 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.58 165.54 12.5 Favored Glycine 0 N--CA 1.409 -3.111 0 O-C-N 124.823 1.327 . . . . 0.6 109.935 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -101.96 -55.22 0.13 Allowed Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.788 -0.449 . . . . 3.29 109.788 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.2 Cg_endo -66.05 119.78 6.85 Favored 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.08 -1.931 . . . . 1.09 107.08 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 115.07 27.31 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 1.36 111.508 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.01 134.59 9.45 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 121.516 1.477 . . . . 0.56 111.356 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -70.61 132.75 45.93 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.519 -1.289 . . . . 1.74 107.519 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.449 HD23 HG13 ' A' ' 29' ' ' VAL . 72.1 mt -100.04 120.45 39.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.968 0.414 . . . . 1.14 110.432 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -122.1 128.05 50.87 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.532 -0.758 . . . . 4.62 109.819 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -93.9 155.37 17.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.082 -0.508 . . . . 0.33 110.627 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 11.5 tp -137.83 141.1 40.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.185 -1.413 . . . . 1.57 107.185 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -119.12 101.96 8.39 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.348 0.659 . . . . 1.04 109.43 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 57.69 31.38 20.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.96 0.904 . . . . 2.17 111.063 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.51 -19.04 55.33 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.707 -0.759 . . . . 0.61 112.74 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.7 t -88.68 140.98 28.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.44 -0.578 . . . . 1.84 109.44 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.21 117.1 2.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.741 -0.663 . . . . 1.31 111.007 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.7 tp -91.13 126.46 36.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.011 -0.737 . . . . 1.33 109.011 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -93.99 137.39 33.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.898 -0.592 . . . . 2.69 109.441 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.76 83.31 5.73 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 1.74 108.754 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -84.48 -178.41 6.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.198 -0.91 . . . . 2.07 110.706 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -58.96 -34.82 72.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.213 0.53 . . . . 1.9 111.67 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -87.43 -13.99 41.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.643 0.609 . . . . 1.89 112.643 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.19 105.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 107.304 -1.369 . . . . 1.18 107.304 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -135.94 145.95 46.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.509 -0.877 . . . . 3.62 112.025 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 m -89.7 110.21 21.12 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.912 -1.144 . . . . 1.15 107.912 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.33 113.38 26.63 Favored 'General case' 0 N--CA 1.418 -2.025 0 C-N-CA 119.325 -0.95 . . . . 2.04 109.047 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -87.74 133.84 33.78 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.831 -1.544 . . . . 0.87 106.831 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.16 164.19 19.31 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.234 -0.986 . . . . 1.7 108.949 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.82 120.5 50.36 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.779 -0.823 . . . . 3.36 108.779 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.12 128.34 30.11 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 122.635 2.223 . . . . 1.63 111.253 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.91 125.45 29.32 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.282 -0.872 . . . . 1.88 108.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.22 -27.81 62.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.0 -1.0 . . . . 2.29 113.006 -173.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.3 -9.16 42.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.047 0.388 . . . . 3.93 112.047 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -102.3 150.28 23.48 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.693 0.759 . . . . 1.89 112.248 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.5 p -105.07 7.99 34.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.991 -1.004 . . . . 1.86 108.701 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 18.1 t -112.0 133.26 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.922 -1.035 . . . . 1.19 109.668 -176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -87.56 134.86 33.55 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.685 -1.598 . . . . 2.36 106.685 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -124.3 155.68 38.25 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.009 0.433 . . . . 1.49 109.891 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.03 -171.63 43.03 Favored Glycine 0 N--CA 1.411 -3.028 0 N-CA-C 109.516 -1.434 . . . . 0.36 109.516 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 71' ' ' ARG . 39.3 t -148.03 141.26 25.12 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.004 0.43 . . . . 0.36 110.793 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.0 tp -88.65 102.23 14.76 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.282 -2.118 . . . . 1.06 105.282 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HG2' ' SG ' ' A' ' 69' ' ' CYS . 85.2 mtm-85 -102.37 129.2 48.77 Favored 'General case' 0 CA--C 1.48 -1.745 0 C-N-CA 119.203 -0.999 . . . . 3.22 110.857 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 23' ' ' TRP . 62.8 mt -86.24 108.47 18.39 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.561 -1.644 . . . . 1.78 106.561 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -67.64 -47.07 70.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 114.691 -1.141 . . . . 2.42 109.011 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -128.12 110.07 19.87 Favored Pre-proline 0 N--CA 1.421 -1.882 0 N-CA-C 106.439 -1.689 . . . . 3.22 106.439 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 35.1 Cg_endo -68.83 130.54 20.69 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 121.607 1.538 . . . . 1.62 111.275 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.6 p -123.96 171.99 9.29 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.57 -0.741 . . . . 1.75 109.632 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -72.46 -8.54 55.59 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.452 0.538 . . . . 2.61 112.452 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.89 -9.54 11.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.394 0.616 . . . . 1.77 110.422 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.647 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.1 m120 -90.12 27.12 1.69 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.711 0.767 . . . . 2.19 110.467 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -126.57 64.96 1.26 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.016 -1.105 . . . . 2.08 108.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.06 -158.55 11.52 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.525 -0.845 . . . . 0.59 112.234 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -96.55 129.22 43.98 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.377 -0.231 . . . . 2.28 110.377 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.647 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 52.6 m-85 -116.64 117.75 30.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.035 0.445 . . . . 1.03 110.427 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.1 m -100.47 136.07 40.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.238 -0.653 . . . . 1.13 109.238 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' SER . 49.3 tp -103.29 114.21 28.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.187 -0.672 . . . . 1.07 109.187 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' A' ' 95' ' ' SER . 2.8 mm? -100.63 116.41 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.145 -1.057 . . . . 1.15 108.145 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -113.72 120.98 42.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.948 -1.13 . . . . 1.11 107.948 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.64 50.67 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.872 -0.331 . . . . 1.34 111.549 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.7 p30 -141.12 175.25 3.18 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.34 -1.355 . . . . 1.61 107.34 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -47.08 -29.77 9.23 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.851 2.368 . . . . 1.33 115.035 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.6 m -71.6 -41.23 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.073 0.463 . . . . 1.1 111.769 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.21 -162.76 35.05 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.571 -0.824 . . . . 0.71 111.051 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 62.4 tt0 -132.47 131.32 41.57 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.857 -0.423 . . . . 1.83 109.857 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.76 150.19 27.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.734 -0.839 . . . . 1.16 108.734 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.0 p -142.8 120.78 12.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.771 0.32 . . . . 0.88 111.831 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.34 147.92 45.04 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.542 -1.281 . . . . 1.09 107.542 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -118.46 123.88 46.25 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 118.002 0.364 . . . . 1.7 111.164 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.92 120.22 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.974 -1.121 . . . . 1.38 107.974 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.53 128.74 39.79 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.288 -1.004 . . . . 1.67 108.288 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.75 116.91 30.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.875 0.369 . . . . 1.26 110.583 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.11 101.4 12.86 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.355 0.598 . . . . 1.4 109.414 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 20.3 t80 -82.18 -68.03 0.73 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.29 -0.868 . . . . 4.75 112.501 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -150.6 -177.88 6.23 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.556 -1.276 . . . . 5.12 107.556 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.57 116.47 22.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.814 -1.18 . . . . 5.33 107.814 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -96.95 114.23 64.28 Favored Pre-proline 0 C--N 1.29 -2.001 0 N-CA-C 108.766 -0.827 . . . . 5.79 108.766 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.44 116.56 4.29 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 121.728 1.619 . . . . 5.07 112.203 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 124.567 1.147 . . . . 10.3 112.789 178.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.882 0.849 . . . . 7.93 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 6' ' ' VAL . 3.8 m-20 -101.27 8.32 42.52 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.658 -1.238 . . . . 6.17 107.658 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.08 -19.56 63.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.905 -1.498 . . . . 5.43 114.011 -168.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -89.66 -32.27 17.13 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.764 -0.774 . . . . 3.87 109.751 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -74.67 -44.19 51.51 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.204 -0.907 . . . . 2.55 111.422 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 2' ' ' ASP . 14.4 m -84.37 98.58 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-O 122.331 1.062 . . . . 2.51 108.699 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -108.49 98.2 7.75 Favored 'General case' 0 N--CA 1.397 -3.077 0 CA-C-O 122.2 1.0 . . . . 2.01 109.515 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.479 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 67.1 m-85 -81.48 109.96 16.43 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 105.775 -1.935 . . . . 1.61 105.775 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.3 t -84.0 175.59 9.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.228 -1.027 . . . . 1.32 108.228 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.71 126.37 39.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 112.852 0.686 . . . . 1.15 112.852 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -123.82 139.13 54.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.515 -1.291 . . . . 1.67 107.515 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.36 114.41 46.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.583 -0.525 . . . . 1.11 109.583 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -111.42 116.72 31.4 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.967 -0.56 . . . . 2.66 110.791 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.7 mt -102.71 156.34 17.7 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.277 -0.874 . . . . 1.08 109.16 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -131.82 153.01 50.59 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.344 -0.613 . . . . 1.34 109.344 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -58.85 137.38 57.8 Favored 'General case' 0 N--CA 1.425 -1.724 0 O-C-N 124.909 1.38 . . . . 1.24 108.728 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 143.03 56.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.19 -0.67 . . . . 1.07 109.19 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.62 129.85 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.52 0.676 . . . . 1.21 110.146 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.73 91.75 4.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.724 -1.125 . . . . 2.52 112.514 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -154.43 -178.32 7.07 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.084 -1.821 . . . . 1.33 106.084 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -71.93 -28.64 63.61 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 120.554 1.525 . . . . 3.4 110.499 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.43 100.96 13.44 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.554 -1.276 . . . . 3.18 107.554 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -81.89 99.55 9.12 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.837 0.827 . . . . 1.0 110.22 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.6 t -103.05 123.05 45.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.717 -1.583 . . . . 0.34 109.123 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.6 mt -105.87 99.97 25.23 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.426 -1.324 . . . . 1.07 107.426 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.29 132.72 18.23 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.361 2.041 . . . . 0.32 112.58 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -128.35 149.9 50.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.232 0.539 . . . . 0.42 109.869 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -136.61 112.68 9.7 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.229 -1.026 . . . . 1.29 108.229 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 66' ' ' ARG . 2.7 p -110.83 119.23 59.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.825 -0.805 . . . . 1.08 108.825 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 25.0 t70 -101.0 132.05 46.59 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.243 -1.021 . . . . 1.39 108.243 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.83 131.66 1.28 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 109.387 -1.485 . . . . 0.6 109.387 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -75.64 -54.77 2.19 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.629 -0.508 . . . . 3.29 109.629 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 19.7 Cg_endo -63.11 120.42 7.89 Favored 'Trans proline' 0 C--N 1.379 2.163 0 N-CA-C 107.384 -1.814 . . . . 1.09 107.384 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.0 12.52 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.193 -0.458 . . . . 1.36 111.807 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.436 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 87.4 Cg_endo -76.64 149.69 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.11 1.874 . . . . 0.56 111.698 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -76.13 109.37 9.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.567 -0.901 . . . . 1.74 108.567 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.36 125.68 34.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.876 0.37 . . . . 1.14 110.953 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -135.52 130.95 35.39 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.223 -0.444 . . . . 4.62 110.11 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -90.97 131.56 36.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.749 -0.659 . . . . 0.33 109.734 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -104.88 127.03 52.55 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 105.247 -2.131 . . . . 1.57 105.247 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.29 109.54 16.97 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 122.662 0.385 . . . . 1.04 110.254 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.8 t30 51.35 52.36 14.96 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.344 1.028 . . . . 2.17 110.58 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.73 51.01 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 114.541 -1.209 . . . . 0.61 114.179 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -122.7 161.27 24.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.862 -0.792 . . . . 1.84 108.862 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.78 117.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 115.338 -0.846 . . . . 1.31 110.416 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.64 98.53 9.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.076 -0.65 . . . . 1.33 110.085 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -84.62 95.64 8.94 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 103.951 -2.611 . . . . 2.69 103.951 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.99 125.54 23.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.875 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.5 p -103.9 -165.44 1.15 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.14 -0.936 . . . . 2.07 111.852 -172.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -84.49 -9.93 57.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.906 0.86 . . . . 1.9 108.876 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -89.02 -39.7 13.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.417 -0.81 . . . . 1.89 109.094 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mt -127.48 106.38 15.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.755 -1.572 . . . . 1.18 106.755 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -131.39 150.37 52.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 119.608 -0.837 . . . . 3.62 112.728 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 m -92.55 110.51 21.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.716 -1.129 . . . . 1.15 110.105 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.48 113.11 23.73 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.693 -0.854 . . . . 2.04 108.693 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.54 138.03 31.81 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.544 0.687 . . . . 0.87 110.687 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.71 136.67 40.21 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.055 -0.975 . . . . 1.7 109.606 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -68.52 112.84 12.36 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 124.802 1.314 . . . . 3.36 111.983 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.33 155.06 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.197 2.598 . . . . 1.63 110.172 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.09 19.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 119.097 -0.478 . . . . 1.88 109.74 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.03 85.09 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 118.724 0.693 . . . . 2.29 112.695 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.07 -2.67 58.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.173 1.175 . . . . 3.93 114.173 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -101.17 157.59 16.66 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.592 -0.843 . . . . 1.89 108.825 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 p -112.4 15.93 20.08 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.834 0.349 . . . . 1.86 111.697 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.12 124.57 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 119.967 -0.693 . . . . 1.19 110.363 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HB2' HG12 ' A' ' 29' ' ' VAL . 78.0 mtp180 -95.73 116.59 29.1 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 105.665 -1.976 . . . . 2.36 105.665 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -98.73 149.5 22.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.181 -1.044 . . . . 1.49 108.181 -174.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.01 174.96 46.01 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 119.338 -1.41 . . . . 0.36 112.388 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -144.76 132.66 21.3 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.471 0.708 . . . . 0.36 109.929 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.2 tp -88.44 113.18 23.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.644 -1.984 . . . . 1.06 105.644 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -107.34 123.37 48.24 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.131 0.491 . . . . 3.22 111.596 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.79 108.37 17.44 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 106.567 -1.642 . . . . 1.78 106.567 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -73.4 -52.94 12.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.071 -0.968 . . . . 2.42 109.059 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.0 101.23 51.25 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.56 -1.274 . . . . 3.22 107.56 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.04 129.47 18.41 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.688 1.592 . . . . 1.62 110.331 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 p -138.62 168.88 18.83 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.138 -1.06 . . . . 1.75 108.138 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -76.13 -6.01 49.24 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 122.243 -0.286 . . . . 2.61 111.479 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.44 -21.41 10.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 109.212 -0.662 . . . . 1.77 109.212 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.27 -10.6 59.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.657 0.741 . . . . 2.19 109.799 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 11.2 t30 -83.57 75.97 9.99 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.23 -1.396 . . . . 2.08 107.23 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.55 -171.58 27.78 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.21 -0.905 . . . . 0.59 111.533 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.29 128.23 38.06 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.42 0.526 . . . . 2.28 112.42 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.47 123.09 48.54 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 61.7 m -115.42 128.99 56.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.19 -0.671 . . . . 1.13 109.19 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.1 tp -99.61 114.59 27.73 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.1 -0.704 . . . . 1.07 109.1 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.14 131.01 50.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.157 -1.053 . . . . 1.15 108.157 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -121.14 119.04 31.23 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.916 -1.142 . . . . 1.11 107.916 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.16 130.4 46.29 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.235 -0.439 . . . . 1.34 110.045 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 42.9 t-20 -155.63 136.36 8.92 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.411 -1.329 . . . . 1.61 107.411 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.12 -17.11 23.81 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.968 3.112 . . . . 1.33 113.352 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.87 -22.49 45.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 1.1 109.537 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.46 146.9 4.51 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.971 -1.252 . . . . 0.71 109.971 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -90.94 135.34 33.8 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.639 -0.504 . . . . 1.83 109.639 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -114.85 151.67 33.5 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.06 -1.089 . . . . 1.16 108.06 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.9 p -160.33 148.96 16.9 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.103 0.478 . . . . 0.88 111.824 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.04 156.97 44.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.365 -1.346 . . . . 1.09 107.365 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -133.4 132.38 41.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.175 -0.676 . . . . 1.7 109.175 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 133.14 41.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.808 -0.812 . . . . 1.38 108.808 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 48.2 ttm -108.95 125.78 52.39 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.877 -0.514 . . . . 1.67 109.7 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -98.05 113.67 25.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.524 -0.917 . . . . 1.26 108.524 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.26 100.16 12.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.014 -0.735 . . . . 1.4 109.014 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 -49.46 22.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.828 -1.078 . . . . 4.75 111.831 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.9 ptp -153.86 154.32 33.69 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.658 -1.238 . . . . 5.12 107.658 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.86 110.73 11.71 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.056 -1.831 . . . . 5.33 106.056 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -56.33 113.29 5.61 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.479 -1.237 . . . . 5.79 113.685 -168.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -78.82 177.85 8.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.693 2.262 . . . . 5.07 112.48 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--N 1.304 -1.394 0 CA-C-N 115.551 -0.75 . . . . 10.3 111.374 -177.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 107.342 -1.355 . . . . 7.93 107.342 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -112.98 155.77 24.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.207 0.527 . . . . 6.17 111.159 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -87.87 46.73 1.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.198 0.999 . . . . 5.43 110.661 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.09 40.8 3.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.268 -0.878 . . . . 3.87 109.924 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.97 -50.85 18.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.669 -0.412 . . . . 2.55 110.349 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 m -98.15 98.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.483 1.135 . . . . 2.51 109.701 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -102.02 99.17 9.31 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.267 -0.879 . . . . 2.01 109.257 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -87.13 129.2 35.03 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.272 -1.01 . . . . 1.61 108.272 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.84 -179.94 7.41 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.322 -0.992 . . . . 1.32 108.322 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.22 117.64 30.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 CA-C-O 121.217 0.532 . . . . 1.15 110.345 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -118.44 134.48 55.03 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 107.039 -1.467 . . . . 1.67 107.039 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.4 t -122.99 119.16 57.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 120.939 -0.305 . . . . 1.11 110.906 -173.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -119.15 117.74 29.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.547 0.689 . . . . 2.66 110.505 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 98' ' ' ILE . 40.8 mt -100.37 157.15 16.83 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.048 -0.978 . . . . 1.08 111.053 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -130.93 144.52 51.53 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.178 -1.045 . . . . 1.34 108.178 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -67.91 137.77 55.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.631 -0.878 . . . . 1.24 108.631 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -47.25 137.82 7.78 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.27 1.028 . . . . 1.07 111.884 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.65 138.35 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.574 -0.739 . . . . 1.21 111.06 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.54 89.43 0.36 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.205 -1.362 . . . . 2.52 112.316 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -150.17 178.52 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.376 -1.342 . . . . 1.33 107.376 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -66.19 -46.46 77.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 119.028 0.831 . . . . 3.4 111.091 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -91.7 128.84 37.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.707 -0.849 . . . . 3.18 108.707 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -82.6 120.37 25.45 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.918 0.866 . . . . 1.0 112.545 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 40.5 t -120.51 121.4 38.37 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.263 -1.335 . . . . 0.34 109.684 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 68.5 mt -102.43 97.64 9.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 107.844 -1.169 . . . . 1.07 107.844 174.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.04 135.54 32.44 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.345 2.03 . . . . 0.32 111.913 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -128.7 149.34 50.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.311 0.577 . . . . 0.42 110.575 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.0 m -131.49 112.21 12.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.318 -0.856 . . . . 1.29 108.76 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.9 124.74 71.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.837 -0.62 . . . . 1.08 109.721 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t0 -101.17 144.07 30.49 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.22 -1.029 . . . . 1.39 108.22 -176.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 158.52 8.67 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 111.43 -0.668 . . . . 0.6 111.43 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -99.94 -58.02 0.13 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-O 118.916 -0.564 . . . . 3.29 110.902 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.0 125.07 17.48 Favored 'Trans proline' 0 C--N 1.366 1.49 0 N-CA-C 108.064 -1.552 . . . . 1.09 108.064 169.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 115.69 19.73 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-O 120.988 0.423 . . . . 1.36 111.768 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.63 142.45 10.34 Favored 'Trans proline' 0 N--CA 1.424 -2.585 0 C-N-CA 121.515 1.477 . . . . 0.56 110.748 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 m -75.28 105.39 6.28 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.919 -1.141 . . . . 1.74 107.919 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.06 116.92 18.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.327 0.584 . . . . 1.14 110.019 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -129.3 130.2 45.85 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.222 -0.899 . . . . 4.62 109.735 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 90.3 m95 -100.09 140.29 34.53 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.091 -0.707 . . . . 0.33 109.091 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 tp -119.56 127.72 53.26 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 105.957 -1.868 . . . . 1.57 105.957 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -121.82 109.41 14.63 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.983 -0.377 . . . . 1.04 109.983 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.08 29.62 17.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.005 0.907 . . . . 2.17 109.967 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.41 60.14 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.309 -0.859 . . . . 0.61 112.62 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.0 t -93.18 142.59 27.13 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.969 -0.752 . . . . 1.84 108.969 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.45 111.01 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.685 -0.688 . . . . 1.31 110.3 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.42 97.53 9.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.374 -0.83 . . . . 1.33 109.23 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.59 127.43 34.06 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.174 -1.417 . . . . 2.69 107.174 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.32 120.45 10.45 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 123.923 0.764 . . . . 1.74 110.659 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.0 p -106.67 -167.39 1.28 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.878 -0.601 . . . . 2.07 109.827 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -80.96 -16.86 52.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.789 -0.819 . . . . 1.9 108.789 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.75 -41.7 11.11 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.102 -0.499 . . . . 1.89 110.438 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.405 HD12 ' ND2' ' A' ' 79' ' ' ASN . 22.6 mt -124.41 106.29 16.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.382 -1.71 . . . . 1.18 106.382 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -130.39 141.93 50.53 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.901 -0.72 . . . . 3.62 111.248 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -83.31 109.97 17.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.896 -0.779 . . . . 1.15 108.896 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' CD ' HH21 ' A' ' 71' ' ' ARG . 42.3 mt-10 -109.9 155.33 21.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.3 0.571 . . . . 2.04 110.222 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.88 151.31 40.82 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 107.749 -1.204 . . . . 0.87 107.749 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -108.82 166.15 11.03 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.251 -1.759 . . . . 1.7 106.251 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -50.94 102.88 0.33 Allowed Pre-proline 0 N--CA 1.473 0.725 0 O-C-N 123.957 0.785 . . . . 3.36 110.367 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.04 129.45 2.01 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.571 2.181 . . . . 1.63 113.411 -173.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 121.11 15.26 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.347 -0.842 . . . . 1.88 109.828 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.08 -4.83 59.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.061 0.457 . . . . 2.29 109.896 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -63.72 -39.33 94.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.697 -1.224 . . . . 3.93 107.697 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.99 163.74 12.03 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.84 -1.073 . . . . 1.89 108.375 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.2 p -94.96 23.63 5.43 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.655 0.264 . . . . 1.86 111.383 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.1 t -116.88 129.47 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-O 121.178 0.514 . . . . 1.19 110.749 -175.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -91.74 132.4 36.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.906 -1.516 . . . . 2.36 106.906 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.19 128.05 56.36 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.451 -0.574 . . . . 1.49 109.451 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.58 -169.06 17.45 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 111.068 -0.813 . . . . 0.36 111.068 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.1 t -152.0 133.3 14.48 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 120.92 0.391 . . . . 0.36 110.81 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 46.3 tp -84.61 90.78 7.75 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 104.747 -2.316 . . . . 1.06 104.747 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.456 HH21 ' CD ' ' A' ' 55' ' ' GLU . 50.1 ttp180 -95.87 120.94 37.03 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 115.595 -0.729 . . . . 3.22 109.734 -176.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.35 108.6 17.9 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.862 -1.532 . . . . 1.78 106.862 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.74 -40.18 91.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.759 -1.564 . . . . 2.42 110.64 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -128.69 101.42 20.69 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.813 -0.81 . . . . 3.22 108.813 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.59 130.41 14.81 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.357 2.038 . . . . 1.62 112.458 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 p -139.39 165.13 28.03 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.958 -1.127 . . . . 1.75 107.958 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 105' ' ' ASN . 16.5 p-80 -76.82 -5.66 49.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.285 0.846 . . . . 2.61 113.285 -173.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.54 -11.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.089 0.471 . . . . 1.77 109.791 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' ND2' HD12 ' A' ' 52' ' ' ILE . 12.6 m120 -92.52 26.49 2.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.571 0.701 . . . . 2.19 110.038 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.606 ' OD1' ' HA ' ' A' ' 101' ' ' ALA . 17.6 t30 -117.51 114.8 23.99 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.344 -0.984 . . . . 2.08 108.344 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.76 -159.2 32.19 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.521 -0.847 . . . . 0.59 112.378 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -88.3 118.01 27.61 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.671 0.388 . . . . 2.28 111.657 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 98' ' ' ILE . 57.0 m-85 -106.8 137.56 44.6 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.588 -0.893 . . . . 1.03 108.588 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 m -137.72 133.89 34.7 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.792 -0.818 . . . . 1.13 108.792 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 39' ' ' TRP . 53.0 tp -106.11 120.68 42.42 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 109.736 -0.468 . . . . 1.07 109.736 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.42 133.41 51.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.339 -0.986 . . . . 1.15 108.339 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.66 121.18 25.09 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.999 -1.111 . . . . 1.11 107.999 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.59 132.53 53.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.024 0.202 . . . . 1.34 110.507 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 31.9 p30 -148.33 173.61 4.07 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-O 117.965 -1.017 . . . . 1.61 108.722 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 17.3 Cg_exo -41.57 -32.29 1.4 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.742 2.961 . . . . 1.33 116.318 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.8 t -81.85 -33.41 30.67 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.698 -0.626 . . . . 1.1 111.735 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.15 -161.94 35.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.563 -1.303 . . . . 0.71 112.825 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.25 133.38 47.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.805 -0.813 . . . . 1.83 108.805 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.27 154.35 29.25 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.656 -0.868 . . . . 1.16 108.656 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 p -149.5 123.77 9.57 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 123.72 0.637 . . . . 0.88 111.256 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.22 149.8 48.8 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.229 -1.397 . . . . 1.09 107.229 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.8 p -118.63 147.99 43.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.638 . . . . 1.7 112.598 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -140.59 118.88 10.28 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 C-N-CA 124.767 1.227 . . . . 1.38 109.041 177.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.435 ' N ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -101.88 100.75 11.1 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.389 -1.708 . . . . 1.67 106.389 179.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.77 113.47 26.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.656 0.741 . . . . 1.26 111.007 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.606 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -105.13 104.98 14.82 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.566 -1.197 . . . . 1.4 108.611 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -103.47 -87.46 0.43 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.304 -0.558 . . . . 4.75 110.791 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.404 ' HB2' ' HA ' ' A' ' 77' ' ' HIS . 65.4 mtt -101.37 139.28 37.26 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.381 -0.97 . . . . 5.12 108.381 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 7.0 p-10 -76.96 148.6 36.22 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.879 -0.6 . . . . 5.33 110.695 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.422 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 7.8 t30 -96.96 104.38 18.48 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.163 -0.68 . . . . 5.79 109.163 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 107' ' ' PHE . 48.1 Cg_exo -65.52 115.7 3.51 Favored 'Trans proline' 0 C--O 1.254 1.293 0 C-N-CA 121.706 1.604 . . . . 5.07 111.552 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 44.0 t80 . . . . . 0 C--O 1.245 0.863 0 O-C-N 125.201 1.563 . . . . 10.3 107.896 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 CA--C 1.495 -1.142 0 N-CA-C 108.821 -0.807 . . . . 7.93 108.821 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -166.07 -61.2 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.816 -0.629 . . . . 6.17 110.214 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.82 51.75 2.29 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.318 -1.364 . . . . 5.43 107.318 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -127.94 37.75 4.13 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.878 -1.51 . . . . 3.87 108.724 -173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.06 -50.69 70.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.205 -0.907 . . . . 2.55 109.03 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.02 102.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.928 -1.033 . . . . 2.51 108.636 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 t -80.02 99.55 7.72 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.49 -0.929 . . . . 2.01 108.49 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.549 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 27.6 m-85 -75.06 121.4 21.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.3 -1.371 . . . . 1.61 107.3 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -83.95 -174.16 5.13 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.154 -1.054 . . . . 1.32 108.154 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.36 118.35 30.83 Favored 'General case' 0 CA--C 1.474 -1.942 0 C-N-CA 119.128 -1.029 . . . . 1.15 109.652 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.1 m -116.67 130.66 56.86 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.789 -1.096 . . . . 1.67 108.569 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.68 119.5 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.331 -0.395 . . . . 1.11 111.379 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -115.11 120.41 39.71 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.162 -0.681 . . . . 2.66 109.162 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 27' ' ' PHE . 33.5 mt -98.41 155.13 17.39 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 109.589 -0.522 . . . . 1.08 109.589 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.67 147.18 52.49 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.917 -1.142 . . . . 1.34 107.917 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 m -60.96 131.72 51.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 124.118 0.886 . . . . 1.24 109.41 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.36 139.27 19.74 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.403 1.064 . . . . 1.07 111.44 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.9 140.98 15.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.515 0.674 . . . . 1.21 110.137 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.72 102.33 11.46 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.346 -1.297 . . . . 2.52 111.731 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -145.12 -167.47 2.68 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.106 -1.442 . . . . 1.33 107.106 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -77.93 -49.46 14.12 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.843 -1.54 . . . . 3.4 106.843 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -89.82 120.13 30.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.554 -1.276 . . . . 3.18 107.554 172.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.62 134.25 35.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.106 0.479 . . . . 1.0 111.05 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.7 t -125.99 126.07 43.71 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.214 -0.903 . . . . 0.34 110.555 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.9 mt -101.33 102.75 22.64 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.149 -1.426 . . . . 1.07 107.149 173.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.14 138.8 23.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.251 1.967 . . . . 0.32 111.558 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 68' ' ' GLY . 50.3 p90 -133.29 144.27 49.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.871 0.367 . . . . 0.42 110.731 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -121.59 106.24 11.18 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.447 -0.945 . . . . 1.29 108.447 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 66' ' ' ARG . 3.0 p -114.33 117.86 56.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.684 -0.858 . . . . 1.08 108.684 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -117.79 156.92 27.49 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.301 -0.56 . . . . 1.39 109.491 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 149.38 5.31 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 108.323 -1.911 . . . . 0.6 108.323 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -86.47 -53.54 0.42 Allowed Pre-proline 0 C--N 1.311 -1.095 0 C-N-CA 118.857 -1.137 . . . . 3.29 110.857 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 14.2 Cg_endo -62.75 119.31 6.34 Favored 'Trans proline' 0 C--N 1.373 1.824 0 N-CA-C 107.439 -1.793 . . . . 1.09 107.439 167.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.11 118.7 61.28 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 115.475 -0.784 . . . . 1.36 112.156 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -86.84 160.33 8.98 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.108 1.872 . . . . 0.56 112.398 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -96.99 138.19 34.9 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.235 -1.024 . . . . 1.74 108.235 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 29' ' ' VAL . 95.1 mt -101.33 134.63 44.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.185 0.517 . . . . 1.14 111.526 -175.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -136.75 131.34 33.3 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.483 -0.781 . . . . 4.62 110.248 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -97.34 138.54 34.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.873 -0.603 . . . . 0.33 110.647 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -129.8 137.04 50.28 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.716 -1.957 . . . . 1.57 105.716 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.45 119.68 20.94 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.962 -0.385 . . . . 1.04 109.962 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 60.06 26.34 15.67 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.24 1.019 . . . . 2.17 110.885 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.28 82.15 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.61 112.252 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 p -108.26 150.86 26.72 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.012 0.434 . . . . 1.84 110.391 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.45 114.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.436 -0.802 . . . . 1.31 112.148 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.38 122.1 32.95 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.936 -1.135 . . . . 1.33 107.936 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.41 137.11 40.18 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.01 -0.541 . . . . 2.69 110.029 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.52 121.03 12.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -138.09 -163.99 1.55 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 120.455 -0.498 . . . . 2.07 110.715 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -64.56 -49.89 69.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.631 0.604 . . . . 1.9 112.631 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -84.87 -31.76 23.58 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 1.89 112.013 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 79' ' ' ASN . 21.0 mt -114.42 106.66 21.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.705 -1.591 . . . . 1.18 106.705 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.23 154.21 50.22 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.542 0.687 . . . . 3.62 111.369 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -95.14 129.3 42.29 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.311 -0.859 . . . . 1.15 109.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -123.13 129.39 51.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.032 -1.47 . . . . 2.04 107.032 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.58 120.84 37.63 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.625 -0.509 . . . . 0.87 109.625 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.15 153.84 27.03 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.548 . . . . 1.7 106.822 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.56 102.05 0.29 Allowed Pre-proline 0 C--N 1.313 -0.998 0 C-N-CA 125.901 1.68 . . . . 3.36 114.0 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -88.91 146.71 5.62 Favored 'Trans proline' 0 C--O 1.264 1.79 0 C-N-CA 122.135 1.89 . . . . 1.63 110.383 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.464 ' HB1' ' HG3' ' A' ' 63' ' ' GLU . . . -84.97 155.08 21.76 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.255 -1.017 . . . . 1.88 108.255 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.54 -22.1 61.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.417 -0.811 . . . . 2.29 112.448 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.17 -2.29 43.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.425 0.528 . . . . 3.93 112.425 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 54.8 mt-10 -83.04 136.84 34.35 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 109.112 -0.699 . . . . 1.89 109.112 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -103.72 27.83 7.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.827 1.298 . . . . 1.86 108.157 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 129.42 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.2 -1.364 . . . . 1.19 108.087 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HB3' HG12 ' A' ' 29' ' ' VAL . 37.2 ttm180 -93.86 119.12 32.38 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.934 -1.506 . . . . 2.36 106.934 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -98.39 115.41 28.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.345 -0.983 . . . . 1.49 108.345 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 27' ' ' PHE . . . -133.22 166.0 23.88 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.157 -1.497 . . . . 0.36 113.517 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 t -139.88 131.93 27.91 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.541 0.736 . . . . 0.36 109.748 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.0 tp -96.39 103.44 15.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.518 -2.03 . . . . 1.06 105.518 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -108.12 127.91 54.22 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.783 0.801 . . . . 3.22 111.539 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.5 mp -103.67 109.43 21.12 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.462 -1.245 . . . . 1.78 108.744 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -66.42 -36.39 82.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.554 -1.203 . . . . 2.42 109.677 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -134.48 101.35 12.09 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 108.021 -1.103 . . . . 3.22 108.021 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.21 130.75 11.32 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.257 1.971 . . . . 1.62 110.329 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -117.56 169.94 9.15 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.684 -0.487 . . . . 1.75 109.684 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -76.27 -7.01 53.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.655 0.613 . . . . 2.61 112.655 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.59 -9.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.503 -0.555 . . . . 1.77 109.503 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.433 HD22 HD12 ' A' ' 52' ' ' ILE . 10.8 m120 -99.59 26.85 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.401 0.68 . . . . 2.19 110.105 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -111.42 100.21 8.84 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.785 -0.82 . . . . 2.08 108.785 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.81 -157.61 30.17 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.335 -1.412 . . . . 0.59 113.85 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.53 118.73 30.21 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.355 0.662 . . . . 2.28 112.293 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.13 127.29 46.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.828 -1.078 . . . . 1.03 108.316 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 29.4 m -117.69 127.22 53.72 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 108.886 -0.783 . . . . 1.13 108.886 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.2 tp -103.39 125.71 50.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.645 -0.502 . . . . 1.07 109.645 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -108.45 129.34 55.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 124.178 0.924 . . . . 1.15 108.794 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.78 121.6 35.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.288 -1.375 . . . . 1.11 107.288 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.49 54.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 112.508 0.558 . . . . 1.34 112.508 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -141.25 162.96 44.87 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.986 -1.487 . . . . 1.61 106.986 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -47.55 -29.68 10.84 Favored 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 122.716 2.278 . . . . 1.33 114.775 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.63 -29.26 64.45 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.008 -0.432 . . . . 1.1 111.804 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.93 165.88 21.86 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.787 -1.197 . . . . 0.71 112.557 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.34 122.5 47.12 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.713 -1.217 . . . . 1.83 107.713 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.64 145.94 28.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.944 -0.762 . . . . 1.16 108.944 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 35.0 p -138.05 138.82 39.17 Favored 'General case' 0 N--CA 1.416 -2.161 0 O-C-N 123.669 0.606 . . . . 0.88 109.837 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.34 155.7 47.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.246 -1.391 . . . . 1.09 107.246 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 p -127.75 143.1 51.15 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.654 0.264 . . . . 1.7 111.686 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.58 131.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.804 -1.924 . . . . 1.38 105.804 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 ttt -112.32 107.5 16.35 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.81 -0.756 . . . . 1.67 109.202 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.37 126.48 55.41 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.292 0.568 . . . . 1.26 111.575 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.05 103.39 15.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.188 -0.915 . . . . 1.4 108.689 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.68 -79.12 0.42 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.381 -0.528 . . . . 4.75 110.795 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 mmt -109.25 129.61 55.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.196 -1.039 . . . . 5.12 108.196 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.03 140.57 42.01 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 122.408 0.283 . . . . 5.33 110.384 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -74.59 121.06 84.4 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.524 -0.307 . . . . 5.79 110.37 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.18 141.31 56.74 Favored 'Trans proline' 0 C--O 1.244 0.815 0 C-N-CA 122.855 2.37 . . . . 5.07 112.804 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.685 1.241 . . . . 10.3 111.265 177.702 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 109.315 -0.624 . . . . 7.93 109.315 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 t70 58.53 79.97 0.2 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.189 1.396 . . . . 6.17 110.642 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -75.81 52.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.379 0.672 . . . . 5.43 110.674 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -157.61 -51.57 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.245 -0.889 . . . . 3.87 109.941 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.12 -49.67 69.01 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.326 0.391 . . . . 2.55 109.98 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -88.47 98.93 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-O 122.291 1.043 . . . . 2.51 109.474 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 p -88.95 98.61 11.85 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 107.037 -1.468 . . . . 2.01 107.037 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.489 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 65.2 m-85 -68.1 134.52 50.71 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.67 -1.233 . . . . 1.61 107.67 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.58 -174.81 5.5 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.572 -1.27 . . . . 1.32 107.572 -174.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.17 121.89 34.99 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 119.788 -0.765 . . . . 1.15 109.462 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -125.13 135.05 52.28 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.764 -1.199 . . . . 1.67 107.764 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.54 119.11 57.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.94 0.4 . . . . 1.11 111.435 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -118.08 116.56 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.952 -0.759 . . . . 2.66 108.952 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.7 mt -98.13 155.95 16.9 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.263 -0.643 . . . . 1.08 109.263 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -130.86 153.92 48.61 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.783 -1.192 . . . . 1.34 107.783 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.0 m -59.32 133.64 56.28 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 124.729 1.268 . . . . 1.24 110.62 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 151.78 45.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.417 -0.81 . . . . 1.07 109.152 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.98 126.73 44.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.689 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HA ' ' CZ3' ' A' ' 23' ' ' TRP . 28.0 mm-40 -72.24 88.83 1.16 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.998 -1.001 . . . . 2.52 110.565 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.28 -178.86 7.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.674 -0.862 . . . . 1.33 108.674 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -61.82 -42.52 99.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.577 0.626 . . . . 3.4 112.067 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.08 109.11 21.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.992 -1.114 . . . . 3.18 107.992 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 92.1 m95 -82.27 106.97 14.59 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.306 0.574 . . . . 1.0 111.602 -174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.0 t -104.48 116.97 33.03 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.574 -1.194 . . . . 0.34 109.023 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.1 mt -102.84 100.14 15.75 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 107.858 -1.164 . . . . 1.07 107.858 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -73.41 130.02 14.53 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.258 1.972 . . . . 0.32 111.738 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -122.3 155.75 35.28 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.209 0.528 . . . . 0.42 110.522 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -138.24 106.98 5.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.462 -0.94 . . . . 1.29 108.462 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.28 117.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.059 0.457 . . . . 1.08 110.008 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.9 t70 -101.91 136.97 40.83 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.946 -0.57 . . . . 1.39 110.461 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.08 150.6 7.95 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.363 -1.095 . . . . 0.6 110.363 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -58.79 0.41 Allowed Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 107.322 -1.362 . . . . 3.29 107.322 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 38.0 Cg_endo -71.97 120.98 7.19 Favored 'Trans proline' 0 C--N 1.369 1.607 0 N-CA-C 108.173 -1.51 . . . . 1.09 108.173 168.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.7 113.63 8.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 1.36 111.065 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.48 142.43 14.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.452 2.101 . . . . 0.56 111.734 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 p -69.47 127.77 34.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.631 -0.713 . . . . 1.74 110.019 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.3 mt -98.94 126.16 44.55 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.88 -0.6 . . . . 1.14 111.069 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -131.85 127.59 36.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.88 -0.6 . . . . 4.62 110.176 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.0 m95 -92.91 126.95 38.24 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.33 110.312 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.94 126.92 54.52 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.677 -1.601 . . . . 1.57 106.677 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -115.74 102.97 10.21 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.177 -0.675 . . . . 1.04 109.177 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 54.15 40.42 31.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.055 0.942 . . . . 2.17 112.101 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.1 84.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.671 -0.695 . . . . 0.61 113.689 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -114.04 136.94 52.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 117.449 0.624 . . . . 1.84 109.716 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.77 121.06 13.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.217 -0.447 . . . . 1.31 110.266 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 tp -82.27 137.82 34.75 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.451 -1.315 . . . . 1.33 107.451 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -109.21 121.22 44.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 123.354 0.409 . . . . 2.69 110.229 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 119.64 13.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.868 -0.79 . . . . 1.74 108.868 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -150.06 -174.03 4.61 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.828 -0.804 . . . . 2.07 108.828 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 t -70.73 3.68 3.02 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 112.932 0.715 . . . . 1.9 112.932 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.16 -28.39 9.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.871 -0.518 . . . . 1.89 109.921 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -149.02 108.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.894 -1.15 . . . . 1.18 107.894 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -135.59 156.28 49.12 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.785 0.661 . . . . 3.62 112.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -100.31 110.43 22.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.293 -0.867 . . . . 1.15 110.421 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.34 146.26 24.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.78 -0.822 . . . . 2.04 108.78 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.07 156.88 32.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.314 -0.624 . . . . 0.87 109.314 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.26 160.35 29.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.422 -1.325 . . . . 1.7 107.422 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -71.68 120.28 79.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 113.916 1.08 . . . . 3.36 113.916 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.53 145.1 29.31 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 123.198 2.599 . . . . 1.63 111.071 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.54 162.0 16.65 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.485 -0.932 . . . . 1.88 108.485 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.75 -11.38 60.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.931 0.715 . . . . 2.29 112.931 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -91.19 3.31 55.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.167 0.984 . . . . 3.93 108.517 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 151.7 48.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.062 -0.972 . . . . 1.89 108.956 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -120.29 23.88 10.69 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.498 -1.667 . . . . 1.86 106.498 165.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 15.1 t -99.76 123.48 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 113.303 -1.771 . . . . 1.19 109.526 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -89.01 116.32 27.21 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.173 -1.788 . . . . 2.36 106.173 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -101.2 137.88 38.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.329 -0.989 . . . . 1.49 108.329 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.45 -170.39 30.33 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 120.19 -1.005 . . . . 0.36 111.046 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.9 t -150.41 132.48 15.29 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 120.874 0.368 . . . . 0.36 110.841 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.6 tp -90.13 111.82 23.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.301 -2.111 . . . . 1.06 105.301 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 10.1 ptp180 -114.09 128.91 56.59 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.046 -1.062 . . . . 3.22 112.49 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.84 107.09 18.79 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 105.455 -2.054 . . . . 1.78 105.455 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -80.81 -35.26 33.25 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.234 -0.439 . . . . 2.42 110.524 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.47 99.79 51.48 Favored Pre-proline 0 N--CA 1.421 -1.909 0 N-CA-C 108.172 -1.048 . . . . 3.22 108.172 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -84.13 143.09 10.1 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 122.229 1.953 . . . . 1.62 111.411 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -136.82 160.93 37.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.108 -1.071 . . . . 1.75 108.108 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.71 -6.89 2.89 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.963 1.097 . . . . 2.61 113.963 -173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.86 -9.93 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.797 0.332 . . . . 1.77 110.572 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -77.86 8.92 3.98 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.643 0.979 . . . . 2.19 113.643 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -91.4 88.56 6.88 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.393 -1.706 . . . . 2.08 106.393 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.65 -171.29 27.51 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.458 -1.83 . . . . 0.59 114.536 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -98.88 103.79 15.78 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.051 0.94 . . . . 2.28 110.611 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -93.3 105.96 17.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.865 -0.791 . . . . 1.03 108.865 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.0 m -103.93 125.94 50.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.239 -0.652 . . . . 1.13 109.239 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.5 tp -100.6 118.28 36.45 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.009 -0.737 . . . . 1.07 109.009 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 130.38 47.21 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.46 -0.941 . . . . 1.15 108.46 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 121.11 28.74 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.557 -1.275 . . . . 1.11 107.557 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.47 130.78 44.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 123.399 0.437 . . . . 1.34 110.504 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -134.9 171.27 9.28 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.415 -1.328 . . . . 1.61 107.415 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.41 -30.11 19.76 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.448 2.099 . . . . 1.33 114.145 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.83 -50.99 37.41 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 111.747 0.277 . . . . 1.1 111.747 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.92 45.22 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.452 -1.356 . . . . 0.71 112.933 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -123.55 133.09 54.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.928 0.428 . . . . 1.83 110.345 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.244 -1.021 . . . . 1.16 108.244 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 31.9 p -144.96 138.84 27.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 109.583 -0.525 . . . . 0.88 109.583 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.72 152.36 47.92 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.384 -1.339 . . . . 1.09 107.384 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 m -131.48 141.32 49.75 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.597 -0.441 . . . . 1.7 111.134 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.34 123.96 39.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 106.441 -1.689 . . . . 1.38 106.441 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -103.88 98.87 8.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.243 -0.651 . . . . 1.67 109.243 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.89 27.28 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.416 -0.811 . . . . 1.26 110.645 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.17 143.33 42.08 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.935 -1.135 . . . . 1.4 107.935 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 75' ' ' PRO . 19.3 t80 -111.77 -78.93 0.58 Allowed 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 112.662 0.616 . . . . 4.75 112.662 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 88.1 mtp -134.45 177.26 7.91 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.151 -0.685 . . . . 5.12 109.151 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.57 135.14 36.02 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.796 -1.187 . . . . 5.33 107.796 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -95.32 111.72 56.15 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 109.203 -0.666 . . . . 5.79 109.203 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -57.75 129.02 31.4 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.907 2.405 . . . . 5.07 111.832 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.817 -1.087 . . . . 10.3 111.551 178.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 110.106 -0.331 . . . . 7.93 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 48.43 57.36 6.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 113.708 1.003 . . . . 6.17 113.708 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.47 -40.12 85.29 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.201 -1.777 . . . . 5.43 106.201 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 59.98 14.14 4.15 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.505 1.922 . . . . 3.87 113.748 167.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.92 -32.9 65.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.462 0.648 . . . . 2.55 110.104 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 m -70.61 98.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-O 122.948 1.356 . . . . 2.51 108.995 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.3 m -110.67 101.0 9.68 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 114.277 -1.329 . . . . 2.01 111.038 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.454 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 p90 -130.38 134.54 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.721 -1.127 . . . . 1.61 108.993 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 73.0 m -84.17 -166.19 1.36 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.57 -0.741 . . . . 1.32 111.93 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.38 131.72 39.74 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.69 0.757 . . . . 1.15 112.018 -172.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 t -111.72 137.48 49.57 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.954 -1.499 . . . . 1.67 106.954 173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -115.6 114.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.116 -0.698 . . . . 1.11 109.116 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -108.44 116.03 31.2 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.033 -0.728 . . . . 2.66 109.033 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -98.97 151.22 21.15 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.539 -0.541 . . . . 1.08 109.539 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -131.32 148.8 52.72 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.43 -0.952 . . . . 1.34 108.43 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -56.59 136.39 54.54 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.224 1.41 . . . . 1.24 109.617 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.96 143.2 57.94 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.952 0.783 . . . . 1.07 110.61 -176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.81 127.58 44.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 109.485 -0.561 . . . . 1.21 109.485 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.73 116.48 16.48 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.522 -0.763 . . . . 2.52 110.567 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.2 ptt? -168.2 -177.06 3.14 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.966 -1.494 . . . . 1.33 106.966 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -71.34 -39.46 71.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 119.517 1.053 . . . . 3.4 112.208 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.409 ' O ' ' HG3' ' A' ' 20' ' ' MET . 37.5 m80 -98.59 115.14 27.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.42 -1.326 . . . . 3.18 107.42 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -81.77 137.94 35.25 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 1.0 111.953 -172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.81 120.62 21.83 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.46 -1.245 . . . . 0.34 109.144 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.9 100.0 15.46 Favored Pre-proline 0 C--O 1.247 0.96 0 N-CA-C 106.88 -1.526 . . . . 1.07 106.88 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.54 135.57 20.19 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.338 2.026 . . . . 0.32 112.084 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.33 155.85 42.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.16 -0.473 . . . . 0.42 109.833 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.4 m -132.58 106.32 7.75 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.768 -1.197 . . . . 1.29 107.768 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 66' ' ' ARG . 3.4 p -110.74 119.28 59.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.67 -0.863 . . . . 1.08 108.67 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -121.22 128.15 52.15 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.624 -0.716 . . . . 1.39 111.303 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.71 147.85 9.35 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.776 -1.73 . . . . 0.6 108.776 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.16 -55.96 1.69 Allowed Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.091 -0.707 . . . . 3.29 109.091 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HB2' HD22 ' A' ' 89' ' ' ASN . 25.2 Cg_endo -63.77 122.01 9.93 Favored 'Trans proline' 0 C--N 1.376 2.0 0 N-CA-C 108.283 -1.468 . . . . 1.09 108.283 169.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.35 121.76 84.31 Favored Pre-proline 0 C--N 1.298 -1.652 0 CA-C-N 115.818 -0.628 . . . . 1.36 112.166 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -90.97 167.77 3.7 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.713 2.276 . . . . 0.56 112.464 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -105.62 126.73 52.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.12 -1.067 . . . . 1.74 108.12 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.99 143.92 26.36 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.883 0.373 . . . . 1.14 111.843 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -144.54 137.99 27.21 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.595 1.158 . . . . 4.62 109.221 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -102.93 146.0 28.99 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.67 0.748 . . . . 0.33 110.871 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 19.2 tp -131.59 127.75 37.75 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.667 -1.605 . . . . 1.57 106.667 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -111.95 106.16 14.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 110.228 -0.286 . . . . 1.04 110.228 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 57.0 30.02 17.44 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.514 0.725 . . . . 2.17 111.883 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.34 64.52 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.741 -0.742 . . . . 0.61 112.086 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 m -90.48 129.85 36.6 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.629 -0.508 . . . . 1.84 109.629 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.37 117.22 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.572 -0.74 . . . . 1.31 110.342 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.0 tp -97.58 101.3 12.79 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.409 -0.814 . . . . 1.33 109.744 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -84.31 130.71 34.78 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.898 -1.519 . . . . 2.69 106.898 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.09 138.22 56.25 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.614 0.765 . . . . 1.74 111.808 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -108.21 -163.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.654 -0.703 . . . . 2.07 109.391 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -85.76 -34.65 21.13 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.849 -0.797 . . . . 1.9 108.849 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -85.2 -28.98 25.08 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.52 -0.309 . . . . 1.89 111.67 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.7 mt -117.93 106.46 19.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.911 -1.144 . . . . 1.18 107.911 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.186 0.517 . . . . 3.62 110.983 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 m -84.54 112.53 20.49 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.114 -1.069 . . . . 1.15 108.114 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.91 127.01 46.13 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.354 -0.98 . . . . 2.04 108.354 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.01 137.14 44.44 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 4.4 pp -96.47 165.79 12.01 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.675 -1.232 . . . . 1.7 107.675 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.61 107.67 2.48 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 117.783 0.265 . . . . 3.36 111.383 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 44.1 Cg_endo -89.41 169.39 4.91 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.662 2.908 . . . . 1.63 111.238 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.95 139.48 30.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.274 -1.38 . . . . 1.88 107.274 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.94 65.51 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.532 0.733 . . . . 2.29 111.824 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -76.07 -13.17 60.22 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.55 -0.295 . . . . 3.93 111.763 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.77 134.78 35.75 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.807 0.336 . . . . 1.89 110.826 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -95.03 -2.94 49.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.073 0.94 . . . . 1.86 108.83 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.01 129.65 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 107.64 -1.244 . . . . 1.19 107.64 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.434 ' HB2' HG12 ' A' ' 29' ' ' VAL . 60.1 mtp85 -97.22 117.13 30.74 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.154 -1.425 . . . . 2.36 107.154 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.7 112.31 24.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.516 -0.766 . . . . 1.49 110.312 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 178.96 31.62 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 111.083 -0.807 . . . . 0.36 111.083 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 t -150.43 145.19 25.9 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.127 -0.323 . . . . 0.36 110.127 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 51.2 tp -80.66 109.93 15.66 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.43 -1.693 . . . . 1.06 106.43 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -97.86 122.81 41.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.76 -0.655 . . . . 3.22 110.986 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.4 mt -99.19 108.45 21.05 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.159 -1.422 . . . . 1.78 107.159 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.4 -54.99 7.78 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.165 -0.925 . . . . 2.42 109.329 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -110.43 106.17 57.72 Favored Pre-proline 0 N--CA 1.427 -1.61 0 N-CA-C 108.307 -0.998 . . . . 3.22 108.307 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.4 135.76 55.49 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.265 2.643 . . . . 1.62 111.343 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 p -142.02 155.34 45.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.939 -0.393 . . . . 1.75 109.939 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -72.88 -5.08 35.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.563 0.579 . . . . 2.61 112.563 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 80' ' ' ASN . 27.3 m -78.66 -9.72 12.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 CA-C-O 120.981 0.42 . . . . 1.77 110.285 171.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.782 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 16.1 m120 -87.81 26.53 1.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.195 0.997 . . . . 2.19 109.407 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 78' ' ' VAL . 66.3 t30 -120.68 87.83 2.82 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.273 -1.38 . . . . 2.08 107.273 -175.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.24 -167.41 39.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.219 -0.991 . . . . 0.59 112.013 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.78 106.45 18.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.94 0.4 . . . . 2.28 111.201 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.782 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 69.7 m-85 -95.42 117.14 29.83 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.078 -1.082 . . . . 1.03 108.078 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 88.1 m -106.83 131.35 54.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.512 -0.551 . . . . 1.13 109.512 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.41 120.53 40.66 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.961 -0.755 . . . . 1.07 108.961 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.52 136.28 44.38 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.537 -1.283 . . . . 1.15 107.537 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.09 119.37 30.11 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.679 -1.601 . . . . 1.11 106.679 171.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.12 127.28 47.73 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 123.378 0.424 . . . . 1.34 109.896 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.511 HD22 ' HB2' ' A' ' 33' ' ' PRO . 25.5 t-20 -150.98 136.95 10.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.16 -1.422 . . . . 1.61 107.16 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -43.13 -34.84 4.43 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 125.252 3.968 . . . . 1.33 115.532 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.0 p -91.33 -33.69 15.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.678 -0.809 . . . . 1.1 111.526 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.86 131.55 2.58 Favored Glycine 0 C--N 1.299 -1.493 0 C-N-CA 120.075 -1.06 . . . . 0.71 112.526 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -103.92 126.58 51.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.903 -0.777 . . . . 1.83 108.903 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.4 152.89 22.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.098 -0.501 . . . . 1.16 109.813 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.7 p -151.2 120.76 6.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.246 -0.433 . . . . 0.88 110.362 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.89 144.32 49.83 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.763 -0.829 . . . . 1.09 108.763 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m -113.89 140.18 48.58 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.084 -0.339 . . . . 1.7 110.084 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.85 118.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.247 -1.019 . . . . 1.38 108.247 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.5 ttm -95.25 108.77 20.93 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.241 -0.583 . . . . 1.67 109.493 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 113.59 25.68 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.287 -0.87 . . . . 1.26 108.759 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.68 101.06 13.29 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.338 -1.356 . . . . 1.4 107.338 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -65.54 -71.76 0.18 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.073 -1.421 . . . . 4.75 111.39 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 68.3 mtt -158.74 -178.82 7.53 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.954 -1.869 . . . . 5.12 105.954 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.14 141.13 50.76 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.916 -0.772 . . . . 5.33 108.916 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -95.22 117.08 66.81 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 109.126 -0.694 . . . . 5.79 109.126 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.25 142.39 99.11 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.861 2.374 . . . . 5.07 112.296 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 . . . . . 0 C--O 1.245 0.845 0 C-N-CA 124.873 1.269 . . . . 10.3 110.097 -178.266 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 108.75 -0.833 . . . . 7.93 108.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 3.7 m-20 68.89 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.592 1.157 . . . . 6.17 113.069 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.25 -28.18 25.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.341 -0.845 . . . . 5.43 109.197 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -89.58 5.4 45.8 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 122.125 0.964 . . . . 3.87 110.23 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 24.1 t70 -66.35 -27.49 67.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.838 -0.619 . . . . 2.55 111.309 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 12.9 m -79.47 98.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.509 1.147 . . . . 2.51 109.065 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m -111.23 98.96 7.88 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.884 -1.053 . . . . 2.01 110.783 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.457 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 98.8 m-85 -98.84 134.02 42.31 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.997 -0.547 . . . . 1.61 109.83 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.3 m -84.09 176.33 8.89 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.52 -0.918 . . . . 1.32 108.52 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.8 130.49 39.8 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.487 -0.485 . . . . 1.15 110.57 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.468 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 5.7 m -126.98 144.4 51.03 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.674 -1.602 . . . . 1.67 106.674 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.79 116.47 43.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 1.11 111.673 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -110.31 126.4 54.17 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.229 -0.656 . . . . 2.66 109.229 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.6 mt -111.78 156.32 22.14 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.225 -0.657 . . . . 1.08 109.225 175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -131.57 145.76 51.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.053 -0.721 . . . . 1.34 109.053 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -52.98 133.54 38.23 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.914 1.384 . . . . 1.24 110.075 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.22 141.53 58.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.214 -0.903 . . . . 1.07 110.004 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.21 130.75 39.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 120.508 -0.477 . . . . 1.21 110.907 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.01 96.46 2.15 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.946 -1.024 . . . . 2.52 112.845 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -167.13 150.73 6.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.848 -1.908 . . . . 1.33 105.848 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -52.33 -30.85 30.53 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.726 1.266 . . . . 3.4 114.068 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -98.73 100.65 11.89 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.212 -1.774 . . . . 3.18 106.212 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -80.63 141.05 35.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.547 0.689 . . . . 1.0 111.672 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.0 t -135.59 124.54 24.17 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.669 -1.15 . . . . 0.34 109.614 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.2 mt -111.02 99.39 42.74 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.556 -1.275 . . . . 1.07 107.556 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 135.76 24.03 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.411 2.074 . . . . 0.32 111.647 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.34 157.17 40.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.808 0.337 . . . . 0.42 110.305 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -142.85 106.74 4.68 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.571 0.701 . . . . 1.29 109.37 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.82 131.61 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.486 -0.779 . . . . 1.08 109.028 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.2 p30 -122.62 150.74 42.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.591 -0.444 . . . . 1.39 111.142 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.17 169.84 30.3 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.697 -1.761 . . . . 0.6 108.697 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 6' ' ' VAL . 21.8 tm0? -93.99 -56.87 0.22 Allowed Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 118.491 1.145 . . . . 3.29 108.52 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.7 Cg_endo -70.4 121.55 8.1 Favored 'Trans proline' 0 C--N 1.368 1.562 0 N-CA-C 107.681 -1.7 . . . . 1.09 107.681 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.63 114.34 9.98 Favored Pre-proline 0 C--N 1.32 -0.69 0 O-C-N 123.546 0.529 . . . . 1.36 109.941 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.22 141.53 20.67 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.203 1.935 . . . . 0.56 111.923 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -71.5 110.95 6.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.807 -0.633 . . . . 1.74 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.7 130.8 34.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.648 -0.705 . . . . 1.14 111.082 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -138.28 136.79 36.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.849 -0.797 . . . . 4.62 108.849 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -100.49 118.77 37.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.097 0.475 . . . . 0.33 109.921 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.01 126.14 50.91 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.376 -2.083 . . . . 1.57 105.376 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -109.92 98.8 8.03 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 121.082 0.467 . . . . 1.04 110.276 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 60.17 25.53 14.89 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.872 1.269 . . . . 2.17 111.221 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.54 -15.17 32.39 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.825 -0.702 . . . . 0.61 113.387 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -109.52 142.44 40.56 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.667 -0.864 . . . . 1.84 108.667 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.12 122.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.517 -0.549 . . . . 1.31 109.517 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.4 tp -77.09 121.4 23.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.717 -0.846 . . . . 1.33 108.717 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -93.49 124.11 37.26 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.166 -1.05 . . . . 2.69 108.166 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 129.54 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.701 -0.481 . . . . 1.74 109.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -166.96 1.4 Allowed 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.883 -0.598 . . . . 2.07 111.035 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -81.82 -12.83 58.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.923 -0.769 . . . . 1.9 108.923 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -103.29 -40.77 6.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.938 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -113.59 106.79 21.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 106.959 -1.497 . . . . 1.18 106.959 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.086 0.47 . . . . 3.62 112.194 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.3 m -84.97 113.05 21.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.982 -0.554 . . . . 1.15 109.822 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -87.49 136.67 32.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.076 -0.511 . . . . 2.04 109.635 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.59 144.0 49.39 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.992 -0.744 . . . . 0.87 108.992 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.45 166.85 15.28 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.087 -0.709 . . . . 1.7 109.087 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.54 124.79 9.7 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 114.234 1.198 . . . . 3.36 114.234 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.81 128.42 2.4 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 121.714 1.609 . . . . 1.63 108.927 169.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.071 -1.085 . . . . 1.88 108.071 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.22 61.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.497 0.665 . . . . 2.29 110.284 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.11 -14.82 60.18 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.56 -1.2 . . . . 3.93 110.056 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.21 161.04 21.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.464 -0.939 . . . . 1.89 108.464 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 3.3 p -112.12 8.13 19.89 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.514 -0.921 . . . . 1.86 108.514 172.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.1 t -95.96 129.72 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 114.511 -1.222 . . . . 1.19 110.366 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -89.68 140.4 29.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.309 -2.108 . . . . 2.36 105.309 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -115.87 133.18 56.29 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.015 -0.735 . . . . 1.49 109.015 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.17 179.83 44.33 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 119.439 -1.363 . . . . 0.36 113.461 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.29 136.71 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.652 0.781 . . . . 0.36 110.285 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 tp -84.88 110.63 18.99 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.682 -1.599 . . . . 1.06 106.682 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -102.06 132.99 47.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.967 0.413 . . . . 3.22 111.813 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.51 109.55 19.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 107.453 -1.314 . . . . 1.78 107.453 172.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -59.09 -37.7 77.75 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.218 -1.356 . . . . 2.42 110.851 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -128.27 135.22 27.21 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 107.929 -1.137 . . . . 3.22 107.929 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.26 130.25 13.89 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 121.473 1.449 . . . . 1.62 109.672 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -115.19 139.97 49.48 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.355 -0.609 . . . . 1.75 109.355 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -75.61 -14.48 60.38 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 112.233 0.457 . . . . 2.61 112.233 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.56 -10.53 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.68 -0.808 . . . . 1.77 113.088 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.263 20.2 m-80 -92.19 26.95 2.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 116.17 1.915 . . . . 2.19 116.17 -171.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.498 HD22 ' HB3' ' A' ' 103' ' ' MET . 87.3 m-20 -80.87 74.25 7.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.998 -0.741 . . . . 2.08 108.998 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.09 -174.9 15.03 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.134 -1.032 . . . . 0.59 112.42 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -93.97 112.04 23.83 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.525 -0.337 . . . . 2.28 110.997 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -86.52 108.09 18.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.414 -0.958 . . . . 1.03 108.414 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 m -102.16 117.99 35.95 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.725 -0.842 . . . . 1.13 108.725 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.8 tp -94.73 118.91 32.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.712 -0.848 . . . . 1.07 108.712 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.0 134.5 46.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.917 . . . . 1.15 108.523 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.85 120.98 19.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.552 -0.907 . . . . 1.11 108.552 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.38 135.34 49.41 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 123.218 0.324 . . . . 1.34 110.4 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -143.91 169.74 9.75 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-O 117.432 -1.27 . . . . 1.61 107.663 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -42.77 -30.99 1.92 Allowed 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 123.317 2.678 . . . . 1.33 115.966 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.0 t -74.97 -47.46 29.23 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.33 -0.548 . . . . 1.1 111.649 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.45 31.36 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.825 -1.178 . . . . 0.71 112.48 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.96 129.31 43.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.093 0.473 . . . . 1.83 109.796 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.6 159.33 21.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.424 -0.954 . . . . 1.16 108.424 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 30.8 p -155.93 153.21 29.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.977 -0.556 . . . . 0.88 110.328 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 158.71 43.52 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.713 -1.588 . . . . 1.09 106.713 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 m -133.72 127.12 32.17 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 120.944 0.402 . . . . 1.7 110.615 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 118.49 45.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.697 -1.223 . . . . 1.38 107.697 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.0 ttm -96.75 114.79 26.46 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.933 -0.707 . . . . 1.67 109.659 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.73 29.72 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.331 -0.618 . . . . 1.26 109.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.83 123.03 36.4 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.667 -0.864 . . . . 1.4 108.667 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -156.99 73.95 0.77 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.003 0.906 . . . . 4.75 110.873 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.498 ' HB3' HD22 ' A' ' 80' ' ' ASN . 23.7 ptt? -100.32 96.71 7.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.898 1.332 . . . . 5.12 111.253 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -97.44 126.13 42.51 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.629 -1.623 . . . . 5.33 107.893 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -98.36 114.47 65.28 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 108.742 -0.836 . . . . 5.79 108.742 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.69 134.89 67.35 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 122.889 2.393 . . . . 5.07 111.229 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 C--O 1.241 0.63 0 C-N-CA 124.993 1.317 . . . . 10.3 110.92 -177.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.497 -1.087 0 N-CA-C 108.787 -0.819 . . . . 7.93 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -127.49 -49.82 1.4 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 120.744 0.307 . . . . 6.17 111.462 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.86 -40.76 79.13 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.331 0.586 . . . . 5.43 110.414 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.35 127.72 9.94 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.068 -1.456 . . . . 3.87 107.068 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.87 -28.59 7.34 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.399 -0.52 . . . . 2.55 110.466 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.61 96.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 122.611 1.196 . . . . 2.51 108.902 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -93.64 96.83 10.07 Favored 'General case' 0 N--CA 1.388 -3.567 0 N-CA-C 106.192 -1.781 . . . . 2.01 106.192 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.434 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 46.6 m-85 -74.31 142.78 45.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.95 -1.023 . . . . 1.61 110.341 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.28 173.42 11.61 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.42 -1.326 . . . . 1.32 107.42 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.24 116.06 28.65 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 121.234 0.54 . . . . 1.15 110.192 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 t -117.02 132.03 56.8 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 107.283 -1.377 . . . . 1.67 107.283 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.86 115.77 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 110.242 -0.281 . . . . 1.11 110.242 -173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -112.31 117.9 33.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.597 -0.52 . . . . 2.66 109.597 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -100.41 151.53 21.41 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 108.654 -0.869 . . . . 1.08 108.654 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -131.24 146.13 52.19 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.238 -1.393 . . . . 1.34 107.238 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.47 132.68 54.22 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 124.087 0.867 . . . . 1.24 110.498 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.88 139.51 39.94 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.596 1.185 . . . . 1.07 111.165 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -91.92 131.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.961 -0.563 . . . . 1.21 110.076 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.08 120.4 21.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.268 -0.878 . . . . 2.52 111.053 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -169.7 -169.84 0.96 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.185 -1.413 . . . . 1.33 107.185 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -72.88 -39.26 66.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.286 0.948 . . . . 3.4 111.968 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -104.89 121.45 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.518 -1.66 . . . . 3.18 106.518 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -82.06 129.48 34.81 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.188 0.518 . . . . 1.0 110.988 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -121.11 118.59 30.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.076 -0.966 . . . . 0.34 110.013 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -101.38 102.23 20.56 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 107.476 -1.305 . . . . 1.07 107.476 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.89 138.15 18.35 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.459 2.106 . . . . 0.32 111.976 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.28 149.01 51.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.323 0.582 . . . . 0.42 110.677 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 m -133.28 106.66 7.67 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.973 -1.121 . . . . 1.29 107.973 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 66' ' ' ARG . 3.6 p -110.93 119.33 59.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 120.933 0.397 . . . . 1.08 109.953 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.59 140.54 35.74 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.838 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.1 134.84 1.74 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.79 -1.724 . . . . 0.6 108.79 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.434 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -71.73 -57.23 4.31 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 106.846 -1.539 . . . . 3.29 106.846 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.51 120.45 7.75 Favored 'Trans proline' 0 C--N 1.373 1.829 0 N-CA-C 108.316 -1.455 . . . . 1.09 108.316 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.4 119.73 59.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.407 -0.815 . . . . 1.36 110.947 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.04 149.46 9.46 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.344 2.029 . . . . 0.56 112.992 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 t -80.97 132.41 35.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.858 -1.534 . . . . 1.74 106.858 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 82.2 mt -103.2 148.24 26.03 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.065 0.46 . . . . 1.14 111.19 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.6 tpm_? -141.72 141.4 33.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.174 -0.676 . . . . 4.62 109.174 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -106.91 125.59 51.21 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.158 0.504 . . . . 0.33 109.952 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 22.4 tp -121.97 128.92 52.04 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.227 -1.398 . . . . 1.57 107.227 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -118.4 106.56 12.85 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.17 -0.678 . . . . 1.04 109.17 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.06 31.77 20.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.121 0.969 . . . . 2.17 111.446 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.93 85.49 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.853 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -107.43 150.53 26.66 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.008 -0.738 . . . . 1.84 109.008 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.3 120.29 24.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.373 -0.376 . . . . 1.31 110.756 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -87.23 128.88 35.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.82 -1.178 . . . . 1.33 107.82 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -104.09 123.96 48.21 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 110.221 -0.289 . . . . 2.69 110.221 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.94 120.96 19.28 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.996 -1.113 . . . . 1.74 107.996 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -136.89 -163.94 1.5 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.889 -0.596 . . . . 2.07 110.117 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 t -58.86 -44.8 91.11 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.505 1.122 . . . . 1.9 111.98 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 72.4 m-85 -92.26 -23.1 19.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.874 0.694 . . . . 1.89 112.874 -174.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mt -124.74 106.3 16.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.974 -1.491 . . . . 1.18 106.974 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -132.9 148.31 52.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.309 0.485 . . . . 3.62 112.309 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 m -101.22 116.96 34.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.442 -0.947 . . . . 1.15 108.442 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.662 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 42.4 mt-10 -96.21 119.85 35.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.458 -0.497 . . . . 2.04 110.513 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -103.38 112.74 25.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.409 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.46 165.57 18.01 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.723 -0.843 . . . . 1.7 108.723 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.4 115.84 43.19 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.945 -0.761 . . . . 3.36 108.945 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.26 134.32 28.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.794 1.663 . . . . 1.63 110.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.33 23.09 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.712 -1.218 . . . . 1.88 107.712 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -23.52 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.256 1.022 . . . . 2.29 113.453 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.99 -24.99 47.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.828 0.347 . . . . 3.93 111.213 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -96.48 152.25 18.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.227 -1.027 . . . . 1.89 108.227 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 p -108.44 16.1 23.35 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.977 0.894 . . . . 1.86 109.399 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 t -109.52 127.22 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.735 -1.121 . . . . 1.19 109.86 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HB3' HG12 ' A' ' 29' ' ' VAL . 21.5 ttm180 -89.59 118.01 28.9 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 2.36 107.165 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -103.85 152.29 22.09 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.426 -0.953 . . . . 1.49 108.426 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.67 -178.72 48.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.661 -1.376 . . . . 0.36 109.661 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.4 t -146.16 142.34 28.37 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 120.939 0.4 . . . . 0.36 111.297 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -92.25 100.99 13.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.936 -1.876 . . . . 1.06 105.936 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.662 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 70.8 mtt85 -99.83 131.7 45.64 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.563 0.697 . . . . 3.22 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.0 109.66 19.88 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.749 -1.204 . . . . 1.78 107.749 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.63 -45.35 83.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.775 -1.102 . . . . 2.42 108.539 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 12.9 mm-40 -130.16 100.85 18.29 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 114.969 -1.014 . . . . 3.22 109.18 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.16 154.25 12.71 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.07 1.847 . . . . 1.62 108.352 173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.52 ' OG1' HG23 ' A' ' 78' ' ' VAL . 21.5 p -125.38 -177.85 4.02 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 118.862 -0.589 . . . . 1.75 109.769 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -67.0 -18.18 65.26 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.32 0.963 . . . . 2.61 110.812 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 HG23 ' OG1' ' A' ' 76' ' ' THR . 13.0 m -72.77 -10.89 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.791 -0.641 . . . . 1.77 109.913 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.525 HD21 ' HH ' ' A' ' 83' ' ' TYR . 23.9 m120 -96.58 26.1 4.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 113.223 0.823 . . . . 2.19 113.223 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -113.6 98.27 6.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.46 -0.941 . . . . 2.08 108.46 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.1 -161.95 29.18 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.392 -0.909 . . . . 0.59 112.247 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.84 116.78 23.49 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.418 -0.216 . . . . 2.28 110.418 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.525 ' HH ' HD21 ' A' ' 79' ' ' ASN . 53.6 m-85 -97.1 105.73 17.93 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.239 -0.652 . . . . 1.03 109.239 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 90.1 m -101.76 124.8 48.0 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.587 -0.733 . . . . 1.13 110.365 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -106.56 123.72 48.53 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.655 -0.869 . . . . 1.07 108.655 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 1.9 mm? -105.48 141.98 36.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.997 -1.112 . . . . 1.15 107.997 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -135.54 121.24 19.58 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.024 -0.732 . . . . 1.11 109.024 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.47 124.14 42.91 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.309 0.485 . . . . 1.34 112.309 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.415 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -138.65 177.04 2.25 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 116.87 -1.538 . . . . 1.61 107.366 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 18.3 Cg_exo -42.64 -26.25 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.53 2.82 . . . . 1.33 116.271 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.63 -34.54 58.32 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.865 -0.522 . . . . 1.1 110.998 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.25 -167.26 29.02 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.951 -0.86 . . . . 0.71 110.951 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 61.8 tt0 -115.36 127.34 55.33 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 122.939 0.496 . . . . 1.83 110.265 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.81 161.77 13.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.182 -0.673 . . . . 1.16 109.182 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.7 p -143.69 136.72 27.61 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.602 -0.518 . . . . 0.88 109.602 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.6 155.03 50.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.954 -1.498 . . . . 1.09 106.954 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -140.07 126.8 20.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.09 0.471 . . . . 1.7 111.452 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.42 130.71 65.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.532 -1.284 . . . . 1.38 107.532 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 tpt -90.5 106.57 18.59 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.633 -0.506 . . . . 1.67 109.633 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.93 132.72 55.61 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.341 0.591 . . . . 1.26 110.686 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.17 119.7 19.16 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.023 -1.473 . . . . 1.4 107.023 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.29 -84.05 0.41 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.384 -0.526 . . . . 4.75 112.315 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.6 ptp -104.21 160.76 14.6 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.265 -0.272 . . . . 5.12 110.265 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -57.76 131.73 51.2 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 124.344 1.027 . . . . 5.33 112.638 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -112.24 136.08 21.37 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 108.946 -0.761 . . . . 5.79 108.946 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.39 178.6 5.38 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.68 2.253 . . . . 5.07 111.013 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 124.419 1.087 . . . . 10.3 108.326 -176.573 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.205 -0.665 . . . . 7.93 109.205 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -86.53 24.38 1.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.67 0.788 . . . . 6.17 109.936 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -94.63 -12.21 27.83 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.081 -0.963 . . . . 5.43 109.999 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.494 ' OD2' HG23 ' A' ' 6' ' ' VAL . 11.1 t70 -106.2 140.25 39.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.441 -0.948 . . . . 3.87 108.441 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.23 -34.9 78.66 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.964 1.305 . . . . 2.55 114.262 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG23 ' OD2' ' A' ' 4' ' ' ASP . 18.0 m -79.99 103.77 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-O 122.59 1.186 . . . . 2.51 113.602 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -108.15 97.88 7.51 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.69 -1.141 . . . . 2.01 108.403 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -92.88 130.65 38.41 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.074 -0.713 . . . . 1.61 109.074 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -84.64 167.26 16.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.79 -1.096 . . . . 1.32 109.045 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.45 127.16 40.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.75 0.31 . . . . 1.15 111.436 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 m -120.74 135.88 55.02 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.834 -1.913 . . . . 1.67 105.834 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.0 t -115.22 114.71 47.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 120.927 0.394 . . . . 1.11 110.342 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.98 123.71 47.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.505 -0.924 . . . . 2.66 108.505 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 98' ' ' ILE . 72.9 mt -104.05 155.95 18.26 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.887 -0.412 . . . . 1.08 109.887 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -132.08 142.95 49.7 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.018 -0.734 . . . . 1.34 109.018 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -53.82 135.89 41.11 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 125.119 1.368 . . . . 1.24 110.858 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.87 57.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 1.07 110.789 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.33 139.07 18.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 121.223 0.535 . . . . 1.21 109.776 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.71 113.34 23.29 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.079 -0.964 . . . . 2.52 111.829 -171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -170.3 -177.65 2.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.191 -2.151 . . . . 1.33 105.191 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.72 -38.45 86.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 120.193 1.361 . . . . 3.4 113.755 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -94.29 115.74 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.465 -0.939 . . . . 3.18 108.465 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.422 ' HB2' HD13 ' A' ' 72' ' ' LEU . 94.0 m95 -82.1 117.52 22.34 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.594 0.711 . . . . 1.0 109.932 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -110.84 122.54 48.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.34 109.305 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.3 mt -106.95 101.71 38.94 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.383 -0.969 . . . . 1.07 108.383 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.59 132.15 15.65 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.416 2.077 . . . . 0.32 111.918 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -122.71 155.34 36.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.117 0.484 . . . . 0.42 110.326 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -136.81 107.7 6.66 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.862 -0.608 . . . . 1.29 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 11' ' ' SER . 3.6 p -119.82 121.49 66.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.827 -0.805 . . . . 1.08 108.827 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.6 p-10 -104.91 161.19 14.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.644 -0.822 . . . . 1.39 110.797 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.77 177.94 24.28 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.396 -1.082 . . . . 0.6 110.396 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.406 ' HA ' ' NE2' ' A' ' 32' ' ' GLN 0.303 17.2 mm-40 -109.85 -54.82 0.05 OUTLIER Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.626 0.602 . . . . 3.29 112.626 175.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -68.93 119.17 6.18 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 N-CA-C 105.819 -2.416 . . . . 1.09 105.819 168.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 109.4 2.47 Favored Pre-proline 0 C--N 1.32 -0.695 0 O-C-N 123.826 0.704 . . . . 1.36 110.727 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 73.9 Cg_endo -72.46 135.03 23.58 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.642 1.561 . . . . 0.56 111.15 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -65.0 108.71 1.89 Allowed 'General case' 0 N--CA 1.433 -1.318 0 O-C-N 123.865 0.728 . . . . 1.74 109.98 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.421 HD22 HG13 ' A' ' 29' ' ' VAL . 87.8 mt -85.57 126.25 33.73 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.288 -0.869 . . . . 1.14 110.128 -176.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -136.77 127.2 26.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.049 -0.523 . . . . 4.62 109.726 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' THR . 85.3 m95 -90.77 134.58 34.32 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.623 -0.717 . . . . 0.33 109.756 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 tp -113.7 126.86 55.71 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 105.447 -2.057 . . . . 1.57 105.447 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -119.8 103.5 9.41 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.45 -0.574 . . . . 1.04 109.45 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 61.39 32.88 19.0 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.208 -0.906 . . . . 2.17 110.783 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.97 -14.48 64.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.807 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -98.88 138.63 35.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.223 -0.658 . . . . 1.84 109.223 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.07 123.79 24.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.941 -0.572 . . . . 1.31 110.395 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.04 120.38 24.13 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.237 -1.023 . . . . 1.33 108.237 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.79 127.62 45.93 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.833 -1.914 . . . . 2.69 105.833 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -57.79 126.73 28.67 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.705 0.628 . . . . 1.74 109.89 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.5 p -128.63 173.77 10.0 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.74 -0.837 . . . . 2.07 108.74 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -77.1 -1.29 28.38 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.738 0.78 . . . . 1.9 110.36 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -105.19 -40.68 5.78 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.305 -0.861 . . . . 1.89 109.002 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -128.58 109.22 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.835 -1.172 . . . . 1.18 107.835 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -143.81 147.07 33.6 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.464 0.65 . . . . 3.62 111.446 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 109.73 11.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.74 -1.118 . . . . 1.15 108.983 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -104.56 108.8 20.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.526 -1.287 . . . . 2.04 107.526 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.02 147.54 24.94 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.937 0.398 . . . . 0.87 111.513 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.81 165.55 13.52 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.428 -1.323 . . . . 1.7 107.428 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -81.58 126.36 76.16 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 113.638 0.977 . . . . 3.36 113.638 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.92 140.4 16.08 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.7 2.267 . . . . 1.63 111.124 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.15 161.15 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.029 -1.1 . . . . 1.88 108.029 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.39 -15.29 63.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.997 0.74 . . . . 2.29 112.997 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.54 -7.73 49.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.381 -0.6 . . . . 3.93 109.381 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.2 134.27 46.89 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.718 -0.475 . . . . 1.89 109.718 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -106.1 20.68 18.57 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.851 -1.537 . . . . 1.86 106.851 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 21.9 t -112.88 132.57 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 114.466 -1.243 . . . . 1.19 110.402 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -84.11 122.86 29.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.985 -1.857 . . . . 2.36 105.985 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -108.56 139.09 43.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.049 -0.352 . . . . 1.49 110.049 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.81 176.21 41.3 Favored Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 110.707 -0.957 . . . . 0.36 110.707 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 t -138.36 132.66 31.85 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.671 -0.492 . . . . 0.36 109.671 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.41 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 53.3 tp -80.26 105.15 11.3 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 104.593 -2.373 . . . . 1.06 104.593 170.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -99.57 116.16 31.06 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.885 -0.598 . . . . 3.22 110.521 -171.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 23' ' ' TRP . 53.9 mt -83.23 107.54 15.84 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 106.651 -1.611 . . . . 1.78 106.651 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -72.85 -49.43 30.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.329 -1.305 . . . . 2.42 109.912 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -122.2 101.46 41.27 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.004 -1.48 . . . . 3.22 107.004 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.46 129.87 29.72 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 121.989 1.793 . . . . 1.62 110.593 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -129.63 157.08 43.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.257 -0.883 . . . . 1.75 108.665 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.38 -5.09 17.03 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 113.639 0.978 . . . . 2.61 113.639 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -82.91 -10.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.406 0.146 . . . . 1.77 110.943 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.03 26.87 0.19 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.396 1.258 . . . . 2.19 114.396 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.9 p30 -113.62 123.56 50.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.069 -1.086 . . . . 2.08 108.069 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -170.81 33.0 Favored Glycine 0 C--N 1.289 -2.072 0 C-N-CA 119.458 -1.353 . . . . 0.59 111.745 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.05 104.91 16.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.616 0.245 . . . . 2.28 110.697 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -85.95 110.78 19.69 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.549 -0.908 . . . . 1.03 108.549 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 39' ' ' TRP . 24.5 m -102.11 133.24 47.26 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.527 -0.546 . . . . 1.13 109.527 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 95' ' ' SER . 47.5 tp -107.99 115.47 30.19 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.828 -0.434 . . . . 1.07 109.828 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.088 -1.079 . . . . 1.15 108.088 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -130.23 124.06 31.61 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.101 -0.703 . . . . 1.11 109.101 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 132.3 53.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.967 -0.293 . . . . 1.34 111.236 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -149.89 176.91 2.03 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.775 -1.565 . . . . 1.61 106.775 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -45.19 -30.31 4.98 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.197 2.598 . . . . 1.33 115.803 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.14 -21.16 59.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.538 0.57 . . . . 1.1 112.538 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -161.14 23.57 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 119.988 -1.101 . . . . 0.71 112.383 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -100.31 133.78 44.22 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.196 0.598 . . . . 1.83 111.173 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.45 42.77 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.625 -1.621 . . . . 1.16 106.625 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 49.7 p -162.06 141.38 9.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.208 0.528 . . . . 0.88 111.751 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.78 164.65 32.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.282 -1.747 . . . . 1.09 106.282 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 p -135.42 139.97 44.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.454 -0.499 . . . . 1.7 111.152 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.13 127.22 70.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.559 -1.274 . . . . 1.38 107.559 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.0 ttt -100.71 128.4 46.77 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.808 -0.757 . . . . 1.67 110.248 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -117.88 135.93 53.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.083 -1.451 . . . . 1.26 107.083 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.44 100.95 9.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.26 0.552 . . . . 1.4 110.666 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -130.65 82.72 2.07 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 121.939 0.876 . . . . 4.75 108.782 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.84 95.64 5.94 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.08 0.943 . . . . 5.12 109.003 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.17 152.84 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.627 -1.169 . . . . 5.33 108.983 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -107.07 99.93 29.49 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.195 -1.039 . . . . 5.79 108.195 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.36 124.24 11.05 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.778 2.319 . . . . 5.07 112.145 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 C--O 1.239 0.538 0 C-N-CA 124.723 1.209 . . . . 10.3 110.817 177.273 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.241 -0.281 . . . . 7.93 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -135.29 -51.13 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.988 0.423 . . . . 6.17 111.224 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.91 -31.37 71.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.762 0.792 . . . . 5.43 111.226 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.537 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 16.8 p-10 -84.1 1.78 42.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.465 -0.789 . . . . 3.87 112.393 -176.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.87 -44.76 69.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.38 0.61 . . . . 2.55 109.802 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -82.0 98.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 122.276 1.036 . . . . 2.51 110.075 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 t -86.83 99.89 12.14 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 114.73 -1.123 . . . . 2.01 108.674 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 19.3 m-85 -78.56 124.73 28.46 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.085 -1.82 . . . . 1.61 106.085 174.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.9 m -83.54 -171.34 3.53 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.082 -0.71 . . . . 1.32 109.082 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 94' ' ' ALA . . . -92.68 119.67 32.32 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 119.093 -1.043 . . . . 1.15 109.746 -172.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.5 m -118.14 128.74 55.02 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.069 -1.086 . . . . 1.67 108.069 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -115.92 119.53 62.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 116.546 -0.297 . . . . 1.11 110.261 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.62 116.85 30.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.255 -0.646 . . . . 2.66 109.255 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 27' ' ' PHE . 37.1 mt -104.46 146.56 28.68 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.156 -0.475 . . . . 1.08 109.769 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -131.25 145.85 52.07 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.612 -0.884 . . . . 1.34 108.612 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -56.3 132.95 52.25 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.589 1.181 . . . . 1.24 111.674 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB1' HG12 ' A' ' 25' ' ' ILE . . . -57.71 140.57 51.04 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.814 -1.085 . . . . 1.07 110.949 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.9 131.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.668 -0.493 . . . . 1.21 109.668 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.1 mt-10 -84.78 104.04 14.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.703 -0.681 . . . . 2.52 111.904 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -155.3 -168.51 2.87 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.497 -1.668 . . . . 1.33 106.497 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -68.5 -40.29 80.91 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.292 0.951 . . . . 3.4 111.124 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -97.89 113.86 25.8 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.21 -1.404 . . . . 3.18 107.21 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.449 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 54.6 m95 -81.45 124.6 29.58 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.82 124.73 42.73 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.639 -0.71 . . . . 0.34 110.72 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 66.7 mt -106.68 103.15 45.46 Favored Pre-proline 0 C--O 1.242 0.676 0 N-CA-C 108.365 -0.976 . . . . 1.07 108.365 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.79 131.24 14.33 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.608 2.205 . . . . 0.32 111.789 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.402 ' HB3' HD21 ' A' ' 14' ' ' LEU . 47.9 p90 -135.66 155.05 51.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.107 0.48 . . . . 0.42 110.289 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -142.45 114.98 8.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.653 0.739 . . . . 1.29 109.536 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.821 -1.081 . . . . 1.08 108.502 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -121.16 151.06 40.35 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.717 -0.793 . . . . 1.39 110.338 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.21 138.73 2.59 Favored Glycine 0 N--CA 1.42 -2.431 0 N-CA-C 108.274 -1.93 . . . . 0.6 108.274 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.537 ' NE2' ' HA ' ' A' ' 4' ' ' ASP . 24.0 tt0 -79.91 -50.97 1.17 Allowed Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.776 -0.77 . . . . 3.29 109.936 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.7 Cg_exo -61.72 120.0 7.41 Favored 'Trans proline' 0 C--N 1.375 1.923 0 N-CA-C 106.273 -2.241 . . . . 1.09 106.273 162.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB2' ' NH2' ' A' ' 66' ' ' ARG . . . -65.43 116.29 29.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.349 -0.841 . . . . 1.36 111.114 -174.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.21 159.56 8.41 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.928 1.752 . . . . 0.56 112.703 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -102.11 131.84 48.35 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.249 -1.019 . . . . 1.74 108.249 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 80.4 mt -97.97 154.05 17.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.788 0.327 . . . . 1.14 110.999 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -155.07 135.64 13.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.798 -0.816 . . . . 4.62 108.798 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.413 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.4 m95 -96.82 121.9 39.19 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.754 -0.461 . . . . 0.33 109.754 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.7 tp -109.88 127.47 54.74 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.791 -1.559 . . . . 1.57 106.791 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -118.29 98.98 6.56 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 109.625 -0.509 . . . . 1.04 109.625 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.86 43.41 21.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.752 1.221 . . . . 2.17 113.284 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.9 61.87 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.53 -0.843 . . . . 0.61 113.742 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 t -107.54 144.85 33.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.004 -1.11 . . . . 1.84 108.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -78.86 129.15 37.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.573 -0.899 . . . . 1.31 108.573 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.66 120.02 24.03 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.992 -0.744 . . . . 1.33 108.992 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -95.57 126.05 40.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.031 -0.729 . . . . 2.69 109.031 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -58.72 122.63 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.968 0.793 . . . . 1.74 109.292 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.6 p -124.73 -172.03 2.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.85 -0.426 . . . . 2.07 109.85 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 t -74.95 -30.69 61.3 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.393 -0.965 . . . . 1.9 108.393 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 43.1 m-85 -82.98 -41.49 18.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.302 -0.863 . . . . 1.89 110.362 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.447 HG22 ' HG ' ' A' ' 72' ' ' LEU . 33.7 mt -124.94 106.9 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.287 -1.005 . . . . 1.18 108.287 -176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -146.04 156.13 43.26 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 118.255 0.48 . . . . 3.62 110.413 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.9 m -92.27 121.41 33.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.629 -0.714 . . . . 1.15 110.792 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.0 134.05 40.88 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.301 -1.37 . . . . 2.04 107.301 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.78 144.27 46.4 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.84 0.352 . . . . 0.87 111.648 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.94 165.68 11.16 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.341 -2.096 . . . . 1.7 105.341 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.58 128.11 28.11 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 113.399 0.889 . . . . 3.36 113.399 -172.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 159.78 27.23 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.185 2.59 . . . . 1.63 110.494 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.51 176.16 6.65 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.124 -0.695 . . . . 1.88 109.124 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.86 77.71 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.59 0.589 . . . . 2.29 112.59 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.74 19.2 11.62 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.14 0.495 . . . . 3.93 112.067 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -111.21 113.08 25.32 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.407 -1.331 . . . . 1.89 107.407 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -93.76 2.62 56.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.8 0.81 . . . . 1.86 108.961 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.41 127.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.677 -1.147 . . . . 1.19 109.473 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' NH2' ' HB2' ' A' ' 34' ' ' ALA . 48.1 mtt180 -103.53 139.31 39.03 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.755 -1.572 . . . . 2.36 106.755 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.9 145.41 49.84 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.896 -1.149 . . . . 1.49 107.896 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.49 -167.98 33.97 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 120.032 -1.08 . . . . 0.36 111.447 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 10.0 t -150.81 132.34 14.77 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 122.069 0.148 . . . . 0.36 110.969 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.413 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 60.0 tp -84.36 112.32 20.23 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.606 -2.368 . . . . 1.06 104.606 169.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -116.69 125.97 52.49 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 119.652 -0.819 . . . . 3.22 112.262 -171.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.6 mp -107.11 109.62 21.51 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.567 -1.197 . . . . 1.78 108.616 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -70.72 -40.01 73.04 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.962 -1.017 . . . . 2.42 110.094 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -135.09 102.1 11.1 Favored Pre-proline 0 N--CA 1.419 -2.005 0 N-CA-C 107.341 -1.355 . . . . 3.22 107.341 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' ' CD1' ' A' ' 23' ' ' TRP . 73.9 Cg_endo -74.98 141.45 26.71 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.14 1.893 . . . . 1.62 111.21 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 p -104.25 171.58 7.26 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.299 -0.63 . . . . 1.75 109.299 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -68.93 -37.35 78.84 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.011 -1.075 . . . . 2.61 111.699 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.24 -10.36 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.46 0.911 . . . . 1.77 113.46 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.15 -8.7 58.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.052 0.76 . . . . 2.19 113.052 -171.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 17.7 p30 -77.65 77.25 4.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.883 0.849 . . . . 2.08 111.804 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -152.34 -153.03 6.13 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.134 -0.939 . . . . 0.59 111.499 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.17 118.66 37.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 122.977 0.511 . . . . 2.28 111.154 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -96.88 112.64 24.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.562 -0.903 . . . . 1.03 108.562 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 60.9 m -102.93 123.41 46.51 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.917 -0.771 . . . . 1.13 108.917 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -98.49 119.24 36.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.947 -0.76 . . . . 1.07 108.947 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 2.9 mm? -102.18 131.72 48.54 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.431 -0.804 . . . . 1.15 109.104 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.74 120.61 31.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.706 -1.22 . . . . 1.11 107.706 173.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.21 132.04 55.89 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 123.448 0.468 . . . . 1.34 111.526 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 p30 -145.06 174.03 3.81 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 107.8 -1.185 . . . . 1.61 107.8 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -48.05 -32.98 19.66 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.979 2.453 . . . . 1.33 115.277 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.38 -36.47 63.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.796 0.331 . . . . 1.1 111.1 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.17 -166.42 38.26 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 119.761 -1.209 . . . . 0.71 112.253 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 60.8 tt0 -128.41 135.59 49.73 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.707 -0.849 . . . . 1.83 108.707 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -106.04 154.87 20.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.743 -0.836 . . . . 1.16 108.743 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 p -146.84 119.48 8.55 Favored 'General case' 0 N--CA 1.426 -1.649 0 O-C-N 123.618 0.574 . . . . 0.88 111.149 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -126.03 148.34 49.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.416 -1.327 . . . . 1.09 107.416 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.2 m -127.83 139.77 52.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 117.934 0.334 . . . . 1.7 111.465 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.64 123.9 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 109.149 -0.686 . . . . 1.38 109.149 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 51.0 ttm -98.17 123.31 42.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.622 -0.51 . . . . 1.67 109.622 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -120.42 125.84 48.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.699 0.285 . . . . 1.26 110.972 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 113.11 24.51 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.703 -0.851 . . . . 1.4 108.703 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -92.64 -78.56 0.41 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.308 -0.406 . . . . 4.75 111.471 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.22 163.01 32.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.338 -0.616 . . . . 5.12 109.338 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 3.9 p-10 -61.61 153.37 28.03 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.128 0.892 . . . . 5.33 111.732 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -94.43 109.62 44.0 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.309 -0.859 . . . . 5.79 111.4 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 104' ' ' ASP . 4.8 Cg_exo -78.94 137.49 13.92 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.792 1.661 . . . . 5.07 108.991 172.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 C--O 1.243 0.727 0 C-N-CA 124.415 1.086 . . . . 10.3 111.131 -179.399 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 122.863 1.316 . . . . 7.93 108.69 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.19 -48.43 1.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.892 -1.504 . . . . 6.17 108.725 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -91.73 19.41 6.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.282 1.039 . . . . 5.43 108.632 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.72 43.94 17.93 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.734 -1.58 . . . . 3.87 106.734 -172.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.94 -50.58 18.67 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 111.693 -2.503 . . . . 2.55 113.526 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 15.4 m -73.45 98.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 122.271 1.034 . . . . 2.51 112.214 -175.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 108.121 -1.066 . . . . 2.01 108.121 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 70.4 m-85 -104.27 132.59 50.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.118 -1.067 . . . . 1.61 108.118 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 m -83.76 175.48 9.63 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.138 -1.06 . . . . 1.32 108.138 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 124.19 38.31 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.869 -0.732 . . . . 1.15 111.404 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 67.5 m -121.57 135.61 54.99 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.456 -1.313 . . . . 1.67 107.456 172.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.7 t -115.44 118.23 58.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.028 0.442 . . . . 1.11 110.695 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 28' ' ' SER . 33.4 mt-30 -113.09 116.46 29.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.651 -1.24 . . . . 2.66 107.651 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.1 mt -100.39 156.63 17.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.16 0.505 . . . . 1.08 111.841 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -131.31 144.49 51.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.693 -1.225 . . . . 1.34 107.693 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -63.73 139.3 58.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 124.241 0.963 . . . . 1.24 108.97 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.42 141.78 29.41 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.045 0.841 . . . . 1.07 111.072 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.04 130.69 39.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.542 0.687 . . . . 1.21 109.978 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -76.89 111.19 12.17 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.433 -1.258 . . . . 2.52 112.385 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.0 ptt? -166.72 -172.89 2.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.538 -1.282 . . . . 1.33 107.538 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -75.78 -32.86 60.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.661 1.119 . . . . 3.4 111.063 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.419 ' O ' ' HG3' ' A' ' 20' ' ' MET . 61.3 m80 -99.0 122.07 41.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.448 -1.316 . . . . 3.18 107.448 176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -86.97 126.26 34.6 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.425 -0.91 . . . . 1.0 113.365 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.65 121.66 32.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.17 -1.377 . . . . 0.34 109.617 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.8 mt -106.18 97.95 17.6 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.467 -1.308 . . . . 1.07 107.467 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.3 138.66 27.9 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.631 2.221 . . . . 0.32 112.141 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -134.29 159.14 41.89 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.964 0.411 . . . . 0.42 110.595 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.407 ' HG ' ' HB2' ' A' ' 13' ' ' GLN . 3.1 p -139.86 116.71 10.95 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.36 -0.836 . . . . 1.29 109.265 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 HG13 HD22 ' A' ' 37' ' ' LEU . 2.4 p -126.39 122.75 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.428 -0.953 . . . . 1.08 108.428 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.2 p-10 -105.63 158.7 16.51 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.951 -1.1 . . . . 1.39 111.13 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.11 165.64 13.34 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.752 -1.113 . . . . 0.6 110.471 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.4 ' H ' ' HD2' ' A' ' 33' ' ' PRO 0.261 20.9 mm-40 -107.34 -52.1 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 118.942 -0.551 . . . . 3.29 111.877 175.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.2 Cg_endo -61.55 120.47 8.12 Favored 'Trans proline' 0 C--N 1.367 1.51 0 N-CA-C 106.703 -2.076 . . . . 1.09 106.703 165.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.19 114.18 11.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 O-C-N 123.55 0.531 . . . . 1.36 112.115 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 86.6 Cg_endo -81.18 142.79 13.71 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.413 1.409 . . . . 0.56 111.731 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 4.3 p -77.28 120.97 23.06 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.935 -0.765 . . . . 1.74 108.935 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 29' ' ' VAL . 93.6 mt -95.8 117.08 29.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.466 0.651 . . . . 1.14 110.477 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -125.95 134.81 51.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.926 -1.034 . . . . 4.62 109.577 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -98.64 115.86 29.61 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.627 -0.508 . . . . 0.33 109.627 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 20.8 tp -101.87 126.89 48.86 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 105.001 -2.222 . . . . 1.57 105.001 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -122.78 108.88 13.53 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 108.995 -0.743 . . . . 1.04 108.995 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.97 34.44 21.53 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 123.94 0.775 . . . . 2.17 111.466 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.3 6.9 88.97 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.849 -0.614 . . . . 0.61 112.586 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -116.24 147.15 41.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.024 -1.102 . . . . 1.84 108.024 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.5 t -76.89 114.75 17.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.142 -1.058 . . . . 1.31 108.142 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.96 118.24 18.53 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.702 -0.851 . . . . 1.33 108.702 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.08 115.04 20.33 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.442 -0.577 . . . . 2.69 109.442 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.26 108.01 5.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.51 -0.922 . . . . 1.74 108.51 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.2 p -104.13 -162.89 0.93 Allowed 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.553 -1.203 . . . . 2.07 109.655 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -81.41 -26.59 35.27 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.857 -0.794 . . . . 1.9 108.857 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -79.04 -40.31 31.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.884 -0.598 . . . . 1.89 110.268 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.6 mt -120.26 105.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.79 -1.93 . . . . 1.18 105.79 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -139.29 140.51 37.64 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.328 -0.549 . . . . 3.62 111.435 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -86.82 112.2 21.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.005 -0.543 . . . . 1.15 110.285 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -110.75 152.52 26.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.993 -0.743 . . . . 2.04 108.993 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -118.64 163.13 17.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 120.768 0.318 . . . . 0.87 110.815 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.92 140.9 52.52 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.873 -1.899 . . . . 1.7 105.873 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.21 116.75 30.29 Favored Pre-proline 0 C--N 1.296 -1.752 0 O-C-N 124.026 0.829 . . . . 3.36 111.394 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.87 169.04 16.91 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.573 2.182 . . . . 1.63 110.609 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.81 142.31 33.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.176 -1.046 . . . . 1.88 108.176 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.76 -15.24 61.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.559 0.577 . . . . 2.29 112.559 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -98.49 8.11 45.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.27 -0.423 . . . . 3.93 111.324 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.8 pt-20 -117.92 155.47 30.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.347 -0.983 . . . . 1.89 108.347 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 p -106.51 8.35 31.36 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.201 0.524 . . . . 1.86 110.887 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 t -100.08 134.62 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.456 -0.793 . . . . 1.19 109.824 -177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -93.67 141.96 27.9 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.286 -1.376 . . . . 2.36 107.286 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -124.29 139.58 53.78 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.927 -0.398 . . . . 1.49 109.927 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.41 -179.44 42.49 Favored Glycine 0 N--CA 1.425 -2.079 0 C-N-CA 120.498 -0.858 . . . . 0.36 111.516 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 t -149.66 138.07 20.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.927 0.394 . . . . 0.36 110.897 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.7 tp -80.32 106.91 12.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.25 -1.759 . . . . 1.06 106.25 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -94.18 103.96 15.99 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.535 -0.757 . . . . 3.22 109.809 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' A' ' 52' ' ' ILE . 4.9 mp -94.64 109.51 21.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.601 -1.259 . . . . 1.78 107.601 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.66 -51.16 11.06 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.67 -1.15 . . . . 2.42 109.469 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.64 101.84 52.01 Favored Pre-proline 0 N--CA 1.423 -1.778 0 N-CA-C 107.477 -1.305 . . . . 3.22 107.477 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.9 130.65 6.71 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.288 1.992 . . . . 1.62 109.917 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -110.53 154.64 23.42 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.796 -1.187 . . . . 1.75 107.796 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -74.07 -5.4 41.38 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.694 -0.629 . . . . 2.61 112.118 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.7 -10.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.77 110.24 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.608 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 16.6 m120 -83.77 -1.62 54.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 2.19 109.545 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -79.45 83.35 5.47 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.799 -1.186 . . . . 2.08 107.799 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.33 -150.64 6.7 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.924 -0.58 . . . . 0.59 111.816 -176.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -107.72 124.13 49.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.701 0.286 . . . . 2.28 111.45 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.608 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 63.4 m-85 -100.27 113.39 26.06 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.742 -0.836 . . . . 1.03 108.742 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.4 m -103.5 121.97 43.96 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.928 -1.138 . . . . 1.13 107.928 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -99.9 119.9 38.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.734 -0.469 . . . . 1.07 109.734 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.56 136.16 44.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.388 -0.967 . . . . 1.15 108.388 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' SER . . . -129.4 120.73 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.438 -1.319 . . . . 1.11 107.438 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 114.05 20.55 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.322 0.582 . . . . 1.34 112.507 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.425 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 39.5 p30 -127.0 161.7 52.19 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 106.538 -1.652 . . . . 1.61 106.538 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 4.5 Cg_exo -40.68 -38.65 2.72 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.895 3.063 . . . . 1.33 115.349 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.63 -34.35 75.6 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 112.488 0.551 . . . . 1.1 112.488 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.21 170.95 36.67 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.816 -1.183 . . . . 0.71 112.508 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -110.67 126.91 55.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.52 -0.918 . . . . 1.83 108.52 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -102.64 155.27 18.41 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.449 -0.575 . . . . 1.16 109.449 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 p -150.95 128.69 11.58 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.651 0.594 . . . . 0.88 110.68 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.77 159.88 41.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.586 -1.635 . . . . 1.09 106.586 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 p -136.69 146.75 46.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.586 0.708 . . . . 1.7 112.653 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.97 122.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.713 -1.217 . . . . 1.38 107.713 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -100.61 123.41 44.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.94 -0.763 . . . . 1.67 108.94 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.93 140.92 51.45 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.189 -0.3 . . . . 1.26 110.189 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.15 142.69 28.77 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.741 -0.663 . . . . 1.4 109.668 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.52 118.69 12.7 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.411 -0.588 . . . . 4.75 109.411 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.9 ptp -105.84 97.13 6.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.939 0.876 . . . . 5.12 110.369 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.1 129.2 44.92 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.285 -0.87 . . . . 5.33 109.276 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -70.45 118.29 63.07 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 123.764 0.665 . . . . 5.79 109.545 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.74 166.53 19.88 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.733 2.288 . . . . 5.07 113.305 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--N 1.293 -1.878 0 CA-C-N 114.954 -1.021 . . . . 10.3 109.407 179.51 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.664 0.745 . . . . 7.93 109.886 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.03 140.04 50.33 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.737 -0.838 . . . . 6.17 108.737 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.79 -19.6 61.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.645 0.591 . . . . 5.43 110.311 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.11 140.31 36.57 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.853 -0.612 . . . . 3.87 109.711 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.25 -17.57 18.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.644 0.735 . . . . 2.55 110.322 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 m -86.73 98.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-O 122.811 1.291 . . . . 2.51 112.131 -173.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.2 m -99.21 98.81 9.75 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 113.997 -1.456 . . . . 2.01 107.704 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.31 135.09 34.05 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.183 -0.917 . . . . 1.61 109.39 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.7 m -84.71 176.65 8.42 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.97 -1.492 . . . . 1.32 106.97 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 128.41 40.89 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.728 -0.789 . . . . 1.15 111.408 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 t -115.33 136.58 52.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 106.464 -1.68 . . . . 1.67 106.464 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.5 t -115.69 116.14 51.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.025 0.44 . . . . 1.11 110.129 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -117.0 116.29 27.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.656 -0.868 . . . . 2.66 108.656 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.9 mt -97.41 156.18 16.58 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.725 -0.472 . . . . 1.08 109.725 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -131.91 146.39 52.08 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.758 -1.571 . . . . 1.34 106.758 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.33 132.21 50.83 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.812 0.695 . . . . 1.24 109.615 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.33 142.74 30.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.648 -1.16 . . . . 1.07 112.107 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.21 130.4 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.543 -0.753 . . . . 1.21 110.117 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.45 ' HG2' ' CH2' ' A' ' 23' ' ' TRP . 36.2 mt-10 -80.64 107.17 13.22 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.837 -1.074 . . . . 2.52 110.263 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 59.8 mtm -134.76 -165.81 1.72 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.41 -1.7 . . . . 1.33 106.41 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -66.02 -39.01 89.86 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.254 -1.017 . . . . 3.4 108.254 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 20' ' ' MET . 66.9 m170 -117.56 153.55 33.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.452 -1.684 . . . . 3.18 106.452 176.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.45 ' CH2' ' HG2' ' A' ' 19' ' ' GLU . 68.6 m95 -98.63 144.85 27.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -136.23 121.01 18.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.788 -1.096 . . . . 0.34 109.384 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 58.8 mt -103.38 100.31 17.94 Favored Pre-proline 0 C--O 1.24 0.562 0 N-CA-C 108.468 -0.938 . . . . 1.07 108.468 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.66 132.91 16.45 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.324 2.016 . . . . 0.32 111.85 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -128.47 152.26 48.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.993 0.425 . . . . 0.42 111.094 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 m -127.31 114.3 17.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.372 -0.973 . . . . 1.29 108.372 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.29 112.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.308 -0.627 . . . . 1.08 109.308 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.2 p-10 -112.02 144.79 40.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.995 -0.682 . . . . 1.39 110.316 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.24 165.48 32.57 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.637 -1.785 . . . . 0.6 108.637 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 19.5 tm0? -91.4 -53.31 0.28 Allowed Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 117.519 0.659 . . . . 3.29 109.999 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 3.2 Cg_exo -80.36 120.63 4.09 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 107.6 -1.731 . . . . 1.09 107.6 170.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.5 115.67 10.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 123.779 0.674 . . . . 1.36 111.763 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 87.7 Cg_endo -81.51 153.2 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.749 2.299 . . . . 0.56 113.204 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 m -79.56 119.31 22.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.531 -1.285 . . . . 1.74 107.531 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 127.41 39.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.927 0.394 . . . . 1.14 110.053 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -123.79 130.67 52.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.941 -0.763 . . . . 4.62 108.941 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -94.57 119.86 33.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.127 0.489 . . . . 0.33 109.948 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 26.3 tp -110.66 126.91 55.0 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.169 -1.419 . . . . 1.57 107.169 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -116.48 106.9 14.11 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 110.204 -0.295 . . . . 1.04 110.204 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 56.39 35.2 25.51 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.227 1.011 . . . . 2.17 111.18 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.49 -18.17 57.96 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.777 -0.647 . . . . 0.61 113.25 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.5 p -106.02 139.71 40.15 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.179 -0.6 . . . . 1.84 110.375 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.14 128.12 28.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.904 -0.589 . . . . 1.31 109.785 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -91.1 111.65 23.21 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.684 -0.689 . . . . 1.33 109.269 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -85.04 135.13 34.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.115 -1.069 . . . . 2.69 108.115 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.61 141.08 48.35 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.8 -0.445 . . . . 1.74 109.8 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -123.87 -163.79 1.17 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.284 -0.635 . . . . 2.07 109.284 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -81.98 -17.44 46.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.831 -0.433 . . . . 1.9 109.831 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.11 -31.46 9.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.409 -0.36 . . . . 1.89 111.405 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.3 mt -113.84 106.73 21.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 106.511 -1.663 . . . . 1.18 106.511 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.42 145.91 33.02 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.273 0.558 . . . . 3.62 111.813 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -85.92 112.95 21.64 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.539 -0.755 . . . . 1.15 110.422 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -96.83 112.54 24.25 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.858 -0.61 . . . . 2.04 110.947 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.52 142.6 27.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.203 -1.036 . . . . 0.87 108.203 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.31 161.68 19.54 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.408 -1.33 . . . . 1.7 107.408 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -67.13 113.67 14.68 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 113.973 1.101 . . . . 3.36 113.973 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.56 157.72 21.98 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.085 2.524 . . . . 1.63 109.61 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.6 145.57 31.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.737 -0.838 . . . . 1.88 108.737 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.03 0.76 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.689 0.756 . . . . 2.29 111.236 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 60' ' ' ALA . 15.4 m120 -123.01 9.55 9.36 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.307 -0.86 . . . . 3.93 109.034 177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.6 pt-20 -135.56 160.77 37.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.268 -1.382 . . . . 1.89 107.268 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 p -118.71 34.71 5.09 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.936 0.875 . . . . 1.86 109.778 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' OE1' ' A' ' 63' ' ' GLU . 18.7 t -109.43 127.18 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.196 -0.911 . . . . 1.19 109.401 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -91.32 129.17 37.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.6 -1.629 . . . . 2.36 106.6 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -114.06 134.99 54.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.386 -0.968 . . . . 1.49 108.386 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.62 179.08 36.34 Favored Glycine 0 N--CA 1.408 -3.176 0 C-N-CA 119.73 -1.224 . . . . 0.36 111.714 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 4.7 t -144.61 132.79 21.66 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.83 0.852 . . . . 0.36 109.932 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.1 tp -84.45 105.66 15.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.224 -2.139 . . . . 1.06 105.224 170.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -100.46 123.83 45.19 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.045 -0.525 . . . . 3.22 110.029 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.02 108.26 19.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.894 -1.15 . . . . 1.78 107.894 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -72.9 -35.46 67.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.514 -1.221 . . . . 2.42 109.805 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.59 108.37 58.19 Favored Pre-proline 0 N--CA 1.423 -1.814 0 N-CA-C 107.243 -1.392 . . . . 3.22 107.243 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.39 129.89 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.475 1.45 . . . . 1.62 109.915 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -126.19 141.11 52.06 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.114 0.483 . . . . 1.75 109.828 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.46 -18.39 48.84 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.144 -0.687 . . . . 2.61 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.7 -12.01 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.238 -0.585 . . . . 1.77 111.491 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 51.7 m-80 -111.62 25.99 11.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.47 0.652 . . . . 2.19 111.386 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.18 104.37 16.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.304 -0.999 . . . . 2.08 108.304 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.05 26.29 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.039 -0.824 . . . . 0.59 111.039 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -96.17 123.48 39.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.117 0.484 . . . . 2.28 111.361 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 97' ' ' SER . 8.0 m-85 -95.97 121.18 37.44 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.158 0.983 . . . . 1.03 108.978 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 53.7 m -107.77 120.9 43.55 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.582 -0.896 . . . . 1.13 108.582 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 95' ' ' SER . 54.0 tp -96.88 118.75 33.99 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.538 -0.912 . . . . 1.07 108.538 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.85 133.62 49.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.415 -0.957 . . . . 1.15 108.415 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -122.07 119.7 32.16 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.417 -0.957 . . . . 1.11 108.417 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.98 131.38 54.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.42 -0.585 . . . . 1.34 109.42 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 8.0 p30 -151.58 165.31 17.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 107.042 -1.466 . . . . 1.61 107.042 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -44.69 -40.58 14.33 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.473 2.782 . . . . 1.33 114.337 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.63 -27.28 61.19 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.85 0.685 . . . . 1.1 112.85 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.48 -156.1 27.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.121 -1.038 . . . . 0.71 112.178 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 28.7 tt0 -138.12 126.81 23.65 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.957 0.408 . . . . 1.83 110.674 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.79 157.75 16.74 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.862 -0.792 . . . . 1.16 108.862 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.2 p -153.7 142.62 21.14 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 123.255 0.347 . . . . 0.88 110.952 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -147.19 152.32 38.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.439 -1.319 . . . . 1.09 107.439 175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 37.8 m -128.77 141.16 51.4 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.103 0.411 . . . . 1.7 111.034 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 134.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.407 -0.96 . . . . 1.38 108.407 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.9 ttm -99.42 119.96 38.84 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.929 -0.482 . . . . 1.67 109.782 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.9 116.58 30.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.503 -0.554 . . . . 1.26 109.503 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.49 100.11 11.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.397 -0.964 . . . . 1.4 108.397 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.64 -68.94 0.52 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.718 -1.128 . . . . 4.75 110.104 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 66.7 mtt -132.41 151.25 51.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.198 -1.408 . . . . 5.12 107.198 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.51 160.37 17.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.801 -0.815 . . . . 5.33 108.801 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.62 111.3 56.74 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 116.093 -0.503 . . . . 5.79 110.606 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.64 134.9 14.06 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.058 1.839 . . . . 5.07 109.639 174.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 123.855 0.862 . . . . 10.3 110.857 -178.247 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 108.105 -1.072 . . . . 7.93 108.105 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 6' ' ' VAL . 5.2 m-20 -111.34 -10.35 14.23 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 122.168 -0.332 . . . . 6.17 111.878 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.04 -39.81 28.8 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 116.029 1.863 . . . . 5.43 116.029 -168.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.14 -30.38 43.58 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.88 -0.513 . . . . 3.87 111.262 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.83 -37.92 18.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.394 -0.366 . . . . 2.55 111.831 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 2' ' ' ASP . 13.1 m -71.05 99.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 122.564 1.173 . . . . 2.51 110.465 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t -87.57 98.01 11.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 115.054 -0.975 . . . . 2.01 108.598 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.2 m-85 -86.0 117.71 25.02 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 105.397 -2.075 . . . . 1.61 105.397 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.7 m -83.22 -179.31 7.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.797 -0.816 . . . . 1.32 108.797 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.31 126.01 38.21 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 119.606 -0.837 . . . . 1.15 110.817 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 20.8 t -118.41 131.43 56.29 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.673 -1.232 . . . . 1.67 107.673 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.5 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.886 -0.783 . . . . 1.11 108.886 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.82 116.05 27.97 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.665 -1.235 . . . . 2.66 107.665 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.479 HD11 HG21 ' A' ' 98' ' ' ILE . 38.3 mt -99.48 156.82 16.83 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.511 -0.768 . . . . 1.08 109.924 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -131.6 153.94 49.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.063 -0.517 . . . . 1.34 109.695 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -57.32 133.59 55.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.175 -1.375 . . . . 1.24 110.36 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.59 141.4 58.78 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.649 -0.705 . . . . 1.07 110.311 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -91.37 124.91 44.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.647 0.736 . . . . 1.21 111.535 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.49 111.95 20.46 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.47 -1.241 . . . . 2.52 109.92 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -162.46 0.53 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.215 -1.402 . . . . 1.33 107.215 176.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -60.85 -28.93 69.2 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.618 1.099 . . . . 3.4 112.793 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -120.86 165.16 15.57 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.884 -1.524 . . . . 3.18 106.884 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -118.19 135.83 54.01 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.76 131.69 35.85 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.552 -0.749 . . . . 0.34 110.002 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -104.65 106.24 53.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.383 -1.339 . . . . 1.07 107.383 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.09 137.8 19.77 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.644 2.229 . . . . 0.32 111.35 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 14' ' ' LEU . 55.1 p90 -140.01 146.47 39.1 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.227 0.537 . . . . 0.42 111.853 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.5 p -126.63 118.87 25.67 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 115.137 -0.938 . . . . 1.29 109.31 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -120.12 110.46 28.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.529 -0.915 . . . . 1.08 108.529 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.8 p-10 -108.49 150.94 26.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.395 -0.522 . . . . 1.39 110.504 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.36 144.35 3.91 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 108.493 -1.843 . . . . 0.6 108.493 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.51 -53.25 2.06 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.472 -0.936 . . . . 3.29 108.472 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 23.7 Cg_exo -67.26 120.96 8.04 Favored 'Trans proline' 0 C--N 1.379 2.168 0 N-CA-C 108.978 -1.201 . . . . 1.09 108.978 171.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.95 87.88 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.735 -0.666 . . . . 1.36 112.041 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -90.55 159.78 4.37 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.474 2.116 . . . . 0.56 111.714 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -96.36 120.6 36.95 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.995 -1.483 . . . . 1.74 106.995 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.56 159.08 19.97 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.667 0.27 . . . . 1.14 110.901 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -159.43 138.03 10.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.723 -0.843 . . . . 4.62 108.723 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -105.72 129.89 53.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.215 0.531 . . . . 0.33 111.361 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -109.33 137.35 47.32 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.839 -1.171 . . . . 1.57 107.839 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -124.82 103.89 8.32 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.982 -1.118 . . . . 1.04 107.982 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 64.36 28.0 13.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.093 0.957 . . . . 2.17 110.358 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.8 71.53 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.12 -0.945 . . . . 0.61 112.201 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -93.16 150.08 20.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.897 -0.779 . . . . 1.84 108.897 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.89 115.82 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 116.164 -0.471 . . . . 1.31 109.925 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -85.75 124.22 32.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.483 -1.303 . . . . 1.33 107.483 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -102.15 126.14 49.04 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.625 -0.879 . . . . 2.69 108.625 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 114.41 3.28 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.818 -0.808 . . . . 1.74 108.818 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -130.06 -170.8 2.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.451 -0.795 . . . . 2.07 109.588 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -60.15 -32.72 71.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.173 0.589 . . . . 1.9 112.113 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -84.7 -36.8 21.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.399 0.518 . . . . 1.89 112.399 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.52 114.63 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.955 -1.128 . . . . 1.18 107.955 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.74 155.54 48.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 118.895 0.771 . . . . 3.62 111.518 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -98.62 110.37 22.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 1.15 109.87 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.82 120.76 43.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.559 -0.534 . . . . 2.04 109.559 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -97.01 153.56 17.84 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 116.09 -0.505 . . . . 0.87 109.81 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.98 159.86 14.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.126 -1.435 . . . . 1.7 107.126 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -72.91 115.14 37.21 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 123.576 0.547 . . . . 3.36 110.273 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.17 153.95 32.28 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.546 2.164 . . . . 1.63 110.551 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.12 146.84 27.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.702 -1.221 . . . . 1.88 107.702 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.84 60.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.073 1.138 . . . . 2.29 114.073 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.18 -0.42 46.89 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.526 -0.469 . . . . 3.93 111.833 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -88.81 138.84 31.05 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.963 0.411 . . . . 1.89 110.693 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -104.45 -2.06 25.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.431 -0.952 . . . . 1.86 108.431 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.0 128.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.351 -0.84 . . . . 1.19 109.399 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.0 ttm-85 -108.88 124.18 50.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.004 -1.11 . . . . 2.36 108.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -111.04 146.53 36.56 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.949 0.404 . . . . 1.49 110.097 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.39 32.37 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.614 -0.994 . . . . 0.36 110.614 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 71' ' ' ARG . 4.6 t -138.05 131.67 30.98 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.65 -0.5 . . . . 0.36 109.65 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.32 94.86 9.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.116 -2.179 . . . . 1.06 105.116 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . 15.5 ptm180 -99.93 126.4 46.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.498 -0.774 . . . . 3.22 110.617 -174.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.91 113.05 25.16 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.948 0.88 . . . . 1.78 109.367 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -61.81 -49.52 76.0 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.18 -1.827 . . . . 2.42 107.593 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -135.29 100.57 11.51 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 107.845 -1.168 . . . . 3.22 107.845 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.524 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -83.65 141.96 10.07 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.123 1.882 . . . . 1.62 111.163 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 p -130.31 -178.73 4.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 118.98 -0.533 . . . . 1.75 111.598 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -69.47 -19.6 63.75 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.382 0.992 . . . . 2.61 111.102 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 m -70.69 -10.67 14.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.77 110.639 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -88.15 14.29 9.55 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.625 -0.716 . . . . 2.19 112.844 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.56 93.64 9.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.301 -1.0 . . . . 2.08 108.301 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.19 -173.22 39.39 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.409 -0.9 . . . . 0.59 112.127 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.35 122.8 36.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.17 0.51 . . . . 2.28 111.13 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 98' ' ' ILE . 22.0 m-85 -102.97 130.43 50.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.72 1.208 . . . . 1.03 107.908 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -130.88 128.29 40.27 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.988 -0.445 . . . . 1.13 109.955 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.441 ' CB ' HD12 ' A' ' 14' ' ' LEU . 50.5 tp -100.37 124.54 45.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.59 -0.893 . . . . 1.07 108.59 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.58 138.27 48.33 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.098 -1.075 . . . . 1.15 108.098 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.3 119.5 34.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.818 -1.549 . . . . 1.11 106.818 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.68 125.41 40.24 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.043 -1.095 . . . . 1.34 108.043 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -151.04 144.78 17.46 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.506 -1.664 . . . . 1.61 106.506 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.62 -17.17 27.35 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 123.526 2.817 . . . . 1.33 113.986 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.3 t -89.65 -8.83 51.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 1.1 110.348 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.16 157.02 7.32 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.147 -0.781 . . . . 0.71 111.147 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 31.8 tt0 -90.65 133.66 34.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.088 -0.708 . . . . 1.83 109.088 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.5 150.63 23.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.641 -0.874 . . . . 1.16 108.641 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -151.45 143.21 23.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 123.355 0.409 . . . . 0.88 111.309 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.56 154.29 42.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.28 -1.378 . . . . 1.09 107.28 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.8 t -119.71 132.37 55.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.46 0.648 . . . . 1.7 111.655 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.479 HG21 HD11 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -136.34 119.76 23.07 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 124.267 1.027 . . . . 1.38 109.469 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -106.75 122.04 45.57 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.153 -0.684 . . . . 1.67 109.153 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.05 147.76 38.17 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.663 -0.415 . . . . 1.26 110.34 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.26 120.11 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.409 -1.33 . . . . 1.4 107.409 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 72.0 t80 -84.37 -72.8 0.45 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.632 -0.713 . . . . 4.75 111.653 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.4 ptm -136.75 -177.25 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.587 -0.894 . . . . 5.12 108.587 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.57 138.83 43.3 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.245 0.545 . . . . 5.33 110.366 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -91.72 132.43 33.14 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.919 -0.582 . . . . 5.79 110.953 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -65.95 117.95 5.08 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.77 2.313 . . . . 5.07 110.066 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 . . . . . 0 N--CA 1.417 -2.118 0 CA-C-O 118.388 -0.815 . . . . 10.3 109.038 -174.22 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 108.913 -0.773 . . . . 7.93 108.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -160.91 128.72 4.35 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.887 -0.783 . . . . 6.17 108.887 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.39 -0.82 8.7 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.087 -0.506 . . . . 5.43 110.933 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 58.38 24.69 11.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.554 0.741 . . . . 3.87 110.688 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -82.01 2.34 31.4 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.693 0.797 . . . . 2.55 110.762 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 m -97.9 98.22 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 CA-C-O 122.389 1.09 . . . . 2.51 108.599 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.1 m -110.54 98.52 7.7 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 115.079 -0.964 . . . . 2.01 109.11 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -89.16 136.35 33.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.706 -1.134 . . . . 1.61 108.55 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.2 t -83.91 169.56 14.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.025 -1.472 . . . . 1.32 107.025 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.92 112.82 24.72 Favored 'General case' 0 CA--C 1.489 -1.404 0 CA-C-O 121.068 0.461 . . . . 1.15 110.63 -173.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.1 t -106.87 131.89 53.45 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.889 -1.152 . . . . 1.67 107.889 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.2 t -115.08 114.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.735 -0.469 . . . . 1.11 109.735 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -113.14 116.16 29.41 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.501 -0.926 . . . . 2.66 108.501 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.9 mt -101.77 150.67 22.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.929 -0.397 . . . . 1.08 109.929 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.64 139.6 49.15 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.523 -0.917 . . . . 1.34 108.523 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -52.44 134.19 34.78 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.035 1.459 . . . . 1.24 110.64 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.76 142.47 49.98 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.908 -1.042 . . . . 1.07 111.072 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.51 125.89 44.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.491 0.662 . . . . 1.21 110.418 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 114.43 12.03 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.616 -1.175 . . . . 2.52 111.345 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 23.9 ptt? -165.68 -177.28 4.27 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.635 1.174 . . . . 1.33 107.996 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -71.63 -31.73 67.18 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.193 1.36 . . . . 3.4 114.47 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.478 ' O ' ' HG3' ' A' ' 20' ' ' MET . 90.1 m-70 -112.04 125.71 54.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.564 -2.013 . . . . 3.18 105.564 173.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 75' ' ' PRO . 60.0 m95 -93.12 143.67 26.02 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 113.838 1.051 . . . . 1.0 113.838 -168.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 t -134.66 125.6 27.44 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.001 -1.0 . . . . 0.34 109.876 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 63.5 mt -106.8 101.19 35.59 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.513 -1.292 . . . . 1.07 107.513 173.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.63 129.66 13.89 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.619 2.213 . . . . 0.32 112.304 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -127.46 143.41 51.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.083 0.468 . . . . 0.42 110.518 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 m -127.18 116.12 20.14 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.551 -0.907 . . . . 1.29 108.551 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.7 p -126.96 121.33 57.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.55 -0.537 . . . . 1.08 109.55 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 p-10 -115.69 148.09 40.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.566 -0.454 . . . . 1.39 109.953 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.37 149.65 6.25 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 108.094 -2.003 . . . . 0.6 108.094 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -75.78 -54.79 2.11 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 118.014 0.907 . . . . 3.29 109.111 -177.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 6.4 Cg_exo -75.99 120.0 5.58 Favored 'Trans proline' 0 C--N 1.369 1.651 0 N-CA-C 107.38 -1.815 . . . . 1.09 107.38 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.93 110.99 3.08 Favored Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 124.055 0.847 . . . . 1.36 110.924 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.47 146.05 34.5 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.213 1.942 . . . . 0.56 112.37 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 t -74.52 111.0 9.27 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.363 -1.347 . . . . 1.74 107.363 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 HD22 HG13 ' A' ' 29' ' ' VAL . 80.3 mt -88.75 125.48 34.9 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.637 -0.711 . . . . 1.14 109.786 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 39' ' ' TRP . 16.4 tpp180 -137.08 137.55 39.43 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.828 -0.434 . . . . 4.62 109.828 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.441 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 91.7 m95 -101.54 140.45 35.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.183 0.516 . . . . 0.33 109.868 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 45' ' ' VAL . 12.3 tp -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.421 -2.066 . . . . 1.57 105.421 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 79' ' ' ASN . 54.6 t80 -116.97 106.99 14.01 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.899 -0.408 . . . . 1.04 109.899 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 58.52 37.96 25.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.206 1.002 . . . . 2.17 110.839 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.72 -17.67 43.65 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.632 -0.713 . . . . 0.61 113.023 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -93.36 135.82 34.22 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.993 -0.743 . . . . 1.84 108.993 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 40' ' ' LEU . 5.1 p -67.35 136.52 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 121.373 0.606 . . . . 1.31 111.239 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 46.6 tp -92.2 124.25 36.14 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.45 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.41 104.81 13.62 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 103.916 -2.624 . . . . 2.69 103.916 167.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.35 137.63 18.26 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.188 0.93 . . . . 1.74 112.504 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -118.48 -166.87 1.28 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.174 -0.921 . . . . 2.07 110.467 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -67.17 -33.59 75.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.014 0.435 . . . . 1.9 111.58 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -88.61 -37.17 15.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.381 -0.372 . . . . 1.89 111.702 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.5 mt -110.0 109.45 28.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.787 -1.19 . . . . 1.18 107.787 -174.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -136.26 138.19 41.53 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.689 -0.804 . . . . 3.62 111.608 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -81.61 109.64 16.23 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.457 -0.792 . . . . 1.15 109.518 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -109.63 144.09 38.46 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.901 0.381 . . . . 2.04 110.914 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.13 153.76 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.041 -0.527 . . . . 0.87 109.629 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.45 155.85 38.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.904 -1.517 . . . . 1.7 106.904 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -74.58 121.68 85.8 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 114.534 1.309 . . . . 3.36 114.534 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.92 154.4 22.87 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.823 2.348 . . . . 1.63 109.622 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.64 176.26 9.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.164 -0.68 . . . . 1.88 109.164 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.12 89.9 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 119.043 0.838 . . . . 2.29 112.384 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.78 -20.14 59.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.993 -0.549 . . . . 3.93 110.531 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.0 113.15 19.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 120.376 -0.53 . . . . 1.89 109.974 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 m -92.25 0.47 57.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.487 1.137 . . . . 1.86 108.089 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 t -91.42 129.06 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.532 -1.213 . . . . 1.19 109.797 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.441 ' HB3' HG12 ' A' ' 29' ' ' VAL . 18.6 ttm180 -85.64 121.05 27.76 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.041 -1.837 . . . . 2.36 106.041 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.69 131.24 54.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.095 -0.705 . . . . 1.49 109.095 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.45 -177.52 35.54 Favored Glycine 0 N--CA 1.414 -2.791 0 C-N-CA 119.989 -1.101 . . . . 0.36 111.821 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.9 136.21 20.18 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.307 0.643 . . . . 0.36 109.527 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 56.7 tp -84.58 98.34 10.1 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 104.451 -2.426 . . . . 1.06 104.451 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -97.22 123.42 41.0 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.414 -0.812 . . . . 3.22 110.759 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.464 HD23 ' CZ ' ' A' ' 102' ' ' PHE . 6.5 mp -102.11 109.31 20.99 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.673 -1.232 . . . . 1.78 107.673 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -59.43 -42.77 92.64 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.656 -1.611 . . . . 2.42 109.965 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -133.17 124.98 18.69 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.274 -1.009 . . . . 3.22 108.274 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HB3' ' CD1' ' A' ' 23' ' ' TRP . 30.9 Cg_endo -66.02 130.52 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.803 2.336 . . . . 1.62 112.036 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.4 p -109.39 141.84 41.2 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.831 -0.803 . . . . 1.75 108.831 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -80.99 -13.16 59.13 Favored 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 120.589 -0.445 . . . . 2.61 110.038 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.32 -13.02 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 119.325 -0.95 . . . . 1.77 111.83 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.5 m-80 -108.48 23.01 15.15 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.957 1.095 . . . . 2.19 113.957 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 105' ' ' ASN . 19.0 p30 -86.26 64.27 8.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.034 0.921 . . . . 2.08 111.761 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.02 -148.12 4.96 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.11 -0.95 . . . . 0.59 111.994 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -102.93 116.76 33.18 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.354 0.597 . . . . 2.28 112.603 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 51.4 m-85 -94.91 140.28 30.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.763 -0.828 . . . . 1.03 108.763 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.0 m -128.8 127.71 42.49 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 108.46 -0.941 . . . . 1.13 108.46 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.9 tp -101.6 122.94 44.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.067 -0.716 . . . . 1.07 109.067 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.13 131.48 55.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.686 -1.227 . . . . 1.15 107.686 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.01 120.11 36.25 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.51 -0.922 . . . . 1.11 108.51 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.28 115.51 27.55 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.594 0.559 . . . . 1.34 110.64 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -134.82 150.76 74.25 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-O 117.76 -1.114 . . . . 1.61 108.211 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.09 -42.15 21.2 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.478 2.119 . . . . 1.33 112.243 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.5 t -57.2 -32.69 66.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 1.1 112.01 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.1 178.57 26.93 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 109.867 -1.293 . . . . 0.71 109.867 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -106.36 129.82 54.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.385 -0.598 . . . . 1.83 109.385 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.83 152.86 20.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.005 -0.739 . . . . 1.16 109.005 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 24.8 p -141.05 146.35 37.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.924 0.392 . . . . 0.88 111.251 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.27 43.36 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.738 -1.208 . . . . 1.09 107.738 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 t -122.91 127.81 49.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.7 -0.481 . . . . 1.7 109.7 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.6 123.85 38.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.77 -0.826 . . . . 1.38 108.77 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.0 mtp -101.73 110.62 22.64 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.2 -0.6 . . . . 1.67 110.285 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.89 133.46 38.59 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.779 -0.646 . . . . 1.26 110.513 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.47 100.63 6.33 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.15 -1.056 . . . . 1.4 108.15 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' CZ ' HD23 ' A' ' 72' ' ' LEU . 33.0 m-85 -78.02 -70.87 0.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.807 -1.182 . . . . 4.75 107.807 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 20.1 ptp -127.68 136.06 51.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 104.415 -2.439 . . . . 5.12 104.415 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.52 141.63 58.4 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 123.525 0.516 . . . . 5.33 110.103 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' HD22 ' A' ' 80' ' ' ASN . 5.8 p30 -72.27 113.2 18.59 Favored Pre-proline 0 CA--C 1.51 -0.559 0 O-C-N 123.906 0.754 . . . . 5.79 112.332 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -82.14 178.14 6.62 Favored 'Trans proline' 0 N--CA 1.424 -2.59 0 C-N-CA 121.748 1.632 . . . . 5.07 111.42 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 114.985 -1.007 . . . . 10.3 108.348 -176.612 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 CA--C 1.497 -1.09 0 N-CA-C 108.779 -0.823 . . . . 7.93 108.779 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 t70 68.65 17.57 8.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.395 1.478 . . . . 6.17 110.235 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.2 m-20 -80.19 -19.09 47.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.976 -1.466 . . . . 5.43 107.461 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.29 -15.47 61.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.043 -1.435 . . . . 3.87 111.083 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.9 -19.72 64.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.591 0.589 . . . . 2.55 112.591 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 3' ' ' ASP . 31.1 m -68.34 99.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 123.299 1.523 . . . . 2.51 108.541 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.2 m -97.77 98.67 10.04 Favored 'General case' 0 N--CA 1.381 -3.894 0 CA-C-N 113.882 -1.508 . . . . 2.01 113.781 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.27 126.57 52.97 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 112.878 -1.965 . . . . 1.61 105.96 171.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.68 174.17 10.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.753 -1.573 . . . . 1.32 106.753 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.09 129.23 40.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 118.882 -1.127 . . . . 1.15 110.501 -174.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -122.03 135.83 54.87 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.798 -1.186 . . . . 1.67 107.798 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.6 t -115.82 123.23 70.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.001 0.429 . . . . 1.11 111.073 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -115.13 139.72 49.66 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.338 -0.986 . . . . 2.66 108.338 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.488 HD11 HG21 ' A' ' 98' ' ' ILE . 36.1 mt -129.85 156.88 43.64 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.348 -0.612 . . . . 1.08 109.348 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -130.7 143.16 50.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.185 -1.043 . . . . 1.34 108.185 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 134.59 56.14 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.496 1.122 . . . . 1.24 109.693 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.31 139.84 58.81 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 124.003 0.815 . . . . 1.07 110.638 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.32 134.04 31.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.976 0.417 . . . . 1.21 111.542 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 92.26 0.34 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.32 -0.855 . . . . 2.52 112.415 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.8 ptt? -144.93 -177.09 5.35 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.092 -0.707 . . . . 1.33 109.092 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -64.1 -41.68 97.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.205 0.817 . . . . 3.4 113.205 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.9 p-80 -112.44 129.24 56.39 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.052 -1.462 . . . . 3.18 107.052 173.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -82.74 147.79 28.23 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 120.849 0.357 . . . . 1.0 111.642 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -137.59 120.26 16.21 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.44 -0.8 . . . . 0.34 110.142 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.4 mt -106.93 97.41 17.61 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.637 -1.245 . . . . 1.07 107.637 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.76 131.8 17.69 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 123.125 2.55 . . . . 0.32 112.602 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.62 154.91 39.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.333 0.587 . . . . 0.42 110.844 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 m -140.14 121.83 15.33 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.617 -0.882 . . . . 1.29 108.617 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.07 111.7 29.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.744 -0.835 . . . . 1.08 108.744 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.7 p-10 -106.85 147.25 29.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.026 -0.534 . . . . 1.39 111.309 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 -170.77 32.64 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.06 -1.216 . . . . 0.6 110.06 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -122.55 -51.94 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.456 0.91 . . . . 3.29 113.456 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.01 121.32 9.62 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 107.854 -1.633 . . . . 1.09 107.854 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.43 111.03 6.24 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 123.765 0.666 . . . . 1.36 111.111 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 71.7 Cg_endo -84.47 146.65 10.96 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.841 1.694 . . . . 0.56 111.842 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 22.9 t -79.57 121.96 25.9 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.715 -1.587 . . . . 1.74 106.715 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -96.51 129.72 43.82 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.639 0.587 . . . . 1.14 109.734 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -136.58 134.7 37.71 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.116 -0.493 . . . . 4.62 110.968 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.85 34.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.617 -0.882 . . . . 0.33 108.617 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.86 130.91 52.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.086 -1.45 . . . . 1.57 107.086 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 87.2 t80 -120.8 103.72 9.31 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.049 -0.723 . . . . 1.04 109.049 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 56.86 33.59 23.38 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.662 0.785 . . . . 2.17 111.923 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.83 82.95 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.687 -0.768 . . . . 0.61 112.895 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 t -105.77 146.69 29.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.976 -1.12 . . . . 1.84 107.976 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.88 123.8 36.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.907 -0.775 . . . . 1.31 108.907 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.75 106.53 12.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.263 -0.643 . . . . 1.33 109.263 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.8 131.41 34.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.585 -0.895 . . . . 2.69 108.585 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.01 149.31 47.84 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.273 0.559 . . . . 1.74 111.268 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -145.6 -169.33 3.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 114.938 -1.028 . . . . 2.07 108.768 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 t -72.25 -25.18 61.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.429 0.633 . . . . 1.9 109.987 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 95.9 m-85 -101.52 -12.09 18.79 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.437 0.903 . . . . 1.89 113.437 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 HD12 ' ND2' ' A' ' 79' ' ' ASN . 44.4 mt -135.75 107.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.311 -1.737 . . . . 1.18 106.311 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -141.45 142.33 33.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 112.308 0.485 . . . . 3.62 112.308 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 m -88.79 109.49 20.22 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.644 -0.707 . . . . 1.15 109.499 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.577 ' HG3' ' HE ' ' A' ' 71' ' ' ARG . 6.7 mm-40 -92.98 124.05 36.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.391 0.615 . . . . 2.04 110.883 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.31 120.5 40.03 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.148 -1.427 . . . . 0.87 107.148 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.514 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 pp -84.31 155.79 22.22 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 106.836 -1.542 . . . . 1.7 106.836 177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.0 105.97 3.4 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 124.138 0.899 . . . . 3.36 110.407 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 79.4 Cg_endo -88.25 169.68 6.05 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.137 2.558 . . . . 1.63 111.051 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.579 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -93.87 139.62 30.67 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.656 -1.238 . . . . 1.88 107.656 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.54 15.11 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.513 0.673 . . . . 2.29 111.413 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.85 -25.62 32.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.069 -0.968 . . . . 3.93 109.829 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.8 pt-20 -97.26 139.4 33.28 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.583 -0.895 . . . . 1.89 108.583 -177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -88.12 13.59 10.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.96 0.886 . . . . 1.86 109.94 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 132.05 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.724 -0.671 . . . . 1.19 110.259 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -95.39 136.23 36.02 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.654 -1.61 . . . . 2.36 106.654 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -125.41 157.74 36.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.163 -0.68 . . . . 1.49 109.163 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.2 -168.24 38.84 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 111.264 -0.734 . . . . 0.36 111.264 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.29 138.41 16.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 123.001 0.52 . . . . 0.36 111.335 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.13 109.83 20.19 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.81 -1.552 . . . . 1.06 106.81 172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.577 ' HE ' ' HG3' ' A' ' 55' ' ' GLU . 76.0 mtm180 -102.28 131.56 48.78 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.795 -0.362 . . . . 3.22 111.574 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.1 mp -119.83 109.56 15.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.777 -0.823 . . . . 1.78 108.777 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.84 -10.61 59.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.759 -0.655 . . . . 2.42 111.184 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -135.09 101.49 11.33 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 108.114 -1.069 . . . . 3.22 108.114 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -88.26 129.59 2.35 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.591 1.528 . . . . 1.62 110.368 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.7 p -136.54 173.15 12.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.842 -0.799 . . . . 1.75 108.842 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -78.79 -5.67 53.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.113 0.412 . . . . 2.61 112.113 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.02 -9.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.611 . . . . 1.77 109.349 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.416 ' ND2' HD12 ' A' ' 52' ' ' ILE . 13.4 m120 -104.81 22.06 15.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.005 -1.109 . . . . 2.19 108.005 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -114.17 117.44 31.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.799 -0.815 . . . . 2.08 108.799 -175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.27 -153.52 24.68 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.637 -1.268 . . . . 0.59 113.18 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 45.8 m-80 -87.28 120.66 28.79 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.55 -0.325 . . . . 2.28 111.406 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -105.56 118.28 36.16 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.311 -0.996 . . . . 1.03 108.311 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 m -122.96 125.02 44.49 Favored 'General case' 0 C--N 1.283 -2.3 0 O-C-N 121.611 -0.681 . . . . 1.13 109.775 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' CB ' HD12 ' A' ' 14' ' ' LEU . 59.0 tp -97.39 117.54 31.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.453 -0.943 . . . . 1.07 108.453 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.43 133.2 52.29 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.467 -0.938 . . . . 1.15 108.467 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . . . -122.16 120.03 33.03 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.719 -1.215 . . . . 1.11 107.719 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.88 132.53 55.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.962 -0.755 . . . . 1.34 108.962 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 91' ' ' CYS . 8.7 p30 -152.62 170.43 8.1 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-O 118.474 -0.774 . . . . 1.61 109.257 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.48 -39.15 54.92 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.85 2.367 . . . . 1.33 114.465 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.427 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 27.0 t -70.0 -32.06 70.06 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-O 121.224 0.535 . . . . 1.1 111.832 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.19 -146.03 11.75 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 119.864 -1.16 . . . . 0.71 111.969 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.63 138.63 38.03 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.146 -0.687 . . . . 1.83 109.146 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -119.81 146.63 45.52 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.965 -1.124 . . . . 1.16 107.965 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 p -143.74 152.85 41.78 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 121.006 -0.277 . . . . 0.88 110.275 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.58 144.92 26.52 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.86 -1.533 . . . . 1.09 106.86 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -122.44 145.72 48.03 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.472 0.654 . . . . 1.7 112.358 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -133.64 124.76 48.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 125.475 1.51 . . . . 1.38 108.572 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 tpt -96.34 96.52 8.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.687 -1.227 . . . . 1.67 107.687 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.02 113.16 26.16 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.349 0.595 . . . . 1.26 111.44 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.31 99.62 9.01 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 107.093 -1.447 . . . . 1.4 107.093 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -79.92 -24.65 40.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.209 1.188 . . . . 4.75 114.209 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 87.2 mmm -137.98 143.91 40.89 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.848 -1.538 . . . . 5.12 106.848 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.21 110.01 12.82 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.68 -1.6 . . . . 5.33 106.68 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.37 113.02 38.46 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 115.191 -0.913 . . . . 5.79 112.083 -172.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.44 124.4 9.36 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.092 1.862 . . . . 5.07 109.354 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 C--N 1.314 -0.953 0 C-N-CA 124.709 1.204 . . . . 10.3 110.528 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.5 -0.963 0 CA-C-O 121.033 0.444 . . . . 7.93 110.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -131.62 99.54 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.956 -0.757 . . . . 6.17 108.956 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.87 -29.56 32.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.556 -1.276 . . . . 5.43 107.556 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.64 123.67 25.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.401 -1.272 . . . . 3.87 109.181 175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.6 -15.94 53.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.868 0.842 . . . . 2.55 109.546 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 m -71.98 99.88 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.945 -1.025 . . . . 2.51 111.223 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.4 p -97.73 107.73 20.29 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.335 -0.848 . . . . 2.01 109.999 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.404 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.2 m-85 -86.52 127.92 34.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.818 -1.083 . . . . 1.61 109.587 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.2 t -84.68 176.47 8.55 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.557 -1.275 . . . . 1.32 107.557 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.11 114.57 26.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 120.357 -0.537 . . . . 1.15 110.55 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.63 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 34.1 t -117.68 131.31 56.65 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.743 -1.206 . . . . 1.67 107.743 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.53 121.26 67.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.507 -0.315 . . . . 1.11 110.936 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.1 123.42 42.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.569 -0.53 . . . . 2.66 109.569 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 27' ' ' PHE . 43.8 mt -105.87 156.02 18.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 1.08 109.937 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.53 151.92 51.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 110.455 -0.202 . . . . 1.34 110.455 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -54.05 133.16 43.68 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 124.786 1.304 . . . . 1.24 110.4 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.49 145.55 55.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.625 -0.716 . . . . 1.07 110.213 -177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.68 127.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.518 0.675 . . . . 1.21 112.745 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.74 108.83 4.08 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 114.281 -1.327 . . . . 2.52 110.926 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -170.61 -171.7 1.1 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.93 -1.507 . . . . 1.33 106.93 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -66.52 -50.59 62.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.393 -0.523 . . . . 3.4 111.982 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -92.39 120.13 32.6 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.797 -0.816 . . . . 3.18 108.797 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -82.32 120.11 24.99 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.271 0.557 . . . . 1.0 111.023 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.8 121.96 44.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.612 -1.176 . . . . 0.34 109.138 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.4 mt -103.73 103.74 38.45 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 108.054 -1.091 . . . . 1.07 108.054 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.25 130.48 13.06 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.456 2.104 . . . . 0.32 111.85 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD21 ' A' ' 14' ' ' LEU . 43.1 p90 -135.35 162.2 33.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.318 0.58 . . . . 0.42 110.482 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.0 m -144.62 123.48 12.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.651 -0.704 . . . . 1.29 109.157 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.7 p -123.6 114.69 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.079 -0.964 . . . . 1.08 108.495 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.63 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 4.1 p-10 -102.25 158.49 16.15 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.736 -1.186 . . . . 1.39 109.755 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.98 138.72 2.61 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.795 -1.322 . . . . 0.6 109.795 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -87.32 -49.6 0.45 Allowed Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 119.571 -0.852 . . . . 3.29 110.316 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.6 Cg_exo -64.17 119.48 6.54 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 105.255 -2.633 . . . . 1.09 105.255 164.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.17 117.79 59.78 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 116.138 -0.483 . . . . 1.36 112.296 -171.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -85.89 149.53 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.398 2.065 . . . . 0.56 111.941 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -90.91 138.81 31.31 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.77 -1.196 . . . . 1.74 107.77 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 80.9 mt -98.23 134.06 41.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.938 0.399 . . . . 1.14 111.094 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -130.29 126.22 36.69 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.037 -0.529 . . . . 4.62 110.064 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -96.78 124.33 40.72 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.599 -0.728 . . . . 0.33 109.702 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.97 128.8 55.61 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.492 -0.929 . . . . 1.57 108.492 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -105.01 104.64 14.41 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.169 -1.419 . . . . 1.04 107.169 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.08 30.76 19.65 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.801 0.81 . . . . 2.17 110.961 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.04 64.25 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.39 -0.823 . . . . 0.61 112.392 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -91.45 150.8 21.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.212 -1.032 . . . . 1.84 108.212 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -72.33 121.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.818 -0.628 . . . . 1.31 111.345 -175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -102.66 122.45 44.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.664 -1.235 . . . . 1.33 107.664 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.81 138.32 35.35 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.773 -0.825 . . . . 2.69 108.773 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -75.84 106.15 7.26 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.329 -0.396 . . . . 1.74 110.214 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -88.28 -170.37 2.93 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.852 -0.425 . . . . 2.07 109.852 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -80.12 -13.61 59.14 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.56 -0.713 . . . . 1.9 109.517 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -97.94 -40.1 8.64 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.695 -0.684 . . . . 1.89 110.137 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.12 104.89 17.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.972 -2.232 . . . . 1.18 104.972 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -135.09 149.52 50.07 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.378 -0.929 . . . . 3.62 112.078 -173.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.9 m -94.36 109.62 21.45 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.357 -0.979 . . . . 1.15 108.357 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -100.75 123.79 45.46 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.544 -0.91 . . . . 2.04 108.544 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -100.4 146.17 27.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.716 -0.846 . . . . 0.87 108.716 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.15 154.5 32.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.833 -1.173 . . . . 1.7 107.833 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.49 120.43 81.45 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 123.94 0.775 . . . . 3.36 110.203 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.94 169.53 16.26 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.873 2.382 . . . . 1.63 109.936 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.73 141.2 38.06 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.315 -1.735 . . . . 1.88 106.315 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.93 -25.35 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.107 1.521 . . . . 2.29 115.107 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -73.5 -32.05 64.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.087 0.47 . . . . 3.93 110.411 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -75.23 142.36 43.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.251 0.548 . . . . 1.89 110.1 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 m -111.29 18.03 19.66 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.382 -1.71 . . . . 1.86 106.382 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.81 121.36 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 113.819 -1.537 . . . . 1.19 108.45 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 77.6 ttt180 -93.14 111.39 23.01 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.173 -1.417 . . . . 2.36 107.173 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -101.61 155.65 17.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.46 -0.57 . . . . 1.49 109.46 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.28 -174.74 44.83 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.278 -0.963 . . . . 0.36 112.092 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.4 t -145.3 134.85 23.27 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.177 0.591 . . . . 0.36 111.025 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.0 tp -88.63 107.59 19.0 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.103 -2.184 . . . . 1.06 105.103 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -117.91 130.41 56.22 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.432 0.634 . . . . 3.22 111.228 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.44 114.79 29.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.928 -1.033 . . . . 1.78 110.802 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.33 -39.35 81.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.769 -1.105 . . . . 2.42 109.019 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.34 100.45 49.86 Favored Pre-proline 0 N--CA 1.435 -1.214 0 N-CA-C 107.897 -1.149 . . . . 3.22 107.897 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.6 135.45 24.05 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 122.652 2.234 . . . . 1.62 109.451 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -133.43 149.19 51.79 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.033 0.444 . . . . 1.75 111.514 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -70.14 -4.21 20.31 Favored 'General case' 0 C--O 1.208 -1.085 0 C-N-CA 123.822 0.849 . . . . 2.61 112.117 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.06 -9.78 11.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.416 -0.356 . . . . 1.77 110.178 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.6 m-80 -115.96 26.48 9.94 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.549 0.944 . . . . 2.19 113.549 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -94.32 72.81 3.88 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.075 0.941 . . . . 2.08 110.011 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.5 -153.11 5.88 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.701 -0.761 . . . . 0.59 113.206 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.35 123.84 43.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.967 -0.383 . . . . 2.28 109.967 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.578 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 27.8 m-85 -101.33 116.57 33.1 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.012 -0.736 . . . . 1.03 109.012 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.9 m -110.72 122.32 47.5 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.192 -1.04 . . . . 1.13 108.192 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.4 tp -99.01 119.2 37.4 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.135 -0.484 . . . . 1.07 109.811 -178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 129.38 53.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.554 -0.906 . . . . 1.15 108.554 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.47 120.99 33.61 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.326 -1.361 . . . . 1.11 107.326 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.04 124.8 46.77 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.457 -0.497 . . . . 1.34 111.492 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 43.9 p30 -138.47 171.1 8.8 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.181 -1.414 . . . . 1.61 107.181 174.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 38.9 Cg_exo -45.35 -37.48 14.22 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.043 2.495 . . . . 1.33 114.648 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.04 -49.62 73.84 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.671 0.272 . . . . 1.1 110.824 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.67 -177.65 48.03 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.131 -1.033 . . . . 0.71 111.816 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -108.1 122.58 47.19 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.992 -1.114 . . . . 1.83 107.992 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.88 149.09 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.397 -0.964 . . . . 1.16 108.397 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.1 p -147.42 140.84 25.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 O-C-N 123.464 0.477 . . . . 0.88 110.883 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.17 42.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.318 -1.364 . . . . 1.09 107.318 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.9 p -130.15 146.35 51.78 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.13 0.49 . . . . 1.7 111.842 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.57 138.6 21.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.621 -1.622 . . . . 1.38 106.621 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -111.12 124.1 51.52 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 1.67 110.336 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.62 115.31 25.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.493 -0.558 . . . . 1.26 109.493 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.43 111.65 23.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.982 -0.554 . . . . 1.4 110.303 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -149.24 121.08 8.14 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.555 0.693 . . . . 4.75 111.636 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.6 mtt -103.03 132.94 48.93 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 5.12 108.117 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -97.44 143.53 28.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.589 -1.263 . . . . 5.33 107.589 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -117.89 99.82 52.12 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 106.77 -1.567 . . . . 5.79 106.77 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.73 172.33 10.74 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.051 1.834 . . . . 5.07 114.228 -175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.409 -2.508 0 CA-C-N 114.051 -1.431 . . . . 10.3 108.631 -173.332 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.648 0.261 . . . . 7.93 110.471 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -97.59 62.36 1.68 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.846 -1.168 . . . . 6.17 107.846 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -103.8 30.55 5.02 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.413 -0.812 . . . . 5.43 112.937 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.24 121.72 31.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.313 -1.366 . . . . 3.87 107.313 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.97 -15.58 63.12 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.515 -0.766 . . . . 2.55 111.579 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.07 98.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 107.633 -1.247 . . . . 2.51 107.633 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 p -81.44 99.4 8.71 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.424 -0.807 . . . . 2.01 109.446 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.34 124.89 24.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.875 -1.057 . . . . 1.61 110.992 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 20.6 t -84.46 160.97 20.45 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.428 -1.693 . . . . 1.32 106.428 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.51 121.24 35.86 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.776 -0.77 . . . . 1.15 111.42 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -112.3 141.88 45.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.454 -1.313 . . . . 1.67 107.454 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.36 114.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 110.056 -0.349 . . . . 1.11 110.056 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -112.35 116.4 30.29 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.379 0.609 . . . . 2.66 109.55 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.497 HD11 HG21 ' A' ' 98' ' ' ILE . 70.7 mt -104.87 156.81 17.68 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.96 -1.018 . . . . 1.08 109.035 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -131.13 156.52 45.14 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.762 -0.829 . . . . 1.34 108.762 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -65.08 134.76 54.51 Favored 'General case' 0 N--CA 1.423 -1.806 0 O-C-N 124.456 1.097 . . . . 1.24 109.63 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.41 140.9 56.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.25 -0.886 . . . . 1.07 109.684 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.67 132.97 33.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.547 0.689 . . . . 1.21 110.652 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.44 102.39 2.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.427 -1.261 . . . . 2.52 112.465 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -161.37 -179.42 7.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.812 -1.551 . . . . 1.33 106.812 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -64.55 -37.66 88.34 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.468 1.031 . . . . 3.4 113.401 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -107.22 117.91 35.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.906 -1.516 . . . . 3.18 106.906 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.435 ' HB2' HD13 ' A' ' 72' ' ' LEU . 78.3 m95 -82.05 125.55 30.96 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.159 -0.616 . . . . 1.0 110.681 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -108.67 121.43 45.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.146 -1.057 . . . . 0.34 108.146 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 69' ' ' CYS . 60.3 mt -102.89 98.11 10.77 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 107.693 -1.225 . . . . 1.07 107.693 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.92 132.08 19.33 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.392 2.061 . . . . 0.32 112.056 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -128.69 152.79 48.0 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.327 0.584 . . . . 0.42 110.481 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -142.18 120.63 12.42 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.265 -0.88 . . . . 1.29 108.927 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 37' ' ' LEU . 2.9 p -124.61 121.16 60.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.335 -0.987 . . . . 1.08 108.335 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 p-10 -111.55 145.49 39.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.737 -0.785 . . . . 1.39 110.204 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.62 4.73 Favored Glycine 0 C--N 1.298 -1.529 0 N-CA-C 107.504 -2.238 . . . . 0.6 107.504 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 33' ' ' PRO 0.278 46.1 tt0 -80.87 -57.43 0.58 Allowed Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 118.649 1.224 . . . . 3.29 113.168 -175.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 32.4 Cg_exo -63.69 119.74 6.89 Favored 'Trans proline' 0 C--N 1.367 1.509 0 N-CA-C 106.28 -2.239 . . . . 1.09 106.28 168.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.93 109.84 2.86 Favored Pre-proline 0 C--N 1.315 -0.923 0 O-C-N 123.806 0.691 . . . . 1.36 111.076 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 59.1 Cg_endo -71.16 141.67 40.14 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.162 1.908 . . . . 0.56 112.512 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -71.26 104.24 3.07 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.463 -0.79 . . . . 1.74 108.952 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 29' ' ' VAL . 96.0 mt -81.78 134.03 35.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.352 -0.84 . . . . 1.14 109.813 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -146.39 138.59 25.03 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 123.687 0.795 . . . . 4.62 108.86 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -102.78 130.67 49.84 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.378 0.609 . . . . 0.33 110.625 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.9 tp -114.72 126.79 55.26 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.954 -1.869 . . . . 1.57 105.954 175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -116.63 98.12 6.36 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 109.077 -0.712 . . . . 1.04 109.077 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 51.92 56.6 7.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.167 0.984 . . . . 2.17 110.23 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.02 -13.95 12.54 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.089 -0.96 . . . . 0.61 113.816 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 m -96.6 140.99 30.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.853 -0.795 . . . . 1.84 108.853 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.92 123.45 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.461 -1.311 . . . . 1.31 107.461 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.4 tp -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.58 0.55 . . . . 1.33 109.587 -178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -82.83 125.83 31.75 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.486 -0.931 . . . . 2.69 108.486 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.36 153.19 35.99 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.222 -0.445 . . . . 1.74 110.031 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.9 t -166.05 -175.28 3.29 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.748 -0.834 . . . . 2.07 108.748 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 m -68.22 -17.67 64.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 119.594 1.088 . . . . 1.9 111.901 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -79.07 -40.17 31.94 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.729 0.3 . . . . 1.89 110.831 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD12 ' ND2' ' A' ' 79' ' ' ASN . 56.9 mt -136.15 115.66 16.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.929 -0.767 . . . . 1.18 108.929 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -142.39 145.69 34.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.107 0.479 . . . . 3.62 112.057 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 m -82.58 111.19 18.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.466 -0.788 . . . . 1.15 109.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 6.4 mm-40 -89.3 140.39 29.54 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.899 -0.778 . . . . 2.04 108.899 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -122.27 140.67 52.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.749 -0.834 . . . . 0.87 108.749 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.59 151.71 41.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.027 -1.101 . . . . 1.7 108.027 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -63.46 119.97 58.2 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 123.96 0.788 . . . . 3.36 112.598 -174.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.95 156.13 38.77 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.588 2.192 . . . . 1.63 110.351 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.89 146.91 33.31 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.667 -0.864 . . . . 1.88 108.667 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.69 -13.05 58.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.019 1.118 . . . . 2.29 114.019 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -90.57 -21.47 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.916 0.388 . . . . 3.93 111.424 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.4 pt-20 -99.28 162.47 13.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.689 -0.804 . . . . 1.89 110.957 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -121.49 29.71 7.09 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.966 -1.494 . . . . 1.86 106.966 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -107.93 128.76 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.22 -1.355 . . . . 1.19 108.807 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB2' HG12 ' A' ' 29' ' ' VAL . 78.2 mtp180 -92.59 132.59 36.73 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.003 -1.48 . . . . 2.36 107.003 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -121.97 143.73 49.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.302 -0.629 . . . . 1.49 109.302 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.7 -166.09 24.11 Favored Glycine 0 N--CA 1.416 -2.642 0 C-N-CA 120.512 -0.851 . . . . 0.36 111.035 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.0 t -156.07 137.57 14.06 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.833 0.453 . . . . 0.36 110.183 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.3 tp -90.16 107.93 19.43 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.851 -1.907 . . . . 1.06 105.851 171.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.419 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 70.6 mtt180 -100.18 120.35 39.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-N 116.502 -0.317 . . . . 3.22 110.873 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 23' ' ' TRP . 73.1 mt -83.7 108.0 16.49 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 105.96 -1.867 . . . . 1.78 105.96 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -66.97 -42.62 84.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.047 -0.979 . . . . 2.42 109.532 -176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -134.98 100.99 11.63 Favored Pre-proline 0 N--CA 1.412 -2.341 0 N-CA-C 106.533 -1.655 . . . . 3.22 106.533 171.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 14.3 Cg_exo -70.38 131.42 20.33 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.022 1.814 . . . . 1.62 110.367 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 p -130.27 155.74 45.8 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.312 -0.995 . . . . 1.75 108.312 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -65.41 -5.42 7.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.444 1.276 . . . . 2.61 114.444 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.49 -10.44 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 109.638 -0.504 . . . . 1.77 109.638 174.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' ND2' HD12 ' A' ' 52' ' ' ILE . 13.8 m120 -89.18 17.15 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.599 0.76 . . . . 2.19 111.882 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -92.15 121.9 34.13 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.874 -0.788 . . . . 2.08 108.874 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.53 -170.45 36.5 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.39 -1.386 . . . . 0.59 112.641 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.83 101.29 13.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.996 -0.602 . . . . 2.28 110.721 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' HB2' HG22 ' A' ' 98' ' ' ILE . 45.1 m-85 -83.97 114.13 21.49 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 108.767 -0.827 . . . . 1.03 108.767 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 35.8 m -117.32 132.46 56.6 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 121.452 -0.78 . . . . 1.13 110.683 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.3 tp -106.18 123.1 47.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.124 -0.695 . . . . 1.07 109.124 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.11 136.07 47.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.254 -1.017 . . . . 1.15 108.254 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -126.84 120.62 29.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.28 117.19 34.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.796 -0.446 . . . . 1.34 109.796 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -131.31 151.59 79.07 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-O 117.405 -1.283 . . . . 1.61 108.31 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -43.1 -38.42 7.43 Favored 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 122.799 2.332 . . . . 1.33 113.38 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.1 t -64.16 -39.66 94.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.486 0.714 . . . . 1.1 112.137 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.14 30.96 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.149 -0.78 . . . . 0.71 111.149 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 64.5 tt0 -128.83 129.91 46.23 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.729 -0.471 . . . . 1.83 109.729 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.43 150.51 23.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.747 -0.834 . . . . 1.16 108.747 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 p -148.65 123.73 10.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.977 -0.556 . . . . 0.88 110.183 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.41 51.88 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.006 -1.109 . . . . 1.09 108.006 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.4 m -121.17 132.79 55.05 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.699 0.761 . . . . 1.7 112.819 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -109.78 126.55 66.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 125.541 1.536 . . . . 1.38 108.685 175.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.51 ' N ' HD13 ' A' ' 98' ' ' ILE . 16.0 tpt -105.08 111.09 23.73 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 1.67 108.209 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.6 149.7 27.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.218 -0.447 . . . . 1.26 109.961 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.6 127.33 23.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.799 -0.637 . . . . 1.4 110.475 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 75' ' ' PRO . 55.4 t80 -161.33 92.75 0.91 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 124.994 1.317 . . . . 4.75 107.876 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.77 96.55 7.15 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.221 -0.591 . . . . 5.12 109.877 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.56 137.62 33.2 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.027 -1.101 . . . . 5.33 108.027 174.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.01 127.57 26.67 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.924 -0.769 . . . . 5.79 108.924 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.76 117.61 4.18 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.482 2.121 . . . . 5.07 110.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.241 1.416 . . . . 10.3 108.802 -175.215 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 t70 . . . . . 0 C--O 1.244 0.772 0 N-CA-C 107.003 -1.48 . . . . 7.93 107.003 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -150.67 77.81 1.29 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.659 0.742 . . . . 6.17 109.402 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -94.5 -26.3 16.5 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.3 -0.864 . . . . 5.43 110.405 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.0 132.65 39.63 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 3.87 109.32 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -96.32 -50.19 4.89 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.682 0.393 . . . . 2.55 111.613 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 m -90.52 98.33 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 113.958 1.096 . . . . 2.51 113.958 -173.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.5 t -104.26 98.1 7.95 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.846 -1.909 . . . . 2.01 105.846 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -72.13 131.73 43.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.262 -0.881 . . . . 1.61 110.084 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.36 157.1 21.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.61 -1.256 . . . . 1.32 107.61 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.56 127.2 41.4 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.624 0.601 . . . . 1.15 112.624 -172.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.3 m -123.87 141.05 52.38 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.933 -1.877 . . . . 1.67 105.933 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.0 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.074 0.464 . . . . 1.11 109.755 -174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -115.81 116.85 28.73 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.001 -0.74 . . . . 2.66 109.001 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -95.68 156.66 16.23 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.965 -0.561 . . . . 1.08 109.631 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -130.54 142.04 50.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.954 -1.499 . . . . 1.34 106.954 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -62.11 130.1 43.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 124.053 0.846 . . . . 1.24 110.558 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.56 140.63 40.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.451 1.1 . . . . 1.07 112.207 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.7 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.754 -0.657 . . . . 1.21 109.886 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.3 117.27 24.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.991 -1.004 . . . . 2.52 112.394 -171.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.0 ptt? -168.28 -174.27 2.23 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.129 -1.434 . . . . 1.33 107.129 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.401 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 8.0 t-80 -65.54 -52.65 50.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.794 0.724 . . . . 3.4 110.639 -176.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.462 ' O ' ' HG3' ' A' ' 20' ' ' MET . 7.8 p-80 -99.35 126.65 45.26 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.625 -0.879 . . . . 3.18 108.625 173.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -82.36 148.0 28.51 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.178 0.513 . . . . 1.0 112.224 -171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 44.0 t -131.55 118.89 20.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.506 -0.924 . . . . 0.34 108.506 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 78.3 mt -103.68 99.18 14.84 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.455 -1.313 . . . . 1.07 107.455 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.0 143.58 36.58 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.087 1.858 . . . . 0.32 110.887 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -137.73 154.58 49.61 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.724 -0.39 . . . . 0.42 110.349 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -132.62 114.06 13.77 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.638 -0.71 . . . . 1.29 110.208 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 37' ' ' LEU . 6.4 p -129.57 137.81 55.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.813 -1.551 . . . . 1.08 106.813 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.3 p-10 -132.34 161.88 32.45 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 119.741 -0.784 . . . . 1.39 110.744 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.94 153.74 7.34 Favored Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 109.502 -1.439 . . . . 0.6 109.502 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -81.31 -56.68 0.59 Allowed Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 107.973 -1.121 . . . . 3.29 107.973 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.83 120.85 7.73 Favored 'Trans proline' 0 C--N 1.375 1.928 0 N-CA-C 107.59 -1.734 . . . . 1.09 107.59 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HB2' HH21 ' A' ' 66' ' ' ARG . . . -61.78 114.41 11.18 Favored Pre-proline 0 C--N 1.312 -1.023 0 O-C-N 123.742 0.651 . . . . 1.36 111.694 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' ALA . 84.8 Cg_endo -79.1 135.05 12.01 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.572 1.515 . . . . 0.56 112.058 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 p -73.53 116.47 14.14 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 109.023 -0.732 . . . . 1.74 109.023 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.432 HD22 HG13 ' A' ' 29' ' ' VAL . 93.2 mt -87.22 127.53 35.16 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.434 -0.803 . . . . 1.14 109.647 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -125.7 130.21 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.127 -0.694 . . . . 4.62 109.127 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.5 m95 -95.64 128.87 42.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.277 0.561 . . . . 0.33 109.734 176.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.1 tp -118.59 127.42 53.59 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.703 -1.962 . . . . 1.57 105.703 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -119.91 110.85 17.21 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.587 -0.523 . . . . 1.04 109.587 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.0 28.5 16.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.061 0.945 . . . . 2.17 111.45 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.09 -12.27 69.4 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 121.389 -0.434 . . . . 0.61 112.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.1 p -103.18 151.31 22.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.754 0.311 . . . . 1.84 110.315 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.28 120.76 17.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.667 -0.697 . . . . 1.31 110.436 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.9 tp -94.42 104.44 16.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.05 -0.722 . . . . 1.33 109.05 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -85.74 137.31 32.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.252 -0.647 . . . . 2.69 109.252 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.42 129.18 39.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.956 -0.566 . . . . 1.74 109.536 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 p -126.64 -163.69 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.853 0.861 . . . . 2.07 109.661 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.6 m -87.19 -5.83 58.83 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.359 0.599 . . . . 1.9 109.661 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -103.0 -35.56 8.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.81 -0.632 . . . . 1.89 109.955 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -127.93 106.97 15.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.231 -1.025 . . . . 1.18 108.231 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -138.78 140.22 38.54 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.817 0.341 . . . . 3.62 110.303 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -86.83 113.81 22.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.706 -0.85 . . . . 1.15 108.706 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -105.52 115.06 29.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.397 0.618 . . . . 2.04 110.062 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -96.37 150.63 20.37 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.35 -0.841 . . . . 0.87 109.455 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.0 pp -106.91 165.15 11.55 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.743 -1.947 . . . . 1.7 105.743 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.4 104.74 21.43 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.556 -0.535 . . . . 3.36 109.556 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 86.9 Cg_endo -84.08 165.32 13.15 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.379 2.052 . . . . 1.63 111.145 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.32 137.29 54.54 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.962 -1.125 . . . . 1.88 107.962 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.03 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.012 0.525 . . . . 2.29 111.981 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.49 -26.01 65.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.755 0.788 . . . . 3.93 109.149 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -98.38 140.1 33.15 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.526 -0.761 . . . . 1.89 109.04 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -104.99 28.72 6.94 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.692 0.758 . . . . 1.86 108.993 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 130.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 115.241 -0.89 . . . . 1.19 109.318 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.431 HH21 ' HB2' ' A' ' 34' ' ' ALA . 75.9 mtt180 -82.74 117.54 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.4 -0.963 . . . . 2.36 108.4 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.505 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 96.1 m-70 -104.38 123.74 47.96 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.368 -0.975 . . . . 1.49 108.368 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.9 39.32 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.473 -0.87 . . . . 0.36 111.395 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.4 t -144.16 137.89 27.76 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 122.439 0.296 . . . . 0.36 110.897 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 58.9 tp -84.68 100.38 11.43 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.759 -2.311 . . . . 1.06 104.759 169.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -104.19 120.17 40.54 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 120.238 -0.585 . . . . 3.22 110.049 -174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.55 108.03 8.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.343 -1.725 . . . . 1.78 106.343 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.82 -49.19 66.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.16 -1.382 . . . . 2.42 109.479 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.4 99.8 18.86 Favored Pre-proline 0 N--CA 1.414 -2.234 0 N-CA-C 104.296 -2.483 . . . . 3.22 104.296 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 21' ' ' HIS . 33.5 Cg_exo -64.06 130.5 27.53 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.388 2.059 . . . . 1.62 111.73 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -135.18 166.02 24.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.56 -0.745 . . . . 1.75 109.383 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 103' ' ' MET . 50.0 p-80 -62.54 -5.18 2.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.748 1.759 . . . . 2.61 115.748 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.17 -10.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.035 0.445 . . . . 1.77 109.834 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.7 26.74 0.39 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.113 1.153 . . . . 2.19 114.113 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.14 125.17 53.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.321 -0.992 . . . . 2.08 108.321 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.38 -165.71 30.96 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.21 -0.995 . . . . 0.59 111.744 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -99.96 124.0 44.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 110.024 -0.362 . . . . 2.28 110.024 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -102.67 105.79 16.32 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.622 -0.881 . . . . 1.03 108.622 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.6 m -97.33 129.58 44.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.948 -0.76 . . . . 1.13 108.948 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.2 tp -109.06 120.77 43.53 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.582 -0.525 . . . . 1.07 109.582 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.23 138.95 42.46 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.283 -1.006 . . . . 1.15 108.283 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.94 120.66 30.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.306 -0.998 . . . . 1.11 108.306 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -97.97 112.46 24.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.34 0.59 . . . . 1.34 110.97 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -130.61 140.92 40.13 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.13 -1.804 . . . . 1.61 106.13 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.16 -19.57 12.43 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 124.052 3.168 . . . . 1.33 113.947 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.0 t -78.93 -24.29 44.11 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.825 0.345 . . . . 1.1 110.593 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.52 163.61 11.76 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.555 -1.018 . . . . 0.71 110.555 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -98.12 127.65 44.18 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.478 -0.564 . . . . 1.83 109.478 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.27 155.35 18.28 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.05 -0.722 . . . . 1.16 109.05 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 39.6 p -146.02 151.56 37.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 123.232 0.332 . . . . 0.88 110.609 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.44 33.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.662 -1.607 . . . . 1.09 106.662 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 m -135.02 135.47 41.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 117.983 0.356 . . . . 1.7 110.157 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.79 134.68 63.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.844 -1.539 . . . . 1.38 106.844 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.9 ttt -108.69 134.27 51.64 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.177 -0.609 . . . . 1.67 110.063 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.54 45.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.018 -1.104 . . . . 1.26 108.018 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.51 121.04 34.64 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.025 0.44 . . . . 1.4 110.351 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -151.2 118.09 5.84 Favored 'General case' 0 N--CA 1.402 -2.847 0 N-CA-C 108.577 -0.897 . . . . 4.75 108.577 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 16.3 ptp -115.45 111.8 21.32 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.762 -0.653 . . . . 5.12 110.639 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.95 126.6 31.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.718 -1.586 . . . . 5.33 106.718 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -120.42 103.98 43.55 Favored Pre-proline 0 C--N 1.285 -2.213 0 CA-C-N 116.344 -0.389 . . . . 5.79 111.732 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -91.46 178.94 1.63 Allowed 'Trans proline' 0 N--CA 1.429 -2.318 0 C-N-CA 121.934 1.756 . . . . 5.07 110.854 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--N 1.275 -2.639 0 N-CA-C 106.478 -1.675 . . . . 10.3 106.478 173.932 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.529 0.566 . . . . 7.93 112.529 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -100.08 -25.71 14.2 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.104 -0.702 . . . . 6.17 109.104 177.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -61.11 -35.04 75.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.498 -1.228 . . . . 5.43 109.263 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 102.955 -2.98 . . . . 3.87 102.955 174.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.12 -43.49 17.72 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 114.233 1.197 . . . . 2.55 114.233 -168.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.508 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 12.6 m -86.94 99.5 8.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 122.114 0.959 . . . . 2.51 112.858 -171.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -90.32 98.97 12.09 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.242 -0.89 . . . . 2.01 108.736 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.508 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 53.9 m-85 -106.41 127.3 53.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.235 -0.654 . . . . 1.61 109.235 176.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 t -84.64 -177.87 6.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.276 . . . . 1.32 107.553 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.29 120.5 34.62 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.069 -0.652 . . . . 1.15 111.186 -174.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 1.5 m -114.82 131.17 56.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.803 -1.184 . . . . 1.67 107.803 177.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.1 t -119.65 115.01 46.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 110.14 -0.318 . . . . 1.11 110.14 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -120.38 121.96 39.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.335 -0.393 . . . . 2.66 110.033 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 27' ' ' PHE . 17.1 mt -104.16 155.25 18.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.917 -0.583 . . . . 1.08 110.786 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -131.96 151.56 51.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.235 -1.024 . . . . 1.34 108.235 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -64.48 135.8 56.42 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.278 0.986 . . . . 1.24 111.515 -174.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB1' HG12 ' A' ' 25' ' ' ILE . . . -61.1 128.91 38.73 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.826 -1.079 . . . . 1.07 111.332 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.64 136.81 24.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 116.053 -0.521 . . . . 1.21 110.427 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -87.37 129.73 34.91 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.271 -0.422 . . . . 2.52 111.155 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -176.86 -166.91 0.16 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.918 -1.512 . . . . 1.33 106.918 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -55.18 -38.44 68.34 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.815 0.672 . . . . 3.4 112.815 -178.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.53 132.72 54.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.102 -1.073 . . . . 3.18 108.102 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.452 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 64.5 m95 -81.94 119.25 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.575 -0.528 . . . . 1.0 109.575 -179.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.4 t -113.53 119.25 36.9 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.625 -0.716 . . . . 0.34 110.356 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.424 HG12 ' HB1' ' A' ' 17' ' ' ALA . 40.8 mt -104.15 96.27 9.39 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.8 -1.556 . . . . 1.07 106.8 171.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.05 141.58 14.89 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.644 2.229 . . . . 0.32 112.723 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.479 ' HB3' HD21 ' A' ' 14' ' ' LEU . 51.4 p90 -145.85 156.78 43.79 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.067 -0.515 . . . . 0.42 111.416 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -129.07 123.53 32.51 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 115.036 -0.984 . . . . 1.29 108.758 175.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' SER . 1.5 p -122.01 110.47 27.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.271 -0.877 . . . . 1.08 109.015 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 p30 -106.8 152.94 23.19 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.879 -0.601 . . . . 1.39 111.353 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.5 158.47 9.92 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 109.315 -1.514 . . . . 0.6 109.315 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 23.8 tm0? -84.79 -51.02 0.56 Allowed Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 117.74 0.77 . . . . 3.29 109.972 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 12.1 Cg_exo -73.57 134.81 21.0 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 N-CA-C 107.589 -1.735 . . . . 1.09 107.589 168.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.0 117.05 61.08 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 110.251 -0.277 . . . . 1.36 110.251 -177.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.412 ' HB3' ' HB2' ' A' ' 89' ' ' ASN . 73.1 Cg_endo -82.97 154.62 14.9 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.442 2.095 . . . . 0.56 112.727 -177.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -83.35 125.14 31.34 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.779 -1.193 . . . . 1.74 107.779 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -94.13 130.95 40.13 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 120.873 0.368 . . . . 1.14 110.044 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -135.61 135.23 40.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.421 -0.808 . . . . 4.62 109.633 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.6 m95 -96.01 132.05 41.75 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.237 0.542 . . . . 0.33 110.528 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.8 tp -119.47 126.86 52.32 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.444 -1.687 . . . . 1.57 106.444 176.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -115.89 107.5 15.09 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.277 -1.008 . . . . 1.04 108.277 -177.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 62.24 19.91 11.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.616 0.766 . . . . 2.17 112.727 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.1 -8.96 50.09 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.263 -0.97 . . . . 0.61 112.213 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 m -105.97 137.88 43.12 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.384 -0.599 . . . . 1.84 109.384 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.3 127.87 28.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.178 0.513 . . . . 1.31 110.345 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.56 106.69 18.22 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.374 -0.973 . . . . 1.33 108.374 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -87.68 121.35 30.01 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.306 -1.368 . . . . 2.69 107.306 178.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.77 142.13 24.63 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.662 1.226 . . . . 1.74 112.386 -177.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 p -128.11 -172.15 2.62 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.67 -0.695 . . . . 2.07 109.982 -177.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 m -76.07 -12.81 60.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.667 0.27 . . . . 1.9 111.286 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.97 -40.84 7.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.918 0.389 . . . . 1.89 110.549 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.3 mt -115.89 106.41 20.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.046 -1.465 . . . . 1.18 107.046 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -147.46 152.57 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.179 0.514 . . . . 3.62 112.057 -175.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 m -96.07 118.7 33.18 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.264 -0.88 . . . . 1.15 111.045 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.13 143.1 33.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.327 -0.99 . . . . 2.04 108.327 173.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.49 135.8 51.55 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.2 -0.296 . . . . 0.87 110.2 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.47 165.44 13.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.747 -1.205 . . . . 1.7 107.747 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -64.23 112.64 8.05 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 113.389 0.885 . . . . 3.36 113.389 -170.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.4 132.26 7.94 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.601 2.201 . . . . 1.63 110.188 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 62' ' ' ASN . . . -90.42 146.24 24.31 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.819 -0.752 . . . . 1.88 109.492 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.37 11.69 2.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.452 0.644 . . . . 2.29 110.809 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 60' ' ' ALA . 17.5 m120 -105.8 2.24 27.63 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.466 1.106 . . . . 3.93 109.34 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.95 157.41 44.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.826 -1.176 . . . . 1.89 107.826 -178.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 p -111.4 36.24 3.3 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.213 1.006 . . . . 1.86 109.259 175.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.66 128.69 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.445 -1.252 . . . . 1.19 109.095 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.426 ' HB3' HG12 ' A' ' 29' ' ' VAL . 77.3 ttt180 -99.71 133.94 43.32 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.0 -1.482 . . . . 2.36 107.0 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -126.62 132.58 51.22 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.982 -0.377 . . . . 1.49 109.982 -174.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.81 27.84 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 119.953 -1.118 . . . . 0.36 111.674 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.579 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 14.2 t -149.78 134.67 17.83 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.569 0.223 . . . . 0.36 110.773 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 38.3 tp -83.24 108.46 16.49 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.22 -1.77 . . . . 1.06 106.22 173.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.579 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 35.7 mtp85 -109.61 102.73 11.54 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.864 -0.607 . . . . 3.22 111.905 -173.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.4 109.98 17.77 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.746 -0.661 . . . . 1.78 109.986 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -69.61 -29.01 66.42 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.585 -1.189 . . . . 2.42 110.219 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -125.62 108.72 25.98 Favored Pre-proline 0 N--CA 1.425 -1.712 0 N-CA-C 108.444 -0.947 . . . . 3.22 108.444 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.65 129.76 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.253 1.302 . . . . 1.62 109.36 176.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -125.99 141.55 51.91 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.329 -0.619 . . . . 1.75 109.329 -175.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -77.83 -18.9 55.79 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 116.163 -0.471 . . . . 2.61 110.715 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.78 -23.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.41 -0.359 . . . . 1.77 111.19 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.568 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 55.5 m-80 -97.84 26.75 4.89 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.852 1.427 . . . . 2.19 114.852 -176.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -83.77 122.73 29.05 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.4 -1.333 . . . . 2.08 107.4 174.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.27 -160.19 32.89 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.622 -1.275 . . . . 0.59 113.215 -177.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.55 111.69 23.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.008 0.523 . . . . 2.28 110.929 -175.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 34.5 m-85 -94.74 115.37 27.43 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.948 -0.569 . . . . 1.03 109.896 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 83.5 m -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 109.304 -0.628 . . . . 1.13 109.304 177.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' SER . 57.3 tp -96.83 121.13 38.35 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.678 -0.86 . . . . 1.07 108.678 179.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.94 134.38 48.15 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.806 -0.813 . . . . 1.15 108.806 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.98 119.52 34.53 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.313 -1.366 . . . . 1.11 107.313 170.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.54 112.7 24.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.614 -0.884 . . . . 1.34 108.614 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 21.0 t-20 -132.94 146.46 61.38 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.761 -1.2 . . . . 1.61 107.761 -175.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.97 -16.43 38.8 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.433 2.756 . . . . 1.33 113.419 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 t -80.79 -38.69 28.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.872 0.368 . . . . 1.1 110.267 175.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 169.75 170.13 33.84 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.267 -1.533 . . . . 0.71 109.267 -177.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -110.27 121.21 44.74 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.034 0.445 . . . . 1.83 110.245 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.89 147.54 26.78 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.849 -0.614 . . . . 1.16 109.844 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 46.9 p -140.46 144.82 36.28 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.216 0.323 . . . . 0.88 110.344 177.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.3 46.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.484 . . . . 1.09 106.992 175.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -129.87 130.36 45.11 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 118.286 0.493 . . . . 1.7 111.073 -174.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 128.1 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.369 -1.345 . . . . 1.38 107.369 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.77 114.98 26.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.985 -1.116 . . . . 1.67 107.985 -178.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.43 113.84 26.23 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.448 0.642 . . . . 1.26 111.028 -175.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.01 102.78 14.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.281 -0.872 . . . . 1.4 109.154 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -84.97 -76.88 0.3 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.409 -0.814 . . . . 4.75 110.841 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.9 mtt -138.83 153.77 48.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.274 -1.38 . . . . 5.12 107.274 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -93.46 162.09 14.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.744 -0.836 . . . . 5.33 108.744 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.22 115.45 62.03 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.699 0.285 . . . . 5.79 110.806 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.08 179.61 3.6 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.233 1.955 . . . . 5.07 110.897 175.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 C--N 1.28 -2.448 0 CA-C-O 118.511 -0.757 . . . . 10.3 109.104 179.814 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.239 0.519 0 N-CA-C 108.539 -0.911 . . . . 7.93 108.539 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.1 t70 57.79 57.52 4.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.892 1.277 . . . . 6.17 109.601 -173.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 6' ' ' VAL . 6.8 m-20 -131.16 23.73 4.87 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 105.978 -1.86 . . . . 5.43 105.978 178.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.91 -12.59 60.39 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.103 -0.953 . . . . 3.87 112.717 -168.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.14 1.63 55.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.361 -0.381 . . . . 2.55 111.469 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 3' ' ' ASP . 31.0 m -68.18 121.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-O 122.235 1.017 . . . . 2.51 110.247 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 p -107.89 98.19 7.8 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-O 122.143 0.973 . . . . 2.01 109.889 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -83.38 129.83 35.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.892 -1.151 . . . . 1.61 107.892 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 27.7 m -84.49 167.03 16.76 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.983 -1.118 . . . . 1.32 107.983 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.66 129.83 41.38 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.565 0.698 . . . . 1.15 112.413 -170.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 t -124.32 136.08 53.83 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.043 -1.836 . . . . 1.67 106.043 175.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -115.31 126.99 73.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.227 0.537 . . . . 1.11 111.155 -175.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -121.14 120.47 35.36 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.809 -1.087 . . . . 2.66 109.062 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.2 mt -111.58 145.55 38.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.842 -0.799 . . . . 1.08 108.842 176.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -132.19 154.21 49.79 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.913 0.387 . . . . 1.34 110.958 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 m -58.99 134.49 57.03 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.708 -1.133 . . . . 1.24 111.684 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.412 ' HB1' HG12 ' A' ' 25' ' ' ILE . . . -60.6 145.53 48.59 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.286 1.034 . . . . 1.07 111.929 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -92.27 138.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.201 -0.454 . . . . 1.21 109.996 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -82.61 108.44 16.0 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.388 0.613 . . . . 2.52 112.618 -176.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -157.97 -178.78 7.56 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.212 -1.773 . . . . 1.33 106.212 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -63.25 -39.45 94.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 119.375 0.989 . . . . 3.4 112.867 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.32 122.42 44.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.485 -1.302 . . . . 3.18 107.485 176.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.24 126.76 32.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.112 0.482 . . . . 1.0 111.593 -173.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -120.35 117.45 27.79 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.34 109.989 -177.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.412 HG12 ' HB1' ' A' ' 17' ' ' ALA . 75.7 mt -99.41 105.04 30.7 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.682 -1.229 . . . . 1.07 107.682 173.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.88 136.74 19.03 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 122.261 1.974 . . . . 0.32 111.687 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -137.56 159.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.187 0.518 . . . . 0.42 110.018 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -141.97 119.55 11.72 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.636 -0.711 . . . . 1.29 109.77 176.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.93 125.95 67.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.044 -1.465 . . . . 1.08 107.044 176.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.4 p-10 -115.36 155.71 26.86 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.246 -0.982 . . . . 1.39 110.592 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 140.77 3.06 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.506 -1.437 . . . . 0.6 109.506 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -75.77 -54.6 2.17 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 108.169 -1.049 . . . . 3.29 108.169 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -65.76 122.8 10.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 N-CA-C 108.644 -1.329 . . . . 1.09 108.644 170.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.96 121.22 80.81 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 116.383 -0.371 . . . . 1.36 111.693 -175.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.76 155.54 11.77 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.898 1.732 . . . . 0.56 111.988 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -82.66 109.98 17.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.903 -0.777 . . . . 1.74 108.903 176.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.97 119.2 25.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.108 0.48 . . . . 1.14 110.472 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -126.65 126.12 43.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.602 -0.726 . . . . 4.62 110.324 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -91.81 119.67 31.83 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.181 -0.918 . . . . 0.33 109.662 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -109.92 127.71 54.91 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 1.57 105.7 173.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -118.81 106.09 12.18 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 110.298 -0.26 . . . . 1.04 110.298 -174.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 59.07 30.95 20.88 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.544 1.164 . . . . 2.17 110.603 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.08 82.61 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.521 -0.763 . . . . 0.61 113.092 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 p -104.78 140.97 37.31 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.338 -0.507 . . . . 1.84 109.872 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.61 114.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 1.31 111.031 -176.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.9 tp -90.21 112.22 23.67 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.337 -0.986 . . . . 1.33 108.337 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -93.49 136.98 33.24 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.682 -0.858 . . . . 2.69 108.682 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.14 100.46 0.61 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.368 0.667 . . . . 1.74 109.924 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.8 p -93.49 -167.1 1.64 Allowed 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.009 0.524 . . . . 2.07 111.397 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -77.09 -20.93 55.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.181 0.515 . . . . 1.9 110.563 175.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 99.6 m-85 -95.8 -36.51 11.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.03 0.443 . . . . 1.89 110.641 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 mt -112.41 105.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.213 -1.403 . . . . 1.18 107.213 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -134.61 155.42 50.49 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.098 0.475 . . . . 3.62 111.538 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -107.29 114.48 28.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.587 -0.523 . . . . 1.15 109.587 -178.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.11 132.4 34.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.358 -0.608 . . . . 2.04 109.358 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -122.13 149.49 43.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.779 -0.452 . . . . 0.87 109.779 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.01 163.43 20.47 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.804 -1.184 . . . . 1.7 107.804 173.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.54 116.63 64.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 123.58 0.55 . . . . 3.36 111.191 -177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.39 141.28 46.27 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.626 2.217 . . . . 1.63 110.35 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.76 145.12 55.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.78 -0.822 . . . . 1.88 108.78 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.17 -10.22 39.29 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.228 0.825 . . . . 2.29 113.228 -174.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -92.58 1.34 57.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.691 0.282 . . . . 3.93 110.875 178.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.23 170.69 15.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.356 -0.609 . . . . 1.89 109.356 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.7 p -132.45 26.8 4.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.401 0.62 . . . . 1.86 111.113 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.55 127.85 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.226 -0.657 . . . . 1.19 109.226 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -88.67 115.16 26.0 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.352 -1.351 . . . . 2.36 107.352 177.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -99.67 136.86 38.96 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.42 -0.955 . . . . 1.49 108.42 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.11 -178.26 43.91 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 119.941 -1.123 . . . . 0.36 112.22 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -148.99 136.6 20.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.69 0.396 . . . . 0.36 110.774 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.8 tp -85.6 103.7 14.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 105.035 -2.209 . . . . 1.06 105.035 171.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -111.44 127.4 55.67 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 119.955 -0.698 . . . . 3.22 110.39 -173.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.9 mp -108.85 109.78 20.98 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.937 -1.505 . . . . 1.78 106.937 178.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.52 -43.39 90.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.604 -0.725 . . . . 2.42 109.267 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -135.59 112.02 10.7 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 107.419 -1.326 . . . . 3.22 107.419 172.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.48 137.41 20.65 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.599 1.533 . . . . 1.62 111.654 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.8 p -83.48 148.52 27.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.553 -1.647 . . . . 1.75 106.553 174.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -58.39 -20.35 43.49 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.564 0.95 . . . . 2.61 113.564 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.69 -10.53 13.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 O-C-N 123.202 0.314 . . . . 1.77 111.433 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.63 26.22 0.24 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.041 1.126 . . . . 2.19 114.041 -174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -106.85 87.76 2.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.676 -1.231 . . . . 2.08 107.676 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.72 -161.72 24.34 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.634 -0.793 . . . . 0.59 112.053 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 52.4 t-20 -97.16 125.2 41.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.764 0.316 . . . . 2.28 110.557 -177.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -98.46 106.55 18.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.317 -0.994 . . . . 1.03 108.317 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -97.85 114.9 27.08 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.486 -0.931 . . . . 1.13 108.486 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.6 tp -95.43 116.86 29.38 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.273 -0.64 . . . . 1.07 109.273 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.37 127.75 52.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.27 -1.011 . . . . 1.15 108.27 177.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.46 120.1 37.08 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.994 -1.113 . . . . 1.11 107.994 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.24 112.65 25.42 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.967 -0.753 . . . . 1.34 108.967 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 26.8 t-20 -120.5 147.06 44.53 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 106.48 -1.674 . . . . 1.61 106.48 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.07 -19.64 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.894 2.396 . . . . 1.33 113.623 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.3 -29.2 23.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.818 0.342 . . . . 1.1 110.239 178.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 170.64 179.37 41.94 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 110.916 -0.874 . . . . 0.71 110.916 -179.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -112.55 139.99 47.68 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 109.448 -0.575 . . . . 1.83 109.448 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -120.53 153.05 37.24 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.9 -0.778 . . . . 1.16 108.9 178.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 48.5 p -150.35 155.39 39.53 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.377 0.423 . . . . 0.88 110.194 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.36 165.53 34.71 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.476 -1.676 . . . . 1.09 106.476 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 35.7 m -143.38 125.85 15.78 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 117.972 0.351 . . . . 1.7 110.625 -177.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.75 122.93 65.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.611 -1.255 . . . . 1.38 107.611 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 22.3 ttt -107.41 111.61 24.01 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.046 0.451 . . . . 1.67 110.08 -176.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.11 154.22 36.44 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.013 -0.539 . . . . 1.26 111.6 -174.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.76 123.67 28.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.994 -1.484 . . . . 1.4 106.994 176.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -101.01 -77.05 0.55 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.291 -0.413 . . . . 4.75 111.959 -176.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -127.34 137.61 52.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.212 -0.662 . . . . 5.12 109.212 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.05 127.71 30.31 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.943 1.297 . . . . 5.33 112.128 -177.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -55.29 109.15 1.43 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.802 1.241 . . . . 5.79 113.108 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.625 ' O ' ' HB2' ' A' ' 107' ' ' PHE . 6.5 Cg_exo -84.34 115.72 1.96 Allowed 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.201 1.934 . . . . 5.07 111.346 174.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 26.8 t80 . . . . . 0 CA--C 1.505 -0.764 0 O-C-N 124.82 1.325 . . . . 10.3 107.776 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 112.95 0.722 . . . . 7.93 112.95 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -104.34 -86.08 0.46 Allowed 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.517 -0.873 . . . . 6.17 110.997 -174.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.14 -15.39 27.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.648 1.213 . . . . 5.43 108.456 178.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.89 138.33 32.15 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.45 -1.705 . . . . 3.87 109.536 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.47 -50.41 2.22 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.276 -0.639 . . . . 2.55 109.276 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.61 101.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.064 -0.971 . . . . 2.51 110.656 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -93.63 98.52 11.2 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.928 0.87 . . . . 2.01 110.136 -174.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -104.72 133.8 48.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.695 -1.139 . . . . 1.61 108.075 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 m -84.86 -165.6 1.24 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.942 -0.762 . . . . 1.32 108.942 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' ALA . . . -94.12 124.62 38.25 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.251 -0.98 . . . . 1.15 111.06 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 t -128.12 129.89 47.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.444 -1.317 . . . . 1.67 107.444 175.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.97 132.56 69.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.673 -0.239 . . . . 1.11 110.664 -174.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -130.38 122.07 27.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.376 0.608 . . . . 2.66 109.711 173.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 48.8 mt -104.68 148.83 26.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.651 -0.704 . . . . 1.08 110.212 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -131.76 150.57 52.11 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.161 -0.681 . . . . 1.34 109.161 -176.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.5 m -49.39 135.23 17.87 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.605 1.562 . . . . 1.24 111.899 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 137.87 50.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.918 -1.037 . . . . 1.07 108.776 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.02 131.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.439 0.638 . . . . 1.21 110.064 -175.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -74.31 91.81 2.22 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.57 -1.196 . . . . 2.52 110.533 -177.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.7 mtm -130.98 -171.61 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.816 -0.439 . . . . 1.33 109.816 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.06 -25.38 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.4 109.691 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -119.84 143.82 47.69 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.456 -0.793 . . . . 3.18 109.83 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.78 124.11 29.96 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.574 0.702 . . . . 1.0 112.044 -177.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.7 121.59 19.88 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.556 -1.202 . . . . 0.34 109.131 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -107.16 100.96 35.76 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 107.738 -1.208 . . . . 1.07 107.738 174.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.14 129.07 11.88 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.545 2.163 . . . . 0.32 112.575 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -126.29 153.38 44.89 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.058 -0.519 . . . . 0.42 110.584 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.1 m -134.93 127.09 29.94 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.94 -0.763 . . . . 1.29 108.94 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 66' ' ' ARG . 2.1 p -127.29 124.99 65.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.39 -0.967 . . . . 1.08 108.39 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -115.49 149.89 37.39 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.83 -0.348 . . . . 1.39 111.821 -176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 -171.83 33.6 Favored Glycine 0 N--CA 1.428 -1.896 0 O-C-N 124.622 1.201 . . . . 0.6 110.851 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -119.0 -57.29 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-O 118.583 -0.722 . . . . 3.29 112.674 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.97 120.53 8.37 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 108.553 -1.364 . . . . 1.09 108.553 171.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 116.23 16.19 Favored Pre-proline 0 N--CA 1.448 -0.549 0 O-C-N 123.871 0.732 . . . . 1.36 111.53 -175.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -85.62 152.9 10.28 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 121.848 1.698 . . . . 0.56 111.842 -179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 p -82.8 106.07 14.33 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.881 -0.785 . . . . 1.74 108.881 174.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.69 119.75 23.7 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 109.405 -0.591 . . . . 1.14 109.405 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -137.82 131.52 31.26 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.696 -0.683 . . . . 4.62 110.679 -177.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 85.3 m95 -94.81 129.01 41.95 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.569 -0.741 . . . . 0.33 109.713 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.97 129.06 54.96 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 106.639 -1.615 . . . . 1.57 106.639 176.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -112.72 98.05 6.96 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.007 0.432 . . . . 1.04 110.28 -178.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.0 47.68 24.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.554 1.141 . . . . 2.17 111.294 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -22.22 36.59 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.367 -0.833 . . . . 0.61 113.57 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -96.37 143.57 27.3 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 1.84 109.332 -176.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.98 118.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.548 -0.751 . . . . 1.31 109.994 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 tp -82.45 120.67 25.76 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.491 -1.299 . . . . 1.33 107.491 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -107.77 140.09 41.36 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.298 -1.001 . . . . 2.69 108.298 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.89 92.93 0.52 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.662 0.744 . . . . 1.74 109.714 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -88.91 178.97 6.28 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.01 -0.996 . . . . 2.07 108.918 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 t -48.6 -36.91 16.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.171 0.988 . . . . 1.9 112.992 -176.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -110.72 5.59 20.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.113 0.783 . . . . 1.89 113.113 -173.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.5 mt -124.15 106.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.472 -1.677 . . . . 1.18 106.472 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -126.72 137.84 53.31 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.414 -0.357 . . . . 3.62 110.439 -171.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 m -92.69 109.39 20.81 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.265 -1.383 . . . . 1.15 107.265 176.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.74 136.9 42.56 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.384 -0.598 . . . . 2.04 109.384 -174.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.01 152.49 36.31 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.9 0.381 . . . . 0.87 110.013 -177.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.51 165.2 11.99 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.402 -1.703 . . . . 1.7 106.402 175.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.38 109.73 11.39 Favored Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 123.169 0.293 . . . . 3.36 110.264 -178.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.72 140.09 20.58 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.221 1.948 . . . . 1.63 110.651 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 31.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.236 -1.024 . . . . 1.88 108.236 177.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.73 -13.21 62.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.458 0.646 . . . . 2.29 110.877 -178.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.4 -26.39 65.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.855 -1.066 . . . . 3.93 110.551 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.08 143.42 33.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.114 0.483 . . . . 1.89 110.071 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.7 p -98.32 18.05 17.32 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.762 -1.199 . . . . 1.86 107.762 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -114.17 129.08 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 114.383 -1.28 . . . . 1.19 109.211 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HB3' HG12 ' A' ' 29' ' ' VAL . 15.5 ttm180 -95.11 132.46 40.01 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.76 -1.57 . . . . 2.36 106.76 177.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -119.6 141.83 48.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.102 -0.333 . . . . 1.49 110.102 -176.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.0 -173.94 34.18 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.409 -1.076 . . . . 0.36 110.409 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 26.8 t -148.27 135.45 20.32 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.064 0.459 . . . . 0.36 111.107 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.3 tp -83.58 114.35 21.46 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 1.06 106.52 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 96.7 mtt180 -114.92 125.05 53.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.506 0.67 . . . . 3.22 111.584 -175.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -111.62 109.84 19.94 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.765 -1.107 . . . . 1.78 108.782 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.46 -35.42 80.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.046 -0.979 . . . . 2.42 111.107 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -128.18 119.76 20.98 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.963 -0.755 . . . . 3.22 108.963 178.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.63 136.95 29.25 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 121.441 1.427 . . . . 1.62 109.068 175.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -128.99 161.04 30.84 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.33 -0.989 . . . . 1.75 108.33 -178.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.401 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 48.7 p-80 -68.7 -5.03 17.99 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.472 0.916 . . . . 2.61 113.472 -174.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.62 -9.02 10.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-O 121.069 0.461 . . . . 1.77 110.301 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.807 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.4 m120 -83.4 27.92 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.292 0.637 . . . . 2.19 112.355 -176.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 104' ' ' ASP . 74.4 m-20 -124.67 103.06 7.91 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.355 -0.98 . . . . 2.08 108.355 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -159.12 30.61 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.684 -0.967 . . . . 0.59 110.684 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.447 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 23.4 t-20 -103.41 122.71 45.42 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 120.736 0.303 . . . . 2.28 110.379 -177.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.807 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 51.3 m-85 -100.49 115.2 29.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.439 -0.578 . . . . 1.03 109.439 178.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -103.31 127.59 50.6 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.496 -0.32 . . . . 1.13 110.183 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.405 ' CB ' HD12 ' A' ' 14' ' ' LEU . 59.9 tp -100.89 120.41 40.11 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.951 -0.759 . . . . 1.07 108.951 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.96 139.09 38.97 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.089 -1.078 . . . . 1.15 108.089 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.07 120.63 19.32 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.164 -1.421 . . . . 1.11 107.164 173.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.53 133.56 53.28 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.754 -0.378 . . . . 1.34 110.996 -178.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -142.76 171.29 7.29 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-O 117.23 -1.367 . . . . 1.61 107.541 175.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.24 -25.16 29.16 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.168 1.912 . . . . 1.33 114.753 -175.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.16 -23.23 38.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.994 0.368 . . . . 1.1 111.994 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.58 -175.63 35.62 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.518 -1.325 . . . . 0.71 113.092 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -124.43 131.19 53.5 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.819 -0.437 . . . . 1.83 109.819 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -106.62 148.46 28.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.454 -0.943 . . . . 1.16 108.454 176.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.4 p -142.57 122.83 13.84 Favored 'General case' 0 N--CA 1.425 -1.705 0 O-C-N 123.401 0.438 . . . . 0.88 110.442 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.81 155.5 43.99 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.799 -1.186 . . . . 1.09 107.799 177.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 50.9 m -130.26 144.22 51.24 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.84 0.352 . . . . 1.7 110.845 -178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -130.24 126.53 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.853 -1.166 . . . . 1.38 107.853 176.908 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 tpt -87.06 114.1 23.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.61 -0.885 . . . . 1.67 108.61 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.11 132.13 53.62 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.87 0.367 . . . . 1.26 110.779 -175.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.23 101.44 4.14 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.154 -1.054 . . . . 1.4 108.154 177.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -81.27 -66.31 0.9 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.991 -0.55 . . . . 4.75 111.865 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -148.7 126.69 11.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.937 -0.764 . . . . 5.12 108.937 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.422 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 19.7 t0 -71.05 163.47 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.205 0.602 . . . . 5.33 111.555 -178.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 77' ' ' HIS . 72.8 m-20 -51.26 126.86 28.75 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.626 1.17 . . . . 5.79 112.522 -174.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -90.07 179.41 2.02 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.803 2.335 . . . . 5.07 110.369 172.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 . . . . . 0 C--N 1.289 -2.063 0 N-CA-C 107.8 -1.185 . . . . 10.3 107.8 174.131 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 CA--C 1.486 -1.484 0 CA-C-O 120.446 0.165 . . . . 7.93 111.065 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.34 69.03 9.92 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 105.921 -1.881 . . . . 6.17 105.921 175.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.19 53.01 1.66 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.899 1.333 . . . . 5.43 113.399 -173.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -135.5 38.35 2.89 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.424 -2.065 . . . . 3.87 105.424 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -69.68 -51.29 35.89 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 114.67 -1.15 . . . . 2.55 109.761 -177.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 m -79.3 99.24 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 CA-C-O 122.464 1.126 . . . . 2.51 110.254 177.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -110.41 98.82 7.95 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.085 -1.08 . . . . 2.01 108.085 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.503 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 97.2 m-85 -89.94 134.47 34.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.022 -1.473 . . . . 1.61 107.022 176.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.0 m -83.26 177.0 8.72 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.879 -1.156 . . . . 1.32 107.879 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 94' ' ' ALA . . . -93.25 124.22 37.08 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 119.37 -0.932 . . . . 1.15 111.17 -170.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -123.86 133.08 53.84 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 106.905 -1.517 . . . . 1.67 106.905 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -115.28 118.35 58.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.735 0.303 . . . . 1.11 110.266 -175.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -116.74 116.24 27.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.768 -0.827 . . . . 2.66 108.768 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.3 mt -96.51 156.99 16.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.651 -0.704 . . . . 1.08 110.72 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -129.93 144.65 51.43 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.876 -1.157 . . . . 1.34 107.876 -174.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -57.55 133.49 55.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.953 1.408 . . . . 1.24 110.652 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.28 141.35 52.4 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.074 -0.966 . . . . 1.07 110.3 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -92.65 127.59 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 113.26 0.837 . . . . 1.21 113.26 -177.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -83.97 88.33 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.891 -1.049 . . . . 2.52 108.796 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.03 -169.67 3.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.545 -1.28 . . . . 1.33 107.545 175.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -48.57 -38.18 19.9 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.103 1.149 . . . . 3.4 114.103 -171.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -133.25 139.57 47.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.417 -0.957 . . . . 3.18 108.417 175.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB2' HD13 ' A' ' 72' ' ' LEU . 73.5 m95 -81.34 127.1 32.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.294 0.569 . . . . 1.0 110.442 -175.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -120.81 121.58 38.46 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 114.563 -1.199 . . . . 0.34 108.144 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 52.3 mt -108.27 96.05 17.46 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.139 -1.43 . . . . 1.07 107.139 175.388 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.69 128.52 13.49 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.333 2.022 . . . . 0.32 111.8 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -120.05 146.68 45.67 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 116.03 -0.532 . . . . 0.42 109.853 178.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -132.59 106.81 8.04 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 108.689 -0.856 . . . . 1.29 108.689 176.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -110.56 111.25 35.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.169 -0.923 . . . . 1.08 108.766 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 p30 -101.3 137.53 39.53 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.396 -0.82 . . . . 1.39 110.148 -178.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.05 146.64 4.61 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 108.699 -1.761 . . . . 0.6 108.699 -176.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.45 -59.79 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 CA-C-O 117.947 -1.025 . . . . 3.29 110.199 -176.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 7.8 Cg_endo -54.81 119.43 6.46 Favored 'Trans proline' 0 C--N 1.393 2.88 0 N-CA-C 107.72 -1.685 . . . . 1.09 107.72 171.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.69 114.68 17.01 Favored Pre-proline 0 C--N 1.291 -1.936 0 CA-C-N 114.567 -1.197 . . . . 1.36 112.746 -171.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.67 150.05 11.35 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 122.134 1.89 . . . . 0.56 112.454 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -84.57 127.04 33.85 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.208 -1.405 . . . . 1.74 107.208 174.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.91 122.69 43.23 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.856 0.36 . . . . 1.14 111.714 -176.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -130.22 128.28 41.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.607 -0.724 . . . . 4.62 110.52 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.452 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 94.1 m95 -90.82 141.2 29.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.924 -0.769 . . . . 0.33 108.924 175.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.32 127.4 41.03 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.206 -1.405 . . . . 1.57 107.206 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -103.13 98.13 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.024 -0.732 . . . . 1.04 109.024 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.67 29.63 7.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.015 0.926 . . . . 2.17 113.311 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.56 -20.57 24.92 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.828 -0.701 . . . . 0.61 113.263 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 m -89.84 137.96 31.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.16 0.48 . . . . 1.84 110.735 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.41 108.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.994 -1.003 . . . . 1.31 111.16 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.8 tp -87.62 114.92 24.68 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.053 -1.091 . . . . 1.33 108.053 178.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.01 140.59 40.95 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.476 -1.305 . . . . 2.69 107.476 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.11 107.87 2.06 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.873 0.869 . . . . 1.74 110.998 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -99.37 -166.13 1.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.191 -0.459 . . . . 2.07 110.122 -178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.5 t -82.02 -13.21 57.71 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.1 -0.704 . . . . 1.9 109.1 176.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -102.03 -38.89 7.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.809 -0.632 . . . . 1.89 110.565 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.8 108.21 24.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.293 -1.373 . . . . 1.18 107.293 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -135.06 137.7 43.15 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.4 -0.92 . . . . 3.62 112.252 -174.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -81.44 111.04 17.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.665 -0.698 . . . . 1.15 110.163 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.28 111.27 23.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.211 0.529 . . . . 2.04 111.051 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -84.09 141.88 30.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.928 -0.578 . . . . 0.87 109.808 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -119.1 160.66 21.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.238 -1.023 . . . . 1.7 108.238 -179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -77.33 119.24 76.68 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 113.368 0.877 . . . . 3.36 113.368 -176.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.1 170.06 8.51 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 123.482 2.788 . . . . 1.63 109.241 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.68 143.02 34.99 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.286 -1.376 . . . . 1.88 107.286 177.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.28 14.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.716 1.747 . . . . 2.29 115.716 -170.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -93.73 -9.98 35.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.61 -0.836 . . . . 3.93 110.831 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.16 126.1 30.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.097 0.475 . . . . 1.89 110.525 178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -95.64 30.75 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.927 1.346 . . . . 1.86 108.372 171.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 33.4 t -116.11 135.48 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.771 -1.558 . . . . 1.19 107.363 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' A' ' 29' ' ' VAL . 31.6 ttm180 -99.44 122.16 42.15 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.361 -1.348 . . . . 2.36 107.361 177.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -108.55 141.13 40.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.485 -0.931 . . . . 1.49 108.485 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.81 -177.34 39.62 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.314 -0.946 . . . . 0.36 110.977 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.2 t -145.14 132.68 20.84 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.556 0.209 . . . . 0.36 110.575 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.9 tp -82.62 111.63 18.77 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.965 -2.235 . . . . 1.06 104.965 170.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -107.23 119.09 38.45 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.96 -0.564 . . . . 3.22 110.195 -172.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 23' ' ' TRP . 77.8 mt -81.05 108.01 14.35 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.695 -1.595 . . . . 1.78 106.695 173.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -69.99 -45.15 67.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.97 -1.014 . . . . 2.42 108.602 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -129.88 101.2 18.47 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.676 -1.602 . . . . 3.22 106.676 172.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -69.03 130.77 20.86 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.37 2.047 . . . . 1.62 111.297 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -128.65 168.85 15.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.361 -0.836 . . . . 1.75 108.983 -177.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.254 14.8 p-80 -68.47 -3.2 10.6 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 113.894 1.072 . . . . 2.61 113.894 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.88 -10.38 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.482 0.658 . . . . 1.77 109.937 174.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.756 HD21 ' HH ' ' A' ' 83' ' ' TYR . 15.7 m120 -85.69 28.09 0.8 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.261 1.025 . . . . 2.19 113.237 -175.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 35.8 p-10 -126.2 99.1 5.74 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.977 0.894 . . . . 2.08 111.735 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . 170.76 -158.18 29.68 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.298 -0.864 . . . . 0.59 111.269 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -97.33 105.69 17.89 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 122.654 0.382 . . . . 2.28 110.343 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.756 ' HH ' HD21 ' A' ' 79' ' ' ASN . 59.0 m-85 -93.0 106.32 18.29 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.244 -0.65 . . . . 1.03 109.244 175.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 38.3 m -92.87 131.99 37.41 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 1.13 109.855 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.2 tp -104.2 117.37 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.148 -0.686 . . . . 1.07 109.148 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.14 129.67 51.87 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.315 -0.994 . . . . 1.15 108.315 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.21 121.03 32.95 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.256 -1.016 . . . . 1.11 108.256 176.2 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.33 126.05 46.15 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.691 -0.403 . . . . 1.34 111.496 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -134.37 169.85 12.81 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 117.448 -1.263 . . . . 1.61 107.695 176.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.9 Cg_endo -43.25 -32.24 3.1 Favored 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 123.539 2.826 . . . . 1.33 115.248 178.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -77.08 -34.91 56.94 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 122.028 -0.42 . . . . 1.1 111.682 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.04 -166.59 38.79 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 120.405 -0.902 . . . . 0.71 112.044 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 27.6 tt0 -124.77 132.97 53.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.993 0.425 . . . . 1.83 110.338 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 10' ' ' ALA . . . -108.25 152.26 24.84 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.147 -0.686 . . . . 1.16 109.147 178.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 p -141.54 148.88 40.07 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 123.482 0.489 . . . . 0.88 111.144 -179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.78 144.22 14.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.318 -1.364 . . . . 1.09 107.318 174.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 49.1 m -121.23 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.992 0.425 . . . . 1.7 110.684 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.11 126.27 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.725 -1.213 . . . . 1.38 107.725 178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.4 ttm -92.59 103.86 16.21 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.335 -0.546 . . . . 1.67 110.649 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -95.4 135.0 37.58 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.478 -1.675 . . . . 1.26 106.478 174.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.82 101.52 5.3 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.248 -0.649 . . . . 1.4 109.248 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -67.97 -71.26 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.387 -0.824 . . . . 4.75 111.085 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.8 mtt -149.42 148.77 29.86 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.443 -1.317 . . . . 5.12 107.443 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.79 127.35 32.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.194 0.934 . . . . 5.33 109.173 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -80.03 117.19 66.25 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 123.891 0.744 . . . . 5.79 112.938 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 107' ' ' PHE . 24.0 Cg_exo -72.55 116.88 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.557 2.171 . . . . 5.07 111.149 174.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 65.2 t80 . . . . . 0 N--CA 1.427 -1.612 0 CA-C-O 118.34 -0.838 . . . . 10.3 109.242 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 120.187 0.041 . . . . 7.93 111.058 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -99.95 131.42 45.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.133 -1.062 . . . . 6.17 108.133 176.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -113.28 40.85 2.25 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.585 0.707 . . . . 5.43 111.313 -175.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -106.01 -27.78 10.95 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.908 -0.495 . . . . 3.87 111.653 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.47 -38.94 65.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.106 -0.701 . . . . 2.55 109.106 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.43 105.54 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.939 0.876 . . . . 2.51 110.708 174.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 t -108.51 99.45 8.83 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.334 -0.848 . . . . 2.01 109.136 -178.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 54.9 m-85 -102.33 122.45 44.28 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.387 -1.338 . . . . 1.61 107.387 174.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.25 -179.19 7.15 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.774 -0.648 . . . . 1.32 109.768 -176.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.43 128.56 39.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 119.51 -0.876 . . . . 1.15 112.373 -168.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -121.57 128.22 51.76 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.815 -1.55 . . . . 1.67 106.815 175.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.0 t -115.25 120.02 63.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.819 0.342 . . . . 1.11 110.466 -175.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -119.47 136.03 54.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.816 -0.629 . . . . 2.66 109.764 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 mt -123.06 149.63 44.17 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.386 0.613 . . . . 1.08 110.897 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -131.07 145.48 52.02 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.975 -1.12 . . . . 1.34 107.975 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 m -64.79 139.22 58.74 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.988 -1.006 . . . . 1.24 110.715 -175.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.96 139.31 28.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.638 -1.165 . . . . 1.07 111.951 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -92.07 142.74 12.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.788 -0.642 . . . . 1.21 109.914 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.41 111.61 20.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.57 0.582 . . . . 2.52 112.57 -173.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.1 ptt? -162.39 -173.24 3.5 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.48 -0.933 . . . . 1.33 108.48 175.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 118.634 0.652 . . . . 3.4 112.367 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.409 ' O ' ' HG3' ' A' ' 20' ' ' MET . 81.9 m-70 -110.8 124.82 52.76 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.645 -1.983 . . . . 3.18 105.645 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -82.6 133.48 35.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.295 0.569 . . . . 1.0 111.568 -173.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.7 t -126.56 120.49 29.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.021 -0.99 . . . . 0.34 110.053 -175.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.5 mt -101.84 101.98 20.98 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.931 -1.137 . . . . 1.07 107.931 174.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.05 131.87 16.04 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.524 2.15 . . . . 0.32 112.504 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.53 160.22 34.8 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.053 0.454 . . . . 0.42 110.374 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -143.99 111.07 5.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.985 -0.746 . . . . 1.29 108.985 176.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG13 HD22 ' A' ' 37' ' ' LEU . 2.6 p -114.06 122.86 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.78 -0.645 . . . . 1.08 109.952 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 28.9 t70 -101.94 141.59 34.55 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.013 -0.54 . . . . 1.39 109.99 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.51 148.13 5.62 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.273 -1.131 . . . . 0.6 110.273 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -55.68 0.39 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.993 -1.114 . . . . 3.29 107.993 178.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.3 Cg_endo -73.28 119.61 6.09 Favored 'Trans proline' 0 C--N 1.382 2.296 0 N-CA-C 107.275 -1.856 . . . . 1.09 107.275 167.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.94 112.85 11.81 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 123.753 0.658 . . . . 1.36 112.512 -172.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 42.1 Cg_endo -70.7 141.49 41.54 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.679 2.253 . . . . 0.56 112.694 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -76.32 112.32 12.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.065 -1.457 . . . . 1.74 107.065 174.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 29' ' ' VAL . 94.2 mt -81.21 131.15 35.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.165 -0.47 . . . . 1.14 111.301 -177.131 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -132.28 131.95 42.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.283 -0.636 . . . . 4.62 109.283 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.482 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 92.0 m95 -98.02 135.39 39.78 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.916 0.389 . . . . 0.33 110.002 177.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.3 tp -116.56 134.44 54.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.246 -1.761 . . . . 1.57 106.246 176.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -121.29 112.52 18.7 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.572 -0.529 . . . . 1.04 109.572 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 57.26 24.82 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.853 0.861 . . . . 2.17 112.464 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.04 4.41 71.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.826 -0.702 . . . . 0.61 112.694 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -113.1 151.85 30.29 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.886 -0.783 . . . . 1.84 108.886 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.31 117.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.157 -0.683 . . . . 1.31 109.157 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.1 tp -82.04 111.33 18.1 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.886 -0.597 . . . . 1.33 109.401 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.66 117.39 23.75 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.147 -1.057 . . . . 2.69 108.147 176.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.96 122.58 18.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.345 -0.389 . . . . 1.74 110.153 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.7 p -105.78 -171.05 1.83 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.389 -0.369 . . . . 2.07 110.047 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -69.35 -21.03 63.85 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.29 0.567 . . . . 1.9 109.828 173.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 58.0 m-85 -91.53 -40.69 11.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.342 -0.39 . . . . 1.89 110.379 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.49 106.47 20.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.628 -1.249 . . . . 1.18 107.628 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.22 145.52 41.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.16 0.505 . . . . 3.62 112.276 -176.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.5 m -84.38 114.06 21.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.63 -0.878 . . . . 1.15 108.63 176.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.4 127.14 54.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.725 -0.843 . . . . 2.04 108.725 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.92 151.17 21.62 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.74 -0.467 . . . . 0.87 109.74 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -119.87 146.61 45.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.65 -1.241 . . . . 1.7 107.65 178.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -47.64 105.95 0.54 Allowed Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 125.744 1.618 . . . . 3.36 114.623 -172.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.54 136.0 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.187 2.592 . . . . 1.63 110.32 174.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.54 159.11 29.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.366 -0.605 . . . . 1.88 109.366 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.62 -3.37 21.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.524 0.564 . . . . 2.29 112.524 -175.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -103.5 9.36 37.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.12 0.486 . . . . 3.93 109.913 175.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.06 131.75 56.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 120.779 -0.369 . . . . 1.89 111.178 -179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.9 p -96.99 2.05 51.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.875 -1.157 . . . . 1.86 107.875 170.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -94.26 128.54 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.17 -1.377 . . . . 1.19 108.578 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.88 121.24 41.02 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.644 -1.613 . . . . 2.36 106.644 178.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -103.8 141.28 36.38 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.758 -0.83 . . . . 1.49 108.758 -175.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.51 -173.7 35.89 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 119.613 -1.28 . . . . 0.36 111.967 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 t -151.07 134.33 16.1 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 123.308 0.643 . . . . 0.36 110.332 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 55.3 tp -84.43 104.19 14.23 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 104.291 -2.485 . . . . 1.06 104.291 169.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -109.34 127.23 54.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.373 -0.531 . . . . 3.22 110.963 -171.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 6.6 mp -103.79 111.36 23.84 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.135 -0.939 . . . . 1.78 109.1 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -64.04 -42.84 96.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.47 -1.241 . . . . 2.42 109.027 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -128.63 113.04 19.23 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.726 -0.842 . . . . 3.22 108.726 176.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.79 130.39 8.62 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.111 1.874 . . . . 1.62 111.885 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 p -107.73 141.4 39.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.263 -1.014 . . . . 1.75 108.263 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -68.38 -14.76 63.22 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 120.965 0.412 . . . . 2.61 111.025 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.95 -15.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.91 -0.587 . . . . 1.77 111.06 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.532 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 47.3 m-80 -102.95 25.84 8.87 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 112.98 0.733 . . . . 2.19 112.98 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.701 -1.592 . . . . 2.08 106.701 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.45 -154.12 6.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.084 -1.055 . . . . 0.59 113.549 -175.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -105.53 120.16 40.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.066 0.46 . . . . 2.28 111.498 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.532 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 16.3 m-85 -101.24 133.79 45.28 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.117 -0.947 . . . . 1.03 108.788 178.755 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.8 m -122.78 129.16 51.4 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.909 -1.145 . . . . 1.13 107.909 176.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.5 tp -100.83 120.47 40.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.017 -0.734 . . . . 1.07 109.017 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.15 136.28 49.63 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.931 -1.137 . . . . 1.15 107.931 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.07 121.28 27.52 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.469 -0.937 . . . . 1.11 108.469 178.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.03 122.51 46.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.046 -0.262 . . . . 1.34 110.409 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 p-10 -137.22 177.24 2.26 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 107.102 -1.444 . . . . 1.61 107.102 177.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.28 -26.98 28.87 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.523 2.149 . . . . 1.33 114.589 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 92.6 m -76.94 -17.85 58.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.883 0.327 . . . . 1.1 111.883 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -158.74 22.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.463 -0.875 . . . . 0.71 111.653 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -107.6 138.23 44.2 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.899 0.381 . . . . 1.83 109.977 -176.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.48 158.26 24.83 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.385 -1.339 . . . . 1.16 107.385 174.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 42.7 p -153.84 159.11 41.71 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 112.442 0.534 . . . . 0.88 112.442 -177.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.17 153.98 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.833 -1.543 . . . . 1.09 106.833 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 p -123.48 151.45 42.74 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 118.075 0.398 . . . . 1.7 111.138 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.8 128.4 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 1.38 107.661 177.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.5 110.99 23.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.066 -1.457 . . . . 1.67 107.066 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.65 112.76 25.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.749 0.785 . . . . 1.26 111.659 -174.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.46 101.2 10.88 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.77 -1.105 . . . . 1.4 108.027 176.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.3 -69.9 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.727 -0.67 . . . . 4.75 109.722 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -142.07 145.47 34.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.169 -1.049 . . . . 5.12 108.169 178.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.97 135.79 40.03 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.834 0.854 . . . . 5.33 111.052 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -56.54 115.81 11.15 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 124.475 1.11 . . . . 5.79 112.495 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.18 149.28 25.03 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.202 1.935 . . . . 5.07 109.798 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 117.51 -1.233 . . . . 10.3 111.511 -178.694 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 108.314 -0.995 . . . . 1.5800000000000001 108.314 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.538 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-85 -97.69 124.26 41.94 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.917 -1.142 . . . . 1.1899999999999999 107.917 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.99 173.93 10.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.712 -1.218 . . . . 1.3200000000000001 107.712 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.43 127.14 41.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.318 -0.553 . . . . 0.45000000000000001 111.978 -173.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 50.3 m -118.17 140.82 49.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.346 -1.353 . . . . 1.1899999999999999 107.346 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 94' ' ' ALA . 95.5 t -115.93 121.22 66.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 121.378 0.608 . . . . 0.28999999999999998 112.025 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 79.3 mt-30 -108.13 130.63 55.1 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.864 -1.161 . . . . 2.1800000000000002 107.864 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 98' ' ' ILE . 28.4 mt -122.96 156.2 35.21 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.232 -0.655 . . . . 0.33000000000000002 109.232 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -132.11 151.01 52.01 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.549 -0.538 . . . . 1.03 109.549 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -60.04 132.47 54.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 124.551 1.157 . . . . 0.48999999999999999 110.058 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -59.42 135.06 57.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 124.473 1.108 . . . . 0.40000000000000002 109.722 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.44 127.91 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.694 -0.484 . . . . 0.56999999999999995 109.694 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.3 mt-10 -77.86 109.96 12.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.126 -0.943 . . . . 2.52 112.058 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -168.9 162.39 11.25 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.807 -2.294 . . . . 0.88 104.807 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -55.63 -36.67 67.26 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.967 1.258 . . . . 2.75 113.42 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -95.5 99.22 11.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.893 -1.521 . . . . 2.46 106.893 172.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 53.3 m95 -81.0 137.59 36.07 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.226 -0.443 . . . . 0.85999999999999999 110.203 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.07 124.04 31.88 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.765 -0.652 . . . . 0.29999999999999999 110.222 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.3 mt -107.27 95.57 13.63 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.12 -1.437 . . . . 0.29999999999999999 107.12 172.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.06 134.92 26.25 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.655 2.237 . . . . 0.28000000000000003 111.912 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -129.74 155.49 45.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.112 0.482 . . . . 0.37 111.171 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 23.0 m -138.72 117.7 12.49 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.349 -0.982 . . . . 0.88 108.349 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -126.08 123.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.27 -1.011 . . . . 0.27000000000000002 108.27 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 6.1 p-10 -108.96 156.33 19.84 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.868 -0.733 . . . . 1.3899999999999999 111.013 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.57 147.25 4.57 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.652 -0.979 . . . . 0.59999999999999998 110.652 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -86.31 -50.28 0.49 Allowed Pre-proline 0 C--N 1.311 -1.078 0 CA-C-O 119.126 -0.464 . . . . 2.6099999999999999 111.253 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.5 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 C--N 1.366 1.453 0 N-CA-C 107.398 -1.808 . . . . 0.78000000000000003 107.398 167.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.67 117.48 45.02 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 115.773 -0.649 . . . . 0.78000000000000003 111.75 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -85.27 145.71 9.67 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.85 1.7 . . . . 0.56000000000000005 111.642 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -78.32 120.17 22.71 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 56' ' ' PHE . 97.2 mt -93.17 123.3 36.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.891 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -134.66 131.82 38.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.029 -0.532 . . . . 3.7799999999999998 110.848 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 87.6 m95 -93.02 135.07 34.52 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.359 -0.837 . . . . 0.28999999999999998 109.495 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -113.11 134.51 54.51 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.894 -1.891 . . . . 0.94999999999999996 105.894 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 81.0 t80 -125.34 111.42 15.16 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.489 -0.56 . . . . 0.88 109.489 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.61 34.59 24.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.165 0.986 . . . . 1.79 111.048 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.6 85.64 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.142 -0.481 . . . . 0.60999999999999999 112.974 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -108.33 153.6 23.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.753 -0.832 . . . . 1.3700000000000001 108.753 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.25 115.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.759 . . . . 0.69999999999999996 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -89.34 122.62 32.75 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.60999999999999999 108.247 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.57 129.92 55.54 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.374 -1.343 . . . . 2.4700000000000002 107.374 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.235 0.614 . . . . 1.74 111.194 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 p -126.26 -165.69 1.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.044 -0.724 . . . . 1.5700000000000001 109.044 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 m -78.62 -22.45 46.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 118.414 0.552 . . . . 1.52 110.597 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.2 m-85 -87.21 -40.39 14.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.745 -0.382 . . . . 1.5900000000000001 110.386 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -112.49 106.71 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.701 -1.222 . . . . 0.5 107.701 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -130.88 139.71 50.15 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.179 0.807 . . . . 2.8900000000000001 113.179 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -84.68 119.96 25.84 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.263 -0.88 . . . . 0.44 109.749 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -94.09 125.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.44 -0.346 . . . . 2.04 110.441 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 37' ' ' LEU . 66.8 m-85 -106.78 106.74 17.41 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.582 -1.636 . . . . 0.87 106.582 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 67' ' ' HIS . 3.5 pp -95.0 154.63 17.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.397 -0.921 . . . . 1.25 108.956 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 8.5 mm-40 -70.26 113.0 14.58 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 123.479 0.711 . . . . 3.3599999999999999 111.574 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.1 Cg_exo -78.81 161.15 27.45 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.727 2.285 . . . . 1.3899999999999999 110.552 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.82 142.06 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.82 -6.19 20.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.136 0.574 . . . . 1.9099999999999999 112.243 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -104.0 -0.7 28.54 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.142 -0.481 . . . . 3.4900000000000002 111.332 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.5 pt-20 -115.04 146.15 41.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.691 -1.226 . . . . 1.8899999999999999 107.691 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -94.12 2.91 55.92 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.134 -0.691 . . . . 1.3 109.134 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 16.8 t -99.94 129.03 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.617 -0.72 . . . . 0.60999999999999999 111.609 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB3' HG13 ' A' ' 29' ' ' VAL . 14.3 ttm180 -94.55 134.97 36.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.148 -1.797 . . . . 1.8400000000000001 106.148 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.502 ' HB2' HD11 ' A' ' 57' ' ' LEU . 47.7 m-70 -121.16 161.79 21.23 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.612 -0.435 . . . . 1.1599999999999999 110.266 -175.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.29 -165.38 35.24 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 120.674 -0.774 . . . . 0.31 111.334 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 t -156.16 141.87 17.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.502 -0.555 . . . . 0.35999999999999999 109.502 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 50.3 tp -91.02 100.93 13.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.618 -2.364 . . . . 0.28000000000000003 104.618 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -103.27 129.27 50.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.218 -0.593 . . . . 2.6800000000000002 110.63 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 5.7 mp -108.73 109.18 20.27 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.617 -0.883 . . . . 1.23 108.617 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -72.15 -43.09 65.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.599 -1.182 . . . . 2.1800000000000002 109.95 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 101.0 31.9 Favored Pre-proline 0 N--CA 1.429 -1.501 0 N-CA-C 105.641 -1.985 . . . . 2.8199999999999998 105.641 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.05 147.11 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.617 2.211 . . . . 1.25 112.372 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 p -130.06 141.29 50.73 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 122.039 -0.413 . . . . 1.22 110.406 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 41.8 p-80 -58.54 -6.4 0.7 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.118 1.525 . . . . 2.0299999999999998 115.118 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.79 -17.06 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.152 -0.684 . . . . 1.3300000000000001 109.152 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 17.5 m120 -83.34 -1.2 52.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.241 1.016 . . . . 2.1899999999999999 109.625 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 39.5 t30 -77.11 81.22 3.63 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.28 -0.873 . . . . 1.96 108.883 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.88 -155.86 8.99 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.201 -0.909 . . . . 0.48999999999999999 111.669 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 26.3 t-20 -98.43 128.97 45.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.841 0.682 . . . . 2.23 112.841 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 76.9 m-85 -108.25 141.57 39.83 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.969 1.308 . . . . 0.68999999999999995 108.021 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.1 m -142.57 134.44 27.0 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.631 -0.668 . . . . 0.34000000000000002 109.353 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.8 tp -104.89 122.45 45.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.77 -0.456 . . . . 0.22 109.77 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.91 125.25 52.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.204 -1.036 . . . . 0.35999999999999999 108.204 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -120.65 120.8 36.78 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.19 -1.041 . . . . 0.31 108.19 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.69 121.6 35.94 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.83 -0.348 . . . . 0.60999999999999999 111.425 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.9 p30 -128.59 170.97 9.39 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 107.576 -1.268 . . . . 1.1799999999999999 107.576 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.9 Cg_exo -48.06 -41.26 33.74 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.602 2.201 . . . . 1.0 114.432 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -67.29 -45.65 75.91 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.509 -0.476 . . . . 1.1000000000000001 112.207 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.01 178.09 47.54 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 119.103 -1.523 . . . . 0.58999999999999997 113.594 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -119.86 133.53 55.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 123.202 0.601 . . . . 1.5700000000000001 109.742 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -113.9 155.28 26.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.138 -0.69 . . . . 0.37 109.138 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.7 p -144.8 148.03 33.57 Favored 'General case' 0 N--CA 1.418 -2.068 0 O-C-N 123.52 0.513 . . . . 0.56999999999999995 110.26 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.82 146.38 29.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.057 -1.831 . . . . 0.29999999999999999 106.057 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -118.48 144.31 46.1 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.473 -0.491 . . . . 1.26 110.318 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.742 HG22 HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -134.67 122.16 37.76 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 C-N-CA 124.807 1.243 . . . . 0.71999999999999997 109.505 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.19 108.6 16.82 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.777 -1.564 . . . . 1.25 106.777 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 155.84 25.22 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.313 -0.403 . . . . 0.57999999999999996 110.924 -174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.38 100.65 10.07 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.385 0.612 . . . . 0.83999999999999997 111.373 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 86.0 m-85 . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 108.146 -1.057 . . . . 3.8599999999999999 108.146 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.403 -2.791 0 N-CA-C 109.374 -0.602 . . . . 1.5800000000000001 109.374 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.612 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.9 m-85 -75.09 115.68 14.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.093 -1.447 . . . . 1.1899999999999999 107.093 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -83.2 178.14 8.23 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.937 -0.764 . . . . 1.3200000000000001 108.937 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 126.92 40.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 119.745 -0.782 . . . . 0.45000000000000001 111.257 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -122.93 143.23 50.04 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.142 -1.429 . . . . 1.1899999999999999 107.142 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 85.4 t -115.81 121.14 66.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.132 0.491 . . . . 0.28999999999999998 110.901 -174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 118.83 37.77 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.301 -0.863 . . . . 2.1800000000000002 108.858 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 98' ' ' ILE . 34.0 mt -115.44 144.64 43.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.943 0.401 . . . . 0.33000000000000002 109.984 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.95 151.27 51.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.968 -0.753 . . . . 1.03 108.968 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 m -57.49 135.1 56.58 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 124.455 1.097 . . . . 0.48999999999999999 110.411 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -56.2 130.86 46.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.393 1.058 . . . . 0.40000000000000002 110.66 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.9 136.14 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.335 0.588 . . . . 0.56999999999999995 110.094 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.93 106.94 7.79 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.331 -1.304 . . . . 2.52 110.54 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.4 mtm -141.93 -163.16 1.53 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.953 -1.499 . . . . 0.88 106.953 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -67.89 -45.03 75.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.99 -0.744 . . . . 2.75 108.99 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -111.85 138.84 47.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 106.393 -1.706 . . . . 2.46 106.393 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 72.4 m95 -81.76 133.54 35.35 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 109.506 -0.553 . . . . 0.85999999999999999 109.506 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 42.1 t -120.26 116.09 24.89 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.3 -0.864 . . . . 0.29999999999999999 110.093 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 69.9 mt -100.08 99.37 9.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.144 -1.428 . . . . 0.29999999999999999 107.144 172.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 2.9 Cg_exo -75.3 125.89 9.41 Favored 'Trans proline' 0 C--O 1.252 1.207 0 C-N-CA 122.502 2.135 . . . . 0.28000000000000003 111.804 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -120.98 153.57 37.14 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.092 -0.707 . . . . 0.37 109.092 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.5 m -140.54 114.3 8.87 Favored 'General case' 0 C--N 1.267 -3.02 0 N-CA-C 108.715 -0.846 . . . . 0.88 108.715 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -110.43 116.31 52.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.596 -0.89 . . . . 0.27000000000000002 108.596 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 8.5 t70 -101.22 137.06 40.07 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.634 -0.876 . . . . 1.3899999999999999 108.634 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.46 145.17 4.27 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 110.326 -1.11 . . . . 0.59999999999999998 110.326 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -84.05 -55.53 0.46 Allowed Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.739 -0.467 . . . . 2.6099999999999999 109.739 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.1 Cg_endo -62.4 120.78 8.48 Favored 'Trans proline' 0 C--N 1.387 2.56 0 N-CA-C 108.643 -1.329 . . . . 0.78000000000000003 108.643 170.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.1 111.59 8.99 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 116.15 -0.477 . . . . 0.78000000000000003 111.531 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -83.97 162.13 13.79 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 122.547 2.165 . . . . 0.56000000000000005 112.344 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 7.9 p -94.37 130.01 40.86 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.516 -0.92 . . . . 1.3700000000000001 108.516 174.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' A' ' 85' ' ' LEU . 88.2 mt -98.54 140.67 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -143.88 133.71 23.89 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.162 -0.681 . . . . 3.7799999999999998 109.162 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.456 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.3 m95 -96.64 117.46 31.04 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.28999999999999998 109.862 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -100.72 127.23 47.21 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.336 -1.727 . . . . 0.94999999999999996 106.336 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.5 ' HZ ' ' O ' ' A' ' 78' ' ' VAL . 88.7 t80 -122.97 108.05 12.51 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 109.213 -0.662 . . . . 0.88 109.213 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.58 17.7 6.39 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.679 0.791 . . . . 1.79 112.835 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.1 -12.16 40.7 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.973 -0.632 . . . . 0.60999999999999999 112.685 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 m -108.62 151.99 25.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.851 -0.796 . . . . 1.3700000000000001 108.851 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.41 123.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.379 -0.373 . . . . 0.69999999999999996 110.017 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.2 tp -82.65 113.38 20.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.845 -0.616 . . . . 0.60999999999999999 109.552 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.01 140.78 30.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.374 -0.602 . . . . 2.4700000000000002 109.374 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.77 137.59 36.25 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.785 -0.643 . . . . 1.74 110.084 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 p -127.16 -165.97 1.54 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.773 0.829 . . . . 1.5700000000000001 110.068 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 m -75.64 -31.91 60.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.023 0.44 . . . . 1.52 110.546 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -89.84 -28.41 19.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.071 0.397 . . . . 1.5900000000000001 112.071 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.43 HG23 HD23 ' A' ' 72' ' ' LEU . 55.9 mt -125.53 106.64 16.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.091 -0.707 . . . . 0.5 109.091 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HE1' HD21 ' A' ' 73' ' ' ASN . 53.0 p90 -145.91 156.27 43.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.61 -0.436 . . . . 2.8900000000000001 110.547 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -85.23 109.79 18.58 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.666 -0.864 . . . . 0.44 108.666 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.54 108.77 21.55 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.37 -0.974 . . . . 2.04 108.37 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -85.95 145.74 27.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.53 -0.915 . . . . 0.87 108.53 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.2 pp -109.42 157.96 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.376 -1.713 . . . . 1.25 106.376 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.07 109.0 5.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 O-C-N 123.485 0.491 . . . . 3.3599999999999999 110.15 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.63 140.92 19.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.393 2.062 . . . . 1.3899999999999999 111.705 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.61 134.66 51.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.069 -1.085 . . . . 1.53 108.069 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.17 -18.28 63.31 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.832 0.678 . . . . 1.9099999999999999 112.832 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.65 -23.2 59.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.256 -0.429 . . . . 3.4900000000000002 110.478 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.83 152.31 18.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.515 -0.55 . . . . 1.8899999999999999 109.515 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 11.12 38.26 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.496 -1.298 . . . . 1.3 107.496 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.5 t -104.74 127.88 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.037 -0.983 . . . . 0.60999999999999999 110.617 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HB2' HG13 ' A' ' 29' ' ' VAL . 66.5 mtp180 -92.43 115.06 27.75 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.574 -1.639 . . . . 1.8400000000000001 106.574 176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 90.5 m-70 -101.97 142.73 32.8 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.263 -0.643 . . . . 1.1599999999999999 109.263 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.78 -178.79 38.4 Favored Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 120.21 -0.995 . . . . 0.31 111.327 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 t -144.33 132.81 22.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 120.547 0.213 . . . . 0.35999999999999999 111.278 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 54.4 tp -87.16 114.01 23.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.433 -2.062 . . . . 0.28000000000000003 105.433 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 16.4 ptm180 -106.76 119.58 39.71 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 112.338 0.495 . . . . 2.6800000000000002 112.338 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.43 HD23 HG23 ' A' ' 52' ' ' ILE . 15.6 mt -92.85 108.2 19.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.75 -2.315 . . . . 1.23 104.75 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.405 HD21 ' HE1' ' A' ' 53' ' ' PHE . 86.8 m-20 -74.35 -52.53 11.93 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 108.982 -0.747 . . . . 2.1800000000000002 108.982 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -128.26 100.23 23.44 Favored Pre-proline 0 N--CA 1.397 -3.111 0 N-CA-C 105.843 -1.91 . . . . 2.8199999999999998 105.843 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 25.2 Cg_exo -67.09 150.39 82.36 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.11 1.873 . . . . 1.25 109.897 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -112.62 178.14 4.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.577 -0.283 . . . . 1.22 111.073 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -52.63 -37.02 57.69 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.469 0.708 . . . . 2.0299999999999998 112.626 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.5 ' O ' ' HZ ' ' A' ' 41' ' ' PHE . 14.6 m -77.17 -10.44 13.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 112.825 0.676 . . . . 1.3300000000000001 112.825 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.58 26.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.701 1.0 . . . . 2.1899999999999999 113.701 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.6 m-20 -110.86 53.47 0.7 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.755 -1.943 . . . . 1.96 105.755 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -133.78 -168.23 11.78 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.38 -1.39 . . . . 0.48999999999999999 114.061 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 15.0 m120 -102.43 114.59 28.91 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.517 0.727 . . . . 2.23 109.989 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.09 116.2 31.56 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.738 -0.838 . . . . 0.68999999999999995 108.738 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 77.8 m -116.62 122.75 45.53 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.694 -0.484 . . . . 0.34000000000000002 109.694 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.1 tp -96.84 118.32 33.02 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.765 -0.457 . . . . 0.22 109.765 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.6 136.33 41.63 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.748 -0.834 . . . . 0.35999999999999999 108.748 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' SER . . . -128.49 120.42 26.77 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.86 -1.163 . . . . 0.31 107.86 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.07 134.4 54.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 123.16 0.288 . . . . 0.60999999999999999 110.599 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -153.2 171.93 6.24 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.67 -1.233 . . . . 1.1799999999999999 107.67 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -55.94 -39.32 91.9 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.284 1.989 . . . . 1.0 113.408 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.55 -15.74 61.77 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.045 0.387 . . . . 1.1000000000000001 112.045 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.27 -161.46 29.72 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 119.02 -1.562 . . . . 0.58999999999999997 113.252 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.72 124.29 25.0 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.814 -0.81 . . . . 1.5700000000000001 108.814 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.38 151.15 22.6 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.66 -0.867 . . . . 0.37 108.66 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 6.4 p -152.23 135.31 15.72 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.719 0.637 . . . . 0.56999999999999995 110.775 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.44 47.08 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.175 -1.417 . . . . 0.29999999999999999 107.175 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -129.54 145.24 51.49 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.875 0.369 . . . . 1.26 111.318 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.516 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -143.98 126.37 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.71999999999999997 107.947 178.066 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -106.67 137.19 45.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.221 -0.659 . . . . 1.25 109.221 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.46 145.86 47.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.765 -0.828 . . . . 0.57999999999999996 108.765 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -127.64 104.08 7.67 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.272 0.558 . . . . 0.83999999999999997 110.433 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 58.2 t80 . . . . . 0 C--N 1.302 -1.484 0 N-CA-C 114.389 1.255 . . . . 3.8599999999999999 114.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.379 -3.976 0 CA-C-O 122.193 0.997 . . . . 1.5800000000000001 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 95.1 m-85 -96.61 127.26 42.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.323 -1.732 . . . . 1.1899999999999999 106.323 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.2 m -92.4 -159.39 0.66 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 119.145 -0.455 . . . . 1.3200000000000001 110.227 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.58 106.84 18.78 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 119.369 0.986 . . . . 0.45000000000000001 112.123 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 39.4 m -112.81 126.68 55.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.399 -0.819 . . . . 1.1899999999999999 108.882 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 94' ' ' ALA . 62.1 t -115.55 124.86 72.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 120.926 0.393 . . . . 0.28999999999999998 112.0 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -124.83 121.13 33.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.092 -1.077 . . . . 2.1800000000000002 108.092 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 98' ' ' ILE . 43.3 mt -105.0 156.12 18.33 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.982 0.42 . . . . 0.33000000000000002 111.494 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -130.91 144.28 51.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.453 -1.314 . . . . 1.03 107.453 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -65.25 136.99 57.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.718 0.807 . . . . 0.48999999999999999 110.089 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -51.58 138.63 22.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.403 1.064 . . . . 0.40000000000000002 110.926 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.62 143.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.036 -0.529 . . . . 0.56999999999999995 110.234 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.86 98.53 2.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.796 -1.093 . . . . 2.52 111.685 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -141.21 -169.59 2.88 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.395 -1.335 . . . . 0.88 107.395 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -78.93 -39.67 34.02 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.995 -0.743 . . . . 2.75 108.995 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -101.55 127.08 48.42 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.858 -1.905 . . . . 2.46 105.858 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.5 m95 -82.78 126.83 32.85 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.099 0.476 . . . . 0.85999999999999999 110.991 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 43.7 t -117.73 118.13 31.23 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.51 -0.768 . . . . 0.29999999999999999 109.435 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 72.6 mt -101.75 97.43 7.94 Favored Pre-proline 0 C--O 1.247 0.952 0 N-CA-C 107.599 -1.26 . . . . 0.29999999999999999 107.599 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 9.7 Cg_exo -74.25 136.0 21.43 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.507 2.138 . . . . 0.28000000000000003 111.427 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -124.41 161.32 26.25 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.283 0.563 . . . . 0.37 110.818 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -140.8 110.51 6.43 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.792 -0.818 . . . . 0.88 108.792 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 66' ' ' ARG . 4.0 p -123.33 117.49 51.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.059 -1.089 . . . . 0.27000000000000002 108.059 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.7 p-10 -103.1 165.94 10.73 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.526 -1.27 . . . . 1.3899999999999999 110.715 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.58 165.54 12.5 Favored Glycine 0 N--CA 1.409 -3.111 0 O-C-N 124.823 1.327 . . . . 0.59999999999999998 109.935 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.402 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 15.6 mm100 -101.96 -55.22 0.13 Allowed Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.788 -0.449 . . . . 2.6099999999999999 109.788 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.2 Cg_endo -66.05 119.78 6.85 Favored 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.08 -1.931 . . . . 0.78000000000000003 107.08 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 115.07 27.31 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 0.78000000000000003 111.508 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 92.7 Cg_endo -81.01 134.59 9.45 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 121.516 1.477 . . . . 0.56000000000000005 111.356 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -70.61 132.75 45.93 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.519 -1.289 . . . . 1.3700000000000001 107.519 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 85' ' ' LEU . 72.1 mt -100.04 120.45 39.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.968 0.414 . . . . 0.5 110.432 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 48' ' ' GLU . 9.2 tpp180 -122.1 128.05 50.87 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.532 -0.758 . . . . 3.7799999999999998 109.819 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -93.9 155.37 17.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.082 -0.508 . . . . 0.28999999999999998 110.627 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 11.5 tp -137.83 141.1 40.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.185 -1.413 . . . . 0.94999999999999996 107.185 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -119.12 101.96 8.39 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.348 0.659 . . . . 0.88 109.43 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 57.69 31.38 20.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.96 0.904 . . . . 1.79 111.063 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.51 -19.04 55.33 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.707 -0.759 . . . . 0.60999999999999999 112.74 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.7 t -88.68 140.98 28.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.44 -0.578 . . . . 1.3700000000000001 109.44 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.21 117.1 2.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.741 -0.663 . . . . 0.69999999999999996 111.007 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.7 tp -91.13 126.46 36.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.011 -0.737 . . . . 0.60999999999999999 109.011 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -93.99 137.39 33.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.898 -0.592 . . . . 2.4700000000000002 109.441 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' HH12 ' A' ' 38' ' ' ARG . 34.9 mt-10 -79.76 83.31 5.73 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 1.74 108.754 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -84.48 -178.41 6.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.198 -0.91 . . . . 1.5700000000000001 110.706 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -58.96 -34.82 72.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.213 0.53 . . . . 1.52 111.67 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -87.43 -13.99 41.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.643 0.609 . . . . 1.5900000000000001 112.643 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.19 105.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 107.304 -1.369 . . . . 0.5 107.304 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -135.94 145.95 46.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.509 -0.877 . . . . 2.8900000000000001 112.025 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 m -89.7 110.21 21.12 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.912 -1.144 . . . . 0.44 107.912 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.33 113.38 26.63 Favored 'General case' 0 N--CA 1.418 -2.025 0 C-N-CA 119.325 -0.95 . . . . 2.04 109.047 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' CE1' HD12 ' A' ' 37' ' ' LEU . 70.5 m-85 -87.74 133.84 33.78 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.831 -1.544 . . . . 0.87 106.831 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.16 164.19 19.31 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.234 -0.986 . . . . 1.25 108.949 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.82 120.5 50.36 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.779 -0.823 . . . . 3.3599999999999999 108.779 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.12 128.34 30.11 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 122.635 2.223 . . . . 1.3899999999999999 111.253 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.91 125.45 29.32 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.282 -0.872 . . . . 1.53 108.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.22 -27.81 62.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.0 -1.0 . . . . 1.9099999999999999 113.006 -173.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.3 -9.16 42.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.047 0.388 . . . . 3.4900000000000002 112.047 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -102.3 150.28 23.48 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.693 0.759 . . . . 1.8899999999999999 112.248 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.5 p -105.07 7.99 34.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.991 -1.004 . . . . 1.3 108.701 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 18.1 t -112.0 133.26 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.922 -1.035 . . . . 0.60999999999999999 109.668 -176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HB2' HG13 ' A' ' 29' ' ' VAL . 64.8 mtp180 -87.56 134.86 33.55 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.685 -1.598 . . . . 1.8400000000000001 106.685 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -124.3 155.68 38.25 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.009 0.433 . . . . 1.1599999999999999 109.891 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.03 -171.63 43.03 Favored Glycine 0 N--CA 1.411 -3.028 0 N-CA-C 109.516 -1.434 . . . . 0.31 109.516 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.422 ' SG ' ' HG2' ' A' ' 71' ' ' ARG . 39.3 t -148.03 141.26 25.12 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.004 0.43 . . . . 0.35999999999999999 110.793 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.0 tp -88.65 102.23 14.76 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.282 -2.118 . . . . 0.28000000000000003 105.282 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HG2' ' SG ' ' A' ' 69' ' ' CYS . 85.2 mtm-85 -102.37 129.2 48.77 Favored 'General case' 0 CA--C 1.48 -1.745 0 C-N-CA 119.203 -0.999 . . . . 2.6800000000000002 110.857 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 23' ' ' TRP . 62.8 mt -86.24 108.47 18.39 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.561 -1.644 . . . . 1.23 106.561 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -67.64 -47.07 70.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 114.691 -1.141 . . . . 2.1800000000000002 109.011 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -128.12 110.07 19.87 Favored Pre-proline 0 N--CA 1.421 -1.882 0 N-CA-C 106.439 -1.689 . . . . 2.8199999999999998 106.439 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 35.1 Cg_endo -68.83 130.54 20.69 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 121.607 1.538 . . . . 1.25 111.275 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.6 p -123.96 171.99 9.29 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.57 -0.741 . . . . 1.22 109.632 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -72.46 -8.54 55.59 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.452 0.538 . . . . 2.0299999999999998 112.452 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.89 -9.54 11.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.394 0.616 . . . . 1.3300000000000001 110.422 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.657 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.1 m120 -90.12 27.12 1.69 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.711 0.767 . . . . 2.1899999999999999 110.467 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -126.57 64.96 1.26 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.016 -1.105 . . . . 1.96 108.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.06 -158.55 11.52 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.525 -0.845 . . . . 0.48999999999999999 112.234 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -96.55 129.22 43.98 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.377 -0.231 . . . . 2.23 110.377 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 52.6 m-85 -116.64 117.75 30.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.035 0.445 . . . . 0.68999999999999995 110.427 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.1 m -100.47 136.07 40.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.238 -0.653 . . . . 0.34000000000000002 109.238 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' SER . 49.3 tp -103.29 114.21 28.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.187 -0.672 . . . . 0.22 109.187 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.8 mm? -100.63 116.41 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.145 -1.057 . . . . 0.35999999999999999 108.145 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -113.72 120.98 42.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.948 -1.13 . . . . 0.31 107.948 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.64 50.67 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.872 -0.331 . . . . 0.60999999999999999 111.549 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 42.7 p30 -141.12 175.25 3.18 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.34 -1.355 . . . . 1.1799999999999999 107.34 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 52.9 Cg_exo -47.08 -29.77 9.23 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.851 2.368 . . . . 1.0 115.035 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.6 m -71.6 -41.23 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.073 0.463 . . . . 1.1000000000000001 111.769 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.21 -162.76 35.05 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.571 -0.824 . . . . 0.58999999999999997 111.051 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 9.4 tt0 -132.47 131.32 41.57 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.857 -0.423 . . . . 1.5700000000000001 109.857 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -107.76 150.19 27.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.0 p -142.8 120.78 12.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.771 0.32 . . . . 0.56999999999999995 111.831 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.34 147.92 45.04 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.542 -1.281 . . . . 0.29999999999999999 107.542 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -118.46 123.88 46.25 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 118.002 0.364 . . . . 1.26 111.164 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.485 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -118.92 120.22 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.974 -1.121 . . . . 0.71999999999999997 107.974 178.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.53 128.74 39.79 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.288 -1.004 . . . . 1.25 108.288 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.75 116.91 30.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.875 0.369 . . . . 0.57999999999999996 110.583 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.11 101.4 12.86 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.355 0.598 . . . . 0.83999999999999997 109.414 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 20.3 t80 . . . . . 0 C--N 1.303 -1.413 0 CA-C-N 115.29 -0.868 . . . . 3.8599999999999999 112.501 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.397 -3.077 0 CA-C-O 122.2 1.0 . . . . 1.5800000000000001 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.488 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 67.1 m-85 -81.48 109.96 16.43 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 105.775 -1.935 . . . . 1.1899999999999999 105.775 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.3 t -84.0 175.59 9.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.228 -1.027 . . . . 1.3200000000000001 108.228 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.71 126.37 39.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 112.852 0.686 . . . . 0.45000000000000001 112.852 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -123.82 139.13 54.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.515 -1.291 . . . . 1.1899999999999999 107.515 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 94' ' ' ALA . 82.7 t -115.36 114.41 46.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.583 -0.525 . . . . 0.28999999999999998 109.583 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.42 116.72 31.4 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.967 -0.56 . . . . 2.1800000000000002 110.791 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.477 HD13 HG22 ' A' ' 98' ' ' ILE . 42.7 mt -102.71 156.34 17.7 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.277 -0.874 . . . . 0.33000000000000002 109.16 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -131.82 153.01 50.59 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.344 -0.613 . . . . 1.03 109.344 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -58.85 137.38 57.8 Favored 'General case' 0 N--CA 1.425 -1.724 0 O-C-N 124.909 1.38 . . . . 0.48999999999999999 108.728 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 143.03 56.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.19 -0.67 . . . . 0.40000000000000002 109.19 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.62 129.85 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.52 0.676 . . . . 0.56999999999999995 110.146 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.73 91.75 4.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.724 -1.125 . . . . 2.52 112.514 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -154.43 -178.32 7.07 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.084 -1.821 . . . . 0.88 106.084 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -71.93 -28.64 63.61 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 120.554 1.525 . . . . 2.75 110.499 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.43 100.96 13.44 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -81.89 99.55 9.12 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.837 0.827 . . . . 0.85999999999999999 110.22 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.6 t -103.05 123.05 45.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.717 -1.583 . . . . 0.29999999999999999 109.123 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 62.6 mt -105.87 99.97 25.23 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.426 -1.324 . . . . 0.29999999999999999 107.426 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.29 132.72 18.23 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.361 2.041 . . . . 0.28000000000000003 112.58 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HB3' HD23 ' A' ' 14' ' ' LEU . 46.9 p90 -128.35 149.9 50.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.232 0.539 . . . . 0.37 109.869 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -136.61 112.68 9.7 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.229 -1.026 . . . . 0.88 108.229 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.7 p -110.83 119.23 59.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.825 -0.805 . . . . 0.27000000000000002 108.825 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 25.0 t70 -101.0 132.05 46.59 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.243 -1.021 . . . . 1.3899999999999999 108.243 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.83 131.66 1.28 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 109.387 -1.485 . . . . 0.59999999999999998 109.387 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 25.4 tt0 -75.64 -54.77 2.19 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.629 -0.508 . . . . 2.6099999999999999 109.629 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 19.7 Cg_endo -63.11 120.42 7.89 Favored 'Trans proline' 0 C--N 1.379 2.163 0 N-CA-C 107.384 -1.814 . . . . 0.78000000000000003 107.384 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.0 12.52 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.193 -0.458 . . . . 0.78000000000000003 111.807 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.503 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 87.4 Cg_endo -76.64 149.69 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.11 1.874 . . . . 0.56000000000000005 111.698 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -76.13 109.37 9.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 29' ' ' VAL . 90.8 mt -87.36 125.68 34.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.876 0.37 . . . . 0.5 110.953 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -135.52 130.95 35.39 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.223 -0.444 . . . . 3.7799999999999998 110.11 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -90.97 131.56 36.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.749 -0.659 . . . . 0.28999999999999998 109.734 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -104.88 127.03 52.55 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 105.247 -2.131 . . . . 0.94999999999999996 105.247 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.29 109.54 16.97 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 122.662 0.385 . . . . 0.88 110.254 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.8 t30 51.35 52.36 14.96 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.344 1.028 . . . . 1.79 110.58 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.73 51.01 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 114.541 -1.209 . . . . 0.60999999999999999 114.179 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -122.7 161.27 24.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.862 -0.792 . . . . 1.3700000000000001 108.862 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.78 117.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 115.338 -0.846 . . . . 0.69999999999999996 110.416 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.64 98.53 9.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.076 -0.65 . . . . 0.60999999999999999 110.085 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -84.62 95.64 8.94 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 103.951 -2.611 . . . . 2.4700000000000002 103.951 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.99 125.54 23.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.875 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.5 p -103.9 -165.44 1.15 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.14 -0.936 . . . . 1.5700000000000001 111.852 -172.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -84.49 -9.93 57.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.906 0.86 . . . . 1.52 108.876 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -89.02 -39.7 13.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.417 -0.81 . . . . 1.5900000000000001 109.094 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 40.5 mt -127.48 106.38 15.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.755 -1.572 . . . . 0.5 106.755 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 32.3 p90 -131.39 150.37 52.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 119.608 -0.837 . . . . 2.8900000000000001 112.728 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 m -92.55 110.51 21.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.716 -1.129 . . . . 0.44 110.105 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.48 113.11 23.73 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.693 -0.854 . . . . 2.04 108.693 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.54 138.03 31.81 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.544 0.687 . . . . 0.87 110.687 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' HIS . 11.0 mt -100.71 136.67 40.21 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.055 -0.975 . . . . 1.25 109.606 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -68.52 112.84 12.36 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 124.802 1.314 . . . . 3.3599999999999999 111.983 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.33 155.06 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.197 2.598 . . . . 1.3899999999999999 110.172 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.09 19.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 119.097 -0.478 . . . . 1.53 109.74 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.03 85.09 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 118.724 0.693 . . . . 1.9099999999999999 112.695 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.07 -2.67 58.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.173 1.175 . . . . 3.4900000000000002 114.173 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -101.17 157.59 16.66 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.592 -0.843 . . . . 1.8899999999999999 108.825 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 p -112.4 15.93 20.08 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.834 0.349 . . . . 1.3 111.697 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.12 124.57 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 119.967 -0.693 . . . . 0.60999999999999999 110.363 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.0 mtp180 -95.73 116.59 29.1 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 105.665 -1.976 . . . . 1.8400000000000001 105.665 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 55.7 m-70 -98.73 149.5 22.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.181 -1.044 . . . . 1.1599999999999999 108.181 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.01 174.96 46.01 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 119.338 -1.41 . . . . 0.31 112.388 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -144.76 132.66 21.3 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.471 0.708 . . . . 0.35999999999999999 109.929 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 42.2 tp -88.44 113.18 23.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.644 -1.984 . . . . 0.28000000000000003 105.644 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -107.34 123.37 48.24 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.131 0.491 . . . . 2.6800000000000002 111.596 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 52' ' ' ILE . 49.5 mt -84.79 108.37 17.44 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 106.567 -1.642 . . . . 1.23 106.567 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.3 t30 -73.4 -52.94 12.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.071 -0.968 . . . . 2.1800000000000002 109.059 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -112.0 101.23 51.25 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.56 -1.274 . . . . 2.8199999999999998 107.56 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.04 129.47 18.41 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.688 1.592 . . . . 1.25 110.331 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 p -138.62 168.88 18.83 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -76.13 -6.01 49.24 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 122.243 -0.286 . . . . 2.0299999999999998 111.479 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.44 -21.41 10.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 109.212 -0.662 . . . . 1.3300000000000001 109.212 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.27 -10.6 59.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.657 0.741 . . . . 2.1899999999999999 109.799 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 11.2 t30 -83.57 75.97 9.99 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.23 -1.396 . . . . 1.96 107.23 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.55 -171.58 27.78 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.21 -0.905 . . . . 0.48999999999999999 111.533 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.29 128.23 38.06 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.42 0.526 . . . . 2.23 112.42 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.47 123.09 48.54 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.224 -1.028 . . . . 0.68999999999999995 108.224 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 61.7 m -115.42 128.99 56.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.19 -0.671 . . . . 0.34000000000000002 109.19 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.1 tp -99.61 114.59 27.73 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.1 -0.704 . . . . 0.22 109.1 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.14 131.01 50.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.157 -1.053 . . . . 0.35999999999999999 108.157 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -121.14 119.04 31.23 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.916 -1.142 . . . . 0.31 107.916 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.16 130.4 46.29 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.235 -0.439 . . . . 0.60999999999999999 110.045 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 42.9 t-20 -155.63 136.36 8.92 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.411 -1.329 . . . . 1.1799999999999999 107.411 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.12 -17.11 23.81 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.968 3.112 . . . . 1.0 113.352 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.87 -22.49 45.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 1.1000000000000001 109.537 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.46 146.9 4.51 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.971 -1.252 . . . . 0.58999999999999997 109.971 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -90.94 135.34 33.8 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.639 -0.504 . . . . 1.5700000000000001 109.639 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -114.85 151.67 33.5 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.06 -1.089 . . . . 0.37 108.06 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.9 p -160.33 148.96 16.9 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.103 0.478 . . . . 0.56999999999999995 111.824 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.04 156.97 44.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.365 -1.346 . . . . 0.29999999999999999 107.365 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -133.4 132.38 41.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.175 -0.676 . . . . 1.26 109.175 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.78 133.14 41.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.808 -0.812 . . . . 0.71999999999999997 108.808 -176.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 48.2 ttm -108.95 125.78 52.39 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.877 -0.514 . . . . 1.25 109.7 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -98.05 113.67 25.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.524 -0.917 . . . . 0.57999999999999996 108.524 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.26 100.16 12.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.014 -0.735 . . . . 0.83999999999999997 109.014 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 36.0 t80 . . . . . 0 C--N 1.3 -1.552 0 CA-C-N 114.828 -1.078 . . . . 3.8599999999999999 111.831 177.626 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.414 -2.273 0 CA-C-O 121.494 0.664 . . . . 1.5800000000000001 109.257 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -87.13 129.2 35.03 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.272 -1.01 . . . . 1.1899999999999999 108.272 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.84 -179.94 7.41 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.322 -0.992 . . . . 1.3200000000000001 108.322 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.22 117.64 30.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 CA-C-O 121.217 0.532 . . . . 0.45000000000000001 110.345 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -118.44 134.48 55.03 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 107.039 -1.467 . . . . 1.1899999999999999 107.039 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 94' ' ' ALA . 68.4 t -122.99 119.16 57.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 120.939 -0.305 . . . . 0.28999999999999998 110.906 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -119.15 117.74 29.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.547 0.689 . . . . 2.1800000000000002 110.505 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.797 HD13 HG22 ' A' ' 98' ' ' ILE . 40.8 mt -100.37 157.15 16.83 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.048 -0.978 . . . . 0.33000000000000002 111.053 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -130.93 144.52 51.53 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.178 -1.045 . . . . 1.03 108.178 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -67.91 137.77 55.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.631 -0.878 . . . . 0.48999999999999999 108.631 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -47.25 137.82 7.78 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.27 1.028 . . . . 0.40000000000000002 111.884 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.65 138.35 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.574 -0.739 . . . . 0.56999999999999995 111.06 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.54 89.43 0.36 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.205 -1.362 . . . . 2.52 112.316 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -150.17 178.52 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.376 -1.342 . . . . 0.88 107.376 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -66.19 -46.46 77.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 119.028 0.831 . . . . 2.75 111.091 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -91.7 128.84 37.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -82.6 120.37 25.45 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.918 0.866 . . . . 0.85999999999999999 112.545 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 40.5 t -120.51 121.4 38.37 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.263 -1.335 . . . . 0.29999999999999999 109.684 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 68.5 mt -102.43 97.64 9.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 107.844 -1.169 . . . . 0.29999999999999999 107.844 174.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 15.2 Cg_exo -69.04 135.54 32.44 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.345 2.03 . . . . 0.28000000000000003 111.913 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -128.7 149.34 50.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.311 0.577 . . . . 0.37 110.575 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.0 m -131.49 112.21 12.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.318 -0.856 . . . . 0.88 108.76 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.9 124.74 71.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.837 -0.62 . . . . 0.27000000000000002 109.721 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t0 -101.17 144.07 30.49 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.22 -1.029 . . . . 1.3899999999999999 108.22 -176.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 158.52 8.67 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 111.43 -0.668 . . . . 0.59999999999999998 111.43 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.407 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 15.3 mm100 -99.94 -58.02 0.13 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-O 118.916 -0.564 . . . . 2.6099999999999999 110.902 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.1 Cg_endo -58.0 125.07 17.48 Favored 'Trans proline' 0 C--N 1.366 1.49 0 N-CA-C 108.064 -1.552 . . . . 0.78000000000000003 108.064 169.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 115.69 19.73 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-O 120.988 0.423 . . . . 0.78000000000000003 111.768 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 91.4 Cg_endo -83.63 142.45 10.34 Favored 'Trans proline' 0 N--CA 1.424 -2.585 0 C-N-CA 121.515 1.477 . . . . 0.56000000000000005 110.748 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 m -75.28 105.39 6.28 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.919 -1.141 . . . . 1.3700000000000001 107.919 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.06 116.92 18.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.327 0.584 . . . . 0.5 110.019 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' A' ' 45' ' ' VAL . 8.4 tpp180 -129.3 130.2 45.85 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.222 -0.899 . . . . 3.7799999999999998 109.735 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 90.3 m95 -100.09 140.29 34.53 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.091 -0.707 . . . . 0.28999999999999998 109.091 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 tp -119.56 127.72 53.26 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 105.957 -1.868 . . . . 0.94999999999999996 105.957 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -121.82 109.41 14.63 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.983 -0.377 . . . . 0.88 109.983 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.8 t30 62.08 29.62 17.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.005 0.907 . . . . 1.79 109.967 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.41 60.14 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.309 -0.859 . . . . 0.60999999999999999 112.62 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.0 t -93.18 142.59 27.13 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.969 -0.752 . . . . 1.3700000000000001 108.969 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' HD2' ' A' ' 38' ' ' ARG . 53.9 t -67.45 111.01 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.685 -0.688 . . . . 0.69999999999999996 110.3 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.42 97.53 9.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.374 -0.83 . . . . 0.60999999999999999 109.23 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.59 127.43 34.06 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.174 -1.417 . . . . 2.4700000000000002 107.174 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.3 mp0 -61.32 120.45 10.45 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 123.923 0.764 . . . . 1.74 110.659 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.0 p -106.67 -167.39 1.28 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.878 -0.601 . . . . 1.5700000000000001 109.827 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -80.96 -16.86 52.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.789 -0.819 . . . . 1.52 108.789 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.75 -41.7 11.11 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.102 -0.499 . . . . 1.5900000000000001 110.438 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -124.41 106.29 16.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.382 -1.71 . . . . 0.5 106.382 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -130.39 141.93 50.53 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.901 -0.72 . . . . 2.8900000000000001 111.248 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -83.31 109.97 17.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.896 -0.779 . . . . 0.44 108.896 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 71' ' ' ARG . 42.3 mt-10 -109.9 155.33 21.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.3 0.571 . . . . 2.04 110.222 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.88 151.31 40.82 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 107.749 -1.204 . . . . 0.87 107.749 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -108.82 166.15 11.03 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.251 -1.759 . . . . 1.25 106.251 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -50.94 102.88 0.33 Allowed Pre-proline 0 N--CA 1.473 0.725 0 O-C-N 123.957 0.785 . . . . 3.3599999999999999 110.367 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.04 129.45 2.01 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.571 2.181 . . . . 1.3899999999999999 113.411 -173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 121.11 15.26 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.347 -0.842 . . . . 1.53 109.828 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.08 -4.83 59.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.061 0.457 . . . . 1.9099999999999999 109.896 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -63.72 -39.33 94.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.697 -1.224 . . . . 3.4900000000000002 107.697 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.99 163.74 12.03 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.84 -1.073 . . . . 1.8899999999999999 108.375 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.2 p -94.96 23.63 5.43 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.655 0.264 . . . . 1.3 111.383 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 24.1 t -116.88 129.47 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-O 121.178 0.514 . . . . 0.60999999999999999 110.749 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -91.74 132.4 36.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.906 -1.516 . . . . 1.8400000000000001 106.906 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.19 128.05 56.36 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.451 -0.574 . . . . 1.1599999999999999 109.451 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.58 -169.06 17.45 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 111.068 -0.813 . . . . 0.31 111.068 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.1 t -152.0 133.3 14.48 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 120.92 0.391 . . . . 0.35999999999999999 110.81 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 46.3 tp -84.61 90.78 7.75 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 104.747 -2.316 . . . . 0.28000000000000003 104.747 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 55' ' ' GLU . 50.1 ttp180 -95.87 120.94 37.03 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 115.595 -0.729 . . . . 2.6800000000000002 109.734 -176.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.35 108.6 17.9 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.862 -1.532 . . . . 1.23 106.862 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.74 -40.18 91.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.759 -1.564 . . . . 2.1800000000000002 110.64 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -128.69 101.42 20.69 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.813 -0.81 . . . . 2.8199999999999998 108.813 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.59 130.41 14.81 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.357 2.038 . . . . 1.25 112.458 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 p -139.39 165.13 28.03 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.958 -1.127 . . . . 1.22 107.958 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -76.82 -5.66 49.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.285 0.846 . . . . 2.0299999999999998 113.285 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.54 -11.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.089 0.471 . . . . 1.3300000000000001 109.791 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -92.52 26.49 2.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.571 0.701 . . . . 2.1899999999999999 110.038 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 101' ' ' ALA . 17.6 t30 -117.51 114.8 23.99 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.344 -0.984 . . . . 1.96 108.344 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.76 -159.2 32.19 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.521 -0.847 . . . . 0.48999999999999999 112.378 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -88.3 118.01 27.61 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.671 0.388 . . . . 2.23 111.657 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.564 ' HB2' HG23 ' A' ' 98' ' ' ILE . 57.0 m-85 -106.8 137.56 44.6 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.588 -0.893 . . . . 0.68999999999999995 108.588 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 m -137.72 133.89 34.7 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.792 -0.818 . . . . 0.34000000000000002 108.792 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' CE2' ' A' ' 39' ' ' TRP . 53.0 tp -106.11 120.68 42.42 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 109.736 -0.468 . . . . 0.22 109.736 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.42 133.41 51.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.339 -0.986 . . . . 0.35999999999999999 108.339 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.66 121.18 25.09 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.999 -1.111 . . . . 0.31 107.999 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.59 132.53 53.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.024 0.202 . . . . 0.60999999999999999 110.507 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 31.9 p30 -148.33 173.61 4.07 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-O 117.965 -1.017 . . . . 1.1799999999999999 108.722 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 17.3 Cg_exo -41.57 -32.29 1.4 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.742 2.961 . . . . 1.0 116.318 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.8 t -81.85 -33.41 30.67 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.698 -0.626 . . . . 1.1000000000000001 111.735 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.15 -161.94 35.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.563 -1.303 . . . . 0.58999999999999997 112.825 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.25 133.38 47.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.805 -0.813 . . . . 1.5700000000000001 108.805 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.27 154.35 29.25 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.656 -0.868 . . . . 0.37 108.656 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 13.4 p -149.5 123.77 9.57 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 123.72 0.637 . . . . 0.56999999999999995 111.256 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.22 149.8 48.8 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.229 -1.397 . . . . 0.29999999999999999 107.229 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.8 p -118.63 147.99 43.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.638 . . . . 1.26 112.598 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.797 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -140.59 118.88 10.28 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 C-N-CA 124.767 1.227 . . . . 0.71999999999999997 109.041 177.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.88 100.75 11.1 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.389 -1.708 . . . . 1.25 106.389 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.77 113.47 26.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.656 0.741 . . . . 0.57999999999999996 111.007 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -105.13 104.98 14.82 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.566 -1.197 . . . . 0.83999999999999997 108.611 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 C--N 1.308 -1.225 0 C-N-CA 120.304 -0.558 . . . . 3.8599999999999999 110.791 179.676 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.413 -2.283 0 N-CA-C 108.49 -0.929 . . . . 1.5800000000000001 108.49 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 27.6 m-85 -75.06 121.4 21.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.3 -1.371 . . . . 1.1899999999999999 107.3 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -83.95 -174.16 5.13 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.154 -1.054 . . . . 1.3200000000000001 108.154 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.36 118.35 30.83 Favored 'General case' 0 CA--C 1.474 -1.942 0 C-N-CA 119.128 -1.029 . . . . 0.45000000000000001 109.652 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.1 m -116.67 130.66 56.86 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.789 -1.096 . . . . 1.1899999999999999 108.569 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 85' ' ' LEU . 77.8 t -116.68 119.5 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.331 -0.395 . . . . 0.28999999999999998 111.379 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -115.11 120.41 39.71 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.162 -0.681 . . . . 2.1800000000000002 109.162 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 27' ' ' PHE . 33.5 mt -98.41 155.13 17.39 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 109.589 -0.522 . . . . 0.33000000000000002 109.589 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.67 147.18 52.49 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.917 -1.142 . . . . 1.03 107.917 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 m -60.96 131.72 51.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 124.118 0.886 . . . . 0.48999999999999999 109.41 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.36 139.27 19.74 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.403 1.064 . . . . 0.40000000000000002 111.44 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.9 140.98 15.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.515 0.674 . . . . 0.56999999999999995 110.137 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.72 102.33 11.46 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.346 -1.297 . . . . 2.52 111.731 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -145.12 -167.47 2.68 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.106 -1.442 . . . . 0.88 107.106 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -77.93 -49.46 14.12 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.843 -1.54 . . . . 2.75 106.843 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -89.82 120.13 30.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 172.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.62 134.25 35.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.106 0.479 . . . . 0.85999999999999999 111.05 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.7 t -125.99 126.07 43.71 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.214 -0.903 . . . . 0.29999999999999999 110.555 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 71.9 mt -101.33 102.75 22.64 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.149 -1.426 . . . . 0.29999999999999999 107.149 173.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.14 138.8 23.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.251 1.967 . . . . 0.28000000000000003 111.558 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB3' HD23 ' A' ' 14' ' ' LEU . 50.3 p90 -133.29 144.27 49.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.871 0.367 . . . . 0.37 110.731 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -121.59 106.24 11.18 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.447 -0.945 . . . . 0.88 108.447 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.0 p -114.33 117.86 56.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.684 -0.858 . . . . 0.27000000000000002 108.684 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -117.79 156.92 27.49 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.301 -0.56 . . . . 1.3899999999999999 109.491 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 149.38 5.31 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 108.323 -1.911 . . . . 0.59999999999999998 108.323 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -86.47 -53.54 0.42 Allowed Pre-proline 0 C--N 1.311 -1.095 0 C-N-CA 118.857 -1.137 . . . . 2.6099999999999999 110.857 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 14.2 Cg_endo -62.75 119.31 6.34 Favored 'Trans proline' 0 C--N 1.373 1.824 0 N-CA-C 107.439 -1.793 . . . . 0.78000000000000003 107.439 167.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.11 118.7 61.28 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 115.475 -0.784 . . . . 0.78000000000000003 112.156 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -86.84 160.33 8.98 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.108 1.872 . . . . 0.56000000000000005 112.398 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -96.99 138.19 34.9 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.235 -1.024 . . . . 1.3700000000000001 108.235 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 HG11 ' A' ' 29' ' ' VAL . 95.1 mt -101.33 134.63 44.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.185 0.517 . . . . 0.5 111.526 -175.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -136.75 131.34 33.3 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.483 -0.781 . . . . 3.7799999999999998 110.248 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -97.34 138.54 34.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.873 -0.603 . . . . 0.28999999999999998 110.647 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -129.8 137.04 50.28 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.716 -1.957 . . . . 0.94999999999999996 105.716 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.45 119.68 20.94 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.962 -0.385 . . . . 0.88 109.962 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 60.06 26.34 15.67 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.24 1.019 . . . . 1.79 110.885 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.28 82.15 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.60999999999999999 112.252 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 p -108.26 150.86 26.72 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.012 0.434 . . . . 1.3700000000000001 110.391 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.45 114.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.436 -0.802 . . . . 0.69999999999999996 112.148 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.38 122.1 32.95 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.936 -1.135 . . . . 0.60999999999999999 107.936 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.41 137.11 40.18 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.01 -0.541 . . . . 2.4700000000000002 110.029 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.52 121.03 12.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -138.09 -163.99 1.55 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 120.455 -0.498 . . . . 1.5700000000000001 110.715 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -64.56 -49.89 69.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.631 0.604 . . . . 1.52 112.631 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -84.87 -31.76 23.58 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 1.5900000000000001 112.013 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 79' ' ' ASN . 21.0 mt -114.42 106.66 21.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.705 -1.591 . . . . 0.5 106.705 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.23 154.21 50.22 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.542 0.687 . . . . 2.8900000000000001 111.369 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -95.14 129.3 42.29 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.311 -0.859 . . . . 0.44 109.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -123.13 129.39 51.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.032 -1.47 . . . . 2.04 107.032 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.58 120.84 37.63 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.625 -0.509 . . . . 0.87 109.625 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.15 153.84 27.03 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.548 . . . . 1.25 106.822 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.56 102.05 0.29 Allowed Pre-proline 0 C--N 1.313 -0.998 0 C-N-CA 125.901 1.68 . . . . 3.3599999999999999 114.0 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -88.91 146.71 5.62 Favored 'Trans proline' 0 C--O 1.264 1.79 0 C-N-CA 122.135 1.89 . . . . 1.3899999999999999 110.383 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -84.97 155.08 21.76 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.255 -1.017 . . . . 1.53 108.255 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.54 -22.1 61.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.417 -0.811 . . . . 1.9099999999999999 112.448 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.17 -2.29 43.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.425 0.528 . . . . 3.4900000000000002 112.425 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 54.8 mt-10 -83.04 136.84 34.35 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 109.112 -0.699 . . . . 1.8899999999999999 109.112 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -103.72 27.83 7.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.827 1.298 . . . . 1.3 108.157 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 129.42 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.2 -1.364 . . . . 0.60999999999999999 108.087 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.648 ' HB3' HG13 ' A' ' 29' ' ' VAL . 37.2 ttm180 -93.86 119.12 32.38 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.934 -1.506 . . . . 1.8400000000000001 106.934 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -98.39 115.41 28.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.345 -0.983 . . . . 1.1599999999999999 108.345 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 27' ' ' PHE . . . -133.22 166.0 23.88 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.157 -1.497 . . . . 0.31 113.517 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 t -139.88 131.93 27.91 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.541 0.736 . . . . 0.35999999999999999 109.748 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.0 tp -96.39 103.44 15.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.518 -2.03 . . . . 0.28000000000000003 105.518 171.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -108.12 127.91 54.22 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.783 0.801 . . . . 2.6800000000000002 111.539 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.401 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.5 mp -103.67 109.43 21.12 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.462 -1.245 . . . . 1.23 108.744 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -66.42 -36.39 82.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.554 -1.203 . . . . 2.1800000000000002 109.677 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -134.48 101.35 12.09 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 108.021 -1.103 . . . . 2.8199999999999998 108.021 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.21 130.75 11.32 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.257 1.971 . . . . 1.25 110.329 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -117.56 169.94 9.15 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.684 -0.487 . . . . 1.22 109.684 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -76.27 -7.01 53.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.655 0.613 . . . . 2.0299999999999998 112.655 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.59 -9.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.503 -0.555 . . . . 1.3300000000000001 109.503 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.479 HD21 HD11 ' A' ' 52' ' ' ILE . 10.8 m120 -99.59 26.85 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.401 0.68 . . . . 2.1899999999999999 110.105 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -111.42 100.21 8.84 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.785 -0.82 . . . . 1.96 108.785 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.81 -157.61 30.17 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.335 -1.412 . . . . 0.48999999999999999 113.85 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.53 118.73 30.21 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.355 0.662 . . . . 2.23 112.293 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.13 127.29 46.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.828 -1.078 . . . . 0.68999999999999995 108.316 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 29.4 m -117.69 127.22 53.72 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 108.886 -0.783 . . . . 0.34000000000000002 108.886 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.2 tp -103.39 125.71 50.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.645 -0.502 . . . . 0.22 109.645 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.7 mm? -108.45 129.34 55.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 124.178 0.924 . . . . 0.35999999999999999 108.794 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.78 121.6 35.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.288 -1.375 . . . . 0.31 107.288 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.49 54.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 112.508 0.558 . . . . 0.60999999999999999 112.508 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -141.25 162.96 44.87 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.986 -1.487 . . . . 1.1799999999999999 106.986 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -47.55 -29.68 10.84 Favored 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 122.716 2.278 . . . . 1.0 114.775 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.63 -29.26 64.45 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.008 -0.432 . . . . 1.1000000000000001 111.804 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.93 165.88 21.86 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.787 -1.197 . . . . 0.58999999999999997 112.557 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.34 122.5 47.12 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.713 -1.217 . . . . 1.5700000000000001 107.713 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.64 145.94 28.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.944 -0.762 . . . . 0.37 108.944 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 35.0 p -138.05 138.82 39.17 Favored 'General case' 0 N--CA 1.416 -2.161 0 O-C-N 123.669 0.606 . . . . 0.56999999999999995 109.837 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.34 155.7 47.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.246 -1.391 . . . . 0.29999999999999999 107.246 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 p -127.75 143.1 51.15 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.654 0.264 . . . . 1.26 111.686 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.461 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -139.58 131.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.804 -1.924 . . . . 0.71999999999999997 105.804 176.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 ttt -112.32 107.5 16.35 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.81 -0.756 . . . . 1.25 109.202 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.37 126.48 55.41 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.292 0.568 . . . . 0.57999999999999996 111.575 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.05 103.39 15.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.188 -0.915 . . . . 0.83999999999999997 108.689 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 C--N 1.314 -0.974 0 C-N-CA 120.381 -0.528 . . . . 3.8599999999999999 110.795 177.872 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.392 -3.337 0 N-CA-C 107.037 -1.468 . . . . 1.5800000000000001 107.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 65.2 m-85 -68.1 134.52 50.71 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.67 -1.233 . . . . 1.1899999999999999 107.67 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.58 -174.81 5.5 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.572 -1.27 . . . . 1.3200000000000001 107.572 -174.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.17 121.89 34.99 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 119.788 -0.765 . . . . 0.45000000000000001 109.462 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -125.13 135.05 52.28 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.764 -1.199 . . . . 1.1899999999999999 107.764 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 94' ' ' ALA . 52.2 t -122.54 119.11 57.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.94 0.4 . . . . 0.28999999999999998 111.435 -173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -118.08 116.56 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.952 -0.759 . . . . 2.1800000000000002 108.952 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 98' ' ' ILE . 32.7 mt -98.13 155.95 16.9 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.263 -0.643 . . . . 0.33000000000000002 109.263 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -130.86 153.92 48.61 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.783 -1.192 . . . . 1.03 107.783 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.0 m -59.32 133.64 56.28 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 124.729 1.268 . . . . 0.48999999999999999 110.62 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -69.9 151.78 45.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.417 -0.81 . . . . 0.40000000000000002 109.152 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.98 126.73 44.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.689 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 23' ' ' TRP . 28.0 mm-40 -72.24 88.83 1.16 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.998 -1.001 . . . . 2.52 110.565 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.28 -178.86 7.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.674 -0.862 . . . . 0.88 108.674 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -61.82 -42.52 99.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.577 0.626 . . . . 2.75 112.067 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.08 109.11 21.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.992 -1.114 . . . . 2.46 107.992 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 92.1 m95 -82.27 106.97 14.59 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.306 0.574 . . . . 0.85999999999999999 111.602 -174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.0 t -104.48 116.97 33.03 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.574 -1.194 . . . . 0.29999999999999999 109.023 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.1 mt -102.84 100.14 15.75 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 107.858 -1.164 . . . . 0.29999999999999999 107.858 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -73.41 130.02 14.53 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.258 1.972 . . . . 0.28000000000000003 111.738 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -122.3 155.75 35.28 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.209 0.528 . . . . 0.37 110.522 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -138.24 106.98 5.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.462 -0.94 . . . . 0.88 108.462 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.3 p -113.28 117.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.059 0.457 . . . . 0.27000000000000002 110.008 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.9 t70 -101.91 136.97 40.83 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.946 -0.57 . . . . 1.3899999999999999 110.461 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.08 150.6 7.95 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.363 -1.095 . . . . 0.59999999999999998 110.363 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -82.88 -58.79 0.41 Allowed Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 107.322 -1.362 . . . . 2.6099999999999999 107.322 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 38.0 Cg_endo -71.97 120.98 7.19 Favored 'Trans proline' 0 C--N 1.369 1.607 0 N-CA-C 108.173 -1.51 . . . . 0.78000000000000003 108.173 168.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.7 113.63 8.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 0.78000000000000003 111.065 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.48 142.43 14.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.452 2.101 . . . . 0.56000000000000005 111.734 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 p -69.47 127.77 34.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.631 -0.713 . . . . 1.3700000000000001 110.019 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.3 mt -98.94 126.16 44.55 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.88 -0.6 . . . . 0.5 111.069 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -131.85 127.59 36.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.88 -0.6 . . . . 3.7799999999999998 110.176 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.0 m95 -92.91 126.95 38.24 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.28999999999999998 110.312 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.94 126.92 54.52 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.677 -1.601 . . . . 0.94999999999999996 106.677 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -115.74 102.97 10.21 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.177 -0.675 . . . . 0.88 109.177 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 54.15 40.42 31.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.055 0.942 . . . . 1.79 112.101 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.1 84.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.671 -0.695 . . . . 0.60999999999999999 113.689 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -114.04 136.94 52.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 117.449 0.624 . . . . 1.3700000000000001 109.716 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.77 121.06 13.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.217 -0.447 . . . . 0.69999999999999996 110.266 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 tp -82.27 137.82 34.75 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.451 -1.315 . . . . 0.60999999999999999 107.451 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -109.21 121.22 44.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 123.354 0.409 . . . . 2.4700000000000002 110.229 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 119.64 13.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.868 -0.79 . . . . 1.74 108.868 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -150.06 -174.03 4.61 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.828 -0.804 . . . . 1.5700000000000001 108.828 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 t -70.73 3.68 3.02 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 112.932 0.715 . . . . 1.52 112.932 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.16 -28.39 9.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.871 -0.518 . . . . 1.5900000000000001 109.921 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -149.02 108.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.894 -1.15 . . . . 0.5 107.894 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -135.59 156.28 49.12 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.785 0.661 . . . . 2.8900000000000001 112.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -100.31 110.43 22.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.421 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.34 146.26 24.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.78 -0.822 . . . . 2.04 108.78 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.07 156.88 32.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.314 -0.624 . . . . 0.87 109.314 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.26 160.35 29.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.422 -1.325 . . . . 1.25 107.422 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 34.6 mm-40 -71.68 120.28 79.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 113.916 1.08 . . . . 3.3599999999999999 113.916 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.53 145.1 29.31 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 123.198 2.599 . . . . 1.3899999999999999 111.071 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.54 162.0 16.65 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.485 -0.932 . . . . 1.53 108.485 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.75 -11.38 60.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.931 0.715 . . . . 1.9099999999999999 112.931 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -91.19 3.31 55.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.167 0.984 . . . . 3.4900000000000002 108.517 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 151.7 48.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.062 -0.972 . . . . 1.8899999999999999 108.956 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -120.29 23.88 10.69 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.498 -1.667 . . . . 1.3 106.498 165.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 15.1 t -99.76 123.48 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 113.303 -1.771 . . . . 0.60999999999999999 109.526 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' VAL . 62.1 mtp180 -89.01 116.32 27.21 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.173 -1.788 . . . . 1.8400000000000001 106.173 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -101.2 137.88 38.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.329 -0.989 . . . . 1.1599999999999999 108.329 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.45 -170.39 30.33 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 120.19 -1.005 . . . . 0.31 111.046 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.9 t -150.41 132.48 15.29 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 120.874 0.368 . . . . 0.35999999999999999 110.841 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.6 tp -90.13 111.82 23.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.301 -2.111 . . . . 0.28000000000000003 105.301 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 10.1 ptp180 -114.09 128.91 56.59 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.046 -1.062 . . . . 2.6800000000000002 112.49 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.84 107.09 18.79 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 105.455 -2.054 . . . . 1.23 105.455 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -80.81 -35.26 33.25 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.234 -0.439 . . . . 2.1800000000000002 110.524 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.47 99.79 51.48 Favored Pre-proline 0 N--CA 1.421 -1.909 0 N-CA-C 108.172 -1.048 . . . . 2.8199999999999998 108.172 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -84.13 143.09 10.1 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 122.229 1.953 . . . . 1.25 111.411 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -136.82 160.93 37.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.108 -1.071 . . . . 1.22 108.108 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.71 -6.89 2.89 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.963 1.097 . . . . 2.0299999999999998 113.963 -173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.86 -9.93 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.797 0.332 . . . . 1.3300000000000001 110.572 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -77.86 8.92 3.98 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.643 0.979 . . . . 2.1899999999999999 113.643 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -91.4 88.56 6.88 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.393 -1.706 . . . . 1.96 106.393 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.65 -171.29 27.51 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.458 -1.83 . . . . 0.48999999999999999 114.536 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -98.88 103.79 15.78 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.051 0.94 . . . . 2.23 110.611 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -93.3 105.96 17.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.865 -0.791 . . . . 0.68999999999999995 108.865 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.0 m -103.93 125.94 50.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.239 -0.652 . . . . 0.34000000000000002 109.239 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.5 tp -100.6 118.28 36.45 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.009 -0.737 . . . . 0.22 109.009 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 130.38 47.21 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.46 -0.941 . . . . 0.35999999999999999 108.46 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 121.11 28.74 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.31 107.557 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.47 130.78 44.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 123.399 0.437 . . . . 0.60999999999999999 110.504 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.1 p30 -134.9 171.27 9.28 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.415 -1.328 . . . . 1.1799999999999999 107.415 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.3 Cg_exo -49.41 -30.11 19.76 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.448 2.099 . . . . 1.0 114.145 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.83 -50.99 37.41 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 111.747 0.277 . . . . 1.1000000000000001 111.747 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.92 45.22 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.452 -1.356 . . . . 0.58999999999999997 112.933 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -123.55 133.09 54.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.928 0.428 . . . . 1.5700000000000001 110.345 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.244 -1.021 . . . . 0.37 108.244 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 31.9 p -144.96 138.84 27.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 109.583 -0.525 . . . . 0.56999999999999995 109.583 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.72 152.36 47.92 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.384 -1.339 . . . . 0.29999999999999999 107.384 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 m -131.48 141.32 49.75 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.597 -0.441 . . . . 1.26 111.134 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.465 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.34 123.96 39.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 106.441 -1.689 . . . . 0.71999999999999997 106.441 176.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -103.88 98.87 8.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.243 -0.651 . . . . 1.25 109.243 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.89 27.28 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.416 -0.811 . . . . 0.57999999999999996 110.645 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.17 143.33 42.08 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.935 -1.135 . . . . 0.83999999999999997 107.935 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 75' ' ' PRO . 19.3 t80 . . . . . 0 C--N 1.29 -1.988 0 N-CA-C 112.662 0.616 . . . . 3.8599999999999999 112.662 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.401 -2.896 0 CA-C-O 121.662 0.744 . . . . 1.5800000000000001 111.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 p90 -130.38 134.54 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.721 -1.127 . . . . 1.1899999999999999 108.993 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 73.0 m -84.17 -166.19 1.36 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.57 -0.741 . . . . 1.3200000000000001 111.93 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 131.72 39.74 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.69 0.757 . . . . 0.45000000000000001 112.018 -172.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 29.4 t -111.72 137.48 49.57 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.954 -1.499 . . . . 1.1899999999999999 106.954 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 94' ' ' ALA . 86.0 t -115.6 114.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.116 -0.698 . . . . 0.28999999999999998 109.116 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 96.0 mt-30 -108.44 116.03 31.2 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.033 -0.728 . . . . 2.1800000000000002 109.033 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 98' ' ' ILE . 23.9 mt -98.97 151.22 21.15 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.539 -0.541 . . . . 0.33000000000000002 109.539 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -131.32 148.8 52.72 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.43 -0.952 . . . . 1.03 108.43 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -56.59 136.39 54.54 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.224 1.41 . . . . 0.48999999999999999 109.617 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -62.96 143.2 57.94 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.952 0.783 . . . . 0.40000000000000002 110.61 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.81 127.58 44.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 109.485 -0.561 . . . . 0.56999999999999995 109.485 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.73 116.48 16.48 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.522 -0.763 . . . . 2.52 110.567 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.2 ptt? -168.2 -177.06 3.14 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.966 -1.494 . . . . 0.88 106.966 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -71.34 -39.46 71.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 119.517 1.053 . . . . 2.75 112.208 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 20' ' ' MET . 37.5 m80 -98.59 115.14 27.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.42 -1.326 . . . . 2.46 107.42 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' HD12 ' A' ' 72' ' ' LEU . 84.0 m95 -81.77 137.94 35.25 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 0.85999999999999999 111.953 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.81 120.62 21.83 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.46 -1.245 . . . . 0.29999999999999999 109.144 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 17' ' ' ALA . 54.9 mt -102.9 100.0 15.46 Favored Pre-proline 0 C--O 1.247 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.29999999999999999 106.88 172.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.54 135.57 20.19 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.338 2.026 . . . . 0.28000000000000003 112.084 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.7 p90 -127.33 155.85 42.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.16 -0.473 . . . . 0.37 109.833 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 10.4 m -132.58 106.32 7.75 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.768 -1.197 . . . . 0.88 107.768 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.4 p -110.74 119.28 59.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.67 -0.863 . . . . 0.27000000000000002 108.67 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 21.8 t70 -121.22 128.15 52.15 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.624 -0.716 . . . . 1.3899999999999999 111.303 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.71 147.85 9.35 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.776 -1.73 . . . . 0.59999999999999998 108.776 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.16 -55.96 1.69 Allowed Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.091 -0.707 . . . . 2.6099999999999999 109.091 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.545 ' HB2' HD21 ' A' ' 89' ' ' ASN . 25.2 Cg_endo -63.77 122.01 9.93 Favored 'Trans proline' 0 C--N 1.376 2.0 0 N-CA-C 108.283 -1.468 . . . . 0.78000000000000003 108.283 169.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.35 121.76 84.31 Favored Pre-proline 0 C--N 1.298 -1.652 0 CA-C-N 115.818 -0.628 . . . . 0.78000000000000003 112.166 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -90.97 167.77 3.7 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.713 2.276 . . . . 0.56000000000000005 112.464 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -105.62 126.73 52.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.12 -1.067 . . . . 1.3700000000000001 108.12 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.99 143.92 26.36 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.883 0.373 . . . . 0.5 111.843 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -144.54 137.99 27.21 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.595 1.158 . . . . 3.7799999999999998 109.221 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -102.93 146.0 28.99 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.67 0.748 . . . . 0.28999999999999998 110.871 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 19.2 tp -131.59 127.75 37.75 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.667 -1.605 . . . . 0.94999999999999996 106.667 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -111.95 106.16 14.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 110.228 -0.286 . . . . 0.88 110.228 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 57.0 30.02 17.44 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.514 0.725 . . . . 1.79 111.883 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.34 64.52 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.741 -0.742 . . . . 0.60999999999999999 112.086 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 m -90.48 129.85 36.6 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.629 -0.508 . . . . 1.3700000000000001 109.629 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.37 117.22 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.572 -0.74 . . . . 0.69999999999999996 110.342 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.0 tp -97.58 101.3 12.79 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.409 -0.814 . . . . 0.60999999999999999 109.744 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -84.31 130.71 34.78 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.898 -1.519 . . . . 2.4700000000000002 106.898 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.09 138.22 56.25 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.614 0.765 . . . . 1.74 111.808 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -108.21 -163.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.654 -0.703 . . . . 1.5700000000000001 109.391 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -85.76 -34.65 21.13 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.849 -0.797 . . . . 1.52 108.849 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -85.2 -28.98 25.08 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.52 -0.309 . . . . 1.5900000000000001 111.67 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.7 mt -117.93 106.46 19.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.911 -1.144 . . . . 0.5 107.911 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.186 0.517 . . . . 2.8900000000000001 110.983 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 m -84.54 112.53 20.49 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.91 127.01 46.13 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.354 -0.98 . . . . 2.04 108.354 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.01 137.14 44.44 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 4.4 pp -96.47 165.79 12.01 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.675 -1.232 . . . . 1.25 107.675 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.61 107.67 2.48 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 117.783 0.265 . . . . 3.3599999999999999 111.383 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 44.1 Cg_endo -89.41 169.39 4.91 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.662 2.908 . . . . 1.3899999999999999 111.238 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -92.95 139.48 30.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.274 -1.38 . . . . 1.53 107.274 175.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.94 65.51 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.532 0.733 . . . . 1.9099999999999999 111.824 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -76.07 -13.17 60.22 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.55 -0.295 . . . . 3.4900000000000002 111.763 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 42.2 mt-10 -93.77 134.78 35.75 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.807 0.336 . . . . 1.8899999999999999 110.826 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -95.03 -2.94 49.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.073 0.94 . . . . 1.3 108.83 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.01 129.65 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 107.64 -1.244 . . . . 0.60999999999999999 107.64 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HB2' HG13 ' A' ' 29' ' ' VAL . 60.1 mtp85 -97.22 117.13 30.74 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.154 -1.425 . . . . 1.8400000000000001 107.154 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.7 112.31 24.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.516 -0.766 . . . . 1.1599999999999999 110.312 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 178.96 31.62 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 111.083 -0.807 . . . . 0.31 111.083 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 t -150.43 145.19 25.9 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.127 -0.323 . . . . 0.35999999999999999 110.127 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 51.2 tp -80.66 109.93 15.66 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.43 -1.693 . . . . 0.28000000000000003 106.43 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -97.86 122.81 41.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.76 -0.655 . . . . 2.6800000000000002 110.986 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 23' ' ' TRP . 37.4 mt -99.19 108.45 21.05 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.159 -1.422 . . . . 1.23 107.159 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.4 -54.99 7.78 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.165 -0.925 . . . . 2.1800000000000002 109.329 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -110.43 106.17 57.72 Favored Pre-proline 0 N--CA 1.427 -1.61 0 N-CA-C 108.307 -0.998 . . . . 2.8199999999999998 108.307 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.4 135.76 55.49 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.265 2.643 . . . . 1.25 111.343 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 p -142.02 155.34 45.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.939 -0.393 . . . . 1.22 109.939 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -72.88 -5.08 35.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.563 0.579 . . . . 2.0299999999999998 112.563 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -78.66 -9.72 12.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 CA-C-O 120.981 0.42 . . . . 1.3300000000000001 110.285 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.795 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 16.1 m120 -87.81 26.53 1.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.195 0.997 . . . . 2.1899999999999999 109.407 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -120.68 87.83 2.82 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.273 -1.38 . . . . 1.96 107.273 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.24 -167.41 39.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.219 -0.991 . . . . 0.48999999999999999 112.013 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.78 106.45 18.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.94 0.4 . . . . 2.23 111.201 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.795 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 69.7 m-85 -95.42 117.14 29.83 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.078 -1.082 . . . . 0.68999999999999995 108.078 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 88.1 m -106.83 131.35 54.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.512 -0.551 . . . . 0.34000000000000002 109.512 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 HG13 ' A' ' 12' ' ' VAL . 55.6 tp -102.41 120.53 40.66 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.961 -0.755 . . . . 0.22 108.961 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.52 136.28 44.38 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.537 -1.283 . . . . 0.35999999999999999 107.537 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.09 119.37 30.11 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.679 -1.601 . . . . 0.31 106.679 171.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.12 127.28 47.73 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 123.378 0.424 . . . . 0.60999999999999999 109.896 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 33' ' ' PRO . 25.5 t-20 -150.98 136.95 10.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.16 -1.422 . . . . 1.1799999999999999 107.16 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -43.13 -34.84 4.43 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 125.252 3.968 . . . . 1.0 115.532 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.0 p -91.33 -33.69 15.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.678 -0.809 . . . . 1.1000000000000001 111.526 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.86 131.55 2.58 Favored Glycine 0 C--N 1.299 -1.493 0 C-N-CA 120.075 -1.06 . . . . 0.58999999999999997 112.526 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -103.92 126.58 51.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.903 -0.777 . . . . 1.5700000000000001 108.903 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -105.4 152.89 22.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.098 -0.501 . . . . 0.37 109.813 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.7 p -151.2 120.76 6.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.246 -0.433 . . . . 0.56999999999999995 110.362 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.89 144.32 49.83 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.763 -0.829 . . . . 0.29999999999999999 108.763 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m -113.89 140.18 48.58 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.084 -0.339 . . . . 1.26 110.084 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.506 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -141.85 118.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.247 -1.019 . . . . 0.71999999999999997 108.247 176.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.5 ttm -95.25 108.77 20.93 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.241 -0.583 . . . . 1.25 109.493 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 113.59 25.68 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.287 -0.87 . . . . 0.57999999999999996 108.759 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.68 101.06 13.29 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.338 -1.356 . . . . 0.83999999999999997 107.338 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 114.073 -1.421 . . . . 3.8599999999999999 111.39 -175.235 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.407 -2.604 0 CA-C-O 121.258 0.551 . . . . 1.5800000000000001 110.783 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 98.8 m-85 -98.84 134.02 42.31 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.997 -0.547 . . . . 1.1899999999999999 109.83 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.3 m -84.09 176.33 8.89 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.52 -0.918 . . . . 1.3200000000000001 108.52 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.8 130.49 39.8 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.487 -0.485 . . . . 0.45000000000000001 110.57 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 5.7 m -126.98 144.4 51.03 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.674 -1.602 . . . . 1.1899999999999999 106.674 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 94' ' ' ALA . 61.9 t -127.79 116.47 43.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.28999999999999998 111.673 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -110.31 126.4 54.17 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.229 -0.656 . . . . 2.1800000000000002 109.229 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 HG22 ' A' ' 98' ' ' ILE . 28.6 mt -111.78 156.32 22.14 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.225 -0.657 . . . . 0.33000000000000002 109.225 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -131.57 145.76 51.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.053 -0.721 . . . . 1.03 109.053 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -52.98 133.54 38.23 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.914 1.384 . . . . 0.48999999999999999 110.075 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.22 141.53 58.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.214 -0.903 . . . . 0.40000000000000002 110.004 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.21 130.75 39.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 120.508 -0.477 . . . . 0.56999999999999995 110.907 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.01 96.46 2.15 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.946 -1.024 . . . . 2.52 112.845 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -167.13 150.73 6.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.848 -1.908 . . . . 0.88 105.848 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -52.33 -30.85 30.53 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.726 1.266 . . . . 2.75 114.068 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -98.73 100.65 11.89 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.212 -1.774 . . . . 2.46 106.212 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -80.63 141.05 35.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.547 0.689 . . . . 0.85999999999999999 111.672 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.0 t -135.59 124.54 24.17 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.669 -1.15 . . . . 0.29999999999999999 109.614 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.2 mt -111.02 99.39 42.74 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.556 -1.275 . . . . 0.29999999999999999 107.556 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 135.76 24.03 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.411 2.074 . . . . 0.28000000000000003 111.647 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.34 157.17 40.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.808 0.337 . . . . 0.37 110.305 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -142.85 106.74 4.68 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.571 0.701 . . . . 0.88 109.37 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -113.82 131.61 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.486 -0.779 . . . . 0.27000000000000002 109.028 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.2 p30 -122.62 150.74 42.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.591 -0.444 . . . . 1.3899999999999999 111.142 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.17 169.84 30.3 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.697 -1.761 . . . . 0.59999999999999998 108.697 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -93.99 -56.87 0.22 Allowed Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 118.491 1.145 . . . . 2.6099999999999999 108.52 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.7 Cg_endo -70.4 121.55 8.1 Favored 'Trans proline' 0 C--N 1.368 1.562 0 N-CA-C 107.681 -1.7 . . . . 0.78000000000000003 107.681 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.63 114.34 9.98 Favored Pre-proline 0 C--N 1.32 -0.69 0 O-C-N 123.546 0.529 . . . . 0.78000000000000003 109.941 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 90.4 Cg_endo -77.22 141.53 20.67 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.203 1.935 . . . . 0.56000000000000005 111.923 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -71.5 110.95 6.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.807 -0.633 . . . . 1.3700000000000001 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.7 130.8 34.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.648 -0.705 . . . . 0.5 111.082 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -138.28 136.79 36.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.849 -0.797 . . . . 3.7799999999999998 108.849 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -100.49 118.77 37.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.097 0.475 . . . . 0.28999999999999998 109.921 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.01 126.14 50.91 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.376 -2.083 . . . . 0.94999999999999996 105.376 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -109.92 98.8 8.03 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 121.082 0.467 . . . . 0.88 110.276 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 60.17 25.53 14.89 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.872 1.269 . . . . 1.79 111.221 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.54 -15.17 32.39 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.825 -0.702 . . . . 0.60999999999999999 113.387 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -109.52 142.44 40.56 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.667 -0.864 . . . . 1.3700000000000001 108.667 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.12 122.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.517 -0.549 . . . . 0.69999999999999996 109.517 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.4 tp -77.09 121.4 23.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.717 -0.846 . . . . 0.60999999999999999 108.717 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -93.49 124.11 37.26 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.166 -1.05 . . . . 2.4700000000000002 108.166 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 129.54 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.701 -0.481 . . . . 1.74 109.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -166.96 1.4 Allowed 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.883 -0.598 . . . . 1.5700000000000001 111.035 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -81.82 -12.83 58.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.923 -0.769 . . . . 1.52 108.923 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -103.29 -40.77 6.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.949 -0.568 . . . . 1.5900000000000001 110.938 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG23 ' HG ' ' A' ' 72' ' ' LEU . 35.3 mt -113.59 106.79 21.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 106.959 -1.497 . . . . 0.5 106.959 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.086 0.47 . . . . 2.8900000000000001 112.194 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.3 m -84.97 113.05 21.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.982 -0.554 . . . . 0.44 109.822 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 14.8 mm-40 -87.49 136.67 32.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.076 -0.511 . . . . 2.04 109.635 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.59 144.0 49.39 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.992 -0.744 . . . . 0.87 108.992 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.45 166.85 15.28 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.087 -0.709 . . . . 1.25 109.087 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.54 124.79 9.7 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 114.234 1.198 . . . . 3.3599999999999999 114.234 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.81 128.42 2.4 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 121.714 1.609 . . . . 1.3899999999999999 108.927 169.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.071 -1.085 . . . . 1.53 108.071 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.22 61.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.497 0.665 . . . . 1.9099999999999999 110.284 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.11 -14.82 60.18 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.56 -1.2 . . . . 3.4900000000000002 110.056 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.21 161.04 21.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.464 -0.939 . . . . 1.8899999999999999 108.464 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 3.3 p -112.12 8.13 19.89 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.514 -0.921 . . . . 1.3 108.514 172.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 30' ' ' ASP . 38.1 t -95.96 129.72 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 114.511 -1.222 . . . . 0.60999999999999999 110.366 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 29' ' ' VAL . 77.4 mtp180 -89.68 140.4 29.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.309 -2.108 . . . . 1.8400000000000001 105.309 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -115.87 133.18 56.29 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.015 -0.735 . . . . 1.1599999999999999 109.015 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.17 179.83 44.33 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 119.439 -1.363 . . . . 0.31 113.461 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.29 136.71 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.652 0.781 . . . . 0.35999999999999999 110.285 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 tp -84.88 110.63 18.99 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.682 -1.599 . . . . 0.28000000000000003 106.682 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 80.3 mtt180 -102.06 132.99 47.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.967 0.413 . . . . 2.6800000000000002 111.813 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -112.51 109.55 19.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 107.453 -1.314 . . . . 1.23 107.453 172.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -59.09 -37.7 77.75 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.218 -1.356 . . . . 2.1800000000000002 110.851 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -128.27 135.22 27.21 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 107.929 -1.137 . . . . 2.8199999999999998 107.929 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.26 130.25 13.89 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 121.473 1.449 . . . . 1.25 109.672 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -115.19 139.97 49.48 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.355 -0.609 . . . . 1.22 109.355 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -75.61 -14.48 60.38 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 112.233 0.457 . . . . 2.0299999999999998 112.233 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.56 -10.53 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.68 -0.808 . . . . 1.3300000000000001 113.088 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.263 20.2 m-80 -92.19 26.95 2.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 116.17 1.915 . . . . 2.1899999999999999 116.17 -171.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.87 74.25 7.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.998 -0.741 . . . . 1.96 108.998 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.09 -174.9 15.03 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.134 -1.032 . . . . 0.48999999999999999 112.42 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -93.97 112.04 23.83 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.525 -0.337 . . . . 2.23 110.997 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -86.52 108.09 18.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.414 -0.958 . . . . 0.68999999999999995 108.414 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 m -102.16 117.99 35.95 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.725 -0.842 . . . . 0.34000000000000002 108.725 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.8 tp -94.73 118.91 32.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.712 -0.848 . . . . 0.22 108.712 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.0 134.5 46.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.917 . . . . 0.35999999999999999 108.523 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -134.85 120.98 19.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.552 -0.907 . . . . 0.31 108.552 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.38 135.34 49.41 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 123.218 0.324 . . . . 0.60999999999999999 110.4 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.7 p30 -143.91 169.74 9.75 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-O 117.432 -1.27 . . . . 1.1799999999999999 107.663 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 24.4 Cg_exo -42.77 -30.99 1.92 Allowed 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 123.317 2.678 . . . . 1.0 115.966 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.0 t -74.97 -47.46 29.23 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.33 -0.548 . . . . 1.1000000000000001 111.649 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.45 31.36 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.825 -1.178 . . . . 0.58999999999999997 112.48 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.96 129.31 43.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.093 0.473 . . . . 1.5700000000000001 109.796 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.6 159.33 21.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 30.8 p -155.93 153.21 29.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.977 -0.556 . . . . 0.56999999999999995 110.328 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 158.71 43.52 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.713 -1.588 . . . . 0.29999999999999999 106.713 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 m -133.72 127.12 32.17 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 120.944 0.402 . . . . 1.26 110.615 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -129.67 118.49 45.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.697 -1.223 . . . . 0.71999999999999997 107.697 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.0 ttm -96.75 114.79 26.46 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.933 -0.707 . . . . 1.25 109.659 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.73 29.72 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.331 -0.618 . . . . 0.57999999999999996 109.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.83 123.03 36.4 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.667 -0.864 . . . . 0.83999999999999997 108.667 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 122.003 0.906 . . . . 3.8599999999999999 110.873 -178.332 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.388 -3.567 0 N-CA-C 106.192 -1.781 . . . . 1.5800000000000001 106.192 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.502 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 46.6 m-85 -74.31 142.78 45.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.95 -1.023 . . . . 1.1899999999999999 110.341 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.28 173.42 11.61 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.42 -1.326 . . . . 1.3200000000000001 107.42 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.24 116.06 28.65 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 121.234 0.54 . . . . 0.45000000000000001 110.192 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 t -117.02 132.03 56.8 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 107.283 -1.377 . . . . 1.1899999999999999 107.283 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 48.5 t -115.86 115.77 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 110.242 -0.281 . . . . 0.28999999999999998 110.242 -173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -112.31 117.9 33.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.597 -0.52 . . . . 2.1800000000000002 109.597 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 98' ' ' ILE . 31.2 mt -100.41 151.53 21.41 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 108.654 -0.869 . . . . 0.33000000000000002 108.654 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -131.24 146.13 52.19 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.238 -1.393 . . . . 1.03 107.238 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.47 132.68 54.22 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 124.087 0.867 . . . . 0.48999999999999999 110.498 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.88 139.51 39.94 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.596 1.185 . . . . 0.40000000000000002 111.165 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -91.92 131.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.961 -0.563 . . . . 0.56999999999999995 110.076 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.08 120.4 21.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.268 -0.878 . . . . 2.52 111.053 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -169.7 -169.84 0.96 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -72.88 -39.26 66.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.286 0.948 . . . . 2.75 111.968 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -104.89 121.45 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.518 -1.66 . . . . 2.46 106.518 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -82.06 129.48 34.81 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.188 0.518 . . . . 0.85999999999999999 110.988 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -121.11 118.59 30.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.076 -0.966 . . . . 0.29999999999999999 110.013 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 17' ' ' ALA . 62.7 mt -101.38 102.23 20.56 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 107.476 -1.305 . . . . 0.29999999999999999 107.476 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.89 138.15 18.35 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.459 2.106 . . . . 0.28000000000000003 111.976 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.28 149.01 51.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.323 0.582 . . . . 0.37 110.677 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 m -133.28 106.66 7.67 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.973 -1.121 . . . . 0.88 107.973 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.6 p -110.93 119.33 59.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 120.933 0.397 . . . . 0.27000000000000002 109.953 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.59 140.54 35.74 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.003 -0.544 . . . . 1.3899999999999999 110.838 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.1 134.84 1.74 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.79 -1.724 . . . . 0.59999999999999998 108.79 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.502 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -71.73 -57.23 4.31 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 106.846 -1.539 . . . . 2.6099999999999999 106.846 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.51 120.45 7.75 Favored 'Trans proline' 0 C--N 1.373 1.829 0 N-CA-C 108.316 -1.455 . . . . 0.78000000000000003 108.316 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.4 119.73 59.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.407 -0.815 . . . . 0.78000000000000003 110.947 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.04 149.46 9.46 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.344 2.029 . . . . 0.56000000000000005 112.992 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 t -80.97 132.41 35.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.858 -1.534 . . . . 1.3700000000000001 106.858 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 82.2 mt -103.2 148.24 26.03 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.065 0.46 . . . . 0.5 111.19 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.6 tpm_? -141.72 141.4 33.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.174 -0.676 . . . . 3.7799999999999998 109.174 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -106.91 125.59 51.21 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.158 0.504 . . . . 0.28999999999999998 109.952 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 22.4 tp -121.97 128.92 52.04 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.227 -1.398 . . . . 0.94999999999999996 107.227 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -118.4 106.56 12.85 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.17 -0.678 . . . . 0.88 109.17 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.06 31.77 20.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.121 0.969 . . . . 1.79 111.446 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.93 85.49 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 121.081 -0.581 . . . . 0.60999999999999999 112.853 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -107.43 150.53 26.66 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.008 -0.738 . . . . 1.3700000000000001 109.008 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.3 120.29 24.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.373 -0.376 . . . . 0.69999999999999996 110.756 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -87.23 128.88 35.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.82 -1.178 . . . . 0.60999999999999999 107.82 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -104.09 123.96 48.21 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 110.221 -0.289 . . . . 2.4700000000000002 110.221 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.94 120.96 19.28 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.996 -1.113 . . . . 1.74 107.996 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -136.89 -163.94 1.5 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.889 -0.596 . . . . 1.5700000000000001 110.117 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 t -58.86 -44.8 91.11 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.505 1.122 . . . . 1.52 111.98 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 72.4 m-85 -92.26 -23.1 19.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.874 0.694 . . . . 1.5900000000000001 112.874 -174.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.405 HG23 ' HG ' ' A' ' 72' ' ' LEU . 45.7 mt -124.74 106.3 16.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.974 -1.491 . . . . 0.5 106.974 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -132.9 148.31 52.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.309 0.485 . . . . 2.8900000000000001 112.309 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 m -101.22 116.96 34.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.442 -0.947 . . . . 0.44 108.442 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 42.4 mt-10 -96.21 119.85 35.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.458 -0.497 . . . . 2.04 110.513 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -103.38 112.74 25.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.409 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.46 165.57 18.01 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.723 -0.843 . . . . 1.25 108.723 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.4 115.84 43.19 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.945 -0.761 . . . . 3.3599999999999999 108.945 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.26 134.32 28.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.794 1.663 . . . . 1.3899999999999999 110.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.33 23.09 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -23.52 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.256 1.022 . . . . 1.9099999999999999 113.453 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.99 -24.99 47.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.828 0.347 . . . . 3.4900000000000002 111.213 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -96.48 152.25 18.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.227 -1.027 . . . . 1.8899999999999999 108.227 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 p -108.44 16.1 23.35 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.977 0.894 . . . . 1.3 109.399 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 t -109.52 127.22 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.735 -1.121 . . . . 0.60999999999999999 109.86 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.608 ' HB3' HG13 ' A' ' 29' ' ' VAL . 21.5 ttm180 -89.59 118.01 28.9 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 1.8400000000000001 107.165 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -103.85 152.29 22.09 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.426 -0.953 . . . . 1.1599999999999999 108.426 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.67 -178.72 48.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.661 -1.376 . . . . 0.31 109.661 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 35.4 t -146.16 142.34 28.37 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 120.939 0.4 . . . . 0.35999999999999999 111.297 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -92.25 100.99 13.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.936 -1.876 . . . . 0.28000000000000003 105.936 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.667 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 70.8 mtt85 -99.83 131.7 45.64 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.563 0.697 . . . . 2.6800000000000002 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 52' ' ' ILE . 3.6 mp -111.0 109.66 19.88 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.749 -1.204 . . . . 1.23 107.749 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.63 -45.35 83.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.775 -1.102 . . . . 2.1800000000000002 108.539 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 12.9 mm-40 -130.16 100.85 18.29 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 114.969 -1.014 . . . . 2.8199999999999998 109.18 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.16 154.25 12.71 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.07 1.847 . . . . 1.25 108.352 173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 78' ' ' VAL . 21.5 p -125.38 -177.85 4.02 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 118.862 -0.589 . . . . 1.22 109.769 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -67.0 -18.18 65.26 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.32 0.963 . . . . 2.0299999999999998 110.812 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG22 ' OG1' ' A' ' 76' ' ' THR . 13.0 m -72.77 -10.89 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.791 -0.641 . . . . 1.3300000000000001 109.913 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.58 26.1 4.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 113.223 0.823 . . . . 2.1899999999999999 113.223 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -113.6 98.27 6.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.46 -0.941 . . . . 1.96 108.46 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.1 -161.95 29.18 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.392 -0.909 . . . . 0.48999999999999999 112.247 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.84 116.78 23.49 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.418 -0.216 . . . . 2.23 110.418 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 53.6 m-85 -97.1 105.73 17.93 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.239 -0.652 . . . . 0.68999999999999995 109.239 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 90.1 m -101.76 124.8 48.0 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.587 -0.733 . . . . 0.34000000000000002 110.365 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -106.56 123.72 48.53 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.655 -0.869 . . . . 0.22 108.655 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 1.9 mm? -105.48 141.98 36.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.997 -1.112 . . . . 0.35999999999999999 107.997 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -135.54 121.24 19.58 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.024 -0.732 . . . . 0.31 109.024 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.47 124.14 42.91 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.309 0.485 . . . . 0.60999999999999999 112.309 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -138.65 177.04 2.25 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 116.87 -1.538 . . . . 1.1799999999999999 107.366 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 18.3 Cg_exo -42.64 -26.25 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.53 2.82 . . . . 1.0 116.271 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.63 -34.54 58.32 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.865 -0.522 . . . . 1.1000000000000001 110.998 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.25 -167.26 29.02 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.951 -0.86 . . . . 0.58999999999999997 110.951 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 61.8 tt0 -115.36 127.34 55.33 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 122.939 0.496 . . . . 1.5700000000000001 110.265 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.81 161.77 13.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.182 -0.673 . . . . 0.37 109.182 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.7 p -143.69 136.72 27.61 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.602 -0.518 . . . . 0.56999999999999995 109.602 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -136.6 155.03 50.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.954 -1.498 . . . . 0.29999999999999999 106.954 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 46.0 m -140.07 126.8 20.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.09 0.471 . . . . 1.26 111.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -112.42 130.71 65.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.532 -1.284 . . . . 0.71999999999999997 107.532 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 tpt -90.5 106.57 18.59 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.633 -0.506 . . . . 1.25 109.633 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.93 132.72 55.61 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.341 0.591 . . . . 0.57999999999999996 110.686 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.17 119.7 19.16 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.023 -1.473 . . . . 0.83999999999999997 107.023 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 C--N 1.306 -1.318 0 C-N-CA 120.384 -0.526 . . . . 3.8599999999999999 112.315 -174.84 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.406 -2.672 0 N-CA-C 108.403 -0.962 . . . . 1.5800000000000001 108.403 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -92.88 130.65 38.41 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.074 -0.713 . . . . 1.1899999999999999 109.074 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -84.64 167.26 16.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.79 -1.096 . . . . 1.3200000000000001 109.045 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.45 127.16 40.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.75 0.31 . . . . 0.45000000000000001 111.436 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 m -120.74 135.88 55.02 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.834 -1.913 . . . . 1.1899999999999999 105.834 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 85' ' ' LEU . 96.0 t -115.22 114.71 47.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 120.927 0.394 . . . . 0.28999999999999998 110.342 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.98 123.71 47.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.505 -0.924 . . . . 2.1800000000000002 108.505 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD13 HG22 ' A' ' 98' ' ' ILE . 72.9 mt -104.05 155.95 18.26 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.887 -0.412 . . . . 0.33000000000000002 109.887 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -132.08 142.95 49.7 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.018 -0.734 . . . . 1.03 109.018 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -53.82 135.89 41.11 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 125.119 1.368 . . . . 0.48999999999999999 110.858 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.87 57.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.40000000000000002 110.789 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.33 139.07 18.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 121.223 0.535 . . . . 0.56999999999999995 109.776 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.71 113.34 23.29 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.079 -0.964 . . . . 2.52 111.829 -171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -170.3 -177.65 2.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.191 -2.151 . . . . 0.88 105.191 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.72 -38.45 86.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 120.193 1.361 . . . . 2.75 113.755 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -94.29 115.74 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.465 -0.939 . . . . 2.46 108.465 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 72' ' ' LEU . 94.0 m95 -82.1 117.52 22.34 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.594 0.711 . . . . 0.85999999999999999 109.932 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -110.84 122.54 48.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.29999999999999999 109.305 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 66.3 mt -106.95 101.71 38.94 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.383 -0.969 . . . . 0.29999999999999999 108.383 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.59 132.15 15.65 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.416 2.077 . . . . 0.28000000000000003 111.918 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -122.71 155.34 36.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.117 0.484 . . . . 0.37 110.326 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -136.81 107.7 6.66 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.862 -0.608 . . . . 0.88 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.6 p -119.82 121.49 66.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.827 -0.805 . . . . 0.27000000000000002 108.827 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.6 p-10 -104.91 161.19 14.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.644 -0.822 . . . . 1.3899999999999999 110.797 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.77 177.94 24.28 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.396 -1.082 . . . . 0.59999999999999998 110.396 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 32' ' ' GLN 0.303 17.2 mm-40 -109.85 -54.82 0.05 OUTLIER Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.626 0.602 . . . . 2.6099999999999999 112.626 175.053 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -68.93 119.17 6.18 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 N-CA-C 105.819 -2.416 . . . . 0.78000000000000003 105.819 168.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 109.4 2.47 Favored Pre-proline 0 C--N 1.32 -0.695 0 O-C-N 123.826 0.704 . . . . 0.78000000000000003 110.727 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.9 Cg_endo -72.46 135.03 23.58 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.642 1.561 . . . . 0.56000000000000005 111.15 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -65.0 108.71 1.89 Allowed 'General case' 0 N--CA 1.433 -1.318 0 O-C-N 123.865 0.728 . . . . 1.3700000000000001 109.98 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 29' ' ' VAL . 87.8 mt -85.57 126.25 33.73 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.288 -0.869 . . . . 0.5 110.128 -176.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -136.77 127.2 26.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.049 -0.523 . . . . 3.7799999999999998 109.726 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 85.3 m95 -90.77 134.58 34.32 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.623 -0.717 . . . . 0.28999999999999998 109.756 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 tp -113.7 126.86 55.71 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 105.447 -2.057 . . . . 0.94999999999999996 105.447 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -119.8 103.5 9.41 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.45 -0.574 . . . . 0.88 109.45 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 61.39 32.88 19.0 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.208 -0.906 . . . . 1.79 110.783 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.97 -14.48 64.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.081 -0.581 . . . . 0.60999999999999999 112.807 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -98.88 138.63 35.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.223 -0.658 . . . . 1.3700000000000001 109.223 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.07 123.79 24.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.941 -0.572 . . . . 0.69999999999999996 110.395 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 62.2 tp -80.04 120.38 24.13 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.237 -1.023 . . . . 0.60999999999999999 108.237 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.79 127.62 45.93 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.833 -1.914 . . . . 2.4700000000000002 105.833 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -57.79 126.73 28.67 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.705 0.628 . . . . 1.74 109.89 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.5 p -128.63 173.77 10.0 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.74 -0.837 . . . . 1.5700000000000001 108.74 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -77.1 -1.29 28.38 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.738 0.78 . . . . 1.52 110.36 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -105.19 -40.68 5.78 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.305 -0.861 . . . . 1.5900000000000001 109.002 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -128.58 109.22 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.835 -1.172 . . . . 0.5 107.835 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -143.81 147.07 33.6 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.464 0.65 . . . . 2.8900000000000001 111.446 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 109.73 11.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.74 -1.118 . . . . 0.44 108.983 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -104.56 108.8 20.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.526 -1.287 . . . . 2.04 107.526 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.02 147.54 24.94 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.937 0.398 . . . . 0.87 111.513 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.81 165.55 13.52 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -81.58 126.36 76.16 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 113.638 0.977 . . . . 3.3599999999999999 113.638 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.92 140.4 16.08 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.7 2.267 . . . . 1.3899999999999999 111.124 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.15 161.15 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.029 -1.1 . . . . 1.53 108.029 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.39 -15.29 63.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.997 0.74 . . . . 1.9099999999999999 112.997 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.54 -7.73 49.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.381 -0.6 . . . . 3.4900000000000002 109.381 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.2 134.27 46.89 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.718 -0.475 . . . . 1.8899999999999999 109.718 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -106.1 20.68 18.57 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.851 -1.537 . . . . 1.3 106.851 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 21.9 t -112.88 132.57 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 114.466 -1.243 . . . . 0.60999999999999999 110.402 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.1 mtp180 -84.11 122.86 29.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.985 -1.857 . . . . 1.8400000000000001 105.985 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -108.56 139.09 43.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.049 -0.352 . . . . 1.1599999999999999 110.049 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.81 176.21 41.3 Favored Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 110.707 -0.957 . . . . 0.31 110.707 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 t -138.36 132.66 31.85 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.671 -0.492 . . . . 0.35999999999999999 109.671 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 53.3 tp -80.26 105.15 11.3 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 104.593 -2.373 . . . . 0.28000000000000003 104.593 170.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -99.57 116.16 31.06 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.885 -0.598 . . . . 2.6800000000000002 110.521 -171.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 23' ' ' TRP . 53.9 mt -83.23 107.54 15.84 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 106.651 -1.611 . . . . 1.23 106.651 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -72.85 -49.43 30.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.329 -1.305 . . . . 2.1800000000000002 109.912 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -122.2 101.46 41.27 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.004 -1.48 . . . . 2.8199999999999998 107.004 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.46 129.87 29.72 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 121.989 1.793 . . . . 1.25 110.593 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -129.63 157.08 43.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.257 -0.883 . . . . 1.22 108.665 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.38 -5.09 17.03 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 113.639 0.978 . . . . 2.0299999999999998 113.639 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -82.91 -10.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.406 0.146 . . . . 1.3300000000000001 110.943 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.03 26.87 0.19 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.396 1.258 . . . . 2.1899999999999999 114.396 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.9 p30 -113.62 123.56 50.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.069 -1.086 . . . . 1.96 108.069 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -170.81 33.0 Favored Glycine 0 C--N 1.289 -2.072 0 C-N-CA 119.458 -1.353 . . . . 0.48999999999999999 111.745 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.05 104.91 16.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.616 0.245 . . . . 2.23 110.697 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -85.95 110.78 19.69 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.549 -0.908 . . . . 0.68999999999999995 108.549 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' TRP . 24.5 m -102.11 133.24 47.26 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.527 -0.546 . . . . 0.34000000000000002 109.527 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 95' ' ' SER . 47.5 tp -107.99 115.47 30.19 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.828 -0.434 . . . . 0.22 109.828 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.088 -1.079 . . . . 0.35999999999999999 108.088 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.23 124.06 31.61 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 132.3 53.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.967 -0.293 . . . . 0.60999999999999999 111.236 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 35.0 p30 -149.89 176.91 2.03 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.775 -1.565 . . . . 1.1799999999999999 106.775 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 40.7 Cg_exo -45.19 -30.31 4.98 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.197 2.598 . . . . 1.0 115.803 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.14 -21.16 59.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.538 0.57 . . . . 1.1000000000000001 112.538 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -161.14 23.57 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 119.988 -1.101 . . . . 0.58999999999999997 112.383 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -100.31 133.78 44.22 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.196 0.598 . . . . 1.5700000000000001 111.173 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.45 42.77 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.625 -1.621 . . . . 0.37 106.625 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 49.7 p -162.06 141.38 9.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.208 0.528 . . . . 0.56999999999999995 111.751 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.78 164.65 32.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.282 -1.747 . . . . 0.29999999999999999 106.282 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 p -135.42 139.97 44.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.454 -0.499 . . . . 1.26 111.152 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.586 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.13 127.22 70.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.559 -1.274 . . . . 0.71999999999999997 107.559 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.0 ttt -100.71 128.4 46.77 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.808 -0.757 . . . . 1.25 110.248 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -117.88 135.93 53.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.083 -1.451 . . . . 0.57999999999999996 107.083 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.44 100.95 9.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.26 0.552 . . . . 0.83999999999999997 110.666 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 N--CA 1.425 -1.714 0 CA-C-O 121.939 0.876 . . . . 3.8599999999999999 108.782 174.619 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.408 -2.534 0 N-CA-C 108.674 -0.861 . . . . 1.5800000000000001 108.674 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.533 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 19.3 m-85 -78.56 124.73 28.46 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.085 -1.82 . . . . 1.1899999999999999 106.085 174.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.9 m -83.54 -171.34 3.53 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.082 -0.71 . . . . 1.3200000000000001 109.082 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -92.68 119.67 32.32 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 119.093 -1.043 . . . . 0.45000000000000001 109.746 -172.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.5 m -118.14 128.74 55.02 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.069 -1.086 . . . . 1.1899999999999999 108.069 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.92 119.53 62.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 116.546 -0.297 . . . . 0.28999999999999998 110.261 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.62 116.85 30.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.255 -0.646 . . . . 2.1800000000000002 109.255 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 98' ' ' ILE . 37.1 mt -104.46 146.56 28.68 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.156 -0.475 . . . . 0.33000000000000002 109.769 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -131.25 145.85 52.07 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.612 -0.884 . . . . 1.03 108.612 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -56.3 132.95 52.25 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.589 1.181 . . . . 0.48999999999999999 111.674 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -57.71 140.57 51.04 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.814 -1.085 . . . . 0.40000000000000002 110.949 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.9 131.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.668 -0.493 . . . . 0.56999999999999995 109.668 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.464 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.1 mt-10 -84.78 104.04 14.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.703 -0.681 . . . . 2.52 111.904 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -155.3 -168.51 2.87 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.497 -1.668 . . . . 0.88 106.497 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -68.5 -40.29 80.91 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.292 0.951 . . . . 2.75 111.124 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -97.89 113.86 25.8 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.21 -1.404 . . . . 2.46 107.21 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 54.6 m95 -81.45 124.6 29.58 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.227 -0.657 . . . . 0.85999999999999999 109.227 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.82 124.73 42.73 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.639 -0.71 . . . . 0.29999999999999999 110.72 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.556 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.7 mt -106.68 103.15 45.46 Favored Pre-proline 0 C--O 1.242 0.676 0 N-CA-C 108.365 -0.976 . . . . 0.29999999999999999 108.365 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.79 131.24 14.33 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.608 2.205 . . . . 0.28000000000000003 111.789 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.9 p90 -135.66 155.05 51.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.107 0.48 . . . . 0.37 110.289 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -142.45 114.98 8.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.653 0.739 . . . . 0.88 109.536 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.821 -1.081 . . . . 0.27000000000000002 108.502 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -121.16 151.06 40.35 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.717 -0.793 . . . . 1.3899999999999999 110.338 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.21 138.73 2.59 Favored Glycine 0 N--CA 1.42 -2.431 0 N-CA-C 108.274 -1.93 . . . . 0.59999999999999998 108.274 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 24.0 tt0 -79.91 -50.97 1.17 Allowed Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.776 -0.77 . . . . 2.6099999999999999 109.936 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.7 Cg_exo -61.72 120.0 7.41 Favored 'Trans proline' 0 C--N 1.375 1.923 0 N-CA-C 106.273 -2.241 . . . . 0.78000000000000003 106.273 162.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB1' ' NH2' ' A' ' 66' ' ' ARG . . . -65.43 116.29 29.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.349 -0.841 . . . . 0.78000000000000003 111.114 -174.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.21 159.56 8.41 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.928 1.752 . . . . 0.56000000000000005 112.703 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -102.11 131.84 48.35 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.249 -1.019 . . . . 1.3700000000000001 108.249 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 80.4 mt -97.97 154.05 17.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.788 0.327 . . . . 0.5 110.999 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -155.07 135.64 13.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.798 -0.816 . . . . 3.7799999999999998 108.798 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.4 m95 -96.82 121.9 39.19 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.754 -0.461 . . . . 0.28999999999999998 109.754 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.7 tp -109.88 127.47 54.74 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.791 -1.559 . . . . 0.94999999999999996 106.791 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -118.29 98.98 6.56 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 109.625 -0.509 . . . . 0.88 109.625 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.86 43.41 21.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.752 1.221 . . . . 1.79 113.284 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.9 61.87 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.53 -0.843 . . . . 0.60999999999999999 113.742 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 t -107.54 144.85 33.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.004 -1.11 . . . . 1.3700000000000001 108.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -78.86 129.15 37.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.573 -0.899 . . . . 0.69999999999999996 108.573 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 50.4 tp -80.66 120.02 24.03 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.992 -0.744 . . . . 0.60999999999999999 108.992 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -95.57 126.05 40.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.031 -0.729 . . . . 2.4700000000000002 109.031 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -58.72 122.63 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.968 0.793 . . . . 1.74 109.292 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.6 p -124.73 -172.03 2.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.85 -0.426 . . . . 1.5700000000000001 109.85 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 t -74.95 -30.69 61.3 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.393 -0.965 . . . . 1.52 108.393 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 43.1 m-85 -82.98 -41.49 18.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.302 -0.863 . . . . 1.5900000000000001 110.362 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 72' ' ' LEU . 33.7 mt -124.94 106.9 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.287 -1.005 . . . . 0.5 108.287 -176.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -146.04 156.13 43.26 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 118.255 0.48 . . . . 2.8900000000000001 110.413 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.9 m -92.27 121.41 33.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.792 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.0 134.05 40.88 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.301 -1.37 . . . . 2.04 107.301 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.78 144.27 46.4 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.84 0.352 . . . . 0.87 111.648 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.94 165.68 11.16 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.341 -2.096 . . . . 1.25 105.341 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.58 128.11 28.11 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 113.399 0.889 . . . . 3.3599999999999999 113.399 -172.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 159.78 27.23 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.185 2.59 . . . . 1.3899999999999999 110.494 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.51 176.16 6.65 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.124 -0.695 . . . . 1.53 109.124 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.86 77.71 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.59 0.589 . . . . 1.9099999999999999 112.59 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.74 19.2 11.62 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.14 0.495 . . . . 3.4900000000000002 112.067 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -111.21 113.08 25.32 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.407 -1.331 . . . . 1.8899999999999999 107.407 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -93.76 2.62 56.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.8 0.81 . . . . 1.3 108.961 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.41 127.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.677 -1.147 . . . . 0.60999999999999999 109.473 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 48.1 mtt180 -103.53 139.31 39.03 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.755 -1.572 . . . . 1.8400000000000001 106.755 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.9 145.41 49.84 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.896 -1.149 . . . . 1.1599999999999999 107.896 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.49 -167.98 33.97 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 120.032 -1.08 . . . . 0.31 111.447 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 10.0 t -150.81 132.34 14.77 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 122.069 0.148 . . . . 0.35999999999999999 110.969 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 60.0 tp -84.36 112.32 20.23 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.606 -2.368 . . . . 0.28000000000000003 104.606 169.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 38.1 ttm180 -116.69 125.97 52.49 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 119.652 -0.819 . . . . 2.6800000000000002 112.262 -171.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.467 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.6 mp -107.11 109.62 21.51 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.567 -1.197 . . . . 1.23 108.616 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -70.72 -40.01 73.04 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.962 -1.017 . . . . 2.1800000000000002 110.094 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -135.09 102.1 11.1 Favored Pre-proline 0 N--CA 1.419 -2.005 0 N-CA-C 107.341 -1.355 . . . . 2.8199999999999998 107.341 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 23' ' ' TRP . 73.9 Cg_endo -74.98 141.45 26.71 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.14 1.893 . . . . 1.25 111.21 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 p -104.25 171.58 7.26 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.299 -0.63 . . . . 1.22 109.299 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -68.93 -37.35 78.84 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.011 -1.075 . . . . 2.0299999999999998 111.699 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.24 -10.36 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.46 0.911 . . . . 1.3300000000000001 113.46 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.15 -8.7 58.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.052 0.76 . . . . 2.1899999999999999 113.052 -171.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 17.7 p30 -77.65 77.25 4.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.883 0.849 . . . . 1.96 111.804 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -152.34 -153.03 6.13 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.134 -0.939 . . . . 0.48999999999999999 111.499 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.17 118.66 37.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 122.977 0.511 . . . . 2.23 111.154 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -96.88 112.64 24.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.562 -0.903 . . . . 0.68999999999999995 108.562 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 60.9 m -102.93 123.41 46.51 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.917 -0.771 . . . . 0.34000000000000002 108.917 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 12' ' ' VAL . 54.2 tp -98.49 119.24 36.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.947 -0.76 . . . . 0.22 108.947 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 2.9 mm? -102.18 131.72 48.54 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.431 -0.804 . . . . 0.35999999999999999 109.104 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.74 120.61 31.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.706 -1.22 . . . . 0.31 107.706 173.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.21 132.04 55.89 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 123.448 0.468 . . . . 0.60999999999999999 111.526 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 37.5 p30 -145.06 174.03 3.81 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 107.8 -1.185 . . . . 1.1799999999999999 107.8 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 56.8 Cg_exo -48.05 -32.98 19.66 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.979 2.453 . . . . 1.0 115.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.38 -36.47 63.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.796 0.331 . . . . 1.1000000000000001 111.1 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.17 -166.42 38.26 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 119.761 -1.209 . . . . 0.58999999999999997 112.253 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 60.8 tt0 -128.41 135.59 49.73 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.707 -0.849 . . . . 1.5700000000000001 108.707 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.04 154.87 20.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 p -146.84 119.48 8.55 Favored 'General case' 0 N--CA 1.426 -1.649 0 O-C-N 123.618 0.574 . . . . 0.56999999999999995 111.149 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -126.03 148.34 49.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.416 -1.327 . . . . 0.29999999999999999 107.416 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.2 m -127.83 139.77 52.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 117.934 0.334 . . . . 1.26 111.465 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.51 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -133.64 123.9 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 109.149 -0.686 . . . . 0.71999999999999997 109.149 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 51.0 ttm -98.17 123.31 42.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.622 -0.51 . . . . 1.25 109.622 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -120.42 125.84 48.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.699 0.285 . . . . 0.57999999999999996 110.972 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 113.11 24.51 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.703 -0.851 . . . . 0.83999999999999997 108.703 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.308 -1.219 0 CA-C-N 116.308 -0.406 . . . . 3.8599999999999999 111.471 -178.291 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.41 -2.436 0 N-CA-C 108.121 -1.066 . . . . 1.5800000000000001 108.121 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.27 132.59 50.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.118 -1.067 . . . . 1.1899999999999999 108.118 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 m -83.76 175.48 9.63 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.138 -1.06 . . . . 1.3200000000000001 108.138 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 124.19 38.31 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.869 -0.732 . . . . 0.45000000000000001 111.404 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 67.5 m -121.57 135.61 54.99 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.456 -1.313 . . . . 1.1899999999999999 107.456 172.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 94' ' ' ALA . 93.7 t -115.44 118.23 58.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.028 0.442 . . . . 0.28999999999999998 110.695 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -113.09 116.46 29.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.651 -1.24 . . . . 2.1800000000000002 107.651 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 98' ' ' ILE . 29.1 mt -100.39 156.63 17.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.16 0.505 . . . . 0.33000000000000002 111.841 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -131.31 144.49 51.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.693 -1.225 . . . . 1.03 107.693 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -63.73 139.3 58.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 124.241 0.963 . . . . 0.48999999999999999 108.97 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.42 141.78 29.41 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.045 0.841 . . . . 0.40000000000000002 111.072 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.04 130.69 39.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.542 0.687 . . . . 0.56999999999999995 109.978 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -76.89 111.19 12.17 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.433 -1.258 . . . . 2.52 112.385 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.0 ptt? -166.72 -172.89 2.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.538 -1.282 . . . . 0.88 107.538 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -75.78 -32.86 60.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.661 1.119 . . . . 2.75 111.063 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.438 ' O ' ' HG3' ' A' ' 20' ' ' MET . 61.3 m80 -99.0 122.07 41.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.448 -1.316 . . . . 2.46 107.448 176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -86.97 126.26 34.6 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.425 -0.91 . . . . 0.85999999999999999 113.365 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.65 121.66 32.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.17 -1.377 . . . . 0.29999999999999999 109.617 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 17' ' ' ALA . 53.8 mt -106.18 97.95 17.6 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.467 -1.308 . . . . 0.29999999999999999 107.467 173.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.3 138.66 27.9 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.631 2.221 . . . . 0.28000000000000003 112.141 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -134.29 159.14 41.89 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.964 0.411 . . . . 0.37 110.595 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -139.86 116.71 10.95 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.36 -0.836 . . . . 0.88 109.265 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.4 p -126.39 122.75 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.428 -0.953 . . . . 0.27000000000000002 108.428 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.2 p-10 -105.63 158.7 16.51 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.951 -1.1 . . . . 1.3899999999999999 111.13 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.11 165.64 13.34 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.752 -1.113 . . . . 0.59999999999999998 110.471 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 33' ' ' PRO 0.261 20.9 mm-40 -107.34 -52.1 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 118.942 -0.551 . . . . 2.6099999999999999 111.877 175.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.2 Cg_endo -61.55 120.47 8.12 Favored 'Trans proline' 0 C--N 1.367 1.51 0 N-CA-C 106.703 -2.076 . . . . 0.78000000000000003 106.703 165.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.19 114.18 11.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 O-C-N 123.55 0.531 . . . . 0.78000000000000003 112.115 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 86.6 Cg_endo -81.18 142.79 13.71 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.413 1.409 . . . . 0.56000000000000005 111.731 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 4.3 p -77.28 120.97 23.06 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.935 -0.765 . . . . 1.3700000000000001 108.935 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD21 HG11 ' A' ' 29' ' ' VAL . 93.6 mt -95.8 117.08 29.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.466 0.651 . . . . 0.5 110.477 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -125.95 134.81 51.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.926 -1.034 . . . . 3.7799999999999998 109.577 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -98.64 115.86 29.61 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.627 -0.508 . . . . 0.28999999999999998 109.627 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 20.8 tp -101.87 126.89 48.86 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 105.001 -2.222 . . . . 0.94999999999999996 105.001 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -122.78 108.88 13.53 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 108.995 -0.743 . . . . 0.88 108.995 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.97 34.44 21.53 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 123.94 0.775 . . . . 1.79 111.466 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.3 6.9 88.97 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.849 -0.614 . . . . 0.60999999999999999 112.586 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -116.24 147.15 41.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.024 -1.102 . . . . 1.3700000000000001 108.024 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.5 t -76.89 114.75 17.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.142 -1.058 . . . . 0.69999999999999996 108.142 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.96 118.24 18.53 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.702 -0.851 . . . . 0.60999999999999999 108.702 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -81.08 115.04 20.33 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.442 -0.577 . . . . 2.4700000000000002 109.442 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.26 108.01 5.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.51 -0.922 . . . . 1.74 108.51 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.2 p -104.13 -162.89 0.93 Allowed 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.553 -1.203 . . . . 1.5700000000000001 109.655 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -81.41 -26.59 35.27 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.857 -0.794 . . . . 1.52 108.857 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -79.04 -40.31 31.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.884 -0.598 . . . . 1.5900000000000001 110.268 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 72' ' ' LEU . 56.6 mt -120.26 105.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.79 -1.93 . . . . 0.5 105.79 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -139.29 140.51 37.64 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.328 -0.549 . . . . 2.8900000000000001 111.435 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -86.82 112.2 21.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.285 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -110.75 152.52 26.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.993 -0.743 . . . . 2.04 108.993 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -118.64 163.13 17.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 120.768 0.318 . . . . 0.87 110.815 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.92 140.9 52.52 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.873 -1.899 . . . . 1.25 105.873 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.21 116.75 30.29 Favored Pre-proline 0 C--N 1.296 -1.752 0 O-C-N 124.026 0.829 . . . . 3.3599999999999999 111.394 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.87 169.04 16.91 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.573 2.182 . . . . 1.3899999999999999 110.609 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.81 142.31 33.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.76 -15.24 61.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.559 0.577 . . . . 1.9099999999999999 112.559 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -98.49 8.11 45.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.27 -0.423 . . . . 3.4900000000000002 111.324 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.8 pt-20 -117.92 155.47 30.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.347 -0.983 . . . . 1.8899999999999999 108.347 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 p -106.51 8.35 31.36 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.201 0.524 . . . . 1.3 110.887 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 26.9 t -100.08 134.62 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.456 -0.793 . . . . 0.60999999999999999 109.824 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 29' ' ' VAL . 80.4 mtp180 -93.67 141.96 27.9 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.286 -1.376 . . . . 1.8400000000000001 107.286 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -124.29 139.58 53.78 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.927 -0.398 . . . . 1.1599999999999999 109.927 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.41 -179.44 42.49 Favored Glycine 0 N--CA 1.425 -2.079 0 C-N-CA 120.498 -0.858 . . . . 0.31 111.516 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 t -149.66 138.07 20.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.927 0.394 . . . . 0.35999999999999999 110.897 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.7 tp -80.32 106.91 12.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.25 -1.759 . . . . 0.28000000000000003 106.25 172.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -94.18 103.96 15.99 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.535 -0.757 . . . . 2.6800000000000002 109.809 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -94.64 109.51 21.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.601 -1.259 . . . . 1.23 107.601 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.66 -51.16 11.06 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.67 -1.15 . . . . 2.1800000000000002 109.469 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -111.64 101.84 52.01 Favored Pre-proline 0 N--CA 1.423 -1.778 0 N-CA-C 107.477 -1.305 . . . . 2.8199999999999998 107.477 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.9 130.65 6.71 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.288 1.992 . . . . 1.25 109.917 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -110.53 154.64 23.42 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -74.07 -5.4 41.38 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.694 -0.629 . . . . 2.0299999999999998 112.118 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.7 -10.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.3300000000000001 110.24 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 16.6 m120 -83.77 -1.62 54.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 2.1899999999999999 109.545 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -79.45 83.35 5.47 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.799 -1.186 . . . . 1.96 107.799 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.33 -150.64 6.7 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.924 -0.58 . . . . 0.48999999999999999 111.816 -176.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -107.72 124.13 49.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.701 0.286 . . . . 2.23 111.45 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 63.4 m-85 -100.27 113.39 26.06 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.742 -0.836 . . . . 0.68999999999999995 108.742 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.4 m -103.5 121.97 43.96 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.928 -1.138 . . . . 0.34000000000000002 107.928 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -99.9 119.9 38.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.734 -0.469 . . . . 0.22 109.734 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.56 136.16 44.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.388 -0.967 . . . . 0.35999999999999999 108.388 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.4 120.73 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.438 -1.319 . . . . 0.31 107.438 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 114.05 20.55 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.322 0.582 . . . . 0.60999999999999999 112.507 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 39.5 p30 -127.0 161.7 52.19 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 106.538 -1.652 . . . . 1.1799999999999999 106.538 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 4.5 Cg_exo -40.68 -38.65 2.72 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.895 3.063 . . . . 1.0 115.349 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.63 -34.35 75.6 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 112.488 0.551 . . . . 1.1000000000000001 112.488 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.21 170.95 36.67 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.816 -1.183 . . . . 0.58999999999999997 112.508 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -110.67 126.91 55.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.52 -0.918 . . . . 1.5700000000000001 108.52 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.64 155.27 18.41 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.449 -0.575 . . . . 0.37 109.449 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 p -150.95 128.69 11.58 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.651 0.594 . . . . 0.56999999999999995 110.68 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.77 159.88 41.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.586 -1.635 . . . . 0.29999999999999999 106.586 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 p -136.69 146.75 46.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.586 0.708 . . . . 1.26 112.653 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.519 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -134.97 122.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.713 -1.217 . . . . 0.71999999999999997 107.713 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -100.61 123.41 44.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.93 140.92 51.45 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.189 -0.3 . . . . 0.57999999999999996 110.189 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.15 142.69 28.77 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.741 -0.663 . . . . 0.83999999999999997 109.668 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--N 1.315 -0.931 0 N-CA-C 109.411 -0.588 . . . . 3.8599999999999999 109.411 -178.681 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.404 -2.774 0 N-CA-C 107.704 -1.221 . . . . 1.5800000000000001 107.704 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.435 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 40.3 m-85 -85.31 135.09 34.05 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.183 -0.917 . . . . 1.1899999999999999 109.39 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.7 m -84.71 176.65 8.42 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.97 -1.492 . . . . 1.3200000000000001 106.97 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 128.41 40.89 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.728 -0.789 . . . . 0.45000000000000001 111.408 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 23.3 t -115.33 136.58 52.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 106.464 -1.68 . . . . 1.1899999999999999 106.464 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 94' ' ' ALA . 99.5 t -115.69 116.14 51.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.025 0.44 . . . . 0.28999999999999998 110.129 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -117.0 116.29 27.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.656 -0.868 . . . . 2.1800000000000002 108.656 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.501 HD13 HG22 ' A' ' 98' ' ' ILE . 31.9 mt -97.41 156.18 16.58 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.725 -0.472 . . . . 0.33000000000000002 109.725 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -131.91 146.39 52.08 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.758 -1.571 . . . . 1.03 106.758 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.33 132.21 50.83 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.812 0.695 . . . . 0.48999999999999999 109.615 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.33 142.74 30.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.648 -1.16 . . . . 0.40000000000000002 112.107 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.21 130.4 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.543 -0.753 . . . . 0.56999999999999995 110.117 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' CH2' ' A' ' 23' ' ' TRP . 36.2 mt-10 -80.64 107.17 13.22 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.837 -1.074 . . . . 2.52 110.263 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 59.8 mtm -134.76 -165.81 1.72 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.41 -1.7 . . . . 0.88 106.41 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -66.02 -39.01 89.86 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.254 -1.017 . . . . 2.75 108.254 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 20' ' ' MET . 66.9 m170 -117.56 153.55 33.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.452 -1.684 . . . . 2.46 106.452 176.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.453 ' CH2' ' HG2' ' A' ' 19' ' ' GLU . 68.6 m95 -98.63 144.85 27.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.017 0.747 . . . . 0.85999999999999999 113.017 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -136.23 121.01 18.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.788 -1.096 . . . . 0.29999999999999999 109.384 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 17' ' ' ALA . 58.8 mt -103.38 100.31 17.94 Favored Pre-proline 0 C--O 1.24 0.562 0 N-CA-C 108.468 -0.938 . . . . 0.29999999999999999 108.468 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.66 132.91 16.45 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.324 2.016 . . . . 0.28000000000000003 111.85 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' A' ' 14' ' ' LEU . 53.8 p90 -128.47 152.26 48.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.993 0.425 . . . . 0.37 111.094 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 m -127.31 114.3 17.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.372 -0.973 . . . . 0.88 108.372 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.2 p -125.29 112.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.308 -0.627 . . . . 0.27000000000000002 109.308 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.2 p-10 -112.02 144.79 40.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.995 -0.682 . . . . 1.3899999999999999 110.316 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.24 165.48 32.57 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.637 -1.785 . . . . 0.59999999999999998 108.637 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 19.5 tm0? -91.4 -53.31 0.28 Allowed Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 117.519 0.659 . . . . 2.6099999999999999 109.999 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 3.2 Cg_exo -80.36 120.63 4.09 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 107.6 -1.731 . . . . 0.78000000000000003 107.6 170.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.5 115.67 10.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 123.779 0.674 . . . . 0.78000000000000003 111.763 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 87.7 Cg_endo -81.51 153.2 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.749 2.299 . . . . 0.56000000000000005 113.204 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 m -79.56 119.31 22.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.531 -1.285 . . . . 1.3700000000000001 107.531 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 127.41 39.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.927 0.394 . . . . 0.5 110.053 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -123.79 130.67 52.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.941 -0.763 . . . . 3.7799999999999998 108.941 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -94.57 119.86 33.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.127 0.489 . . . . 0.28999999999999998 109.948 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 26.3 tp -110.66 126.91 55.0 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.169 -1.419 . . . . 0.94999999999999996 107.169 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -116.48 106.9 14.11 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 110.204 -0.295 . . . . 0.88 110.204 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.39 35.2 25.51 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.227 1.011 . . . . 1.79 111.18 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.49 -18.17 57.96 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.777 -0.647 . . . . 0.60999999999999999 113.25 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.5 p -106.02 139.71 40.15 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.179 -0.6 . . . . 1.3700000000000001 110.375 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.14 128.12 28.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.904 -0.589 . . . . 0.69999999999999996 109.785 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -91.1 111.65 23.21 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.684 -0.689 . . . . 0.60999999999999999 109.269 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -85.04 135.13 34.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.115 -1.069 . . . . 2.4700000000000002 108.115 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.61 141.08 48.35 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.8 -0.445 . . . . 1.74 109.8 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -123.87 -163.79 1.17 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.284 -0.635 . . . . 1.5700000000000001 109.284 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -81.98 -17.44 46.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.831 -0.433 . . . . 1.52 109.831 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.11 -31.46 9.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.409 -0.36 . . . . 1.5900000000000001 111.405 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.3 mt -113.84 106.73 21.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 106.511 -1.663 . . . . 0.5 106.511 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.42 145.91 33.02 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.273 0.558 . . . . 2.8900000000000001 111.813 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -85.92 112.95 21.64 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.422 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -96.83 112.54 24.25 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.858 -0.61 . . . . 2.04 110.947 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.52 142.6 27.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.203 -1.036 . . . . 0.87 108.203 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.31 161.68 19.54 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.408 -1.33 . . . . 1.25 107.408 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 47.7 mt-10 -67.13 113.67 14.68 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 113.973 1.101 . . . . 3.3599999999999999 113.973 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.7 Cg_exo -80.56 157.72 21.98 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.085 2.524 . . . . 1.3899999999999999 109.61 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.6 145.57 31.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.737 -0.838 . . . . 1.53 108.737 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.03 0.76 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.689 0.756 . . . . 1.9099999999999999 111.236 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -123.01 9.55 9.36 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.307 -0.86 . . . . 3.4900000000000002 109.034 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.6 pt-20 -135.56 160.77 37.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.268 -1.382 . . . . 1.8899999999999999 107.268 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 p -118.71 34.71 5.09 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.936 0.875 . . . . 1.3 109.778 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 63' ' ' GLU . 18.7 t -109.43 127.18 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.196 -0.911 . . . . 0.60999999999999999 109.401 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.2 mtp180 -91.32 129.17 37.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.6 -1.629 . . . . 1.8400000000000001 106.6 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -114.06 134.99 54.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.386 -0.968 . . . . 1.1599999999999999 108.386 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.62 179.08 36.34 Favored Glycine 0 N--CA 1.408 -3.176 0 C-N-CA 119.73 -1.224 . . . . 0.31 111.714 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 4.7 t -144.61 132.79 21.66 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.83 0.852 . . . . 0.35999999999999999 109.932 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.1 tp -84.45 105.66 15.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.224 -2.139 . . . . 0.28000000000000003 105.224 170.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -100.46 123.83 45.19 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.045 -0.525 . . . . 2.6800000000000002 110.029 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.02 108.26 19.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.894 -1.15 . . . . 1.23 107.894 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -72.9 -35.46 67.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.514 -1.221 . . . . 2.1800000000000002 109.805 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.59 108.37 58.19 Favored Pre-proline 0 N--CA 1.423 -1.814 0 N-CA-C 107.243 -1.392 . . . . 2.8199999999999998 107.243 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.39 129.89 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.475 1.45 . . . . 1.25 109.915 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.405 ' HB ' HG22 ' A' ' 78' ' ' VAL . 17.9 p -126.19 141.11 52.06 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.114 0.483 . . . . 1.22 109.828 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.46 -18.39 48.84 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.144 -0.687 . . . . 2.0299999999999998 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 76' ' ' THR . 22.3 m -68.7 -12.01 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.238 -0.585 . . . . 1.3300000000000001 111.491 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.505 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 51.7 m-80 -111.62 25.99 11.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.47 0.652 . . . . 2.1899999999999999 111.386 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.18 104.37 16.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.304 -0.999 . . . . 1.96 108.304 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.05 26.29 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.039 -0.824 . . . . 0.48999999999999999 111.039 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -96.17 123.48 39.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.117 0.484 . . . . 2.23 111.361 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 97' ' ' SER . 8.0 m-85 -95.97 121.18 37.44 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.158 0.983 . . . . 0.68999999999999995 108.978 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 53.7 m -107.77 120.9 43.55 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.582 -0.896 . . . . 0.34000000000000002 108.582 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 95' ' ' SER . 54.0 tp -96.88 118.75 33.99 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.538 -0.912 . . . . 0.22 108.538 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.85 133.62 49.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.415 -0.957 . . . . 0.35999999999999999 108.415 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -122.07 119.7 32.16 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.417 -0.957 . . . . 0.31 108.417 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.98 131.38 54.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.42 -0.585 . . . . 0.60999999999999999 109.42 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 8.0 p30 -151.58 165.31 17.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 107.042 -1.466 . . . . 1.1799999999999999 107.042 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 Cg_endo -44.69 -40.58 14.33 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.473 2.782 . . . . 1.0 114.337 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.63 -27.28 61.19 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.85 0.685 . . . . 1.1000000000000001 112.85 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.48 -156.1 27.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.121 -1.038 . . . . 0.58999999999999997 112.178 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 28.7 tt0 -138.12 126.81 23.65 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.957 0.408 . . . . 1.5700000000000001 110.674 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.79 157.75 16.74 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.2 p -153.7 142.62 21.14 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 123.255 0.347 . . . . 0.56999999999999995 110.952 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -147.19 152.32 38.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.439 -1.319 . . . . 0.29999999999999999 107.439 175.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 37.8 m -128.77 141.16 51.4 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.103 0.411 . . . . 1.26 111.034 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.501 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.33 134.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.407 -0.96 . . . . 0.71999999999999997 108.407 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.9 ttm -99.42 119.96 38.84 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.929 -0.482 . . . . 1.25 109.782 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.9 116.58 30.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.503 -0.554 . . . . 0.57999999999999996 109.503 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.49 100.11 11.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.397 -0.964 . . . . 0.83999999999999997 108.397 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 114.718 -1.128 . . . . 3.8599999999999999 110.104 -179.19 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.396 -3.15 0 N-CA-C 108.598 -0.889 . . . . 1.5800000000000001 108.598 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.2 m-85 -86.0 117.71 25.02 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 105.397 -2.075 . . . . 1.1899999999999999 105.397 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.7 m -83.22 -179.31 7.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.797 -0.816 . . . . 1.3200000000000001 108.797 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.31 126.01 38.21 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 119.606 -0.837 . . . . 0.45000000000000001 110.817 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 20.8 t -118.41 131.43 56.29 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.673 -1.232 . . . . 1.1899999999999999 107.673 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 90.4 t -114.5 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.886 -0.783 . . . . 0.28999999999999998 108.886 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.82 116.05 27.97 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.665 -1.235 . . . . 2.1800000000000002 107.665 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 98' ' ' ILE . 38.3 mt -99.48 156.82 16.83 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.511 -0.768 . . . . 0.33000000000000002 109.924 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -131.6 153.94 49.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.063 -0.517 . . . . 1.03 109.695 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -57.32 133.59 55.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.175 -1.375 . . . . 0.48999999999999999 110.36 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.59 141.4 58.78 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.649 -0.705 . . . . 0.40000000000000002 110.311 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -91.37 124.91 44.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.647 0.736 . . . . 0.56999999999999995 111.535 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.49 111.95 20.46 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.47 -1.241 . . . . 2.52 109.92 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -162.46 0.53 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.215 -1.402 . . . . 0.88 107.215 176.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -60.85 -28.93 69.2 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.618 1.099 . . . . 2.75 112.793 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -120.86 165.16 15.57 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.884 -1.524 . . . . 2.46 106.884 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -118.19 135.83 54.01 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.198 -0.667 . . . . 0.85999999999999999 109.198 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.76 131.69 35.85 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.552 -0.749 . . . . 0.29999999999999999 110.002 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.4 HD12 HD23 ' A' ' 70' ' ' LEU . 61.8 mt -104.65 106.24 53.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.383 -1.339 . . . . 0.29999999999999999 107.383 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.09 137.8 19.77 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.644 2.229 . . . . 0.28000000000000003 111.35 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 14' ' ' LEU . 55.1 p90 -140.01 146.47 39.1 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.227 0.537 . . . . 0.37 111.853 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.5 p -126.63 118.87 25.67 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 115.137 -0.938 . . . . 0.88 109.31 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -120.12 110.46 28.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.529 -0.915 . . . . 0.27000000000000002 108.529 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.8 p-10 -108.49 150.94 26.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.395 -0.522 . . . . 1.3899999999999999 110.504 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.36 144.35 3.91 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 108.493 -1.843 . . . . 0.59999999999999998 108.493 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.51 -53.25 2.06 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.472 -0.936 . . . . 2.6099999999999999 108.472 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 23.7 Cg_exo -67.26 120.96 8.04 Favored 'Trans proline' 0 C--N 1.379 2.168 0 N-CA-C 108.978 -1.201 . . . . 0.78000000000000003 108.978 171.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.95 87.88 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.735 -0.666 . . . . 0.78000000000000003 112.041 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -90.55 159.78 4.37 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.474 2.116 . . . . 0.56000000000000005 111.714 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -96.36 120.6 36.95 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.995 -1.483 . . . . 1.3700000000000001 106.995 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.56 159.08 19.97 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.667 0.27 . . . . 0.5 110.901 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -159.43 138.03 10.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.723 -0.843 . . . . 3.7799999999999998 108.723 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -105.72 129.89 53.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.215 0.531 . . . . 0.28999999999999998 111.361 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -109.33 137.35 47.32 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.839 -1.171 . . . . 0.94999999999999996 107.839 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -124.82 103.89 8.32 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.982 -1.118 . . . . 0.88 107.982 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 64.36 28.0 13.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.093 0.957 . . . . 1.79 110.358 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.8 71.53 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.12 -0.945 . . . . 0.60999999999999999 112.201 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -93.16 150.08 20.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.897 -0.779 . . . . 1.3700000000000001 108.897 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.89 115.82 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 116.164 -0.471 . . . . 0.69999999999999996 109.925 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -85.75 124.22 32.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.483 -1.303 . . . . 0.60999999999999999 107.483 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -102.15 126.14 49.04 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.625 -0.879 . . . . 2.4700000000000002 108.625 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 114.41 3.28 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.818 -0.808 . . . . 1.74 108.818 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -130.06 -170.8 2.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.451 -0.795 . . . . 1.5700000000000001 109.588 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -60.15 -32.72 71.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.173 0.589 . . . . 1.52 112.113 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -84.7 -36.8 21.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.399 0.518 . . . . 1.5900000000000001 112.399 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.401 HD11 HD21 ' A' ' 79' ' ' ASN . 14.2 mt -132.52 114.63 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.955 -1.128 . . . . 0.5 107.955 -171.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.74 155.54 48.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 118.895 0.771 . . . . 2.8900000000000001 111.518 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -98.62 110.37 22.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.44 109.87 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.82 120.76 43.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.559 -0.534 . . . . 2.04 109.559 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -97.01 153.56 17.84 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 116.09 -0.505 . . . . 0.87 109.81 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.98 159.86 14.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.126 -1.435 . . . . 1.25 107.126 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 61.6 mm-40 -72.91 115.14 37.21 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 123.576 0.547 . . . . 3.3599999999999999 110.273 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 3.7 Cg_exo -77.17 153.95 32.28 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.546 2.164 . . . . 1.3899999999999999 110.551 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.12 146.84 27.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.702 -1.221 . . . . 1.53 107.702 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.84 60.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.073 1.138 . . . . 1.9099999999999999 114.073 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.18 -0.42 46.89 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.526 -0.469 . . . . 3.4900000000000002 111.833 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -88.81 138.84 31.05 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.963 0.411 . . . . 1.8899999999999999 110.693 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -104.45 -2.06 25.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.431 -0.952 . . . . 1.3 108.431 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.0 128.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.351 -0.84 . . . . 0.60999999999999999 109.399 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.0 ttm-85 -108.88 124.18 50.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.004 -1.11 . . . . 1.8400000000000001 108.004 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -111.04 146.53 36.56 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.949 0.404 . . . . 1.1599999999999999 110.097 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.39 32.37 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.614 -0.994 . . . . 0.31 110.614 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 71' ' ' ARG . 4.6 t -138.05 131.67 30.98 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.65 -0.5 . . . . 0.35999999999999999 109.65 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.4 HD23 HD12 ' A' ' 25' ' ' ILE . 47.2 tp -91.32 94.86 9.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.116 -2.179 . . . . 0.28000000000000003 105.116 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . 15.5 ptm180 -99.93 126.4 46.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.498 -0.774 . . . . 2.6800000000000002 110.617 -174.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.91 113.05 25.16 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.948 0.88 . . . . 1.23 109.367 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -61.81 -49.52 76.0 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.18 -1.827 . . . . 2.1800000000000002 107.593 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -135.29 100.57 11.51 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 107.845 -1.168 . . . . 2.8199999999999998 107.845 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -83.65 141.96 10.07 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.123 1.882 . . . . 1.25 111.163 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 p -130.31 -178.73 4.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 118.98 -0.533 . . . . 1.22 111.598 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -69.47 -19.6 63.75 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.382 0.992 . . . . 2.0299999999999998 111.102 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 m -70.69 -10.67 14.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.3300000000000001 110.639 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.401 HD21 HD11 ' A' ' 52' ' ' ILE . 24.9 m120 -88.15 14.29 9.55 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.625 -0.716 . . . . 2.1899999999999999 112.844 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.56 93.64 9.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.301 -1.0 . . . . 1.96 108.301 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.19 -173.22 39.39 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.409 -0.9 . . . . 0.48999999999999999 112.127 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.35 122.8 36.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.17 0.51 . . . . 2.23 111.13 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 98' ' ' ILE . 22.0 m-85 -102.97 130.43 50.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.72 1.208 . . . . 0.68999999999999995 107.908 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -130.88 128.29 40.27 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.988 -0.445 . . . . 0.34000000000000002 109.955 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.451 ' CB ' HD11 ' A' ' 14' ' ' LEU . 50.5 tp -100.37 124.54 45.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.59 -0.893 . . . . 0.22 108.59 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.58 138.27 48.33 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.098 -1.075 . . . . 0.35999999999999999 108.098 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.3 119.5 34.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.818 -1.549 . . . . 0.31 106.818 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.68 125.41 40.24 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.043 -1.095 . . . . 0.60999999999999999 108.043 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -151.04 144.78 17.46 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.506 -1.664 . . . . 1.1799999999999999 106.506 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.62 -17.17 27.35 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 123.526 2.817 . . . . 1.0 113.986 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.3 t -89.65 -8.83 51.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 1.1000000000000001 110.348 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.16 157.02 7.32 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.147 -0.781 . . . . 0.58999999999999997 111.147 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 31.8 tt0 -90.65 133.66 34.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.088 -0.708 . . . . 1.5700000000000001 109.088 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.5 150.63 23.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.641 -0.874 . . . . 0.37 108.641 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -151.45 143.21 23.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 123.355 0.409 . . . . 0.56999999999999995 111.309 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.56 154.29 42.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.28 -1.378 . . . . 0.29999999999999999 107.28 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.8 t -119.71 132.37 55.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.46 0.648 . . . . 1.26 111.655 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -136.34 119.76 23.07 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 124.267 1.027 . . . . 0.71999999999999997 109.469 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -106.75 122.04 45.57 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.153 -0.684 . . . . 1.25 109.153 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.05 147.76 38.17 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.663 -0.415 . . . . 0.57999999999999996 110.34 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.26 120.11 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.409 -1.33 . . . . 0.83999999999999997 107.409 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 72.0 t80 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 115.632 -0.713 . . . . 3.8599999999999999 111.653 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.402 -2.85 0 N-CA-C 109.11 -0.7 . . . . 1.5800000000000001 109.11 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 97.1 m-85 -89.16 136.35 33.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.706 -1.134 . . . . 1.1899999999999999 108.55 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.2 t -83.91 169.56 14.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.025 -1.472 . . . . 1.3200000000000001 107.025 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.92 112.82 24.72 Favored 'General case' 0 CA--C 1.489 -1.404 0 CA-C-O 121.068 0.461 . . . . 0.45000000000000001 110.63 -173.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.1 t -106.87 131.89 53.45 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.889 -1.152 . . . . 1.1899999999999999 107.889 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 94' ' ' ALA . 89.2 t -115.08 114.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.735 -0.469 . . . . 0.28999999999999998 109.735 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -113.14 116.16 29.41 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.501 -0.926 . . . . 2.1800000000000002 108.501 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 43.9 mt -101.77 150.67 22.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.929 -0.397 . . . . 0.33000000000000002 109.929 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.64 139.6 49.15 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.523 -0.917 . . . . 1.03 108.523 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -52.44 134.19 34.78 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.035 1.459 . . . . 0.48999999999999999 110.64 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -58.76 142.47 49.98 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.908 -1.042 . . . . 0.40000000000000002 111.072 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.51 125.89 44.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.491 0.662 . . . . 0.56999999999999995 110.418 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 114.43 12.03 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.616 -1.175 . . . . 2.52 111.345 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 23.9 ptt? -165.68 -177.28 4.27 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.635 1.174 . . . . 0.88 107.996 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -71.63 -31.73 67.18 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.193 1.36 . . . . 2.75 114.47 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.495 ' O ' ' HG3' ' A' ' 20' ' ' MET . 90.1 m-70 -112.04 125.71 54.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.564 -2.013 . . . . 2.46 105.564 173.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 75' ' ' PRO . 60.0 m95 -93.12 143.67 26.02 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 113.838 1.051 . . . . 0.85999999999999999 113.838 -168.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 t -134.66 125.6 27.44 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.001 -1.0 . . . . 0.29999999999999999 109.876 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.5 mt -106.8 101.19 35.59 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.513 -1.292 . . . . 0.29999999999999999 107.513 173.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.63 129.66 13.89 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.619 2.213 . . . . 0.28000000000000003 112.304 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -127.46 143.41 51.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.083 0.468 . . . . 0.37 110.518 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 m -127.18 116.12 20.14 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.551 -0.907 . . . . 0.88 108.551 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.96 121.33 57.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.55 -0.537 . . . . 0.27000000000000002 109.55 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 p-10 -115.69 148.09 40.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.566 -0.454 . . . . 1.3899999999999999 109.953 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.37 149.65 6.25 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 108.094 -2.003 . . . . 0.59999999999999998 108.094 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 11.2 tm0? -75.78 -54.79 2.11 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 118.014 0.907 . . . . 2.6099999999999999 109.111 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 6.4 Cg_exo -75.99 120.0 5.58 Favored 'Trans proline' 0 C--N 1.369 1.651 0 N-CA-C 107.38 -1.815 . . . . 0.78000000000000003 107.38 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.93 110.99 3.08 Favored Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 124.055 0.847 . . . . 0.78000000000000003 110.924 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.7 Cg_endo -74.47 146.05 34.5 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.213 1.942 . . . . 0.56000000000000005 112.37 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 24.5 t -74.52 111.0 9.27 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.363 -1.347 . . . . 1.3700000000000001 107.363 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 29' ' ' VAL . 80.3 mt -88.75 125.48 34.9 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.637 -0.711 . . . . 0.5 109.786 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 39' ' ' TRP . 16.4 tpp180 -137.08 137.55 39.43 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.828 -0.434 . . . . 3.7799999999999998 109.828 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.422 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 91.7 m95 -101.54 140.45 35.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.183 0.516 . . . . 0.28999999999999998 109.868 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 45' ' ' VAL . 12.3 tp -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.421 -2.066 . . . . 0.94999999999999996 105.421 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 79' ' ' ASN . 54.6 t80 -116.97 106.99 14.01 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.899 -0.408 . . . . 0.88 109.899 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 58.52 37.96 25.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.206 1.002 . . . . 1.79 110.839 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.72 -17.67 43.65 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.632 -0.713 . . . . 0.60999999999999999 113.023 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -93.36 135.82 34.22 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.993 -0.743 . . . . 1.3700000000000001 108.993 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' A' ' 40' ' ' LEU . 5.1 p -67.35 136.52 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 121.373 0.606 . . . . 0.69999999999999996 111.239 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 46.6 tp -92.2 124.25 36.14 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 116.16 -0.473 . . . . 0.60999999999999999 110.45 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.41 104.81 13.62 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 103.916 -2.624 . . . . 2.4700000000000002 103.916 167.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 2.0 pm0 -50.35 137.63 18.26 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.188 0.93 . . . . 1.74 112.504 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -118.48 -166.87 1.28 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.174 -0.921 . . . . 1.5700000000000001 110.467 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -67.17 -33.59 75.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.014 0.435 . . . . 1.52 111.58 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -88.61 -37.17 15.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.381 -0.372 . . . . 1.5900000000000001 111.702 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.452 HG23 ' HG ' ' A' ' 72' ' ' LEU . 21.5 mt -110.0 109.45 28.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.787 -1.19 . . . . 0.5 107.787 -174.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -136.26 138.19 41.53 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.689 -0.804 . . . . 2.8900000000000001 111.608 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -81.61 109.64 16.23 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.457 -0.792 . . . . 0.44 109.518 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -109.63 144.09 38.46 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.901 0.381 . . . . 2.04 110.914 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.13 153.76 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.041 -0.527 . . . . 0.87 109.629 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.45 155.85 38.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.904 -1.517 . . . . 1.25 106.904 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -74.58 121.68 85.8 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 114.534 1.309 . . . . 3.3599999999999999 114.534 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.92 154.4 22.87 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.823 2.348 . . . . 1.3899999999999999 109.622 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.64 176.26 9.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.164 -0.68 . . . . 1.53 109.164 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.12 89.9 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 119.043 0.838 . . . . 1.9099999999999999 112.384 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.78 -20.14 59.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.993 -0.549 . . . . 3.4900000000000002 110.531 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.0 113.15 19.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 120.376 -0.53 . . . . 1.8899999999999999 109.974 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 m -92.25 0.47 57.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.487 1.137 . . . . 1.3 108.089 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 t -91.42 129.06 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.532 -1.213 . . . . 0.60999999999999999 109.797 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB3' HG13 ' A' ' 29' ' ' VAL . 18.6 ttm180 -85.64 121.05 27.76 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.041 -1.837 . . . . 1.8400000000000001 106.041 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.69 131.24 54.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.095 -0.705 . . . . 1.1599999999999999 109.095 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.45 -177.52 35.54 Favored Glycine 0 N--CA 1.414 -2.791 0 C-N-CA 119.989 -1.101 . . . . 0.31 111.821 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.9 136.21 20.18 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.307 0.643 . . . . 0.35999999999999999 109.527 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 56.7 tp -84.58 98.34 10.1 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 104.451 -2.426 . . . . 0.28000000000000003 104.451 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -97.22 123.42 41.0 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.414 -0.812 . . . . 2.6800000000000002 110.759 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HG ' HG23 ' A' ' 52' ' ' ILE . 6.5 mp -102.11 109.31 20.99 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.673 -1.232 . . . . 1.23 107.673 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.43 -42.77 92.64 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.656 -1.611 . . . . 2.1800000000000002 109.965 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -133.17 124.98 18.69 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.274 -1.009 . . . . 2.8199999999999998 108.274 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 23' ' ' TRP . 30.9 Cg_endo -66.02 130.52 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.803 2.336 . . . . 1.25 112.036 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.4 p -109.39 141.84 41.2 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.831 -0.803 . . . . 1.22 108.831 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -80.99 -13.16 59.13 Favored 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 120.589 -0.445 . . . . 2.0299999999999998 110.038 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.32 -13.02 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 119.325 -0.95 . . . . 1.3300000000000001 111.83 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 18.1 m120 -108.48 23.01 15.15 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.957 1.095 . . . . 2.1899999999999999 113.957 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -86.26 64.27 8.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.034 0.921 . . . . 1.96 111.761 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.02 -148.12 4.96 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.11 -0.95 . . . . 0.48999999999999999 111.994 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -102.93 116.76 33.18 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.354 0.597 . . . . 2.23 112.603 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 51.4 m-85 -94.91 140.28 30.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.763 -0.828 . . . . 0.68999999999999995 108.763 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.0 m -128.8 127.71 42.49 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 108.46 -0.941 . . . . 0.34000000000000002 108.46 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.9 tp -101.6 122.94 44.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.067 -0.716 . . . . 0.22 109.067 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.13 131.48 55.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.686 -1.227 . . . . 0.35999999999999999 107.686 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.01 120.11 36.25 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.51 -0.922 . . . . 0.31 108.51 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' SER . . . -96.28 115.51 27.55 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.594 0.559 . . . . 0.60999999999999999 110.64 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -134.82 150.76 74.25 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-O 117.76 -1.114 . . . . 1.1799999999999999 108.211 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.09 -42.15 21.2 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.478 2.119 . . . . 1.0 112.243 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.5 t -57.2 -32.69 66.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 1.1000000000000001 112.01 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.1 178.57 26.93 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 109.867 -1.293 . . . . 0.58999999999999997 109.867 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -106.36 129.82 54.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.385 -0.598 . . . . 1.5700000000000001 109.385 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.83 152.86 20.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.005 -0.739 . . . . 0.37 109.005 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 24.8 p -141.05 146.35 37.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.924 0.392 . . . . 0.56999999999999995 111.251 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.27 43.36 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.738 -1.208 . . . . 0.29999999999999999 107.738 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 t -122.91 127.81 49.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.7 -0.481 . . . . 1.26 109.7 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.6 123.85 38.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.77 -0.826 . . . . 0.71999999999999997 108.77 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.0 mtp -101.73 110.62 22.64 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.2 -0.6 . . . . 1.25 110.285 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.89 133.46 38.59 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.779 -0.646 . . . . 0.57999999999999996 110.513 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.47 100.63 6.33 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.15 -1.056 . . . . 0.83999999999999997 108.15 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 72' ' ' LEU . 33.0 m-85 . . . . . 0 C--N 1.3 -1.584 0 N-CA-C 107.807 -1.182 . . . . 3.8599999999999999 107.807 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.381 -3.894 0 CA-C-O 122.582 1.182 . . . . 1.5800000000000001 113.781 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.27 126.57 52.97 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 112.878 -1.965 . . . . 1.1899999999999999 105.96 171.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.68 174.17 10.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.753 -1.573 . . . . 1.3200000000000001 106.753 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.09 129.23 40.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 118.882 -1.127 . . . . 0.45000000000000001 110.501 -174.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 m -122.03 135.83 54.87 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.798 -1.186 . . . . 1.1899999999999999 107.798 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.6 t -115.82 123.23 70.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.001 0.429 . . . . 0.28999999999999998 111.073 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -115.13 139.72 49.66 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.338 -0.986 . . . . 2.1800000000000002 108.338 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 98' ' ' ILE . 36.1 mt -129.85 156.88 43.64 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.348 -0.612 . . . . 0.33000000000000002 109.348 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -130.7 143.16 50.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.185 -1.043 . . . . 1.03 108.185 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 134.59 56.14 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.496 1.122 . . . . 0.48999999999999999 109.693 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.31 139.84 58.81 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 124.003 0.815 . . . . 0.40000000000000002 110.638 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.32 134.04 31.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.976 0.417 . . . . 0.56999999999999995 111.542 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 92.26 0.34 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.32 -0.855 . . . . 2.52 112.415 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.8 ptt? -144.93 -177.09 5.35 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -64.1 -41.68 97.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.205 0.817 . . . . 2.75 113.205 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.9 p-80 -112.44 129.24 56.39 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.052 -1.462 . . . . 2.46 107.052 173.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -82.74 147.79 28.23 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 120.849 0.357 . . . . 0.85999999999999999 111.642 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -137.59 120.26 16.21 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.44 -0.8 . . . . 0.29999999999999999 110.142 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.4 mt -106.93 97.41 17.61 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.637 -1.245 . . . . 0.29999999999999999 107.637 173.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.76 131.8 17.69 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 123.125 2.55 . . . . 0.28000000000000003 112.602 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.62 154.91 39.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.333 0.587 . . . . 0.37 110.844 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 m -140.14 121.83 15.33 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.617 -0.882 . . . . 0.88 108.617 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.3 p -124.07 111.7 29.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.744 -0.835 . . . . 0.27000000000000002 108.744 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.7 p-10 -106.85 147.25 29.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.026 -0.534 . . . . 1.3899999999999999 111.309 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 -170.77 32.64 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.06 -1.216 . . . . 0.59999999999999998 110.06 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -122.55 -51.94 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.456 0.91 . . . . 2.6099999999999999 113.456 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.01 121.32 9.62 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 107.854 -1.633 . . . . 0.78000000000000003 107.854 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.43 111.03 6.24 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 123.765 0.666 . . . . 0.78000000000000003 111.111 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 71.7 Cg_endo -84.47 146.65 10.96 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.841 1.694 . . . . 0.56000000000000005 111.842 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 22.9 t -79.57 121.96 25.9 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.715 -1.587 . . . . 1.3700000000000001 106.715 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -96.51 129.72 43.82 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.639 0.587 . . . . 0.5 109.734 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -136.58 134.7 37.71 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.116 -0.493 . . . . 3.7799999999999998 110.968 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.85 34.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.617 -0.882 . . . . 0.28999999999999998 108.617 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.86 130.91 52.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.086 -1.45 . . . . 0.94999999999999996 107.086 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 87.2 t80 -120.8 103.72 9.31 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.049 -0.723 . . . . 0.88 109.049 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 56.86 33.59 23.38 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.662 0.785 . . . . 1.79 111.923 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.83 82.95 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.687 -0.768 . . . . 0.60999999999999999 112.895 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 t -105.77 146.69 29.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.976 -1.12 . . . . 1.3700000000000001 107.976 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.88 123.8 36.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.75 106.53 12.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.263 -0.643 . . . . 0.60999999999999999 109.263 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.8 131.41 34.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.585 -0.895 . . . . 2.4700000000000002 108.585 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.01 149.31 47.84 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.273 0.559 . . . . 1.74 111.268 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -145.6 -169.33 3.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 114.938 -1.028 . . . . 1.5700000000000001 108.768 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 t -72.25 -25.18 61.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.429 0.633 . . . . 1.52 109.987 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 95.9 m-85 -101.52 -12.09 18.79 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.437 0.903 . . . . 1.5900000000000001 113.437 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' ND2' ' A' ' 79' ' ' ASN . 44.4 mt -135.75 107.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.311 -1.737 . . . . 0.5 106.311 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -141.45 142.33 33.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 112.308 0.485 . . . . 2.8900000000000001 112.308 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 m -88.79 109.49 20.22 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.644 -0.707 . . . . 0.44 109.499 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.671 ' HG3' ' HE ' ' A' ' 71' ' ' ARG . 6.7 mm-40 -92.98 124.05 36.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.391 0.615 . . . . 2.04 110.883 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.31 120.5 40.03 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.148 -1.427 . . . . 0.87 107.148 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 pp -84.31 155.79 22.22 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 106.836 -1.542 . . . . 1.25 106.836 177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.0 105.97 3.4 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 124.138 0.899 . . . . 3.3599999999999999 110.407 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 79.4 Cg_endo -88.25 169.68 6.05 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.137 2.558 . . . . 1.3899999999999999 111.051 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -93.87 139.62 30.67 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.656 -1.238 . . . . 1.53 107.656 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.54 15.11 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.513 0.673 . . . . 1.9099999999999999 111.413 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.85 -25.62 32.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.069 -0.968 . . . . 3.4900000000000002 109.829 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.8 pt-20 -97.26 139.4 33.28 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.583 -0.895 . . . . 1.8899999999999999 108.583 -177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -88.12 13.59 10.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.96 0.886 . . . . 1.3 109.94 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.6 t -119.57 132.05 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.724 -0.671 . . . . 0.60999999999999999 110.259 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.54 ' HB2' HG13 ' A' ' 29' ' ' VAL . 22.8 mtp180 -95.39 136.23 36.02 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.654 -1.61 . . . . 1.8400000000000001 106.654 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -125.41 157.74 36.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.163 -0.68 . . . . 1.1599999999999999 109.163 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.2 -168.24 38.84 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 111.264 -0.734 . . . . 0.31 111.264 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.29 138.41 16.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 123.001 0.52 . . . . 0.35999999999999999 111.335 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.13 109.83 20.19 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.81 -1.552 . . . . 0.28000000000000003 106.81 172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.671 ' HE ' ' HG3' ' A' ' 55' ' ' GLU . 76.0 mtm180 -102.28 131.56 48.78 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.795 -0.362 . . . . 2.6800000000000002 111.574 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.1 mp -119.83 109.56 15.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.777 -0.823 . . . . 1.23 108.777 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.84 -10.61 59.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.759 -0.655 . . . . 2.1800000000000002 111.184 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 33.3 tt0 -135.09 101.49 11.33 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 108.114 -1.069 . . . . 2.8199999999999998 108.114 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -88.26 129.59 2.35 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.591 1.528 . . . . 1.25 110.368 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.7 p -136.54 173.15 12.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.842 -0.799 . . . . 1.22 108.842 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -78.79 -5.67 53.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.113 0.412 . . . . 2.0299999999999998 112.113 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.02 -9.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.611 . . . . 1.3300000000000001 109.349 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.4 m120 -104.81 22.06 15.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.005 -1.109 . . . . 2.1899999999999999 108.005 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -114.17 117.44 31.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.799 -0.815 . . . . 1.96 108.799 -175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.27 -153.52 24.68 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.637 -1.268 . . . . 0.48999999999999999 113.18 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 45.8 m-80 -87.28 120.66 28.79 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.55 -0.325 . . . . 2.23 111.406 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 98' ' ' ILE . 39.4 m-85 -105.56 118.28 36.16 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.311 -0.996 . . . . 0.68999999999999995 108.311 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 m -122.96 125.02 44.49 Favored 'General case' 0 C--N 1.283 -2.3 0 O-C-N 121.611 -0.681 . . . . 0.34000000000000002 109.775 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.434 HD23 HG13 ' A' ' 12' ' ' VAL . 59.0 tp -97.39 117.54 31.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.43 133.2 52.29 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.467 -0.938 . . . . 0.35999999999999999 108.467 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -122.16 120.03 33.03 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.719 -1.215 . . . . 0.31 107.719 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.88 132.53 55.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.962 -0.755 . . . . 0.60999999999999999 108.962 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 91' ' ' CYS . 8.7 p30 -152.62 170.43 8.1 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-O 118.474 -0.774 . . . . 1.1799999999999999 109.257 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.48 -39.15 54.92 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.85 2.367 . . . . 1.0 114.465 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.438 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 27.0 t -70.0 -32.06 70.06 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-O 121.224 0.535 . . . . 1.1000000000000001 111.832 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.19 -146.03 11.75 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 119.864 -1.16 . . . . 0.58999999999999997 111.969 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.63 138.63 38.03 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.146 -0.687 . . . . 1.5700000000000001 109.146 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -119.81 146.63 45.52 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.965 -1.124 . . . . 0.37 107.965 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 p -143.74 152.85 41.78 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 121.006 -0.277 . . . . 0.56999999999999995 110.275 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.58 144.92 26.52 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.86 -1.533 . . . . 0.29999999999999999 106.86 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -122.44 145.72 48.03 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.472 0.654 . . . . 1.26 112.358 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.755 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -133.64 124.76 48.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 125.475 1.51 . . . . 0.71999999999999997 108.572 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 tpt -96.34 96.52 8.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.687 -1.227 . . . . 1.25 107.687 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.02 113.16 26.16 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.349 0.595 . . . . 0.57999999999999996 111.44 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.31 99.62 9.01 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 107.093 -1.447 . . . . 0.83999999999999997 107.093 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 114.209 1.188 . . . . 3.8599999999999999 114.209 -178.577 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.411 -2.377 0 CA-C-O 121.478 0.656 . . . . 1.5800000000000001 109.999 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.431 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.2 m-85 -86.52 127.92 34.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.818 -1.083 . . . . 1.1899999999999999 109.587 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.2 t -84.68 176.47 8.55 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.557 -1.275 . . . . 1.3200000000000001 107.557 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.11 114.57 26.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 120.357 -0.537 . . . . 0.45000000000000001 110.55 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.642 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 34.1 t -117.68 131.31 56.65 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.743 -1.206 . . . . 1.1899999999999999 107.743 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.53 121.26 67.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.507 -0.315 . . . . 0.28999999999999998 110.936 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -121.1 123.42 42.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.569 -0.53 . . . . 2.1800000000000002 109.569 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 27' ' ' PHE . 43.8 mt -105.87 156.02 18.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.33000000000000002 109.937 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.53 151.92 51.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 110.455 -0.202 . . . . 1.03 110.455 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -54.05 133.16 43.68 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 124.786 1.304 . . . . 0.48999999999999999 110.4 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -66.49 145.55 55.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.625 -0.716 . . . . 0.40000000000000002 110.213 -177.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.68 127.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.518 0.675 . . . . 0.56999999999999995 112.745 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.74 108.83 4.08 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 114.281 -1.327 . . . . 2.52 110.926 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -170.61 -171.7 1.1 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.93 -1.507 . . . . 0.88 106.93 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -66.52 -50.59 62.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.393 -0.523 . . . . 2.75 111.982 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -92.39 120.13 32.6 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -82.32 120.11 24.99 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.271 0.557 . . . . 0.85999999999999999 111.023 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.8 121.96 44.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.612 -1.176 . . . . 0.29999999999999999 109.138 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.4 mt -103.73 103.74 38.45 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 108.054 -1.091 . . . . 0.29999999999999999 108.054 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.25 130.48 13.06 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.456 2.104 . . . . 0.28000000000000003 111.85 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.502 ' HB3' HD23 ' A' ' 14' ' ' LEU . 43.1 p90 -135.35 162.2 33.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.318 0.58 . . . . 0.37 110.482 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.0 m -144.62 123.48 12.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.651 -0.704 . . . . 0.88 109.157 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.7 p -123.6 114.69 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.079 -0.964 . . . . 0.27000000000000002 108.495 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.642 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 4.1 p-10 -102.25 158.49 16.15 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.736 -1.186 . . . . 1.3899999999999999 109.755 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.98 138.72 2.61 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.795 -1.322 . . . . 0.59999999999999998 109.795 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -87.32 -49.6 0.45 Allowed Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 119.571 -0.852 . . . . 2.6099999999999999 110.316 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.6 Cg_exo -64.17 119.48 6.54 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 105.255 -2.633 . . . . 0.78000000000000003 105.255 164.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.17 117.79 59.78 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 116.138 -0.483 . . . . 0.78000000000000003 112.296 -171.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -85.89 149.53 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.398 2.065 . . . . 0.56000000000000005 111.941 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -90.91 138.81 31.31 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.77 -1.196 . . . . 1.3700000000000001 107.77 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.424 ' HB3' HD11 ' A' ' 85' ' ' LEU . 80.9 mt -98.23 134.06 41.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.938 0.399 . . . . 0.5 111.094 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -130.29 126.22 36.69 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.037 -0.529 . . . . 3.7799999999999998 110.064 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -96.78 124.33 40.72 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.599 -0.728 . . . . 0.28999999999999998 109.702 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.97 128.8 55.61 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.492 -0.929 . . . . 0.94999999999999996 108.492 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -105.01 104.64 14.41 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.169 -1.419 . . . . 0.88 107.169 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.08 30.76 19.65 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.801 0.81 . . . . 1.79 110.961 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.04 64.25 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.39 -0.823 . . . . 0.60999999999999999 112.392 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -91.45 150.8 21.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.212 -1.032 . . . . 1.3700000000000001 108.212 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -72.33 121.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.818 -0.628 . . . . 0.69999999999999996 111.345 -175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -102.66 122.45 44.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.664 -1.235 . . . . 0.60999999999999999 107.664 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.81 138.32 35.35 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.773 -0.825 . . . . 2.4700000000000002 108.773 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -75.84 106.15 7.26 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.329 -0.396 . . . . 1.74 110.214 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -88.28 -170.37 2.93 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.852 -0.425 . . . . 1.5700000000000001 109.852 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -80.12 -13.61 59.14 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.56 -0.713 . . . . 1.52 109.517 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -97.94 -40.1 8.64 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.695 -0.684 . . . . 1.5900000000000001 110.137 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HG ' ' A' ' 72' ' ' LEU . 37.5 mt -107.12 104.89 17.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.972 -2.232 . . . . 0.5 104.972 174.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -135.09 149.52 50.07 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.378 -0.929 . . . . 2.8900000000000001 112.078 -173.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.9 m -94.36 109.62 21.45 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.357 -0.979 . . . . 0.44 108.357 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -100.75 123.79 45.46 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.544 -0.91 . . . . 2.04 108.544 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -100.4 146.17 27.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.716 -0.846 . . . . 0.87 108.716 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.15 154.5 32.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.833 -1.173 . . . . 1.25 107.833 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.49 120.43 81.45 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 123.94 0.775 . . . . 3.3599999999999999 110.203 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.94 169.53 16.26 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.873 2.382 . . . . 1.3899999999999999 109.936 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.73 141.2 38.06 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.315 -1.735 . . . . 1.53 106.315 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.93 -25.35 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.107 1.521 . . . . 1.9099999999999999 115.107 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -73.5 -32.05 64.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.087 0.47 . . . . 3.4900000000000002 110.411 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -75.23 142.36 43.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.251 0.548 . . . . 1.8899999999999999 110.1 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 m -111.29 18.03 19.66 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.382 -1.71 . . . . 1.3 106.382 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.81 121.36 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 113.819 -1.537 . . . . 0.60999999999999999 108.45 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 77.6 ttt180 -93.14 111.39 23.01 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.173 -1.417 . . . . 1.8400000000000001 107.173 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -101.61 155.65 17.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.46 -0.57 . . . . 1.1599999999999999 109.46 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.28 -174.74 44.83 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.278 -0.963 . . . . 0.31 112.092 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.4 t -145.3 134.85 23.27 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.177 0.591 . . . . 0.35999999999999999 111.025 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.0 tp -88.63 107.59 19.0 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.103 -2.184 . . . . 0.28000000000000003 105.103 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -117.91 130.41 56.22 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.432 0.634 . . . . 2.6800000000000002 111.228 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.8 mp -102.44 114.79 29.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.928 -1.033 . . . . 1.23 110.802 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.33 -39.35 81.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.769 -1.105 . . . . 2.1800000000000002 109.019 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.34 100.45 49.86 Favored Pre-proline 0 N--CA 1.435 -1.214 0 N-CA-C 107.897 -1.149 . . . . 2.8199999999999998 107.897 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.6 135.45 24.05 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 122.652 2.234 . . . . 1.25 109.451 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -133.43 149.19 51.79 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.033 0.444 . . . . 1.22 111.514 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -70.14 -4.21 20.31 Favored 'General case' 0 C--O 1.208 -1.085 0 C-N-CA 123.822 0.849 . . . . 2.0299999999999998 112.117 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.06 -9.78 11.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.416 -0.356 . . . . 1.3300000000000001 110.178 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.586 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.6 m-80 -115.96 26.48 9.94 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.549 0.944 . . . . 2.1899999999999999 113.549 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -94.32 72.81 3.88 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.075 0.941 . . . . 1.96 110.011 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.5 -153.11 5.88 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.701 -0.761 . . . . 0.48999999999999999 113.206 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.35 123.84 43.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.967 -0.383 . . . . 2.23 109.967 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 27.8 m-85 -101.33 116.57 33.1 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.012 -0.736 . . . . 0.68999999999999995 109.012 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.9 m -110.72 122.32 47.5 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.192 -1.04 . . . . 0.34000000000000002 108.192 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.4 tp -99.01 119.2 37.4 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.135 -0.484 . . . . 0.22 109.811 -178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 129.38 53.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.554 -0.906 . . . . 0.35999999999999999 108.554 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.47 120.99 33.61 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.326 -1.361 . . . . 0.31 107.326 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.04 124.8 46.77 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.457 -0.497 . . . . 0.60999999999999999 111.492 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 43.9 p30 -138.47 171.1 8.8 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.181 -1.414 . . . . 1.1799999999999999 107.181 174.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 38.9 Cg_exo -45.35 -37.48 14.22 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.043 2.495 . . . . 1.0 114.648 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.04 -49.62 73.84 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.671 0.272 . . . . 1.1000000000000001 110.824 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.67 -177.65 48.03 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.131 -1.033 . . . . 0.58999999999999997 111.816 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -108.1 122.58 47.19 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.992 -1.114 . . . . 1.5700000000000001 107.992 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.88 149.09 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.397 -0.964 . . . . 0.37 108.397 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.1 p -147.42 140.84 25.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 O-C-N 123.464 0.477 . . . . 0.56999999999999995 110.883 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.17 42.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.318 -1.364 . . . . 0.29999999999999999 107.318 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.9 p -130.15 146.35 51.78 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.13 0.49 . . . . 1.26 111.842 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -145.57 138.6 21.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.621 -1.622 . . . . 0.71999999999999997 106.621 178.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -111.12 124.1 51.52 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 1.25 110.336 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.62 115.31 25.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.493 -0.558 . . . . 0.57999999999999996 109.493 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.43 111.65 23.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.982 -0.554 . . . . 0.83999999999999997 110.303 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 N--CA 1.432 -1.331 0 CA-C-O 121.555 0.693 . . . . 3.8599999999999999 111.636 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.417 -2.117 0 CA-C-O 121.784 0.802 . . . . 1.5800000000000001 109.446 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.34 124.89 24.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.875 -1.057 . . . . 1.1899999999999999 110.992 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 20.6 t -84.46 160.97 20.45 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.428 -1.693 . . . . 1.3200000000000001 106.428 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.51 121.24 35.86 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.776 -0.77 . . . . 0.45000000000000001 111.42 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -112.3 141.88 45.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.454 -1.313 . . . . 1.1899999999999999 107.454 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.8 t -115.36 114.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 110.056 -0.349 . . . . 0.28999999999999998 110.056 -176.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.35 116.4 30.29 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.379 0.609 . . . . 2.1800000000000002 109.55 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 98' ' ' ILE . 70.7 mt -104.87 156.81 17.68 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.96 -1.018 . . . . 0.33000000000000002 109.035 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -131.13 156.52 45.14 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.762 -0.829 . . . . 1.03 108.762 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -65.08 134.76 54.51 Favored 'General case' 0 N--CA 1.423 -1.806 0 O-C-N 124.456 1.097 . . . . 0.48999999999999999 109.63 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.41 140.9 56.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.25 -0.886 . . . . 0.40000000000000002 109.684 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.67 132.97 33.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.547 0.689 . . . . 0.56999999999999995 110.652 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.44 102.39 2.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.427 -1.261 . . . . 2.52 112.465 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -161.37 -179.42 7.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.812 -1.551 . . . . 0.88 106.812 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -64.55 -37.66 88.34 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.468 1.031 . . . . 2.75 113.401 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -107.22 117.91 35.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.906 -1.516 . . . . 2.46 106.906 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.452 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.3 m95 -82.05 125.55 30.96 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.159 -0.616 . . . . 0.85999999999999999 110.681 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -108.67 121.43 45.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.146 -1.057 . . . . 0.29999999999999999 108.146 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.3 mt -102.89 98.11 10.77 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 107.693 -1.225 . . . . 0.29999999999999999 107.693 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.92 132.08 19.33 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.392 2.061 . . . . 0.28000000000000003 112.056 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -128.69 152.79 48.0 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.327 0.584 . . . . 0.37 110.481 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 48.7 m -142.18 120.63 12.42 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.265 -0.88 . . . . 0.88 108.927 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -124.61 121.16 60.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.335 -0.987 . . . . 0.27000000000000002 108.335 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 p-10 -111.55 145.49 39.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.737 -0.785 . . . . 1.3899999999999999 110.204 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.62 4.73 Favored Glycine 0 C--N 1.298 -1.529 0 N-CA-C 107.504 -2.238 . . . . 0.59999999999999998 107.504 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' HD3' ' A' ' 33' ' ' PRO 0.278 46.1 tt0 -80.87 -57.43 0.58 Allowed Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 118.649 1.224 . . . . 2.6099999999999999 113.168 -175.362 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 32.4 Cg_exo -63.69 119.74 6.89 Favored 'Trans proline' 0 C--N 1.367 1.509 0 N-CA-C 106.28 -2.239 . . . . 0.78000000000000003 106.28 168.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.93 109.84 2.86 Favored Pre-proline 0 C--N 1.315 -0.923 0 O-C-N 123.806 0.691 . . . . 0.78000000000000003 111.076 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 59.1 Cg_endo -71.16 141.67 40.14 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.162 1.908 . . . . 0.56000000000000005 112.512 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -71.26 104.24 3.07 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.463 -0.79 . . . . 1.3700000000000001 108.952 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 29' ' ' VAL . 96.0 mt -81.78 134.03 35.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.352 -0.84 . . . . 0.5 109.813 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -146.39 138.59 25.03 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 123.687 0.795 . . . . 3.7799999999999998 108.86 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 95.6 m95 -102.78 130.67 49.84 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.378 0.609 . . . . 0.28999999999999998 110.625 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.9 tp -114.72 126.79 55.26 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.954 -1.869 . . . . 0.94999999999999996 105.954 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -116.63 98.12 6.36 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 109.077 -0.712 . . . . 0.88 109.077 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 51.92 56.6 7.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.167 0.984 . . . . 1.79 110.23 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.02 -13.95 12.54 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.089 -0.96 . . . . 0.60999999999999999 113.816 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 m -96.6 140.99 30.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.853 -0.795 . . . . 1.3700000000000001 108.853 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.92 123.45 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 47.4 tp -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.58 0.55 . . . . 0.60999999999999999 109.587 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -82.83 125.83 31.75 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.486 -0.931 . . . . 2.4700000000000002 108.486 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.36 153.19 35.99 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.222 -0.445 . . . . 1.74 110.031 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.9 t -166.05 -175.28 3.29 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.748 -0.834 . . . . 1.5700000000000001 108.748 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 m -68.22 -17.67 64.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 119.594 1.088 . . . . 1.52 111.901 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -79.07 -40.17 31.94 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.729 0.3 . . . . 1.5900000000000001 110.831 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.42 HD11 ' ND2' ' A' ' 79' ' ' ASN . 56.9 mt -136.15 115.66 16.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.929 -0.767 . . . . 0.5 108.929 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 8.8 p90 -142.39 145.69 34.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.107 0.479 . . . . 2.8900000000000001 112.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 m -82.58 111.19 18.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.466 -0.788 . . . . 0.44 109.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 6.4 mm-40 -89.3 140.39 29.54 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.899 -0.778 . . . . 2.04 108.899 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -122.27 140.67 52.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.749 -0.834 . . . . 0.87 108.749 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.59 151.71 41.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.027 -1.101 . . . . 1.25 108.027 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 32.6 mm-40 -63.46 119.97 58.2 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 123.96 0.788 . . . . 3.3599999999999999 112.598 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.95 156.13 38.77 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.588 2.192 . . . . 1.3899999999999999 110.351 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.89 146.91 33.31 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.667 -0.864 . . . . 1.53 108.667 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.69 -13.05 58.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.019 1.118 . . . . 1.9099999999999999 114.019 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -90.57 -21.47 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.916 0.388 . . . . 3.4900000000000002 111.424 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.4 pt-20 -99.28 162.47 13.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.689 -0.804 . . . . 1.8899999999999999 110.957 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -121.49 29.71 7.09 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.966 -1.494 . . . . 1.3 106.966 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 30' ' ' ASP . 21.7 t -107.93 128.76 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.22 -1.355 . . . . 0.60999999999999999 108.807 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.2 mtp180 -92.59 132.59 36.73 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.003 -1.48 . . . . 1.8400000000000001 107.003 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -121.97 143.73 49.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.302 -0.629 . . . . 1.1599999999999999 109.302 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.7 -166.09 24.11 Favored Glycine 0 N--CA 1.416 -2.642 0 C-N-CA 120.512 -0.851 . . . . 0.31 111.035 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.0 t -156.07 137.57 14.06 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.833 0.453 . . . . 0.35999999999999999 110.183 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 38.3 tp -90.16 107.93 19.43 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.851 -1.907 . . . . 0.28000000000000003 105.851 171.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 70.6 mtt180 -100.18 120.35 39.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-N 116.502 -0.317 . . . . 2.6800000000000002 110.873 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 23' ' ' TRP . 73.1 mt -83.7 108.0 16.49 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 105.96 -1.867 . . . . 1.23 105.96 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.408 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 50.4 t30 -66.97 -42.62 84.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.047 -0.979 . . . . 2.1800000000000002 109.532 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -134.98 100.99 11.63 Favored Pre-proline 0 N--CA 1.412 -2.341 0 N-CA-C 106.533 -1.655 . . . . 2.8199999999999998 106.533 171.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 14.3 Cg_exo -70.38 131.42 20.33 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.022 1.814 . . . . 1.25 110.367 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 p -130.27 155.74 45.8 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.312 -0.995 . . . . 1.22 108.312 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -65.41 -5.42 7.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.444 1.276 . . . . 2.0299999999999998 114.444 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.49 -10.44 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 109.638 -0.504 . . . . 1.3300000000000001 109.638 174.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.42 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.8 m120 -89.18 17.15 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.599 0.76 . . . . 2.1899999999999999 111.882 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -92.15 121.9 34.13 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.874 -0.788 . . . . 1.96 108.874 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.53 -170.45 36.5 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.39 -1.386 . . . . 0.48999999999999999 112.641 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.83 101.29 13.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.996 -0.602 . . . . 2.23 110.721 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.49 ' HB2' HG23 ' A' ' 98' ' ' ILE . 45.1 m-85 -83.97 114.13 21.49 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 108.767 -0.827 . . . . 0.68999999999999995 108.767 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 35.8 m -117.32 132.46 56.6 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 121.452 -0.78 . . . . 0.34000000000000002 110.683 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 12' ' ' VAL . 44.3 tp -106.18 123.1 47.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.124 -0.695 . . . . 0.22 109.124 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.11 136.07 47.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.254 -1.017 . . . . 0.35999999999999999 108.254 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -126.84 120.62 29.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.549 -0.908 . . . . 0.31 108.549 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.28 117.19 34.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.796 -0.446 . . . . 0.60999999999999999 109.796 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 20.4 t-20 -131.31 151.59 79.07 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-O 117.405 -1.283 . . . . 1.1799999999999999 108.31 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -43.1 -38.42 7.43 Favored 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 122.799 2.332 . . . . 1.0 113.38 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.1 t -64.16 -39.66 94.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.486 0.714 . . . . 1.1000000000000001 112.137 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.14 30.96 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.149 -0.78 . . . . 0.58999999999999997 111.149 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 64.5 tt0 -128.83 129.91 46.23 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.729 -0.471 . . . . 1.5700000000000001 109.729 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.43 150.51 23.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.747 -0.834 . . . . 0.37 108.747 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 p -148.65 123.73 10.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.977 -0.556 . . . . 0.56999999999999995 110.183 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.41 51.88 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.006 -1.109 . . . . 0.29999999999999999 108.006 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.4 m -121.17 132.79 55.05 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.699 0.761 . . . . 1.26 112.819 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -109.78 126.55 66.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 125.541 1.536 . . . . 0.71999999999999997 108.685 175.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' ILE . 16.0 tpt -105.08 111.09 23.73 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 1.25 108.209 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.6 149.7 27.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.218 -0.447 . . . . 0.57999999999999996 109.961 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.6 127.33 23.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.799 -0.637 . . . . 0.83999999999999997 110.475 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 75' ' ' PRO . 55.4 t80 . . . . . 0 C--N 1.299 -1.604 0 C-N-CA 124.994 1.317 . . . . 3.8599999999999999 107.876 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 105.846 -1.909 . . . . 1.5800000000000001 105.846 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -72.13 131.73 43.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.262 -0.881 . . . . 1.1899999999999999 110.084 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.36 157.1 21.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.61 -1.256 . . . . 1.3200000000000001 107.61 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.56 127.2 41.4 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.624 0.601 . . . . 0.45000000000000001 112.624 -172.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.3 m -123.87 141.05 52.38 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.933 -1.877 . . . . 1.1899999999999999 105.933 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.7 t -115.0 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.074 0.464 . . . . 0.28999999999999998 109.755 -174.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -115.81 116.85 28.73 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.001 -0.74 . . . . 2.1800000000000002 109.001 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 38.8 mt -95.68 156.66 16.23 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.965 -0.561 . . . . 0.33000000000000002 109.631 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -130.54 142.04 50.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.954 -1.499 . . . . 1.03 106.954 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -62.11 130.1 43.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 124.053 0.846 . . . . 0.48999999999999999 110.558 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.56 140.63 40.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.451 1.1 . . . . 0.40000000000000002 112.207 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.7 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.754 -0.657 . . . . 0.56999999999999995 109.886 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.3 117.27 24.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.991 -1.004 . . . . 2.52 112.394 -171.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.0 ptt? -168.28 -174.27 2.23 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.129 -1.434 . . . . 0.88 107.129 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 8.0 t-80 -65.54 -52.65 50.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.794 0.724 . . . . 2.75 110.639 -176.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.479 ' O ' ' HG3' ' A' ' 20' ' ' MET . 7.8 p-80 -99.35 126.65 45.26 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.625 -0.879 . . . . 2.46 108.625 173.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 82.7 m95 -82.36 148.0 28.51 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.178 0.513 . . . . 0.85999999999999999 112.224 -171.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 44.0 t -131.55 118.89 20.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.506 -0.924 . . . . 0.29999999999999999 108.506 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 17' ' ' ALA . 78.3 mt -103.68 99.18 14.84 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.455 -1.313 . . . . 0.29999999999999999 107.455 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.0 143.58 36.58 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.087 1.858 . . . . 0.28000000000000003 110.887 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -137.73 154.58 49.61 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.724 -0.39 . . . . 0.37 110.349 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -132.62 114.06 13.77 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.638 -0.71 . . . . 0.88 110.208 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 37' ' ' LEU . 6.4 p -129.57 137.81 55.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.813 -1.551 . . . . 0.27000000000000002 106.813 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.3 p-10 -132.34 161.88 32.45 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 119.741 -0.784 . . . . 1.3899999999999999 110.744 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.94 153.74 7.34 Favored Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 109.502 -1.439 . . . . 0.59999999999999998 109.502 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -81.31 -56.68 0.59 Allowed Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 107.973 -1.121 . . . . 2.6099999999999999 107.973 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.83 120.85 7.73 Favored 'Trans proline' 0 C--N 1.375 1.928 0 N-CA-C 107.59 -1.734 . . . . 0.78000000000000003 107.59 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB1' HH21 ' A' ' 66' ' ' ARG . . . -61.78 114.41 11.18 Favored Pre-proline 0 C--N 1.312 -1.023 0 O-C-N 123.742 0.651 . . . . 0.78000000000000003 111.694 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' ALA . 84.8 Cg_endo -79.1 135.05 12.01 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.572 1.515 . . . . 0.56000000000000005 112.058 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 p -73.53 116.47 14.14 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 109.023 -0.732 . . . . 1.3700000000000001 109.023 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.516 HD21 HG11 ' A' ' 29' ' ' VAL . 93.2 mt -87.22 127.53 35.16 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.5 109.647 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -125.7 130.21 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.127 -0.694 . . . . 3.7799999999999998 109.127 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.5 m95 -95.64 128.87 42.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.277 0.561 . . . . 0.28999999999999998 109.734 176.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.1 tp -118.59 127.42 53.59 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.703 -1.962 . . . . 0.94999999999999996 105.703 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -119.91 110.85 17.21 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.587 -0.523 . . . . 0.88 109.587 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.0 28.5 16.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.061 0.945 . . . . 1.79 111.45 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.09 -12.27 69.4 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 121.389 -0.434 . . . . 0.60999999999999999 112.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.1 p -103.18 151.31 22.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.754 0.311 . . . . 1.3700000000000001 110.315 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.28 120.76 17.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.667 -0.697 . . . . 0.69999999999999996 110.436 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.9 tp -94.42 104.44 16.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.05 -0.722 . . . . 0.60999999999999999 109.05 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -85.74 137.31 32.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.252 -0.647 . . . . 2.4700000000000002 109.252 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.42 129.18 39.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.956 -0.566 . . . . 1.74 109.536 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 p -126.64 -163.69 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.853 0.861 . . . . 1.5700000000000001 109.661 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.6 m -87.19 -5.83 58.83 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.359 0.599 . . . . 1.52 109.661 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -103.0 -35.56 8.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.81 -0.632 . . . . 1.5900000000000001 109.955 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -127.93 106.97 15.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.231 -1.025 . . . . 0.5 108.231 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -138.78 140.22 38.54 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.817 0.341 . . . . 2.8900000000000001 110.303 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -86.83 113.81 22.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.706 -0.85 . . . . 0.44 108.706 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 71' ' ' ARG . 43.4 mt-10 -105.52 115.06 29.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.397 0.618 . . . . 2.04 110.062 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -96.37 150.63 20.37 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.35 -0.841 . . . . 0.87 109.455 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.0 pp -106.91 165.15 11.55 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.743 -1.947 . . . . 1.25 105.743 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.4 104.74 21.43 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.556 -0.535 . . . . 3.3599999999999999 109.556 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 86.9 Cg_endo -84.08 165.32 13.15 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.379 2.052 . . . . 1.3899999999999999 111.145 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.32 137.29 54.54 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.962 -1.125 . . . . 1.53 107.962 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.03 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.012 0.525 . . . . 1.9099999999999999 111.981 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.49 -26.01 65.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.755 0.788 . . . . 3.4900000000000002 109.149 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -98.38 140.1 33.15 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.526 -0.761 . . . . 1.8899999999999999 109.04 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -104.99 28.72 6.94 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.692 0.758 . . . . 1.3 108.993 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 130.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 115.241 -0.89 . . . . 0.60999999999999999 109.318 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.455 HH21 ' HB1' ' A' ' 34' ' ' ALA . 75.9 mtt180 -82.74 117.54 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.4 -0.963 . . . . 1.8400000000000001 108.4 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.518 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 96.1 m-70 -104.38 123.74 47.96 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.368 -0.975 . . . . 1.1599999999999999 108.368 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.9 39.32 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.473 -0.87 . . . . 0.31 111.395 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.4 t -144.16 137.89 27.76 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 122.439 0.296 . . . . 0.35999999999999999 110.897 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 58.9 tp -84.68 100.38 11.43 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.759 -2.311 . . . . 0.28000000000000003 104.759 169.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 55' ' ' GLU . 47.8 ttp180 -104.19 120.17 40.54 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 120.238 -0.585 . . . . 2.6800000000000002 110.049 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 23' ' ' TRP . 75.2 mt -75.55 108.03 8.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.343 -1.725 . . . . 1.23 106.343 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.82 -49.19 66.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.16 -1.382 . . . . 2.1800000000000002 109.479 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.4 99.8 18.86 Favored Pre-proline 0 N--CA 1.414 -2.234 0 N-CA-C 104.296 -2.483 . . . . 2.8199999999999998 104.296 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' HG2' ' O ' ' A' ' 21' ' ' HIS . 33.5 Cg_exo -64.06 130.5 27.53 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.388 2.059 . . . . 1.25 111.73 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -135.18 166.02 24.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.56 -0.745 . . . . 1.22 109.383 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -62.54 -5.18 2.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.748 1.759 . . . . 2.0299999999999998 115.748 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.17 -10.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.035 0.445 . . . . 1.3300000000000001 109.834 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.7 26.74 0.39 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.113 1.153 . . . . 2.1899999999999999 114.113 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.14 125.17 53.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.321 -0.992 . . . . 1.96 108.321 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.38 -165.71 30.96 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.21 -0.995 . . . . 0.48999999999999999 111.744 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -99.96 124.0 44.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 110.024 -0.362 . . . . 2.23 110.024 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -102.67 105.79 16.32 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.622 -0.881 . . . . 0.68999999999999995 108.622 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.6 m -97.33 129.58 44.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.948 -0.76 . . . . 0.34000000000000002 108.948 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.2 tp -109.06 120.77 43.53 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.582 -0.525 . . . . 0.22 109.582 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.23 138.95 42.46 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.283 -1.006 . . . . 0.35999999999999999 108.283 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -125.94 120.66 30.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.306 -0.998 . . . . 0.31 108.306 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -97.97 112.46 24.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.34 0.59 . . . . 0.60999999999999999 110.97 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -130.61 140.92 40.13 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.13 -1.804 . . . . 1.1799999999999999 106.13 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.16 -19.57 12.43 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 124.052 3.168 . . . . 1.0 113.947 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.0 t -78.93 -24.29 44.11 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.825 0.345 . . . . 1.1000000000000001 110.593 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.52 163.61 11.76 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.555 -1.018 . . . . 0.58999999999999997 110.555 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -98.12 127.65 44.18 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.478 -0.564 . . . . 1.5700000000000001 109.478 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.27 155.35 18.28 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.05 -0.722 . . . . 0.37 109.05 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 39.6 p -146.02 151.56 37.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 123.232 0.332 . . . . 0.56999999999999995 110.609 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.44 33.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.662 -1.607 . . . . 0.29999999999999999 106.662 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 m -135.02 135.47 41.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 117.983 0.356 . . . . 1.26 110.157 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -128.79 134.68 63.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.844 -1.539 . . . . 0.71999999999999997 106.844 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.9 ttt -108.69 134.27 51.64 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.177 -0.609 . . . . 1.25 110.063 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.54 45.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.018 -1.104 . . . . 0.57999999999999996 108.018 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.51 121.04 34.64 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.025 0.44 . . . . 0.83999999999999997 110.351 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.5 t80 . . . . . 0 N--CA 1.402 -2.847 0 N-CA-C 108.577 -0.897 . . . . 3.8599999999999999 108.577 179.35 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 108.736 -0.839 . . . . 1.5800000000000001 108.736 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.41 127.3 53.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.235 -0.654 . . . . 1.1899999999999999 109.235 176.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 t -84.64 -177.87 6.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.276 . . . . 1.3200000000000001 107.553 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.29 120.5 34.62 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.069 -0.652 . . . . 0.45000000000000001 111.186 -174.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 1.5 m -114.82 131.17 56.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.803 -1.184 . . . . 1.1899999999999999 107.803 177.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.1 t -119.65 115.01 46.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 110.14 -0.318 . . . . 0.28999999999999998 110.14 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -120.38 121.96 39.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.335 -0.393 . . . . 2.1800000000000002 110.033 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 27' ' ' PHE . 17.1 mt -104.16 155.25 18.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.917 -0.583 . . . . 0.33000000000000002 110.786 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -131.96 151.56 51.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.235 -1.024 . . . . 1.03 108.235 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -64.48 135.8 56.42 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.278 0.986 . . . . 0.48999999999999999 111.515 -174.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -61.1 128.91 38.73 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.826 -1.079 . . . . 0.40000000000000002 111.332 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.64 136.81 24.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.427 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -87.37 129.73 34.91 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.271 -0.422 . . . . 2.52 111.155 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -176.86 -166.91 0.16 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.918 -1.512 . . . . 0.88 106.918 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -55.18 -38.44 68.34 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.815 0.672 . . . . 2.75 112.815 -178.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.53 132.72 54.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.102 -1.073 . . . . 2.46 108.102 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 64.5 m95 -81.94 119.25 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.575 -0.528 . . . . 0.85999999999999999 109.575 -179.03 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.4 t -113.53 119.25 36.9 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.625 -0.716 . . . . 0.29999999999999999 110.356 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 17' ' ' ALA . 40.8 mt -104.15 96.27 9.39 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.8 -1.556 . . . . 0.29999999999999999 106.8 171.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.05 141.58 14.89 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.644 2.229 . . . . 0.28000000000000003 112.723 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 14' ' ' LEU . 51.4 p90 -145.85 156.78 43.79 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.067 -0.515 . . . . 0.37 111.416 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -129.07 123.53 32.51 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 115.036 -0.984 . . . . 0.88 108.758 175.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ARG . 1.5 p -122.01 110.47 27.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.271 -0.877 . . . . 0.27000000000000002 109.015 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 p30 -106.8 152.94 23.19 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.879 -0.601 . . . . 1.3899999999999999 111.353 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.5 158.47 9.92 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 109.315 -1.514 . . . . 0.59999999999999998 109.315 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 23.8 tm0? -84.79 -51.02 0.56 Allowed Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 117.74 0.77 . . . . 2.6099999999999999 109.972 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 12.1 Cg_exo -73.57 134.81 21.0 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 N-CA-C 107.589 -1.735 . . . . 0.78000000000000003 107.589 168.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.0 117.05 61.08 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 110.251 -0.277 . . . . 0.78000000000000003 110.251 -177.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' A' ' 89' ' ' ASN . 73.1 Cg_endo -82.97 154.62 14.9 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.442 2.095 . . . . 0.56000000000000005 112.727 -177.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -83.35 125.14 31.34 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.779 -1.193 . . . . 1.3700000000000001 107.779 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 29' ' ' VAL . 97.0 mt -94.13 130.95 40.13 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 120.873 0.368 . . . . 0.5 110.044 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -135.61 135.23 40.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.421 -0.808 . . . . 3.7799999999999998 109.633 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.6 m95 -96.01 132.05 41.75 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.237 0.542 . . . . 0.28999999999999998 110.528 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.8 tp -119.47 126.86 52.32 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.444 -1.687 . . . . 0.94999999999999996 106.444 176.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -115.89 107.5 15.09 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.277 -1.008 . . . . 0.88 108.277 -177.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 62.24 19.91 11.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.616 0.766 . . . . 1.79 112.727 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.1 -8.96 50.09 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.263 -0.97 . . . . 0.60999999999999999 112.213 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 m -105.97 137.88 43.12 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.384 -0.599 . . . . 1.3700000000000001 109.384 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.3 127.87 28.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.178 0.513 . . . . 0.69999999999999996 110.345 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.56 106.69 18.22 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.374 -0.973 . . . . 0.60999999999999999 108.374 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -87.68 121.35 30.01 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.306 -1.368 . . . . 2.4700000000000002 107.306 178.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.77 142.13 24.63 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.662 1.226 . . . . 1.74 112.386 -177.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 p -128.11 -172.15 2.62 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.67 -0.695 . . . . 1.5700000000000001 109.982 -177.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 m -76.07 -12.81 60.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.667 0.27 . . . . 1.52 111.286 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.97 -40.84 7.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.918 0.389 . . . . 1.5900000000000001 110.549 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.3 mt -115.89 106.41 20.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.046 -1.465 . . . . 0.5 107.046 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -147.46 152.57 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.179 0.514 . . . . 2.8900000000000001 112.057 -175.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 m -96.07 118.7 33.18 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.045 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.13 143.1 33.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.327 -0.99 . . . . 2.04 108.327 173.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.49 135.8 51.55 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.2 -0.296 . . . . 0.87 110.2 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.47 165.44 13.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.747 -1.205 . . . . 1.25 107.747 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -64.23 112.64 8.05 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 113.389 0.885 . . . . 3.3599999999999999 113.389 -170.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.4 132.26 7.94 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.601 2.201 . . . . 1.3899999999999999 110.188 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.42 146.24 24.31 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.819 -0.752 . . . . 1.53 109.492 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.37 11.69 2.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.452 0.644 . . . . 1.9099999999999999 110.809 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -105.8 2.24 27.63 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.466 1.106 . . . . 3.4900000000000002 109.34 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.95 157.41 44.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.826 -1.176 . . . . 1.8899999999999999 107.826 -178.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 p -111.4 36.24 3.3 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.213 1.006 . . . . 1.3 109.259 175.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.66 128.69 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.445 -1.252 . . . . 0.60999999999999999 109.095 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HB3' HG13 ' A' ' 29' ' ' VAL . 77.3 ttt180 -99.71 133.94 43.32 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.0 -1.482 . . . . 1.8400000000000001 107.0 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -126.62 132.58 51.22 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.982 -0.377 . . . . 1.1599999999999999 109.982 -174.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.81 27.84 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 119.953 -1.118 . . . . 0.31 111.674 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 14.2 t -149.78 134.67 17.83 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.569 0.223 . . . . 0.35999999999999999 110.773 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 38.3 tp -83.24 108.46 16.49 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.22 -1.77 . . . . 0.28000000000000003 106.22 173.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.596 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 35.7 mtp85 -109.61 102.73 11.54 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.864 -0.607 . . . . 2.6800000000000002 111.905 -173.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.4 109.98 17.77 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.746 -0.661 . . . . 1.23 109.986 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -69.61 -29.01 66.42 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.585 -1.189 . . . . 2.1800000000000002 110.219 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -125.62 108.72 25.98 Favored Pre-proline 0 N--CA 1.425 -1.712 0 N-CA-C 108.444 -0.947 . . . . 2.8199999999999998 108.444 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.65 129.76 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.253 1.302 . . . . 1.25 109.36 176.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -125.99 141.55 51.91 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.329 -0.619 . . . . 1.22 109.329 -175.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -77.83 -18.9 55.79 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 116.163 -0.471 . . . . 2.0299999999999998 110.715 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.78 -23.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.41 -0.359 . . . . 1.3300000000000001 111.19 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 21.7 m120 -97.84 26.75 4.89 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.852 1.427 . . . . 2.1899999999999999 114.852 -176.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -83.77 122.73 29.05 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.4 -1.333 . . . . 1.96 107.4 174.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.27 -160.19 32.89 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.622 -1.275 . . . . 0.48999999999999999 113.215 -177.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.55 111.69 23.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.008 0.523 . . . . 2.23 110.929 -175.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.581 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 34.5 m-85 -94.74 115.37 27.43 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.948 -0.569 . . . . 0.68999999999999995 109.896 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 83.5 m -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 109.304 -0.628 . . . . 0.34000000000000002 109.304 177.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' SER . 57.3 tp -96.83 121.13 38.35 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.678 -0.86 . . . . 0.22 108.678 179.059 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' LEU . 2.8 mm? -104.94 134.38 48.15 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.806 -0.813 . . . . 0.35999999999999999 108.806 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.98 119.52 34.53 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.313 -1.366 . . . . 0.31 107.313 170.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.54 112.7 24.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.614 -0.884 . . . . 0.60999999999999999 108.614 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 21.0 t-20 -132.94 146.46 61.38 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.761 -1.2 . . . . 1.1799999999999999 107.761 -175.141 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.97 -16.43 38.8 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.433 2.756 . . . . 1.0 113.419 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 t -80.79 -38.69 28.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.872 0.368 . . . . 1.1000000000000001 110.267 175.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 169.75 170.13 33.84 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.267 -1.533 . . . . 0.58999999999999997 109.267 -177.592 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -110.27 121.21 44.74 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.034 0.445 . . . . 1.5700000000000001 110.245 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.89 147.54 26.78 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.849 -0.614 . . . . 0.37 109.844 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 46.9 p -140.46 144.82 36.28 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.216 0.323 . . . . 0.56999999999999995 110.344 177.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.3 46.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.484 . . . . 0.29999999999999999 106.992 175.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -129.87 130.36 45.11 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 118.286 0.493 . . . . 1.26 111.073 -174.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 128.1 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.369 -1.345 . . . . 0.71999999999999997 107.369 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.77 114.98 26.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.985 -1.116 . . . . 1.25 107.985 -178.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.43 113.84 26.23 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.448 0.642 . . . . 0.57999999999999996 111.028 -175.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.01 102.78 14.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.281 -0.872 . . . . 0.83999999999999997 109.154 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.409 -0.814 . . . . 3.8599999999999999 110.841 179.704 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.379 -3.987 0 CA-C-O 122.143 0.973 . . . . 1.5800000000000001 109.889 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -83.38 129.83 35.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.892 -1.151 . . . . 1.1899999999999999 107.892 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 27.7 m -84.49 167.03 16.76 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.983 -1.118 . . . . 1.3200000000000001 107.983 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.66 129.83 41.38 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.565 0.698 . . . . 0.45000000000000001 112.413 -170.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 t -124.32 136.08 53.83 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.043 -1.836 . . . . 1.1899999999999999 106.043 175.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.31 126.99 73.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.227 0.537 . . . . 0.28999999999999998 111.155 -175.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -121.14 120.47 35.36 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.809 -1.087 . . . . 2.1800000000000002 109.062 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD13 HG22 ' A' ' 98' ' ' ILE . 44.2 mt -111.58 145.55 38.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.842 -0.799 . . . . 0.33000000000000002 108.842 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -132.19 154.21 49.79 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.913 0.387 . . . . 1.03 110.958 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 m -58.99 134.49 57.03 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.708 -1.133 . . . . 0.48999999999999999 111.684 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.6 145.53 48.59 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.286 1.034 . . . . 0.40000000000000002 111.929 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -92.27 138.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 109.996 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -82.61 108.44 16.0 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.388 0.613 . . . . 2.52 112.618 -176.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -157.97 -178.78 7.56 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.212 -1.773 . . . . 0.88 106.212 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -63.25 -39.45 94.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 119.375 0.989 . . . . 2.75 112.867 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.32 122.42 44.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.485 -1.302 . . . . 2.46 107.485 176.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.24 126.76 32.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.112 0.482 . . . . 0.85999999999999999 111.593 -173.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -120.35 117.45 27.79 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.29999999999999999 109.989 -177.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 17' ' ' ALA . 75.7 mt -99.41 105.04 30.7 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.682 -1.229 . . . . 0.29999999999999999 107.682 173.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.88 136.74 19.03 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 122.261 1.974 . . . . 0.28000000000000003 111.687 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 14' ' ' LEU . 49.8 p90 -137.56 159.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.187 0.518 . . . . 0.37 110.018 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -141.97 119.55 11.72 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.636 -0.711 . . . . 0.88 109.77 176.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.93 125.95 67.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.044 -1.465 . . . . 0.27000000000000002 107.044 176.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.4 p-10 -115.36 155.71 26.86 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.246 -0.982 . . . . 1.3899999999999999 110.592 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 140.77 3.06 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.506 -1.437 . . . . 0.59999999999999998 109.506 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -75.77 -54.6 2.17 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 108.169 -1.049 . . . . 2.6099999999999999 108.169 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HG2' HD21 ' A' ' 89' ' ' ASN . 18.7 Cg_endo -65.76 122.8 10.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 N-CA-C 108.644 -1.329 . . . . 0.78000000000000003 108.644 170.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.96 121.22 80.81 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 116.383 -0.371 . . . . 0.78000000000000003 111.693 -175.082 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.76 155.54 11.77 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.898 1.732 . . . . 0.56000000000000005 111.988 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -82.66 109.98 17.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.903 -0.777 . . . . 1.3700000000000001 108.903 176.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.97 119.2 25.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.108 0.48 . . . . 0.5 110.472 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -126.65 126.12 43.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.602 -0.726 . . . . 3.7799999999999998 110.324 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -91.81 119.67 31.83 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.181 -0.918 . . . . 0.28999999999999998 109.662 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -109.92 127.71 54.91 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 0.94999999999999996 105.7 173.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -118.81 106.09 12.18 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 110.298 -0.26 . . . . 0.88 110.298 -174.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 59.07 30.95 20.88 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.544 1.164 . . . . 1.79 110.603 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.08 82.61 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.521 -0.763 . . . . 0.60999999999999999 113.092 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 p -104.78 140.97 37.31 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.338 -0.507 . . . . 1.3700000000000001 109.872 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.61 114.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.69999999999999996 111.031 -176.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.9 tp -90.21 112.22 23.67 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.337 -0.986 . . . . 0.60999999999999999 108.337 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -93.49 136.98 33.24 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.682 -0.858 . . . . 2.4700000000000002 108.682 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.14 100.46 0.61 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.368 0.667 . . . . 1.74 109.924 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.8 p -93.49 -167.1 1.64 Allowed 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.009 0.524 . . . . 1.5700000000000001 111.397 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -77.09 -20.93 55.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.181 0.515 . . . . 1.52 110.563 175.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 99.6 m-85 -95.8 -36.51 11.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.03 0.443 . . . . 1.5900000000000001 110.641 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 mt -112.41 105.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.213 -1.403 . . . . 0.5 107.213 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -134.61 155.42 50.49 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.098 0.475 . . . . 2.8900000000000001 111.538 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -107.29 114.48 28.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.587 -0.523 . . . . 0.44 109.587 -178.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.11 132.4 34.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.358 -0.608 . . . . 2.04 109.358 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -122.13 149.49 43.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.779 -0.452 . . . . 0.87 109.779 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.01 163.43 20.47 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.804 -1.184 . . . . 1.25 107.804 173.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 10.8 mm-40 -81.54 116.63 64.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 123.58 0.55 . . . . 3.3599999999999999 111.191 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 14.9 Cg_exo -69.39 141.28 46.27 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.626 2.217 . . . . 1.3899999999999999 110.35 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.76 145.12 55.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.78 -0.822 . . . . 1.53 108.78 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.17 -10.22 39.29 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.228 0.825 . . . . 1.9099999999999999 113.228 -174.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -92.58 1.34 57.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.691 0.282 . . . . 3.4900000000000002 110.875 178.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.23 170.69 15.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.356 -0.609 . . . . 1.8899999999999999 109.356 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.7 p -132.45 26.8 4.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.401 0.62 . . . . 1.3 111.113 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.55 127.85 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.226 -0.657 . . . . 0.60999999999999999 109.226 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB3' HG13 ' A' ' 29' ' ' VAL . 25.3 ttm180 -88.67 115.16 26.0 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.352 -1.351 . . . . 1.8400000000000001 107.352 177.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -99.67 136.86 38.96 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.42 -0.955 . . . . 1.1599999999999999 108.42 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.11 -178.26 43.91 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 119.941 -1.123 . . . . 0.31 112.22 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -148.99 136.6 20.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.69 0.396 . . . . 0.35999999999999999 110.774 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.8 tp -85.6 103.7 14.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 105.035 -2.209 . . . . 0.28000000000000003 105.035 171.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -111.44 127.4 55.67 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 119.955 -0.698 . . . . 2.6800000000000002 110.39 -173.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.9 mp -108.85 109.78 20.98 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.937 -1.505 . . . . 1.23 106.937 178.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.52 -43.39 90.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.604 -0.725 . . . . 2.1800000000000002 109.267 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -135.59 112.02 10.7 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 107.419 -1.326 . . . . 2.8199999999999998 107.419 172.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.48 137.41 20.65 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.599 1.533 . . . . 1.25 111.654 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.8 p -83.48 148.52 27.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.553 -1.647 . . . . 1.22 106.553 174.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -58.39 -20.35 43.49 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.564 0.95 . . . . 2.0299999999999998 113.564 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.69 -10.53 13.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 O-C-N 123.202 0.314 . . . . 1.3300000000000001 111.433 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.63 26.22 0.24 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.041 1.126 . . . . 2.1899999999999999 114.041 -174.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -106.85 87.76 2.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.676 -1.231 . . . . 1.96 107.676 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.72 -161.72 24.34 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.634 -0.793 . . . . 0.48999999999999999 112.053 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 99' ' ' MET . 52.4 t-20 -97.16 125.2 41.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.764 0.316 . . . . 2.23 110.557 -177.173 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -98.46 106.55 18.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.317 -0.994 . . . . 0.68999999999999995 108.317 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -97.85 114.9 27.08 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.486 -0.931 . . . . 0.34000000000000002 108.486 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.6 tp -95.43 116.86 29.38 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.273 -0.64 . . . . 0.22 109.273 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.37 127.75 52.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.27 -1.011 . . . . 0.35999999999999999 108.27 177.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.46 120.1 37.08 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.994 -1.113 . . . . 0.31 107.994 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.24 112.65 25.42 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.967 -0.753 . . . . 0.60999999999999999 108.967 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 26.8 t-20 -120.5 147.06 44.53 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 106.48 -1.674 . . . . 1.1799999999999999 106.48 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.07 -19.64 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.894 2.396 . . . . 1.0 113.623 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.3 -29.2 23.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 110.239 178.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 170.64 179.37 41.94 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 110.916 -0.874 . . . . 0.58999999999999997 110.916 -179.001 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -112.55 139.99 47.68 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 109.448 -0.575 . . . . 1.5700000000000001 109.448 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -120.53 153.05 37.24 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 178.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 48.5 p -150.35 155.39 39.53 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.377 0.423 . . . . 0.56999999999999995 110.194 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.36 165.53 34.71 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.476 -1.676 . . . . 0.29999999999999999 106.476 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.41 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 35.7 m -143.38 125.85 15.78 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 117.972 0.351 . . . . 1.26 110.625 -177.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.502 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -123.75 122.93 65.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.611 -1.255 . . . . 0.71999999999999997 107.611 178.486 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 22.3 ttt -107.41 111.61 24.01 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.046 0.451 . . . . 1.25 110.08 -176.35 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.11 154.22 36.44 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.013 -0.539 . . . . 0.57999999999999996 111.6 -174.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.76 123.67 28.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.994 -1.484 . . . . 0.83999999999999997 106.994 176.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 116.291 -0.413 . . . . 3.8599999999999999 111.959 -176.312 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.419 -1.995 0 CA-C-O 121.928 0.87 . . . . 1.5800000000000001 110.136 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.41 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 46.4 m-85 -104.72 133.8 48.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.695 -1.139 . . . . 1.1899999999999999 108.075 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 m -84.86 -165.6 1.24 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.942 -0.762 . . . . 1.3200000000000001 108.942 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -94.12 124.62 38.25 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.251 -0.98 . . . . 0.45000000000000001 111.06 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 t -128.12 129.89 47.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.444 -1.317 . . . . 1.1899999999999999 107.444 175.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 94' ' ' ALA . 87.7 t -119.97 132.56 69.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.673 -0.239 . . . . 0.28999999999999998 110.664 -174.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -130.38 122.07 27.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.376 0.608 . . . . 2.1800000000000002 109.711 173.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 48.8 mt -104.68 148.83 26.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 110.212 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -131.76 150.57 52.11 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.161 -0.681 . . . . 1.03 109.161 -176.286 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.5 m -49.39 135.23 17.87 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.605 1.562 . . . . 0.48999999999999999 111.899 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 137.87 50.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.918 -1.037 . . . . 0.40000000000000002 108.776 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.02 131.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.439 0.638 . . . . 0.56999999999999995 110.064 -175.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -74.31 91.81 2.22 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.57 -1.196 . . . . 2.52 110.533 -177.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.7 mtm -130.98 -171.61 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.816 -0.439 . . . . 0.88 109.816 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.06 -25.38 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 2.75 109.691 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -119.84 143.82 47.69 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.456 -0.793 . . . . 2.46 109.83 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.78 124.11 29.96 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.574 0.702 . . . . 0.85999999999999999 112.044 -177.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.7 121.59 19.88 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.556 -1.202 . . . . 0.29999999999999999 109.131 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -107.16 100.96 35.76 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 107.738 -1.208 . . . . 0.29999999999999999 107.738 174.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.14 129.07 11.88 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.545 2.163 . . . . 0.28000000000000003 112.575 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -126.29 153.38 44.89 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.058 -0.519 . . . . 0.37 110.584 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.1 m -134.93 127.09 29.94 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.94 -0.763 . . . . 0.88 108.94 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.1 p -127.29 124.99 65.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.39 -0.967 . . . . 0.27000000000000002 108.39 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 65' ' ' VAL . 5.2 p-10 -115.49 149.89 37.39 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.83 -0.348 . . . . 1.3899999999999999 111.821 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 -171.83 33.6 Favored Glycine 0 N--CA 1.428 -1.896 0 O-C-N 124.622 1.201 . . . . 0.59999999999999998 110.851 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -119.0 -57.29 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-O 118.583 -0.722 . . . . 2.6099999999999999 112.674 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.3 Cg_exo -59.97 120.53 8.37 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 108.553 -1.364 . . . . 0.78000000000000003 108.553 171.008 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 116.23 16.19 Favored Pre-proline 0 N--CA 1.448 -0.549 0 O-C-N 123.871 0.732 . . . . 0.78000000000000003 111.53 -175.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 93.4 Cg_endo -85.62 152.9 10.28 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 121.848 1.698 . . . . 0.56000000000000005 111.842 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 p -82.8 106.07 14.33 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.881 -0.785 . . . . 1.3700000000000001 108.881 174.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.69 119.75 23.7 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 109.405 -0.591 . . . . 0.5 109.405 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -137.82 131.52 31.26 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.696 -0.683 . . . . 3.7799999999999998 110.679 -177.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.414 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 85.3 m95 -94.81 129.01 41.95 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.569 -0.741 . . . . 0.28999999999999998 109.713 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.97 129.06 54.96 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 106.639 -1.615 . . . . 0.94999999999999996 106.639 176.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -112.72 98.05 6.96 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.007 0.432 . . . . 0.88 110.28 -178.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.0 47.68 24.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.554 1.141 . . . . 1.79 111.294 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -22.22 36.59 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.367 -0.833 . . . . 0.60999999999999999 113.57 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -96.37 143.57 27.3 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 1.3700000000000001 109.332 -176.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.98 118.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.548 -0.751 . . . . 0.69999999999999996 109.994 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 tp -82.45 120.67 25.76 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.491 -1.299 . . . . 0.60999999999999999 107.491 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -107.77 140.09 41.36 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.298 -1.001 . . . . 2.4700000000000002 108.298 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.89 92.93 0.52 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.662 0.744 . . . . 1.74 109.714 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -88.91 178.97 6.28 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.01 -0.996 . . . . 1.5700000000000001 108.918 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 t -48.6 -36.91 16.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.171 0.988 . . . . 1.52 112.992 -176.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -110.72 5.59 20.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.113 0.783 . . . . 1.5900000000000001 113.113 -173.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.428 HG12 HD23 ' A' ' 72' ' ' LEU . 54.5 mt -124.15 106.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.472 -1.677 . . . . 0.5 106.472 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -126.72 137.84 53.31 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.414 -0.357 . . . . 2.8900000000000001 110.439 -171.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 m -92.69 109.39 20.81 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.265 -1.383 . . . . 0.44 107.265 176.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.74 136.9 42.56 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.384 -0.598 . . . . 2.04 109.384 -174.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.01 152.49 36.31 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.9 0.381 . . . . 0.87 110.013 -177.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 67' ' ' HIS . 4.5 pp -110.51 165.2 11.99 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.402 -1.703 . . . . 1.25 106.402 175.012 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.38 109.73 11.39 Favored Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 123.169 0.293 . . . . 3.3599999999999999 110.264 -178.003 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.72 140.09 20.58 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.221 1.948 . . . . 1.3899999999999999 110.651 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 31.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.236 -1.024 . . . . 1.53 108.236 177.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.73 -13.21 62.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.458 0.646 . . . . 1.9099999999999999 110.877 -178.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.4 -26.39 65.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.855 -1.066 . . . . 3.4900000000000002 110.551 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.08 143.42 33.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.114 0.483 . . . . 1.8899999999999999 110.071 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.7 p -98.32 18.05 17.32 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.762 -1.199 . . . . 1.3 107.762 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 30' ' ' ASP . 16.5 t -114.17 129.08 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 114.383 -1.28 . . . . 0.60999999999999999 109.211 -177.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.537 ' HB3' HG13 ' A' ' 29' ' ' VAL . 15.5 ttm180 -95.11 132.46 40.01 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.76 -1.57 . . . . 1.8400000000000001 106.76 177.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 57' ' ' LEU . 87.9 m-70 -119.6 141.83 48.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.102 -0.333 . . . . 1.1599999999999999 110.102 -176.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.0 -173.94 34.18 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.409 -1.076 . . . . 0.31 110.409 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.416 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 26.8 t -148.27 135.45 20.32 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.064 0.459 . . . . 0.35999999999999999 111.107 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.3 tp -83.58 114.35 21.46 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.28000000000000003 106.52 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 96.7 mtt180 -114.92 125.05 53.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.506 0.67 . . . . 2.6800000000000002 111.584 -175.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 52' ' ' ILE . 4.5 mp -111.62 109.84 19.94 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.765 -1.107 . . . . 1.23 108.782 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.46 -35.42 80.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.046 -0.979 . . . . 2.1800000000000002 111.107 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -128.18 119.76 20.98 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.963 -0.755 . . . . 2.8199999999999998 108.963 178.012 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.63 136.95 29.25 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 121.441 1.427 . . . . 1.25 109.068 175.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -128.99 161.04 30.84 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.33 -0.989 . . . . 1.22 108.33 -178.058 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -68.7 -5.03 17.99 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.472 0.916 . . . . 2.0299999999999998 113.472 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.62 -9.02 10.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-O 121.069 0.461 . . . . 1.3300000000000001 110.301 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.815 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.4 m120 -83.4 27.92 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.292 0.637 . . . . 2.1899999999999999 112.355 -176.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.4 m-20 -124.67 103.06 7.91 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -159.12 30.61 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.684 -0.967 . . . . 0.48999999999999999 110.684 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 23.4 t-20 -103.41 122.71 45.42 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 120.736 0.303 . . . . 2.23 110.379 -177.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.815 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 51.3 m-85 -100.49 115.2 29.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.439 -0.578 . . . . 0.68999999999999995 109.439 178.453 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -103.31 127.59 50.6 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.496 -0.32 . . . . 0.34000000000000002 110.183 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 ' CB ' HD11 ' A' ' 14' ' ' LEU . 59.9 tp -100.89 120.41 40.11 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.951 -0.759 . . . . 0.22 108.951 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.96 139.09 38.97 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.089 -1.078 . . . . 0.35999999999999999 108.089 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -135.07 120.63 19.32 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.164 -1.421 . . . . 0.31 107.164 173.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.53 133.56 53.28 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.754 -0.378 . . . . 0.60999999999999999 110.996 -178.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -142.76 171.29 7.29 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-O 117.23 -1.367 . . . . 1.1799999999999999 107.541 175.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.24 -25.16 29.16 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.168 1.912 . . . . 1.0 114.753 -175.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.16 -23.23 38.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.994 0.368 . . . . 1.1000000000000001 111.994 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.58 -175.63 35.62 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.518 -1.325 . . . . 0.58999999999999997 113.092 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -124.43 131.19 53.5 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.819 -0.437 . . . . 1.5700000000000001 109.819 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.62 148.46 28.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.454 -0.943 . . . . 0.37 108.454 176.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.4 p -142.57 122.83 13.84 Favored 'General case' 0 N--CA 1.425 -1.705 0 O-C-N 123.401 0.438 . . . . 0.56999999999999995 110.442 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.81 155.5 43.99 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.799 -1.186 . . . . 0.29999999999999999 107.799 177.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 50.9 m -130.26 144.22 51.24 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.84 0.352 . . . . 1.26 110.845 -178.027 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -130.24 126.53 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.853 -1.166 . . . . 0.71999999999999997 107.853 176.908 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 tpt -87.06 114.1 23.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.61 -0.885 . . . . 1.25 108.61 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.11 132.13 53.62 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.87 0.367 . . . . 0.57999999999999996 110.779 -175.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -140.23 101.44 4.14 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.154 -1.054 . . . . 0.83999999999999997 108.154 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.991 -0.55 . . . . 3.8599999999999999 111.865 -179.034 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.408 -2.554 0 N-CA-C 108.085 -1.08 . . . . 1.5800000000000001 108.085 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.497 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 97.2 m-85 -89.94 134.47 34.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.022 -1.473 . . . . 1.1899999999999999 107.022 176.043 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.0 m -83.26 177.0 8.72 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.879 -1.156 . . . . 1.3200000000000001 107.879 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -93.25 124.22 37.08 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 119.37 -0.932 . . . . 0.45000000000000001 111.17 -170.065 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -123.86 133.08 53.84 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 106.905 -1.517 . . . . 1.1899999999999999 106.905 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 94' ' ' ALA . 88.3 t -115.28 118.35 58.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.735 0.303 . . . . 0.28999999999999998 110.266 -175.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -116.74 116.24 27.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.768 -0.827 . . . . 2.1800000000000002 108.768 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 98' ' ' ILE . 41.3 mt -96.51 156.99 16.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 110.72 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -129.93 144.65 51.43 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.876 -1.157 . . . . 1.03 107.876 -174.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -57.55 133.49 55.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.953 1.408 . . . . 0.48999999999999999 110.652 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -70.28 141.35 52.4 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.074 -0.966 . . . . 0.40000000000000002 110.3 -176.192 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -92.65 127.59 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 113.26 0.837 . . . . 0.56999999999999995 113.26 -177.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -83.97 88.33 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.891 -1.049 . . . . 2.52 108.796 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.03 -169.67 3.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.545 -1.28 . . . . 0.88 107.545 175.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -48.57 -38.18 19.9 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.103 1.149 . . . . 2.75 114.103 -171.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -133.25 139.57 47.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.417 -0.957 . . . . 2.46 108.417 175.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' HD12 ' A' ' 72' ' ' LEU . 73.5 m95 -81.34 127.1 32.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.294 0.569 . . . . 0.85999999999999999 110.442 -175.017 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -120.81 121.58 38.46 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 114.563 -1.199 . . . . 0.29999999999999999 108.144 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 17' ' ' ALA . 52.3 mt -108.27 96.05 17.46 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.139 -1.43 . . . . 0.29999999999999999 107.139 175.388 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.69 128.52 13.49 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.333 2.022 . . . . 0.28000000000000003 111.8 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -120.05 146.68 45.67 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 116.03 -0.532 . . . . 0.37 109.853 178.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -132.59 106.81 8.04 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 108.689 -0.856 . . . . 0.88 108.689 176.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -110.56 111.25 35.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.169 -0.923 . . . . 0.27000000000000002 108.766 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 p30 -101.3 137.53 39.53 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.396 -0.82 . . . . 1.3899999999999999 110.148 -178.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.05 146.64 4.61 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 108.699 -1.761 . . . . 0.59999999999999998 108.699 -176.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.45 -59.79 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 CA-C-O 117.947 -1.025 . . . . 2.6099999999999999 110.199 -176.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 7.8 Cg_endo -54.81 119.43 6.46 Favored 'Trans proline' 0 C--N 1.393 2.88 0 N-CA-C 107.72 -1.685 . . . . 0.78000000000000003 107.72 171.052 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.69 114.68 17.01 Favored Pre-proline 0 C--N 1.291 -1.936 0 CA-C-N 114.567 -1.197 . . . . 0.78000000000000003 112.746 -171.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.67 150.05 11.35 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 122.134 1.89 . . . . 0.56000000000000005 112.454 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -84.57 127.04 33.85 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.208 -1.405 . . . . 1.3700000000000001 107.208 174.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.91 122.69 43.23 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.856 0.36 . . . . 0.5 111.714 -176.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -130.22 128.28 41.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.607 -0.724 . . . . 3.7799999999999998 110.52 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 94.1 m95 -90.82 141.2 29.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.924 -0.769 . . . . 0.28999999999999998 108.924 175.213 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.32 127.4 41.03 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.206 -1.405 . . . . 0.94999999999999996 107.206 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -103.13 98.13 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.024 -0.732 . . . . 0.88 109.024 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.67 29.63 7.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.015 0.926 . . . . 1.79 113.311 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.56 -20.57 24.92 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.828 -0.701 . . . . 0.60999999999999999 113.263 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 m -89.84 137.96 31.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.16 0.48 . . . . 1.3700000000000001 110.735 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.41 108.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.994 -1.003 . . . . 0.69999999999999996 111.16 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.8 tp -87.62 114.92 24.68 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.053 -1.091 . . . . 0.60999999999999999 108.053 178.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.01 140.59 40.95 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.476 -1.305 . . . . 2.4700000000000002 107.476 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.11 107.87 2.06 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.873 0.869 . . . . 1.74 110.998 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -99.37 -166.13 1.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.191 -0.459 . . . . 1.5700000000000001 110.122 -178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.5 t -82.02 -13.21 57.71 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.1 -0.704 . . . . 1.52 109.1 176.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -102.03 -38.89 7.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.809 -0.632 . . . . 1.5900000000000001 110.565 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.8 108.21 24.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.293 -1.373 . . . . 0.5 107.293 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -135.06 137.7 43.15 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.4 -0.92 . . . . 2.8900000000000001 112.252 -174.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -81.44 111.04 17.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.665 -0.698 . . . . 0.44 110.163 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.28 111.27 23.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.211 0.529 . . . . 2.04 111.051 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -84.09 141.88 30.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.928 -0.578 . . . . 0.87 109.808 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -119.1 160.66 21.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.238 -1.023 . . . . 1.25 108.238 -179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -77.33 119.24 76.68 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 113.368 0.877 . . . . 3.3599999999999999 113.368 -176.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.1 170.06 8.51 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 123.482 2.788 . . . . 1.3899999999999999 109.241 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.68 143.02 34.99 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.286 -1.376 . . . . 1.53 107.286 177.112 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.28 14.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.716 1.747 . . . . 1.9099999999999999 115.716 -170.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -93.73 -9.98 35.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.61 -0.836 . . . . 3.4900000000000002 110.831 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.16 126.1 30.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.097 0.475 . . . . 1.8899999999999999 110.525 178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -95.64 30.75 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.927 1.346 . . . . 1.3 108.372 171.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 33.4 t -116.11 135.48 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.771 -1.558 . . . . 0.60999999999999999 107.363 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.6 ttm180 -99.44 122.16 42.15 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.361 -1.348 . . . . 1.8400000000000001 107.361 177.241 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -108.55 141.13 40.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.485 -0.931 . . . . 1.1599999999999999 108.485 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.81 -177.34 39.62 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.314 -0.946 . . . . 0.31 110.977 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.2 t -145.14 132.68 20.84 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.556 0.209 . . . . 0.35999999999999999 110.575 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.9 tp -82.62 111.63 18.77 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.965 -2.235 . . . . 0.28000000000000003 104.965 170.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -107.23 119.09 38.45 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.96 -0.564 . . . . 2.6800000000000002 110.195 -172.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 23' ' ' TRP . 77.8 mt -81.05 108.01 14.35 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.695 -1.595 . . . . 1.23 106.695 173.407 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -69.99 -45.15 67.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.97 -1.014 . . . . 2.1800000000000002 108.602 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -129.88 101.2 18.47 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.676 -1.602 . . . . 2.8199999999999998 106.676 172.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -69.03 130.77 20.86 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.37 2.047 . . . . 1.25 111.297 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -128.65 168.85 15.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.361 -0.836 . . . . 1.22 108.983 -177.299 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.254 14.8 p-80 -68.47 -3.2 10.6 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 113.894 1.072 . . . . 2.0299999999999998 113.894 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.88 -10.38 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.482 0.658 . . . . 1.3300000000000001 109.937 174.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.696 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.7 m120 -85.69 28.09 0.8 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.261 1.025 . . . . 2.1899999999999999 113.237 -175.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 35.8 p-10 -126.2 99.1 5.74 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.977 0.894 . . . . 1.96 111.735 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . 170.76 -158.18 29.68 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.298 -0.864 . . . . 0.48999999999999999 111.269 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -97.33 105.69 17.89 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 122.654 0.382 . . . . 2.23 110.343 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.696 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 59.0 m-85 -93.0 106.32 18.29 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.244 -0.65 . . . . 0.68999999999999995 109.244 175.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 38.3 m -92.87 131.99 37.41 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 0.34000000000000002 109.855 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 12' ' ' VAL . 53.2 tp -104.2 117.37 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.148 -0.686 . . . . 0.22 109.148 177.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.14 129.67 51.87 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.315 -0.994 . . . . 0.35999999999999999 108.315 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.21 121.03 32.95 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.256 -1.016 . . . . 0.31 108.256 176.2 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.33 126.05 46.15 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.691 -0.403 . . . . 0.60999999999999999 111.496 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -134.37 169.85 12.81 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 117.448 -1.263 . . . . 1.1799999999999999 107.695 176.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.9 Cg_endo -43.25 -32.24 3.1 Favored 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 123.539 2.826 . . . . 1.0 115.248 178.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -77.08 -34.91 56.94 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 122.028 -0.42 . . . . 1.1000000000000001 111.682 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.04 -166.59 38.79 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 120.405 -0.902 . . . . 0.58999999999999997 112.044 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 27.6 tt0 -124.77 132.97 53.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.993 0.425 . . . . 1.5700000000000001 110.338 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -108.25 152.26 24.84 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.147 -0.686 . . . . 0.37 109.147 178.052 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 p -141.54 148.88 40.07 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 123.482 0.489 . . . . 0.56999999999999995 111.144 -179.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.78 144.22 14.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.318 -1.364 . . . . 0.29999999999999999 107.318 174.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 49.1 m -121.23 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.992 0.425 . . . . 1.26 110.684 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.494 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.11 126.27 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.725 -1.213 . . . . 0.71999999999999997 107.725 178.48 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.4 ttm -92.59 103.86 16.21 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.335 -0.546 . . . . 1.25 110.649 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -95.4 135.0 37.58 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.478 -1.675 . . . . 0.57999999999999996 106.478 174.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.82 101.52 5.3 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.248 -0.649 . . . . 0.83999999999999997 109.248 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 34.9 t80 . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.387 -0.824 . . . . 3.8599999999999999 111.085 179.916 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.421 -1.89 0 N-CA-C 109.136 -0.69 . . . . 1.5800000000000001 109.136 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.603 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 54.9 m-85 -102.33 122.45 44.28 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.387 -1.338 . . . . 1.1899999999999999 107.387 174.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.25 -179.19 7.15 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.774 -0.648 . . . . 1.3200000000000001 109.768 -176.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.43 128.56 39.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 119.51 -0.876 . . . . 0.45000000000000001 112.373 -168.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -121.57 128.22 51.76 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.815 -1.55 . . . . 1.1899999999999999 106.815 175.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 94' ' ' ALA . 98.0 t -115.25 120.02 63.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.819 0.342 . . . . 0.28999999999999998 110.466 -175.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -119.47 136.03 54.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.816 -0.629 . . . . 2.1800000000000002 109.764 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 98' ' ' ILE . 36.7 mt -123.06 149.63 44.17 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.386 0.613 . . . . 0.33000000000000002 110.897 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -131.07 145.48 52.02 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.975 -1.12 . . . . 1.03 107.975 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 m -64.79 139.22 58.74 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.988 -1.006 . . . . 0.48999999999999999 110.715 -175.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -52.96 139.31 28.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.638 -1.165 . . . . 0.40000000000000002 111.951 -178.195 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -92.07 142.74 12.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.788 -0.642 . . . . 0.56999999999999995 109.914 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.41 111.61 20.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.57 0.582 . . . . 2.52 112.57 -173.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.1 ptt? -162.39 -173.24 3.5 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.48 -0.933 . . . . 0.88 108.48 175.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 118.634 0.652 . . . . 2.75 112.367 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 20' ' ' MET . 81.9 m-70 -110.8 124.82 52.76 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.645 -1.983 . . . . 2.46 105.645 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -82.6 133.48 35.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.295 0.569 . . . . 0.85999999999999999 111.568 -173.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.7 t -126.56 120.49 29.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.021 -0.99 . . . . 0.29999999999999999 110.053 -175.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.5 mt -101.84 101.98 20.98 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.931 -1.137 . . . . 0.29999999999999999 107.931 174.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.05 131.87 16.04 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.524 2.15 . . . . 0.28000000000000003 112.504 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.53 160.22 34.8 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.053 0.454 . . . . 0.37 110.374 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -143.99 111.07 5.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.985 -0.746 . . . . 0.88 108.985 176.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -114.06 122.86 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.78 -0.645 . . . . 0.27000000000000002 109.952 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 28.9 t70 -101.94 141.59 34.55 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.013 -0.54 . . . . 1.3899999999999999 109.99 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.51 148.13 5.62 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.273 -1.131 . . . . 0.59999999999999998 110.273 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -85.9 -55.68 0.39 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.993 -1.114 . . . . 2.6099999999999999 107.993 178.784 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.3 Cg_endo -73.28 119.61 6.09 Favored 'Trans proline' 0 C--N 1.382 2.296 0 N-CA-C 107.275 -1.856 . . . . 0.78000000000000003 107.275 167.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.94 112.85 11.81 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 123.753 0.658 . . . . 0.78000000000000003 112.512 -172.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 42.1 Cg_endo -70.7 141.49 41.54 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.679 2.253 . . . . 0.56000000000000005 112.694 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -76.32 112.32 12.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.065 -1.457 . . . . 1.3700000000000001 107.065 174.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.21 131.15 35.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.165 -0.47 . . . . 0.5 111.301 -177.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -132.28 131.95 42.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.283 -0.636 . . . . 3.7799999999999998 109.283 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 92.0 m95 -98.02 135.39 39.78 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.916 0.389 . . . . 0.28999999999999998 110.002 177.428 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.3 tp -116.56 134.44 54.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.246 -1.761 . . . . 0.94999999999999996 106.246 176.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -121.29 112.52 18.7 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.572 -0.529 . . . . 0.88 109.572 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 57.26 24.82 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.853 0.861 . . . . 1.79 112.464 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.04 4.41 71.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.826 -0.702 . . . . 0.60999999999999999 112.694 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -113.1 151.85 30.29 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.886 -0.783 . . . . 1.3700000000000001 108.886 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.31 117.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.157 -0.683 . . . . 0.69999999999999996 109.157 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.1 tp -82.04 111.33 18.1 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.886 -0.597 . . . . 0.60999999999999999 109.401 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.66 117.39 23.75 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.147 -1.057 . . . . 2.4700000000000002 108.147 176.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.96 122.58 18.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.345 -0.389 . . . . 1.74 110.153 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.7 p -105.78 -171.05 1.83 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.389 -0.369 . . . . 1.5700000000000001 110.047 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -69.35 -21.03 63.85 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.29 0.567 . . . . 1.52 109.828 173.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 58.0 m-85 -91.53 -40.69 11.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.342 -0.39 . . . . 1.5900000000000001 110.379 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.49 106.47 20.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.628 -1.249 . . . . 0.5 107.628 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.22 145.52 41.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.16 0.505 . . . . 2.8900000000000001 112.276 -176.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.5 m -84.38 114.06 21.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.63 -0.878 . . . . 0.44 108.63 176.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.4 127.14 54.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.725 -0.843 . . . . 2.04 108.725 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.92 151.17 21.62 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.74 -0.467 . . . . 0.87 109.74 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -119.87 146.61 45.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 178.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 4.2 mp0 -47.64 105.95 0.54 Allowed Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 125.744 1.618 . . . . 3.3599999999999999 114.623 -172.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.54 136.0 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.187 2.592 . . . . 1.3899999999999999 110.32 174.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.54 159.11 29.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.366 -0.605 . . . . 1.53 109.366 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.62 -3.37 21.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.524 0.564 . . . . 1.9099999999999999 112.524 -175.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -103.5 9.36 37.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.12 0.486 . . . . 3.4900000000000002 109.913 175.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.06 131.75 56.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 120.779 -0.369 . . . . 1.8899999999999999 111.178 -179.178 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.9 p -96.99 2.05 51.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.875 -1.157 . . . . 1.3 107.875 170.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 19.6 t -94.26 128.54 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.17 -1.377 . . . . 0.60999999999999999 108.578 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 67.1 mtp180 -99.88 121.24 41.02 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.644 -1.613 . . . . 1.8400000000000001 106.644 178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -103.8 141.28 36.38 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.758 -0.83 . . . . 1.1599999999999999 108.758 -175.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.51 -173.7 35.89 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 119.613 -1.28 . . . . 0.31 111.967 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 t -151.07 134.33 16.1 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 123.308 0.643 . . . . 0.35999999999999999 110.332 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 55.3 tp -84.43 104.19 14.23 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 104.291 -2.485 . . . . 0.28000000000000003 104.291 169.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -109.34 127.23 54.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.373 -0.531 . . . . 2.6800000000000002 110.963 -171.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 6.6 mp -103.79 111.36 23.84 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.135 -0.939 . . . . 1.23 109.1 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -64.04 -42.84 96.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.47 -1.241 . . . . 2.1800000000000002 109.027 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -128.63 113.04 19.23 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.726 -0.842 . . . . 2.8199999999999998 108.726 176.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.79 130.39 8.62 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.111 1.874 . . . . 1.25 111.885 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 p -107.73 141.4 39.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.263 -1.014 . . . . 1.22 108.263 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -68.38 -14.76 63.22 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 120.965 0.412 . . . . 2.0299999999999998 111.025 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.95 -15.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.91 -0.587 . . . . 1.3300000000000001 111.06 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 47.3 m-80 -102.95 25.84 8.87 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 112.98 0.733 . . . . 2.1899999999999999 112.98 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.701 -1.592 . . . . 1.96 106.701 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.45 -154.12 6.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.084 -1.055 . . . . 0.48999999999999999 113.549 -175.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -105.53 120.16 40.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.066 0.46 . . . . 2.23 111.498 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 16.3 m-85 -101.24 133.79 45.28 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.117 -0.947 . . . . 0.68999999999999995 108.788 178.755 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.8 m -122.78 129.16 51.4 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.909 -1.145 . . . . 0.34000000000000002 107.909 176.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.5 tp -100.83 120.47 40.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.017 -0.734 . . . . 0.22 109.017 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.15 136.28 49.63 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.931 -1.137 . . . . 0.35999999999999999 107.931 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.07 121.28 27.52 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.469 -0.937 . . . . 0.31 108.469 178.051 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.03 122.51 46.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.046 -0.262 . . . . 0.60999999999999999 110.409 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 p-10 -137.22 177.24 2.26 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 107.102 -1.444 . . . . 1.1799999999999999 107.102 177.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.28 -26.98 28.87 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.523 2.149 . . . . 1.0 114.589 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 92.6 m -76.94 -17.85 58.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.883 0.327 . . . . 1.1000000000000001 111.883 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -158.74 22.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.463 -0.875 . . . . 0.58999999999999997 111.653 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -107.6 138.23 44.2 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.899 0.381 . . . . 1.5700000000000001 109.977 -176.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -117.48 158.26 24.83 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.385 -1.339 . . . . 0.37 107.385 174.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 42.7 p -153.84 159.11 41.71 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 112.442 0.534 . . . . 0.56999999999999995 112.442 -177.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.17 153.98 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.833 -1.543 . . . . 0.29999999999999999 106.833 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 p -123.48 151.45 42.74 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 118.075 0.398 . . . . 1.26 111.138 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -148.8 128.4 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.71999999999999997 107.661 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.5 110.99 23.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.066 -1.457 . . . . 1.25 107.066 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.65 112.76 25.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.749 0.785 . . . . 0.57999999999999996 111.659 -174.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.46 101.2 10.88 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.77 -1.105 . . . . 0.83999999999999997 108.027 176.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.308 -1.22 0 CA-C-N 115.727 -0.67 . . . . 3.8599999999999999 109.722 179.681 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.893 0.378 . . . . 7.9299999999999997 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.77 126.23 51.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.948 0.404 . . . . 6.1699999999999999 109.918 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.79 -27.77 9.57 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.1 0.952 . . . . 5.4299999999999997 109.359 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -134.86 97.97 3.9 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.468 -1.242 . . . . 3.8700000000000001 107.804 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -85.41 -26.51 26.35 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.633 -0.712 . . . . 2.5499999999999998 109.571 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 16.9 m -65.9 102.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.72 -1.127 . . . . 2.0800000000000001 112.036 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -107.24 97.99 7.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.314 -0.995 . . . . 1.5800000000000001 108.314 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.538 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-85 -97.69 124.26 41.94 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.917 -1.142 . . . . 1.1899999999999999 107.917 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.99 173.93 10.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.712 -1.218 . . . . 1.3200000000000001 107.712 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.43 127.14 41.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.318 -0.553 . . . . 0.45000000000000001 111.978 -173.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 50.3 m -118.17 140.82 49.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.346 -1.353 . . . . 1.1899999999999999 107.346 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 94' ' ' ALA . 95.5 t -115.93 121.22 66.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 121.378 0.608 . . . . 0.28999999999999998 112.025 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 79.3 mt-30 -108.13 130.63 55.1 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.864 -1.161 . . . . 2.1800000000000002 107.864 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 98' ' ' ILE . 28.4 mt -122.96 156.2 35.21 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.232 -0.655 . . . . 0.33000000000000002 109.232 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -132.11 151.01 52.01 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.549 -0.538 . . . . 1.03 109.549 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -60.04 132.47 54.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 124.551 1.157 . . . . 0.48999999999999999 110.058 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -59.42 135.06 57.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 124.473 1.108 . . . . 0.40000000000000002 109.722 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.44 127.91 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.694 -0.484 . . . . 0.56999999999999995 109.694 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.3 mt-10 -77.86 109.96 12.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.126 -0.943 . . . . 2.52 112.058 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -168.9 162.39 11.25 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.807 -2.294 . . . . 0.88 104.807 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -55.63 -36.67 67.26 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.967 1.258 . . . . 2.75 113.42 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -95.5 99.22 11.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.893 -1.521 . . . . 2.46 106.893 172.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 53.3 m95 -81.0 137.59 36.07 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.226 -0.443 . . . . 0.85999999999999999 110.203 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.07 124.04 31.88 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.765 -0.652 . . . . 0.29999999999999999 110.222 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.3 mt -107.27 95.57 13.63 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.12 -1.437 . . . . 0.29999999999999999 107.12 172.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.06 134.92 26.25 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.655 2.237 . . . . 0.28000000000000003 111.912 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -129.74 155.49 45.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.112 0.482 . . . . 0.37 111.171 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 23.0 m -138.72 117.7 12.49 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.349 -0.982 . . . . 0.88 108.349 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -126.08 123.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.27 -1.011 . . . . 0.27000000000000002 108.27 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 6.1 p-10 -108.96 156.33 19.84 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.868 -0.733 . . . . 1.3899999999999999 111.013 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.57 147.25 4.57 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.652 -0.979 . . . . 0.59999999999999998 110.652 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -86.31 -50.28 0.49 Allowed Pre-proline 0 C--N 1.311 -1.078 0 CA-C-O 119.126 -0.464 . . . . 2.6099999999999999 111.253 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.5 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 C--N 1.366 1.453 0 N-CA-C 107.398 -1.808 . . . . 0.78000000000000003 107.398 167.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.67 117.48 45.02 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 115.773 -0.649 . . . . 0.78000000000000003 111.75 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -85.27 145.71 9.67 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.85 1.7 . . . . 0.56000000000000005 111.642 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -78.32 120.17 22.71 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 56' ' ' PHE . 97.2 mt -93.17 123.3 36.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.891 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -134.66 131.82 38.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.029 -0.532 . . . . 3.7799999999999998 110.848 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 87.6 m95 -93.02 135.07 34.52 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.359 -0.837 . . . . 0.28999999999999998 109.495 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -113.11 134.51 54.51 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.894 -1.891 . . . . 0.94999999999999996 105.894 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 81.0 t80 -125.34 111.42 15.16 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.489 -0.56 . . . . 0.88 109.489 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.61 34.59 24.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.165 0.986 . . . . 1.79 111.048 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.6 85.64 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.142 -0.481 . . . . 0.60999999999999999 112.974 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -108.33 153.6 23.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.753 -0.832 . . . . 1.3700000000000001 108.753 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.25 115.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.759 . . . . 0.69999999999999996 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -89.34 122.62 32.75 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.60999999999999999 108.247 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.57 129.92 55.54 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.374 -1.343 . . . . 2.4700000000000002 107.374 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.235 0.614 . . . . 1.74 111.194 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 p -126.26 -165.69 1.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.044 -0.724 . . . . 1.5700000000000001 109.044 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 m -78.62 -22.45 46.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 118.414 0.552 . . . . 1.52 110.597 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.2 m-85 -87.21 -40.39 14.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.745 -0.382 . . . . 1.5900000000000001 110.386 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -112.49 106.71 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.701 -1.222 . . . . 0.5 107.701 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -130.88 139.71 50.15 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.179 0.807 . . . . 2.8900000000000001 113.179 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -84.68 119.96 25.84 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.263 -0.88 . . . . 0.44 109.749 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -94.09 125.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.44 -0.346 . . . . 2.04 110.441 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 37' ' ' LEU . 66.8 m-85 -106.78 106.74 17.41 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.582 -1.636 . . . . 0.87 106.582 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 67' ' ' HIS . 3.5 pp -95.0 154.63 17.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.397 -0.921 . . . . 1.25 108.956 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 8.5 mm-40 -70.26 113.0 14.58 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 123.479 0.711 . . . . 3.3599999999999999 111.574 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.1 Cg_exo -78.81 161.15 27.45 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.727 2.285 . . . . 1.3899999999999999 110.552 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.82 142.06 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.82 -6.19 20.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.136 0.574 . . . . 1.9099999999999999 112.243 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -104.0 -0.7 28.54 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.142 -0.481 . . . . 3.4900000000000002 111.332 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.5 pt-20 -115.04 146.15 41.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.691 -1.226 . . . . 1.8899999999999999 107.691 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -94.12 2.91 55.92 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.134 -0.691 . . . . 1.3 109.134 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 16.8 t -99.94 129.03 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.617 -0.72 . . . . 0.60999999999999999 111.609 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB3' HG13 ' A' ' 29' ' ' VAL . 14.3 ttm180 -94.55 134.97 36.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.148 -1.797 . . . . 1.8400000000000001 106.148 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.502 ' HB2' HD11 ' A' ' 57' ' ' LEU . 47.7 m-70 -121.16 161.79 21.23 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.612 -0.435 . . . . 1.1599999999999999 110.266 -175.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.29 -165.38 35.24 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 120.674 -0.774 . . . . 0.31 111.334 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 t -156.16 141.87 17.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.502 -0.555 . . . . 0.35999999999999999 109.502 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 50.3 tp -91.02 100.93 13.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.618 -2.364 . . . . 0.28000000000000003 104.618 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -103.27 129.27 50.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.218 -0.593 . . . . 2.6800000000000002 110.63 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 5.7 mp -108.73 109.18 20.27 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.617 -0.883 . . . . 1.23 108.617 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -72.15 -43.09 65.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.599 -1.182 . . . . 2.1800000000000002 109.95 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 101.0 31.9 Favored Pre-proline 0 N--CA 1.429 -1.501 0 N-CA-C 105.641 -1.985 . . . . 2.8199999999999998 105.641 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.05 147.11 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.617 2.211 . . . . 1.25 112.372 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 p -130.06 141.29 50.73 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 122.039 -0.413 . . . . 1.22 110.406 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 41.8 p-80 -58.54 -6.4 0.7 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.118 1.525 . . . . 2.0299999999999998 115.118 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.79 -17.06 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.152 -0.684 . . . . 1.3300000000000001 109.152 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 17.5 m120 -83.34 -1.2 52.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.241 1.016 . . . . 2.1899999999999999 109.625 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 39.5 t30 -77.11 81.22 3.63 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.28 -0.873 . . . . 1.96 108.883 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.88 -155.86 8.99 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.201 -0.909 . . . . 0.48999999999999999 111.669 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 26.3 t-20 -98.43 128.97 45.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.841 0.682 . . . . 2.23 112.841 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 76.9 m-85 -108.25 141.57 39.83 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.969 1.308 . . . . 0.68999999999999995 108.021 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.1 m -142.57 134.44 27.0 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.631 -0.668 . . . . 0.34000000000000002 109.353 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.8 tp -104.89 122.45 45.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.77 -0.456 . . . . 0.22 109.77 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.91 125.25 52.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.204 -1.036 . . . . 0.35999999999999999 108.204 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -120.65 120.8 36.78 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.19 -1.041 . . . . 0.31 108.19 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.69 121.6 35.94 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.83 -0.348 . . . . 0.60999999999999999 111.425 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.9 p30 -128.59 170.97 9.39 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 107.576 -1.268 . . . . 1.1799999999999999 107.576 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.9 Cg_exo -48.06 -41.26 33.74 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.602 2.201 . . . . 1.0 114.432 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -67.29 -45.65 75.91 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.509 -0.476 . . . . 1.1000000000000001 112.207 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.01 178.09 47.54 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 119.103 -1.523 . . . . 0.58999999999999997 113.594 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -119.86 133.53 55.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 123.202 0.601 . . . . 1.5700000000000001 109.742 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -113.9 155.28 26.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.138 -0.69 . . . . 0.37 109.138 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.7 p -144.8 148.03 33.57 Favored 'General case' 0 N--CA 1.418 -2.068 0 O-C-N 123.52 0.513 . . . . 0.56999999999999995 110.26 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.82 146.38 29.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.057 -1.831 . . . . 0.29999999999999999 106.057 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -118.48 144.31 46.1 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.473 -0.491 . . . . 1.26 110.318 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.742 HG22 HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -134.67 122.16 37.76 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 C-N-CA 124.807 1.243 . . . . 0.71999999999999997 109.505 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.19 108.6 16.82 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.777 -1.564 . . . . 1.25 106.777 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 155.84 25.22 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.313 -0.403 . . . . 0.57999999999999996 110.924 -174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.38 100.65 10.07 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.385 0.612 . . . . 0.83999999999999997 111.373 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 86.0 m-85 -100.07 78.43 2.08 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.146 -1.057 . . . . 3.8599999999999999 108.146 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.7 mtt -101.81 113.9 27.5 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.016 -0.538 . . . . 4.7199999999999998 110.572 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 77' ' ' HIS . 76.2 m-20 -98.06 159.42 14.95 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 121.516 0.674 . . . . 5.3300000000000001 111.255 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -120.75 99.83 46.99 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.423 -2.066 . . . . 5.3399999999999999 105.423 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.83 140.01 10.23 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.469 2.779 . . . . 5.0700000000000003 113.449 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 125.223 1.409 . . . . 9.5199999999999996 109.789 -175.706 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.501 -0.942 0 N-CA-C 107.926 -1.139 . . . . 7.9299999999999997 107.926 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 53.3 34.01 16.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.416 0.687 . . . . 6.1699999999999999 110.147 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 52.0 1.29 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.212 1.19 . . . . 5.4299999999999997 114.212 -171.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t70 38.6 54.89 1.92 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.217 2.207 . . . . 3.8700000000000001 113.544 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -98.05 -50.49 4.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.391 -0.966 . . . . 2.5499999999999998 108.391 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 m -94.24 98.92 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-O 122.155 0.979 . . . . 2.0800000000000001 109.0 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 p -89.18 98.72 11.92 Favored 'General case' 0 N--CA 1.403 -2.791 0 CA-C-N 115.291 -0.868 . . . . 1.5800000000000001 109.374 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.612 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.9 m-85 -75.09 115.68 14.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.093 -1.447 . . . . 1.1899999999999999 107.093 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -83.2 178.14 8.23 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.937 -0.764 . . . . 1.3200000000000001 108.937 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 126.92 40.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 119.745 -0.782 . . . . 0.45000000000000001 111.257 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -122.93 143.23 50.04 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.142 -1.429 . . . . 1.1899999999999999 107.142 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 85.4 t -115.81 121.14 66.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.132 0.491 . . . . 0.28999999999999998 110.901 -174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 118.83 37.77 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.301 -0.863 . . . . 2.1800000000000002 108.858 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 98' ' ' ILE . 34.0 mt -115.44 144.64 43.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.943 0.401 . . . . 0.33000000000000002 109.984 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.95 151.27 51.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.968 -0.753 . . . . 1.03 108.968 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 m -57.49 135.1 56.58 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 124.455 1.097 . . . . 0.48999999999999999 110.411 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -56.2 130.86 46.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.393 1.058 . . . . 0.40000000000000002 110.66 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.9 136.14 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.335 0.588 . . . . 0.56999999999999995 110.094 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.93 106.94 7.79 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.331 -1.304 . . . . 2.52 110.54 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.4 mtm -141.93 -163.16 1.53 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.953 -1.499 . . . . 0.88 106.953 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -67.89 -45.03 75.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.99 -0.744 . . . . 2.75 108.99 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -111.85 138.84 47.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 106.393 -1.706 . . . . 2.46 106.393 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 72.4 m95 -81.76 133.54 35.35 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 109.506 -0.553 . . . . 0.85999999999999999 109.506 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 42.1 t -120.26 116.09 24.89 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.3 -0.864 . . . . 0.29999999999999999 110.093 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 69.9 mt -100.08 99.37 9.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.144 -1.428 . . . . 0.29999999999999999 107.144 172.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 2.9 Cg_exo -75.3 125.89 9.41 Favored 'Trans proline' 0 C--O 1.252 1.207 0 C-N-CA 122.502 2.135 . . . . 0.28000000000000003 111.804 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -120.98 153.57 37.14 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.092 -0.707 . . . . 0.37 109.092 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.5 m -140.54 114.3 8.87 Favored 'General case' 0 C--N 1.267 -3.02 0 N-CA-C 108.715 -0.846 . . . . 0.88 108.715 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -110.43 116.31 52.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.596 -0.89 . . . . 0.27000000000000002 108.596 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 8.5 t70 -101.22 137.06 40.07 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.634 -0.876 . . . . 1.3899999999999999 108.634 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.46 145.17 4.27 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 110.326 -1.11 . . . . 0.59999999999999998 110.326 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -84.05 -55.53 0.46 Allowed Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.739 -0.467 . . . . 2.6099999999999999 109.739 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.1 Cg_endo -62.4 120.78 8.48 Favored 'Trans proline' 0 C--N 1.387 2.56 0 N-CA-C 108.643 -1.329 . . . . 0.78000000000000003 108.643 170.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.1 111.59 8.99 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 116.15 -0.477 . . . . 0.78000000000000003 111.531 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -83.97 162.13 13.79 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 122.547 2.165 . . . . 0.56000000000000005 112.344 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 7.9 p -94.37 130.01 40.86 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.516 -0.92 . . . . 1.3700000000000001 108.516 174.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' A' ' 85' ' ' LEU . 88.2 mt -98.54 140.67 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -143.88 133.71 23.89 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.162 -0.681 . . . . 3.7799999999999998 109.162 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.456 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.3 m95 -96.64 117.46 31.04 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.28999999999999998 109.862 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -100.72 127.23 47.21 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.336 -1.727 . . . . 0.94999999999999996 106.336 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.5 ' HZ ' ' O ' ' A' ' 78' ' ' VAL . 88.7 t80 -122.97 108.05 12.51 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 109.213 -0.662 . . . . 0.88 109.213 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.58 17.7 6.39 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.679 0.791 . . . . 1.79 112.835 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.1 -12.16 40.7 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.973 -0.632 . . . . 0.60999999999999999 112.685 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 m -108.62 151.99 25.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.851 -0.796 . . . . 1.3700000000000001 108.851 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.41 123.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.379 -0.373 . . . . 0.69999999999999996 110.017 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.2 tp -82.65 113.38 20.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.845 -0.616 . . . . 0.60999999999999999 109.552 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.01 140.78 30.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.374 -0.602 . . . . 2.4700000000000002 109.374 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.77 137.59 36.25 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.785 -0.643 . . . . 1.74 110.084 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 p -127.16 -165.97 1.54 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.773 0.829 . . . . 1.5700000000000001 110.068 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 m -75.64 -31.91 60.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.023 0.44 . . . . 1.52 110.546 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -89.84 -28.41 19.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.071 0.397 . . . . 1.5900000000000001 112.071 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.43 HG23 HD23 ' A' ' 72' ' ' LEU . 55.9 mt -125.53 106.64 16.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.091 -0.707 . . . . 0.5 109.091 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HE1' HD21 ' A' ' 73' ' ' ASN . 53.0 p90 -145.91 156.27 43.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.61 -0.436 . . . . 2.8900000000000001 110.547 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -85.23 109.79 18.58 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.666 -0.864 . . . . 0.44 108.666 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.54 108.77 21.55 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.37 -0.974 . . . . 2.04 108.37 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -85.95 145.74 27.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.53 -0.915 . . . . 0.87 108.53 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.2 pp -109.42 157.96 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.376 -1.713 . . . . 1.25 106.376 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.07 109.0 5.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 O-C-N 123.485 0.491 . . . . 3.3599999999999999 110.15 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.63 140.92 19.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.393 2.062 . . . . 1.3899999999999999 111.705 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.61 134.66 51.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.069 -1.085 . . . . 1.53 108.069 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.17 -18.28 63.31 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.832 0.678 . . . . 1.9099999999999999 112.832 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.65 -23.2 59.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.256 -0.429 . . . . 3.4900000000000002 110.478 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.83 152.31 18.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.515 -0.55 . . . . 1.8899999999999999 109.515 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 11.12 38.26 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.496 -1.298 . . . . 1.3 107.496 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.5 t -104.74 127.88 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.037 -0.983 . . . . 0.60999999999999999 110.617 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HB2' HG13 ' A' ' 29' ' ' VAL . 66.5 mtp180 -92.43 115.06 27.75 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.574 -1.639 . . . . 1.8400000000000001 106.574 176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 90.5 m-70 -101.97 142.73 32.8 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.263 -0.643 . . . . 1.1599999999999999 109.263 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.78 -178.79 38.4 Favored Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 120.21 -0.995 . . . . 0.31 111.327 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 t -144.33 132.81 22.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 120.547 0.213 . . . . 0.35999999999999999 111.278 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 54.4 tp -87.16 114.01 23.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.433 -2.062 . . . . 0.28000000000000003 105.433 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 16.4 ptm180 -106.76 119.58 39.71 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 112.338 0.495 . . . . 2.6800000000000002 112.338 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.43 HD23 HG23 ' A' ' 52' ' ' ILE . 15.6 mt -92.85 108.2 19.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.75 -2.315 . . . . 1.23 104.75 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.405 HD21 ' HE1' ' A' ' 53' ' ' PHE . 86.8 m-20 -74.35 -52.53 11.93 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 108.982 -0.747 . . . . 2.1800000000000002 108.982 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -128.26 100.23 23.44 Favored Pre-proline 0 N--CA 1.397 -3.111 0 N-CA-C 105.843 -1.91 . . . . 2.8199999999999998 105.843 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 25.2 Cg_exo -67.09 150.39 82.36 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.11 1.873 . . . . 1.25 109.897 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -112.62 178.14 4.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.577 -0.283 . . . . 1.22 111.073 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -52.63 -37.02 57.69 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.469 0.708 . . . . 2.0299999999999998 112.626 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.5 ' O ' ' HZ ' ' A' ' 41' ' ' PHE . 14.6 m -77.17 -10.44 13.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 112.825 0.676 . . . . 1.3300000000000001 112.825 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.58 26.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.701 1.0 . . . . 2.1899999999999999 113.701 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.6 m-20 -110.86 53.47 0.7 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.755 -1.943 . . . . 1.96 105.755 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -133.78 -168.23 11.78 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.38 -1.39 . . . . 0.48999999999999999 114.061 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 15.0 m120 -102.43 114.59 28.91 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.517 0.727 . . . . 2.23 109.989 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.09 116.2 31.56 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.738 -0.838 . . . . 0.68999999999999995 108.738 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 77.8 m -116.62 122.75 45.53 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.694 -0.484 . . . . 0.34000000000000002 109.694 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.1 tp -96.84 118.32 33.02 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.765 -0.457 . . . . 0.22 109.765 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.6 136.33 41.63 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.748 -0.834 . . . . 0.35999999999999999 108.748 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' SER . . . -128.49 120.42 26.77 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.86 -1.163 . . . . 0.31 107.86 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.07 134.4 54.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 123.16 0.288 . . . . 0.60999999999999999 110.599 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -153.2 171.93 6.24 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.67 -1.233 . . . . 1.1799999999999999 107.67 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -55.94 -39.32 91.9 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.284 1.989 . . . . 1.0 113.408 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.55 -15.74 61.77 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.045 0.387 . . . . 1.1000000000000001 112.045 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.27 -161.46 29.72 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 119.02 -1.562 . . . . 0.58999999999999997 113.252 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.72 124.29 25.0 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.814 -0.81 . . . . 1.5700000000000001 108.814 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.38 151.15 22.6 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.66 -0.867 . . . . 0.37 108.66 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 6.4 p -152.23 135.31 15.72 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.719 0.637 . . . . 0.56999999999999995 110.775 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.44 47.08 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.175 -1.417 . . . . 0.29999999999999999 107.175 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -129.54 145.24 51.49 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.875 0.369 . . . . 1.26 111.318 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.516 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -143.98 126.37 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.71999999999999997 107.947 178.066 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -106.67 137.19 45.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.221 -0.659 . . . . 1.25 109.221 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.46 145.86 47.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.765 -0.828 . . . . 0.57999999999999996 108.765 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -127.64 104.08 7.67 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.272 0.558 . . . . 0.83999999999999997 110.433 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 58.2 t80 -72.88 -54.45 8.72 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 114.389 1.255 . . . . 3.8599999999999999 114.389 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.7 ptm -145.36 -178.48 6.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.603 -0.517 . . . . 4.7199999999999998 109.603 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 120.5 31.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.312 -1.736 . . . . 5.3300000000000001 106.312 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.27 130.84 87.34 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 112.223 0.453 . . . . 5.3399999999999999 112.223 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.69 117.08 4.81 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 121.917 1.745 . . . . 5.0700000000000003 109.221 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.217 -0.897 . . . . 9.5199999999999996 111.211 -178.414 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 112.084 0.402 . . . . 7.9299999999999997 112.084 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -93.74 -72.3 0.62 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.551 0.614 . . . . 6.1699999999999999 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -68.9 -38.22 79.48 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.659 1.219 . . . . 5.4299999999999997 107.753 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.0 66.69 5.57 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.773 -1.558 . . . . 3.8700000000000001 108.68 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -92.42 -31.68 15.21 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.44 -1.319 . . . . 2.5499999999999998 107.44 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -50.04 99.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 C-N-CA 126.078 1.751 . . . . 2.0800000000000001 110.973 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.6 m -104.99 97.74 7.55 Favored 'General case' 0 N--CA 1.379 -3.976 0 CA-C-N 114.411 -1.268 . . . . 1.5800000000000001 110.259 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 95.1 m-85 -96.61 127.26 42.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.323 -1.732 . . . . 1.1899999999999999 106.323 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.2 m -92.4 -159.39 0.66 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 119.145 -0.455 . . . . 1.3200000000000001 110.227 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.58 106.84 18.78 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 119.369 0.986 . . . . 0.45000000000000001 112.123 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 39.4 m -112.81 126.68 55.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.399 -0.819 . . . . 1.1899999999999999 108.882 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 94' ' ' ALA . 62.1 t -115.55 124.86 72.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 120.926 0.393 . . . . 0.28999999999999998 112.0 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -124.83 121.13 33.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.092 -1.077 . . . . 2.1800000000000002 108.092 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 98' ' ' ILE . 43.3 mt -105.0 156.12 18.33 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.982 0.42 . . . . 0.33000000000000002 111.494 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -130.91 144.28 51.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.453 -1.314 . . . . 1.03 107.453 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -65.25 136.99 57.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.718 0.807 . . . . 0.48999999999999999 110.089 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -51.58 138.63 22.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.403 1.064 . . . . 0.40000000000000002 110.926 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.62 143.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.036 -0.529 . . . . 0.56999999999999995 110.234 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.86 98.53 2.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.796 -1.093 . . . . 2.52 111.685 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -141.21 -169.59 2.88 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.395 -1.335 . . . . 0.88 107.395 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -78.93 -39.67 34.02 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.995 -0.743 . . . . 2.75 108.995 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -101.55 127.08 48.42 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.858 -1.905 . . . . 2.46 105.858 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.5 m95 -82.78 126.83 32.85 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.099 0.476 . . . . 0.85999999999999999 110.991 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 43.7 t -117.73 118.13 31.23 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.51 -0.768 . . . . 0.29999999999999999 109.435 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 72.6 mt -101.75 97.43 7.94 Favored Pre-proline 0 C--O 1.247 0.952 0 N-CA-C 107.599 -1.26 . . . . 0.29999999999999999 107.599 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 9.7 Cg_exo -74.25 136.0 21.43 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.507 2.138 . . . . 0.28000000000000003 111.427 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -124.41 161.32 26.25 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.283 0.563 . . . . 0.37 110.818 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -140.8 110.51 6.43 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.792 -0.818 . . . . 0.88 108.792 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 66' ' ' ARG . 4.0 p -123.33 117.49 51.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.059 -1.089 . . . . 0.27000000000000002 108.059 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.7 p-10 -103.1 165.94 10.73 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.526 -1.27 . . . . 1.3899999999999999 110.715 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.58 165.54 12.5 Favored Glycine 0 N--CA 1.409 -3.111 0 O-C-N 124.823 1.327 . . . . 0.59999999999999998 109.935 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.402 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 15.6 mm100 -101.96 -55.22 0.13 Allowed Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.788 -0.449 . . . . 2.6099999999999999 109.788 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.2 Cg_endo -66.05 119.78 6.85 Favored 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.08 -1.931 . . . . 0.78000000000000003 107.08 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 115.07 27.31 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 0.78000000000000003 111.508 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 92.7 Cg_endo -81.01 134.59 9.45 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 121.516 1.477 . . . . 0.56000000000000005 111.356 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -70.61 132.75 45.93 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.519 -1.289 . . . . 1.3700000000000001 107.519 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 85' ' ' LEU . 72.1 mt -100.04 120.45 39.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.968 0.414 . . . . 0.5 110.432 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 48' ' ' GLU . 9.2 tpp180 -122.1 128.05 50.87 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.532 -0.758 . . . . 3.7799999999999998 109.819 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -93.9 155.37 17.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.082 -0.508 . . . . 0.28999999999999998 110.627 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 11.5 tp -137.83 141.1 40.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.185 -1.413 . . . . 0.94999999999999996 107.185 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -119.12 101.96 8.39 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.348 0.659 . . . . 0.88 109.43 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 57.69 31.38 20.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.96 0.904 . . . . 1.79 111.063 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.51 -19.04 55.33 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.707 -0.759 . . . . 0.60999999999999999 112.74 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.7 t -88.68 140.98 28.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.44 -0.578 . . . . 1.3700000000000001 109.44 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.21 117.1 2.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.741 -0.663 . . . . 0.69999999999999996 111.007 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.7 tp -91.13 126.46 36.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.011 -0.737 . . . . 0.60999999999999999 109.011 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -93.99 137.39 33.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.898 -0.592 . . . . 2.4700000000000002 109.441 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' HH12 ' A' ' 38' ' ' ARG . 34.9 mt-10 -79.76 83.31 5.73 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 1.74 108.754 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -84.48 -178.41 6.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.198 -0.91 . . . . 1.5700000000000001 110.706 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -58.96 -34.82 72.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.213 0.53 . . . . 1.52 111.67 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -87.43 -13.99 41.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.643 0.609 . . . . 1.5900000000000001 112.643 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.19 105.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 107.304 -1.369 . . . . 0.5 107.304 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -135.94 145.95 46.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.509 -0.877 . . . . 2.8900000000000001 112.025 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 m -89.7 110.21 21.12 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.912 -1.144 . . . . 0.44 107.912 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.33 113.38 26.63 Favored 'General case' 0 N--CA 1.418 -2.025 0 C-N-CA 119.325 -0.95 . . . . 2.04 109.047 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' CE1' HD12 ' A' ' 37' ' ' LEU . 70.5 m-85 -87.74 133.84 33.78 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.831 -1.544 . . . . 0.87 106.831 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.16 164.19 19.31 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.234 -0.986 . . . . 1.25 108.949 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.82 120.5 50.36 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.779 -0.823 . . . . 3.3599999999999999 108.779 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.12 128.34 30.11 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 122.635 2.223 . . . . 1.3899999999999999 111.253 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.91 125.45 29.32 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.282 -0.872 . . . . 1.53 108.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.22 -27.81 62.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.0 -1.0 . . . . 1.9099999999999999 113.006 -173.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.3 -9.16 42.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.047 0.388 . . . . 3.4900000000000002 112.047 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -102.3 150.28 23.48 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.693 0.759 . . . . 1.8899999999999999 112.248 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.5 p -105.07 7.99 34.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.991 -1.004 . . . . 1.3 108.701 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 18.1 t -112.0 133.26 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.922 -1.035 . . . . 0.60999999999999999 109.668 -176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HB2' HG13 ' A' ' 29' ' ' VAL . 64.8 mtp180 -87.56 134.86 33.55 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.685 -1.598 . . . . 1.8400000000000001 106.685 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -124.3 155.68 38.25 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.009 0.433 . . . . 1.1599999999999999 109.891 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.03 -171.63 43.03 Favored Glycine 0 N--CA 1.411 -3.028 0 N-CA-C 109.516 -1.434 . . . . 0.31 109.516 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.422 ' SG ' ' HG2' ' A' ' 71' ' ' ARG . 39.3 t -148.03 141.26 25.12 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.004 0.43 . . . . 0.35999999999999999 110.793 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.0 tp -88.65 102.23 14.76 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.282 -2.118 . . . . 0.28000000000000003 105.282 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HG2' ' SG ' ' A' ' 69' ' ' CYS . 85.2 mtm-85 -102.37 129.2 48.77 Favored 'General case' 0 CA--C 1.48 -1.745 0 C-N-CA 119.203 -0.999 . . . . 2.6800000000000002 110.857 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 23' ' ' TRP . 62.8 mt -86.24 108.47 18.39 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.561 -1.644 . . . . 1.23 106.561 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -67.64 -47.07 70.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 114.691 -1.141 . . . . 2.1800000000000002 109.011 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -128.12 110.07 19.87 Favored Pre-proline 0 N--CA 1.421 -1.882 0 N-CA-C 106.439 -1.689 . . . . 2.8199999999999998 106.439 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 35.1 Cg_endo -68.83 130.54 20.69 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 121.607 1.538 . . . . 1.25 111.275 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.6 p -123.96 171.99 9.29 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.57 -0.741 . . . . 1.22 109.632 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -72.46 -8.54 55.59 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.452 0.538 . . . . 2.0299999999999998 112.452 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.89 -9.54 11.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.394 0.616 . . . . 1.3300000000000001 110.422 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.657 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.1 m120 -90.12 27.12 1.69 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.711 0.767 . . . . 2.1899999999999999 110.467 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -126.57 64.96 1.26 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.016 -1.105 . . . . 1.96 108.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.06 -158.55 11.52 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.525 -0.845 . . . . 0.48999999999999999 112.234 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -96.55 129.22 43.98 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.377 -0.231 . . . . 2.23 110.377 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 52.6 m-85 -116.64 117.75 30.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.035 0.445 . . . . 0.68999999999999995 110.427 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.1 m -100.47 136.07 40.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.238 -0.653 . . . . 0.34000000000000002 109.238 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' SER . 49.3 tp -103.29 114.21 28.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.187 -0.672 . . . . 0.22 109.187 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.8 mm? -100.63 116.41 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.145 -1.057 . . . . 0.35999999999999999 108.145 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -113.72 120.98 42.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.948 -1.13 . . . . 0.31 107.948 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.64 50.67 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.872 -0.331 . . . . 0.60999999999999999 111.549 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 42.7 p30 -141.12 175.25 3.18 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.34 -1.355 . . . . 1.1799999999999999 107.34 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 52.9 Cg_exo -47.08 -29.77 9.23 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.851 2.368 . . . . 1.0 115.035 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.6 m -71.6 -41.23 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.073 0.463 . . . . 1.1000000000000001 111.769 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.21 -162.76 35.05 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.571 -0.824 . . . . 0.58999999999999997 111.051 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 9.4 tt0 -132.47 131.32 41.57 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.857 -0.423 . . . . 1.5700000000000001 109.857 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -107.76 150.19 27.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.0 p -142.8 120.78 12.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.771 0.32 . . . . 0.56999999999999995 111.831 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.34 147.92 45.04 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.542 -1.281 . . . . 0.29999999999999999 107.542 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -118.46 123.88 46.25 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 118.002 0.364 . . . . 1.26 111.164 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.485 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -118.92 120.22 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.974 -1.121 . . . . 0.71999999999999997 107.974 178.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.53 128.74 39.79 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.288 -1.004 . . . . 1.25 108.288 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.75 116.91 30.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.875 0.369 . . . . 0.57999999999999996 110.583 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.11 101.4 12.86 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.355 0.598 . . . . 0.83999999999999997 109.414 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 20.3 t80 -82.18 -68.03 0.73 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.29 -0.868 . . . . 3.8599999999999999 112.501 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -150.6 -177.88 6.23 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.556 -1.276 . . . . 4.7199999999999998 107.556 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.57 116.47 22.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.814 -1.18 . . . . 5.3300000000000001 107.814 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -96.95 114.23 64.28 Favored Pre-proline 0 C--N 1.29 -2.001 0 N-CA-C 108.766 -0.827 . . . . 5.3399999999999999 108.766 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.44 116.56 4.29 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 121.728 1.619 . . . . 5.0700000000000003 112.203 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 124.567 1.147 . . . . 9.5199999999999996 112.789 178.851 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.882 0.849 . . . . 7.9299999999999997 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 6' ' ' VAL . 3.8 m-20 -101.27 8.32 42.52 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.658 -1.238 . . . . 6.1699999999999999 107.658 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.08 -19.56 63.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.905 -1.498 . . . . 5.4299999999999997 114.011 -168.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -89.66 -32.27 17.13 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.764 -0.774 . . . . 3.8700000000000001 109.751 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -74.67 -44.19 51.51 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.204 -0.907 . . . . 2.5499999999999998 111.422 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 2' ' ' ASP . 14.4 m -84.37 98.58 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-O 122.331 1.062 . . . . 2.0800000000000001 108.699 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -108.49 98.2 7.75 Favored 'General case' 0 N--CA 1.397 -3.077 0 CA-C-O 122.2 1.0 . . . . 1.5800000000000001 109.515 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.488 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 67.1 m-85 -81.48 109.96 16.43 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 105.775 -1.935 . . . . 1.1899999999999999 105.775 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.3 t -84.0 175.59 9.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.228 -1.027 . . . . 1.3200000000000001 108.228 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.71 126.37 39.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 112.852 0.686 . . . . 0.45000000000000001 112.852 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -123.82 139.13 54.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.515 -1.291 . . . . 1.1899999999999999 107.515 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 94' ' ' ALA . 82.7 t -115.36 114.41 46.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.583 -0.525 . . . . 0.28999999999999998 109.583 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -111.42 116.72 31.4 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.967 -0.56 . . . . 2.1800000000000002 110.791 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.477 HD13 HG22 ' A' ' 98' ' ' ILE . 42.7 mt -102.71 156.34 17.7 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.277 -0.874 . . . . 0.33000000000000002 109.16 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -131.82 153.01 50.59 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.344 -0.613 . . . . 1.03 109.344 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -58.85 137.38 57.8 Favored 'General case' 0 N--CA 1.425 -1.724 0 O-C-N 124.909 1.38 . . . . 0.48999999999999999 108.728 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 143.03 56.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.19 -0.67 . . . . 0.40000000000000002 109.19 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.62 129.85 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.52 0.676 . . . . 0.56999999999999995 110.146 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.73 91.75 4.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.724 -1.125 . . . . 2.52 112.514 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -154.43 -178.32 7.07 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.084 -1.821 . . . . 0.88 106.084 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -71.93 -28.64 63.61 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 120.554 1.525 . . . . 2.75 110.499 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.43 100.96 13.44 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -81.89 99.55 9.12 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.837 0.827 . . . . 0.85999999999999999 110.22 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.6 t -103.05 123.05 45.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.717 -1.583 . . . . 0.29999999999999999 109.123 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 62.6 mt -105.87 99.97 25.23 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.426 -1.324 . . . . 0.29999999999999999 107.426 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.29 132.72 18.23 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.361 2.041 . . . . 0.28000000000000003 112.58 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HB3' HD23 ' A' ' 14' ' ' LEU . 46.9 p90 -128.35 149.9 50.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.232 0.539 . . . . 0.37 109.869 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -136.61 112.68 9.7 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.229 -1.026 . . . . 0.88 108.229 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.7 p -110.83 119.23 59.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.825 -0.805 . . . . 0.27000000000000002 108.825 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 25.0 t70 -101.0 132.05 46.59 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.243 -1.021 . . . . 1.3899999999999999 108.243 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.83 131.66 1.28 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 109.387 -1.485 . . . . 0.59999999999999998 109.387 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 25.4 tt0 -75.64 -54.77 2.19 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.629 -0.508 . . . . 2.6099999999999999 109.629 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 19.7 Cg_endo -63.11 120.42 7.89 Favored 'Trans proline' 0 C--N 1.379 2.163 0 N-CA-C 107.384 -1.814 . . . . 0.78000000000000003 107.384 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.0 12.52 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.193 -0.458 . . . . 0.78000000000000003 111.807 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.503 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 87.4 Cg_endo -76.64 149.69 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.11 1.874 . . . . 0.56000000000000005 111.698 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -76.13 109.37 9.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.567 -0.901 . . . . 1.3700000000000001 108.567 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 29' ' ' VAL . 90.8 mt -87.36 125.68 34.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.876 0.37 . . . . 0.5 110.953 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -135.52 130.95 35.39 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.223 -0.444 . . . . 3.7799999999999998 110.11 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -90.97 131.56 36.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.749 -0.659 . . . . 0.28999999999999998 109.734 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -104.88 127.03 52.55 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 105.247 -2.131 . . . . 0.94999999999999996 105.247 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.29 109.54 16.97 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 122.662 0.385 . . . . 0.88 110.254 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.8 t30 51.35 52.36 14.96 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.344 1.028 . . . . 1.79 110.58 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.73 51.01 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 114.541 -1.209 . . . . 0.60999999999999999 114.179 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -122.7 161.27 24.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.862 -0.792 . . . . 1.3700000000000001 108.862 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.78 117.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 115.338 -0.846 . . . . 0.69999999999999996 110.416 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.64 98.53 9.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.076 -0.65 . . . . 0.60999999999999999 110.085 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -84.62 95.64 8.94 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 103.951 -2.611 . . . . 2.4700000000000002 103.951 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.99 125.54 23.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.875 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.5 p -103.9 -165.44 1.15 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.14 -0.936 . . . . 1.5700000000000001 111.852 -172.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -84.49 -9.93 57.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.906 0.86 . . . . 1.52 108.876 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -89.02 -39.7 13.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.417 -0.81 . . . . 1.5900000000000001 109.094 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 40.5 mt -127.48 106.38 15.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.755 -1.572 . . . . 0.5 106.755 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 32.3 p90 -131.39 150.37 52.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 119.608 -0.837 . . . . 2.8900000000000001 112.728 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 m -92.55 110.51 21.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.716 -1.129 . . . . 0.44 110.105 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.48 113.11 23.73 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.693 -0.854 . . . . 2.04 108.693 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.54 138.03 31.81 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.544 0.687 . . . . 0.87 110.687 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' HIS . 11.0 mt -100.71 136.67 40.21 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.055 -0.975 . . . . 1.25 109.606 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -68.52 112.84 12.36 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 124.802 1.314 . . . . 3.3599999999999999 111.983 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.33 155.06 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.197 2.598 . . . . 1.3899999999999999 110.172 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.09 19.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 119.097 -0.478 . . . . 1.53 109.74 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.03 85.09 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 118.724 0.693 . . . . 1.9099999999999999 112.695 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.07 -2.67 58.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.173 1.175 . . . . 3.4900000000000002 114.173 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -101.17 157.59 16.66 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.592 -0.843 . . . . 1.8899999999999999 108.825 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 p -112.4 15.93 20.08 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.834 0.349 . . . . 1.3 111.697 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.12 124.57 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 119.967 -0.693 . . . . 0.60999999999999999 110.363 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.0 mtp180 -95.73 116.59 29.1 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 105.665 -1.976 . . . . 1.8400000000000001 105.665 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 55.7 m-70 -98.73 149.5 22.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.181 -1.044 . . . . 1.1599999999999999 108.181 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.01 174.96 46.01 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 119.338 -1.41 . . . . 0.31 112.388 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -144.76 132.66 21.3 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.471 0.708 . . . . 0.35999999999999999 109.929 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 42.2 tp -88.44 113.18 23.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.644 -1.984 . . . . 0.28000000000000003 105.644 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -107.34 123.37 48.24 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.131 0.491 . . . . 2.6800000000000002 111.596 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 52' ' ' ILE . 49.5 mt -84.79 108.37 17.44 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 106.567 -1.642 . . . . 1.23 106.567 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.3 t30 -73.4 -52.94 12.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.071 -0.968 . . . . 2.1800000000000002 109.059 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -112.0 101.23 51.25 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.56 -1.274 . . . . 2.8199999999999998 107.56 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.04 129.47 18.41 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.688 1.592 . . . . 1.25 110.331 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 p -138.62 168.88 18.83 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -76.13 -6.01 49.24 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 122.243 -0.286 . . . . 2.0299999999999998 111.479 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.44 -21.41 10.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 109.212 -0.662 . . . . 1.3300000000000001 109.212 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.27 -10.6 59.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.657 0.741 . . . . 2.1899999999999999 109.799 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 11.2 t30 -83.57 75.97 9.99 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.23 -1.396 . . . . 1.96 107.23 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.55 -171.58 27.78 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.21 -0.905 . . . . 0.48999999999999999 111.533 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.29 128.23 38.06 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.42 0.526 . . . . 2.23 112.42 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.47 123.09 48.54 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.224 -1.028 . . . . 0.68999999999999995 108.224 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 61.7 m -115.42 128.99 56.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.19 -0.671 . . . . 0.34000000000000002 109.19 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.1 tp -99.61 114.59 27.73 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.1 -0.704 . . . . 0.22 109.1 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.14 131.01 50.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.157 -1.053 . . . . 0.35999999999999999 108.157 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -121.14 119.04 31.23 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.916 -1.142 . . . . 0.31 107.916 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.16 130.4 46.29 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.235 -0.439 . . . . 0.60999999999999999 110.045 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 42.9 t-20 -155.63 136.36 8.92 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.411 -1.329 . . . . 1.1799999999999999 107.411 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.12 -17.11 23.81 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.968 3.112 . . . . 1.0 113.352 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.87 -22.49 45.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 1.1000000000000001 109.537 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.46 146.9 4.51 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.971 -1.252 . . . . 0.58999999999999997 109.971 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -90.94 135.34 33.8 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.639 -0.504 . . . . 1.5700000000000001 109.639 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -114.85 151.67 33.5 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.06 -1.089 . . . . 0.37 108.06 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.9 p -160.33 148.96 16.9 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.103 0.478 . . . . 0.56999999999999995 111.824 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.04 156.97 44.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.365 -1.346 . . . . 0.29999999999999999 107.365 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -133.4 132.38 41.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.175 -0.676 . . . . 1.26 109.175 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.78 133.14 41.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.808 -0.812 . . . . 0.71999999999999997 108.808 -176.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 48.2 ttm -108.95 125.78 52.39 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.877 -0.514 . . . . 1.25 109.7 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -98.05 113.67 25.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.524 -0.917 . . . . 0.57999999999999996 108.524 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.26 100.16 12.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.014 -0.735 . . . . 0.83999999999999997 109.014 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 -49.46 22.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.828 -1.078 . . . . 3.8599999999999999 111.831 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.9 ptp -153.86 154.32 33.69 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.658 -1.238 . . . . 4.7199999999999998 107.658 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.86 110.73 11.71 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.056 -1.831 . . . . 5.3300000000000001 106.056 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -56.33 113.29 5.61 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.479 -1.237 . . . . 5.3399999999999999 113.685 -168.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -78.82 177.85 8.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.693 2.262 . . . . 5.0700000000000003 112.48 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--N 1.304 -1.394 0 CA-C-N 115.551 -0.75 . . . . 9.5199999999999996 111.374 -177.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 107.342 -1.355 . . . . 7.9299999999999997 107.342 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -112.98 155.77 24.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.207 0.527 . . . . 6.1699999999999999 111.159 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -87.87 46.73 1.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.198 0.999 . . . . 5.4299999999999997 110.661 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.09 40.8 3.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.268 -0.878 . . . . 3.8700000000000001 109.924 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.97 -50.85 18.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.669 -0.412 . . . . 2.5499999999999998 110.349 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 m -98.15 98.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.483 1.135 . . . . 2.0800000000000001 109.701 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -102.02 99.17 9.31 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.267 -0.879 . . . . 1.5800000000000001 109.257 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -87.13 129.2 35.03 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.272 -1.01 . . . . 1.1899999999999999 108.272 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.84 -179.94 7.41 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.322 -0.992 . . . . 1.3200000000000001 108.322 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.22 117.64 30.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 CA-C-O 121.217 0.532 . . . . 0.45000000000000001 110.345 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -118.44 134.48 55.03 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 107.039 -1.467 . . . . 1.1899999999999999 107.039 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 94' ' ' ALA . 68.4 t -122.99 119.16 57.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 120.939 -0.305 . . . . 0.28999999999999998 110.906 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -119.15 117.74 29.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.547 0.689 . . . . 2.1800000000000002 110.505 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.797 HD13 HG22 ' A' ' 98' ' ' ILE . 40.8 mt -100.37 157.15 16.83 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.048 -0.978 . . . . 0.33000000000000002 111.053 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -130.93 144.52 51.53 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.178 -1.045 . . . . 1.03 108.178 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -67.91 137.77 55.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.631 -0.878 . . . . 0.48999999999999999 108.631 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -47.25 137.82 7.78 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.27 1.028 . . . . 0.40000000000000002 111.884 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.65 138.35 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.574 -0.739 . . . . 0.56999999999999995 111.06 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.54 89.43 0.36 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.205 -1.362 . . . . 2.52 112.316 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -150.17 178.52 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.376 -1.342 . . . . 0.88 107.376 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -66.19 -46.46 77.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 119.028 0.831 . . . . 2.75 111.091 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -91.7 128.84 37.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -82.6 120.37 25.45 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.918 0.866 . . . . 0.85999999999999999 112.545 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 40.5 t -120.51 121.4 38.37 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.263 -1.335 . . . . 0.29999999999999999 109.684 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 68.5 mt -102.43 97.64 9.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 107.844 -1.169 . . . . 0.29999999999999999 107.844 174.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 15.2 Cg_exo -69.04 135.54 32.44 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.345 2.03 . . . . 0.28000000000000003 111.913 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -128.7 149.34 50.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.311 0.577 . . . . 0.37 110.575 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.0 m -131.49 112.21 12.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.318 -0.856 . . . . 0.88 108.76 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.9 124.74 71.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.837 -0.62 . . . . 0.27000000000000002 109.721 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t0 -101.17 144.07 30.49 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.22 -1.029 . . . . 1.3899999999999999 108.22 -176.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 158.52 8.67 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 111.43 -0.668 . . . . 0.59999999999999998 111.43 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.407 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 15.3 mm100 -99.94 -58.02 0.13 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-O 118.916 -0.564 . . . . 2.6099999999999999 110.902 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.1 Cg_endo -58.0 125.07 17.48 Favored 'Trans proline' 0 C--N 1.366 1.49 0 N-CA-C 108.064 -1.552 . . . . 0.78000000000000003 108.064 169.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 115.69 19.73 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-O 120.988 0.423 . . . . 0.78000000000000003 111.768 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 91.4 Cg_endo -83.63 142.45 10.34 Favored 'Trans proline' 0 N--CA 1.424 -2.585 0 C-N-CA 121.515 1.477 . . . . 0.56000000000000005 110.748 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 m -75.28 105.39 6.28 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.919 -1.141 . . . . 1.3700000000000001 107.919 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.06 116.92 18.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.327 0.584 . . . . 0.5 110.019 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' A' ' 45' ' ' VAL . 8.4 tpp180 -129.3 130.2 45.85 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.222 -0.899 . . . . 3.7799999999999998 109.735 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 90.3 m95 -100.09 140.29 34.53 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.091 -0.707 . . . . 0.28999999999999998 109.091 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 tp -119.56 127.72 53.26 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 105.957 -1.868 . . . . 0.94999999999999996 105.957 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -121.82 109.41 14.63 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.983 -0.377 . . . . 0.88 109.983 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.8 t30 62.08 29.62 17.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.005 0.907 . . . . 1.79 109.967 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.41 60.14 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.309 -0.859 . . . . 0.60999999999999999 112.62 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.0 t -93.18 142.59 27.13 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.969 -0.752 . . . . 1.3700000000000001 108.969 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' HD2' ' A' ' 38' ' ' ARG . 53.9 t -67.45 111.01 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.685 -0.688 . . . . 0.69999999999999996 110.3 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.42 97.53 9.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.374 -0.83 . . . . 0.60999999999999999 109.23 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.59 127.43 34.06 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.174 -1.417 . . . . 2.4700000000000002 107.174 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.3 mp0 -61.32 120.45 10.45 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 123.923 0.764 . . . . 1.74 110.659 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.0 p -106.67 -167.39 1.28 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.878 -0.601 . . . . 1.5700000000000001 109.827 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -80.96 -16.86 52.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.789 -0.819 . . . . 1.52 108.789 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.75 -41.7 11.11 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.102 -0.499 . . . . 1.5900000000000001 110.438 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -124.41 106.29 16.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.382 -1.71 . . . . 0.5 106.382 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -130.39 141.93 50.53 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.901 -0.72 . . . . 2.8900000000000001 111.248 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -83.31 109.97 17.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.896 -0.779 . . . . 0.44 108.896 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 71' ' ' ARG . 42.3 mt-10 -109.9 155.33 21.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.3 0.571 . . . . 2.04 110.222 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.88 151.31 40.82 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 107.749 -1.204 . . . . 0.87 107.749 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -108.82 166.15 11.03 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.251 -1.759 . . . . 1.25 106.251 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -50.94 102.88 0.33 Allowed Pre-proline 0 N--CA 1.473 0.725 0 O-C-N 123.957 0.785 . . . . 3.3599999999999999 110.367 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.04 129.45 2.01 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.571 2.181 . . . . 1.3899999999999999 113.411 -173.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 121.11 15.26 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.347 -0.842 . . . . 1.53 109.828 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.08 -4.83 59.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.061 0.457 . . . . 1.9099999999999999 109.896 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -63.72 -39.33 94.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.697 -1.224 . . . . 3.4900000000000002 107.697 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.99 163.74 12.03 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.84 -1.073 . . . . 1.8899999999999999 108.375 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.2 p -94.96 23.63 5.43 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.655 0.264 . . . . 1.3 111.383 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 24.1 t -116.88 129.47 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-O 121.178 0.514 . . . . 0.60999999999999999 110.749 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -91.74 132.4 36.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.906 -1.516 . . . . 1.8400000000000001 106.906 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.19 128.05 56.36 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.451 -0.574 . . . . 1.1599999999999999 109.451 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.58 -169.06 17.45 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 111.068 -0.813 . . . . 0.31 111.068 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.1 t -152.0 133.3 14.48 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 120.92 0.391 . . . . 0.35999999999999999 110.81 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 46.3 tp -84.61 90.78 7.75 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 104.747 -2.316 . . . . 0.28000000000000003 104.747 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 55' ' ' GLU . 50.1 ttp180 -95.87 120.94 37.03 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 115.595 -0.729 . . . . 2.6800000000000002 109.734 -176.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.35 108.6 17.9 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.862 -1.532 . . . . 1.23 106.862 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.74 -40.18 91.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.759 -1.564 . . . . 2.1800000000000002 110.64 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -128.69 101.42 20.69 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.813 -0.81 . . . . 2.8199999999999998 108.813 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.59 130.41 14.81 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.357 2.038 . . . . 1.25 112.458 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 p -139.39 165.13 28.03 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.958 -1.127 . . . . 1.22 107.958 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 103' ' ' MET . 29.3 p80 -76.82 -5.66 49.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.285 0.846 . . . . 2.0299999999999998 113.285 -173.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.54 -11.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.089 0.471 . . . . 1.3300000000000001 109.791 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -92.52 26.49 2.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.571 0.701 . . . . 2.1899999999999999 110.038 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 101' ' ' ALA . 17.6 t30 -117.51 114.8 23.99 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.344 -0.984 . . . . 1.96 108.344 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.76 -159.2 32.19 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.521 -0.847 . . . . 0.48999999999999999 112.378 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -88.3 118.01 27.61 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.671 0.388 . . . . 2.23 111.657 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.564 ' HB2' HG23 ' A' ' 98' ' ' ILE . 57.0 m-85 -106.8 137.56 44.6 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.588 -0.893 . . . . 0.68999999999999995 108.588 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 m -137.72 133.89 34.7 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.792 -0.818 . . . . 0.34000000000000002 108.792 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' CE2' ' A' ' 39' ' ' TRP . 53.0 tp -106.11 120.68 42.42 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 109.736 -0.468 . . . . 0.22 109.736 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.42 133.41 51.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.339 -0.986 . . . . 0.35999999999999999 108.339 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.66 121.18 25.09 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.999 -1.111 . . . . 0.31 107.999 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.59 132.53 53.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.024 0.202 . . . . 0.60999999999999999 110.507 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 31.9 p30 -148.33 173.61 4.07 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-O 117.965 -1.017 . . . . 1.1799999999999999 108.722 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 17.3 Cg_exo -41.57 -32.29 1.4 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.742 2.961 . . . . 1.0 116.318 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.8 t -81.85 -33.41 30.67 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.698 -0.626 . . . . 1.1000000000000001 111.735 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.15 -161.94 35.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.563 -1.303 . . . . 0.58999999999999997 112.825 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.25 133.38 47.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.805 -0.813 . . . . 1.5700000000000001 108.805 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.27 154.35 29.25 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.656 -0.868 . . . . 0.37 108.656 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 13.4 p -149.5 123.77 9.57 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 123.72 0.637 . . . . 0.56999999999999995 111.256 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.22 149.8 48.8 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.229 -1.397 . . . . 0.29999999999999999 107.229 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.8 p -118.63 147.99 43.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.638 . . . . 1.26 112.598 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.797 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -140.59 118.88 10.28 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 C-N-CA 124.767 1.227 . . . . 0.71999999999999997 109.041 177.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.88 100.75 11.1 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.389 -1.708 . . . . 1.25 106.389 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.77 113.47 26.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.656 0.741 . . . . 0.57999999999999996 111.007 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -105.13 104.98 14.82 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.566 -1.197 . . . . 0.83999999999999997 108.611 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -103.47 -87.46 0.43 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.304 -0.558 . . . . 3.8599999999999999 110.791 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.479 ' HB2' ' HA ' ' A' ' 77' ' ' HIS . 65.4 mtt -101.37 139.28 37.26 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.381 -0.97 . . . . 4.7199999999999998 108.381 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.503 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 7.0 p-10 -76.96 148.6 36.22 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.879 -0.6 . . . . 5.3300000000000001 110.695 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -96.96 104.38 18.48 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.163 -0.68 . . . . 5.3399999999999999 109.163 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 107' ' ' PHE . 48.1 Cg_exo -65.52 115.7 3.51 Favored 'Trans proline' 0 C--O 1.254 1.293 0 C-N-CA 121.706 1.604 . . . . 5.0700000000000003 111.552 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 44.0 t80 . . . . . 0 C--O 1.245 0.863 0 O-C-N 125.201 1.563 . . . . 9.5199999999999996 107.896 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 CA--C 1.495 -1.142 0 N-CA-C 108.821 -0.807 . . . . 7.9299999999999997 108.821 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -166.07 -61.2 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.816 -0.629 . . . . 6.1699999999999999 110.214 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.82 51.75 2.29 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.318 -1.364 . . . . 5.4299999999999997 107.318 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' HA ' HE22 ' A' ' 32' ' ' GLN . 5.0 m-20 -127.94 37.75 4.13 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.878 -1.51 . . . . 3.8700000000000001 108.724 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.06 -50.69 70.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.205 -0.907 . . . . 2.5499999999999998 109.03 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.02 102.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.928 -1.033 . . . . 2.0800000000000001 108.636 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 t -80.02 99.55 7.72 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.49 -0.929 . . . . 1.5800000000000001 108.49 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 27.6 m-85 -75.06 121.4 21.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.3 -1.371 . . . . 1.1899999999999999 107.3 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -83.95 -174.16 5.13 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.154 -1.054 . . . . 1.3200000000000001 108.154 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.36 118.35 30.83 Favored 'General case' 0 CA--C 1.474 -1.942 0 C-N-CA 119.128 -1.029 . . . . 0.45000000000000001 109.652 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.1 m -116.67 130.66 56.86 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.789 -1.096 . . . . 1.1899999999999999 108.569 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 85' ' ' LEU . 77.8 t -116.68 119.5 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.331 -0.395 . . . . 0.28999999999999998 111.379 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -115.11 120.41 39.71 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.162 -0.681 . . . . 2.1800000000000002 109.162 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 27' ' ' PHE . 33.5 mt -98.41 155.13 17.39 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 109.589 -0.522 . . . . 0.33000000000000002 109.589 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.67 147.18 52.49 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.917 -1.142 . . . . 1.03 107.917 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 m -60.96 131.72 51.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 124.118 0.886 . . . . 0.48999999999999999 109.41 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.36 139.27 19.74 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.403 1.064 . . . . 0.40000000000000002 111.44 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.9 140.98 15.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.515 0.674 . . . . 0.56999999999999995 110.137 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.72 102.33 11.46 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.346 -1.297 . . . . 2.52 111.731 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -145.12 -167.47 2.68 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.106 -1.442 . . . . 0.88 107.106 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -77.93 -49.46 14.12 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.843 -1.54 . . . . 2.75 106.843 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -89.82 120.13 30.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 172.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.62 134.25 35.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.106 0.479 . . . . 0.85999999999999999 111.05 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.7 t -125.99 126.07 43.71 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.214 -0.903 . . . . 0.29999999999999999 110.555 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 71.9 mt -101.33 102.75 22.64 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.149 -1.426 . . . . 0.29999999999999999 107.149 173.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.14 138.8 23.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.251 1.967 . . . . 0.28000000000000003 111.558 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB3' HD23 ' A' ' 14' ' ' LEU . 50.3 p90 -133.29 144.27 49.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.871 0.367 . . . . 0.37 110.731 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -121.59 106.24 11.18 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.447 -0.945 . . . . 0.88 108.447 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.0 p -114.33 117.86 56.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.684 -0.858 . . . . 0.27000000000000002 108.684 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -117.79 156.92 27.49 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.301 -0.56 . . . . 1.3899999999999999 109.491 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 149.38 5.31 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 108.323 -1.911 . . . . 0.59999999999999998 108.323 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.449 HE22 ' HA ' ' A' ' 4' ' ' ASP . 12.3 tt0 -86.47 -53.54 0.42 Allowed Pre-proline 0 C--N 1.311 -1.095 0 C-N-CA 118.857 -1.137 . . . . 2.6099999999999999 110.857 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 14.2 Cg_endo -62.75 119.31 6.34 Favored 'Trans proline' 0 C--N 1.373 1.824 0 N-CA-C 107.439 -1.793 . . . . 0.78000000000000003 107.439 167.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.11 118.7 61.28 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 115.475 -0.784 . . . . 0.78000000000000003 112.156 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -86.84 160.33 8.98 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.108 1.872 . . . . 0.56000000000000005 112.398 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -96.99 138.19 34.9 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.235 -1.024 . . . . 1.3700000000000001 108.235 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 HG11 ' A' ' 29' ' ' VAL . 95.1 mt -101.33 134.63 44.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.185 0.517 . . . . 0.5 111.526 -175.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -136.75 131.34 33.3 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.483 -0.781 . . . . 3.7799999999999998 110.248 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -97.34 138.54 34.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.873 -0.603 . . . . 0.28999999999999998 110.647 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -129.8 137.04 50.28 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.716 -1.957 . . . . 0.94999999999999996 105.716 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.45 119.68 20.94 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.962 -0.385 . . . . 0.88 109.962 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 60.06 26.34 15.67 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.24 1.019 . . . . 1.79 110.885 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.28 82.15 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.60999999999999999 112.252 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 p -108.26 150.86 26.72 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.012 0.434 . . . . 1.3700000000000001 110.391 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.45 114.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.436 -0.802 . . . . 0.69999999999999996 112.148 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.38 122.1 32.95 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.936 -1.135 . . . . 0.60999999999999999 107.936 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.41 137.11 40.18 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.01 -0.541 . . . . 2.4700000000000002 110.029 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.52 121.03 12.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -138.09 -163.99 1.55 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 120.455 -0.498 . . . . 1.5700000000000001 110.715 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -64.56 -49.89 69.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.631 0.604 . . . . 1.52 112.631 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -84.87 -31.76 23.58 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 1.5900000000000001 112.013 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 79' ' ' ASN . 21.0 mt -114.42 106.66 21.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.705 -1.591 . . . . 0.5 106.705 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.23 154.21 50.22 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.542 0.687 . . . . 2.8900000000000001 111.369 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -95.14 129.3 42.29 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.311 -0.859 . . . . 0.44 109.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -123.13 129.39 51.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.032 -1.47 . . . . 2.04 107.032 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.58 120.84 37.63 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.625 -0.509 . . . . 0.87 109.625 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.15 153.84 27.03 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.548 . . . . 1.25 106.822 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.56 102.05 0.29 Allowed Pre-proline 0 C--N 1.313 -0.998 0 C-N-CA 125.901 1.68 . . . . 3.3599999999999999 114.0 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -88.91 146.71 5.62 Favored 'Trans proline' 0 C--O 1.264 1.79 0 C-N-CA 122.135 1.89 . . . . 1.3899999999999999 110.383 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -84.97 155.08 21.76 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.255 -1.017 . . . . 1.53 108.255 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.54 -22.1 61.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.417 -0.811 . . . . 1.9099999999999999 112.448 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.17 -2.29 43.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.425 0.528 . . . . 3.4900000000000002 112.425 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 54.8 mt-10 -83.04 136.84 34.35 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 109.112 -0.699 . . . . 1.8899999999999999 109.112 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -103.72 27.83 7.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.827 1.298 . . . . 1.3 108.157 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 129.42 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.2 -1.364 . . . . 0.60999999999999999 108.087 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.648 ' HB3' HG13 ' A' ' 29' ' ' VAL . 37.2 ttm180 -93.86 119.12 32.38 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.934 -1.506 . . . . 1.8400000000000001 106.934 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -98.39 115.41 28.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.345 -0.983 . . . . 1.1599999999999999 108.345 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 27' ' ' PHE . . . -133.22 166.0 23.88 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.157 -1.497 . . . . 0.31 113.517 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 t -139.88 131.93 27.91 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.541 0.736 . . . . 0.35999999999999999 109.748 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.0 tp -96.39 103.44 15.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.518 -2.03 . . . . 0.28000000000000003 105.518 171.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -108.12 127.91 54.22 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.783 0.801 . . . . 2.6800000000000002 111.539 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.5 mp -103.67 109.43 21.12 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.462 -1.245 . . . . 1.23 108.744 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -66.42 -36.39 82.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.554 -1.203 . . . . 2.1800000000000002 109.677 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -134.48 101.35 12.09 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 108.021 -1.103 . . . . 2.8199999999999998 108.021 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.21 130.75 11.32 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.257 1.971 . . . . 1.25 110.329 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -117.56 169.94 9.15 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.684 -0.487 . . . . 1.22 109.684 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -76.27 -7.01 53.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.655 0.613 . . . . 2.0299999999999998 112.655 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.59 -9.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.503 -0.555 . . . . 1.3300000000000001 109.503 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.479 HD21 HD11 ' A' ' 52' ' ' ILE . 10.8 m120 -99.59 26.85 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.401 0.68 . . . . 2.1899999999999999 110.105 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -111.42 100.21 8.84 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.785 -0.82 . . . . 1.96 108.785 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.81 -157.61 30.17 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.335 -1.412 . . . . 0.48999999999999999 113.85 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.53 118.73 30.21 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.355 0.662 . . . . 2.23 112.293 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.13 127.29 46.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.828 -1.078 . . . . 0.68999999999999995 108.316 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 29.4 m -117.69 127.22 53.72 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 108.886 -0.783 . . . . 0.34000000000000002 108.886 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.2 tp -103.39 125.71 50.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.645 -0.502 . . . . 0.22 109.645 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.7 mm? -108.45 129.34 55.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 124.178 0.924 . . . . 0.35999999999999999 108.794 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.78 121.6 35.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.288 -1.375 . . . . 0.31 107.288 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.49 54.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 112.508 0.558 . . . . 0.60999999999999999 112.508 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -141.25 162.96 44.87 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.986 -1.487 . . . . 1.1799999999999999 106.986 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -47.55 -29.68 10.84 Favored 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 122.716 2.278 . . . . 1.0 114.775 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.63 -29.26 64.45 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.008 -0.432 . . . . 1.1000000000000001 111.804 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.93 165.88 21.86 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.787 -1.197 . . . . 0.58999999999999997 112.557 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.34 122.5 47.12 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.713 -1.217 . . . . 1.5700000000000001 107.713 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.64 145.94 28.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.944 -0.762 . . . . 0.37 108.944 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 35.0 p -138.05 138.82 39.17 Favored 'General case' 0 N--CA 1.416 -2.161 0 O-C-N 123.669 0.606 . . . . 0.56999999999999995 109.837 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.34 155.7 47.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.246 -1.391 . . . . 0.29999999999999999 107.246 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 p -127.75 143.1 51.15 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.654 0.264 . . . . 1.26 111.686 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.461 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -139.58 131.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.804 -1.924 . . . . 0.71999999999999997 105.804 176.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 ttt -112.32 107.5 16.35 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.81 -0.756 . . . . 1.25 109.202 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.37 126.48 55.41 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.292 0.568 . . . . 0.57999999999999996 111.575 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.05 103.39 15.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.188 -0.915 . . . . 0.83999999999999997 108.689 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.68 -79.12 0.42 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.381 -0.528 . . . . 3.8599999999999999 110.795 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 mmt -109.25 129.61 55.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.196 -1.039 . . . . 4.7199999999999998 108.196 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.03 140.57 42.01 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 122.408 0.283 . . . . 5.3300000000000001 110.384 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -74.59 121.06 84.4 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.524 -0.307 . . . . 5.3399999999999999 110.37 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.18 141.31 56.74 Favored 'Trans proline' 0 C--O 1.244 0.815 0 C-N-CA 122.855 2.37 . . . . 5.0700000000000003 112.804 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.685 1.241 . . . . 9.5199999999999996 111.265 177.702 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 109.315 -0.624 . . . . 7.9299999999999997 109.315 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 t70 58.53 79.97 0.2 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.189 1.396 . . . . 6.1699999999999999 110.642 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -75.81 52.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.379 0.672 . . . . 5.4299999999999997 110.674 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -157.61 -51.57 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.245 -0.889 . . . . 3.8700000000000001 109.941 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.12 -49.67 69.01 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.326 0.391 . . . . 2.5499999999999998 109.98 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -88.47 98.93 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-O 122.291 1.043 . . . . 2.0800000000000001 109.474 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 p -88.95 98.61 11.85 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 107.037 -1.468 . . . . 1.5800000000000001 107.037 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 65.2 m-85 -68.1 134.52 50.71 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.67 -1.233 . . . . 1.1899999999999999 107.67 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.58 -174.81 5.5 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.572 -1.27 . . . . 1.3200000000000001 107.572 -174.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.17 121.89 34.99 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 119.788 -0.765 . . . . 0.45000000000000001 109.462 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -125.13 135.05 52.28 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.764 -1.199 . . . . 1.1899999999999999 107.764 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 94' ' ' ALA . 52.2 t -122.54 119.11 57.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.94 0.4 . . . . 0.28999999999999998 111.435 -173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -118.08 116.56 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.952 -0.759 . . . . 2.1800000000000002 108.952 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 98' ' ' ILE . 32.7 mt -98.13 155.95 16.9 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.263 -0.643 . . . . 0.33000000000000002 109.263 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -130.86 153.92 48.61 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.783 -1.192 . . . . 1.03 107.783 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.0 m -59.32 133.64 56.28 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 124.729 1.268 . . . . 0.48999999999999999 110.62 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -69.9 151.78 45.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.417 -0.81 . . . . 0.40000000000000002 109.152 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.98 126.73 44.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 116.214 -0.448 . . . . 0.56999999999999995 110.689 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 23' ' ' TRP . 28.0 mm-40 -72.24 88.83 1.16 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.998 -1.001 . . . . 2.52 110.565 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.28 -178.86 7.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.674 -0.862 . . . . 0.88 108.674 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -61.82 -42.52 99.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.577 0.626 . . . . 2.75 112.067 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.08 109.11 21.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.992 -1.114 . . . . 2.46 107.992 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 92.1 m95 -82.27 106.97 14.59 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.306 0.574 . . . . 0.85999999999999999 111.602 -174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.0 t -104.48 116.97 33.03 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.574 -1.194 . . . . 0.29999999999999999 109.023 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.1 mt -102.84 100.14 15.75 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 107.858 -1.164 . . . . 0.29999999999999999 107.858 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -73.41 130.02 14.53 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.258 1.972 . . . . 0.28000000000000003 111.738 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -122.3 155.75 35.28 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.209 0.528 . . . . 0.37 110.522 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -138.24 106.98 5.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.462 -0.94 . . . . 0.88 108.462 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.3 p -113.28 117.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.059 0.457 . . . . 0.27000000000000002 110.008 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.9 t70 -101.91 136.97 40.83 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.946 -0.57 . . . . 1.3899999999999999 110.461 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.08 150.6 7.95 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.363 -1.095 . . . . 0.59999999999999998 110.363 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -82.88 -58.79 0.41 Allowed Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 107.322 -1.362 . . . . 2.6099999999999999 107.322 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 38.0 Cg_endo -71.97 120.98 7.19 Favored 'Trans proline' 0 C--N 1.369 1.607 0 N-CA-C 108.173 -1.51 . . . . 0.78000000000000003 108.173 168.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.7 113.63 8.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 0.78000000000000003 111.065 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.48 142.43 14.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.452 2.101 . . . . 0.56000000000000005 111.734 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 p -69.47 127.77 34.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.631 -0.713 . . . . 1.3700000000000001 110.019 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.3 mt -98.94 126.16 44.55 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.88 -0.6 . . . . 0.5 111.069 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -131.85 127.59 36.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.88 -0.6 . . . . 3.7799999999999998 110.176 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.0 m95 -92.91 126.95 38.24 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.28999999999999998 110.312 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.94 126.92 54.52 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.677 -1.601 . . . . 0.94999999999999996 106.677 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -115.74 102.97 10.21 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.177 -0.675 . . . . 0.88 109.177 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 54.15 40.42 31.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.055 0.942 . . . . 1.79 112.101 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.1 84.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.671 -0.695 . . . . 0.60999999999999999 113.689 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -114.04 136.94 52.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 117.449 0.624 . . . . 1.3700000000000001 109.716 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.77 121.06 13.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.217 -0.447 . . . . 0.69999999999999996 110.266 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 tp -82.27 137.82 34.75 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.451 -1.315 . . . . 0.60999999999999999 107.451 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -109.21 121.22 44.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 123.354 0.409 . . . . 2.4700000000000002 110.229 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 119.64 13.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.868 -0.79 . . . . 1.74 108.868 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -150.06 -174.03 4.61 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.828 -0.804 . . . . 1.5700000000000001 108.828 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 t -70.73 3.68 3.02 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 112.932 0.715 . . . . 1.52 112.932 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.16 -28.39 9.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.871 -0.518 . . . . 1.5900000000000001 109.921 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -149.02 108.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.894 -1.15 . . . . 0.5 107.894 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -135.59 156.28 49.12 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.785 0.661 . . . . 2.8900000000000001 112.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -100.31 110.43 22.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.421 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.34 146.26 24.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.78 -0.822 . . . . 2.04 108.78 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.07 156.88 32.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.314 -0.624 . . . . 0.87 109.314 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.26 160.35 29.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.422 -1.325 . . . . 1.25 107.422 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 34.6 mm-40 -71.68 120.28 79.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 113.916 1.08 . . . . 3.3599999999999999 113.916 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.53 145.1 29.31 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 123.198 2.599 . . . . 1.3899999999999999 111.071 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.54 162.0 16.65 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.485 -0.932 . . . . 1.53 108.485 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.75 -11.38 60.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.931 0.715 . . . . 1.9099999999999999 112.931 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -91.19 3.31 55.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.167 0.984 . . . . 3.4900000000000002 108.517 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 151.7 48.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.062 -0.972 . . . . 1.8899999999999999 108.956 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -120.29 23.88 10.69 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.498 -1.667 . . . . 1.3 106.498 165.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 15.1 t -99.76 123.48 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 113.303 -1.771 . . . . 0.60999999999999999 109.526 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' VAL . 62.1 mtp180 -89.01 116.32 27.21 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.173 -1.788 . . . . 1.8400000000000001 106.173 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -101.2 137.88 38.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.329 -0.989 . . . . 1.1599999999999999 108.329 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.45 -170.39 30.33 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 120.19 -1.005 . . . . 0.31 111.046 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.9 t -150.41 132.48 15.29 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 120.874 0.368 . . . . 0.35999999999999999 110.841 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.6 tp -90.13 111.82 23.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.301 -2.111 . . . . 0.28000000000000003 105.301 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 10.1 ptp180 -114.09 128.91 56.59 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.046 -1.062 . . . . 2.6800000000000002 112.49 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.84 107.09 18.79 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 105.455 -2.054 . . . . 1.23 105.455 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -80.81 -35.26 33.25 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.234 -0.439 . . . . 2.1800000000000002 110.524 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.47 99.79 51.48 Favored Pre-proline 0 N--CA 1.421 -1.909 0 N-CA-C 108.172 -1.048 . . . . 2.8199999999999998 108.172 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -84.13 143.09 10.1 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 122.229 1.953 . . . . 1.25 111.411 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -136.82 160.93 37.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.108 -1.071 . . . . 1.22 108.108 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -61.71 -6.89 2.89 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.963 1.097 . . . . 2.0299999999999998 113.963 -173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.86 -9.93 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.797 0.332 . . . . 1.3300000000000001 110.572 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -77.86 8.92 3.98 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.643 0.979 . . . . 2.1899999999999999 113.643 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -91.4 88.56 6.88 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.393 -1.706 . . . . 1.96 106.393 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.65 -171.29 27.51 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.458 -1.83 . . . . 0.48999999999999999 114.536 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -98.88 103.79 15.78 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.051 0.94 . . . . 2.23 110.611 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -93.3 105.96 17.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.865 -0.791 . . . . 0.68999999999999995 108.865 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.0 m -103.93 125.94 50.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.239 -0.652 . . . . 0.34000000000000002 109.239 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.5 tp -100.6 118.28 36.45 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.009 -0.737 . . . . 0.22 109.009 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 130.38 47.21 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.46 -0.941 . . . . 0.35999999999999999 108.46 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 121.11 28.74 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.31 107.557 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.47 130.78 44.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 123.399 0.437 . . . . 0.60999999999999999 110.504 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.1 p30 -134.9 171.27 9.28 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.415 -1.328 . . . . 1.1799999999999999 107.415 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.3 Cg_exo -49.41 -30.11 19.76 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.448 2.099 . . . . 1.0 114.145 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.83 -50.99 37.41 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 111.747 0.277 . . . . 1.1000000000000001 111.747 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.92 45.22 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.452 -1.356 . . . . 0.58999999999999997 112.933 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -123.55 133.09 54.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.928 0.428 . . . . 1.5700000000000001 110.345 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.244 -1.021 . . . . 0.37 108.244 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 31.9 p -144.96 138.84 27.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 109.583 -0.525 . . . . 0.56999999999999995 109.583 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.72 152.36 47.92 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.384 -1.339 . . . . 0.29999999999999999 107.384 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 m -131.48 141.32 49.75 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.597 -0.441 . . . . 1.26 111.134 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.465 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.34 123.96 39.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 106.441 -1.689 . . . . 0.71999999999999997 106.441 176.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -103.88 98.87 8.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.243 -0.651 . . . . 1.25 109.243 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.89 27.28 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.416 -0.811 . . . . 0.57999999999999996 110.645 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.17 143.33 42.08 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.935 -1.135 . . . . 0.83999999999999997 107.935 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 75' ' ' PRO . 19.3 t80 -111.77 -78.93 0.58 Allowed 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 112.662 0.616 . . . . 3.8599999999999999 112.662 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 88.1 mtp -134.45 177.26 7.91 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.151 -0.685 . . . . 4.7199999999999998 109.151 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.57 135.14 36.02 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.796 -1.187 . . . . 5.3300000000000001 107.796 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -95.32 111.72 56.15 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 109.203 -0.666 . . . . 5.3399999999999999 109.203 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -57.75 129.02 31.4 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.907 2.405 . . . . 5.0700000000000003 111.832 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.817 -1.087 . . . . 9.5199999999999996 111.551 178.705 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 110.106 -0.331 . . . . 7.9299999999999997 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 48.43 57.36 6.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 113.708 1.003 . . . . 6.1699999999999999 113.708 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.47 -40.12 85.29 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.201 -1.777 . . . . 5.4299999999999997 106.201 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 59.98 14.14 4.15 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.505 1.922 . . . . 3.8700000000000001 113.748 167.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.92 -32.9 65.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.462 0.648 . . . . 2.5499999999999998 110.104 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 m -70.61 98.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-O 122.948 1.356 . . . . 2.0800000000000001 108.995 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.3 m -110.67 101.0 9.68 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 114.277 -1.329 . . . . 1.5800000000000001 111.038 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 p90 -130.38 134.54 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.721 -1.127 . . . . 1.1899999999999999 108.993 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 73.0 m -84.17 -166.19 1.36 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.57 -0.741 . . . . 1.3200000000000001 111.93 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 131.72 39.74 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.69 0.757 . . . . 0.45000000000000001 112.018 -172.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 29.4 t -111.72 137.48 49.57 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.954 -1.499 . . . . 1.1899999999999999 106.954 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 94' ' ' ALA . 86.0 t -115.6 114.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.116 -0.698 . . . . 0.28999999999999998 109.116 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 96.0 mt-30 -108.44 116.03 31.2 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.033 -0.728 . . . . 2.1800000000000002 109.033 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 98' ' ' ILE . 23.9 mt -98.97 151.22 21.15 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.539 -0.541 . . . . 0.33000000000000002 109.539 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -131.32 148.8 52.72 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.43 -0.952 . . . . 1.03 108.43 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -56.59 136.39 54.54 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.224 1.41 . . . . 0.48999999999999999 109.617 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -62.96 143.2 57.94 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.952 0.783 . . . . 0.40000000000000002 110.61 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.81 127.58 44.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 109.485 -0.561 . . . . 0.56999999999999995 109.485 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.73 116.48 16.48 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.522 -0.763 . . . . 2.52 110.567 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.2 ptt? -168.2 -177.06 3.14 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.966 -1.494 . . . . 0.88 106.966 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -71.34 -39.46 71.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 119.517 1.053 . . . . 2.75 112.208 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 20' ' ' MET . 37.5 m80 -98.59 115.14 27.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.42 -1.326 . . . . 2.46 107.42 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' HD12 ' A' ' 72' ' ' LEU . 84.0 m95 -81.77 137.94 35.25 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 0.85999999999999999 111.953 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.81 120.62 21.83 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.46 -1.245 . . . . 0.29999999999999999 109.144 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 17' ' ' ALA . 54.9 mt -102.9 100.0 15.46 Favored Pre-proline 0 C--O 1.247 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.29999999999999999 106.88 172.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.54 135.57 20.19 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.338 2.026 . . . . 0.28000000000000003 112.084 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.7 p90 -127.33 155.85 42.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.16 -0.473 . . . . 0.37 109.833 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 10.4 m -132.58 106.32 7.75 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.768 -1.197 . . . . 0.88 107.768 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.4 p -110.74 119.28 59.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.67 -0.863 . . . . 0.27000000000000002 108.67 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 21.8 t70 -121.22 128.15 52.15 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.624 -0.716 . . . . 1.3899999999999999 111.303 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.71 147.85 9.35 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.776 -1.73 . . . . 0.59999999999999998 108.776 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.16 -55.96 1.69 Allowed Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.091 -0.707 . . . . 2.6099999999999999 109.091 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.545 ' HB2' HD21 ' A' ' 89' ' ' ASN . 25.2 Cg_endo -63.77 122.01 9.93 Favored 'Trans proline' 0 C--N 1.376 2.0 0 N-CA-C 108.283 -1.468 . . . . 0.78000000000000003 108.283 169.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.35 121.76 84.31 Favored Pre-proline 0 C--N 1.298 -1.652 0 CA-C-N 115.818 -0.628 . . . . 0.78000000000000003 112.166 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -90.97 167.77 3.7 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.713 2.276 . . . . 0.56000000000000005 112.464 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -105.62 126.73 52.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.12 -1.067 . . . . 1.3700000000000001 108.12 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.99 143.92 26.36 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.883 0.373 . . . . 0.5 111.843 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -144.54 137.99 27.21 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.595 1.158 . . . . 3.7799999999999998 109.221 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -102.93 146.0 28.99 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.67 0.748 . . . . 0.28999999999999998 110.871 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 19.2 tp -131.59 127.75 37.75 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.667 -1.605 . . . . 0.94999999999999996 106.667 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -111.95 106.16 14.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 110.228 -0.286 . . . . 0.88 110.228 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 57.0 30.02 17.44 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.514 0.725 . . . . 1.79 111.883 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.34 64.52 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.741 -0.742 . . . . 0.60999999999999999 112.086 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 m -90.48 129.85 36.6 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.629 -0.508 . . . . 1.3700000000000001 109.629 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.37 117.22 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.572 -0.74 . . . . 0.69999999999999996 110.342 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.0 tp -97.58 101.3 12.79 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.409 -0.814 . . . . 0.60999999999999999 109.744 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -84.31 130.71 34.78 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.898 -1.519 . . . . 2.4700000000000002 106.898 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.09 138.22 56.25 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.614 0.765 . . . . 1.74 111.808 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -108.21 -163.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.654 -0.703 . . . . 1.5700000000000001 109.391 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -85.76 -34.65 21.13 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.849 -0.797 . . . . 1.52 108.849 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -85.2 -28.98 25.08 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.52 -0.309 . . . . 1.5900000000000001 111.67 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.7 mt -117.93 106.46 19.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.911 -1.144 . . . . 0.5 107.911 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.186 0.517 . . . . 2.8900000000000001 110.983 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 m -84.54 112.53 20.49 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.91 127.01 46.13 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.354 -0.98 . . . . 2.04 108.354 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.01 137.14 44.44 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 4.4 pp -96.47 165.79 12.01 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.675 -1.232 . . . . 1.25 107.675 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.61 107.67 2.48 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 117.783 0.265 . . . . 3.3599999999999999 111.383 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 44.1 Cg_endo -89.41 169.39 4.91 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.662 2.908 . . . . 1.3899999999999999 111.238 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -92.95 139.48 30.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.274 -1.38 . . . . 1.53 107.274 175.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.94 65.51 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.532 0.733 . . . . 1.9099999999999999 111.824 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -76.07 -13.17 60.22 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.55 -0.295 . . . . 3.4900000000000002 111.763 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 42.2 mt-10 -93.77 134.78 35.75 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.807 0.336 . . . . 1.8899999999999999 110.826 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -95.03 -2.94 49.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.073 0.94 . . . . 1.3 108.83 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.01 129.65 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 107.64 -1.244 . . . . 0.60999999999999999 107.64 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HB2' HG13 ' A' ' 29' ' ' VAL . 60.1 mtp85 -97.22 117.13 30.74 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.154 -1.425 . . . . 1.8400000000000001 107.154 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.7 112.31 24.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.516 -0.766 . . . . 1.1599999999999999 110.312 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 178.96 31.62 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 111.083 -0.807 . . . . 0.31 111.083 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 t -150.43 145.19 25.9 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.127 -0.323 . . . . 0.35999999999999999 110.127 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 51.2 tp -80.66 109.93 15.66 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.43 -1.693 . . . . 0.28000000000000003 106.43 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -97.86 122.81 41.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.76 -0.655 . . . . 2.6800000000000002 110.986 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 23' ' ' TRP . 37.4 mt -99.19 108.45 21.05 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.159 -1.422 . . . . 1.23 107.159 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.4 -54.99 7.78 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.165 -0.925 . . . . 2.1800000000000002 109.329 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -110.43 106.17 57.72 Favored Pre-proline 0 N--CA 1.427 -1.61 0 N-CA-C 108.307 -0.998 . . . . 2.8199999999999998 108.307 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.4 135.76 55.49 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.265 2.643 . . . . 1.25 111.343 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 p -142.02 155.34 45.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.939 -0.393 . . . . 1.22 109.939 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -72.88 -5.08 35.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.563 0.579 . . . . 2.0299999999999998 112.563 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -78.66 -9.72 12.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 CA-C-O 120.981 0.42 . . . . 1.3300000000000001 110.285 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.795 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 16.1 m120 -87.81 26.53 1.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.195 0.997 . . . . 2.1899999999999999 109.407 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -120.68 87.83 2.82 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.273 -1.38 . . . . 1.96 107.273 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.24 -167.41 39.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.219 -0.991 . . . . 0.48999999999999999 112.013 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.78 106.45 18.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.94 0.4 . . . . 2.23 111.201 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.795 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 69.7 m-85 -95.42 117.14 29.83 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.078 -1.082 . . . . 0.68999999999999995 108.078 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 88.1 m -106.83 131.35 54.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.512 -0.551 . . . . 0.34000000000000002 109.512 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 HG13 ' A' ' 12' ' ' VAL . 55.6 tp -102.41 120.53 40.66 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.961 -0.755 . . . . 0.22 108.961 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.52 136.28 44.38 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.537 -1.283 . . . . 0.35999999999999999 107.537 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.09 119.37 30.11 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.679 -1.601 . . . . 0.31 106.679 171.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.12 127.28 47.73 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 123.378 0.424 . . . . 0.60999999999999999 109.896 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 33' ' ' PRO . 25.5 t-20 -150.98 136.95 10.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.16 -1.422 . . . . 1.1799999999999999 107.16 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -43.13 -34.84 4.43 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 125.252 3.968 . . . . 1.0 115.532 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.0 p -91.33 -33.69 15.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.678 -0.809 . . . . 1.1000000000000001 111.526 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.86 131.55 2.58 Favored Glycine 0 C--N 1.299 -1.493 0 C-N-CA 120.075 -1.06 . . . . 0.58999999999999997 112.526 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -103.92 126.58 51.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.903 -0.777 . . . . 1.5700000000000001 108.903 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -105.4 152.89 22.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.098 -0.501 . . . . 0.37 109.813 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.7 p -151.2 120.76 6.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.246 -0.433 . . . . 0.56999999999999995 110.362 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.89 144.32 49.83 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.763 -0.829 . . . . 0.29999999999999999 108.763 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m -113.89 140.18 48.58 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.084 -0.339 . . . . 1.26 110.084 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.506 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -141.85 118.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.247 -1.019 . . . . 0.71999999999999997 108.247 176.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.5 ttm -95.25 108.77 20.93 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.241 -0.583 . . . . 1.25 109.493 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 113.59 25.68 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.287 -0.87 . . . . 0.57999999999999996 108.759 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.68 101.06 13.29 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.338 -1.356 . . . . 0.83999999999999997 107.338 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -65.54 -71.76 0.18 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.073 -1.421 . . . . 3.8599999999999999 111.39 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 68.3 mtt -158.74 -178.82 7.53 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.954 -1.869 . . . . 4.7199999999999998 105.954 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.14 141.13 50.76 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.916 -0.772 . . . . 5.3300000000000001 108.916 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 10.6 t30 -95.22 117.08 66.81 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 109.126 -0.694 . . . . 5.3399999999999999 109.126 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 31.9 Cg_exo -59.25 142.39 99.11 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.861 2.374 . . . . 5.0700000000000003 112.296 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 . . . . . 0 C--O 1.245 0.845 0 C-N-CA 124.873 1.269 . . . . 9.5199999999999996 110.097 -178.266 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 108.75 -0.833 . . . . 7.9299999999999997 108.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 3.7 m-20 68.89 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.592 1.157 . . . . 6.1699999999999999 113.069 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.25 -28.18 25.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.341 -0.845 . . . . 5.4299999999999997 109.197 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -89.58 5.4 45.8 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 122.125 0.964 . . . . 3.8700000000000001 110.23 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 24.1 t70 -66.35 -27.49 67.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.838 -0.619 . . . . 2.5499999999999998 111.309 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 12.9 m -79.47 98.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.509 1.147 . . . . 2.0800000000000001 109.065 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m -111.23 98.96 7.88 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.884 -1.053 . . . . 1.5800000000000001 110.783 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 98.8 m-85 -98.84 134.02 42.31 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.997 -0.547 . . . . 1.1899999999999999 109.83 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.3 m -84.09 176.33 8.89 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.52 -0.918 . . . . 1.3200000000000001 108.52 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.8 130.49 39.8 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.487 -0.485 . . . . 0.45000000000000001 110.57 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 5.7 m -126.98 144.4 51.03 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.674 -1.602 . . . . 1.1899999999999999 106.674 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 94' ' ' ALA . 61.9 t -127.79 116.47 43.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.28999999999999998 111.673 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -110.31 126.4 54.17 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.229 -0.656 . . . . 2.1800000000000002 109.229 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 HG22 ' A' ' 98' ' ' ILE . 28.6 mt -111.78 156.32 22.14 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.225 -0.657 . . . . 0.33000000000000002 109.225 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -131.57 145.76 51.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.053 -0.721 . . . . 1.03 109.053 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -52.98 133.54 38.23 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.914 1.384 . . . . 0.48999999999999999 110.075 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.22 141.53 58.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.214 -0.903 . . . . 0.40000000000000002 110.004 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.21 130.75 39.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 120.508 -0.477 . . . . 0.56999999999999995 110.907 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.01 96.46 2.15 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.946 -1.024 . . . . 2.52 112.845 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -167.13 150.73 6.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.848 -1.908 . . . . 0.88 105.848 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -52.33 -30.85 30.53 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.726 1.266 . . . . 2.75 114.068 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -98.73 100.65 11.89 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.212 -1.774 . . . . 2.46 106.212 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -80.63 141.05 35.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.547 0.689 . . . . 0.85999999999999999 111.672 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.0 t -135.59 124.54 24.17 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.669 -1.15 . . . . 0.29999999999999999 109.614 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.2 mt -111.02 99.39 42.74 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.556 -1.275 . . . . 0.29999999999999999 107.556 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 135.76 24.03 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.411 2.074 . . . . 0.28000000000000003 111.647 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.34 157.17 40.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.808 0.337 . . . . 0.37 110.305 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -142.85 106.74 4.68 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.571 0.701 . . . . 0.88 109.37 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -113.82 131.61 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.486 -0.779 . . . . 0.27000000000000002 109.028 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.2 p30 -122.62 150.74 42.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.591 -0.444 . . . . 1.3899999999999999 111.142 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.17 169.84 30.3 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.697 -1.761 . . . . 0.59999999999999998 108.697 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 6' ' ' VAL . 21.8 tm0? -93.99 -56.87 0.22 Allowed Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 118.491 1.145 . . . . 2.6099999999999999 108.52 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.7 Cg_endo -70.4 121.55 8.1 Favored 'Trans proline' 0 C--N 1.368 1.562 0 N-CA-C 107.681 -1.7 . . . . 0.78000000000000003 107.681 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.63 114.34 9.98 Favored Pre-proline 0 C--N 1.32 -0.69 0 O-C-N 123.546 0.529 . . . . 0.78000000000000003 109.941 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 90.4 Cg_endo -77.22 141.53 20.67 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.203 1.935 . . . . 0.56000000000000005 111.923 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -71.5 110.95 6.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.807 -0.633 . . . . 1.3700000000000001 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.7 130.8 34.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.648 -0.705 . . . . 0.5 111.082 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -138.28 136.79 36.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.849 -0.797 . . . . 3.7799999999999998 108.849 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -100.49 118.77 37.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.097 0.475 . . . . 0.28999999999999998 109.921 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.01 126.14 50.91 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.376 -2.083 . . . . 0.94999999999999996 105.376 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -109.92 98.8 8.03 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 121.082 0.467 . . . . 0.88 110.276 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 60.17 25.53 14.89 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.872 1.269 . . . . 1.79 111.221 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.54 -15.17 32.39 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.825 -0.702 . . . . 0.60999999999999999 113.387 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -109.52 142.44 40.56 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.667 -0.864 . . . . 1.3700000000000001 108.667 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.12 122.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.517 -0.549 . . . . 0.69999999999999996 109.517 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.4 tp -77.09 121.4 23.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.717 -0.846 . . . . 0.60999999999999999 108.717 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -93.49 124.11 37.26 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.166 -1.05 . . . . 2.4700000000000002 108.166 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 129.54 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.701 -0.481 . . . . 1.74 109.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -166.96 1.4 Allowed 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.883 -0.598 . . . . 1.5700000000000001 111.035 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -81.82 -12.83 58.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.923 -0.769 . . . . 1.52 108.923 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -103.29 -40.77 6.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.949 -0.568 . . . . 1.5900000000000001 110.938 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG23 ' HG ' ' A' ' 72' ' ' LEU . 35.3 mt -113.59 106.79 21.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 106.959 -1.497 . . . . 0.5 106.959 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.086 0.47 . . . . 2.8900000000000001 112.194 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.3 m -84.97 113.05 21.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.982 -0.554 . . . . 0.44 109.822 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 14.8 mm-40 -87.49 136.67 32.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.076 -0.511 . . . . 2.04 109.635 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.59 144.0 49.39 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.992 -0.744 . . . . 0.87 108.992 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.45 166.85 15.28 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.087 -0.709 . . . . 1.25 109.087 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.54 124.79 9.7 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 114.234 1.198 . . . . 3.3599999999999999 114.234 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.81 128.42 2.4 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 121.714 1.609 . . . . 1.3899999999999999 108.927 169.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.071 -1.085 . . . . 1.53 108.071 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.22 61.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.497 0.665 . . . . 1.9099999999999999 110.284 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.11 -14.82 60.18 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.56 -1.2 . . . . 3.4900000000000002 110.056 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.21 161.04 21.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.464 -0.939 . . . . 1.8899999999999999 108.464 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 3.3 p -112.12 8.13 19.89 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.514 -0.921 . . . . 1.3 108.514 172.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 30' ' ' ASP . 38.1 t -95.96 129.72 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 114.511 -1.222 . . . . 0.60999999999999999 110.366 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 29' ' ' VAL . 77.4 mtp180 -89.68 140.4 29.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.309 -2.108 . . . . 1.8400000000000001 105.309 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -115.87 133.18 56.29 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.015 -0.735 . . . . 1.1599999999999999 109.015 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.17 179.83 44.33 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 119.439 -1.363 . . . . 0.31 113.461 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.29 136.71 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.652 0.781 . . . . 0.35999999999999999 110.285 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 tp -84.88 110.63 18.99 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.682 -1.599 . . . . 0.28000000000000003 106.682 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 80.3 mtt180 -102.06 132.99 47.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.967 0.413 . . . . 2.6800000000000002 111.813 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -112.51 109.55 19.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 107.453 -1.314 . . . . 1.23 107.453 172.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -59.09 -37.7 77.75 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.218 -1.356 . . . . 2.1800000000000002 110.851 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -128.27 135.22 27.21 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 107.929 -1.137 . . . . 2.8199999999999998 107.929 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.26 130.25 13.89 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 121.473 1.449 . . . . 1.25 109.672 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -115.19 139.97 49.48 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.355 -0.609 . . . . 1.22 109.355 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' MET . 5.4 p80 -75.61 -14.48 60.38 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 112.233 0.457 . . . . 2.0299999999999998 112.233 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.56 -10.53 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.68 -0.808 . . . . 1.3300000000000001 113.088 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.263 20.2 m-80 -92.19 26.95 2.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 116.17 1.915 . . . . 2.1899999999999999 116.17 -171.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 103' ' ' MET . 87.3 m-20 -80.87 74.25 7.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.998 -0.741 . . . . 1.96 108.998 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.09 -174.9 15.03 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.134 -1.032 . . . . 0.48999999999999999 112.42 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -93.97 112.04 23.83 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.525 -0.337 . . . . 2.23 110.997 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -86.52 108.09 18.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.414 -0.958 . . . . 0.68999999999999995 108.414 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 m -102.16 117.99 35.95 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.725 -0.842 . . . . 0.34000000000000002 108.725 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.8 tp -94.73 118.91 32.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.712 -0.848 . . . . 0.22 108.712 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.0 134.5 46.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.917 . . . . 0.35999999999999999 108.523 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -134.85 120.98 19.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.552 -0.907 . . . . 0.31 108.552 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.38 135.34 49.41 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 123.218 0.324 . . . . 0.60999999999999999 110.4 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.7 p30 -143.91 169.74 9.75 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-O 117.432 -1.27 . . . . 1.1799999999999999 107.663 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 24.4 Cg_exo -42.77 -30.99 1.92 Allowed 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 123.317 2.678 . . . . 1.0 115.966 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.0 t -74.97 -47.46 29.23 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.33 -0.548 . . . . 1.1000000000000001 111.649 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.45 31.36 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.825 -1.178 . . . . 0.58999999999999997 112.48 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.96 129.31 43.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.093 0.473 . . . . 1.5700000000000001 109.796 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.6 159.33 21.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 30.8 p -155.93 153.21 29.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.977 -0.556 . . . . 0.56999999999999995 110.328 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 158.71 43.52 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.713 -1.588 . . . . 0.29999999999999999 106.713 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 m -133.72 127.12 32.17 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 120.944 0.402 . . . . 1.26 110.615 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -129.67 118.49 45.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.697 -1.223 . . . . 0.71999999999999997 107.697 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.0 ttm -96.75 114.79 26.46 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.933 -0.707 . . . . 1.25 109.659 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.73 29.72 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.331 -0.618 . . . . 0.57999999999999996 109.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.83 123.03 36.4 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.667 -0.864 . . . . 0.83999999999999997 108.667 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -156.99 73.95 0.77 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.003 0.906 . . . . 3.8599999999999999 110.873 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.513 ' HB3' HD21 ' A' ' 80' ' ' ASN . 23.7 ptt? -100.32 96.71 7.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.898 1.332 . . . . 4.7199999999999998 111.253 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -97.44 126.13 42.51 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.629 -1.623 . . . . 5.3300000000000001 107.893 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -98.36 114.47 65.28 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 108.742 -0.836 . . . . 5.3399999999999999 108.742 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.69 134.89 67.35 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 122.889 2.393 . . . . 5.0700000000000003 111.229 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 C--O 1.241 0.63 0 C-N-CA 124.993 1.317 . . . . 9.5199999999999996 110.92 -177.571 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.497 -1.087 0 N-CA-C 108.787 -0.819 . . . . 7.9299999999999997 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -127.49 -49.82 1.4 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 120.744 0.307 . . . . 6.1699999999999999 111.462 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.86 -40.76 79.13 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.331 0.586 . . . . 5.4299999999999997 110.414 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.35 127.72 9.94 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.068 -1.456 . . . . 3.8700000000000001 107.068 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.87 -28.59 7.34 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.399 -0.52 . . . . 2.5499999999999998 110.466 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.61 96.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 122.611 1.196 . . . . 2.0800000000000001 108.902 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -93.64 96.83 10.07 Favored 'General case' 0 N--CA 1.388 -3.567 0 N-CA-C 106.192 -1.781 . . . . 1.5800000000000001 106.192 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.502 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 46.6 m-85 -74.31 142.78 45.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.95 -1.023 . . . . 1.1899999999999999 110.341 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.28 173.42 11.61 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.42 -1.326 . . . . 1.3200000000000001 107.42 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.24 116.06 28.65 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 121.234 0.54 . . . . 0.45000000000000001 110.192 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 t -117.02 132.03 56.8 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 107.283 -1.377 . . . . 1.1899999999999999 107.283 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 48.5 t -115.86 115.77 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 110.242 -0.281 . . . . 0.28999999999999998 110.242 -173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -112.31 117.9 33.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.597 -0.52 . . . . 2.1800000000000002 109.597 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 98' ' ' ILE . 31.2 mt -100.41 151.53 21.41 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 108.654 -0.869 . . . . 0.33000000000000002 108.654 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -131.24 146.13 52.19 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.238 -1.393 . . . . 1.03 107.238 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.47 132.68 54.22 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 124.087 0.867 . . . . 0.48999999999999999 110.498 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.88 139.51 39.94 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.596 1.185 . . . . 0.40000000000000002 111.165 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -91.92 131.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.961 -0.563 . . . . 0.56999999999999995 110.076 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.08 120.4 21.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.268 -0.878 . . . . 2.52 111.053 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -169.7 -169.84 0.96 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -72.88 -39.26 66.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.286 0.948 . . . . 2.75 111.968 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -104.89 121.45 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.518 -1.66 . . . . 2.46 106.518 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -82.06 129.48 34.81 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.188 0.518 . . . . 0.85999999999999999 110.988 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -121.11 118.59 30.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.076 -0.966 . . . . 0.29999999999999999 110.013 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 17' ' ' ALA . 62.7 mt -101.38 102.23 20.56 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 107.476 -1.305 . . . . 0.29999999999999999 107.476 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.89 138.15 18.35 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.459 2.106 . . . . 0.28000000000000003 111.976 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.28 149.01 51.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.323 0.582 . . . . 0.37 110.677 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 m -133.28 106.66 7.67 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.973 -1.121 . . . . 0.88 107.973 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.6 p -110.93 119.33 59.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 120.933 0.397 . . . . 0.27000000000000002 109.953 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.59 140.54 35.74 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.003 -0.544 . . . . 1.3899999999999999 110.838 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.1 134.84 1.74 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.79 -1.724 . . . . 0.59999999999999998 108.79 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.502 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -71.73 -57.23 4.31 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 106.846 -1.539 . . . . 2.6099999999999999 106.846 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.51 120.45 7.75 Favored 'Trans proline' 0 C--N 1.373 1.829 0 N-CA-C 108.316 -1.455 . . . . 0.78000000000000003 108.316 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.4 119.73 59.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.407 -0.815 . . . . 0.78000000000000003 110.947 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.04 149.46 9.46 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.344 2.029 . . . . 0.56000000000000005 112.992 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 t -80.97 132.41 35.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.858 -1.534 . . . . 1.3700000000000001 106.858 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 82.2 mt -103.2 148.24 26.03 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.065 0.46 . . . . 0.5 111.19 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.6 tpm_? -141.72 141.4 33.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.174 -0.676 . . . . 3.7799999999999998 109.174 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -106.91 125.59 51.21 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.158 0.504 . . . . 0.28999999999999998 109.952 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 22.4 tp -121.97 128.92 52.04 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.227 -1.398 . . . . 0.94999999999999996 107.227 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -118.4 106.56 12.85 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.17 -0.678 . . . . 0.88 109.17 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.06 31.77 20.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.121 0.969 . . . . 1.79 111.446 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.93 85.49 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 121.081 -0.581 . . . . 0.60999999999999999 112.853 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -107.43 150.53 26.66 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.008 -0.738 . . . . 1.3700000000000001 109.008 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.3 120.29 24.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.373 -0.376 . . . . 0.69999999999999996 110.756 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -87.23 128.88 35.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.82 -1.178 . . . . 0.60999999999999999 107.82 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -104.09 123.96 48.21 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 110.221 -0.289 . . . . 2.4700000000000002 110.221 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.94 120.96 19.28 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.996 -1.113 . . . . 1.74 107.996 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -136.89 -163.94 1.5 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.889 -0.596 . . . . 1.5700000000000001 110.117 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 t -58.86 -44.8 91.11 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.505 1.122 . . . . 1.52 111.98 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 72.4 m-85 -92.26 -23.1 19.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.874 0.694 . . . . 1.5900000000000001 112.874 -174.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.405 HG23 ' HG ' ' A' ' 72' ' ' LEU . 45.7 mt -124.74 106.3 16.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.974 -1.491 . . . . 0.5 106.974 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -132.9 148.31 52.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.309 0.485 . . . . 2.8900000000000001 112.309 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 m -101.22 116.96 34.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.442 -0.947 . . . . 0.44 108.442 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 42.4 mt-10 -96.21 119.85 35.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.458 -0.497 . . . . 2.04 110.513 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -103.38 112.74 25.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.409 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.46 165.57 18.01 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.723 -0.843 . . . . 1.25 108.723 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.4 115.84 43.19 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.945 -0.761 . . . . 3.3599999999999999 108.945 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.26 134.32 28.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.794 1.663 . . . . 1.3899999999999999 110.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.33 23.09 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -23.52 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.256 1.022 . . . . 1.9099999999999999 113.453 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.99 -24.99 47.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.828 0.347 . . . . 3.4900000000000002 111.213 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -96.48 152.25 18.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.227 -1.027 . . . . 1.8899999999999999 108.227 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 p -108.44 16.1 23.35 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.977 0.894 . . . . 1.3 109.399 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 t -109.52 127.22 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.735 -1.121 . . . . 0.60999999999999999 109.86 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.608 ' HB3' HG13 ' A' ' 29' ' ' VAL . 21.5 ttm180 -89.59 118.01 28.9 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 1.8400000000000001 107.165 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -103.85 152.29 22.09 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.426 -0.953 . . . . 1.1599999999999999 108.426 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.67 -178.72 48.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.661 -1.376 . . . . 0.31 109.661 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 35.4 t -146.16 142.34 28.37 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 120.939 0.4 . . . . 0.35999999999999999 111.297 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -92.25 100.99 13.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.936 -1.876 . . . . 0.28000000000000003 105.936 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.667 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 70.8 mtt85 -99.83 131.7 45.64 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.563 0.697 . . . . 2.6800000000000002 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 52' ' ' ILE . 3.6 mp -111.0 109.66 19.88 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.749 -1.204 . . . . 1.23 107.749 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.63 -45.35 83.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.775 -1.102 . . . . 2.1800000000000002 108.539 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 12.9 mm-40 -130.16 100.85 18.29 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 114.969 -1.014 . . . . 2.8199999999999998 109.18 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.16 154.25 12.71 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.07 1.847 . . . . 1.25 108.352 173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 78' ' ' VAL . 21.5 p -125.38 -177.85 4.02 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 118.862 -0.589 . . . . 1.22 109.769 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 105' ' ' ASN . 13.1 p80 -67.0 -18.18 65.26 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.32 0.963 . . . . 2.0299999999999998 110.812 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG22 ' OG1' ' A' ' 76' ' ' THR . 13.0 m -72.77 -10.89 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.791 -0.641 . . . . 1.3300000000000001 109.913 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.58 26.1 4.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 113.223 0.823 . . . . 2.1899999999999999 113.223 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -113.6 98.27 6.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.46 -0.941 . . . . 1.96 108.46 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.1 -161.95 29.18 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.392 -0.909 . . . . 0.48999999999999999 112.247 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.84 116.78 23.49 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.418 -0.216 . . . . 2.23 110.418 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 53.6 m-85 -97.1 105.73 17.93 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.239 -0.652 . . . . 0.68999999999999995 109.239 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 90.1 m -101.76 124.8 48.0 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.587 -0.733 . . . . 0.34000000000000002 110.365 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -106.56 123.72 48.53 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.655 -0.869 . . . . 0.22 108.655 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 1.9 mm? -105.48 141.98 36.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.997 -1.112 . . . . 0.35999999999999999 107.997 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -135.54 121.24 19.58 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.024 -0.732 . . . . 0.31 109.024 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.47 124.14 42.91 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.309 0.485 . . . . 0.60999999999999999 112.309 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -138.65 177.04 2.25 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 116.87 -1.538 . . . . 1.1799999999999999 107.366 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 18.3 Cg_exo -42.64 -26.25 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.53 2.82 . . . . 1.0 116.271 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.63 -34.54 58.32 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.865 -0.522 . . . . 1.1000000000000001 110.998 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.25 -167.26 29.02 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.951 -0.86 . . . . 0.58999999999999997 110.951 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 61.8 tt0 -115.36 127.34 55.33 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 122.939 0.496 . . . . 1.5700000000000001 110.265 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.81 161.77 13.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.182 -0.673 . . . . 0.37 109.182 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.7 p -143.69 136.72 27.61 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.602 -0.518 . . . . 0.56999999999999995 109.602 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -136.6 155.03 50.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.954 -1.498 . . . . 0.29999999999999999 106.954 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 46.0 m -140.07 126.8 20.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.09 0.471 . . . . 1.26 111.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -112.42 130.71 65.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.532 -1.284 . . . . 0.71999999999999997 107.532 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 tpt -90.5 106.57 18.59 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.633 -0.506 . . . . 1.25 109.633 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.93 132.72 55.61 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.341 0.591 . . . . 0.57999999999999996 110.686 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.17 119.7 19.16 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.023 -1.473 . . . . 0.83999999999999997 107.023 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.29 -84.05 0.41 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.384 -0.526 . . . . 3.8599999999999999 112.315 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.6 ptp -104.21 160.76 14.6 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.265 -0.272 . . . . 4.7199999999999998 110.265 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -57.76 131.73 51.2 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 124.344 1.027 . . . . 5.3300000000000001 112.638 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 77' ' ' HIS . 7.1 p30 -112.24 136.08 21.37 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 108.946 -0.761 . . . . 5.3399999999999999 108.946 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 12.0 Cg_exo -71.39 178.6 5.38 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.68 2.253 . . . . 5.0700000000000003 111.013 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 124.419 1.087 . . . . 9.5199999999999996 108.326 -176.573 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.205 -0.665 . . . . 7.9299999999999997 109.205 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -86.53 24.38 1.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.67 0.788 . . . . 6.1699999999999999 109.936 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -94.63 -12.21 27.83 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.081 -0.963 . . . . 5.4299999999999997 109.999 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.497 ' OD2' HG22 ' A' ' 6' ' ' VAL . 11.1 t70 -106.2 140.25 39.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.441 -0.948 . . . . 3.8700000000000001 108.441 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.23 -34.9 78.66 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.964 1.305 . . . . 2.5499999999999998 114.262 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 ' OD2' ' A' ' 4' ' ' ASP . 18.0 m -79.99 103.77 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-O 122.59 1.186 . . . . 2.0800000000000001 113.602 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -108.15 97.88 7.51 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.69 -1.141 . . . . 1.5800000000000001 108.403 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 92.9 m-85 -92.88 130.65 38.41 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.074 -0.713 . . . . 1.1899999999999999 109.074 174.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -84.64 167.26 16.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.79 -1.096 . . . . 1.3200000000000001 109.045 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.45 127.16 40.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.75 0.31 . . . . 0.45000000000000001 111.436 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 m -120.74 135.88 55.02 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.834 -1.913 . . . . 1.1899999999999999 105.834 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 85' ' ' LEU . 96.0 t -115.22 114.71 47.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 120.927 0.394 . . . . 0.28999999999999998 110.342 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.98 123.71 47.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.505 -0.924 . . . . 2.1800000000000002 108.505 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD13 HG22 ' A' ' 98' ' ' ILE . 72.9 mt -104.05 155.95 18.26 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.887 -0.412 . . . . 0.33000000000000002 109.887 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -132.08 142.95 49.7 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.018 -0.734 . . . . 1.03 109.018 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -53.82 135.89 41.11 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 125.119 1.368 . . . . 0.48999999999999999 110.858 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.87 57.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.40000000000000002 110.789 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.33 139.07 18.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 121.223 0.535 . . . . 0.56999999999999995 109.776 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.71 113.34 23.29 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.079 -0.964 . . . . 2.52 111.829 -171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -170.3 -177.65 2.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.191 -2.151 . . . . 0.88 105.191 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.72 -38.45 86.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 120.193 1.361 . . . . 2.75 113.755 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -94.29 115.74 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.465 -0.939 . . . . 2.46 108.465 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 72' ' ' LEU . 94.0 m95 -82.1 117.52 22.34 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.594 0.711 . . . . 0.85999999999999999 109.932 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -110.84 122.54 48.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.29999999999999999 109.305 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 66.3 mt -106.95 101.71 38.94 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.383 -0.969 . . . . 0.29999999999999999 108.383 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.59 132.15 15.65 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.416 2.077 . . . . 0.28000000000000003 111.918 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -122.71 155.34 36.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.117 0.484 . . . . 0.37 110.326 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -136.81 107.7 6.66 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.862 -0.608 . . . . 0.88 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.6 p -119.82 121.49 66.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.827 -0.805 . . . . 0.27000000000000002 108.827 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.6 p-10 -104.91 161.19 14.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.644 -0.822 . . . . 1.3899999999999999 110.797 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.77 177.94 24.28 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.396 -1.082 . . . . 0.59999999999999998 110.396 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 32' ' ' GLN 0.303 17.2 mm-40 -109.85 -54.82 0.05 OUTLIER Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.626 0.602 . . . . 2.6099999999999999 112.626 175.053 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -68.93 119.17 6.18 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 N-CA-C 105.819 -2.416 . . . . 0.78000000000000003 105.819 168.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 109.4 2.47 Favored Pre-proline 0 C--N 1.32 -0.695 0 O-C-N 123.826 0.704 . . . . 0.78000000000000003 110.727 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.9 Cg_endo -72.46 135.03 23.58 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.642 1.561 . . . . 0.56000000000000005 111.15 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -65.0 108.71 1.89 Allowed 'General case' 0 N--CA 1.433 -1.318 0 O-C-N 123.865 0.728 . . . . 1.3700000000000001 109.98 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 29' ' ' VAL . 87.8 mt -85.57 126.25 33.73 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.288 -0.869 . . . . 0.5 110.128 -176.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -136.77 127.2 26.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.049 -0.523 . . . . 3.7799999999999998 109.726 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 85.3 m95 -90.77 134.58 34.32 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.623 -0.717 . . . . 0.28999999999999998 109.756 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 tp -113.7 126.86 55.71 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 105.447 -2.057 . . . . 0.94999999999999996 105.447 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -119.8 103.5 9.41 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.45 -0.574 . . . . 0.88 109.45 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 61.39 32.88 19.0 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.208 -0.906 . . . . 1.79 110.783 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.97 -14.48 64.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.081 -0.581 . . . . 0.60999999999999999 112.807 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -98.88 138.63 35.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.223 -0.658 . . . . 1.3700000000000001 109.223 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.07 123.79 24.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.941 -0.572 . . . . 0.69999999999999996 110.395 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 62.2 tp -80.04 120.38 24.13 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.237 -1.023 . . . . 0.60999999999999999 108.237 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.79 127.62 45.93 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.833 -1.914 . . . . 2.4700000000000002 105.833 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -57.79 126.73 28.67 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.705 0.628 . . . . 1.74 109.89 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.5 p -128.63 173.77 10.0 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.74 -0.837 . . . . 1.5700000000000001 108.74 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -77.1 -1.29 28.38 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.738 0.78 . . . . 1.52 110.36 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -105.19 -40.68 5.78 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.305 -0.861 . . . . 1.5900000000000001 109.002 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -128.58 109.22 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.835 -1.172 . . . . 0.5 107.835 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -143.81 147.07 33.6 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.464 0.65 . . . . 2.8900000000000001 111.446 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 109.73 11.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.74 -1.118 . . . . 0.44 108.983 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -104.56 108.8 20.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.526 -1.287 . . . . 2.04 107.526 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.02 147.54 24.94 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.937 0.398 . . . . 0.87 111.513 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.81 165.55 13.52 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -81.58 126.36 76.16 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 113.638 0.977 . . . . 3.3599999999999999 113.638 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.92 140.4 16.08 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.7 2.267 . . . . 1.3899999999999999 111.124 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.15 161.15 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.029 -1.1 . . . . 1.53 108.029 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.39 -15.29 63.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.997 0.74 . . . . 1.9099999999999999 112.997 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.54 -7.73 49.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.381 -0.6 . . . . 3.4900000000000002 109.381 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.2 134.27 46.89 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.718 -0.475 . . . . 1.8899999999999999 109.718 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -106.1 20.68 18.57 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.851 -1.537 . . . . 1.3 106.851 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 21.9 t -112.88 132.57 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 114.466 -1.243 . . . . 0.60999999999999999 110.402 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.1 mtp180 -84.11 122.86 29.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.985 -1.857 . . . . 1.8400000000000001 105.985 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -108.56 139.09 43.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.049 -0.352 . . . . 1.1599999999999999 110.049 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.81 176.21 41.3 Favored Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 110.707 -0.957 . . . . 0.31 110.707 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 t -138.36 132.66 31.85 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.671 -0.492 . . . . 0.35999999999999999 109.671 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 53.3 tp -80.26 105.15 11.3 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 104.593 -2.373 . . . . 0.28000000000000003 104.593 170.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -99.57 116.16 31.06 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.885 -0.598 . . . . 2.6800000000000002 110.521 -171.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 23' ' ' TRP . 53.9 mt -83.23 107.54 15.84 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 106.651 -1.611 . . . . 1.23 106.651 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -72.85 -49.43 30.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.329 -1.305 . . . . 2.1800000000000002 109.912 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -122.2 101.46 41.27 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.004 -1.48 . . . . 2.8199999999999998 107.004 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.46 129.87 29.72 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 121.989 1.793 . . . . 1.25 110.593 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -129.63 157.08 43.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.257 -0.883 . . . . 1.22 108.665 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.38 -5.09 17.03 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 113.639 0.978 . . . . 2.0299999999999998 113.639 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -82.91 -10.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.406 0.146 . . . . 1.3300000000000001 110.943 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.03 26.87 0.19 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.396 1.258 . . . . 2.1899999999999999 114.396 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.9 p30 -113.62 123.56 50.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.069 -1.086 . . . . 1.96 108.069 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -170.81 33.0 Favored Glycine 0 C--N 1.289 -2.072 0 C-N-CA 119.458 -1.353 . . . . 0.48999999999999999 111.745 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.05 104.91 16.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.616 0.245 . . . . 2.23 110.697 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -85.95 110.78 19.69 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.549 -0.908 . . . . 0.68999999999999995 108.549 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' TRP . 24.5 m -102.11 133.24 47.26 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.527 -0.546 . . . . 0.34000000000000002 109.527 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 95' ' ' SER . 47.5 tp -107.99 115.47 30.19 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.828 -0.434 . . . . 0.22 109.828 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.088 -1.079 . . . . 0.35999999999999999 108.088 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.23 124.06 31.61 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 132.3 53.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.967 -0.293 . . . . 0.60999999999999999 111.236 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 35.0 p30 -149.89 176.91 2.03 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.775 -1.565 . . . . 1.1799999999999999 106.775 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 40.7 Cg_exo -45.19 -30.31 4.98 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.197 2.598 . . . . 1.0 115.803 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.14 -21.16 59.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.538 0.57 . . . . 1.1000000000000001 112.538 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -161.14 23.57 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 119.988 -1.101 . . . . 0.58999999999999997 112.383 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -100.31 133.78 44.22 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.196 0.598 . . . . 1.5700000000000001 111.173 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.45 42.77 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.625 -1.621 . . . . 0.37 106.625 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 49.7 p -162.06 141.38 9.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.208 0.528 . . . . 0.56999999999999995 111.751 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.78 164.65 32.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.282 -1.747 . . . . 0.29999999999999999 106.282 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 p -135.42 139.97 44.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.454 -0.499 . . . . 1.26 111.152 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.586 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.13 127.22 70.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.559 -1.274 . . . . 0.71999999999999997 107.559 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.0 ttt -100.71 128.4 46.77 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.808 -0.757 . . . . 1.25 110.248 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -117.88 135.93 53.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.083 -1.451 . . . . 0.57999999999999996 107.083 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.44 100.95 9.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.26 0.552 . . . . 0.83999999999999997 110.666 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -130.65 82.72 2.07 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 121.939 0.876 . . . . 3.8599999999999999 108.782 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.84 95.64 5.94 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.08 0.943 . . . . 4.7199999999999998 109.003 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.17 152.84 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.627 -1.169 . . . . 5.3300000000000001 108.983 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -107.07 99.93 29.49 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.195 -1.039 . . . . 5.3399999999999999 108.195 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.36 124.24 11.05 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.778 2.319 . . . . 5.0700000000000003 112.145 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 C--O 1.239 0.538 0 C-N-CA 124.723 1.209 . . . . 9.5199999999999996 110.817 177.273 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.241 -0.281 . . . . 7.9299999999999997 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -135.29 -51.13 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.988 0.423 . . . . 6.1699999999999999 111.224 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.91 -31.37 71.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.762 0.792 . . . . 5.4299999999999997 111.226 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 16.8 p-10 -84.1 1.78 42.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.465 -0.789 . . . . 3.8700000000000001 112.393 -176.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.87 -44.76 69.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.38 0.61 . . . . 2.5499999999999998 109.802 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -82.0 98.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 122.276 1.036 . . . . 2.0800000000000001 110.075 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 t -86.83 99.89 12.14 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 114.73 -1.123 . . . . 1.5800000000000001 108.674 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.533 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 19.3 m-85 -78.56 124.73 28.46 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.085 -1.82 . . . . 1.1899999999999999 106.085 174.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.9 m -83.54 -171.34 3.53 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.082 -0.71 . . . . 1.3200000000000001 109.082 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -92.68 119.67 32.32 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 119.093 -1.043 . . . . 0.45000000000000001 109.746 -172.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.5 m -118.14 128.74 55.02 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.069 -1.086 . . . . 1.1899999999999999 108.069 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.92 119.53 62.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 116.546 -0.297 . . . . 0.28999999999999998 110.261 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.62 116.85 30.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.255 -0.646 . . . . 2.1800000000000002 109.255 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 98' ' ' ILE . 37.1 mt -104.46 146.56 28.68 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.156 -0.475 . . . . 0.33000000000000002 109.769 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -131.25 145.85 52.07 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.612 -0.884 . . . . 1.03 108.612 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -56.3 132.95 52.25 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.589 1.181 . . . . 0.48999999999999999 111.674 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -57.71 140.57 51.04 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.814 -1.085 . . . . 0.40000000000000002 110.949 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.9 131.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.668 -0.493 . . . . 0.56999999999999995 109.668 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.464 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.1 mt-10 -84.78 104.04 14.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.703 -0.681 . . . . 2.52 111.904 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -155.3 -168.51 2.87 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.497 -1.668 . . . . 0.88 106.497 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -68.5 -40.29 80.91 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.292 0.951 . . . . 2.75 111.124 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -97.89 113.86 25.8 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.21 -1.404 . . . . 2.46 107.21 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 54.6 m95 -81.45 124.6 29.58 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.227 -0.657 . . . . 0.85999999999999999 109.227 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.82 124.73 42.73 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.639 -0.71 . . . . 0.29999999999999999 110.72 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.556 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.7 mt -106.68 103.15 45.46 Favored Pre-proline 0 C--O 1.242 0.676 0 N-CA-C 108.365 -0.976 . . . . 0.29999999999999999 108.365 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.79 131.24 14.33 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.608 2.205 . . . . 0.28000000000000003 111.789 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.9 p90 -135.66 155.05 51.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.107 0.48 . . . . 0.37 110.289 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -142.45 114.98 8.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.653 0.739 . . . . 0.88 109.536 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.821 -1.081 . . . . 0.27000000000000002 108.502 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -121.16 151.06 40.35 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.717 -0.793 . . . . 1.3899999999999999 110.338 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.21 138.73 2.59 Favored Glycine 0 N--CA 1.42 -2.431 0 N-CA-C 108.274 -1.93 . . . . 0.59999999999999998 108.274 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 34.1 tt0 -79.91 -50.97 1.17 Allowed Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.776 -0.77 . . . . 2.6099999999999999 109.936 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.7 Cg_exo -61.72 120.0 7.41 Favored 'Trans proline' 0 C--N 1.375 1.923 0 N-CA-C 106.273 -2.241 . . . . 0.78000000000000003 106.273 162.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB1' ' NH2' ' A' ' 66' ' ' ARG . . . -65.43 116.29 29.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.349 -0.841 . . . . 0.78000000000000003 111.114 -174.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.21 159.56 8.41 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.928 1.752 . . . . 0.56000000000000005 112.703 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -102.11 131.84 48.35 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.249 -1.019 . . . . 1.3700000000000001 108.249 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 80.4 mt -97.97 154.05 17.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.788 0.327 . . . . 0.5 110.999 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -155.07 135.64 13.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.798 -0.816 . . . . 3.7799999999999998 108.798 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.4 m95 -96.82 121.9 39.19 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.754 -0.461 . . . . 0.28999999999999998 109.754 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.7 tp -109.88 127.47 54.74 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.791 -1.559 . . . . 0.94999999999999996 106.791 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -118.29 98.98 6.56 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 109.625 -0.509 . . . . 0.88 109.625 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.86 43.41 21.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.752 1.221 . . . . 1.79 113.284 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.9 61.87 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.53 -0.843 . . . . 0.60999999999999999 113.742 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 t -107.54 144.85 33.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.004 -1.11 . . . . 1.3700000000000001 108.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -78.86 129.15 37.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.573 -0.899 . . . . 0.69999999999999996 108.573 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 50.4 tp -80.66 120.02 24.03 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.992 -0.744 . . . . 0.60999999999999999 108.992 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -95.57 126.05 40.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.031 -0.729 . . . . 2.4700000000000002 109.031 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -58.72 122.63 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.968 0.793 . . . . 1.74 109.292 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.6 p -124.73 -172.03 2.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.85 -0.426 . . . . 1.5700000000000001 109.85 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 t -74.95 -30.69 61.3 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.393 -0.965 . . . . 1.52 108.393 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 43.1 m-85 -82.98 -41.49 18.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.302 -0.863 . . . . 1.5900000000000001 110.362 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 72' ' ' LEU . 33.7 mt -124.94 106.9 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.287 -1.005 . . . . 0.5 108.287 -176.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -146.04 156.13 43.26 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 118.255 0.48 . . . . 2.8900000000000001 110.413 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.9 m -92.27 121.41 33.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.792 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.0 134.05 40.88 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.301 -1.37 . . . . 2.04 107.301 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.78 144.27 46.4 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.84 0.352 . . . . 0.87 111.648 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.94 165.68 11.16 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.341 -2.096 . . . . 1.25 105.341 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.58 128.11 28.11 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 113.399 0.889 . . . . 3.3599999999999999 113.399 -172.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 159.78 27.23 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.185 2.59 . . . . 1.3899999999999999 110.494 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.51 176.16 6.65 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.124 -0.695 . . . . 1.53 109.124 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.86 77.71 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.59 0.589 . . . . 1.9099999999999999 112.59 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.74 19.2 11.62 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.14 0.495 . . . . 3.4900000000000002 112.067 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -111.21 113.08 25.32 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.407 -1.331 . . . . 1.8899999999999999 107.407 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -93.76 2.62 56.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.8 0.81 . . . . 1.3 108.961 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.41 127.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.677 -1.147 . . . . 0.60999999999999999 109.473 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 48.1 mtt180 -103.53 139.31 39.03 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.755 -1.572 . . . . 1.8400000000000001 106.755 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.9 145.41 49.84 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.896 -1.149 . . . . 1.1599999999999999 107.896 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.49 -167.98 33.97 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 120.032 -1.08 . . . . 0.31 111.447 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 10.0 t -150.81 132.34 14.77 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 122.069 0.148 . . . . 0.35999999999999999 110.969 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 60.0 tp -84.36 112.32 20.23 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.606 -2.368 . . . . 0.28000000000000003 104.606 169.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 38.1 ttm180 -116.69 125.97 52.49 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 119.652 -0.819 . . . . 2.6800000000000002 112.262 -171.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.467 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.6 mp -107.11 109.62 21.51 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.567 -1.197 . . . . 1.23 108.616 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -70.72 -40.01 73.04 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.962 -1.017 . . . . 2.1800000000000002 110.094 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -135.09 102.1 11.1 Favored Pre-proline 0 N--CA 1.419 -2.005 0 N-CA-C 107.341 -1.355 . . . . 2.8199999999999998 107.341 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 23' ' ' TRP . 73.9 Cg_endo -74.98 141.45 26.71 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.14 1.893 . . . . 1.25 111.21 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 p -104.25 171.58 7.26 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.299 -0.63 . . . . 1.22 109.299 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -68.93 -37.35 78.84 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.011 -1.075 . . . . 2.0299999999999998 111.699 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.24 -10.36 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.46 0.911 . . . . 1.3300000000000001 113.46 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.15 -8.7 58.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.052 0.76 . . . . 2.1899999999999999 113.052 -171.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 17.7 p30 -77.65 77.25 4.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.883 0.849 . . . . 1.96 111.804 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -152.34 -153.03 6.13 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.134 -0.939 . . . . 0.48999999999999999 111.499 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.17 118.66 37.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 122.977 0.511 . . . . 2.23 111.154 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -96.88 112.64 24.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.562 -0.903 . . . . 0.68999999999999995 108.562 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 60.9 m -102.93 123.41 46.51 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.917 -0.771 . . . . 0.34000000000000002 108.917 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 12' ' ' VAL . 54.2 tp -98.49 119.24 36.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.947 -0.76 . . . . 0.22 108.947 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 2.9 mm? -102.18 131.72 48.54 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.431 -0.804 . . . . 0.35999999999999999 109.104 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.74 120.61 31.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.706 -1.22 . . . . 0.31 107.706 173.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.21 132.04 55.89 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 123.448 0.468 . . . . 0.60999999999999999 111.526 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 37.5 p30 -145.06 174.03 3.81 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 107.8 -1.185 . . . . 1.1799999999999999 107.8 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 56.8 Cg_exo -48.05 -32.98 19.66 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.979 2.453 . . . . 1.0 115.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.38 -36.47 63.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.796 0.331 . . . . 1.1000000000000001 111.1 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.17 -166.42 38.26 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 119.761 -1.209 . . . . 0.58999999999999997 112.253 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 60.8 tt0 -128.41 135.59 49.73 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.707 -0.849 . . . . 1.5700000000000001 108.707 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.04 154.87 20.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 p -146.84 119.48 8.55 Favored 'General case' 0 N--CA 1.426 -1.649 0 O-C-N 123.618 0.574 . . . . 0.56999999999999995 111.149 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -126.03 148.34 49.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.416 -1.327 . . . . 0.29999999999999999 107.416 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.2 m -127.83 139.77 52.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 117.934 0.334 . . . . 1.26 111.465 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.51 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -133.64 123.9 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 109.149 -0.686 . . . . 0.71999999999999997 109.149 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 51.0 ttm -98.17 123.31 42.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.622 -0.51 . . . . 1.25 109.622 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -120.42 125.84 48.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.699 0.285 . . . . 0.57999999999999996 110.972 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 113.11 24.51 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.703 -0.851 . . . . 0.83999999999999997 108.703 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -92.64 -78.56 0.41 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.308 -0.406 . . . . 3.8599999999999999 111.471 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.22 163.01 32.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.338 -0.616 . . . . 4.7199999999999998 109.338 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 3.9 p-10 -61.61 153.37 28.03 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.128 0.892 . . . . 5.3300000000000001 111.732 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -94.43 109.62 44.0 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.309 -0.859 . . . . 5.3399999999999999 111.4 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 104' ' ' ASP . 4.8 Cg_exo -78.94 137.49 13.92 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.792 1.661 . . . . 5.0700000000000003 108.991 172.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 C--O 1.243 0.727 0 C-N-CA 124.415 1.086 . . . . 9.5199999999999996 111.131 -179.399 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 122.863 1.316 . . . . 7.9299999999999997 108.69 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.19 -48.43 1.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.892 -1.504 . . . . 6.1699999999999999 108.725 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -91.73 19.41 6.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.282 1.039 . . . . 5.4299999999999997 108.632 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.72 43.94 17.93 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.734 -1.58 . . . . 3.8700000000000001 106.734 -172.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.94 -50.58 18.67 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 111.693 -2.503 . . . . 2.5499999999999998 113.526 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 15.4 m -73.45 98.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 122.271 1.034 . . . . 2.0800000000000001 112.214 -175.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 108.121 -1.066 . . . . 1.5800000000000001 108.121 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 70.4 m-85 -104.27 132.59 50.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.118 -1.067 . . . . 1.1899999999999999 108.118 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 m -83.76 175.48 9.63 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.138 -1.06 . . . . 1.3200000000000001 108.138 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 124.19 38.31 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.869 -0.732 . . . . 0.45000000000000001 111.404 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 67.5 m -121.57 135.61 54.99 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.456 -1.313 . . . . 1.1899999999999999 107.456 172.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 94' ' ' ALA . 93.7 t -115.44 118.23 58.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.028 0.442 . . . . 0.28999999999999998 110.695 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -113.09 116.46 29.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.651 -1.24 . . . . 2.1800000000000002 107.651 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 98' ' ' ILE . 29.1 mt -100.39 156.63 17.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.16 0.505 . . . . 0.33000000000000002 111.841 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -131.31 144.49 51.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.693 -1.225 . . . . 1.03 107.693 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -63.73 139.3 58.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 124.241 0.963 . . . . 0.48999999999999999 108.97 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.42 141.78 29.41 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.045 0.841 . . . . 0.40000000000000002 111.072 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.04 130.69 39.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.542 0.687 . . . . 0.56999999999999995 109.978 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -76.89 111.19 12.17 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.433 -1.258 . . . . 2.52 112.385 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.0 ptt? -166.72 -172.89 2.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.538 -1.282 . . . . 0.88 107.538 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -75.78 -32.86 60.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.661 1.119 . . . . 2.75 111.063 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.438 ' O ' ' HG3' ' A' ' 20' ' ' MET . 61.3 m80 -99.0 122.07 41.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.448 -1.316 . . . . 2.46 107.448 176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -86.97 126.26 34.6 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.425 -0.91 . . . . 0.85999999999999999 113.365 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.65 121.66 32.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.17 -1.377 . . . . 0.29999999999999999 109.617 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 17' ' ' ALA . 53.8 mt -106.18 97.95 17.6 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.467 -1.308 . . . . 0.29999999999999999 107.467 173.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.3 138.66 27.9 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.631 2.221 . . . . 0.28000000000000003 112.141 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -134.29 159.14 41.89 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.964 0.411 . . . . 0.37 110.595 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -139.86 116.71 10.95 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.36 -0.836 . . . . 0.88 109.265 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.4 p -126.39 122.75 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.428 -0.953 . . . . 0.27000000000000002 108.428 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.2 p-10 -105.63 158.7 16.51 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.951 -1.1 . . . . 1.3899999999999999 111.13 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.11 165.64 13.34 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.752 -1.113 . . . . 0.59999999999999998 110.471 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 33' ' ' PRO 0.261 20.9 mm-40 -107.34 -52.1 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 118.942 -0.551 . . . . 2.6099999999999999 111.877 175.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.2 Cg_endo -61.55 120.47 8.12 Favored 'Trans proline' 0 C--N 1.367 1.51 0 N-CA-C 106.703 -2.076 . . . . 0.78000000000000003 106.703 165.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.19 114.18 11.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 O-C-N 123.55 0.531 . . . . 0.78000000000000003 112.115 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 86.6 Cg_endo -81.18 142.79 13.71 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.413 1.409 . . . . 0.56000000000000005 111.731 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 4.3 p -77.28 120.97 23.06 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.935 -0.765 . . . . 1.3700000000000001 108.935 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD21 HG11 ' A' ' 29' ' ' VAL . 93.6 mt -95.8 117.08 29.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.466 0.651 . . . . 0.5 110.477 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -125.95 134.81 51.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.926 -1.034 . . . . 3.7799999999999998 109.577 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -98.64 115.86 29.61 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.627 -0.508 . . . . 0.28999999999999998 109.627 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 20.8 tp -101.87 126.89 48.86 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 105.001 -2.222 . . . . 0.94999999999999996 105.001 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -122.78 108.88 13.53 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 108.995 -0.743 . . . . 0.88 108.995 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.97 34.44 21.53 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 123.94 0.775 . . . . 1.79 111.466 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.3 6.9 88.97 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.849 -0.614 . . . . 0.60999999999999999 112.586 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -116.24 147.15 41.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.024 -1.102 . . . . 1.3700000000000001 108.024 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.5 t -76.89 114.75 17.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.142 -1.058 . . . . 0.69999999999999996 108.142 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.96 118.24 18.53 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.702 -0.851 . . . . 0.60999999999999999 108.702 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -81.08 115.04 20.33 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.442 -0.577 . . . . 2.4700000000000002 109.442 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.26 108.01 5.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.51 -0.922 . . . . 1.74 108.51 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.2 p -104.13 -162.89 0.93 Allowed 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.553 -1.203 . . . . 1.5700000000000001 109.655 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -81.41 -26.59 35.27 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.857 -0.794 . . . . 1.52 108.857 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -79.04 -40.31 31.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.884 -0.598 . . . . 1.5900000000000001 110.268 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 72' ' ' LEU . 56.6 mt -120.26 105.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.79 -1.93 . . . . 0.5 105.79 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -139.29 140.51 37.64 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.328 -0.549 . . . . 2.8900000000000001 111.435 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -86.82 112.2 21.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.285 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -110.75 152.52 26.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.993 -0.743 . . . . 2.04 108.993 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -118.64 163.13 17.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 120.768 0.318 . . . . 0.87 110.815 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.92 140.9 52.52 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.873 -1.899 . . . . 1.25 105.873 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.21 116.75 30.29 Favored Pre-proline 0 C--N 1.296 -1.752 0 O-C-N 124.026 0.829 . . . . 3.3599999999999999 111.394 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.87 169.04 16.91 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.573 2.182 . . . . 1.3899999999999999 110.609 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.81 142.31 33.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.76 -15.24 61.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.559 0.577 . . . . 1.9099999999999999 112.559 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -98.49 8.11 45.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.27 -0.423 . . . . 3.4900000000000002 111.324 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.8 pt-20 -117.92 155.47 30.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.347 -0.983 . . . . 1.8899999999999999 108.347 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 p -106.51 8.35 31.36 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.201 0.524 . . . . 1.3 110.887 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 26.9 t -100.08 134.62 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.456 -0.793 . . . . 0.60999999999999999 109.824 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 29' ' ' VAL . 80.4 mtp180 -93.67 141.96 27.9 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.286 -1.376 . . . . 1.8400000000000001 107.286 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -124.29 139.58 53.78 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.927 -0.398 . . . . 1.1599999999999999 109.927 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.41 -179.44 42.49 Favored Glycine 0 N--CA 1.425 -2.079 0 C-N-CA 120.498 -0.858 . . . . 0.31 111.516 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 t -149.66 138.07 20.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.927 0.394 . . . . 0.35999999999999999 110.897 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.7 tp -80.32 106.91 12.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.25 -1.759 . . . . 0.28000000000000003 106.25 172.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -94.18 103.96 15.99 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.535 -0.757 . . . . 2.6800000000000002 109.809 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -94.64 109.51 21.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.601 -1.259 . . . . 1.23 107.601 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.66 -51.16 11.06 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.67 -1.15 . . . . 2.1800000000000002 109.469 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -111.64 101.84 52.01 Favored Pre-proline 0 N--CA 1.423 -1.778 0 N-CA-C 107.477 -1.305 . . . . 2.8199999999999998 107.477 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.9 130.65 6.71 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.288 1.992 . . . . 1.25 109.917 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -110.53 154.64 23.42 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -74.07 -5.4 41.38 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.694 -0.629 . . . . 2.0299999999999998 112.118 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.7 -10.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.3300000000000001 110.24 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 16.6 m120 -83.77 -1.62 54.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 2.1899999999999999 109.545 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -79.45 83.35 5.47 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.799 -1.186 . . . . 1.96 107.799 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.33 -150.64 6.7 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.924 -0.58 . . . . 0.48999999999999999 111.816 -176.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -107.72 124.13 49.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.701 0.286 . . . . 2.23 111.45 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 63.4 m-85 -100.27 113.39 26.06 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.742 -0.836 . . . . 0.68999999999999995 108.742 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.4 m -103.5 121.97 43.96 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.928 -1.138 . . . . 0.34000000000000002 107.928 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -99.9 119.9 38.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.734 -0.469 . . . . 0.22 109.734 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.56 136.16 44.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.388 -0.967 . . . . 0.35999999999999999 108.388 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.4 120.73 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.438 -1.319 . . . . 0.31 107.438 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 114.05 20.55 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.322 0.582 . . . . 0.60999999999999999 112.507 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 39.5 p30 -127.0 161.7 52.19 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 106.538 -1.652 . . . . 1.1799999999999999 106.538 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 4.5 Cg_exo -40.68 -38.65 2.72 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.895 3.063 . . . . 1.0 115.349 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.63 -34.35 75.6 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 112.488 0.551 . . . . 1.1000000000000001 112.488 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.21 170.95 36.67 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.816 -1.183 . . . . 0.58999999999999997 112.508 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -110.67 126.91 55.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.52 -0.918 . . . . 1.5700000000000001 108.52 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.64 155.27 18.41 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.449 -0.575 . . . . 0.37 109.449 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 p -150.95 128.69 11.58 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.651 0.594 . . . . 0.56999999999999995 110.68 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.77 159.88 41.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.586 -1.635 . . . . 0.29999999999999999 106.586 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 p -136.69 146.75 46.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.586 0.708 . . . . 1.26 112.653 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.519 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -134.97 122.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.713 -1.217 . . . . 0.71999999999999997 107.713 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -100.61 123.41 44.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.93 140.92 51.45 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.189 -0.3 . . . . 0.57999999999999996 110.189 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.15 142.69 28.77 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.741 -0.663 . . . . 0.83999999999999997 109.668 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.52 118.69 12.7 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.411 -0.588 . . . . 3.8599999999999999 109.411 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.9 ptp -105.84 97.13 6.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.939 0.876 . . . . 4.7199999999999998 110.369 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.1 129.2 44.92 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.285 -0.87 . . . . 5.3300000000000001 109.276 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -70.45 118.29 63.07 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 123.764 0.665 . . . . 5.3399999999999999 109.545 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.74 166.53 19.88 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.733 2.288 . . . . 5.0700000000000003 113.305 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--N 1.293 -1.878 0 CA-C-N 114.954 -1.021 . . . . 9.5199999999999996 109.407 179.51 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.664 0.745 . . . . 7.9299999999999997 109.886 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.03 140.04 50.33 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.737 -0.838 . . . . 6.1699999999999999 108.737 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.79 -19.6 61.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.645 0.591 . . . . 5.4299999999999997 110.311 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.11 140.31 36.57 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.853 -0.612 . . . . 3.8700000000000001 109.711 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.25 -17.57 18.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.644 0.735 . . . . 2.5499999999999998 110.322 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 m -86.73 98.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-O 122.811 1.291 . . . . 2.0800000000000001 112.131 -173.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.2 m -99.21 98.81 9.75 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 113.997 -1.456 . . . . 1.5800000000000001 107.704 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.435 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 40.3 m-85 -85.31 135.09 34.05 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.183 -0.917 . . . . 1.1899999999999999 109.39 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.7 m -84.71 176.65 8.42 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.97 -1.492 . . . . 1.3200000000000001 106.97 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 128.41 40.89 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.728 -0.789 . . . . 0.45000000000000001 111.408 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 23.3 t -115.33 136.58 52.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 106.464 -1.68 . . . . 1.1899999999999999 106.464 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 94' ' ' ALA . 99.5 t -115.69 116.14 51.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.025 0.44 . . . . 0.28999999999999998 110.129 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -117.0 116.29 27.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.656 -0.868 . . . . 2.1800000000000002 108.656 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.501 HD13 HG22 ' A' ' 98' ' ' ILE . 31.9 mt -97.41 156.18 16.58 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.725 -0.472 . . . . 0.33000000000000002 109.725 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -131.91 146.39 52.08 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.758 -1.571 . . . . 1.03 106.758 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.33 132.21 50.83 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.812 0.695 . . . . 0.48999999999999999 109.615 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.33 142.74 30.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.648 -1.16 . . . . 0.40000000000000002 112.107 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.21 130.4 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.543 -0.753 . . . . 0.56999999999999995 110.117 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' CH2' ' A' ' 23' ' ' TRP . 36.2 mt-10 -80.64 107.17 13.22 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.837 -1.074 . . . . 2.52 110.263 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 59.8 mtm -134.76 -165.81 1.72 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.41 -1.7 . . . . 0.88 106.41 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -66.02 -39.01 89.86 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.254 -1.017 . . . . 2.75 108.254 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 20' ' ' MET . 66.9 m170 -117.56 153.55 33.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.452 -1.684 . . . . 2.46 106.452 176.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.453 ' CH2' ' HG2' ' A' ' 19' ' ' GLU . 68.6 m95 -98.63 144.85 27.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.017 0.747 . . . . 0.85999999999999999 113.017 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -136.23 121.01 18.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.788 -1.096 . . . . 0.29999999999999999 109.384 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 17' ' ' ALA . 58.8 mt -103.38 100.31 17.94 Favored Pre-proline 0 C--O 1.24 0.562 0 N-CA-C 108.468 -0.938 . . . . 0.29999999999999999 108.468 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.66 132.91 16.45 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.324 2.016 . . . . 0.28000000000000003 111.85 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' A' ' 14' ' ' LEU . 53.8 p90 -128.47 152.26 48.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.993 0.425 . . . . 0.37 111.094 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 m -127.31 114.3 17.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.372 -0.973 . . . . 0.88 108.372 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.2 p -125.29 112.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.308 -0.627 . . . . 0.27000000000000002 109.308 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.2 p-10 -112.02 144.79 40.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.995 -0.682 . . . . 1.3899999999999999 110.316 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.24 165.48 32.57 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.637 -1.785 . . . . 0.59999999999999998 108.637 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 19.5 tm0? -91.4 -53.31 0.28 Allowed Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 117.519 0.659 . . . . 2.6099999999999999 109.999 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 3.2 Cg_exo -80.36 120.63 4.09 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 107.6 -1.731 . . . . 0.78000000000000003 107.6 170.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.5 115.67 10.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 123.779 0.674 . . . . 0.78000000000000003 111.763 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 87.7 Cg_endo -81.51 153.2 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.749 2.299 . . . . 0.56000000000000005 113.204 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 m -79.56 119.31 22.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.531 -1.285 . . . . 1.3700000000000001 107.531 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 127.41 39.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.927 0.394 . . . . 0.5 110.053 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -123.79 130.67 52.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.941 -0.763 . . . . 3.7799999999999998 108.941 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -94.57 119.86 33.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.127 0.489 . . . . 0.28999999999999998 109.948 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 26.3 tp -110.66 126.91 55.0 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.169 -1.419 . . . . 0.94999999999999996 107.169 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -116.48 106.9 14.11 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 110.204 -0.295 . . . . 0.88 110.204 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.39 35.2 25.51 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.227 1.011 . . . . 1.79 111.18 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.49 -18.17 57.96 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.777 -0.647 . . . . 0.60999999999999999 113.25 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.5 p -106.02 139.71 40.15 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.179 -0.6 . . . . 1.3700000000000001 110.375 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.14 128.12 28.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.904 -0.589 . . . . 0.69999999999999996 109.785 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -91.1 111.65 23.21 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.684 -0.689 . . . . 0.60999999999999999 109.269 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -85.04 135.13 34.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.115 -1.069 . . . . 2.4700000000000002 108.115 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.61 141.08 48.35 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.8 -0.445 . . . . 1.74 109.8 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -123.87 -163.79 1.17 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.284 -0.635 . . . . 1.5700000000000001 109.284 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -81.98 -17.44 46.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.831 -0.433 . . . . 1.52 109.831 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.11 -31.46 9.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.409 -0.36 . . . . 1.5900000000000001 111.405 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.3 mt -113.84 106.73 21.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 106.511 -1.663 . . . . 0.5 106.511 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.42 145.91 33.02 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.273 0.558 . . . . 2.8900000000000001 111.813 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -85.92 112.95 21.64 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.422 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -96.83 112.54 24.25 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.858 -0.61 . . . . 2.04 110.947 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.52 142.6 27.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.203 -1.036 . . . . 0.87 108.203 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.31 161.68 19.54 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.408 -1.33 . . . . 1.25 107.408 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 47.7 mt-10 -67.13 113.67 14.68 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 113.973 1.101 . . . . 3.3599999999999999 113.973 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.7 Cg_exo -80.56 157.72 21.98 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.085 2.524 . . . . 1.3899999999999999 109.61 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.6 145.57 31.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.737 -0.838 . . . . 1.53 108.737 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.03 0.76 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.689 0.756 . . . . 1.9099999999999999 111.236 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -123.01 9.55 9.36 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.307 -0.86 . . . . 3.4900000000000002 109.034 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.6 pt-20 -135.56 160.77 37.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.268 -1.382 . . . . 1.8899999999999999 107.268 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 p -118.71 34.71 5.09 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.936 0.875 . . . . 1.3 109.778 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 63' ' ' GLU . 18.7 t -109.43 127.18 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.196 -0.911 . . . . 0.60999999999999999 109.401 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.2 mtp180 -91.32 129.17 37.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.6 -1.629 . . . . 1.8400000000000001 106.6 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -114.06 134.99 54.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.386 -0.968 . . . . 1.1599999999999999 108.386 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.62 179.08 36.34 Favored Glycine 0 N--CA 1.408 -3.176 0 C-N-CA 119.73 -1.224 . . . . 0.31 111.714 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 4.7 t -144.61 132.79 21.66 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.83 0.852 . . . . 0.35999999999999999 109.932 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.1 tp -84.45 105.66 15.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.224 -2.139 . . . . 0.28000000000000003 105.224 170.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -100.46 123.83 45.19 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.045 -0.525 . . . . 2.6800000000000002 110.029 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.02 108.26 19.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.894 -1.15 . . . . 1.23 107.894 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -72.9 -35.46 67.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.514 -1.221 . . . . 2.1800000000000002 109.805 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.59 108.37 58.19 Favored Pre-proline 0 N--CA 1.423 -1.814 0 N-CA-C 107.243 -1.392 . . . . 2.8199999999999998 107.243 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.39 129.89 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.475 1.45 . . . . 1.25 109.915 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.405 ' HB ' HG22 ' A' ' 78' ' ' VAL . 17.9 p -126.19 141.11 52.06 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.114 0.483 . . . . 1.22 109.828 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.46 -18.39 48.84 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.144 -0.687 . . . . 2.0299999999999998 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 76' ' ' THR . 22.3 m -68.7 -12.01 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.238 -0.585 . . . . 1.3300000000000001 111.491 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.505 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 51.7 m-80 -111.62 25.99 11.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.47 0.652 . . . . 2.1899999999999999 111.386 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.18 104.37 16.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.304 -0.999 . . . . 1.96 108.304 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.05 26.29 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.039 -0.824 . . . . 0.48999999999999999 111.039 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -96.17 123.48 39.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.117 0.484 . . . . 2.23 111.361 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 97' ' ' SER . 8.0 m-85 -95.97 121.18 37.44 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.158 0.983 . . . . 0.68999999999999995 108.978 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 53.7 m -107.77 120.9 43.55 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.582 -0.896 . . . . 0.34000000000000002 108.582 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 95' ' ' SER . 54.0 tp -96.88 118.75 33.99 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.538 -0.912 . . . . 0.22 108.538 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.85 133.62 49.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.415 -0.957 . . . . 0.35999999999999999 108.415 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -122.07 119.7 32.16 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.417 -0.957 . . . . 0.31 108.417 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.98 131.38 54.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.42 -0.585 . . . . 0.60999999999999999 109.42 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 8.0 p30 -151.58 165.31 17.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 107.042 -1.466 . . . . 1.1799999999999999 107.042 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 Cg_endo -44.69 -40.58 14.33 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.473 2.782 . . . . 1.0 114.337 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.63 -27.28 61.19 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.85 0.685 . . . . 1.1000000000000001 112.85 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.48 -156.1 27.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.121 -1.038 . . . . 0.58999999999999997 112.178 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 28.7 tt0 -138.12 126.81 23.65 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.957 0.408 . . . . 1.5700000000000001 110.674 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.79 157.75 16.74 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.2 p -153.7 142.62 21.14 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 123.255 0.347 . . . . 0.56999999999999995 110.952 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -147.19 152.32 38.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.439 -1.319 . . . . 0.29999999999999999 107.439 175.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 37.8 m -128.77 141.16 51.4 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.103 0.411 . . . . 1.26 111.034 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.501 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.33 134.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.407 -0.96 . . . . 0.71999999999999997 108.407 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.9 ttm -99.42 119.96 38.84 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.929 -0.482 . . . . 1.25 109.782 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.9 116.58 30.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.503 -0.554 . . . . 0.57999999999999996 109.503 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.49 100.11 11.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.397 -0.964 . . . . 0.83999999999999997 108.397 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.64 -68.94 0.52 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.718 -1.128 . . . . 3.8599999999999999 110.104 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 66.7 mtt -132.41 151.25 51.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.198 -1.408 . . . . 4.7199999999999998 107.198 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.51 160.37 17.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.801 -0.815 . . . . 5.3300000000000001 108.801 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.62 111.3 56.74 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 116.093 -0.503 . . . . 5.3399999999999999 110.606 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.64 134.9 14.06 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.058 1.839 . . . . 5.0700000000000003 109.639 174.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 123.855 0.862 . . . . 9.5199999999999996 110.857 -178.247 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 108.105 -1.072 . . . . 7.9299999999999997 108.105 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.522 ' O ' HG22 ' A' ' 6' ' ' VAL . 5.2 m-20 -111.34 -10.35 14.23 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 122.168 -0.332 . . . . 6.1699999999999999 111.878 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.04 -39.81 28.8 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 116.029 1.863 . . . . 5.4299999999999997 116.029 -168.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.14 -30.38 43.58 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.88 -0.513 . . . . 3.8700000000000001 111.262 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.83 -37.92 18.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.394 -0.366 . . . . 2.5499999999999998 111.831 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 2' ' ' ASP . 13.1 m -71.05 99.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 122.564 1.173 . . . . 2.0800000000000001 110.465 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t -87.57 98.01 11.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 115.054 -0.975 . . . . 1.5800000000000001 108.598 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.2 m-85 -86.0 117.71 25.02 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 105.397 -2.075 . . . . 1.1899999999999999 105.397 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.7 m -83.22 -179.31 7.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.797 -0.816 . . . . 1.3200000000000001 108.797 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.31 126.01 38.21 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 119.606 -0.837 . . . . 0.45000000000000001 110.817 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 20.8 t -118.41 131.43 56.29 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.673 -1.232 . . . . 1.1899999999999999 107.673 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 90.4 t -114.5 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.886 -0.783 . . . . 0.28999999999999998 108.886 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.82 116.05 27.97 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.665 -1.235 . . . . 2.1800000000000002 107.665 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 98' ' ' ILE . 38.3 mt -99.48 156.82 16.83 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.511 -0.768 . . . . 0.33000000000000002 109.924 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -131.6 153.94 49.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.063 -0.517 . . . . 1.03 109.695 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -57.32 133.59 55.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.175 -1.375 . . . . 0.48999999999999999 110.36 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.59 141.4 58.78 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.649 -0.705 . . . . 0.40000000000000002 110.311 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -91.37 124.91 44.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.647 0.736 . . . . 0.56999999999999995 111.535 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.49 111.95 20.46 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.47 -1.241 . . . . 2.52 109.92 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -162.46 0.53 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.215 -1.402 . . . . 0.88 107.215 176.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -60.85 -28.93 69.2 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.618 1.099 . . . . 2.75 112.793 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -120.86 165.16 15.57 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.884 -1.524 . . . . 2.46 106.884 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -118.19 135.83 54.01 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.198 -0.667 . . . . 0.85999999999999999 109.198 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.76 131.69 35.85 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.552 -0.749 . . . . 0.29999999999999999 110.002 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.4 HD12 HD23 ' A' ' 70' ' ' LEU . 61.8 mt -104.65 106.24 53.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.383 -1.339 . . . . 0.29999999999999999 107.383 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.09 137.8 19.77 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.644 2.229 . . . . 0.28000000000000003 111.35 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 14' ' ' LEU . 55.1 p90 -140.01 146.47 39.1 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.227 0.537 . . . . 0.37 111.853 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.5 p -126.63 118.87 25.67 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 115.137 -0.938 . . . . 0.88 109.31 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -120.12 110.46 28.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.529 -0.915 . . . . 0.27000000000000002 108.529 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.8 p-10 -108.49 150.94 26.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.395 -0.522 . . . . 1.3899999999999999 110.504 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.36 144.35 3.91 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 108.493 -1.843 . . . . 0.59999999999999998 108.493 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.51 -53.25 2.06 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.472 -0.936 . . . . 2.6099999999999999 108.472 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 23.7 Cg_exo -67.26 120.96 8.04 Favored 'Trans proline' 0 C--N 1.379 2.168 0 N-CA-C 108.978 -1.201 . . . . 0.78000000000000003 108.978 171.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.95 87.88 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.735 -0.666 . . . . 0.78000000000000003 112.041 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -90.55 159.78 4.37 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.474 2.116 . . . . 0.56000000000000005 111.714 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -96.36 120.6 36.95 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.995 -1.483 . . . . 1.3700000000000001 106.995 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.56 159.08 19.97 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.667 0.27 . . . . 0.5 110.901 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -159.43 138.03 10.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.723 -0.843 . . . . 3.7799999999999998 108.723 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -105.72 129.89 53.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.215 0.531 . . . . 0.28999999999999998 111.361 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -109.33 137.35 47.32 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.839 -1.171 . . . . 0.94999999999999996 107.839 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -124.82 103.89 8.32 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.982 -1.118 . . . . 0.88 107.982 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 64.36 28.0 13.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.093 0.957 . . . . 1.79 110.358 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.8 71.53 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.12 -0.945 . . . . 0.60999999999999999 112.201 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -93.16 150.08 20.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.897 -0.779 . . . . 1.3700000000000001 108.897 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.89 115.82 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 116.164 -0.471 . . . . 0.69999999999999996 109.925 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -85.75 124.22 32.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.483 -1.303 . . . . 0.60999999999999999 107.483 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -102.15 126.14 49.04 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.625 -0.879 . . . . 2.4700000000000002 108.625 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 114.41 3.28 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.818 -0.808 . . . . 1.74 108.818 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -130.06 -170.8 2.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.451 -0.795 . . . . 1.5700000000000001 109.588 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -60.15 -32.72 71.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.173 0.589 . . . . 1.52 112.113 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -84.7 -36.8 21.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.399 0.518 . . . . 1.5900000000000001 112.399 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.401 HD11 HD21 ' A' ' 79' ' ' ASN . 14.2 mt -132.52 114.63 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.955 -1.128 . . . . 0.5 107.955 -171.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.74 155.54 48.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 118.895 0.771 . . . . 2.8900000000000001 111.518 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -98.62 110.37 22.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.44 109.87 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.82 120.76 43.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.559 -0.534 . . . . 2.04 109.559 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -97.01 153.56 17.84 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 116.09 -0.505 . . . . 0.87 109.81 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.98 159.86 14.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.126 -1.435 . . . . 1.25 107.126 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 61.6 mm-40 -72.91 115.14 37.21 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 123.576 0.547 . . . . 3.3599999999999999 110.273 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 3.7 Cg_exo -77.17 153.95 32.28 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.546 2.164 . . . . 1.3899999999999999 110.551 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.12 146.84 27.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.702 -1.221 . . . . 1.53 107.702 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.84 60.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.073 1.138 . . . . 1.9099999999999999 114.073 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.18 -0.42 46.89 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.526 -0.469 . . . . 3.4900000000000002 111.833 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -88.81 138.84 31.05 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.963 0.411 . . . . 1.8899999999999999 110.693 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -104.45 -2.06 25.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.431 -0.952 . . . . 1.3 108.431 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.0 128.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.351 -0.84 . . . . 0.60999999999999999 109.399 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.0 ttm-85 -108.88 124.18 50.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.004 -1.11 . . . . 1.8400000000000001 108.004 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -111.04 146.53 36.56 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.949 0.404 . . . . 1.1599999999999999 110.097 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.39 32.37 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.614 -0.994 . . . . 0.31 110.614 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 71' ' ' ARG . 4.6 t -138.05 131.67 30.98 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.65 -0.5 . . . . 0.35999999999999999 109.65 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.4 HD23 HD12 ' A' ' 25' ' ' ILE . 47.2 tp -91.32 94.86 9.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.116 -2.179 . . . . 0.28000000000000003 105.116 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . 15.5 ptm180 -99.93 126.4 46.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.498 -0.774 . . . . 2.6800000000000002 110.617 -174.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.91 113.05 25.16 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.948 0.88 . . . . 1.23 109.367 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -61.81 -49.52 76.0 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.18 -1.827 . . . . 2.1800000000000002 107.593 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -135.29 100.57 11.51 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 107.845 -1.168 . . . . 2.8199999999999998 107.845 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -83.65 141.96 10.07 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.123 1.882 . . . . 1.25 111.163 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 p -130.31 -178.73 4.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 118.98 -0.533 . . . . 1.22 111.598 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -69.47 -19.6 63.75 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.382 0.992 . . . . 2.0299999999999998 111.102 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 m -70.69 -10.67 14.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.3300000000000001 110.639 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.401 HD21 HD11 ' A' ' 52' ' ' ILE . 24.9 m120 -88.15 14.29 9.55 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.625 -0.716 . . . . 2.1899999999999999 112.844 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.56 93.64 9.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.301 -1.0 . . . . 1.96 108.301 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.19 -173.22 39.39 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.409 -0.9 . . . . 0.48999999999999999 112.127 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.35 122.8 36.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.17 0.51 . . . . 2.23 111.13 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 98' ' ' ILE . 22.0 m-85 -102.97 130.43 50.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.72 1.208 . . . . 0.68999999999999995 107.908 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -130.88 128.29 40.27 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.988 -0.445 . . . . 0.34000000000000002 109.955 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.451 ' CB ' HD11 ' A' ' 14' ' ' LEU . 50.5 tp -100.37 124.54 45.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.59 -0.893 . . . . 0.22 108.59 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.58 138.27 48.33 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.098 -1.075 . . . . 0.35999999999999999 108.098 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.3 119.5 34.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.818 -1.549 . . . . 0.31 106.818 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.68 125.41 40.24 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.043 -1.095 . . . . 0.60999999999999999 108.043 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -151.04 144.78 17.46 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.506 -1.664 . . . . 1.1799999999999999 106.506 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.62 -17.17 27.35 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 123.526 2.817 . . . . 1.0 113.986 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.3 t -89.65 -8.83 51.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 1.1000000000000001 110.348 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.16 157.02 7.32 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.147 -0.781 . . . . 0.58999999999999997 111.147 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 31.8 tt0 -90.65 133.66 34.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.088 -0.708 . . . . 1.5700000000000001 109.088 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.5 150.63 23.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.641 -0.874 . . . . 0.37 108.641 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -151.45 143.21 23.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 123.355 0.409 . . . . 0.56999999999999995 111.309 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.56 154.29 42.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.28 -1.378 . . . . 0.29999999999999999 107.28 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.8 t -119.71 132.37 55.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.46 0.648 . . . . 1.26 111.655 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -136.34 119.76 23.07 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 124.267 1.027 . . . . 0.71999999999999997 109.469 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -106.75 122.04 45.57 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.153 -0.684 . . . . 1.25 109.153 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.05 147.76 38.17 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.663 -0.415 . . . . 0.57999999999999996 110.34 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.26 120.11 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.409 -1.33 . . . . 0.83999999999999997 107.409 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 72.0 t80 -84.37 -72.8 0.45 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.632 -0.713 . . . . 3.8599999999999999 111.653 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.4 ptm -136.75 -177.25 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.587 -0.894 . . . . 4.7199999999999998 108.587 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.57 138.83 43.3 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.245 0.545 . . . . 5.3300000000000001 110.366 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -91.72 132.43 33.14 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.919 -0.582 . . . . 5.3399999999999999 110.953 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -65.95 117.95 5.08 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.77 2.313 . . . . 5.0700000000000003 110.066 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 . . . . . 0 N--CA 1.417 -2.118 0 CA-C-O 118.388 -0.815 . . . . 9.5199999999999996 109.038 -174.22 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 108.913 -0.773 . . . . 7.9299999999999997 108.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -160.91 128.72 4.35 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.887 -0.783 . . . . 6.1699999999999999 108.887 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.39 -0.82 8.7 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.087 -0.506 . . . . 5.4299999999999997 110.933 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 58.38 24.69 11.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.554 0.741 . . . . 3.8700000000000001 110.688 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -82.01 2.34 31.4 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.693 0.797 . . . . 2.5499999999999998 110.762 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 m -97.9 98.22 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 CA-C-O 122.389 1.09 . . . . 2.0800000000000001 108.599 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.1 m -110.54 98.52 7.7 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 115.079 -0.964 . . . . 1.5800000000000001 109.11 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 97.1 m-85 -89.16 136.35 33.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.706 -1.134 . . . . 1.1899999999999999 108.55 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.2 t -83.91 169.56 14.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.025 -1.472 . . . . 1.3200000000000001 107.025 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.92 112.82 24.72 Favored 'General case' 0 CA--C 1.489 -1.404 0 CA-C-O 121.068 0.461 . . . . 0.45000000000000001 110.63 -173.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.1 t -106.87 131.89 53.45 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.889 -1.152 . . . . 1.1899999999999999 107.889 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 94' ' ' ALA . 89.2 t -115.08 114.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.735 -0.469 . . . . 0.28999999999999998 109.735 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -113.14 116.16 29.41 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.501 -0.926 . . . . 2.1800000000000002 108.501 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 43.9 mt -101.77 150.67 22.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.929 -0.397 . . . . 0.33000000000000002 109.929 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.64 139.6 49.15 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.523 -0.917 . . . . 1.03 108.523 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -52.44 134.19 34.78 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.035 1.459 . . . . 0.48999999999999999 110.64 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -58.76 142.47 49.98 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.908 -1.042 . . . . 0.40000000000000002 111.072 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.51 125.89 44.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.491 0.662 . . . . 0.56999999999999995 110.418 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 114.43 12.03 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.616 -1.175 . . . . 2.52 111.345 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 23.9 ptt? -165.68 -177.28 4.27 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.635 1.174 . . . . 0.88 107.996 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -71.63 -31.73 67.18 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.193 1.36 . . . . 2.75 114.47 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.495 ' O ' ' HG3' ' A' ' 20' ' ' MET . 90.1 m-70 -112.04 125.71 54.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.564 -2.013 . . . . 2.46 105.564 173.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 75' ' ' PRO . 60.0 m95 -93.12 143.67 26.02 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 113.838 1.051 . . . . 0.85999999999999999 113.838 -168.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 t -134.66 125.6 27.44 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.001 -1.0 . . . . 0.29999999999999999 109.876 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.5 mt -106.8 101.19 35.59 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.513 -1.292 . . . . 0.29999999999999999 107.513 173.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.63 129.66 13.89 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.619 2.213 . . . . 0.28000000000000003 112.304 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -127.46 143.41 51.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.083 0.468 . . . . 0.37 110.518 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 m -127.18 116.12 20.14 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.551 -0.907 . . . . 0.88 108.551 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.96 121.33 57.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.55 -0.537 . . . . 0.27000000000000002 109.55 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 p-10 -115.69 148.09 40.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.566 -0.454 . . . . 1.3899999999999999 109.953 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.37 149.65 6.25 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 108.094 -2.003 . . . . 0.59999999999999998 108.094 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 11.2 tm0? -75.78 -54.79 2.11 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 118.014 0.907 . . . . 2.6099999999999999 109.111 -177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 6.4 Cg_exo -75.99 120.0 5.58 Favored 'Trans proline' 0 C--N 1.369 1.651 0 N-CA-C 107.38 -1.815 . . . . 0.78000000000000003 107.38 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.93 110.99 3.08 Favored Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 124.055 0.847 . . . . 0.78000000000000003 110.924 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.7 Cg_endo -74.47 146.05 34.5 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.213 1.942 . . . . 0.56000000000000005 112.37 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 24.5 t -74.52 111.0 9.27 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.363 -1.347 . . . . 1.3700000000000001 107.363 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 29' ' ' VAL . 80.3 mt -88.75 125.48 34.9 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.637 -0.711 . . . . 0.5 109.786 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 39' ' ' TRP . 16.4 tpp180 -137.08 137.55 39.43 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.828 -0.434 . . . . 3.7799999999999998 109.828 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.422 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 91.7 m95 -101.54 140.45 35.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.183 0.516 . . . . 0.28999999999999998 109.868 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 45' ' ' VAL . 12.3 tp -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.421 -2.066 . . . . 0.94999999999999996 105.421 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 79' ' ' ASN . 54.6 t80 -116.97 106.99 14.01 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.899 -0.408 . . . . 0.88 109.899 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 58.52 37.96 25.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.206 1.002 . . . . 1.79 110.839 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.72 -17.67 43.65 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.632 -0.713 . . . . 0.60999999999999999 113.023 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -93.36 135.82 34.22 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.993 -0.743 . . . . 1.3700000000000001 108.993 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' A' ' 40' ' ' LEU . 5.1 p -67.35 136.52 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 121.373 0.606 . . . . 0.69999999999999996 111.239 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 46.6 tp -92.2 124.25 36.14 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 116.16 -0.473 . . . . 0.60999999999999999 110.45 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.41 104.81 13.62 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 103.916 -2.624 . . . . 2.4700000000000002 103.916 167.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 2.0 pm0 -50.35 137.63 18.26 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.188 0.93 . . . . 1.74 112.504 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -118.48 -166.87 1.28 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.174 -0.921 . . . . 1.5700000000000001 110.467 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -67.17 -33.59 75.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.014 0.435 . . . . 1.52 111.58 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -88.61 -37.17 15.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.381 -0.372 . . . . 1.5900000000000001 111.702 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.452 HG23 ' HG ' ' A' ' 72' ' ' LEU . 21.5 mt -110.0 109.45 28.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.787 -1.19 . . . . 0.5 107.787 -174.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -136.26 138.19 41.53 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.689 -0.804 . . . . 2.8900000000000001 111.608 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -81.61 109.64 16.23 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.457 -0.792 . . . . 0.44 109.518 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -109.63 144.09 38.46 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.901 0.381 . . . . 2.04 110.914 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.13 153.76 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.041 -0.527 . . . . 0.87 109.629 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.45 155.85 38.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.904 -1.517 . . . . 1.25 106.904 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -74.58 121.68 85.8 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 114.534 1.309 . . . . 3.3599999999999999 114.534 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.92 154.4 22.87 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.823 2.348 . . . . 1.3899999999999999 109.622 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.64 176.26 9.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.164 -0.68 . . . . 1.53 109.164 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.12 89.9 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 119.043 0.838 . . . . 1.9099999999999999 112.384 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.78 -20.14 59.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.993 -0.549 . . . . 3.4900000000000002 110.531 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.0 113.15 19.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 120.376 -0.53 . . . . 1.8899999999999999 109.974 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 m -92.25 0.47 57.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.487 1.137 . . . . 1.3 108.089 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 t -91.42 129.06 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.532 -1.213 . . . . 0.60999999999999999 109.797 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB3' HG13 ' A' ' 29' ' ' VAL . 18.6 ttm180 -85.64 121.05 27.76 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.041 -1.837 . . . . 1.8400000000000001 106.041 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.69 131.24 54.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.095 -0.705 . . . . 1.1599999999999999 109.095 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.45 -177.52 35.54 Favored Glycine 0 N--CA 1.414 -2.791 0 C-N-CA 119.989 -1.101 . . . . 0.31 111.821 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.9 136.21 20.18 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.307 0.643 . . . . 0.35999999999999999 109.527 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 56.7 tp -84.58 98.34 10.1 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 104.451 -2.426 . . . . 0.28000000000000003 104.451 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -97.22 123.42 41.0 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.414 -0.812 . . . . 2.6800000000000002 110.759 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HG ' HG23 ' A' ' 52' ' ' ILE . 6.5 mp -102.11 109.31 20.99 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.673 -1.232 . . . . 1.23 107.673 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.43 -42.77 92.64 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.656 -1.611 . . . . 2.1800000000000002 109.965 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -133.17 124.98 18.69 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.274 -1.009 . . . . 2.8199999999999998 108.274 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 23' ' ' TRP . 30.9 Cg_endo -66.02 130.52 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.803 2.336 . . . . 1.25 112.036 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.4 p -109.39 141.84 41.2 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.831 -0.803 . . . . 1.22 108.831 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -80.99 -13.16 59.13 Favored 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 120.589 -0.445 . . . . 2.0299999999999998 110.038 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.32 -13.02 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 119.325 -0.95 . . . . 1.3300000000000001 111.83 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 18.1 m120 -108.48 23.01 15.15 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.957 1.095 . . . . 2.1899999999999999 113.957 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.45 HD21 ' HB3' ' A' ' 105' ' ' ASN . 19.0 p30 -86.26 64.27 8.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.034 0.921 . . . . 1.96 111.761 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.02 -148.12 4.96 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.11 -0.95 . . . . 0.48999999999999999 111.994 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -102.93 116.76 33.18 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.354 0.597 . . . . 2.23 112.603 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 51.4 m-85 -94.91 140.28 30.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.763 -0.828 . . . . 0.68999999999999995 108.763 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.0 m -128.8 127.71 42.49 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 108.46 -0.941 . . . . 0.34000000000000002 108.46 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.9 tp -101.6 122.94 44.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.067 -0.716 . . . . 0.22 109.067 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.13 131.48 55.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.686 -1.227 . . . . 0.35999999999999999 107.686 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.01 120.11 36.25 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.51 -0.922 . . . . 0.31 108.51 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' SER . . . -96.28 115.51 27.55 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.594 0.559 . . . . 0.60999999999999999 110.64 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -134.82 150.76 74.25 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-O 117.76 -1.114 . . . . 1.1799999999999999 108.211 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.09 -42.15 21.2 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.478 2.119 . . . . 1.0 112.243 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.5 t -57.2 -32.69 66.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 1.1000000000000001 112.01 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.1 178.57 26.93 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 109.867 -1.293 . . . . 0.58999999999999997 109.867 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -106.36 129.82 54.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.385 -0.598 . . . . 1.5700000000000001 109.385 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.83 152.86 20.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.005 -0.739 . . . . 0.37 109.005 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 24.8 p -141.05 146.35 37.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.924 0.392 . . . . 0.56999999999999995 111.251 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.27 43.36 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.738 -1.208 . . . . 0.29999999999999999 107.738 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 t -122.91 127.81 49.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.7 -0.481 . . . . 1.26 109.7 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.6 123.85 38.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.77 -0.826 . . . . 0.71999999999999997 108.77 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.0 mtp -101.73 110.62 22.64 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.2 -0.6 . . . . 1.25 110.285 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.89 133.46 38.59 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.779 -0.646 . . . . 0.57999999999999996 110.513 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.47 100.63 6.33 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.15 -1.056 . . . . 0.83999999999999997 108.15 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 72' ' ' LEU . 33.0 m-85 -78.02 -70.87 0.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.807 -1.182 . . . . 3.8599999999999999 107.807 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 20.1 ptp -127.68 136.06 51.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 104.415 -2.439 . . . . 4.7199999999999998 104.415 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.52 141.63 58.4 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 123.525 0.516 . . . . 5.3300000000000001 110.103 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.45 ' HB3' HD21 ' A' ' 80' ' ' ASN . 5.8 p30 -72.27 113.2 18.59 Favored Pre-proline 0 CA--C 1.51 -0.559 0 O-C-N 123.906 0.754 . . . . 5.3399999999999999 112.332 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -82.14 178.14 6.62 Favored 'Trans proline' 0 N--CA 1.424 -2.59 0 C-N-CA 121.748 1.632 . . . . 5.0700000000000003 111.42 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 114.985 -1.007 . . . . 9.5199999999999996 108.348 -176.612 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 CA--C 1.497 -1.09 0 N-CA-C 108.779 -0.823 . . . . 7.9299999999999997 108.779 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 t70 68.65 17.57 8.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.395 1.478 . . . . 6.1699999999999999 110.235 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 6' ' ' VAL . 15.2 m-20 -80.19 -19.09 47.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.976 -1.466 . . . . 5.4299999999999997 107.461 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.29 -15.47 61.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.043 -1.435 . . . . 3.8700000000000001 111.083 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.9 -19.72 64.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.591 0.589 . . . . 2.5499999999999998 112.591 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 3' ' ' ASP . 31.1 m -68.34 99.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 123.299 1.523 . . . . 2.0800000000000001 108.541 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.2 m -97.77 98.67 10.04 Favored 'General case' 0 N--CA 1.381 -3.894 0 CA-C-N 113.882 -1.508 . . . . 1.5800000000000001 113.781 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.27 126.57 52.97 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 112.878 -1.965 . . . . 1.1899999999999999 105.96 171.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.68 174.17 10.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.753 -1.573 . . . . 1.3200000000000001 106.753 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.09 129.23 40.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 118.882 -1.127 . . . . 0.45000000000000001 110.501 -174.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 m -122.03 135.83 54.87 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.798 -1.186 . . . . 1.1899999999999999 107.798 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.6 t -115.82 123.23 70.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.001 0.429 . . . . 0.28999999999999998 111.073 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -115.13 139.72 49.66 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.338 -0.986 . . . . 2.1800000000000002 108.338 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 98' ' ' ILE . 36.1 mt -129.85 156.88 43.64 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.348 -0.612 . . . . 0.33000000000000002 109.348 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -130.7 143.16 50.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.185 -1.043 . . . . 1.03 108.185 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 134.59 56.14 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.496 1.122 . . . . 0.48999999999999999 109.693 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.31 139.84 58.81 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 124.003 0.815 . . . . 0.40000000000000002 110.638 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.32 134.04 31.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.976 0.417 . . . . 0.56999999999999995 111.542 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 92.26 0.34 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.32 -0.855 . . . . 2.52 112.415 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.8 ptt? -144.93 -177.09 5.35 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -64.1 -41.68 97.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.205 0.817 . . . . 2.75 113.205 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.9 p-80 -112.44 129.24 56.39 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.052 -1.462 . . . . 2.46 107.052 173.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -82.74 147.79 28.23 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 120.849 0.357 . . . . 0.85999999999999999 111.642 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -137.59 120.26 16.21 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.44 -0.8 . . . . 0.29999999999999999 110.142 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.4 mt -106.93 97.41 17.61 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.637 -1.245 . . . . 0.29999999999999999 107.637 173.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.76 131.8 17.69 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 123.125 2.55 . . . . 0.28000000000000003 112.602 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.62 154.91 39.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.333 0.587 . . . . 0.37 110.844 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 m -140.14 121.83 15.33 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.617 -0.882 . . . . 0.88 108.617 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.3 p -124.07 111.7 29.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.744 -0.835 . . . . 0.27000000000000002 108.744 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.7 p-10 -106.85 147.25 29.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.026 -0.534 . . . . 1.3899999999999999 111.309 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 -170.77 32.64 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.06 -1.216 . . . . 0.59999999999999998 110.06 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -122.55 -51.94 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.456 0.91 . . . . 2.6099999999999999 113.456 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.01 121.32 9.62 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 107.854 -1.633 . . . . 0.78000000000000003 107.854 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.43 111.03 6.24 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 123.765 0.666 . . . . 0.78000000000000003 111.111 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 71.7 Cg_endo -84.47 146.65 10.96 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.841 1.694 . . . . 0.56000000000000005 111.842 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 22.9 t -79.57 121.96 25.9 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.715 -1.587 . . . . 1.3700000000000001 106.715 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -96.51 129.72 43.82 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.639 0.587 . . . . 0.5 109.734 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -136.58 134.7 37.71 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.116 -0.493 . . . . 3.7799999999999998 110.968 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.85 34.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.617 -0.882 . . . . 0.28999999999999998 108.617 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.86 130.91 52.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.086 -1.45 . . . . 0.94999999999999996 107.086 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 87.2 t80 -120.8 103.72 9.31 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.049 -0.723 . . . . 0.88 109.049 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 56.86 33.59 23.38 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.662 0.785 . . . . 1.79 111.923 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.83 82.95 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.687 -0.768 . . . . 0.60999999999999999 112.895 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 t -105.77 146.69 29.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.976 -1.12 . . . . 1.3700000000000001 107.976 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.88 123.8 36.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.75 106.53 12.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.263 -0.643 . . . . 0.60999999999999999 109.263 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.8 131.41 34.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.585 -0.895 . . . . 2.4700000000000002 108.585 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.01 149.31 47.84 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.273 0.559 . . . . 1.74 111.268 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -145.6 -169.33 3.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 114.938 -1.028 . . . . 1.5700000000000001 108.768 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 t -72.25 -25.18 61.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.429 0.633 . . . . 1.52 109.987 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 95.9 m-85 -101.52 -12.09 18.79 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.437 0.903 . . . . 1.5900000000000001 113.437 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' ND2' ' A' ' 79' ' ' ASN . 44.4 mt -135.75 107.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.311 -1.737 . . . . 0.5 106.311 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -141.45 142.33 33.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 112.308 0.485 . . . . 2.8900000000000001 112.308 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 m -88.79 109.49 20.22 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.644 -0.707 . . . . 0.44 109.499 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.671 ' HG3' ' HE ' ' A' ' 71' ' ' ARG . 6.7 mm-40 -92.98 124.05 36.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.391 0.615 . . . . 2.04 110.883 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.31 120.5 40.03 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.148 -1.427 . . . . 0.87 107.148 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 pp -84.31 155.79 22.22 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 106.836 -1.542 . . . . 1.25 106.836 177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.0 105.97 3.4 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 124.138 0.899 . . . . 3.3599999999999999 110.407 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 79.4 Cg_endo -88.25 169.68 6.05 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.137 2.558 . . . . 1.3899999999999999 111.051 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -93.87 139.62 30.67 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.656 -1.238 . . . . 1.53 107.656 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.54 15.11 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.513 0.673 . . . . 1.9099999999999999 111.413 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.85 -25.62 32.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.069 -0.968 . . . . 3.4900000000000002 109.829 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.8 pt-20 -97.26 139.4 33.28 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.583 -0.895 . . . . 1.8899999999999999 108.583 -177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -88.12 13.59 10.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.96 0.886 . . . . 1.3 109.94 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.6 t -119.57 132.05 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.724 -0.671 . . . . 0.60999999999999999 110.259 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.54 ' HB2' HG13 ' A' ' 29' ' ' VAL . 22.8 mtp180 -95.39 136.23 36.02 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.654 -1.61 . . . . 1.8400000000000001 106.654 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -125.41 157.74 36.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.163 -0.68 . . . . 1.1599999999999999 109.163 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.2 -168.24 38.84 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 111.264 -0.734 . . . . 0.31 111.264 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.29 138.41 16.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 123.001 0.52 . . . . 0.35999999999999999 111.335 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.13 109.83 20.19 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.81 -1.552 . . . . 0.28000000000000003 106.81 172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.671 ' HE ' ' HG3' ' A' ' 55' ' ' GLU . 76.0 mtm180 -102.28 131.56 48.78 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.795 -0.362 . . . . 2.6800000000000002 111.574 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.1 mp -119.83 109.56 15.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.777 -0.823 . . . . 1.23 108.777 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.84 -10.61 59.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.759 -0.655 . . . . 2.1800000000000002 111.184 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 33.3 tt0 -135.09 101.49 11.33 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 108.114 -1.069 . . . . 2.8199999999999998 108.114 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -88.26 129.59 2.35 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.591 1.528 . . . . 1.25 110.368 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.7 p -136.54 173.15 12.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.842 -0.799 . . . . 1.22 108.842 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -78.79 -5.67 53.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.113 0.412 . . . . 2.0299999999999998 112.113 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.02 -9.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.611 . . . . 1.3300000000000001 109.349 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.4 m120 -104.81 22.06 15.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.005 -1.109 . . . . 2.1899999999999999 108.005 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -114.17 117.44 31.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.799 -0.815 . . . . 1.96 108.799 -175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.27 -153.52 24.68 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.637 -1.268 . . . . 0.48999999999999999 113.18 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 45.8 m-80 -87.28 120.66 28.79 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.55 -0.325 . . . . 2.23 111.406 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 98' ' ' ILE . 39.4 m-85 -105.56 118.28 36.16 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.311 -0.996 . . . . 0.68999999999999995 108.311 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 m -122.96 125.02 44.49 Favored 'General case' 0 C--N 1.283 -2.3 0 O-C-N 121.611 -0.681 . . . . 0.34000000000000002 109.775 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.434 HD23 HG13 ' A' ' 12' ' ' VAL . 59.0 tp -97.39 117.54 31.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.43 133.2 52.29 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.467 -0.938 . . . . 0.35999999999999999 108.467 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -122.16 120.03 33.03 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.719 -1.215 . . . . 0.31 107.719 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.88 132.53 55.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.962 -0.755 . . . . 0.60999999999999999 108.962 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 91' ' ' CYS . 8.7 p30 -152.62 170.43 8.1 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-O 118.474 -0.774 . . . . 1.1799999999999999 109.257 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.48 -39.15 54.92 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.85 2.367 . . . . 1.0 114.465 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.438 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 27.0 t -70.0 -32.06 70.06 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-O 121.224 0.535 . . . . 1.1000000000000001 111.832 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.19 -146.03 11.75 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 119.864 -1.16 . . . . 0.58999999999999997 111.969 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.63 138.63 38.03 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.146 -0.687 . . . . 1.5700000000000001 109.146 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -119.81 146.63 45.52 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.965 -1.124 . . . . 0.37 107.965 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 p -143.74 152.85 41.78 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 121.006 -0.277 . . . . 0.56999999999999995 110.275 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.58 144.92 26.52 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.86 -1.533 . . . . 0.29999999999999999 106.86 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -122.44 145.72 48.03 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.472 0.654 . . . . 1.26 112.358 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.755 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -133.64 124.76 48.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 125.475 1.51 . . . . 0.71999999999999997 108.572 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 tpt -96.34 96.52 8.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.687 -1.227 . . . . 1.25 107.687 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.02 113.16 26.16 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.349 0.595 . . . . 0.57999999999999996 111.44 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.31 99.62 9.01 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 107.093 -1.447 . . . . 0.83999999999999997 107.093 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -79.92 -24.65 40.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.209 1.188 . . . . 3.8599999999999999 114.209 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 87.2 mmm -137.98 143.91 40.89 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.848 -1.538 . . . . 4.7199999999999998 106.848 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.21 110.01 12.82 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.68 -1.6 . . . . 5.3300000000000001 106.68 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.37 113.02 38.46 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 115.191 -0.913 . . . . 5.3399999999999999 112.083 -172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.44 124.4 9.36 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.092 1.862 . . . . 5.0700000000000003 109.354 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 C--N 1.314 -0.953 0 C-N-CA 124.709 1.204 . . . . 9.5199999999999996 110.528 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.5 -0.963 0 CA-C-O 121.033 0.444 . . . . 7.9299999999999997 110.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -131.62 99.54 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.956 -0.757 . . . . 6.1699999999999999 108.956 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.87 -29.56 32.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.556 -1.276 . . . . 5.4299999999999997 107.556 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.64 123.67 25.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.401 -1.272 . . . . 3.8700000000000001 109.181 175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.6 -15.94 53.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.868 0.842 . . . . 2.5499999999999998 109.546 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 m -71.98 99.88 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.945 -1.025 . . . . 2.0800000000000001 111.223 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.4 p -97.73 107.73 20.29 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.335 -0.848 . . . . 1.5800000000000001 109.999 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.2 m-85 -86.52 127.92 34.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.818 -1.083 . . . . 1.1899999999999999 109.587 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.2 t -84.68 176.47 8.55 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.557 -1.275 . . . . 1.3200000000000001 107.557 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.11 114.57 26.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 120.357 -0.537 . . . . 0.45000000000000001 110.55 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.642 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 34.1 t -117.68 131.31 56.65 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.743 -1.206 . . . . 1.1899999999999999 107.743 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.53 121.26 67.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.507 -0.315 . . . . 0.28999999999999998 110.936 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -121.1 123.42 42.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.569 -0.53 . . . . 2.1800000000000002 109.569 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 27' ' ' PHE . 43.8 mt -105.87 156.02 18.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.33000000000000002 109.937 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.53 151.92 51.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 110.455 -0.202 . . . . 1.03 110.455 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -54.05 133.16 43.68 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 124.786 1.304 . . . . 0.48999999999999999 110.4 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -66.49 145.55 55.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.625 -0.716 . . . . 0.40000000000000002 110.213 -177.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.68 127.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.518 0.675 . . . . 0.56999999999999995 112.745 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.74 108.83 4.08 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 114.281 -1.327 . . . . 2.52 110.926 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -170.61 -171.7 1.1 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.93 -1.507 . . . . 0.88 106.93 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -66.52 -50.59 62.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.393 -0.523 . . . . 2.75 111.982 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -92.39 120.13 32.6 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -82.32 120.11 24.99 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.271 0.557 . . . . 0.85999999999999999 111.023 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.8 121.96 44.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.612 -1.176 . . . . 0.29999999999999999 109.138 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.4 mt -103.73 103.74 38.45 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 108.054 -1.091 . . . . 0.29999999999999999 108.054 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.25 130.48 13.06 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.456 2.104 . . . . 0.28000000000000003 111.85 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.502 ' HB3' HD23 ' A' ' 14' ' ' LEU . 43.1 p90 -135.35 162.2 33.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.318 0.58 . . . . 0.37 110.482 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.0 m -144.62 123.48 12.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.651 -0.704 . . . . 0.88 109.157 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.7 p -123.6 114.69 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.079 -0.964 . . . . 0.27000000000000002 108.495 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.642 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 4.1 p-10 -102.25 158.49 16.15 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.736 -1.186 . . . . 1.3899999999999999 109.755 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.98 138.72 2.61 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.795 -1.322 . . . . 0.59999999999999998 109.795 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -87.32 -49.6 0.45 Allowed Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 119.571 -0.852 . . . . 2.6099999999999999 110.316 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.6 Cg_exo -64.17 119.48 6.54 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 105.255 -2.633 . . . . 0.78000000000000003 105.255 164.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.17 117.79 59.78 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 116.138 -0.483 . . . . 0.78000000000000003 112.296 -171.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -85.89 149.53 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.398 2.065 . . . . 0.56000000000000005 111.941 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -90.91 138.81 31.31 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.77 -1.196 . . . . 1.3700000000000001 107.77 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.424 ' HB3' HD11 ' A' ' 85' ' ' LEU . 80.9 mt -98.23 134.06 41.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.938 0.399 . . . . 0.5 111.094 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -130.29 126.22 36.69 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.037 -0.529 . . . . 3.7799999999999998 110.064 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -96.78 124.33 40.72 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.599 -0.728 . . . . 0.28999999999999998 109.702 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.97 128.8 55.61 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.492 -0.929 . . . . 0.94999999999999996 108.492 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -105.01 104.64 14.41 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.169 -1.419 . . . . 0.88 107.169 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.08 30.76 19.65 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.801 0.81 . . . . 1.79 110.961 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.04 64.25 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.39 -0.823 . . . . 0.60999999999999999 112.392 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -91.45 150.8 21.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.212 -1.032 . . . . 1.3700000000000001 108.212 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -72.33 121.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.818 -0.628 . . . . 0.69999999999999996 111.345 -175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -102.66 122.45 44.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.664 -1.235 . . . . 0.60999999999999999 107.664 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.81 138.32 35.35 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.773 -0.825 . . . . 2.4700000000000002 108.773 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -75.84 106.15 7.26 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.329 -0.396 . . . . 1.74 110.214 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -88.28 -170.37 2.93 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.852 -0.425 . . . . 1.5700000000000001 109.852 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -80.12 -13.61 59.14 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.56 -0.713 . . . . 1.52 109.517 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -97.94 -40.1 8.64 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.695 -0.684 . . . . 1.5900000000000001 110.137 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HG ' ' A' ' 72' ' ' LEU . 37.5 mt -107.12 104.89 17.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.972 -2.232 . . . . 0.5 104.972 174.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -135.09 149.52 50.07 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.378 -0.929 . . . . 2.8900000000000001 112.078 -173.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.9 m -94.36 109.62 21.45 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.357 -0.979 . . . . 0.44 108.357 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -100.75 123.79 45.46 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.544 -0.91 . . . . 2.04 108.544 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -100.4 146.17 27.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.716 -0.846 . . . . 0.87 108.716 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.15 154.5 32.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.833 -1.173 . . . . 1.25 107.833 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.49 120.43 81.45 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 123.94 0.775 . . . . 3.3599999999999999 110.203 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.94 169.53 16.26 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.873 2.382 . . . . 1.3899999999999999 109.936 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.73 141.2 38.06 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.315 -1.735 . . . . 1.53 106.315 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.93 -25.35 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.107 1.521 . . . . 1.9099999999999999 115.107 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -73.5 -32.05 64.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.087 0.47 . . . . 3.4900000000000002 110.411 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -75.23 142.36 43.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.251 0.548 . . . . 1.8899999999999999 110.1 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 m -111.29 18.03 19.66 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.382 -1.71 . . . . 1.3 106.382 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.81 121.36 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 113.819 -1.537 . . . . 0.60999999999999999 108.45 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 77.6 ttt180 -93.14 111.39 23.01 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.173 -1.417 . . . . 1.8400000000000001 107.173 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -101.61 155.65 17.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.46 -0.57 . . . . 1.1599999999999999 109.46 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.28 -174.74 44.83 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.278 -0.963 . . . . 0.31 112.092 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.4 t -145.3 134.85 23.27 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.177 0.591 . . . . 0.35999999999999999 111.025 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.0 tp -88.63 107.59 19.0 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.103 -2.184 . . . . 0.28000000000000003 105.103 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -117.91 130.41 56.22 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.432 0.634 . . . . 2.6800000000000002 111.228 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.8 mp -102.44 114.79 29.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.928 -1.033 . . . . 1.23 110.802 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -68.33 -39.35 81.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.769 -1.105 . . . . 2.1800000000000002 109.019 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.34 100.45 49.86 Favored Pre-proline 0 N--CA 1.435 -1.214 0 N-CA-C 107.897 -1.149 . . . . 2.8199999999999998 107.897 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.6 135.45 24.05 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 122.652 2.234 . . . . 1.25 109.451 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -133.43 149.19 51.79 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.033 0.444 . . . . 1.22 111.514 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -70.14 -4.21 20.31 Favored 'General case' 0 C--O 1.208 -1.085 0 C-N-CA 123.822 0.849 . . . . 2.0299999999999998 112.117 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.06 -9.78 11.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.416 -0.356 . . . . 1.3300000000000001 110.178 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.586 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.6 m-80 -115.96 26.48 9.94 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.549 0.944 . . . . 2.1899999999999999 113.549 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -94.32 72.81 3.88 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.075 0.941 . . . . 1.96 110.011 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.5 -153.11 5.88 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.701 -0.761 . . . . 0.48999999999999999 113.206 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.35 123.84 43.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.967 -0.383 . . . . 2.23 109.967 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 27.8 m-85 -101.33 116.57 33.1 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.012 -0.736 . . . . 0.68999999999999995 109.012 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.9 m -110.72 122.32 47.5 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.192 -1.04 . . . . 0.34000000000000002 108.192 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.4 tp -99.01 119.2 37.4 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.135 -0.484 . . . . 0.22 109.811 -178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 129.38 53.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.554 -0.906 . . . . 0.35999999999999999 108.554 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.47 120.99 33.61 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.326 -1.361 . . . . 0.31 107.326 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.04 124.8 46.77 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.457 -0.497 . . . . 0.60999999999999999 111.492 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 43.9 p30 -138.47 171.1 8.8 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.181 -1.414 . . . . 1.1799999999999999 107.181 174.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 38.9 Cg_exo -45.35 -37.48 14.22 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.043 2.495 . . . . 1.0 114.648 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.04 -49.62 73.84 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.671 0.272 . . . . 1.1000000000000001 110.824 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.67 -177.65 48.03 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.131 -1.033 . . . . 0.58999999999999997 111.816 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -108.1 122.58 47.19 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.992 -1.114 . . . . 1.5700000000000001 107.992 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.88 149.09 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.397 -0.964 . . . . 0.37 108.397 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.1 p -147.42 140.84 25.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 O-C-N 123.464 0.477 . . . . 0.56999999999999995 110.883 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.17 42.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.318 -1.364 . . . . 0.29999999999999999 107.318 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.9 p -130.15 146.35 51.78 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.13 0.49 . . . . 1.26 111.842 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -145.57 138.6 21.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.621 -1.622 . . . . 0.71999999999999997 106.621 178.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -111.12 124.1 51.52 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 1.25 110.336 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.62 115.31 25.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.493 -0.558 . . . . 0.57999999999999996 109.493 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.43 111.65 23.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.982 -0.554 . . . . 0.83999999999999997 110.303 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -149.24 121.08 8.14 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.555 0.693 . . . . 3.8599999999999999 111.636 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.6 mtt -103.03 132.94 48.93 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 4.7199999999999998 108.117 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -97.44 143.53 28.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.589 -1.263 . . . . 5.3300000000000001 107.589 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -117.89 99.82 52.12 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 106.77 -1.567 . . . . 5.3399999999999999 106.77 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.73 172.33 10.74 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.051 1.834 . . . . 5.0700000000000003 114.228 -175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.409 -2.508 0 CA-C-N 114.051 -1.431 . . . . 9.5199999999999996 108.631 -173.332 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.648 0.261 . . . . 7.9299999999999997 110.471 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -97.59 62.36 1.68 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.846 -1.168 . . . . 6.1699999999999999 107.846 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -103.8 30.55 5.02 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.413 -0.812 . . . . 5.4299999999999997 112.937 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.24 121.72 31.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.313 -1.366 . . . . 3.8700000000000001 107.313 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.97 -15.58 63.12 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.515 -0.766 . . . . 2.5499999999999998 111.579 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.07 98.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 107.633 -1.247 . . . . 2.0800000000000001 107.633 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 p -81.44 99.4 8.71 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.424 -0.807 . . . . 1.5800000000000001 109.446 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.34 124.89 24.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.875 -1.057 . . . . 1.1899999999999999 110.992 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 20.6 t -84.46 160.97 20.45 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.428 -1.693 . . . . 1.3200000000000001 106.428 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.51 121.24 35.86 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.776 -0.77 . . . . 0.45000000000000001 111.42 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -112.3 141.88 45.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.454 -1.313 . . . . 1.1899999999999999 107.454 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.8 t -115.36 114.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 110.056 -0.349 . . . . 0.28999999999999998 110.056 -176.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.35 116.4 30.29 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.379 0.609 . . . . 2.1800000000000002 109.55 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 98' ' ' ILE . 70.7 mt -104.87 156.81 17.68 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.96 -1.018 . . . . 0.33000000000000002 109.035 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -131.13 156.52 45.14 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.762 -0.829 . . . . 1.03 108.762 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -65.08 134.76 54.51 Favored 'General case' 0 N--CA 1.423 -1.806 0 O-C-N 124.456 1.097 . . . . 0.48999999999999999 109.63 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.41 140.9 56.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.25 -0.886 . . . . 0.40000000000000002 109.684 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.67 132.97 33.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.547 0.689 . . . . 0.56999999999999995 110.652 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.44 102.39 2.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.427 -1.261 . . . . 2.52 112.465 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -161.37 -179.42 7.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.812 -1.551 . . . . 0.88 106.812 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -64.55 -37.66 88.34 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.468 1.031 . . . . 2.75 113.401 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -107.22 117.91 35.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.906 -1.516 . . . . 2.46 106.906 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.452 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.3 m95 -82.05 125.55 30.96 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.159 -0.616 . . . . 0.85999999999999999 110.681 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -108.67 121.43 45.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.146 -1.057 . . . . 0.29999999999999999 108.146 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.3 mt -102.89 98.11 10.77 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 107.693 -1.225 . . . . 0.29999999999999999 107.693 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.92 132.08 19.33 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.392 2.061 . . . . 0.28000000000000003 112.056 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -128.69 152.79 48.0 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.327 0.584 . . . . 0.37 110.481 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 48.7 m -142.18 120.63 12.42 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.265 -0.88 . . . . 0.88 108.927 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -124.61 121.16 60.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.335 -0.987 . . . . 0.27000000000000002 108.335 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 p-10 -111.55 145.49 39.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.737 -0.785 . . . . 1.3899999999999999 110.204 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.62 4.73 Favored Glycine 0 C--N 1.298 -1.529 0 N-CA-C 107.504 -2.238 . . . . 0.59999999999999998 107.504 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' HD3' ' A' ' 33' ' ' PRO 0.278 46.1 tt0 -80.87 -57.43 0.58 Allowed Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 118.649 1.224 . . . . 2.6099999999999999 113.168 -175.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 32.4 Cg_exo -63.69 119.74 6.89 Favored 'Trans proline' 0 C--N 1.367 1.509 0 N-CA-C 106.28 -2.239 . . . . 0.78000000000000003 106.28 168.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.93 109.84 2.86 Favored Pre-proline 0 C--N 1.315 -0.923 0 O-C-N 123.806 0.691 . . . . 0.78000000000000003 111.076 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 59.1 Cg_endo -71.16 141.67 40.14 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.162 1.908 . . . . 0.56000000000000005 112.512 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -71.26 104.24 3.07 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.463 -0.79 . . . . 1.3700000000000001 108.952 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 29' ' ' VAL . 96.0 mt -81.78 134.03 35.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.352 -0.84 . . . . 0.5 109.813 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -146.39 138.59 25.03 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 123.687 0.795 . . . . 3.7799999999999998 108.86 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 95.6 m95 -102.78 130.67 49.84 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.378 0.609 . . . . 0.28999999999999998 110.625 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.9 tp -114.72 126.79 55.26 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.954 -1.869 . . . . 0.94999999999999996 105.954 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -116.63 98.12 6.36 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 109.077 -0.712 . . . . 0.88 109.077 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 51.92 56.6 7.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.167 0.984 . . . . 1.79 110.23 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.02 -13.95 12.54 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.089 -0.96 . . . . 0.60999999999999999 113.816 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 m -96.6 140.99 30.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.853 -0.795 . . . . 1.3700000000000001 108.853 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.92 123.45 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 47.4 tp -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.58 0.55 . . . . 0.60999999999999999 109.587 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -82.83 125.83 31.75 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.486 -0.931 . . . . 2.4700000000000002 108.486 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.36 153.19 35.99 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.222 -0.445 . . . . 1.74 110.031 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.9 t -166.05 -175.28 3.29 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.748 -0.834 . . . . 1.5700000000000001 108.748 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 m -68.22 -17.67 64.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 119.594 1.088 . . . . 1.52 111.901 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -79.07 -40.17 31.94 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.729 0.3 . . . . 1.5900000000000001 110.831 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.42 HD11 ' ND2' ' A' ' 79' ' ' ASN . 56.9 mt -136.15 115.66 16.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.929 -0.767 . . . . 0.5 108.929 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 8.8 p90 -142.39 145.69 34.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.107 0.479 . . . . 2.8900000000000001 112.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 m -82.58 111.19 18.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.466 -0.788 . . . . 0.44 109.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 6.4 mm-40 -89.3 140.39 29.54 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.899 -0.778 . . . . 2.04 108.899 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -122.27 140.67 52.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.749 -0.834 . . . . 0.87 108.749 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.59 151.71 41.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.027 -1.101 . . . . 1.25 108.027 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 32.6 mm-40 -63.46 119.97 58.2 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 123.96 0.788 . . . . 3.3599999999999999 112.598 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.95 156.13 38.77 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.588 2.192 . . . . 1.3899999999999999 110.351 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.89 146.91 33.31 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.667 -0.864 . . . . 1.53 108.667 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.69 -13.05 58.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.019 1.118 . . . . 1.9099999999999999 114.019 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -90.57 -21.47 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.916 0.388 . . . . 3.4900000000000002 111.424 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.4 pt-20 -99.28 162.47 13.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.689 -0.804 . . . . 1.8899999999999999 110.957 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -121.49 29.71 7.09 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.966 -1.494 . . . . 1.3 106.966 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 30' ' ' ASP . 21.7 t -107.93 128.76 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.22 -1.355 . . . . 0.60999999999999999 108.807 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.2 mtp180 -92.59 132.59 36.73 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.003 -1.48 . . . . 1.8400000000000001 107.003 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -121.97 143.73 49.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.302 -0.629 . . . . 1.1599999999999999 109.302 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.7 -166.09 24.11 Favored Glycine 0 N--CA 1.416 -2.642 0 C-N-CA 120.512 -0.851 . . . . 0.31 111.035 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.0 t -156.07 137.57 14.06 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.833 0.453 . . . . 0.35999999999999999 110.183 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 38.3 tp -90.16 107.93 19.43 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.851 -1.907 . . . . 0.28000000000000003 105.851 171.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 70.6 mtt180 -100.18 120.35 39.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-N 116.502 -0.317 . . . . 2.6800000000000002 110.873 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 23' ' ' TRP . 73.1 mt -83.7 108.0 16.49 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 105.96 -1.867 . . . . 1.23 105.96 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.408 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 50.4 t30 -66.97 -42.62 84.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.047 -0.979 . . . . 2.1800000000000002 109.532 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -134.98 100.99 11.63 Favored Pre-proline 0 N--CA 1.412 -2.341 0 N-CA-C 106.533 -1.655 . . . . 2.8199999999999998 106.533 171.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 14.3 Cg_exo -70.38 131.42 20.33 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.022 1.814 . . . . 1.25 110.367 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 p -130.27 155.74 45.8 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.312 -0.995 . . . . 1.22 108.312 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -65.41 -5.42 7.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.444 1.276 . . . . 2.0299999999999998 114.444 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.49 -10.44 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 109.638 -0.504 . . . . 1.3300000000000001 109.638 174.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.42 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.8 m120 -89.18 17.15 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.599 0.76 . . . . 2.1899999999999999 111.882 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -92.15 121.9 34.13 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.874 -0.788 . . . . 1.96 108.874 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.53 -170.45 36.5 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.39 -1.386 . . . . 0.48999999999999999 112.641 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.83 101.29 13.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.996 -0.602 . . . . 2.23 110.721 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.49 ' HB2' HG23 ' A' ' 98' ' ' ILE . 45.1 m-85 -83.97 114.13 21.49 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 108.767 -0.827 . . . . 0.68999999999999995 108.767 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 35.8 m -117.32 132.46 56.6 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 121.452 -0.78 . . . . 0.34000000000000002 110.683 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 12' ' ' VAL . 44.3 tp -106.18 123.1 47.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.124 -0.695 . . . . 0.22 109.124 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.11 136.07 47.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.254 -1.017 . . . . 0.35999999999999999 108.254 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -126.84 120.62 29.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.549 -0.908 . . . . 0.31 108.549 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.28 117.19 34.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.796 -0.446 . . . . 0.60999999999999999 109.796 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 20.4 t-20 -131.31 151.59 79.07 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-O 117.405 -1.283 . . . . 1.1799999999999999 108.31 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -43.1 -38.42 7.43 Favored 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 122.799 2.332 . . . . 1.0 113.38 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.1 t -64.16 -39.66 94.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.486 0.714 . . . . 1.1000000000000001 112.137 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.14 30.96 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.149 -0.78 . . . . 0.58999999999999997 111.149 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 64.5 tt0 -128.83 129.91 46.23 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.729 -0.471 . . . . 1.5700000000000001 109.729 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.43 150.51 23.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.747 -0.834 . . . . 0.37 108.747 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 p -148.65 123.73 10.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.977 -0.556 . . . . 0.56999999999999995 110.183 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.41 51.88 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.006 -1.109 . . . . 0.29999999999999999 108.006 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.4 m -121.17 132.79 55.05 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.699 0.761 . . . . 1.26 112.819 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -109.78 126.55 66.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 125.541 1.536 . . . . 0.71999999999999997 108.685 175.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' ILE . 16.0 tpt -105.08 111.09 23.73 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 1.25 108.209 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.6 149.7 27.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.218 -0.447 . . . . 0.57999999999999996 109.961 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.6 127.33 23.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.799 -0.637 . . . . 0.83999999999999997 110.475 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 75' ' ' PRO . 55.4 t80 -161.33 92.75 0.91 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 124.994 1.317 . . . . 3.8599999999999999 107.876 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.77 96.55 7.15 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.221 -0.591 . . . . 4.7199999999999998 109.877 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.56 137.62 33.2 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.027 -1.101 . . . . 5.3300000000000001 108.027 174.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.01 127.57 26.67 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.924 -0.769 . . . . 5.3399999999999999 108.924 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.76 117.61 4.18 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.482 2.121 . . . . 5.0700000000000003 110.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.241 1.416 . . . . 9.5199999999999996 108.802 -175.215 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 t70 . . . . . 0 C--O 1.244 0.772 0 N-CA-C 107.003 -1.48 . . . . 7.9299999999999997 107.003 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -150.67 77.81 1.29 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.659 0.742 . . . . 6.1699999999999999 109.402 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -94.5 -26.3 16.5 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.3 -0.864 . . . . 5.4299999999999997 110.405 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.0 132.65 39.63 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 3.8700000000000001 109.32 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -96.32 -50.19 4.89 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.682 0.393 . . . . 2.5499999999999998 111.613 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 m -90.52 98.33 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 113.958 1.096 . . . . 2.0800000000000001 113.958 -173.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.5 t -104.26 98.1 7.95 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.846 -1.909 . . . . 1.5800000000000001 105.846 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -72.13 131.73 43.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.262 -0.881 . . . . 1.1899999999999999 110.084 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.36 157.1 21.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.61 -1.256 . . . . 1.3200000000000001 107.61 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.56 127.2 41.4 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.624 0.601 . . . . 0.45000000000000001 112.624 -172.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.3 m -123.87 141.05 52.38 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.933 -1.877 . . . . 1.1899999999999999 105.933 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.7 t -115.0 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.074 0.464 . . . . 0.28999999999999998 109.755 -174.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -115.81 116.85 28.73 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.001 -0.74 . . . . 2.1800000000000002 109.001 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 38.8 mt -95.68 156.66 16.23 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.965 -0.561 . . . . 0.33000000000000002 109.631 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -130.54 142.04 50.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.954 -1.499 . . . . 1.03 106.954 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -62.11 130.1 43.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 124.053 0.846 . . . . 0.48999999999999999 110.558 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.56 140.63 40.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.451 1.1 . . . . 0.40000000000000002 112.207 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.7 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.754 -0.657 . . . . 0.56999999999999995 109.886 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.3 117.27 24.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.991 -1.004 . . . . 2.52 112.394 -171.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.0 ptt? -168.28 -174.27 2.23 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.129 -1.434 . . . . 0.88 107.129 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 8.0 t-80 -65.54 -52.65 50.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.794 0.724 . . . . 2.75 110.639 -176.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.479 ' O ' ' HG3' ' A' ' 20' ' ' MET . 7.8 p-80 -99.35 126.65 45.26 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.625 -0.879 . . . . 2.46 108.625 173.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 82.7 m95 -82.36 148.0 28.51 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.178 0.513 . . . . 0.85999999999999999 112.224 -171.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 44.0 t -131.55 118.89 20.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.506 -0.924 . . . . 0.29999999999999999 108.506 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 17' ' ' ALA . 78.3 mt -103.68 99.18 14.84 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.455 -1.313 . . . . 0.29999999999999999 107.455 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.0 143.58 36.58 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.087 1.858 . . . . 0.28000000000000003 110.887 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -137.73 154.58 49.61 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.724 -0.39 . . . . 0.37 110.349 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -132.62 114.06 13.77 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.638 -0.71 . . . . 0.88 110.208 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 37' ' ' LEU . 6.4 p -129.57 137.81 55.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.813 -1.551 . . . . 0.27000000000000002 106.813 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.3 p-10 -132.34 161.88 32.45 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 119.741 -0.784 . . . . 1.3899999999999999 110.744 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.94 153.74 7.34 Favored Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 109.502 -1.439 . . . . 0.59999999999999998 109.502 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -81.31 -56.68 0.59 Allowed Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 107.973 -1.121 . . . . 2.6099999999999999 107.973 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.83 120.85 7.73 Favored 'Trans proline' 0 C--N 1.375 1.928 0 N-CA-C 107.59 -1.734 . . . . 0.78000000000000003 107.59 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB1' HH21 ' A' ' 66' ' ' ARG . . . -61.78 114.41 11.18 Favored Pre-proline 0 C--N 1.312 -1.023 0 O-C-N 123.742 0.651 . . . . 0.78000000000000003 111.694 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' ALA . 84.8 Cg_endo -79.1 135.05 12.01 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.572 1.515 . . . . 0.56000000000000005 112.058 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 p -73.53 116.47 14.14 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 109.023 -0.732 . . . . 1.3700000000000001 109.023 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.516 HD21 HG11 ' A' ' 29' ' ' VAL . 93.2 mt -87.22 127.53 35.16 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.5 109.647 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -125.7 130.21 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.127 -0.694 . . . . 3.7799999999999998 109.127 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.5 m95 -95.64 128.87 42.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.277 0.561 . . . . 0.28999999999999998 109.734 176.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.1 tp -118.59 127.42 53.59 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.703 -1.962 . . . . 0.94999999999999996 105.703 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -119.91 110.85 17.21 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.587 -0.523 . . . . 0.88 109.587 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.0 28.5 16.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.061 0.945 . . . . 1.79 111.45 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.09 -12.27 69.4 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 121.389 -0.434 . . . . 0.60999999999999999 112.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.1 p -103.18 151.31 22.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.754 0.311 . . . . 1.3700000000000001 110.315 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.28 120.76 17.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.667 -0.697 . . . . 0.69999999999999996 110.436 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.9 tp -94.42 104.44 16.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.05 -0.722 . . . . 0.60999999999999999 109.05 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -85.74 137.31 32.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.252 -0.647 . . . . 2.4700000000000002 109.252 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.42 129.18 39.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.956 -0.566 . . . . 1.74 109.536 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 p -126.64 -163.69 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.853 0.861 . . . . 1.5700000000000001 109.661 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.6 m -87.19 -5.83 58.83 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.359 0.599 . . . . 1.52 109.661 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -103.0 -35.56 8.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.81 -0.632 . . . . 1.5900000000000001 109.955 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -127.93 106.97 15.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.231 -1.025 . . . . 0.5 108.231 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -138.78 140.22 38.54 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.817 0.341 . . . . 2.8900000000000001 110.303 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -86.83 113.81 22.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.706 -0.85 . . . . 0.44 108.706 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 71' ' ' ARG . 43.4 mt-10 -105.52 115.06 29.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.397 0.618 . . . . 2.04 110.062 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -96.37 150.63 20.37 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.35 -0.841 . . . . 0.87 109.455 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.0 pp -106.91 165.15 11.55 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.743 -1.947 . . . . 1.25 105.743 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.4 104.74 21.43 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.556 -0.535 . . . . 3.3599999999999999 109.556 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 86.9 Cg_endo -84.08 165.32 13.15 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.379 2.052 . . . . 1.3899999999999999 111.145 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.32 137.29 54.54 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.962 -1.125 . . . . 1.53 107.962 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.03 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.012 0.525 . . . . 1.9099999999999999 111.981 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.49 -26.01 65.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.755 0.788 . . . . 3.4900000000000002 109.149 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -98.38 140.1 33.15 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.526 -0.761 . . . . 1.8899999999999999 109.04 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -104.99 28.72 6.94 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.692 0.758 . . . . 1.3 108.993 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 130.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 115.241 -0.89 . . . . 0.60999999999999999 109.318 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.455 HH21 ' HB1' ' A' ' 34' ' ' ALA . 75.9 mtt180 -82.74 117.54 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.4 -0.963 . . . . 1.8400000000000001 108.4 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.518 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 96.1 m-70 -104.38 123.74 47.96 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.368 -0.975 . . . . 1.1599999999999999 108.368 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.9 39.32 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.473 -0.87 . . . . 0.31 111.395 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.4 t -144.16 137.89 27.76 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 122.439 0.296 . . . . 0.35999999999999999 110.897 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 58.9 tp -84.68 100.38 11.43 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.759 -2.311 . . . . 0.28000000000000003 104.759 169.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 55' ' ' GLU . 47.8 ttp180 -104.19 120.17 40.54 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 120.238 -0.585 . . . . 2.6800000000000002 110.049 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 23' ' ' TRP . 75.2 mt -75.55 108.03 8.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.343 -1.725 . . . . 1.23 106.343 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.82 -49.19 66.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.16 -1.382 . . . . 2.1800000000000002 109.479 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.4 99.8 18.86 Favored Pre-proline 0 N--CA 1.414 -2.234 0 N-CA-C 104.296 -2.483 . . . . 2.8199999999999998 104.296 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' HG2' ' O ' ' A' ' 21' ' ' HIS . 33.5 Cg_exo -64.06 130.5 27.53 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.388 2.059 . . . . 1.25 111.73 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -135.18 166.02 24.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.56 -0.745 . . . . 1.22 109.383 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 103' ' ' MET . 50.0 p-80 -62.54 -5.18 2.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.748 1.759 . . . . 2.0299999999999998 115.748 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.17 -10.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.035 0.445 . . . . 1.3300000000000001 109.834 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.7 26.74 0.39 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.113 1.153 . . . . 2.1899999999999999 114.113 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.14 125.17 53.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.321 -0.992 . . . . 1.96 108.321 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.38 -165.71 30.96 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.21 -0.995 . . . . 0.48999999999999999 111.744 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -99.96 124.0 44.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 110.024 -0.362 . . . . 2.23 110.024 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -102.67 105.79 16.32 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.622 -0.881 . . . . 0.68999999999999995 108.622 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.6 m -97.33 129.58 44.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.948 -0.76 . . . . 0.34000000000000002 108.948 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.2 tp -109.06 120.77 43.53 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.582 -0.525 . . . . 0.22 109.582 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.23 138.95 42.46 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.283 -1.006 . . . . 0.35999999999999999 108.283 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -125.94 120.66 30.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.306 -0.998 . . . . 0.31 108.306 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -97.97 112.46 24.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.34 0.59 . . . . 0.60999999999999999 110.97 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -130.61 140.92 40.13 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.13 -1.804 . . . . 1.1799999999999999 106.13 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.16 -19.57 12.43 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 124.052 3.168 . . . . 1.0 113.947 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.0 t -78.93 -24.29 44.11 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.825 0.345 . . . . 1.1000000000000001 110.593 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.52 163.61 11.76 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.555 -1.018 . . . . 0.58999999999999997 110.555 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -98.12 127.65 44.18 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.478 -0.564 . . . . 1.5700000000000001 109.478 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.27 155.35 18.28 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.05 -0.722 . . . . 0.37 109.05 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 39.6 p -146.02 151.56 37.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 123.232 0.332 . . . . 0.56999999999999995 110.609 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.44 33.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.662 -1.607 . . . . 0.29999999999999999 106.662 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 m -135.02 135.47 41.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 117.983 0.356 . . . . 1.26 110.157 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -128.79 134.68 63.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.844 -1.539 . . . . 0.71999999999999997 106.844 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.9 ttt -108.69 134.27 51.64 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.177 -0.609 . . . . 1.25 110.063 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.54 45.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.018 -1.104 . . . . 0.57999999999999996 108.018 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.51 121.04 34.64 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.025 0.44 . . . . 0.83999999999999997 110.351 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -151.2 118.09 5.84 Favored 'General case' 0 N--CA 1.402 -2.847 0 N-CA-C 108.577 -0.897 . . . . 3.8599999999999999 108.577 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 16.3 ptp -115.45 111.8 21.32 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.762 -0.653 . . . . 4.7199999999999998 110.639 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.95 126.6 31.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.718 -1.586 . . . . 5.3300000000000001 106.718 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -120.42 103.98 43.55 Favored Pre-proline 0 C--N 1.285 -2.213 0 CA-C-N 116.344 -0.389 . . . . 5.3399999999999999 111.732 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -91.46 178.94 1.63 Allowed 'Trans proline' 0 N--CA 1.429 -2.318 0 C-N-CA 121.934 1.756 . . . . 5.0700000000000003 110.854 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--N 1.275 -2.639 0 N-CA-C 106.478 -1.675 . . . . 9.5199999999999996 106.478 173.932 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.529 0.566 . . . . 7.9299999999999997 112.529 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -100.08 -25.71 14.2 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.104 -0.702 . . . . 6.1699999999999999 109.104 177.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -61.11 -35.04 75.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.498 -1.228 . . . . 5.4299999999999997 109.263 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 102.955 -2.98 . . . . 3.8700000000000001 102.955 174.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.12 -43.49 17.72 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 114.233 1.197 . . . . 2.5499999999999998 114.233 -168.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 12.6 m -86.94 99.5 8.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 122.114 0.959 . . . . 2.0800000000000001 112.858 -171.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -90.32 98.97 12.09 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.242 -0.89 . . . . 1.5800000000000001 108.736 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 53.9 m-85 -106.41 127.3 53.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.235 -0.654 . . . . 1.1899999999999999 109.235 176.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 t -84.64 -177.87 6.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.276 . . . . 1.3200000000000001 107.553 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.29 120.5 34.62 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.069 -0.652 . . . . 0.45000000000000001 111.186 -174.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 1.5 m -114.82 131.17 56.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.803 -1.184 . . . . 1.1899999999999999 107.803 177.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.1 t -119.65 115.01 46.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 110.14 -0.318 . . . . 0.28999999999999998 110.14 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -120.38 121.96 39.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.335 -0.393 . . . . 2.1800000000000002 110.033 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 27' ' ' PHE . 17.1 mt -104.16 155.25 18.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.917 -0.583 . . . . 0.33000000000000002 110.786 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -131.96 151.56 51.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.235 -1.024 . . . . 1.03 108.235 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -64.48 135.8 56.42 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.278 0.986 . . . . 0.48999999999999999 111.515 -174.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -61.1 128.91 38.73 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.826 -1.079 . . . . 0.40000000000000002 111.332 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.64 136.81 24.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.427 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -87.37 129.73 34.91 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.271 -0.422 . . . . 2.52 111.155 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -176.86 -166.91 0.16 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.918 -1.512 . . . . 0.88 106.918 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -55.18 -38.44 68.34 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.815 0.672 . . . . 2.75 112.815 -178.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.53 132.72 54.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.102 -1.073 . . . . 2.46 108.102 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 64.5 m95 -81.94 119.25 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.575 -0.528 . . . . 0.85999999999999999 109.575 -179.03 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.4 t -113.53 119.25 36.9 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.625 -0.716 . . . . 0.29999999999999999 110.356 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 17' ' ' ALA . 40.8 mt -104.15 96.27 9.39 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.8 -1.556 . . . . 0.29999999999999999 106.8 171.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.05 141.58 14.89 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.644 2.229 . . . . 0.28000000000000003 112.723 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 14' ' ' LEU . 51.4 p90 -145.85 156.78 43.79 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.067 -0.515 . . . . 0.37 111.416 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -129.07 123.53 32.51 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 115.036 -0.984 . . . . 0.88 108.758 175.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ARG . 1.5 p -122.01 110.47 27.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.271 -0.877 . . . . 0.27000000000000002 109.015 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 p30 -106.8 152.94 23.19 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.879 -0.601 . . . . 1.3899999999999999 111.353 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.5 158.47 9.92 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 109.315 -1.514 . . . . 0.59999999999999998 109.315 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 23.8 tm0? -84.79 -51.02 0.56 Allowed Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 117.74 0.77 . . . . 2.6099999999999999 109.972 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 12.1 Cg_exo -73.57 134.81 21.0 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 N-CA-C 107.589 -1.735 . . . . 0.78000000000000003 107.589 168.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.0 117.05 61.08 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 110.251 -0.277 . . . . 0.78000000000000003 110.251 -177.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' A' ' 89' ' ' ASN . 73.1 Cg_endo -82.97 154.62 14.9 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.442 2.095 . . . . 0.56000000000000005 112.727 -177.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -83.35 125.14 31.34 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.779 -1.193 . . . . 1.3700000000000001 107.779 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 29' ' ' VAL . 97.0 mt -94.13 130.95 40.13 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 120.873 0.368 . . . . 0.5 110.044 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -135.61 135.23 40.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.421 -0.808 . . . . 3.7799999999999998 109.633 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.6 m95 -96.01 132.05 41.75 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.237 0.542 . . . . 0.28999999999999998 110.528 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.8 tp -119.47 126.86 52.32 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.444 -1.687 . . . . 0.94999999999999996 106.444 176.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -115.89 107.5 15.09 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.277 -1.008 . . . . 0.88 108.277 -177.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 62.24 19.91 11.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.616 0.766 . . . . 1.79 112.727 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.1 -8.96 50.09 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.263 -0.97 . . . . 0.60999999999999999 112.213 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 m -105.97 137.88 43.12 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.384 -0.599 . . . . 1.3700000000000001 109.384 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.3 127.87 28.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.178 0.513 . . . . 0.69999999999999996 110.345 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.56 106.69 18.22 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.374 -0.973 . . . . 0.60999999999999999 108.374 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -87.68 121.35 30.01 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.306 -1.368 . . . . 2.4700000000000002 107.306 178.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.77 142.13 24.63 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.662 1.226 . . . . 1.74 112.386 -177.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 p -128.11 -172.15 2.62 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.67 -0.695 . . . . 1.5700000000000001 109.982 -177.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 m -76.07 -12.81 60.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.667 0.27 . . . . 1.52 111.286 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.97 -40.84 7.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.918 0.389 . . . . 1.5900000000000001 110.549 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.3 mt -115.89 106.41 20.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.046 -1.465 . . . . 0.5 107.046 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -147.46 152.57 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.179 0.514 . . . . 2.8900000000000001 112.057 -175.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 m -96.07 118.7 33.18 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.045 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.13 143.1 33.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.327 -0.99 . . . . 2.04 108.327 173.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.49 135.8 51.55 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.2 -0.296 . . . . 0.87 110.2 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.47 165.44 13.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.747 -1.205 . . . . 1.25 107.747 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -64.23 112.64 8.05 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 113.389 0.885 . . . . 3.3599999999999999 113.389 -170.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.4 132.26 7.94 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.601 2.201 . . . . 1.3899999999999999 110.188 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.42 146.24 24.31 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.819 -0.752 . . . . 1.53 109.492 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.37 11.69 2.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.452 0.644 . . . . 1.9099999999999999 110.809 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -105.8 2.24 27.63 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.466 1.106 . . . . 3.4900000000000002 109.34 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.95 157.41 44.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.826 -1.176 . . . . 1.8899999999999999 107.826 -178.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 p -111.4 36.24 3.3 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.213 1.006 . . . . 1.3 109.259 175.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.66 128.69 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.445 -1.252 . . . . 0.60999999999999999 109.095 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HB3' HG13 ' A' ' 29' ' ' VAL . 77.3 ttt180 -99.71 133.94 43.32 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.0 -1.482 . . . . 1.8400000000000001 107.0 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -126.62 132.58 51.22 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.982 -0.377 . . . . 1.1599999999999999 109.982 -174.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.81 27.84 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 119.953 -1.118 . . . . 0.31 111.674 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 14.2 t -149.78 134.67 17.83 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.569 0.223 . . . . 0.35999999999999999 110.773 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 38.3 tp -83.24 108.46 16.49 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.22 -1.77 . . . . 0.28000000000000003 106.22 173.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.596 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 35.7 mtp85 -109.61 102.73 11.54 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.864 -0.607 . . . . 2.6800000000000002 111.905 -173.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.4 109.98 17.77 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.746 -0.661 . . . . 1.23 109.986 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -69.61 -29.01 66.42 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.585 -1.189 . . . . 2.1800000000000002 110.219 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -125.62 108.72 25.98 Favored Pre-proline 0 N--CA 1.425 -1.712 0 N-CA-C 108.444 -0.947 . . . . 2.8199999999999998 108.444 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.65 129.76 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.253 1.302 . . . . 1.25 109.36 176.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -125.99 141.55 51.91 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.329 -0.619 . . . . 1.22 109.329 -175.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -77.83 -18.9 55.79 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 116.163 -0.471 . . . . 2.0299999999999998 110.715 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.78 -23.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.41 -0.359 . . . . 1.3300000000000001 111.19 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 21.7 m120 -97.84 26.75 4.89 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.852 1.427 . . . . 2.1899999999999999 114.852 -176.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -83.77 122.73 29.05 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.4 -1.333 . . . . 1.96 107.4 174.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.27 -160.19 32.89 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.622 -1.275 . . . . 0.48999999999999999 113.215 -177.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.55 111.69 23.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.008 0.523 . . . . 2.23 110.929 -175.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.581 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 34.5 m-85 -94.74 115.37 27.43 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.948 -0.569 . . . . 0.68999999999999995 109.896 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 83.5 m -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 109.304 -0.628 . . . . 0.34000000000000002 109.304 177.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' SER . 57.3 tp -96.83 121.13 38.35 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.678 -0.86 . . . . 0.22 108.678 179.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' LEU . 2.8 mm? -104.94 134.38 48.15 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.806 -0.813 . . . . 0.35999999999999999 108.806 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.98 119.52 34.53 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.313 -1.366 . . . . 0.31 107.313 170.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.54 112.7 24.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.614 -0.884 . . . . 0.60999999999999999 108.614 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 21.0 t-20 -132.94 146.46 61.38 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.761 -1.2 . . . . 1.1799999999999999 107.761 -175.141 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.97 -16.43 38.8 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.433 2.756 . . . . 1.0 113.419 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 t -80.79 -38.69 28.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.872 0.368 . . . . 1.1000000000000001 110.267 175.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 169.75 170.13 33.84 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.267 -1.533 . . . . 0.58999999999999997 109.267 -177.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -110.27 121.21 44.74 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.034 0.445 . . . . 1.5700000000000001 110.245 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.89 147.54 26.78 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.849 -0.614 . . . . 0.37 109.844 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 46.9 p -140.46 144.82 36.28 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.216 0.323 . . . . 0.56999999999999995 110.344 177.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.3 46.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.484 . . . . 0.29999999999999999 106.992 175.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -129.87 130.36 45.11 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 118.286 0.493 . . . . 1.26 111.073 -174.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 128.1 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.369 -1.345 . . . . 0.71999999999999997 107.369 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.77 114.98 26.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.985 -1.116 . . . . 1.25 107.985 -178.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.43 113.84 26.23 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.448 0.642 . . . . 0.57999999999999996 111.028 -175.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.01 102.78 14.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.281 -0.872 . . . . 0.83999999999999997 109.154 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -84.97 -76.88 0.3 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.409 -0.814 . . . . 3.8599999999999999 110.841 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.9 mtt -138.83 153.77 48.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.274 -1.38 . . . . 4.7199999999999998 107.274 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -93.46 162.09 14.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.744 -0.836 . . . . 5.3300000000000001 108.744 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.22 115.45 62.03 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.699 0.285 . . . . 5.3399999999999999 110.806 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.08 179.61 3.6 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.233 1.955 . . . . 5.0700000000000003 110.897 175.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 C--N 1.28 -2.448 0 CA-C-O 118.511 -0.757 . . . . 9.5199999999999996 109.104 179.814 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.239 0.519 0 N-CA-C 108.539 -0.911 . . . . 7.9299999999999997 108.539 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.1 t70 57.79 57.52 4.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.892 1.277 . . . . 6.1699999999999999 109.601 -173.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 6' ' ' VAL . 6.8 m-20 -131.16 23.73 4.87 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 105.978 -1.86 . . . . 5.4299999999999997 105.978 178.387 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.91 -12.59 60.39 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.103 -0.953 . . . . 3.8700000000000001 112.717 -168.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.14 1.63 55.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.361 -0.381 . . . . 2.5499999999999998 111.469 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 3' ' ' ASP . 31.0 m -68.18 121.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-O 122.235 1.017 . . . . 2.0800000000000001 110.247 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 p -107.89 98.19 7.8 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-O 122.143 0.973 . . . . 1.5800000000000001 109.889 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -83.38 129.83 35.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.892 -1.151 . . . . 1.1899999999999999 107.892 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 27.7 m -84.49 167.03 16.76 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.983 -1.118 . . . . 1.3200000000000001 107.983 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.66 129.83 41.38 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.565 0.698 . . . . 0.45000000000000001 112.413 -170.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 t -124.32 136.08 53.83 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.043 -1.836 . . . . 1.1899999999999999 106.043 175.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.31 126.99 73.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.227 0.537 . . . . 0.28999999999999998 111.155 -175.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -121.14 120.47 35.36 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.809 -1.087 . . . . 2.1800000000000002 109.062 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD13 HG22 ' A' ' 98' ' ' ILE . 44.2 mt -111.58 145.55 38.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.842 -0.799 . . . . 0.33000000000000002 108.842 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -132.19 154.21 49.79 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.913 0.387 . . . . 1.03 110.958 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 m -58.99 134.49 57.03 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.708 -1.133 . . . . 0.48999999999999999 111.684 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.6 145.53 48.59 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.286 1.034 . . . . 0.40000000000000002 111.929 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -92.27 138.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.201 -0.454 . . . . 0.56999999999999995 109.996 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -82.61 108.44 16.0 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.388 0.613 . . . . 2.52 112.618 -176.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -157.97 -178.78 7.56 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.212 -1.773 . . . . 0.88 106.212 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -63.25 -39.45 94.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 119.375 0.989 . . . . 2.75 112.867 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.32 122.42 44.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.485 -1.302 . . . . 2.46 107.485 176.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.24 126.76 32.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.112 0.482 . . . . 0.85999999999999999 111.593 -173.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -120.35 117.45 27.79 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.29999999999999999 109.989 -177.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 17' ' ' ALA . 75.7 mt -99.41 105.04 30.7 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.682 -1.229 . . . . 0.29999999999999999 107.682 173.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.88 136.74 19.03 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 122.261 1.974 . . . . 0.28000000000000003 111.687 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 14' ' ' LEU . 49.8 p90 -137.56 159.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.187 0.518 . . . . 0.37 110.018 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -141.97 119.55 11.72 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.636 -0.711 . . . . 0.88 109.77 176.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.93 125.95 67.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.044 -1.465 . . . . 0.27000000000000002 107.044 176.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.4 p-10 -115.36 155.71 26.86 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.246 -0.982 . . . . 1.3899999999999999 110.592 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 140.77 3.06 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.506 -1.437 . . . . 0.59999999999999998 109.506 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -75.77 -54.6 2.17 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 108.169 -1.049 . . . . 2.6099999999999999 108.169 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HG2' HD21 ' A' ' 89' ' ' ASN . 18.7 Cg_endo -65.76 122.8 10.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 N-CA-C 108.644 -1.329 . . . . 0.78000000000000003 108.644 170.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.96 121.22 80.81 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 116.383 -0.371 . . . . 0.78000000000000003 111.693 -175.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.76 155.54 11.77 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.898 1.732 . . . . 0.56000000000000005 111.988 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -82.66 109.98 17.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.903 -0.777 . . . . 1.3700000000000001 108.903 176.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.97 119.2 25.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.108 0.48 . . . . 0.5 110.472 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -126.65 126.12 43.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.602 -0.726 . . . . 3.7799999999999998 110.324 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -91.81 119.67 31.83 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.181 -0.918 . . . . 0.28999999999999998 109.662 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -109.92 127.71 54.91 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 0.94999999999999996 105.7 173.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -118.81 106.09 12.18 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 110.298 -0.26 . . . . 0.88 110.298 -174.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 59.07 30.95 20.88 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.544 1.164 . . . . 1.79 110.603 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.08 82.61 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.521 -0.763 . . . . 0.60999999999999999 113.092 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 p -104.78 140.97 37.31 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.338 -0.507 . . . . 1.3700000000000001 109.872 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.61 114.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.69999999999999996 111.031 -176.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.9 tp -90.21 112.22 23.67 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.337 -0.986 . . . . 0.60999999999999999 108.337 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -93.49 136.98 33.24 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.682 -0.858 . . . . 2.4700000000000002 108.682 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.14 100.46 0.61 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.368 0.667 . . . . 1.74 109.924 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.8 p -93.49 -167.1 1.64 Allowed 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.009 0.524 . . . . 1.5700000000000001 111.397 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -77.09 -20.93 55.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.181 0.515 . . . . 1.52 110.563 175.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 99.6 m-85 -95.8 -36.51 11.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.03 0.443 . . . . 1.5900000000000001 110.641 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 mt -112.41 105.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.213 -1.403 . . . . 0.5 107.213 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -134.61 155.42 50.49 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.098 0.475 . . . . 2.8900000000000001 111.538 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -107.29 114.48 28.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.587 -0.523 . . . . 0.44 109.587 -178.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.11 132.4 34.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.358 -0.608 . . . . 2.04 109.358 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -122.13 149.49 43.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.779 -0.452 . . . . 0.87 109.779 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.01 163.43 20.47 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.804 -1.184 . . . . 1.25 107.804 173.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 10.8 mm-40 -81.54 116.63 64.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 123.58 0.55 . . . . 3.3599999999999999 111.191 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 14.9 Cg_exo -69.39 141.28 46.27 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.626 2.217 . . . . 1.3899999999999999 110.35 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.76 145.12 55.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.78 -0.822 . . . . 1.53 108.78 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.17 -10.22 39.29 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.228 0.825 . . . . 1.9099999999999999 113.228 -174.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -92.58 1.34 57.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.691 0.282 . . . . 3.4900000000000002 110.875 178.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.23 170.69 15.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.356 -0.609 . . . . 1.8899999999999999 109.356 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.7 p -132.45 26.8 4.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.401 0.62 . . . . 1.3 111.113 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.55 127.85 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.226 -0.657 . . . . 0.60999999999999999 109.226 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB3' HG13 ' A' ' 29' ' ' VAL . 25.3 ttm180 -88.67 115.16 26.0 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.352 -1.351 . . . . 1.8400000000000001 107.352 177.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -99.67 136.86 38.96 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.42 -0.955 . . . . 1.1599999999999999 108.42 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.11 -178.26 43.91 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 119.941 -1.123 . . . . 0.31 112.22 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -148.99 136.6 20.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.69 0.396 . . . . 0.35999999999999999 110.774 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.8 tp -85.6 103.7 14.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 105.035 -2.209 . . . . 0.28000000000000003 105.035 171.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -111.44 127.4 55.67 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 119.955 -0.698 . . . . 2.6800000000000002 110.39 -173.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.9 mp -108.85 109.78 20.98 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.937 -1.505 . . . . 1.23 106.937 178.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.52 -43.39 90.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.604 -0.725 . . . . 2.1800000000000002 109.267 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -135.59 112.02 10.7 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 107.419 -1.326 . . . . 2.8199999999999998 107.419 172.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.48 137.41 20.65 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.599 1.533 . . . . 1.25 111.654 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.8 p -83.48 148.52 27.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.553 -1.647 . . . . 1.22 106.553 174.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -58.39 -20.35 43.49 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.564 0.95 . . . . 2.0299999999999998 113.564 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.69 -10.53 13.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 O-C-N 123.202 0.314 . . . . 1.3300000000000001 111.433 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.63 26.22 0.24 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.041 1.126 . . . . 2.1899999999999999 114.041 -174.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -106.85 87.76 2.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.676 -1.231 . . . . 1.96 107.676 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.72 -161.72 24.34 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.634 -0.793 . . . . 0.48999999999999999 112.053 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 99' ' ' MET . 52.4 t-20 -97.16 125.2 41.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.764 0.316 . . . . 2.23 110.557 -177.173 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -98.46 106.55 18.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.317 -0.994 . . . . 0.68999999999999995 108.317 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -97.85 114.9 27.08 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.486 -0.931 . . . . 0.34000000000000002 108.486 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.6 tp -95.43 116.86 29.38 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.273 -0.64 . . . . 0.22 109.273 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.37 127.75 52.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.27 -1.011 . . . . 0.35999999999999999 108.27 177.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.46 120.1 37.08 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.994 -1.113 . . . . 0.31 107.994 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.24 112.65 25.42 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.967 -0.753 . . . . 0.60999999999999999 108.967 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 26.8 t-20 -120.5 147.06 44.53 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 106.48 -1.674 . . . . 1.1799999999999999 106.48 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.07 -19.64 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.894 2.396 . . . . 1.0 113.623 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.3 -29.2 23.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 110.239 178.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 170.64 179.37 41.94 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 110.916 -0.874 . . . . 0.58999999999999997 110.916 -179.001 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -112.55 139.99 47.68 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 109.448 -0.575 . . . . 1.5700000000000001 109.448 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -120.53 153.05 37.24 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 178.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 48.5 p -150.35 155.39 39.53 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.377 0.423 . . . . 0.56999999999999995 110.194 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.36 165.53 34.71 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.476 -1.676 . . . . 0.29999999999999999 106.476 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.41 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 35.7 m -143.38 125.85 15.78 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 117.972 0.351 . . . . 1.26 110.625 -177.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.502 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -123.75 122.93 65.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.611 -1.255 . . . . 0.71999999999999997 107.611 178.486 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 22.3 ttt -107.41 111.61 24.01 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.046 0.451 . . . . 1.25 110.08 -176.35 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.11 154.22 36.44 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.013 -0.539 . . . . 0.57999999999999996 111.6 -174.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.76 123.67 28.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.994 -1.484 . . . . 0.83999999999999997 106.994 176.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -101.01 -77.05 0.55 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.291 -0.413 . . . . 3.8599999999999999 111.959 -176.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -127.34 137.61 52.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.212 -0.662 . . . . 4.7199999999999998 109.212 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.05 127.71 30.31 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.943 1.297 . . . . 5.3300000000000001 112.128 -177.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -55.29 109.15 1.43 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.802 1.241 . . . . 5.3399999999999999 113.108 -178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 107' ' ' PHE . 6.5 Cg_exo -84.34 115.72 1.96 Allowed 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.201 1.934 . . . . 5.0700000000000003 111.346 174.149 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 26.8 t80 . . . . . 0 CA--C 1.505 -0.764 0 O-C-N 124.82 1.325 . . . . 9.5199999999999996 107.776 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 112.95 0.722 . . . . 7.9299999999999997 112.95 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -104.34 -86.08 0.46 Allowed 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.517 -0.873 . . . . 6.1699999999999999 110.997 -174.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.14 -15.39 27.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.648 1.213 . . . . 5.4299999999999997 108.456 178.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.89 138.33 32.15 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.45 -1.705 . . . . 3.8700000000000001 109.536 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.47 -50.41 2.22 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.276 -0.639 . . . . 2.5499999999999998 109.276 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.61 101.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.064 -0.971 . . . . 2.0800000000000001 110.656 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -93.63 98.52 11.2 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.928 0.87 . . . . 1.5800000000000001 110.136 -174.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.41 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 46.4 m-85 -104.72 133.8 48.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.695 -1.139 . . . . 1.1899999999999999 108.075 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 m -84.86 -165.6 1.24 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.942 -0.762 . . . . 1.3200000000000001 108.942 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -94.12 124.62 38.25 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.251 -0.98 . . . . 0.45000000000000001 111.06 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 t -128.12 129.89 47.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.444 -1.317 . . . . 1.1899999999999999 107.444 175.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 94' ' ' ALA . 87.7 t -119.97 132.56 69.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.673 -0.239 . . . . 0.28999999999999998 110.664 -174.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -130.38 122.07 27.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.376 0.608 . . . . 2.1800000000000002 109.711 173.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 48.8 mt -104.68 148.83 26.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 110.212 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -131.76 150.57 52.11 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.161 -0.681 . . . . 1.03 109.161 -176.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.5 m -49.39 135.23 17.87 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.605 1.562 . . . . 0.48999999999999999 111.899 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 137.87 50.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.918 -1.037 . . . . 0.40000000000000002 108.776 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.02 131.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.439 0.638 . . . . 0.56999999999999995 110.064 -175.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -74.31 91.81 2.22 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.57 -1.196 . . . . 2.52 110.533 -177.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.7 mtm -130.98 -171.61 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.816 -0.439 . . . . 0.88 109.816 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.06 -25.38 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 2.75 109.691 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -119.84 143.82 47.69 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.456 -0.793 . . . . 2.46 109.83 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.78 124.11 29.96 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.574 0.702 . . . . 0.85999999999999999 112.044 -177.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.7 121.59 19.88 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.556 -1.202 . . . . 0.29999999999999999 109.131 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -107.16 100.96 35.76 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 107.738 -1.208 . . . . 0.29999999999999999 107.738 174.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.14 129.07 11.88 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.545 2.163 . . . . 0.28000000000000003 112.575 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -126.29 153.38 44.89 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.058 -0.519 . . . . 0.37 110.584 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.1 m -134.93 127.09 29.94 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.94 -0.763 . . . . 0.88 108.94 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.1 p -127.29 124.99 65.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.39 -0.967 . . . . 0.27000000000000002 108.39 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 65' ' ' VAL . 5.2 p-10 -115.49 149.89 37.39 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.83 -0.348 . . . . 1.3899999999999999 111.821 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 -171.83 33.6 Favored Glycine 0 N--CA 1.428 -1.896 0 O-C-N 124.622 1.201 . . . . 0.59999999999999998 110.851 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -119.0 -57.29 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-O 118.583 -0.722 . . . . 2.6099999999999999 112.674 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.3 Cg_exo -59.97 120.53 8.37 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 108.553 -1.364 . . . . 0.78000000000000003 108.553 171.008 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 116.23 16.19 Favored Pre-proline 0 N--CA 1.448 -0.549 0 O-C-N 123.871 0.732 . . . . 0.78000000000000003 111.53 -175.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 93.4 Cg_endo -85.62 152.9 10.28 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 121.848 1.698 . . . . 0.56000000000000005 111.842 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 p -82.8 106.07 14.33 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.881 -0.785 . . . . 1.3700000000000001 108.881 174.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.69 119.75 23.7 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 109.405 -0.591 . . . . 0.5 109.405 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -137.82 131.52 31.26 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.696 -0.683 . . . . 3.7799999999999998 110.679 -177.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.414 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 85.3 m95 -94.81 129.01 41.95 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.569 -0.741 . . . . 0.28999999999999998 109.713 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.97 129.06 54.96 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 106.639 -1.615 . . . . 0.94999999999999996 106.639 176.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -112.72 98.05 6.96 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.007 0.432 . . . . 0.88 110.28 -178.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.0 47.68 24.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.554 1.141 . . . . 1.79 111.294 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -22.22 36.59 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.367 -0.833 . . . . 0.60999999999999999 113.57 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -96.37 143.57 27.3 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 1.3700000000000001 109.332 -176.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.98 118.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.548 -0.751 . . . . 0.69999999999999996 109.994 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 tp -82.45 120.67 25.76 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.491 -1.299 . . . . 0.60999999999999999 107.491 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -107.77 140.09 41.36 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.298 -1.001 . . . . 2.4700000000000002 108.298 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.89 92.93 0.52 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.662 0.744 . . . . 1.74 109.714 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -88.91 178.97 6.28 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.01 -0.996 . . . . 1.5700000000000001 108.918 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 t -48.6 -36.91 16.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.171 0.988 . . . . 1.52 112.992 -176.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -110.72 5.59 20.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.113 0.783 . . . . 1.5900000000000001 113.113 -173.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.428 HG12 HD23 ' A' ' 72' ' ' LEU . 54.5 mt -124.15 106.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.472 -1.677 . . . . 0.5 106.472 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -126.72 137.84 53.31 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.414 -0.357 . . . . 2.8900000000000001 110.439 -171.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 m -92.69 109.39 20.81 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.265 -1.383 . . . . 0.44 107.265 176.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.74 136.9 42.56 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.384 -0.598 . . . . 2.04 109.384 -174.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.01 152.49 36.31 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.9 0.381 . . . . 0.87 110.013 -177.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 67' ' ' HIS . 4.5 pp -110.51 165.2 11.99 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.402 -1.703 . . . . 1.25 106.402 175.012 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.38 109.73 11.39 Favored Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 123.169 0.293 . . . . 3.3599999999999999 110.264 -178.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.72 140.09 20.58 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.221 1.948 . . . . 1.3899999999999999 110.651 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 31.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.236 -1.024 . . . . 1.53 108.236 177.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.73 -13.21 62.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.458 0.646 . . . . 1.9099999999999999 110.877 -178.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.4 -26.39 65.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.855 -1.066 . . . . 3.4900000000000002 110.551 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.08 143.42 33.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.114 0.483 . . . . 1.8899999999999999 110.071 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.7 p -98.32 18.05 17.32 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.762 -1.199 . . . . 1.3 107.762 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 30' ' ' ASP . 16.5 t -114.17 129.08 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 114.383 -1.28 . . . . 0.60999999999999999 109.211 -177.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.537 ' HB3' HG13 ' A' ' 29' ' ' VAL . 15.5 ttm180 -95.11 132.46 40.01 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.76 -1.57 . . . . 1.8400000000000001 106.76 177.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 57' ' ' LEU . 87.9 m-70 -119.6 141.83 48.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.102 -0.333 . . . . 1.1599999999999999 110.102 -176.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.0 -173.94 34.18 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.409 -1.076 . . . . 0.31 110.409 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.416 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 26.8 t -148.27 135.45 20.32 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.064 0.459 . . . . 0.35999999999999999 111.107 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.3 tp -83.58 114.35 21.46 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.28000000000000003 106.52 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 96.7 mtt180 -114.92 125.05 53.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.506 0.67 . . . . 2.6800000000000002 111.584 -175.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 52' ' ' ILE . 4.5 mp -111.62 109.84 19.94 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.765 -1.107 . . . . 1.23 108.782 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.46 -35.42 80.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.046 -0.979 . . . . 2.1800000000000002 111.107 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -128.18 119.76 20.98 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.963 -0.755 . . . . 2.8199999999999998 108.963 178.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.63 136.95 29.25 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 121.441 1.427 . . . . 1.25 109.068 175.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -128.99 161.04 30.84 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.33 -0.989 . . . . 1.22 108.33 -178.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -68.7 -5.03 17.99 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.472 0.916 . . . . 2.0299999999999998 113.472 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.62 -9.02 10.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-O 121.069 0.461 . . . . 1.3300000000000001 110.301 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.815 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.4 m120 -83.4 27.92 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.292 0.637 . . . . 2.1899999999999999 112.355 -176.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.4 m-20 -124.67 103.06 7.91 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -159.12 30.61 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.684 -0.967 . . . . 0.48999999999999999 110.684 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 23.4 t-20 -103.41 122.71 45.42 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 120.736 0.303 . . . . 2.23 110.379 -177.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.815 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 51.3 m-85 -100.49 115.2 29.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.439 -0.578 . . . . 0.68999999999999995 109.439 178.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -103.31 127.59 50.6 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.496 -0.32 . . . . 0.34000000000000002 110.183 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 ' CB ' HD11 ' A' ' 14' ' ' LEU . 59.9 tp -100.89 120.41 40.11 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.951 -0.759 . . . . 0.22 108.951 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.96 139.09 38.97 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.089 -1.078 . . . . 0.35999999999999999 108.089 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -135.07 120.63 19.32 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.164 -1.421 . . . . 0.31 107.164 173.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.53 133.56 53.28 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.754 -0.378 . . . . 0.60999999999999999 110.996 -178.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -142.76 171.29 7.29 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-O 117.23 -1.367 . . . . 1.1799999999999999 107.541 175.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.24 -25.16 29.16 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.168 1.912 . . . . 1.0 114.753 -175.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.16 -23.23 38.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.994 0.368 . . . . 1.1000000000000001 111.994 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.58 -175.63 35.62 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.518 -1.325 . . . . 0.58999999999999997 113.092 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -124.43 131.19 53.5 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.819 -0.437 . . . . 1.5700000000000001 109.819 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.62 148.46 28.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.454 -0.943 . . . . 0.37 108.454 176.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.4 p -142.57 122.83 13.84 Favored 'General case' 0 N--CA 1.425 -1.705 0 O-C-N 123.401 0.438 . . . . 0.56999999999999995 110.442 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.81 155.5 43.99 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.799 -1.186 . . . . 0.29999999999999999 107.799 177.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 50.9 m -130.26 144.22 51.24 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.84 0.352 . . . . 1.26 110.845 -178.027 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -130.24 126.53 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.853 -1.166 . . . . 0.71999999999999997 107.853 176.908 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 tpt -87.06 114.1 23.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.61 -0.885 . . . . 1.25 108.61 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.11 132.13 53.62 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.87 0.367 . . . . 0.57999999999999996 110.779 -175.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -140.23 101.44 4.14 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.154 -1.054 . . . . 0.83999999999999997 108.154 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -81.27 -66.31 0.9 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.991 -0.55 . . . . 3.8599999999999999 111.865 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -148.7 126.69 11.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.937 -0.764 . . . . 4.7199999999999998 108.937 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.407 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 19.7 t0 -71.05 163.47 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.205 0.602 . . . . 5.3300000000000001 111.555 -178.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 72.8 m-20 -51.26 126.86 28.75 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.626 1.17 . . . . 5.3399999999999999 112.522 -174.082 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 11.7 Cg_endo -90.07 179.41 2.02 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.803 2.335 . . . . 5.0700000000000003 110.369 172.164 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 . . . . . 0 C--N 1.289 -2.063 0 N-CA-C 107.8 -1.185 . . . . 9.5199999999999996 107.8 174.131 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 CA--C 1.486 -1.484 0 CA-C-O 120.446 0.165 . . . . 7.9299999999999997 111.065 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.34 69.03 9.92 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 105.921 -1.881 . . . . 6.1699999999999999 105.921 175.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.19 53.01 1.66 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.899 1.333 . . . . 5.4299999999999997 113.399 -173.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -135.5 38.35 2.89 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.424 -2.065 . . . . 3.8700000000000001 105.424 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -69.68 -51.29 35.89 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 114.67 -1.15 . . . . 2.5499999999999998 109.761 -177.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 m -79.3 99.24 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 CA-C-O 122.464 1.126 . . . . 2.0800000000000001 110.254 177.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -110.41 98.82 7.95 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.085 -1.08 . . . . 1.5800000000000001 108.085 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.497 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 97.2 m-85 -89.94 134.47 34.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.022 -1.473 . . . . 1.1899999999999999 107.022 176.043 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.0 m -83.26 177.0 8.72 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.879 -1.156 . . . . 1.3200000000000001 107.879 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -93.25 124.22 37.08 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 119.37 -0.932 . . . . 0.45000000000000001 111.17 -170.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -123.86 133.08 53.84 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 106.905 -1.517 . . . . 1.1899999999999999 106.905 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 94' ' ' ALA . 88.3 t -115.28 118.35 58.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.735 0.303 . . . . 0.28999999999999998 110.266 -175.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -116.74 116.24 27.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.768 -0.827 . . . . 2.1800000000000002 108.768 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 98' ' ' ILE . 41.3 mt -96.51 156.99 16.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.651 -0.704 . . . . 0.33000000000000002 110.72 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -129.93 144.65 51.43 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.876 -1.157 . . . . 1.03 107.876 -174.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -57.55 133.49 55.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.953 1.408 . . . . 0.48999999999999999 110.652 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -70.28 141.35 52.4 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.074 -0.966 . . . . 0.40000000000000002 110.3 -176.192 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -92.65 127.59 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 113.26 0.837 . . . . 0.56999999999999995 113.26 -177.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -83.97 88.33 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.891 -1.049 . . . . 2.52 108.796 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.03 -169.67 3.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.545 -1.28 . . . . 0.88 107.545 175.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -48.57 -38.18 19.9 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.103 1.149 . . . . 2.75 114.103 -171.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -133.25 139.57 47.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.417 -0.957 . . . . 2.46 108.417 175.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' HD12 ' A' ' 72' ' ' LEU . 73.5 m95 -81.34 127.1 32.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.294 0.569 . . . . 0.85999999999999999 110.442 -175.017 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -120.81 121.58 38.46 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 114.563 -1.199 . . . . 0.29999999999999999 108.144 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 17' ' ' ALA . 52.3 mt -108.27 96.05 17.46 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.139 -1.43 . . . . 0.29999999999999999 107.139 175.388 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.69 128.52 13.49 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.333 2.022 . . . . 0.28000000000000003 111.8 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -120.05 146.68 45.67 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 116.03 -0.532 . . . . 0.37 109.853 178.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -132.59 106.81 8.04 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 108.689 -0.856 . . . . 0.88 108.689 176.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -110.56 111.25 35.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.169 -0.923 . . . . 0.27000000000000002 108.766 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 p30 -101.3 137.53 39.53 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.396 -0.82 . . . . 1.3899999999999999 110.148 -178.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.05 146.64 4.61 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 108.699 -1.761 . . . . 0.59999999999999998 108.699 -176.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.45 -59.79 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 CA-C-O 117.947 -1.025 . . . . 2.6099999999999999 110.199 -176.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 7.8 Cg_endo -54.81 119.43 6.46 Favored 'Trans proline' 0 C--N 1.393 2.88 0 N-CA-C 107.72 -1.685 . . . . 0.78000000000000003 107.72 171.052 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.69 114.68 17.01 Favored Pre-proline 0 C--N 1.291 -1.936 0 CA-C-N 114.567 -1.197 . . . . 0.78000000000000003 112.746 -171.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.67 150.05 11.35 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 122.134 1.89 . . . . 0.56000000000000005 112.454 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -84.57 127.04 33.85 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.208 -1.405 . . . . 1.3700000000000001 107.208 174.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.91 122.69 43.23 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.856 0.36 . . . . 0.5 111.714 -176.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -130.22 128.28 41.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.607 -0.724 . . . . 3.7799999999999998 110.52 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 94.1 m95 -90.82 141.2 29.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.924 -0.769 . . . . 0.28999999999999998 108.924 175.213 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.32 127.4 41.03 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.206 -1.405 . . . . 0.94999999999999996 107.206 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -103.13 98.13 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.024 -0.732 . . . . 0.88 109.024 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.67 29.63 7.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.015 0.926 . . . . 1.79 113.311 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.56 -20.57 24.92 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.828 -0.701 . . . . 0.60999999999999999 113.263 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 m -89.84 137.96 31.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.16 0.48 . . . . 1.3700000000000001 110.735 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.41 108.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.994 -1.003 . . . . 0.69999999999999996 111.16 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.8 tp -87.62 114.92 24.68 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.053 -1.091 . . . . 0.60999999999999999 108.053 178.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.01 140.59 40.95 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.476 -1.305 . . . . 2.4700000000000002 107.476 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.11 107.87 2.06 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.873 0.869 . . . . 1.74 110.998 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -99.37 -166.13 1.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.191 -0.459 . . . . 1.5700000000000001 110.122 -178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.5 t -82.02 -13.21 57.71 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.1 -0.704 . . . . 1.52 109.1 176.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -102.03 -38.89 7.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.809 -0.632 . . . . 1.5900000000000001 110.565 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.8 108.21 24.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.293 -1.373 . . . . 0.5 107.293 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -135.06 137.7 43.15 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.4 -0.92 . . . . 2.8900000000000001 112.252 -174.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -81.44 111.04 17.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.665 -0.698 . . . . 0.44 110.163 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.28 111.27 23.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.211 0.529 . . . . 2.04 111.051 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -84.09 141.88 30.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.928 -0.578 . . . . 0.87 109.808 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -119.1 160.66 21.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.238 -1.023 . . . . 1.25 108.238 -179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -77.33 119.24 76.68 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 113.368 0.877 . . . . 3.3599999999999999 113.368 -176.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.1 170.06 8.51 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 123.482 2.788 . . . . 1.3899999999999999 109.241 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.68 143.02 34.99 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.286 -1.376 . . . . 1.53 107.286 177.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.28 14.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.716 1.747 . . . . 1.9099999999999999 115.716 -170.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -93.73 -9.98 35.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.61 -0.836 . . . . 3.4900000000000002 110.831 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.16 126.1 30.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.097 0.475 . . . . 1.8899999999999999 110.525 178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -95.64 30.75 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.927 1.346 . . . . 1.3 108.372 171.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 33.4 t -116.11 135.48 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.771 -1.558 . . . . 0.60999999999999999 107.363 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.6 ttm180 -99.44 122.16 42.15 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.361 -1.348 . . . . 1.8400000000000001 107.361 177.241 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -108.55 141.13 40.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.485 -0.931 . . . . 1.1599999999999999 108.485 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.81 -177.34 39.62 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.314 -0.946 . . . . 0.31 110.977 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.2 t -145.14 132.68 20.84 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.556 0.209 . . . . 0.35999999999999999 110.575 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.9 tp -82.62 111.63 18.77 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.965 -2.235 . . . . 0.28000000000000003 104.965 170.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -107.23 119.09 38.45 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.96 -0.564 . . . . 2.6800000000000002 110.195 -172.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 23' ' ' TRP . 77.8 mt -81.05 108.01 14.35 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.695 -1.595 . . . . 1.23 106.695 173.407 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -69.99 -45.15 67.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.97 -1.014 . . . . 2.1800000000000002 108.602 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -129.88 101.2 18.47 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.676 -1.602 . . . . 2.8199999999999998 106.676 172.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -69.03 130.77 20.86 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.37 2.047 . . . . 1.25 111.297 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -128.65 168.85 15.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.361 -0.836 . . . . 1.22 108.983 -177.299 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.254 14.8 p-80 -68.47 -3.2 10.6 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 113.894 1.072 . . . . 2.0299999999999998 113.894 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.88 -10.38 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.482 0.658 . . . . 1.3300000000000001 109.937 174.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.696 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.7 m120 -85.69 28.09 0.8 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.261 1.025 . . . . 2.1899999999999999 113.237 -175.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 35.8 p-10 -126.2 99.1 5.74 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.977 0.894 . . . . 1.96 111.735 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . 170.76 -158.18 29.68 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.298 -0.864 . . . . 0.48999999999999999 111.269 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -97.33 105.69 17.89 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 122.654 0.382 . . . . 2.23 110.343 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.696 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 59.0 m-85 -93.0 106.32 18.29 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.244 -0.65 . . . . 0.68999999999999995 109.244 175.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 38.3 m -92.87 131.99 37.41 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 0.34000000000000002 109.855 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 12' ' ' VAL . 53.2 tp -104.2 117.37 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.148 -0.686 . . . . 0.22 109.148 177.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.14 129.67 51.87 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.315 -0.994 . . . . 0.35999999999999999 108.315 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.21 121.03 32.95 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.256 -1.016 . . . . 0.31 108.256 176.2 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.33 126.05 46.15 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.691 -0.403 . . . . 0.60999999999999999 111.496 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -134.37 169.85 12.81 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 117.448 -1.263 . . . . 1.1799999999999999 107.695 176.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.9 Cg_endo -43.25 -32.24 3.1 Favored 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 123.539 2.826 . . . . 1.0 115.248 178.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -77.08 -34.91 56.94 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 122.028 -0.42 . . . . 1.1000000000000001 111.682 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.04 -166.59 38.79 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 120.405 -0.902 . . . . 0.58999999999999997 112.044 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 27.6 tt0 -124.77 132.97 53.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.993 0.425 . . . . 1.5700000000000001 110.338 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -108.25 152.26 24.84 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.147 -0.686 . . . . 0.37 109.147 178.052 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 p -141.54 148.88 40.07 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 123.482 0.489 . . . . 0.56999999999999995 111.144 -179.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.78 144.22 14.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.318 -1.364 . . . . 0.29999999999999999 107.318 174.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 49.1 m -121.23 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.992 0.425 . . . . 1.26 110.684 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.494 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.11 126.27 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.725 -1.213 . . . . 0.71999999999999997 107.725 178.48 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.4 ttm -92.59 103.86 16.21 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.335 -0.546 . . . . 1.25 110.649 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -95.4 135.0 37.58 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.478 -1.675 . . . . 0.57999999999999996 106.478 174.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.82 101.52 5.3 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.248 -0.649 . . . . 0.83999999999999997 109.248 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -67.97 -71.26 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.387 -0.824 . . . . 3.8599999999999999 111.085 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.8 mtt -149.42 148.77 29.86 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.443 -1.317 . . . . 4.7199999999999998 107.443 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.79 127.35 32.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.194 0.934 . . . . 5.3300000000000001 109.173 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -80.03 117.19 66.25 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 123.891 0.744 . . . . 5.3399999999999999 112.938 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.55 116.88 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.557 2.171 . . . . 5.0700000000000003 111.149 174.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.427 -1.612 0 CA-C-O 118.34 -0.838 . . . . 9.5199999999999996 109.242 178.972 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 120.187 0.041 . . . . 7.9299999999999997 111.058 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -99.95 131.42 45.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.133 -1.062 . . . . 6.1699999999999999 108.133 176.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -113.28 40.85 2.25 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.585 0.707 . . . . 5.4299999999999997 111.313 -175.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -106.01 -27.78 10.95 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.908 -0.495 . . . . 3.8700000000000001 111.653 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.47 -38.94 65.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.106 -0.701 . . . . 2.5499999999999998 109.106 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.43 105.54 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.939 0.876 . . . . 2.0800000000000001 110.708 174.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 t -108.51 99.45 8.83 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.334 -0.848 . . . . 1.5800000000000001 109.136 -178.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.603 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 54.9 m-85 -102.33 122.45 44.28 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.387 -1.338 . . . . 1.1899999999999999 107.387 174.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.25 -179.19 7.15 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.774 -0.648 . . . . 1.3200000000000001 109.768 -176.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.43 128.56 39.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 119.51 -0.876 . . . . 0.45000000000000001 112.373 -168.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -121.57 128.22 51.76 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.815 -1.55 . . . . 1.1899999999999999 106.815 175.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 94' ' ' ALA . 98.0 t -115.25 120.02 63.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.819 0.342 . . . . 0.28999999999999998 110.466 -175.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -119.47 136.03 54.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.816 -0.629 . . . . 2.1800000000000002 109.764 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 98' ' ' ILE . 36.7 mt -123.06 149.63 44.17 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.386 0.613 . . . . 0.33000000000000002 110.897 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -131.07 145.48 52.02 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.975 -1.12 . . . . 1.03 107.975 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 m -64.79 139.22 58.74 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.988 -1.006 . . . . 0.48999999999999999 110.715 -175.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -52.96 139.31 28.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.638 -1.165 . . . . 0.40000000000000002 111.951 -178.195 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -92.07 142.74 12.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.788 -0.642 . . . . 0.56999999999999995 109.914 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.41 111.61 20.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.57 0.582 . . . . 2.52 112.57 -173.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.1 ptt? -162.39 -173.24 3.5 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.48 -0.933 . . . . 0.88 108.48 175.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 118.634 0.652 . . . . 2.75 112.367 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 20' ' ' MET . 81.9 m-70 -110.8 124.82 52.76 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.645 -1.983 . . . . 2.46 105.645 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -82.6 133.48 35.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.295 0.569 . . . . 0.85999999999999999 111.568 -173.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.7 t -126.56 120.49 29.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.021 -0.99 . . . . 0.29999999999999999 110.053 -175.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.5 mt -101.84 101.98 20.98 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.931 -1.137 . . . . 0.29999999999999999 107.931 174.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.05 131.87 16.04 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.524 2.15 . . . . 0.28000000000000003 112.504 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.53 160.22 34.8 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.053 0.454 . . . . 0.37 110.374 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -143.99 111.07 5.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.985 -0.746 . . . . 0.88 108.985 176.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -114.06 122.86 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.78 -0.645 . . . . 0.27000000000000002 109.952 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 28.9 t70 -101.94 141.59 34.55 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.013 -0.54 . . . . 1.3899999999999999 109.99 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.51 148.13 5.62 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.273 -1.131 . . . . 0.59999999999999998 110.273 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -85.9 -55.68 0.39 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.993 -1.114 . . . . 2.6099999999999999 107.993 178.784 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.3 Cg_endo -73.28 119.61 6.09 Favored 'Trans proline' 0 C--N 1.382 2.296 0 N-CA-C 107.275 -1.856 . . . . 0.78000000000000003 107.275 167.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.94 112.85 11.81 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 123.753 0.658 . . . . 0.78000000000000003 112.512 -172.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 42.1 Cg_endo -70.7 141.49 41.54 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.679 2.253 . . . . 0.56000000000000005 112.694 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -76.32 112.32 12.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.065 -1.457 . . . . 1.3700000000000001 107.065 174.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.21 131.15 35.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.165 -0.47 . . . . 0.5 111.301 -177.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -132.28 131.95 42.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.283 -0.636 . . . . 3.7799999999999998 109.283 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 92.0 m95 -98.02 135.39 39.78 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.916 0.389 . . . . 0.28999999999999998 110.002 177.428 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.3 tp -116.56 134.44 54.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.246 -1.761 . . . . 0.94999999999999996 106.246 176.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -121.29 112.52 18.7 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.572 -0.529 . . . . 0.88 109.572 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 57.26 24.82 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.853 0.861 . . . . 1.79 112.464 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.04 4.41 71.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.826 -0.702 . . . . 0.60999999999999999 112.694 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -113.1 151.85 30.29 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.886 -0.783 . . . . 1.3700000000000001 108.886 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.31 117.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.157 -0.683 . . . . 0.69999999999999996 109.157 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.1 tp -82.04 111.33 18.1 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.886 -0.597 . . . . 0.60999999999999999 109.401 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.66 117.39 23.75 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.147 -1.057 . . . . 2.4700000000000002 108.147 176.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.96 122.58 18.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.345 -0.389 . . . . 1.74 110.153 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.7 p -105.78 -171.05 1.83 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.389 -0.369 . . . . 1.5700000000000001 110.047 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -69.35 -21.03 63.85 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.29 0.567 . . . . 1.52 109.828 173.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 58.0 m-85 -91.53 -40.69 11.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.342 -0.39 . . . . 1.5900000000000001 110.379 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.49 106.47 20.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.628 -1.249 . . . . 0.5 107.628 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.22 145.52 41.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.16 0.505 . . . . 2.8900000000000001 112.276 -176.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.5 m -84.38 114.06 21.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.63 -0.878 . . . . 0.44 108.63 176.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.4 127.14 54.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.725 -0.843 . . . . 2.04 108.725 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.92 151.17 21.62 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.74 -0.467 . . . . 0.87 109.74 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -119.87 146.61 45.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 178.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 4.2 mp0 -47.64 105.95 0.54 Allowed Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 125.744 1.618 . . . . 3.3599999999999999 114.623 -172.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.54 136.0 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.187 2.592 . . . . 1.3899999999999999 110.32 174.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.54 159.11 29.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.366 -0.605 . . . . 1.53 109.366 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.62 -3.37 21.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.524 0.564 . . . . 1.9099999999999999 112.524 -175.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -103.5 9.36 37.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.12 0.486 . . . . 3.4900000000000002 109.913 175.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.06 131.75 56.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 120.779 -0.369 . . . . 1.8899999999999999 111.178 -179.178 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.9 p -96.99 2.05 51.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.875 -1.157 . . . . 1.3 107.875 170.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 19.6 t -94.26 128.54 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.17 -1.377 . . . . 0.60999999999999999 108.578 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 67.1 mtp180 -99.88 121.24 41.02 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.644 -1.613 . . . . 1.8400000000000001 106.644 178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -103.8 141.28 36.38 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.758 -0.83 . . . . 1.1599999999999999 108.758 -175.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.51 -173.7 35.89 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 119.613 -1.28 . . . . 0.31 111.967 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 t -151.07 134.33 16.1 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 123.308 0.643 . . . . 0.35999999999999999 110.332 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 55.3 tp -84.43 104.19 14.23 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 104.291 -2.485 . . . . 0.28000000000000003 104.291 169.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -109.34 127.23 54.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.373 -0.531 . . . . 2.6800000000000002 110.963 -171.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 6.6 mp -103.79 111.36 23.84 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.135 -0.939 . . . . 1.23 109.1 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -64.04 -42.84 96.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.47 -1.241 . . . . 2.1800000000000002 109.027 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -128.63 113.04 19.23 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.726 -0.842 . . . . 2.8199999999999998 108.726 176.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.79 130.39 8.62 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.111 1.874 . . . . 1.25 111.885 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 p -107.73 141.4 39.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.263 -1.014 . . . . 1.22 108.263 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -68.38 -14.76 63.22 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 120.965 0.412 . . . . 2.0299999999999998 111.025 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.95 -15.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.91 -0.587 . . . . 1.3300000000000001 111.06 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 47.3 m-80 -102.95 25.84 8.87 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 112.98 0.733 . . . . 2.1899999999999999 112.98 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.701 -1.592 . . . . 1.96 106.701 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.45 -154.12 6.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.084 -1.055 . . . . 0.48999999999999999 113.549 -175.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -105.53 120.16 40.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.066 0.46 . . . . 2.23 111.498 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 16.3 m-85 -101.24 133.79 45.28 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.117 -0.947 . . . . 0.68999999999999995 108.788 178.755 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.8 m -122.78 129.16 51.4 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.909 -1.145 . . . . 0.34000000000000002 107.909 176.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.5 tp -100.83 120.47 40.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.017 -0.734 . . . . 0.22 109.017 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.15 136.28 49.63 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.931 -1.137 . . . . 0.35999999999999999 107.931 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.07 121.28 27.52 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.469 -0.937 . . . . 0.31 108.469 178.051 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.03 122.51 46.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.046 -0.262 . . . . 0.60999999999999999 110.409 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 p-10 -137.22 177.24 2.26 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 107.102 -1.444 . . . . 1.1799999999999999 107.102 177.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.28 -26.98 28.87 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.523 2.149 . . . . 1.0 114.589 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 92.6 m -76.94 -17.85 58.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.883 0.327 . . . . 1.1000000000000001 111.883 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -158.74 22.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.463 -0.875 . . . . 0.58999999999999997 111.653 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -107.6 138.23 44.2 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.899 0.381 . . . . 1.5700000000000001 109.977 -176.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -117.48 158.26 24.83 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.385 -1.339 . . . . 0.37 107.385 174.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 42.7 p -153.84 159.11 41.71 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 112.442 0.534 . . . . 0.56999999999999995 112.442 -177.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.17 153.98 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.833 -1.543 . . . . 0.29999999999999999 106.833 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 p -123.48 151.45 42.74 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 118.075 0.398 . . . . 1.26 111.138 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -148.8 128.4 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.71999999999999997 107.661 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.5 110.99 23.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.066 -1.457 . . . . 1.25 107.066 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.65 112.76 25.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.749 0.785 . . . . 0.57999999999999996 111.659 -174.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.46 101.2 10.88 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.77 -1.105 . . . . 0.83999999999999997 108.027 176.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.3 -69.9 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.727 -0.67 . . . . 3.8599999999999999 109.722 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -142.07 145.47 34.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.169 -1.049 . . . . 4.7199999999999998 108.169 178.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.97 135.79 40.03 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.834 0.854 . . . . 5.3300000000000001 111.052 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 16.5 t-20 -56.54 115.81 11.15 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 124.475 1.11 . . . . 5.3399999999999999 112.495 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 4.0 Cg_exo -78.18 149.28 25.03 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.202 1.935 . . . . 5.0700000000000003 109.798 173.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 117.51 -1.233 . . . . 9.5199999999999996 111.511 -178.694 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.418 -2.047 0 N-CA-C 108.314 -0.995 . . . . 1.58 108.314 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.538 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-85 -97.69 124.26 41.94 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.917 -1.142 . . . . 1.19 107.917 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.99 173.93 10.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.712 -1.218 . . . . 1.32 107.712 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.43 127.14 41.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.318 -0.553 . . . . 0.45 111.978 -173.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 50.3 m -118.17 140.82 49.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.346 -1.353 . . . . 1.19 107.346 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 94' ' ' ALA . 95.5 t -115.93 121.22 66.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 121.378 0.608 . . . . 0.29 112.025 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 79.3 mt-30 -108.13 130.63 55.1 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.864 -1.161 . . . . 2.18 107.864 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 98' ' ' ILE . 28.4 mt -122.96 156.2 35.21 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.232 -0.655 . . . . 0.33 109.232 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -132.11 151.01 52.01 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.549 -0.538 . . . . 1.03 109.549 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -60.04 132.47 54.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 124.551 1.157 . . . . 0.49 110.058 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -59.42 135.06 57.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 124.473 1.108 . . . . 0.4 109.722 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.44 127.91 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.694 -0.484 . . . . 0.57 109.694 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.3 mt-10 -77.86 109.96 12.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.126 -0.943 . . . . 2.52 112.058 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -168.9 162.39 11.25 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.807 -2.294 . . . . 0.88 104.807 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -55.63 -36.67 67.26 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.967 1.258 . . . . 2.75 113.42 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -95.5 99.22 11.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.893 -1.521 . . . . 2.46 106.893 172.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 53.3 m95 -81.0 137.59 36.07 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.226 -0.443 . . . . 0.86 110.203 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.07 124.04 31.88 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.765 -0.652 . . . . 0.3 110.222 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.3 mt -107.27 95.57 13.63 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.12 -1.437 . . . . 0.3 107.12 172.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.06 134.92 26.25 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.655 2.237 . . . . 0.28 111.912 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -129.74 155.49 45.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.112 0.482 . . . . 0.37 111.171 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 23.0 m -138.72 117.7 12.49 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.349 -0.982 . . . . 0.88 108.349 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -126.08 123.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.27 -1.011 . . . . 0.27 108.27 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 6.1 p-10 -108.96 156.33 19.84 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.868 -0.733 . . . . 1.39 111.013 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.57 147.25 4.57 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.652 -0.979 . . . . 0.6 110.652 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -86.31 -50.28 0.49 Allowed Pre-proline 0 C--N 1.311 -1.078 0 CA-C-O 119.126 -0.464 . . . . 2.61 111.253 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.5 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 C--N 1.366 1.453 0 N-CA-C 107.398 -1.808 . . . . 0.78 107.398 167.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.67 117.48 45.02 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 115.773 -0.649 . . . . 0.78 111.75 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -85.27 145.71 9.67 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.85 1.7 . . . . 0.56 111.642 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -78.32 120.17 22.71 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.122 -1.066 . . . . 1.37 108.122 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 56' ' ' PHE . 97.2 mt -93.17 123.3 36.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.891 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -134.66 131.82 38.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.029 -0.532 . . . . 3.78 110.848 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 87.6 m95 -93.02 135.07 34.52 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.359 -0.837 . . . . 0.29 109.495 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -113.11 134.51 54.51 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.894 -1.891 . . . . 0.95 105.894 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 81.0 t80 -125.34 111.42 15.16 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.489 -0.56 . . . . 0.88 109.489 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.61 34.59 24.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.165 0.986 . . . . 1.79 111.048 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.6 85.64 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.142 -0.481 . . . . 0.61 112.974 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -108.33 153.6 23.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.753 -0.832 . . . . 1.37 108.753 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.25 115.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.759 . . . . 0.7 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -89.34 122.62 32.75 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.61 108.247 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.57 129.92 55.54 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.374 -1.343 . . . . 2.47 107.374 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.235 0.614 . . . . 1.74 111.194 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 p -126.26 -165.69 1.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.044 -0.724 . . . . 1.57 109.044 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 m -78.62 -22.45 46.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 118.414 0.552 . . . . 1.52 110.597 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.2 m-85 -87.21 -40.39 14.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.745 -0.382 . . . . 1.59 110.386 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -112.49 106.71 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.701 -1.222 . . . . 0.5 107.701 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -130.88 139.71 50.15 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.179 0.807 . . . . 2.89 113.179 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -84.68 119.96 25.84 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.263 -0.88 . . . . 0.44 109.749 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -94.09 125.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.44 -0.346 . . . . 2.04 110.441 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 37' ' ' LEU . 66.8 m-85 -106.78 106.74 17.41 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.582 -1.636 . . . . 0.87 106.582 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 67' ' ' HIS . 3.5 pp -95.0 154.63 17.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.397 -0.921 . . . . 1.25 108.956 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 8.5 mm-40 -70.26 113.0 14.58 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 123.479 0.711 . . . . 3.36 111.574 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.1 Cg_exo -78.81 161.15 27.45 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.727 2.285 . . . . 1.39 110.552 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.82 142.06 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.82 -6.19 20.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.136 0.574 . . . . 1.91 112.243 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -104.0 -0.7 28.54 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.142 -0.481 . . . . 3.49 111.332 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.5 pt-20 -115.04 146.15 41.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.691 -1.226 . . . . 1.89 107.691 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -94.12 2.91 55.92 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.134 -0.691 . . . . 1.3 109.134 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 16.8 t -99.94 129.03 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.617 -0.72 . . . . 0.61 111.609 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB3' HG13 ' A' ' 29' ' ' VAL . 14.3 ttm180 -94.55 134.97 36.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.148 -1.797 . . . . 1.84 106.148 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.502 ' HB2' HD11 ' A' ' 57' ' ' LEU . 47.7 m-70 -121.16 161.79 21.23 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.612 -0.435 . . . . 1.16 110.266 -175.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.29 -165.38 35.24 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 120.674 -0.774 . . . . 0.31 111.334 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 t -156.16 141.87 17.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.502 -0.555 . . . . 0.36 109.502 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 50.3 tp -91.02 100.93 13.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.618 -2.364 . . . . 0.28 104.618 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -103.27 129.27 50.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.218 -0.593 . . . . 2.68 110.63 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 5.7 mp -108.73 109.18 20.27 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.617 -0.883 . . . . 1.23 108.617 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -72.15 -43.09 65.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.599 -1.182 . . . . 2.18 109.95 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 101.0 31.9 Favored Pre-proline 0 N--CA 1.429 -1.501 0 N-CA-C 105.641 -1.985 . . . . 2.82 105.641 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.05 147.11 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.617 2.211 . . . . 1.25 112.372 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 p -130.06 141.29 50.73 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 122.039 -0.413 . . . . 1.22 110.406 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 41.8 p-80 -58.54 -6.4 0.7 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.118 1.525 . . . . 2.03 115.118 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.79 -17.06 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.152 -0.684 . . . . 1.33 109.152 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 17.5 m120 -83.34 -1.2 52.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.241 1.016 . . . . 2.19 109.625 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 39.5 t30 -77.11 81.22 3.63 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.28 -0.873 . . . . 1.96 108.883 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.88 -155.86 8.99 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.201 -0.909 . . . . 0.49 111.669 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 26.3 t-20 -98.43 128.97 45.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.841 0.682 . . . . 2.23 112.841 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 76.9 m-85 -108.25 141.57 39.83 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.969 1.308 . . . . 0.69 108.021 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.1 m -142.57 134.44 27.0 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.631 -0.668 . . . . 0.34 109.353 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.8 tp -104.89 122.45 45.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.77 -0.456 . . . . 0.22 109.77 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.91 125.25 52.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.204 -1.036 . . . . 0.36 108.204 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -120.65 120.8 36.78 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.19 -1.041 . . . . 0.31 108.19 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.69 121.6 35.94 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.83 -0.348 . . . . 0.61 111.425 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.9 p30 -128.59 170.97 9.39 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 107.576 -1.268 . . . . 1.18 107.576 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.9 Cg_exo -48.06 -41.26 33.74 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.602 2.201 . . . . 1.0 114.432 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -67.29 -45.65 75.91 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.509 -0.476 . . . . 1.1 112.207 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.01 178.09 47.54 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 119.103 -1.523 . . . . 0.59 113.594 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -119.86 133.53 55.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 123.202 0.601 . . . . 1.57 109.742 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -113.9 155.28 26.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.138 -0.69 . . . . 0.37 109.138 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.7 p -144.8 148.03 33.57 Favored 'General case' 0 N--CA 1.418 -2.068 0 O-C-N 123.52 0.513 . . . . 0.57 110.26 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.82 146.38 29.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.057 -1.831 . . . . 0.3 106.057 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -118.48 144.31 46.1 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.473 -0.491 . . . . 1.26 110.318 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.742 HG22 HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -134.67 122.16 37.76 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 C-N-CA 124.807 1.243 . . . . 0.72 109.505 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.19 108.6 16.82 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.777 -1.564 . . . . 1.25 106.777 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 155.84 25.22 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.313 -0.403 . . . . 0.58 110.924 -174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.38 100.65 10.07 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.385 0.612 . . . . 0.84 111.373 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 86.0 m-85 . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 108.146 -1.057 . . . . 3.86 108.146 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.403 -2.791 0 N-CA-C 109.374 -0.602 . . . . 1.58 109.374 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.612 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.9 m-85 -75.09 115.68 14.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.093 -1.447 . . . . 1.19 107.093 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -83.2 178.14 8.23 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.937 -0.764 . . . . 1.32 108.937 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 126.92 40.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 119.745 -0.782 . . . . 0.45 111.257 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -122.93 143.23 50.04 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.142 -1.429 . . . . 1.19 107.142 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 85.4 t -115.81 121.14 66.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.132 0.491 . . . . 0.29 110.901 -174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 118.83 37.77 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.301 -0.863 . . . . 2.18 108.858 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 98' ' ' ILE . 34.0 mt -115.44 144.64 43.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.943 0.401 . . . . 0.33 109.984 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.95 151.27 51.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.968 -0.753 . . . . 1.03 108.968 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 m -57.49 135.1 56.58 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 124.455 1.097 . . . . 0.49 110.411 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -56.2 130.86 46.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.393 1.058 . . . . 0.4 110.66 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.9 136.14 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.335 0.588 . . . . 0.57 110.094 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.93 106.94 7.79 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.331 -1.304 . . . . 2.52 110.54 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.4 mtm -141.93 -163.16 1.53 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.953 -1.499 . . . . 0.88 106.953 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -67.89 -45.03 75.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.99 -0.744 . . . . 2.75 108.99 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -111.85 138.84 47.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 106.393 -1.706 . . . . 2.46 106.393 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 72.4 m95 -81.76 133.54 35.35 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 109.506 -0.553 . . . . 0.86 109.506 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 42.1 t -120.26 116.09 24.89 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.3 -0.864 . . . . 0.3 110.093 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 69.9 mt -100.08 99.37 9.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.144 -1.428 . . . . 0.3 107.144 172.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 2.9 Cg_exo -75.3 125.89 9.41 Favored 'Trans proline' 0 C--O 1.252 1.207 0 C-N-CA 122.502 2.135 . . . . 0.28 111.804 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -120.98 153.57 37.14 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.092 -0.707 . . . . 0.37 109.092 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.5 m -140.54 114.3 8.87 Favored 'General case' 0 C--N 1.267 -3.02 0 N-CA-C 108.715 -0.846 . . . . 0.88 108.715 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -110.43 116.31 52.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.596 -0.89 . . . . 0.27 108.596 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 8.5 t70 -101.22 137.06 40.07 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.634 -0.876 . . . . 1.39 108.634 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.46 145.17 4.27 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 110.326 -1.11 . . . . 0.6 110.326 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -84.05 -55.53 0.46 Allowed Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.739 -0.467 . . . . 2.61 109.739 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.1 Cg_endo -62.4 120.78 8.48 Favored 'Trans proline' 0 C--N 1.387 2.56 0 N-CA-C 108.643 -1.329 . . . . 0.78 108.643 170.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.1 111.59 8.99 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 116.15 -0.477 . . . . 0.78 111.531 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -83.97 162.13 13.79 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 122.547 2.165 . . . . 0.56 112.344 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 7.9 p -94.37 130.01 40.86 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.516 -0.92 . . . . 1.37 108.516 174.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' A' ' 85' ' ' LEU . 88.2 mt -98.54 140.67 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -143.88 133.71 23.89 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.162 -0.681 . . . . 3.78 109.162 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.456 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.3 m95 -96.64 117.46 31.04 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.29 109.862 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -100.72 127.23 47.21 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.336 -1.727 . . . . 0.95 106.336 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.5 ' HZ ' ' O ' ' A' ' 78' ' ' VAL . 88.7 t80 -122.97 108.05 12.51 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 109.213 -0.662 . . . . 0.88 109.213 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.58 17.7 6.39 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.679 0.791 . . . . 1.79 112.835 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.1 -12.16 40.7 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.973 -0.632 . . . . 0.61 112.685 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 m -108.62 151.99 25.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.851 -0.796 . . . . 1.37 108.851 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.41 123.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.379 -0.373 . . . . 0.7 110.017 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.2 tp -82.65 113.38 20.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.845 -0.616 . . . . 0.61 109.552 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.01 140.78 30.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.374 -0.602 . . . . 2.47 109.374 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.77 137.59 36.25 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.785 -0.643 . . . . 1.74 110.084 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 p -127.16 -165.97 1.54 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.773 0.829 . . . . 1.57 110.068 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 m -75.64 -31.91 60.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.023 0.44 . . . . 1.52 110.546 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -89.84 -28.41 19.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.071 0.397 . . . . 1.59 112.071 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.43 HG23 HD23 ' A' ' 72' ' ' LEU . 55.9 mt -125.53 106.64 16.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.091 -0.707 . . . . 0.5 109.091 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HE1' HD21 ' A' ' 73' ' ' ASN . 53.0 p90 -145.91 156.27 43.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.61 -0.436 . . . . 2.89 110.547 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -85.23 109.79 18.58 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.666 -0.864 . . . . 0.44 108.666 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.54 108.77 21.55 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.37 -0.974 . . . . 2.04 108.37 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -85.95 145.74 27.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.53 -0.915 . . . . 0.87 108.53 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.2 pp -109.42 157.96 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.376 -1.713 . . . . 1.25 106.376 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.07 109.0 5.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 O-C-N 123.485 0.491 . . . . 3.36 110.15 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.63 140.92 19.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.393 2.062 . . . . 1.39 111.705 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.61 134.66 51.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.069 -1.085 . . . . 1.53 108.069 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.17 -18.28 63.31 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.832 0.678 . . . . 1.91 112.832 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.65 -23.2 59.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.256 -0.429 . . . . 3.49 110.478 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.83 152.31 18.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.515 -0.55 . . . . 1.89 109.515 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 11.12 38.26 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.496 -1.298 . . . . 1.3 107.496 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.5 t -104.74 127.88 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.037 -0.983 . . . . 0.61 110.617 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HB2' HG13 ' A' ' 29' ' ' VAL . 66.5 mtp180 -92.43 115.06 27.75 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.574 -1.639 . . . . 1.84 106.574 176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 90.5 m-70 -101.97 142.73 32.8 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.263 -0.643 . . . . 1.16 109.263 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.78 -178.79 38.4 Favored Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 120.21 -0.995 . . . . 0.31 111.327 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 t -144.33 132.81 22.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 120.547 0.213 . . . . 0.36 111.278 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 54.4 tp -87.16 114.01 23.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.433 -2.062 . . . . 0.28 105.433 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 16.4 ptm180 -106.76 119.58 39.71 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 112.338 0.495 . . . . 2.68 112.338 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.43 HD23 HG23 ' A' ' 52' ' ' ILE . 15.6 mt -92.85 108.2 19.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.75 -2.315 . . . . 1.23 104.75 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.405 HD21 ' HE1' ' A' ' 53' ' ' PHE . 86.8 m-20 -74.35 -52.53 11.93 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 108.982 -0.747 . . . . 2.18 108.982 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -128.26 100.23 23.44 Favored Pre-proline 0 N--CA 1.397 -3.111 0 N-CA-C 105.843 -1.91 . . . . 2.82 105.843 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 25.2 Cg_exo -67.09 150.39 82.36 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.11 1.873 . . . . 1.25 109.897 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -112.62 178.14 4.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.577 -0.283 . . . . 1.22 111.073 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -52.63 -37.02 57.69 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.469 0.708 . . . . 2.03 112.626 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.5 ' O ' ' HZ ' ' A' ' 41' ' ' PHE . 14.6 m -77.17 -10.44 13.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 112.825 0.676 . . . . 1.33 112.825 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.58 26.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.701 1.0 . . . . 2.19 113.701 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.6 m-20 -110.86 53.47 0.7 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.755 -1.943 . . . . 1.96 105.755 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -133.78 -168.23 11.78 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.38 -1.39 . . . . 0.49 114.061 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 15.0 m120 -102.43 114.59 28.91 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.517 0.727 . . . . 2.23 109.989 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.09 116.2 31.56 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.738 -0.838 . . . . 0.69 108.738 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 77.8 m -116.62 122.75 45.53 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.694 -0.484 . . . . 0.34 109.694 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.1 tp -96.84 118.32 33.02 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.765 -0.457 . . . . 0.22 109.765 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.6 136.33 41.63 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.748 -0.834 . . . . 0.36 108.748 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' SER . . . -128.49 120.42 26.77 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.86 -1.163 . . . . 0.31 107.86 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.07 134.4 54.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 123.16 0.288 . . . . 0.61 110.599 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -153.2 171.93 6.24 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.67 -1.233 . . . . 1.18 107.67 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -55.94 -39.32 91.9 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.284 1.989 . . . . 1.0 113.408 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.55 -15.74 61.77 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.045 0.387 . . . . 1.1 112.045 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.27 -161.46 29.72 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 119.02 -1.562 . . . . 0.59 113.252 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.72 124.29 25.0 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.814 -0.81 . . . . 1.57 108.814 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.38 151.15 22.6 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.66 -0.867 . . . . 0.37 108.66 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 6.4 p -152.23 135.31 15.72 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.719 0.637 . . . . 0.57 110.775 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.44 47.08 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.175 -1.417 . . . . 0.3 107.175 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -129.54 145.24 51.49 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.875 0.369 . . . . 1.26 111.318 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.516 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -143.98 126.37 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.72 107.947 178.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -106.67 137.19 45.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.221 -0.659 . . . . 1.25 109.221 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.46 145.86 47.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.765 -0.828 . . . . 0.58 108.765 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -127.64 104.08 7.67 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.272 0.558 . . . . 0.84 110.433 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 58.2 t80 . . . . . 0 C--N 1.302 -1.484 0 N-CA-C 114.389 1.255 . . . . 3.86 114.389 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.379 -3.976 0 CA-C-O 122.193 0.997 . . . . 1.58 110.259 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 95.1 m-85 -96.61 127.26 42.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.323 -1.732 . . . . 1.19 106.323 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.2 m -92.4 -159.39 0.66 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 119.145 -0.455 . . . . 1.32 110.227 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.58 106.84 18.78 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 119.369 0.986 . . . . 0.45 112.123 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 39.4 m -112.81 126.68 55.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.399 -0.819 . . . . 1.19 108.882 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 94' ' ' ALA . 62.1 t -115.55 124.86 72.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 120.926 0.393 . . . . 0.29 112.0 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -124.83 121.13 33.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.092 -1.077 . . . . 2.18 108.092 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 98' ' ' ILE . 43.3 mt -105.0 156.12 18.33 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.982 0.42 . . . . 0.33 111.494 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -130.91 144.28 51.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.453 -1.314 . . . . 1.03 107.453 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -65.25 136.99 57.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.718 0.807 . . . . 0.49 110.089 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -51.58 138.63 22.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.403 1.064 . . . . 0.4 110.926 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.62 143.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.036 -0.529 . . . . 0.57 110.234 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.86 98.53 2.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.796 -1.093 . . . . 2.52 111.685 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -141.21 -169.59 2.88 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.395 -1.335 . . . . 0.88 107.395 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -78.93 -39.67 34.02 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.995 -0.743 . . . . 2.75 108.995 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -101.55 127.08 48.42 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.858 -1.905 . . . . 2.46 105.858 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.5 m95 -82.78 126.83 32.85 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.099 0.476 . . . . 0.86 110.991 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 43.7 t -117.73 118.13 31.23 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.51 -0.768 . . . . 0.3 109.435 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 72.6 mt -101.75 97.43 7.94 Favored Pre-proline 0 C--O 1.247 0.952 0 N-CA-C 107.599 -1.26 . . . . 0.3 107.599 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 9.7 Cg_exo -74.25 136.0 21.43 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.507 2.138 . . . . 0.28 111.427 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -124.41 161.32 26.25 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.283 0.563 . . . . 0.37 110.818 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -140.8 110.51 6.43 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.792 -0.818 . . . . 0.88 108.792 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 66' ' ' ARG . 4.0 p -123.33 117.49 51.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.059 -1.089 . . . . 0.27 108.059 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.7 p-10 -103.1 165.94 10.73 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.526 -1.27 . . . . 1.39 110.715 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.58 165.54 12.5 Favored Glycine 0 N--CA 1.409 -3.111 0 O-C-N 124.823 1.327 . . . . 0.6 109.935 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.402 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 23.8 mm-40 -101.96 -55.22 0.13 Allowed Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.788 -0.449 . . . . 2.61 109.788 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.2 Cg_endo -66.05 119.78 6.85 Favored 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.08 -1.931 . . . . 0.78 107.08 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 115.07 27.31 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 0.78 111.508 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 92.7 Cg_endo -81.01 134.59 9.45 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 121.516 1.477 . . . . 0.56 111.356 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -70.61 132.75 45.93 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.519 -1.289 . . . . 1.37 107.519 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 85' ' ' LEU . 72.1 mt -100.04 120.45 39.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.968 0.414 . . . . 0.5 110.432 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 48' ' ' GLU . 9.2 tpp180 -122.1 128.05 50.87 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.532 -0.758 . . . . 3.78 109.819 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -93.9 155.37 17.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.082 -0.508 . . . . 0.29 110.627 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 11.5 tp -137.83 141.1 40.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.185 -1.413 . . . . 0.95 107.185 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -119.12 101.96 8.39 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.348 0.659 . . . . 0.88 109.43 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 57.69 31.38 20.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.96 0.904 . . . . 1.79 111.063 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.51 -19.04 55.33 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.707 -0.759 . . . . 0.61 112.74 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.7 t -88.68 140.98 28.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.44 -0.578 . . . . 1.37 109.44 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.21 117.1 2.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.741 -0.663 . . . . 0.7 111.007 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.7 tp -91.13 126.46 36.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.011 -0.737 . . . . 0.61 109.011 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -93.99 137.39 33.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.898 -0.592 . . . . 2.47 109.441 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' HH12 ' A' ' 38' ' ' ARG . 34.9 mt-10 -79.76 83.31 5.73 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 1.74 108.754 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -84.48 -178.41 6.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.198 -0.91 . . . . 1.57 110.706 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -58.96 -34.82 72.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.213 0.53 . . . . 1.52 111.67 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -87.43 -13.99 41.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.643 0.609 . . . . 1.59 112.643 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.19 105.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 107.304 -1.369 . . . . 0.5 107.304 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -135.94 145.95 46.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.509 -0.877 . . . . 2.89 112.025 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 m -89.7 110.21 21.12 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.912 -1.144 . . . . 0.44 107.912 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.33 113.38 26.63 Favored 'General case' 0 N--CA 1.418 -2.025 0 C-N-CA 119.325 -0.95 . . . . 2.04 109.047 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' CE1' HD12 ' A' ' 37' ' ' LEU . 70.5 m-85 -87.74 133.84 33.78 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.831 -1.544 . . . . 0.87 106.831 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.16 164.19 19.31 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.234 -0.986 . . . . 1.25 108.949 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.82 120.5 50.36 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.779 -0.823 . . . . 3.36 108.779 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.12 128.34 30.11 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 122.635 2.223 . . . . 1.39 111.253 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.91 125.45 29.32 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.282 -0.872 . . . . 1.53 108.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.22 -27.81 62.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.0 -1.0 . . . . 1.91 113.006 -173.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.3 -9.16 42.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.047 0.388 . . . . 3.49 112.047 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -102.3 150.28 23.48 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.693 0.759 . . . . 1.89 112.248 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.5 p -105.07 7.99 34.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.991 -1.004 . . . . 1.3 108.701 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 18.1 t -112.0 133.26 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.922 -1.035 . . . . 0.61 109.668 -176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HB2' HG13 ' A' ' 29' ' ' VAL . 64.8 mtp180 -87.56 134.86 33.55 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.685 -1.598 . . . . 1.84 106.685 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -124.3 155.68 38.25 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.009 0.433 . . . . 1.16 109.891 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.03 -171.63 43.03 Favored Glycine 0 N--CA 1.411 -3.028 0 N-CA-C 109.516 -1.434 . . . . 0.31 109.516 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.422 ' SG ' ' HG2' ' A' ' 71' ' ' ARG . 39.3 t -148.03 141.26 25.12 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.004 0.43 . . . . 0.36 110.793 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.0 tp -88.65 102.23 14.76 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.282 -2.118 . . . . 0.28 105.282 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HG2' ' SG ' ' A' ' 69' ' ' CYS . 85.2 mtm-85 -102.37 129.2 48.77 Favored 'General case' 0 CA--C 1.48 -1.745 0 C-N-CA 119.203 -0.999 . . . . 2.68 110.857 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 23' ' ' TRP . 62.8 mt -86.24 108.47 18.39 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.561 -1.644 . . . . 1.23 106.561 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -67.64 -47.07 70.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 114.691 -1.141 . . . . 2.18 109.011 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -128.12 110.07 19.87 Favored Pre-proline 0 N--CA 1.421 -1.882 0 N-CA-C 106.439 -1.689 . . . . 2.82 106.439 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 35.1 Cg_endo -68.83 130.54 20.69 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 121.607 1.538 . . . . 1.25 111.275 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.6 p -123.96 171.99 9.29 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.57 -0.741 . . . . 1.22 109.632 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -72.46 -8.54 55.59 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.452 0.538 . . . . 2.03 112.452 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.89 -9.54 11.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.394 0.616 . . . . 1.33 110.422 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.657 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.1 m120 -90.12 27.12 1.69 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.711 0.767 . . . . 2.19 110.467 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -126.57 64.96 1.26 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.016 -1.105 . . . . 1.96 108.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.06 -158.55 11.52 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.525 -0.845 . . . . 0.49 112.234 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -96.55 129.22 43.98 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.377 -0.231 . . . . 2.23 110.377 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 52.6 m-85 -116.64 117.75 30.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.035 0.445 . . . . 0.69 110.427 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.1 m -100.47 136.07 40.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.238 -0.653 . . . . 0.34 109.238 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' SER . 49.3 tp -103.29 114.21 28.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.187 -0.672 . . . . 0.22 109.187 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.8 mm? -100.63 116.41 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.145 -1.057 . . . . 0.36 108.145 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -113.72 120.98 42.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.948 -1.13 . . . . 0.31 107.948 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.64 50.67 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.872 -0.331 . . . . 0.61 111.549 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 42.7 p30 -141.12 175.25 3.18 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.34 -1.355 . . . . 1.18 107.34 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 52.9 Cg_exo -47.08 -29.77 9.23 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.851 2.368 . . . . 1.0 115.035 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.6 m -71.6 -41.23 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.073 0.463 . . . . 1.1 111.769 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.21 -162.76 35.05 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.571 -0.824 . . . . 0.59 111.051 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 62.4 tt0 -132.47 131.32 41.57 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.857 -0.423 . . . . 1.57 109.857 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -107.76 150.19 27.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.0 p -142.8 120.78 12.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.771 0.32 . . . . 0.57 111.831 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.34 147.92 45.04 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.542 -1.281 . . . . 0.3 107.542 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -118.46 123.88 46.25 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 118.002 0.364 . . . . 1.26 111.164 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.485 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -118.92 120.22 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.974 -1.121 . . . . 0.72 107.974 178.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.53 128.74 39.79 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.288 -1.004 . . . . 1.25 108.288 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.75 116.91 30.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.875 0.369 . . . . 0.58 110.583 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.11 101.4 12.86 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.355 0.598 . . . . 0.84 109.414 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 20.3 t80 . . . . . 0 C--N 1.303 -1.413 0 CA-C-N 115.29 -0.868 . . . . 3.86 112.501 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.397 -3.077 0 CA-C-O 122.2 1.0 . . . . 1.58 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.488 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 67.1 m-85 -81.48 109.96 16.43 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 105.775 -1.935 . . . . 1.19 105.775 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.3 t -84.0 175.59 9.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.228 -1.027 . . . . 1.32 108.228 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.71 126.37 39.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 112.852 0.686 . . . . 0.45 112.852 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -123.82 139.13 54.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.515 -1.291 . . . . 1.19 107.515 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 94' ' ' ALA . 82.7 t -115.36 114.41 46.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.583 -0.525 . . . . 0.29 109.583 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -111.42 116.72 31.4 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.967 -0.56 . . . . 2.18 110.791 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.477 HD13 HG22 ' A' ' 98' ' ' ILE . 42.7 mt -102.71 156.34 17.7 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.277 -0.874 . . . . 0.33 109.16 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -131.82 153.01 50.59 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.344 -0.613 . . . . 1.03 109.344 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -58.85 137.38 57.8 Favored 'General case' 0 N--CA 1.425 -1.724 0 O-C-N 124.909 1.38 . . . . 0.49 108.728 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 143.03 56.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.19 -0.67 . . . . 0.4 109.19 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.62 129.85 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.52 0.676 . . . . 0.57 110.146 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.73 91.75 4.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.724 -1.125 . . . . 2.52 112.514 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -154.43 -178.32 7.07 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.084 -1.821 . . . . 0.88 106.084 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -71.93 -28.64 63.61 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 120.554 1.525 . . . . 2.75 110.499 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.43 100.96 13.44 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -81.89 99.55 9.12 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.837 0.827 . . . . 0.86 110.22 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.6 t -103.05 123.05 45.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.717 -1.583 . . . . 0.3 109.123 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 62.6 mt -105.87 99.97 25.23 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.426 -1.324 . . . . 0.3 107.426 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.29 132.72 18.23 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.361 2.041 . . . . 0.28 112.58 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HB3' HD23 ' A' ' 14' ' ' LEU . 46.9 p90 -128.35 149.9 50.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.232 0.539 . . . . 0.37 109.869 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -136.61 112.68 9.7 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.229 -1.026 . . . . 0.88 108.229 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.7 p -110.83 119.23 59.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.825 -0.805 . . . . 0.27 108.825 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 25.0 t70 -101.0 132.05 46.59 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.243 -1.021 . . . . 1.39 108.243 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.83 131.66 1.28 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 109.387 -1.485 . . . . 0.6 109.387 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.448 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 25.4 tt0 -75.64 -54.77 2.19 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.629 -0.508 . . . . 2.61 109.629 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 19.7 Cg_endo -63.11 120.42 7.89 Favored 'Trans proline' 0 C--N 1.379 2.163 0 N-CA-C 107.384 -1.814 . . . . 0.78 107.384 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.0 12.52 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.193 -0.458 . . . . 0.78 111.807 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.503 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 87.4 Cg_endo -76.64 149.69 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.11 1.874 . . . . 0.56 111.698 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -76.13 109.37 9.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.567 -0.901 . . . . 1.37 108.567 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 29' ' ' VAL . 90.8 mt -87.36 125.68 34.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.876 0.37 . . . . 0.5 110.953 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -135.52 130.95 35.39 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.223 -0.444 . . . . 3.78 110.11 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -90.97 131.56 36.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.749 -0.659 . . . . 0.29 109.734 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -104.88 127.03 52.55 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 105.247 -2.131 . . . . 0.95 105.247 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.29 109.54 16.97 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 122.662 0.385 . . . . 0.88 110.254 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.8 t30 51.35 52.36 14.96 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.344 1.028 . . . . 1.79 110.58 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.73 51.01 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 114.541 -1.209 . . . . 0.61 114.179 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -122.7 161.27 24.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.862 -0.792 . . . . 1.37 108.862 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.78 117.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 115.338 -0.846 . . . . 0.7 110.416 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.64 98.53 9.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.076 -0.65 . . . . 0.61 110.085 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -84.62 95.64 8.94 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 103.951 -2.611 . . . . 2.47 103.951 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.99 125.54 23.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.875 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.5 p -103.9 -165.44 1.15 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.14 -0.936 . . . . 1.57 111.852 -172.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -84.49 -9.93 57.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.906 0.86 . . . . 1.52 108.876 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -89.02 -39.7 13.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.417 -0.81 . . . . 1.59 109.094 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 40.5 mt -127.48 106.38 15.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.755 -1.572 . . . . 0.5 106.755 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 32.3 p90 -131.39 150.37 52.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 119.608 -0.837 . . . . 2.89 112.728 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 m -92.55 110.51 21.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.716 -1.129 . . . . 0.44 110.105 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.48 113.11 23.73 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.693 -0.854 . . . . 2.04 108.693 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.54 138.03 31.81 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.544 0.687 . . . . 0.87 110.687 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' HIS . 11.0 mt -100.71 136.67 40.21 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.055 -0.975 . . . . 1.25 109.606 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -68.52 112.84 12.36 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 124.802 1.314 . . . . 3.36 111.983 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.33 155.06 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.197 2.598 . . . . 1.39 110.172 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.09 19.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 119.097 -0.478 . . . . 1.53 109.74 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.03 85.09 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 118.724 0.693 . . . . 1.91 112.695 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.07 -2.67 58.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.173 1.175 . . . . 3.49 114.173 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -101.17 157.59 16.66 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.592 -0.843 . . . . 1.89 108.825 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 p -112.4 15.93 20.08 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.834 0.349 . . . . 1.3 111.697 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.12 124.57 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 119.967 -0.693 . . . . 0.61 110.363 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.0 mtp180 -95.73 116.59 29.1 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 105.665 -1.976 . . . . 1.84 105.665 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 55.7 m-70 -98.73 149.5 22.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.181 -1.044 . . . . 1.16 108.181 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.01 174.96 46.01 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 119.338 -1.41 . . . . 0.31 112.388 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -144.76 132.66 21.3 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.471 0.708 . . . . 0.36 109.929 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 42.2 tp -88.44 113.18 23.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.644 -1.984 . . . . 0.28 105.644 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -107.34 123.37 48.24 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.131 0.491 . . . . 2.68 111.596 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 52' ' ' ILE . 49.5 mt -84.79 108.37 17.44 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 106.567 -1.642 . . . . 1.23 106.567 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.3 t30 -73.4 -52.94 12.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.071 -0.968 . . . . 2.18 109.059 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.0 101.23 51.25 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.56 -1.274 . . . . 2.82 107.56 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.04 129.47 18.41 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.688 1.592 . . . . 1.25 110.331 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 p -138.62 168.88 18.83 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -76.13 -6.01 49.24 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 122.243 -0.286 . . . . 2.03 111.479 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.44 -21.41 10.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 109.212 -0.662 . . . . 1.33 109.212 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.27 -10.6 59.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.657 0.741 . . . . 2.19 109.799 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 11.2 t30 -83.57 75.97 9.99 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.23 -1.396 . . . . 1.96 107.23 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.55 -171.58 27.78 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.21 -0.905 . . . . 0.49 111.533 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.29 128.23 38.06 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.42 0.526 . . . . 2.23 112.42 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.47 123.09 48.54 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.224 -1.028 . . . . 0.69 108.224 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 61.7 m -115.42 128.99 56.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.19 -0.671 . . . . 0.34 109.19 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.1 tp -99.61 114.59 27.73 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.1 -0.704 . . . . 0.22 109.1 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.14 131.01 50.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.157 -1.053 . . . . 0.36 108.157 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -121.14 119.04 31.23 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.916 -1.142 . . . . 0.31 107.916 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.16 130.4 46.29 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.235 -0.439 . . . . 0.61 110.045 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 42.9 t-20 -155.63 136.36 8.92 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.411 -1.329 . . . . 1.18 107.411 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.12 -17.11 23.81 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.968 3.112 . . . . 1.0 113.352 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.87 -22.49 45.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 1.1 109.537 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.46 146.9 4.51 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.971 -1.252 . . . . 0.59 109.971 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -90.94 135.34 33.8 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.639 -0.504 . . . . 1.57 109.639 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -114.85 151.67 33.5 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.06 -1.089 . . . . 0.37 108.06 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.9 p -160.33 148.96 16.9 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.103 0.478 . . . . 0.57 111.824 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.04 156.97 44.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.365 -1.346 . . . . 0.3 107.365 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -133.4 132.38 41.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.175 -0.676 . . . . 1.26 109.175 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.78 133.14 41.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.808 -0.812 . . . . 0.72 108.808 -176.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 48.2 ttm -108.95 125.78 52.39 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.877 -0.514 . . . . 1.25 109.7 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -98.05 113.67 25.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.524 -0.917 . . . . 0.58 108.524 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.26 100.16 12.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.014 -0.735 . . . . 0.84 109.014 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 36.0 t80 . . . . . 0 C--N 1.3 -1.552 0 CA-C-N 114.828 -1.078 . . . . 3.86 111.831 177.626 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.414 -2.273 0 CA-C-O 121.494 0.664 . . . . 1.58 109.257 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -87.13 129.2 35.03 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.272 -1.01 . . . . 1.19 108.272 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.84 -179.94 7.41 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.322 -0.992 . . . . 1.32 108.322 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.22 117.64 30.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 CA-C-O 121.217 0.532 . . . . 0.45 110.345 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -118.44 134.48 55.03 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 107.039 -1.467 . . . . 1.19 107.039 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 94' ' ' ALA . 68.4 t -122.99 119.16 57.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 120.939 -0.305 . . . . 0.29 110.906 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -119.15 117.74 29.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.547 0.689 . . . . 2.18 110.505 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.797 HD13 HG22 ' A' ' 98' ' ' ILE . 40.8 mt -100.37 157.15 16.83 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.048 -0.978 . . . . 0.33 111.053 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -130.93 144.52 51.53 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.178 -1.045 . . . . 1.03 108.178 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -67.91 137.77 55.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.631 -0.878 . . . . 0.49 108.631 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -47.25 137.82 7.78 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.27 1.028 . . . . 0.4 111.884 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.65 138.35 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.574 -0.739 . . . . 0.57 111.06 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.54 89.43 0.36 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.205 -1.362 . . . . 2.52 112.316 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -150.17 178.52 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.376 -1.342 . . . . 0.88 107.376 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -66.19 -46.46 77.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 119.028 0.831 . . . . 2.75 111.091 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -91.7 128.84 37.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -82.6 120.37 25.45 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.918 0.866 . . . . 0.86 112.545 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 40.5 t -120.51 121.4 38.37 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.263 -1.335 . . . . 0.3 109.684 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 68.5 mt -102.43 97.64 9.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 107.844 -1.169 . . . . 0.3 107.844 174.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 15.2 Cg_exo -69.04 135.54 32.44 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.345 2.03 . . . . 0.28 111.913 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -128.7 149.34 50.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.311 0.577 . . . . 0.37 110.575 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.0 m -131.49 112.21 12.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.318 -0.856 . . . . 0.88 108.76 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.9 124.74 71.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.837 -0.62 . . . . 0.27 109.721 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t0 -101.17 144.07 30.49 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.22 -1.029 . . . . 1.39 108.22 -176.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 158.52 8.67 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 111.43 -0.668 . . . . 0.6 111.43 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.407 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 mm-40 -99.94 -58.02 0.13 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-O 118.916 -0.564 . . . . 2.61 110.902 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.1 Cg_endo -58.0 125.07 17.48 Favored 'Trans proline' 0 C--N 1.366 1.49 0 N-CA-C 108.064 -1.552 . . . . 0.78 108.064 169.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 115.69 19.73 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-O 120.988 0.423 . . . . 0.78 111.768 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 91.4 Cg_endo -83.63 142.45 10.34 Favored 'Trans proline' 0 N--CA 1.424 -2.585 0 C-N-CA 121.515 1.477 . . . . 0.56 110.748 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 m -75.28 105.39 6.28 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.919 -1.141 . . . . 1.37 107.919 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.06 116.92 18.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.327 0.584 . . . . 0.5 110.019 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' A' ' 45' ' ' VAL . 8.4 tpp180 -129.3 130.2 45.85 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.222 -0.899 . . . . 3.78 109.735 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 90.3 m95 -100.09 140.29 34.53 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.091 -0.707 . . . . 0.29 109.091 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 tp -119.56 127.72 53.26 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 105.957 -1.868 . . . . 0.95 105.957 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -121.82 109.41 14.63 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.983 -0.377 . . . . 0.88 109.983 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.08 29.62 17.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.005 0.907 . . . . 1.79 109.967 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.41 60.14 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.309 -0.859 . . . . 0.61 112.62 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.0 t -93.18 142.59 27.13 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.969 -0.752 . . . . 1.37 108.969 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' HD2' ' A' ' 38' ' ' ARG . 53.9 t -67.45 111.01 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.685 -0.688 . . . . 0.7 110.3 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.42 97.53 9.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.374 -0.83 . . . . 0.61 109.23 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.59 127.43 34.06 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.174 -1.417 . . . . 2.47 107.174 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.3 mp0 -61.32 120.45 10.45 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 123.923 0.764 . . . . 1.74 110.659 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.0 p -106.67 -167.39 1.28 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.878 -0.601 . . . . 1.57 109.827 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -80.96 -16.86 52.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.789 -0.819 . . . . 1.52 108.789 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.75 -41.7 11.11 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.102 -0.499 . . . . 1.59 110.438 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -124.41 106.29 16.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.382 -1.71 . . . . 0.5 106.382 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -130.39 141.93 50.53 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.901 -0.72 . . . . 2.89 111.248 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -83.31 109.97 17.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.896 -0.779 . . . . 0.44 108.896 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 71' ' ' ARG . 42.3 mt-10 -109.9 155.33 21.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.3 0.571 . . . . 2.04 110.222 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.88 151.31 40.82 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 107.749 -1.204 . . . . 0.87 107.749 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -108.82 166.15 11.03 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.251 -1.759 . . . . 1.25 106.251 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -50.94 102.88 0.33 Allowed Pre-proline 0 N--CA 1.473 0.725 0 O-C-N 123.957 0.785 . . . . 3.36 110.367 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.04 129.45 2.01 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.571 2.181 . . . . 1.39 113.411 -173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 121.11 15.26 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.347 -0.842 . . . . 1.53 109.828 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.08 -4.83 59.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.061 0.457 . . . . 1.91 109.896 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -63.72 -39.33 94.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.697 -1.224 . . . . 3.49 107.697 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.99 163.74 12.03 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.84 -1.073 . . . . 1.89 108.375 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.2 p -94.96 23.63 5.43 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.655 0.264 . . . . 1.3 111.383 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 24.1 t -116.88 129.47 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-O 121.178 0.514 . . . . 0.61 110.749 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -91.74 132.4 36.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.906 -1.516 . . . . 1.84 106.906 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.19 128.05 56.36 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.451 -0.574 . . . . 1.16 109.451 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.58 -169.06 17.45 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 111.068 -0.813 . . . . 0.31 111.068 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.1 t -152.0 133.3 14.48 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 120.92 0.391 . . . . 0.36 110.81 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 46.3 tp -84.61 90.78 7.75 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 104.747 -2.316 . . . . 0.28 104.747 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 55' ' ' GLU . 50.1 ttp180 -95.87 120.94 37.03 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 115.595 -0.729 . . . . 2.68 109.734 -176.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.35 108.6 17.9 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.862 -1.532 . . . . 1.23 106.862 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.74 -40.18 91.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.759 -1.564 . . . . 2.18 110.64 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -128.69 101.42 20.69 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.813 -0.81 . . . . 2.82 108.813 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.59 130.41 14.81 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.357 2.038 . . . . 1.25 112.458 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 p -139.39 165.13 28.03 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.958 -1.127 . . . . 1.22 107.958 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -76.82 -5.66 49.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.285 0.846 . . . . 2.03 113.285 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.54 -11.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.089 0.471 . . . . 1.33 109.791 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -92.52 26.49 2.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.571 0.701 . . . . 2.19 110.038 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 101' ' ' ALA . 17.6 t30 -117.51 114.8 23.99 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.344 -0.984 . . . . 1.96 108.344 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.76 -159.2 32.19 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.521 -0.847 . . . . 0.49 112.378 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -88.3 118.01 27.61 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.671 0.388 . . . . 2.23 111.657 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.564 ' HB2' HG23 ' A' ' 98' ' ' ILE . 57.0 m-85 -106.8 137.56 44.6 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.588 -0.893 . . . . 0.69 108.588 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 m -137.72 133.89 34.7 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.792 -0.818 . . . . 0.34 108.792 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' CE2' ' A' ' 39' ' ' TRP . 53.0 tp -106.11 120.68 42.42 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 109.736 -0.468 . . . . 0.22 109.736 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.42 133.41 51.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.339 -0.986 . . . . 0.36 108.339 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.66 121.18 25.09 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.999 -1.111 . . . . 0.31 107.999 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.59 132.53 53.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.024 0.202 . . . . 0.61 110.507 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 31.9 p30 -148.33 173.61 4.07 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-O 117.965 -1.017 . . . . 1.18 108.722 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 17.3 Cg_exo -41.57 -32.29 1.4 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.742 2.961 . . . . 1.0 116.318 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.8 t -81.85 -33.41 30.67 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.698 -0.626 . . . . 1.1 111.735 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.15 -161.94 35.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.563 -1.303 . . . . 0.59 112.825 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.25 133.38 47.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.805 -0.813 . . . . 1.57 108.805 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.27 154.35 29.25 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.656 -0.868 . . . . 0.37 108.656 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 13.4 p -149.5 123.77 9.57 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 123.72 0.637 . . . . 0.57 111.256 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.22 149.8 48.8 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.229 -1.397 . . . . 0.3 107.229 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.8 p -118.63 147.99 43.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.638 . . . . 1.26 112.598 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.797 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -140.59 118.88 10.28 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 C-N-CA 124.767 1.227 . . . . 0.72 109.041 177.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.88 100.75 11.1 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.389 -1.708 . . . . 1.25 106.389 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.77 113.47 26.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.656 0.741 . . . . 0.58 111.007 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -105.13 104.98 14.82 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.566 -1.197 . . . . 0.84 108.611 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 C--N 1.308 -1.225 0 C-N-CA 120.304 -0.558 . . . . 3.86 110.791 179.676 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.413 -2.283 0 N-CA-C 108.49 -0.929 . . . . 1.58 108.49 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 27.6 m-85 -75.06 121.4 21.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.3 -1.371 . . . . 1.19 107.3 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -83.95 -174.16 5.13 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.154 -1.054 . . . . 1.32 108.154 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.36 118.35 30.83 Favored 'General case' 0 CA--C 1.474 -1.942 0 C-N-CA 119.128 -1.029 . . . . 0.45 109.652 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.1 m -116.67 130.66 56.86 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.789 -1.096 . . . . 1.19 108.569 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 85' ' ' LEU . 77.8 t -116.68 119.5 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.331 -0.395 . . . . 0.29 111.379 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -115.11 120.41 39.71 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.162 -0.681 . . . . 2.18 109.162 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 27' ' ' PHE . 33.5 mt -98.41 155.13 17.39 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 109.589 -0.522 . . . . 0.33 109.589 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.67 147.18 52.49 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.917 -1.142 . . . . 1.03 107.917 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 m -60.96 131.72 51.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 124.118 0.886 . . . . 0.49 109.41 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.36 139.27 19.74 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.403 1.064 . . . . 0.4 111.44 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.9 140.98 15.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.515 0.674 . . . . 0.57 110.137 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.72 102.33 11.46 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.346 -1.297 . . . . 2.52 111.731 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -145.12 -167.47 2.68 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.106 -1.442 . . . . 0.88 107.106 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -77.93 -49.46 14.12 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.843 -1.54 . . . . 2.75 106.843 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -89.82 120.13 30.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 172.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.62 134.25 35.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.106 0.479 . . . . 0.86 111.05 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.7 t -125.99 126.07 43.71 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.214 -0.903 . . . . 0.3 110.555 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 71.9 mt -101.33 102.75 22.64 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.149 -1.426 . . . . 0.3 107.149 173.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.14 138.8 23.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.251 1.967 . . . . 0.28 111.558 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB3' HD23 ' A' ' 14' ' ' LEU . 50.3 p90 -133.29 144.27 49.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.871 0.367 . . . . 0.37 110.731 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -121.59 106.24 11.18 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.447 -0.945 . . . . 0.88 108.447 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.0 p -114.33 117.86 56.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.684 -0.858 . . . . 0.27 108.684 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -117.79 156.92 27.49 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.301 -0.56 . . . . 1.39 109.491 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 149.38 5.31 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 108.323 -1.911 . . . . 0.6 108.323 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -86.47 -53.54 0.42 Allowed Pre-proline 0 C--N 1.311 -1.095 0 C-N-CA 118.857 -1.137 . . . . 2.61 110.857 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 14.2 Cg_endo -62.75 119.31 6.34 Favored 'Trans proline' 0 C--N 1.373 1.824 0 N-CA-C 107.439 -1.793 . . . . 0.78 107.439 167.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.11 118.7 61.28 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 115.475 -0.784 . . . . 0.78 112.156 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -86.84 160.33 8.98 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.108 1.872 . . . . 0.56 112.398 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -96.99 138.19 34.9 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.235 -1.024 . . . . 1.37 108.235 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 HG11 ' A' ' 29' ' ' VAL . 95.1 mt -101.33 134.63 44.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.185 0.517 . . . . 0.5 111.526 -175.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -136.75 131.34 33.3 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.483 -0.781 . . . . 3.78 110.248 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -97.34 138.54 34.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.873 -0.603 . . . . 0.29 110.647 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -129.8 137.04 50.28 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.716 -1.957 . . . . 0.95 105.716 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.45 119.68 20.94 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.962 -0.385 . . . . 0.88 109.962 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 60.06 26.34 15.67 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.24 1.019 . . . . 1.79 110.885 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.28 82.15 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.61 112.252 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 p -108.26 150.86 26.72 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.012 0.434 . . . . 1.37 110.391 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.45 114.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.436 -0.802 . . . . 0.7 112.148 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.38 122.1 32.95 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.936 -1.135 . . . . 0.61 107.936 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.41 137.11 40.18 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.01 -0.541 . . . . 2.47 110.029 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.52 121.03 12.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -138.09 -163.99 1.55 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 120.455 -0.498 . . . . 1.57 110.715 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -64.56 -49.89 69.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.631 0.604 . . . . 1.52 112.631 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -84.87 -31.76 23.58 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 1.59 112.013 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 79' ' ' ASN . 21.0 mt -114.42 106.66 21.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.705 -1.591 . . . . 0.5 106.705 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.23 154.21 50.22 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.542 0.687 . . . . 2.89 111.369 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -95.14 129.3 42.29 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.311 -0.859 . . . . 0.44 109.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -123.13 129.39 51.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.032 -1.47 . . . . 2.04 107.032 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.58 120.84 37.63 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.625 -0.509 . . . . 0.87 109.625 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.15 153.84 27.03 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.548 . . . . 1.25 106.822 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.56 102.05 0.29 Allowed Pre-proline 0 C--N 1.313 -0.998 0 C-N-CA 125.901 1.68 . . . . 3.36 114.0 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -88.91 146.71 5.62 Favored 'Trans proline' 0 C--O 1.264 1.79 0 C-N-CA 122.135 1.89 . . . . 1.39 110.383 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -84.97 155.08 21.76 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.255 -1.017 . . . . 1.53 108.255 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.54 -22.1 61.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.417 -0.811 . . . . 1.91 112.448 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.17 -2.29 43.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.425 0.528 . . . . 3.49 112.425 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 54.8 mt-10 -83.04 136.84 34.35 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 109.112 -0.699 . . . . 1.89 109.112 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -103.72 27.83 7.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.827 1.298 . . . . 1.3 108.157 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 129.42 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.2 -1.364 . . . . 0.61 108.087 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.648 ' HB3' HG13 ' A' ' 29' ' ' VAL . 37.2 ttm180 -93.86 119.12 32.38 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.934 -1.506 . . . . 1.84 106.934 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -98.39 115.41 28.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.345 -0.983 . . . . 1.16 108.345 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 27' ' ' PHE . . . -133.22 166.0 23.88 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.157 -1.497 . . . . 0.31 113.517 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 t -139.88 131.93 27.91 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.541 0.736 . . . . 0.36 109.748 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.0 tp -96.39 103.44 15.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.518 -2.03 . . . . 0.28 105.518 171.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -108.12 127.91 54.22 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.783 0.801 . . . . 2.68 111.539 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.401 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.5 mp -103.67 109.43 21.12 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.462 -1.245 . . . . 1.23 108.744 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -66.42 -36.39 82.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.554 -1.203 . . . . 2.18 109.677 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -134.48 101.35 12.09 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 108.021 -1.103 . . . . 2.82 108.021 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.21 130.75 11.32 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.257 1.971 . . . . 1.25 110.329 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -117.56 169.94 9.15 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.684 -0.487 . . . . 1.22 109.684 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -76.27 -7.01 53.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.655 0.613 . . . . 2.03 112.655 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.59 -9.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.503 -0.555 . . . . 1.33 109.503 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.479 HD21 HD11 ' A' ' 52' ' ' ILE . 10.8 m120 -99.59 26.85 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.401 0.68 . . . . 2.19 110.105 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -111.42 100.21 8.84 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.785 -0.82 . . . . 1.96 108.785 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.81 -157.61 30.17 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.335 -1.412 . . . . 0.49 113.85 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.53 118.73 30.21 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.355 0.662 . . . . 2.23 112.293 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.13 127.29 46.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.828 -1.078 . . . . 0.69 108.316 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 29.4 m -117.69 127.22 53.72 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 108.886 -0.783 . . . . 0.34 108.886 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.2 tp -103.39 125.71 50.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.645 -0.502 . . . . 0.22 109.645 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.7 mm? -108.45 129.34 55.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 124.178 0.924 . . . . 0.36 108.794 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.78 121.6 35.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.288 -1.375 . . . . 0.31 107.288 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.49 54.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 112.508 0.558 . . . . 0.61 112.508 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -141.25 162.96 44.87 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.986 -1.487 . . . . 1.18 106.986 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -47.55 -29.68 10.84 Favored 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 122.716 2.278 . . . . 1.0 114.775 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.63 -29.26 64.45 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.008 -0.432 . . . . 1.1 111.804 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.93 165.88 21.86 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.787 -1.197 . . . . 0.59 112.557 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.34 122.5 47.12 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.713 -1.217 . . . . 1.57 107.713 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.64 145.94 28.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.944 -0.762 . . . . 0.37 108.944 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 35.0 p -138.05 138.82 39.17 Favored 'General case' 0 N--CA 1.416 -2.161 0 O-C-N 123.669 0.606 . . . . 0.57 109.837 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.34 155.7 47.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.246 -1.391 . . . . 0.3 107.246 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 p -127.75 143.1 51.15 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.654 0.264 . . . . 1.26 111.686 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.461 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -139.58 131.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.804 -1.924 . . . . 0.72 105.804 176.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 ttt -112.32 107.5 16.35 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.81 -0.756 . . . . 1.25 109.202 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.37 126.48 55.41 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.292 0.568 . . . . 0.58 111.575 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.05 103.39 15.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.188 -0.915 . . . . 0.84 108.689 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 . . . . . 0 C--N 1.314 -0.974 0 C-N-CA 120.381 -0.528 . . . . 3.86 110.795 177.872 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.392 -3.337 0 N-CA-C 107.037 -1.468 . . . . 1.58 107.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 65.2 m-85 -68.1 134.52 50.71 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.67 -1.233 . . . . 1.19 107.67 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.58 -174.81 5.5 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.572 -1.27 . . . . 1.32 107.572 -174.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.17 121.89 34.99 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 119.788 -0.765 . . . . 0.45 109.462 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -125.13 135.05 52.28 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.764 -1.199 . . . . 1.19 107.764 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 94' ' ' ALA . 52.2 t -122.54 119.11 57.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.94 0.4 . . . . 0.29 111.435 -173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -118.08 116.56 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.952 -0.759 . . . . 2.18 108.952 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 98' ' ' ILE . 32.7 mt -98.13 155.95 16.9 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.263 -0.643 . . . . 0.33 109.263 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -130.86 153.92 48.61 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.783 -1.192 . . . . 1.03 107.783 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.0 m -59.32 133.64 56.28 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 124.729 1.268 . . . . 0.49 110.62 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -69.9 151.78 45.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.417 -0.81 . . . . 0.4 109.152 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.98 126.73 44.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.689 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 23' ' ' TRP . 28.0 mm-40 -72.24 88.83 1.16 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.998 -1.001 . . . . 2.52 110.565 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.28 -178.86 7.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.674 -0.862 . . . . 0.88 108.674 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -61.82 -42.52 99.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.577 0.626 . . . . 2.75 112.067 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.08 109.11 21.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.992 -1.114 . . . . 2.46 107.992 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 92.1 m95 -82.27 106.97 14.59 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.306 0.574 . . . . 0.86 111.602 -174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.0 t -104.48 116.97 33.03 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.574 -1.194 . . . . 0.3 109.023 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.1 mt -102.84 100.14 15.75 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 107.858 -1.164 . . . . 0.3 107.858 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -73.41 130.02 14.53 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.258 1.972 . . . . 0.28 111.738 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -122.3 155.75 35.28 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.209 0.528 . . . . 0.37 110.522 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -138.24 106.98 5.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.462 -0.94 . . . . 0.88 108.462 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.3 p -113.28 117.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.059 0.457 . . . . 0.27 110.008 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.9 t70 -101.91 136.97 40.83 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.946 -0.57 . . . . 1.39 110.461 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.08 150.6 7.95 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.363 -1.095 . . . . 0.6 110.363 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -82.88 -58.79 0.41 Allowed Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 107.322 -1.362 . . . . 2.61 107.322 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 38.0 Cg_endo -71.97 120.98 7.19 Favored 'Trans proline' 0 C--N 1.369 1.607 0 N-CA-C 108.173 -1.51 . . . . 0.78 108.173 168.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.7 113.63 8.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 0.78 111.065 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.48 142.43 14.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.452 2.101 . . . . 0.56 111.734 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 p -69.47 127.77 34.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.631 -0.713 . . . . 1.37 110.019 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.3 mt -98.94 126.16 44.55 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.88 -0.6 . . . . 0.5 111.069 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -131.85 127.59 36.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.88 -0.6 . . . . 3.78 110.176 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.0 m95 -92.91 126.95 38.24 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.29 110.312 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.94 126.92 54.52 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.677 -1.601 . . . . 0.95 106.677 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -115.74 102.97 10.21 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.177 -0.675 . . . . 0.88 109.177 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 54.15 40.42 31.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.055 0.942 . . . . 1.79 112.101 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.1 84.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.671 -0.695 . . . . 0.61 113.689 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -114.04 136.94 52.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 117.449 0.624 . . . . 1.37 109.716 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.77 121.06 13.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.217 -0.447 . . . . 0.7 110.266 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 tp -82.27 137.82 34.75 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.451 -1.315 . . . . 0.61 107.451 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -109.21 121.22 44.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 123.354 0.409 . . . . 2.47 110.229 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 119.64 13.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.868 -0.79 . . . . 1.74 108.868 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -150.06 -174.03 4.61 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.828 -0.804 . . . . 1.57 108.828 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 t -70.73 3.68 3.02 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 112.932 0.715 . . . . 1.52 112.932 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.16 -28.39 9.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.871 -0.518 . . . . 1.59 109.921 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -149.02 108.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.894 -1.15 . . . . 0.5 107.894 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -135.59 156.28 49.12 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.785 0.661 . . . . 2.89 112.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -100.31 110.43 22.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.421 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.34 146.26 24.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.78 -0.822 . . . . 2.04 108.78 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.07 156.88 32.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.314 -0.624 . . . . 0.87 109.314 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.26 160.35 29.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.422 -1.325 . . . . 1.25 107.422 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 34.6 mm-40 -71.68 120.28 79.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 113.916 1.08 . . . . 3.36 113.916 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.53 145.1 29.31 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 123.198 2.599 . . . . 1.39 111.071 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.54 162.0 16.65 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.485 -0.932 . . . . 1.53 108.485 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.75 -11.38 60.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.931 0.715 . . . . 1.91 112.931 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -91.19 3.31 55.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.167 0.984 . . . . 3.49 108.517 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 151.7 48.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.062 -0.972 . . . . 1.89 108.956 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -120.29 23.88 10.69 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.498 -1.667 . . . . 1.3 106.498 165.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 15.1 t -99.76 123.48 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 113.303 -1.771 . . . . 0.61 109.526 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' VAL . 62.1 mtp180 -89.01 116.32 27.21 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.173 -1.788 . . . . 1.84 106.173 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -101.2 137.88 38.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.329 -0.989 . . . . 1.16 108.329 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.45 -170.39 30.33 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 120.19 -1.005 . . . . 0.31 111.046 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.9 t -150.41 132.48 15.29 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 120.874 0.368 . . . . 0.36 110.841 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.6 tp -90.13 111.82 23.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.301 -2.111 . . . . 0.28 105.301 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 10.1 ptp180 -114.09 128.91 56.59 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.046 -1.062 . . . . 2.68 112.49 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.84 107.09 18.79 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 105.455 -2.054 . . . . 1.23 105.455 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -80.81 -35.26 33.25 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.234 -0.439 . . . . 2.18 110.524 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.47 99.79 51.48 Favored Pre-proline 0 N--CA 1.421 -1.909 0 N-CA-C 108.172 -1.048 . . . . 2.82 108.172 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -84.13 143.09 10.1 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 122.229 1.953 . . . . 1.25 111.411 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -136.82 160.93 37.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.108 -1.071 . . . . 1.22 108.108 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.71 -6.89 2.89 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.963 1.097 . . . . 2.03 113.963 -173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.86 -9.93 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.797 0.332 . . . . 1.33 110.572 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -77.86 8.92 3.98 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.643 0.979 . . . . 2.19 113.643 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -91.4 88.56 6.88 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.393 -1.706 . . . . 1.96 106.393 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.65 -171.29 27.51 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.458 -1.83 . . . . 0.49 114.536 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -98.88 103.79 15.78 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.051 0.94 . . . . 2.23 110.611 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -93.3 105.96 17.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.865 -0.791 . . . . 0.69 108.865 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.0 m -103.93 125.94 50.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.239 -0.652 . . . . 0.34 109.239 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.5 tp -100.6 118.28 36.45 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.009 -0.737 . . . . 0.22 109.009 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 130.38 47.21 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.46 -0.941 . . . . 0.36 108.46 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 121.11 28.74 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.31 107.557 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.47 130.78 44.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 123.399 0.437 . . . . 0.61 110.504 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.1 p30 -134.9 171.27 9.28 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.415 -1.328 . . . . 1.18 107.415 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.3 Cg_exo -49.41 -30.11 19.76 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.448 2.099 . . . . 1.0 114.145 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.83 -50.99 37.41 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 111.747 0.277 . . . . 1.1 111.747 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.92 45.22 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.452 -1.356 . . . . 0.59 112.933 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -123.55 133.09 54.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.928 0.428 . . . . 1.57 110.345 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.244 -1.021 . . . . 0.37 108.244 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 31.9 p -144.96 138.84 27.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 109.583 -0.525 . . . . 0.57 109.583 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.72 152.36 47.92 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.384 -1.339 . . . . 0.3 107.384 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 m -131.48 141.32 49.75 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.597 -0.441 . . . . 1.26 111.134 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.465 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.34 123.96 39.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 106.441 -1.689 . . . . 0.72 106.441 176.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -103.88 98.87 8.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.243 -0.651 . . . . 1.25 109.243 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.89 27.28 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.416 -0.811 . . . . 0.58 110.645 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.17 143.33 42.08 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.935 -1.135 . . . . 0.84 107.935 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 75' ' ' PRO . 19.3 t80 . . . . . 0 C--N 1.29 -1.988 0 N-CA-C 112.662 0.616 . . . . 3.86 112.662 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.401 -2.896 0 CA-C-O 121.662 0.744 . . . . 1.58 111.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 p90 -130.38 134.54 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.721 -1.127 . . . . 1.19 108.993 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 73.0 m -84.17 -166.19 1.36 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.57 -0.741 . . . . 1.32 111.93 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 131.72 39.74 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.69 0.757 . . . . 0.45 112.018 -172.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 29.4 t -111.72 137.48 49.57 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.954 -1.499 . . . . 1.19 106.954 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 94' ' ' ALA . 86.0 t -115.6 114.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.116 -0.698 . . . . 0.29 109.116 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 96.0 mt-30 -108.44 116.03 31.2 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.033 -0.728 . . . . 2.18 109.033 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 98' ' ' ILE . 23.9 mt -98.97 151.22 21.15 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.539 -0.541 . . . . 0.33 109.539 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -131.32 148.8 52.72 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.43 -0.952 . . . . 1.03 108.43 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -56.59 136.39 54.54 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.224 1.41 . . . . 0.49 109.617 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -62.96 143.2 57.94 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.952 0.783 . . . . 0.4 110.61 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.81 127.58 44.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 109.485 -0.561 . . . . 0.57 109.485 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.73 116.48 16.48 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.522 -0.763 . . . . 2.52 110.567 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.2 ptt? -168.2 -177.06 3.14 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.966 -1.494 . . . . 0.88 106.966 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -71.34 -39.46 71.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 119.517 1.053 . . . . 2.75 112.208 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 20' ' ' MET . 37.5 m80 -98.59 115.14 27.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.42 -1.326 . . . . 2.46 107.42 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' HD12 ' A' ' 72' ' ' LEU . 84.0 m95 -81.77 137.94 35.25 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 0.86 111.953 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.81 120.62 21.83 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.46 -1.245 . . . . 0.3 109.144 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 17' ' ' ALA . 54.9 mt -102.9 100.0 15.46 Favored Pre-proline 0 C--O 1.247 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.3 106.88 172.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.54 135.57 20.19 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.338 2.026 . . . . 0.28 112.084 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.7 p90 -127.33 155.85 42.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.16 -0.473 . . . . 0.37 109.833 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 10.4 m -132.58 106.32 7.75 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.768 -1.197 . . . . 0.88 107.768 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.4 p -110.74 119.28 59.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.67 -0.863 . . . . 0.27 108.67 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 21.8 t70 -121.22 128.15 52.15 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.624 -0.716 . . . . 1.39 111.303 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.71 147.85 9.35 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.776 -1.73 . . . . 0.6 108.776 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.16 -55.96 1.69 Allowed Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.091 -0.707 . . . . 2.61 109.091 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.545 ' HB2' HD21 ' A' ' 89' ' ' ASN . 25.2 Cg_endo -63.77 122.01 9.93 Favored 'Trans proline' 0 C--N 1.376 2.0 0 N-CA-C 108.283 -1.468 . . . . 0.78 108.283 169.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.35 121.76 84.31 Favored Pre-proline 0 C--N 1.298 -1.652 0 CA-C-N 115.818 -0.628 . . . . 0.78 112.166 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -90.97 167.77 3.7 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.713 2.276 . . . . 0.56 112.464 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -105.62 126.73 52.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.12 -1.067 . . . . 1.37 108.12 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.99 143.92 26.36 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.883 0.373 . . . . 0.5 111.843 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -144.54 137.99 27.21 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.595 1.158 . . . . 3.78 109.221 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -102.93 146.0 28.99 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.67 0.748 . . . . 0.29 110.871 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 19.2 tp -131.59 127.75 37.75 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.667 -1.605 . . . . 0.95 106.667 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -111.95 106.16 14.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 110.228 -0.286 . . . . 0.88 110.228 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 57.0 30.02 17.44 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.514 0.725 . . . . 1.79 111.883 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.34 64.52 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.741 -0.742 . . . . 0.61 112.086 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 m -90.48 129.85 36.6 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.629 -0.508 . . . . 1.37 109.629 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.37 117.22 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.572 -0.74 . . . . 0.7 110.342 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.0 tp -97.58 101.3 12.79 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.409 -0.814 . . . . 0.61 109.744 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -84.31 130.71 34.78 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.898 -1.519 . . . . 2.47 106.898 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.09 138.22 56.25 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.614 0.765 . . . . 1.74 111.808 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -108.21 -163.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.654 -0.703 . . . . 1.57 109.391 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -85.76 -34.65 21.13 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.849 -0.797 . . . . 1.52 108.849 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -85.2 -28.98 25.08 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.52 -0.309 . . . . 1.59 111.67 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.7 mt -117.93 106.46 19.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.911 -1.144 . . . . 0.5 107.911 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.186 0.517 . . . . 2.89 110.983 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 m -84.54 112.53 20.49 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.91 127.01 46.13 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.354 -0.98 . . . . 2.04 108.354 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.01 137.14 44.44 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 4.4 pp -96.47 165.79 12.01 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.675 -1.232 . . . . 1.25 107.675 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.61 107.67 2.48 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 117.783 0.265 . . . . 3.36 111.383 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 44.1 Cg_endo -89.41 169.39 4.91 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.662 2.908 . . . . 1.39 111.238 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -92.95 139.48 30.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.274 -1.38 . . . . 1.53 107.274 175.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.94 65.51 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.532 0.733 . . . . 1.91 111.824 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -76.07 -13.17 60.22 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.55 -0.295 . . . . 3.49 111.763 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 42.2 mt-10 -93.77 134.78 35.75 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.807 0.336 . . . . 1.89 110.826 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -95.03 -2.94 49.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.073 0.94 . . . . 1.3 108.83 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.01 129.65 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 107.64 -1.244 . . . . 0.61 107.64 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HB2' HG13 ' A' ' 29' ' ' VAL . 60.1 mtp85 -97.22 117.13 30.74 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.154 -1.425 . . . . 1.84 107.154 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.7 112.31 24.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.516 -0.766 . . . . 1.16 110.312 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 178.96 31.62 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 111.083 -0.807 . . . . 0.31 111.083 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 t -150.43 145.19 25.9 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.127 -0.323 . . . . 0.36 110.127 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 51.2 tp -80.66 109.93 15.66 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.43 -1.693 . . . . 0.28 106.43 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -97.86 122.81 41.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.76 -0.655 . . . . 2.68 110.986 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 23' ' ' TRP . 37.4 mt -99.19 108.45 21.05 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.159 -1.422 . . . . 1.23 107.159 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.4 -54.99 7.78 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.165 -0.925 . . . . 2.18 109.329 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -110.43 106.17 57.72 Favored Pre-proline 0 N--CA 1.427 -1.61 0 N-CA-C 108.307 -0.998 . . . . 2.82 108.307 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.4 135.76 55.49 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.265 2.643 . . . . 1.25 111.343 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 p -142.02 155.34 45.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.939 -0.393 . . . . 1.22 109.939 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -72.88 -5.08 35.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.563 0.579 . . . . 2.03 112.563 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -78.66 -9.72 12.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 CA-C-O 120.981 0.42 . . . . 1.33 110.285 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.795 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 16.1 m120 -87.81 26.53 1.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.195 0.997 . . . . 2.19 109.407 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -120.68 87.83 2.82 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.273 -1.38 . . . . 1.96 107.273 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.24 -167.41 39.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.219 -0.991 . . . . 0.49 112.013 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.78 106.45 18.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.94 0.4 . . . . 2.23 111.201 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.795 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 69.7 m-85 -95.42 117.14 29.83 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.078 -1.082 . . . . 0.69 108.078 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 88.1 m -106.83 131.35 54.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.512 -0.551 . . . . 0.34 109.512 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 HG13 ' A' ' 12' ' ' VAL . 55.6 tp -102.41 120.53 40.66 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.961 -0.755 . . . . 0.22 108.961 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.52 136.28 44.38 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.537 -1.283 . . . . 0.36 107.537 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.09 119.37 30.11 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.679 -1.601 . . . . 0.31 106.679 171.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.12 127.28 47.73 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 123.378 0.424 . . . . 0.61 109.896 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 33' ' ' PRO . 25.5 t-20 -150.98 136.95 10.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.16 -1.422 . . . . 1.18 107.16 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -43.13 -34.84 4.43 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 125.252 3.968 . . . . 1.0 115.532 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.0 p -91.33 -33.69 15.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.678 -0.809 . . . . 1.1 111.526 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.86 131.55 2.58 Favored Glycine 0 C--N 1.299 -1.493 0 C-N-CA 120.075 -1.06 . . . . 0.59 112.526 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -103.92 126.58 51.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.903 -0.777 . . . . 1.57 108.903 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -105.4 152.89 22.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.098 -0.501 . . . . 0.37 109.813 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.7 p -151.2 120.76 6.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.246 -0.433 . . . . 0.57 110.362 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.89 144.32 49.83 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.763 -0.829 . . . . 0.3 108.763 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m -113.89 140.18 48.58 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.084 -0.339 . . . . 1.26 110.084 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.506 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -141.85 118.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.247 -1.019 . . . . 0.72 108.247 176.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.5 ttm -95.25 108.77 20.93 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.241 -0.583 . . . . 1.25 109.493 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 113.59 25.68 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.287 -0.87 . . . . 0.58 108.759 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.68 101.06 13.29 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.338 -1.356 . . . . 0.84 107.338 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 114.073 -1.421 . . . . 3.86 111.39 -175.235 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.407 -2.604 0 CA-C-O 121.258 0.551 . . . . 1.58 110.783 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 98.8 m-85 -98.84 134.02 42.31 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.997 -0.547 . . . . 1.19 109.83 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.3 m -84.09 176.33 8.89 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.52 -0.918 . . . . 1.32 108.52 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.8 130.49 39.8 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.487 -0.485 . . . . 0.45 110.57 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 5.7 m -126.98 144.4 51.03 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.674 -1.602 . . . . 1.19 106.674 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 94' ' ' ALA . 61.9 t -127.79 116.47 43.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.29 111.673 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -110.31 126.4 54.17 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.229 -0.656 . . . . 2.18 109.229 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 HG22 ' A' ' 98' ' ' ILE . 28.6 mt -111.78 156.32 22.14 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.225 -0.657 . . . . 0.33 109.225 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -131.57 145.76 51.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.053 -0.721 . . . . 1.03 109.053 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -52.98 133.54 38.23 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.914 1.384 . . . . 0.49 110.075 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.22 141.53 58.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.214 -0.903 . . . . 0.4 110.004 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.21 130.75 39.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 120.508 -0.477 . . . . 0.57 110.907 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.01 96.46 2.15 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.946 -1.024 . . . . 2.52 112.845 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -167.13 150.73 6.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.848 -1.908 . . . . 0.88 105.848 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -52.33 -30.85 30.53 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.726 1.266 . . . . 2.75 114.068 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -98.73 100.65 11.89 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.212 -1.774 . . . . 2.46 106.212 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -80.63 141.05 35.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.547 0.689 . . . . 0.86 111.672 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.0 t -135.59 124.54 24.17 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.669 -1.15 . . . . 0.3 109.614 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.2 mt -111.02 99.39 42.74 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.556 -1.275 . . . . 0.3 107.556 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 135.76 24.03 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.411 2.074 . . . . 0.28 111.647 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.34 157.17 40.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.808 0.337 . . . . 0.37 110.305 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -142.85 106.74 4.68 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.571 0.701 . . . . 0.88 109.37 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -113.82 131.61 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.486 -0.779 . . . . 0.27 109.028 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.2 p30 -122.62 150.74 42.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.591 -0.444 . . . . 1.39 111.142 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.17 169.84 30.3 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.697 -1.761 . . . . 0.6 108.697 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -93.99 -56.87 0.22 Allowed Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 118.491 1.145 . . . . 2.61 108.52 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.7 Cg_endo -70.4 121.55 8.1 Favored 'Trans proline' 0 C--N 1.368 1.562 0 N-CA-C 107.681 -1.7 . . . . 0.78 107.681 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.63 114.34 9.98 Favored Pre-proline 0 C--N 1.32 -0.69 0 O-C-N 123.546 0.529 . . . . 0.78 109.941 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 90.4 Cg_endo -77.22 141.53 20.67 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.203 1.935 . . . . 0.56 111.923 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -71.5 110.95 6.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.807 -0.633 . . . . 1.37 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.7 130.8 34.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.648 -0.705 . . . . 0.5 111.082 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -138.28 136.79 36.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.849 -0.797 . . . . 3.78 108.849 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -100.49 118.77 37.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.097 0.475 . . . . 0.29 109.921 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.01 126.14 50.91 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.376 -2.083 . . . . 0.95 105.376 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -109.92 98.8 8.03 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 121.082 0.467 . . . . 0.88 110.276 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 60.17 25.53 14.89 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.872 1.269 . . . . 1.79 111.221 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.54 -15.17 32.39 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.825 -0.702 . . . . 0.61 113.387 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -109.52 142.44 40.56 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.667 -0.864 . . . . 1.37 108.667 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.12 122.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.517 -0.549 . . . . 0.7 109.517 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.4 tp -77.09 121.4 23.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.717 -0.846 . . . . 0.61 108.717 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -93.49 124.11 37.26 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.166 -1.05 . . . . 2.47 108.166 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 129.54 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.701 -0.481 . . . . 1.74 109.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -166.96 1.4 Allowed 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.883 -0.598 . . . . 1.57 111.035 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -81.82 -12.83 58.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.923 -0.769 . . . . 1.52 108.923 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -103.29 -40.77 6.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.949 -0.568 . . . . 1.59 110.938 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG23 ' HG ' ' A' ' 72' ' ' LEU . 35.3 mt -113.59 106.79 21.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 106.959 -1.497 . . . . 0.5 106.959 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.086 0.47 . . . . 2.89 112.194 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.3 m -84.97 113.05 21.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.982 -0.554 . . . . 0.44 109.822 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 14.8 mm-40 -87.49 136.67 32.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.076 -0.511 . . . . 2.04 109.635 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.59 144.0 49.39 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.992 -0.744 . . . . 0.87 108.992 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.45 166.85 15.28 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.087 -0.709 . . . . 1.25 109.087 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.54 124.79 9.7 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 114.234 1.198 . . . . 3.36 114.234 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.81 128.42 2.4 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 121.714 1.609 . . . . 1.39 108.927 169.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.071 -1.085 . . . . 1.53 108.071 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.22 61.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.497 0.665 . . . . 1.91 110.284 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.11 -14.82 60.18 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.56 -1.2 . . . . 3.49 110.056 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.21 161.04 21.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.464 -0.939 . . . . 1.89 108.464 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 3.3 p -112.12 8.13 19.89 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.514 -0.921 . . . . 1.3 108.514 172.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 30' ' ' ASP . 38.1 t -95.96 129.72 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 114.511 -1.222 . . . . 0.61 110.366 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 29' ' ' VAL . 77.4 mtp180 -89.68 140.4 29.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.309 -2.108 . . . . 1.84 105.309 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -115.87 133.18 56.29 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.015 -0.735 . . . . 1.16 109.015 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.17 179.83 44.33 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 119.439 -1.363 . . . . 0.31 113.461 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.29 136.71 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.652 0.781 . . . . 0.36 110.285 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 tp -84.88 110.63 18.99 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.682 -1.599 . . . . 0.28 106.682 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 80.3 mtt180 -102.06 132.99 47.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.967 0.413 . . . . 2.68 111.813 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -112.51 109.55 19.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 107.453 -1.314 . . . . 1.23 107.453 172.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -59.09 -37.7 77.75 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.218 -1.356 . . . . 2.18 110.851 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -128.27 135.22 27.21 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 107.929 -1.137 . . . . 2.82 107.929 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.26 130.25 13.89 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 121.473 1.449 . . . . 1.25 109.672 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -115.19 139.97 49.48 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.355 -0.609 . . . . 1.22 109.355 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -75.61 -14.48 60.38 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 112.233 0.457 . . . . 2.03 112.233 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.56 -10.53 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.68 -0.808 . . . . 1.33 113.088 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.263 20.2 m-80 -92.19 26.95 2.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 116.17 1.915 . . . . 2.19 116.17 -171.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -80.87 74.25 7.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.998 -0.741 . . . . 1.96 108.998 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.09 -174.9 15.03 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.134 -1.032 . . . . 0.49 112.42 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -93.97 112.04 23.83 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.525 -0.337 . . . . 2.23 110.997 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -86.52 108.09 18.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.414 -0.958 . . . . 0.69 108.414 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 m -102.16 117.99 35.95 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.725 -0.842 . . . . 0.34 108.725 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.8 tp -94.73 118.91 32.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.712 -0.848 . . . . 0.22 108.712 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.0 134.5 46.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.917 . . . . 0.36 108.523 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -134.85 120.98 19.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.552 -0.907 . . . . 0.31 108.552 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.38 135.34 49.41 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 123.218 0.324 . . . . 0.61 110.4 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.7 p30 -143.91 169.74 9.75 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-O 117.432 -1.27 . . . . 1.18 107.663 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 24.4 Cg_exo -42.77 -30.99 1.92 Allowed 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 123.317 2.678 . . . . 1.0 115.966 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.0 t -74.97 -47.46 29.23 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.33 -0.548 . . . . 1.1 111.649 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.45 31.36 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.825 -1.178 . . . . 0.59 112.48 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.96 129.31 43.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.093 0.473 . . . . 1.57 109.796 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.6 159.33 21.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 30.8 p -155.93 153.21 29.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.977 -0.556 . . . . 0.57 110.328 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 158.71 43.52 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.713 -1.588 . . . . 0.3 106.713 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 m -133.72 127.12 32.17 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 120.944 0.402 . . . . 1.26 110.615 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -129.67 118.49 45.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.697 -1.223 . . . . 0.72 107.697 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.0 ttm -96.75 114.79 26.46 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.933 -0.707 . . . . 1.25 109.659 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.73 29.72 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.331 -0.618 . . . . 0.58 109.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.83 123.03 36.4 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.667 -0.864 . . . . 0.84 108.667 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 122.003 0.906 . . . . 3.86 110.873 -178.332 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.388 -3.567 0 N-CA-C 106.192 -1.781 . . . . 1.58 106.192 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.502 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 46.6 m-85 -74.31 142.78 45.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.95 -1.023 . . . . 1.19 110.341 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.28 173.42 11.61 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.42 -1.326 . . . . 1.32 107.42 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.24 116.06 28.65 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 121.234 0.54 . . . . 0.45 110.192 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 t -117.02 132.03 56.8 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 107.283 -1.377 . . . . 1.19 107.283 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 48.5 t -115.86 115.77 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 110.242 -0.281 . . . . 0.29 110.242 -173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -112.31 117.9 33.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.597 -0.52 . . . . 2.18 109.597 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 98' ' ' ILE . 31.2 mt -100.41 151.53 21.41 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 108.654 -0.869 . . . . 0.33 108.654 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -131.24 146.13 52.19 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.238 -1.393 . . . . 1.03 107.238 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.47 132.68 54.22 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 124.087 0.867 . . . . 0.49 110.498 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.88 139.51 39.94 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.596 1.185 . . . . 0.4 111.165 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -91.92 131.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.961 -0.563 . . . . 0.57 110.076 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.08 120.4 21.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.268 -0.878 . . . . 2.52 111.053 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -169.7 -169.84 0.96 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -72.88 -39.26 66.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.286 0.948 . . . . 2.75 111.968 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -104.89 121.45 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.518 -1.66 . . . . 2.46 106.518 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -82.06 129.48 34.81 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.188 0.518 . . . . 0.86 110.988 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -121.11 118.59 30.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.076 -0.966 . . . . 0.3 110.013 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 17' ' ' ALA . 62.7 mt -101.38 102.23 20.56 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 107.476 -1.305 . . . . 0.3 107.476 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.89 138.15 18.35 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.459 2.106 . . . . 0.28 111.976 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.28 149.01 51.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.323 0.582 . . . . 0.37 110.677 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 m -133.28 106.66 7.67 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.973 -1.121 . . . . 0.88 107.973 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.6 p -110.93 119.33 59.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 120.933 0.397 . . . . 0.27 109.953 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.59 140.54 35.74 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.838 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.1 134.84 1.74 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.79 -1.724 . . . . 0.6 108.79 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.502 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -71.73 -57.23 4.31 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 106.846 -1.539 . . . . 2.61 106.846 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.51 120.45 7.75 Favored 'Trans proline' 0 C--N 1.373 1.829 0 N-CA-C 108.316 -1.455 . . . . 0.78 108.316 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.4 119.73 59.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.407 -0.815 . . . . 0.78 110.947 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.04 149.46 9.46 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.344 2.029 . . . . 0.56 112.992 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 t -80.97 132.41 35.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.858 -1.534 . . . . 1.37 106.858 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 82.2 mt -103.2 148.24 26.03 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.065 0.46 . . . . 0.5 111.19 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 1.6 tpm_? -141.72 141.4 33.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.174 -0.676 . . . . 3.78 109.174 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -106.91 125.59 51.21 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.158 0.504 . . . . 0.29 109.952 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 22.4 tp -121.97 128.92 52.04 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.227 -1.398 . . . . 0.95 107.227 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -118.4 106.56 12.85 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.17 -0.678 . . . . 0.88 109.17 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.06 31.77 20.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.121 0.969 . . . . 1.79 111.446 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.93 85.49 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.853 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -107.43 150.53 26.66 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.008 -0.738 . . . . 1.37 109.008 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.3 120.29 24.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.373 -0.376 . . . . 0.7 110.756 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -87.23 128.88 35.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.82 -1.178 . . . . 0.61 107.82 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -104.09 123.96 48.21 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 110.221 -0.289 . . . . 2.47 110.221 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.94 120.96 19.28 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.996 -1.113 . . . . 1.74 107.996 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -136.89 -163.94 1.5 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.889 -0.596 . . . . 1.57 110.117 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 t -58.86 -44.8 91.11 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.505 1.122 . . . . 1.52 111.98 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 72.4 m-85 -92.26 -23.1 19.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.874 0.694 . . . . 1.59 112.874 -174.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.405 HG23 ' HG ' ' A' ' 72' ' ' LEU . 45.7 mt -124.74 106.3 16.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.974 -1.491 . . . . 0.5 106.974 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -132.9 148.31 52.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.309 0.485 . . . . 2.89 112.309 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 m -101.22 116.96 34.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.442 -0.947 . . . . 0.44 108.442 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 42.4 mt-10 -96.21 119.85 35.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.458 -0.497 . . . . 2.04 110.513 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -103.38 112.74 25.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.409 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.46 165.57 18.01 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.723 -0.843 . . . . 1.25 108.723 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.4 115.84 43.19 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.945 -0.761 . . . . 3.36 108.945 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.26 134.32 28.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.794 1.663 . . . . 1.39 110.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.33 23.09 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -23.52 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.256 1.022 . . . . 1.91 113.453 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.99 -24.99 47.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.828 0.347 . . . . 3.49 111.213 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -96.48 152.25 18.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.227 -1.027 . . . . 1.89 108.227 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 p -108.44 16.1 23.35 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.977 0.894 . . . . 1.3 109.399 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 t -109.52 127.22 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.735 -1.121 . . . . 0.61 109.86 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.608 ' HB3' HG13 ' A' ' 29' ' ' VAL . 21.5 ttm180 -89.59 118.01 28.9 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 1.84 107.165 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -103.85 152.29 22.09 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.426 -0.953 . . . . 1.16 108.426 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.67 -178.72 48.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.661 -1.376 . . . . 0.31 109.661 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 35.4 t -146.16 142.34 28.37 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 120.939 0.4 . . . . 0.36 111.297 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -92.25 100.99 13.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.936 -1.876 . . . . 0.28 105.936 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.667 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 70.8 mtt85 -99.83 131.7 45.64 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.563 0.697 . . . . 2.68 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 52' ' ' ILE . 3.6 mp -111.0 109.66 19.88 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.749 -1.204 . . . . 1.23 107.749 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.63 -45.35 83.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.775 -1.102 . . . . 2.18 108.539 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 12.9 mm-40 -130.16 100.85 18.29 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 114.969 -1.014 . . . . 2.82 109.18 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.16 154.25 12.71 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.07 1.847 . . . . 1.25 108.352 173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 78' ' ' VAL . 21.5 p -125.38 -177.85 4.02 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 118.862 -0.589 . . . . 1.22 109.769 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -67.0 -18.18 65.26 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.32 0.963 . . . . 2.03 110.812 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG22 ' OG1' ' A' ' 76' ' ' THR . 13.0 m -72.77 -10.89 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.791 -0.641 . . . . 1.33 109.913 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.58 26.1 4.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 113.223 0.823 . . . . 2.19 113.223 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -113.6 98.27 6.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.46 -0.941 . . . . 1.96 108.46 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.1 -161.95 29.18 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.392 -0.909 . . . . 0.49 112.247 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.84 116.78 23.49 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.418 -0.216 . . . . 2.23 110.418 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 53.6 m-85 -97.1 105.73 17.93 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.239 -0.652 . . . . 0.69 109.239 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 90.1 m -101.76 124.8 48.0 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.587 -0.733 . . . . 0.34 110.365 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -106.56 123.72 48.53 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.655 -0.869 . . . . 0.22 108.655 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 1.9 mm? -105.48 141.98 36.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.997 -1.112 . . . . 0.36 107.997 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -135.54 121.24 19.58 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.024 -0.732 . . . . 0.31 109.024 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.47 124.14 42.91 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.309 0.485 . . . . 0.61 112.309 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -138.65 177.04 2.25 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 116.87 -1.538 . . . . 1.18 107.366 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 18.3 Cg_exo -42.64 -26.25 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.53 2.82 . . . . 1.0 116.271 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.63 -34.54 58.32 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.865 -0.522 . . . . 1.1 110.998 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.25 -167.26 29.02 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.951 -0.86 . . . . 0.59 110.951 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 61.8 tt0 -115.36 127.34 55.33 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 122.939 0.496 . . . . 1.57 110.265 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.81 161.77 13.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.182 -0.673 . . . . 0.37 109.182 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.7 p -143.69 136.72 27.61 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.602 -0.518 . . . . 0.57 109.602 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -136.6 155.03 50.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.954 -1.498 . . . . 0.3 106.954 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 46.0 m -140.07 126.8 20.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.09 0.471 . . . . 1.26 111.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -112.42 130.71 65.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.532 -1.284 . . . . 0.72 107.532 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 tpt -90.5 106.57 18.59 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.633 -0.506 . . . . 1.25 109.633 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.93 132.72 55.61 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.341 0.591 . . . . 0.58 110.686 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.17 119.7 19.16 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.023 -1.473 . . . . 0.84 107.023 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 C--N 1.306 -1.318 0 C-N-CA 120.384 -0.526 . . . . 3.86 112.315 -174.84 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.406 -2.672 0 N-CA-C 108.403 -0.962 . . . . 1.58 108.403 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -92.88 130.65 38.41 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.074 -0.713 . . . . 1.19 109.074 174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -84.64 167.26 16.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.79 -1.096 . . . . 1.32 109.045 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.45 127.16 40.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.75 0.31 . . . . 0.45 111.436 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 m -120.74 135.88 55.02 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.834 -1.913 . . . . 1.19 105.834 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 85' ' ' LEU . 96.0 t -115.22 114.71 47.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 120.927 0.394 . . . . 0.29 110.342 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.98 123.71 47.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD13 HG22 ' A' ' 98' ' ' ILE . 72.9 mt -104.05 155.95 18.26 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.887 -0.412 . . . . 0.33 109.887 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -132.08 142.95 49.7 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.018 -0.734 . . . . 1.03 109.018 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -53.82 135.89 41.11 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 125.119 1.368 . . . . 0.49 110.858 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.87 57.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.4 110.789 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.33 139.07 18.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 121.223 0.535 . . . . 0.57 109.776 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.71 113.34 23.29 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.079 -0.964 . . . . 2.52 111.829 -171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -170.3 -177.65 2.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.191 -2.151 . . . . 0.88 105.191 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.72 -38.45 86.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 120.193 1.361 . . . . 2.75 113.755 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -94.29 115.74 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.465 -0.939 . . . . 2.46 108.465 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 72' ' ' LEU . 94.0 m95 -82.1 117.52 22.34 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.594 0.711 . . . . 0.86 109.932 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -110.84 122.54 48.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.3 109.305 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 66.3 mt -106.95 101.71 38.94 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.383 -0.969 . . . . 0.3 108.383 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.59 132.15 15.65 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.416 2.077 . . . . 0.28 111.918 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -122.71 155.34 36.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.117 0.484 . . . . 0.37 110.326 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -136.81 107.7 6.66 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.862 -0.608 . . . . 0.88 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.6 p -119.82 121.49 66.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.827 -0.805 . . . . 0.27 108.827 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.6 p-10 -104.91 161.19 14.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.644 -0.822 . . . . 1.39 110.797 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.77 177.94 24.28 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.396 -1.082 . . . . 0.6 110.396 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HA ' ' NE2' ' A' ' 32' ' ' GLN 0.303 17.2 mm-40 -109.85 -54.82 0.05 OUTLIER Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.626 0.602 . . . . 2.61 112.626 175.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -68.93 119.17 6.18 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 N-CA-C 105.819 -2.416 . . . . 0.78 105.819 168.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 109.4 2.47 Favored Pre-proline 0 C--N 1.32 -0.695 0 O-C-N 123.826 0.704 . . . . 0.78 110.727 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.9 Cg_endo -72.46 135.03 23.58 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.642 1.561 . . . . 0.56 111.15 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -65.0 108.71 1.89 Allowed 'General case' 0 N--CA 1.433 -1.318 0 O-C-N 123.865 0.728 . . . . 1.37 109.98 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 29' ' ' VAL . 87.8 mt -85.57 126.25 33.73 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.288 -0.869 . . . . 0.5 110.128 -176.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -136.77 127.2 26.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.049 -0.523 . . . . 3.78 109.726 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 85.3 m95 -90.77 134.58 34.32 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.623 -0.717 . . . . 0.29 109.756 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 tp -113.7 126.86 55.71 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 105.447 -2.057 . . . . 0.95 105.447 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -119.8 103.5 9.41 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.45 -0.574 . . . . 0.88 109.45 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 61.39 32.88 19.0 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.208 -0.906 . . . . 1.79 110.783 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.97 -14.48 64.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.807 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -98.88 138.63 35.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.223 -0.658 . . . . 1.37 109.223 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.07 123.79 24.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.941 -0.572 . . . . 0.7 110.395 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 62.2 tp -80.04 120.38 24.13 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.237 -1.023 . . . . 0.61 108.237 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.79 127.62 45.93 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.833 -1.914 . . . . 2.47 105.833 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -57.79 126.73 28.67 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.705 0.628 . . . . 1.74 109.89 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.5 p -128.63 173.77 10.0 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.74 -0.837 . . . . 1.57 108.74 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -77.1 -1.29 28.38 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.738 0.78 . . . . 1.52 110.36 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -105.19 -40.68 5.78 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.305 -0.861 . . . . 1.59 109.002 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -128.58 109.22 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.835 -1.172 . . . . 0.5 107.835 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -143.81 147.07 33.6 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.464 0.65 . . . . 2.89 111.446 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 109.73 11.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.74 -1.118 . . . . 0.44 108.983 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -104.56 108.8 20.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.526 -1.287 . . . . 2.04 107.526 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.02 147.54 24.94 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.937 0.398 . . . . 0.87 111.513 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.81 165.55 13.52 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -81.58 126.36 76.16 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 113.638 0.977 . . . . 3.36 113.638 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.92 140.4 16.08 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.7 2.267 . . . . 1.39 111.124 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.15 161.15 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.029 -1.1 . . . . 1.53 108.029 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.39 -15.29 63.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.997 0.74 . . . . 1.91 112.997 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.54 -7.73 49.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.381 -0.6 . . . . 3.49 109.381 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.2 134.27 46.89 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.718 -0.475 . . . . 1.89 109.718 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -106.1 20.68 18.57 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.851 -1.537 . . . . 1.3 106.851 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 21.9 t -112.88 132.57 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 114.466 -1.243 . . . . 0.61 110.402 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.1 mtp180 -84.11 122.86 29.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.985 -1.857 . . . . 1.84 105.985 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -108.56 139.09 43.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.049 -0.352 . . . . 1.16 110.049 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.81 176.21 41.3 Favored Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 110.707 -0.957 . . . . 0.31 110.707 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 t -138.36 132.66 31.85 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.671 -0.492 . . . . 0.36 109.671 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 53.3 tp -80.26 105.15 11.3 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 104.593 -2.373 . . . . 0.28 104.593 170.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -99.57 116.16 31.06 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.885 -0.598 . . . . 2.68 110.521 -171.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 23' ' ' TRP . 53.9 mt -83.23 107.54 15.84 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 106.651 -1.611 . . . . 1.23 106.651 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -72.85 -49.43 30.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.329 -1.305 . . . . 2.18 109.912 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -122.2 101.46 41.27 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.004 -1.48 . . . . 2.82 107.004 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.46 129.87 29.72 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 121.989 1.793 . . . . 1.25 110.593 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -129.63 157.08 43.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.257 -0.883 . . . . 1.22 108.665 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.38 -5.09 17.03 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 113.639 0.978 . . . . 2.03 113.639 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -82.91 -10.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.406 0.146 . . . . 1.33 110.943 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.03 26.87 0.19 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.396 1.258 . . . . 2.19 114.396 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.9 p30 -113.62 123.56 50.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.069 -1.086 . . . . 1.96 108.069 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -170.81 33.0 Favored Glycine 0 C--N 1.289 -2.072 0 C-N-CA 119.458 -1.353 . . . . 0.49 111.745 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.05 104.91 16.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.616 0.245 . . . . 2.23 110.697 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -85.95 110.78 19.69 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.549 -0.908 . . . . 0.69 108.549 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' TRP . 24.5 m -102.11 133.24 47.26 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.527 -0.546 . . . . 0.34 109.527 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 95' ' ' SER . 47.5 tp -107.99 115.47 30.19 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.828 -0.434 . . . . 0.22 109.828 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.088 -1.079 . . . . 0.36 108.088 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.23 124.06 31.61 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 132.3 53.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.967 -0.293 . . . . 0.61 111.236 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 35.0 p30 -149.89 176.91 2.03 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.775 -1.565 . . . . 1.18 106.775 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 40.7 Cg_exo -45.19 -30.31 4.98 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.197 2.598 . . . . 1.0 115.803 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.14 -21.16 59.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.538 0.57 . . . . 1.1 112.538 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -161.14 23.57 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 119.988 -1.101 . . . . 0.59 112.383 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -100.31 133.78 44.22 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.196 0.598 . . . . 1.57 111.173 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.45 42.77 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.625 -1.621 . . . . 0.37 106.625 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 49.7 p -162.06 141.38 9.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.208 0.528 . . . . 0.57 111.751 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.78 164.65 32.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.282 -1.747 . . . . 0.3 106.282 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 p -135.42 139.97 44.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.454 -0.499 . . . . 1.26 111.152 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.586 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.13 127.22 70.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.559 -1.274 . . . . 0.72 107.559 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.0 ttt -100.71 128.4 46.77 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.808 -0.757 . . . . 1.25 110.248 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -117.88 135.93 53.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.083 -1.451 . . . . 0.58 107.083 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.44 100.95 9.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.26 0.552 . . . . 0.84 110.666 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 N--CA 1.425 -1.714 0 CA-C-O 121.939 0.876 . . . . 3.86 108.782 174.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.408 -2.534 0 N-CA-C 108.674 -0.861 . . . . 1.58 108.674 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.533 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 19.3 m-85 -78.56 124.73 28.46 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.085 -1.82 . . . . 1.19 106.085 174.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.9 m -83.54 -171.34 3.53 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.082 -0.71 . . . . 1.32 109.082 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -92.68 119.67 32.32 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 119.093 -1.043 . . . . 0.45 109.746 -172.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.5 m -118.14 128.74 55.02 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.069 -1.086 . . . . 1.19 108.069 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.92 119.53 62.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 116.546 -0.297 . . . . 0.29 110.261 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.62 116.85 30.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.255 -0.646 . . . . 2.18 109.255 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 98' ' ' ILE . 37.1 mt -104.46 146.56 28.68 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.156 -0.475 . . . . 0.33 109.769 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -131.25 145.85 52.07 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.612 -0.884 . . . . 1.03 108.612 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -56.3 132.95 52.25 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.589 1.181 . . . . 0.49 111.674 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -57.71 140.57 51.04 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.814 -1.085 . . . . 0.4 110.949 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.9 131.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.668 -0.493 . . . . 0.57 109.668 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.464 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.1 mt-10 -84.78 104.04 14.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.703 -0.681 . . . . 2.52 111.904 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -155.3 -168.51 2.87 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.497 -1.668 . . . . 0.88 106.497 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -68.5 -40.29 80.91 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.292 0.951 . . . . 2.75 111.124 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -97.89 113.86 25.8 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.21 -1.404 . . . . 2.46 107.21 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 54.6 m95 -81.45 124.6 29.58 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.227 -0.657 . . . . 0.86 109.227 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.82 124.73 42.73 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.639 -0.71 . . . . 0.3 110.72 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.556 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.7 mt -106.68 103.15 45.46 Favored Pre-proline 0 C--O 1.242 0.676 0 N-CA-C 108.365 -0.976 . . . . 0.3 108.365 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.79 131.24 14.33 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.608 2.205 . . . . 0.28 111.789 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.9 p90 -135.66 155.05 51.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.107 0.48 . . . . 0.37 110.289 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -142.45 114.98 8.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.653 0.739 . . . . 0.88 109.536 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.821 -1.081 . . . . 0.27 108.502 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -121.16 151.06 40.35 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.717 -0.793 . . . . 1.39 110.338 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.21 138.73 2.59 Favored Glycine 0 N--CA 1.42 -2.431 0 N-CA-C 108.274 -1.93 . . . . 0.6 108.274 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 24.0 tt0 -79.91 -50.97 1.17 Allowed Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.776 -0.77 . . . . 2.61 109.936 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.7 Cg_exo -61.72 120.0 7.41 Favored 'Trans proline' 0 C--N 1.375 1.923 0 N-CA-C 106.273 -2.241 . . . . 0.78 106.273 162.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB1' ' NH2' ' A' ' 66' ' ' ARG . . . -65.43 116.29 29.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.349 -0.841 . . . . 0.78 111.114 -174.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.21 159.56 8.41 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.928 1.752 . . . . 0.56 112.703 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -102.11 131.84 48.35 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.249 -1.019 . . . . 1.37 108.249 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 80.4 mt -97.97 154.05 17.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.788 0.327 . . . . 0.5 110.999 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -155.07 135.64 13.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.798 -0.816 . . . . 3.78 108.798 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.4 m95 -96.82 121.9 39.19 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.754 -0.461 . . . . 0.29 109.754 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.7 tp -109.88 127.47 54.74 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.791 -1.559 . . . . 0.95 106.791 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -118.29 98.98 6.56 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 109.625 -0.509 . . . . 0.88 109.625 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.86 43.41 21.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.752 1.221 . . . . 1.79 113.284 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.9 61.87 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.53 -0.843 . . . . 0.61 113.742 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 t -107.54 144.85 33.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.004 -1.11 . . . . 1.37 108.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -78.86 129.15 37.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.573 -0.899 . . . . 0.7 108.573 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 50.4 tp -80.66 120.02 24.03 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.992 -0.744 . . . . 0.61 108.992 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -95.57 126.05 40.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.031 -0.729 . . . . 2.47 109.031 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -58.72 122.63 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.968 0.793 . . . . 1.74 109.292 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.6 p -124.73 -172.03 2.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.85 -0.426 . . . . 1.57 109.85 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 t -74.95 -30.69 61.3 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.393 -0.965 . . . . 1.52 108.393 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 43.1 m-85 -82.98 -41.49 18.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.302 -0.863 . . . . 1.59 110.362 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 72' ' ' LEU . 33.7 mt -124.94 106.9 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.287 -1.005 . . . . 0.5 108.287 -176.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -146.04 156.13 43.26 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 118.255 0.48 . . . . 2.89 110.413 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.9 m -92.27 121.41 33.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.792 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.0 134.05 40.88 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.301 -1.37 . . . . 2.04 107.301 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.78 144.27 46.4 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.84 0.352 . . . . 0.87 111.648 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.94 165.68 11.16 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.341 -2.096 . . . . 1.25 105.341 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.58 128.11 28.11 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 113.399 0.889 . . . . 3.36 113.399 -172.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 159.78 27.23 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.185 2.59 . . . . 1.39 110.494 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.51 176.16 6.65 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.124 -0.695 . . . . 1.53 109.124 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.86 77.71 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.59 0.589 . . . . 1.91 112.59 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.74 19.2 11.62 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.14 0.495 . . . . 3.49 112.067 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -111.21 113.08 25.32 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.407 -1.331 . . . . 1.89 107.407 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -93.76 2.62 56.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.8 0.81 . . . . 1.3 108.961 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.41 127.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.677 -1.147 . . . . 0.61 109.473 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 48.1 mtt180 -103.53 139.31 39.03 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.755 -1.572 . . . . 1.84 106.755 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.9 145.41 49.84 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.896 -1.149 . . . . 1.16 107.896 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.49 -167.98 33.97 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 120.032 -1.08 . . . . 0.31 111.447 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 10.0 t -150.81 132.34 14.77 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 122.069 0.148 . . . . 0.36 110.969 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 60.0 tp -84.36 112.32 20.23 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.606 -2.368 . . . . 0.28 104.606 169.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 38.1 ttm180 -116.69 125.97 52.49 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 119.652 -0.819 . . . . 2.68 112.262 -171.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.467 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.6 mp -107.11 109.62 21.51 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.567 -1.197 . . . . 1.23 108.616 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -70.72 -40.01 73.04 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.962 -1.017 . . . . 2.18 110.094 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -135.09 102.1 11.1 Favored Pre-proline 0 N--CA 1.419 -2.005 0 N-CA-C 107.341 -1.355 . . . . 2.82 107.341 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 23' ' ' TRP . 73.9 Cg_endo -74.98 141.45 26.71 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.14 1.893 . . . . 1.25 111.21 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 p -104.25 171.58 7.26 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.299 -0.63 . . . . 1.22 109.299 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -68.93 -37.35 78.84 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.011 -1.075 . . . . 2.03 111.699 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.24 -10.36 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.46 0.911 . . . . 1.33 113.46 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.15 -8.7 58.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.052 0.76 . . . . 2.19 113.052 -171.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 17.7 p30 -77.65 77.25 4.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.883 0.849 . . . . 1.96 111.804 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -152.34 -153.03 6.13 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.134 -0.939 . . . . 0.49 111.499 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.17 118.66 37.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 122.977 0.511 . . . . 2.23 111.154 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -96.88 112.64 24.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.562 -0.903 . . . . 0.69 108.562 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 60.9 m -102.93 123.41 46.51 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.917 -0.771 . . . . 0.34 108.917 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 12' ' ' VAL . 54.2 tp -98.49 119.24 36.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.947 -0.76 . . . . 0.22 108.947 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 2.9 mm? -102.18 131.72 48.54 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.431 -0.804 . . . . 0.36 109.104 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.74 120.61 31.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.706 -1.22 . . . . 0.31 107.706 173.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.21 132.04 55.89 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 123.448 0.468 . . . . 0.61 111.526 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 37.5 p30 -145.06 174.03 3.81 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 107.8 -1.185 . . . . 1.18 107.8 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 56.8 Cg_exo -48.05 -32.98 19.66 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.979 2.453 . . . . 1.0 115.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.38 -36.47 63.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.796 0.331 . . . . 1.1 111.1 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.17 -166.42 38.26 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 119.761 -1.209 . . . . 0.59 112.253 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 60.8 tt0 -128.41 135.59 49.73 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.707 -0.849 . . . . 1.57 108.707 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.04 154.87 20.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 p -146.84 119.48 8.55 Favored 'General case' 0 N--CA 1.426 -1.649 0 O-C-N 123.618 0.574 . . . . 0.57 111.149 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -126.03 148.34 49.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.416 -1.327 . . . . 0.3 107.416 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.2 m -127.83 139.77 52.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 117.934 0.334 . . . . 1.26 111.465 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.51 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -133.64 123.9 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 109.149 -0.686 . . . . 0.72 109.149 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 51.0 ttm -98.17 123.31 42.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.622 -0.51 . . . . 1.25 109.622 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -120.42 125.84 48.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.699 0.285 . . . . 0.58 110.972 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 113.11 24.51 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.703 -0.851 . . . . 0.84 108.703 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.308 -1.219 0 CA-C-N 116.308 -0.406 . . . . 3.86 111.471 -178.291 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.41 -2.436 0 N-CA-C 108.121 -1.066 . . . . 1.58 108.121 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -104.27 132.59 50.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.118 -1.067 . . . . 1.19 108.118 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 m -83.76 175.48 9.63 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.138 -1.06 . . . . 1.32 108.138 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 124.19 38.31 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.869 -0.732 . . . . 0.45 111.404 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 67.5 m -121.57 135.61 54.99 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.456 -1.313 . . . . 1.19 107.456 172.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 94' ' ' ALA . 93.7 t -115.44 118.23 58.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.028 0.442 . . . . 0.29 110.695 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -113.09 116.46 29.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.651 -1.24 . . . . 2.18 107.651 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 98' ' ' ILE . 29.1 mt -100.39 156.63 17.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.16 0.505 . . . . 0.33 111.841 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -131.31 144.49 51.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.693 -1.225 . . . . 1.03 107.693 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -63.73 139.3 58.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 124.241 0.963 . . . . 0.49 108.97 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.42 141.78 29.41 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.045 0.841 . . . . 0.4 111.072 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.04 130.69 39.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.542 0.687 . . . . 0.57 109.978 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -76.89 111.19 12.17 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.433 -1.258 . . . . 2.52 112.385 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.0 ptt? -166.72 -172.89 2.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.538 -1.282 . . . . 0.88 107.538 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -75.78 -32.86 60.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.661 1.119 . . . . 2.75 111.063 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.438 ' O ' ' HG3' ' A' ' 20' ' ' MET . 61.3 m80 -99.0 122.07 41.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.448 -1.316 . . . . 2.46 107.448 176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -86.97 126.26 34.6 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.425 -0.91 . . . . 0.86 113.365 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.65 121.66 32.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.17 -1.377 . . . . 0.3 109.617 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 17' ' ' ALA . 53.8 mt -106.18 97.95 17.6 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.467 -1.308 . . . . 0.3 107.467 173.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.3 138.66 27.9 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.631 2.221 . . . . 0.28 112.141 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -134.29 159.14 41.89 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.964 0.411 . . . . 0.37 110.595 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -139.86 116.71 10.95 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.36 -0.836 . . . . 0.88 109.265 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.4 p -126.39 122.75 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.428 -0.953 . . . . 0.27 108.428 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.2 p-10 -105.63 158.7 16.51 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.951 -1.1 . . . . 1.39 111.13 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.11 165.64 13.34 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.752 -1.113 . . . . 0.6 110.471 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 33' ' ' PRO 0.261 20.9 mm-40 -107.34 -52.1 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 118.942 -0.551 . . . . 2.61 111.877 175.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.2 Cg_endo -61.55 120.47 8.12 Favored 'Trans proline' 0 C--N 1.367 1.51 0 N-CA-C 106.703 -2.076 . . . . 0.78 106.703 165.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.19 114.18 11.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 O-C-N 123.55 0.531 . . . . 0.78 112.115 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 86.6 Cg_endo -81.18 142.79 13.71 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.413 1.409 . . . . 0.56 111.731 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 4.3 p -77.28 120.97 23.06 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.935 -0.765 . . . . 1.37 108.935 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD21 HG11 ' A' ' 29' ' ' VAL . 93.6 mt -95.8 117.08 29.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.466 0.651 . . . . 0.5 110.477 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -125.95 134.81 51.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.926 -1.034 . . . . 3.78 109.577 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -98.64 115.86 29.61 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.627 -0.508 . . . . 0.29 109.627 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 20.8 tp -101.87 126.89 48.86 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 105.001 -2.222 . . . . 0.95 105.001 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -122.78 108.88 13.53 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 108.995 -0.743 . . . . 0.88 108.995 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.97 34.44 21.53 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 123.94 0.775 . . . . 1.79 111.466 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.3 6.9 88.97 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.849 -0.614 . . . . 0.61 112.586 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -116.24 147.15 41.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.024 -1.102 . . . . 1.37 108.024 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.5 t -76.89 114.75 17.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.142 -1.058 . . . . 0.7 108.142 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.96 118.24 18.53 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.702 -0.851 . . . . 0.61 108.702 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.08 115.04 20.33 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.442 -0.577 . . . . 2.47 109.442 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.26 108.01 5.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.51 -0.922 . . . . 1.74 108.51 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.2 p -104.13 -162.89 0.93 Allowed 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.553 -1.203 . . . . 1.57 109.655 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -81.41 -26.59 35.27 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.857 -0.794 . . . . 1.52 108.857 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -79.04 -40.31 31.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.884 -0.598 . . . . 1.59 110.268 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 72' ' ' LEU . 56.6 mt -120.26 105.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.79 -1.93 . . . . 0.5 105.79 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -139.29 140.51 37.64 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.328 -0.549 . . . . 2.89 111.435 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -86.82 112.2 21.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.285 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -110.75 152.52 26.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.993 -0.743 . . . . 2.04 108.993 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -118.64 163.13 17.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 120.768 0.318 . . . . 0.87 110.815 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.92 140.9 52.52 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.873 -1.899 . . . . 1.25 105.873 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.21 116.75 30.29 Favored Pre-proline 0 C--N 1.296 -1.752 0 O-C-N 124.026 0.829 . . . . 3.36 111.394 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.87 169.04 16.91 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.573 2.182 . . . . 1.39 110.609 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.81 142.31 33.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.76 -15.24 61.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.559 0.577 . . . . 1.91 112.559 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -98.49 8.11 45.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.27 -0.423 . . . . 3.49 111.324 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.8 pt-20 -117.92 155.47 30.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.347 -0.983 . . . . 1.89 108.347 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 p -106.51 8.35 31.36 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.201 0.524 . . . . 1.3 110.887 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 26.9 t -100.08 134.62 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.456 -0.793 . . . . 0.61 109.824 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 29' ' ' VAL . 80.4 mtp180 -93.67 141.96 27.9 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.286 -1.376 . . . . 1.84 107.286 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -124.29 139.58 53.78 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.927 -0.398 . . . . 1.16 109.927 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.41 -179.44 42.49 Favored Glycine 0 N--CA 1.425 -2.079 0 C-N-CA 120.498 -0.858 . . . . 0.31 111.516 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 t -149.66 138.07 20.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.927 0.394 . . . . 0.36 110.897 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.7 tp -80.32 106.91 12.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.25 -1.759 . . . . 0.28 106.25 172.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -94.18 103.96 15.99 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.535 -0.757 . . . . 2.68 109.809 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -94.64 109.51 21.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.601 -1.259 . . . . 1.23 107.601 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.66 -51.16 11.06 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.67 -1.15 . . . . 2.18 109.469 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.64 101.84 52.01 Favored Pre-proline 0 N--CA 1.423 -1.778 0 N-CA-C 107.477 -1.305 . . . . 2.82 107.477 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.9 130.65 6.71 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.288 1.992 . . . . 1.25 109.917 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -110.53 154.64 23.42 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -74.07 -5.4 41.38 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.694 -0.629 . . . . 2.03 112.118 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.7 -10.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.33 110.24 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 16.6 m120 -83.77 -1.62 54.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 2.19 109.545 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -79.45 83.35 5.47 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.799 -1.186 . . . . 1.96 107.799 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.33 -150.64 6.7 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.924 -0.58 . . . . 0.49 111.816 -176.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -107.72 124.13 49.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.701 0.286 . . . . 2.23 111.45 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 63.4 m-85 -100.27 113.39 26.06 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.742 -0.836 . . . . 0.69 108.742 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.4 m -103.5 121.97 43.96 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.928 -1.138 . . . . 0.34 107.928 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -99.9 119.9 38.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.734 -0.469 . . . . 0.22 109.734 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.56 136.16 44.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.388 -0.967 . . . . 0.36 108.388 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.4 120.73 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.438 -1.319 . . . . 0.31 107.438 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 114.05 20.55 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.322 0.582 . . . . 0.61 112.507 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 39.5 p30 -127.0 161.7 52.19 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 106.538 -1.652 . . . . 1.18 106.538 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 4.5 Cg_exo -40.68 -38.65 2.72 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.895 3.063 . . . . 1.0 115.349 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.63 -34.35 75.6 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 112.488 0.551 . . . . 1.1 112.488 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.21 170.95 36.67 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.816 -1.183 . . . . 0.59 112.508 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -110.67 126.91 55.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.52 -0.918 . . . . 1.57 108.52 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.64 155.27 18.41 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.449 -0.575 . . . . 0.37 109.449 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 p -150.95 128.69 11.58 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.651 0.594 . . . . 0.57 110.68 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.77 159.88 41.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.586 -1.635 . . . . 0.3 106.586 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 p -136.69 146.75 46.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.586 0.708 . . . . 1.26 112.653 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.519 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -134.97 122.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.713 -1.217 . . . . 0.72 107.713 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -100.61 123.41 44.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.93 140.92 51.45 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.189 -0.3 . . . . 0.58 110.189 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.15 142.69 28.77 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.741 -0.663 . . . . 0.84 109.668 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--N 1.315 -0.931 0 N-CA-C 109.411 -0.588 . . . . 3.86 109.411 -178.681 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.404 -2.774 0 N-CA-C 107.704 -1.221 . . . . 1.58 107.704 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.435 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 40.3 m-85 -85.31 135.09 34.05 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.183 -0.917 . . . . 1.19 109.39 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.7 m -84.71 176.65 8.42 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.97 -1.492 . . . . 1.32 106.97 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 128.41 40.89 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.728 -0.789 . . . . 0.45 111.408 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 23.3 t -115.33 136.58 52.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 106.464 -1.68 . . . . 1.19 106.464 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 94' ' ' ALA . 99.5 t -115.69 116.14 51.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.025 0.44 . . . . 0.29 110.129 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -117.0 116.29 27.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.656 -0.868 . . . . 2.18 108.656 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.501 HD13 HG22 ' A' ' 98' ' ' ILE . 31.9 mt -97.41 156.18 16.58 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.725 -0.472 . . . . 0.33 109.725 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -131.91 146.39 52.08 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.758 -1.571 . . . . 1.03 106.758 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.33 132.21 50.83 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.812 0.695 . . . . 0.49 109.615 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.33 142.74 30.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.648 -1.16 . . . . 0.4 112.107 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.21 130.4 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.543 -0.753 . . . . 0.57 110.117 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' CH2' ' A' ' 23' ' ' TRP . 36.2 mt-10 -80.64 107.17 13.22 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.837 -1.074 . . . . 2.52 110.263 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 59.8 mtm -134.76 -165.81 1.72 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.41 -1.7 . . . . 0.88 106.41 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -66.02 -39.01 89.86 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.254 -1.017 . . . . 2.75 108.254 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 20' ' ' MET . 66.9 m170 -117.56 153.55 33.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.452 -1.684 . . . . 2.46 106.452 176.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.453 ' CH2' ' HG2' ' A' ' 19' ' ' GLU . 68.6 m95 -98.63 144.85 27.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.017 0.747 . . . . 0.86 113.017 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -136.23 121.01 18.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.788 -1.096 . . . . 0.3 109.384 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 17' ' ' ALA . 58.8 mt -103.38 100.31 17.94 Favored Pre-proline 0 C--O 1.24 0.562 0 N-CA-C 108.468 -0.938 . . . . 0.3 108.468 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.66 132.91 16.45 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.324 2.016 . . . . 0.28 111.85 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' A' ' 14' ' ' LEU . 53.8 p90 -128.47 152.26 48.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.993 0.425 . . . . 0.37 111.094 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 m -127.31 114.3 17.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.372 -0.973 . . . . 0.88 108.372 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.2 p -125.29 112.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.308 -0.627 . . . . 0.27 109.308 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.2 p-10 -112.02 144.79 40.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.995 -0.682 . . . . 1.39 110.316 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.24 165.48 32.57 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.637 -1.785 . . . . 0.6 108.637 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 19.5 tm0? -91.4 -53.31 0.28 Allowed Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 117.519 0.659 . . . . 2.61 109.999 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 3.2 Cg_exo -80.36 120.63 4.09 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 107.6 -1.731 . . . . 0.78 107.6 170.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.5 115.67 10.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 123.779 0.674 . . . . 0.78 111.763 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 87.7 Cg_endo -81.51 153.2 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.749 2.299 . . . . 0.56 113.204 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 m -79.56 119.31 22.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.531 -1.285 . . . . 1.37 107.531 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 127.41 39.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.927 0.394 . . . . 0.5 110.053 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -123.79 130.67 52.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.941 -0.763 . . . . 3.78 108.941 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -94.57 119.86 33.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.127 0.489 . . . . 0.29 109.948 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 26.3 tp -110.66 126.91 55.0 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.169 -1.419 . . . . 0.95 107.169 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -116.48 106.9 14.11 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 110.204 -0.295 . . . . 0.88 110.204 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 56.39 35.2 25.51 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.227 1.011 . . . . 1.79 111.18 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.49 -18.17 57.96 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.777 -0.647 . . . . 0.61 113.25 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.5 p -106.02 139.71 40.15 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.179 -0.6 . . . . 1.37 110.375 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.14 128.12 28.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.904 -0.589 . . . . 0.7 109.785 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -91.1 111.65 23.21 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.684 -0.689 . . . . 0.61 109.269 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -85.04 135.13 34.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.115 -1.069 . . . . 2.47 108.115 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.61 141.08 48.35 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.8 -0.445 . . . . 1.74 109.8 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -123.87 -163.79 1.17 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.284 -0.635 . . . . 1.57 109.284 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -81.98 -17.44 46.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.831 -0.433 . . . . 1.52 109.831 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.11 -31.46 9.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.409 -0.36 . . . . 1.59 111.405 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.3 mt -113.84 106.73 21.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 106.511 -1.663 . . . . 0.5 106.511 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.42 145.91 33.02 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.273 0.558 . . . . 2.89 111.813 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -85.92 112.95 21.64 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.422 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -96.83 112.54 24.25 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.858 -0.61 . . . . 2.04 110.947 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.52 142.6 27.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.203 -1.036 . . . . 0.87 108.203 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.31 161.68 19.54 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.408 -1.33 . . . . 1.25 107.408 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 47.7 mt-10 -67.13 113.67 14.68 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 113.973 1.101 . . . . 3.36 113.973 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.7 Cg_exo -80.56 157.72 21.98 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.085 2.524 . . . . 1.39 109.61 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.6 145.57 31.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.737 -0.838 . . . . 1.53 108.737 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.03 0.76 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.689 0.756 . . . . 1.91 111.236 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -123.01 9.55 9.36 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.307 -0.86 . . . . 3.49 109.034 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.6 pt-20 -135.56 160.77 37.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.268 -1.382 . . . . 1.89 107.268 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 p -118.71 34.71 5.09 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.936 0.875 . . . . 1.3 109.778 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 63' ' ' GLU . 18.7 t -109.43 127.18 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.196 -0.911 . . . . 0.61 109.401 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.2 mtp180 -91.32 129.17 37.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.6 -1.629 . . . . 1.84 106.6 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -114.06 134.99 54.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.386 -0.968 . . . . 1.16 108.386 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.62 179.08 36.34 Favored Glycine 0 N--CA 1.408 -3.176 0 C-N-CA 119.73 -1.224 . . . . 0.31 111.714 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 4.7 t -144.61 132.79 21.66 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.83 0.852 . . . . 0.36 109.932 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.1 tp -84.45 105.66 15.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.224 -2.139 . . . . 0.28 105.224 170.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -100.46 123.83 45.19 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.045 -0.525 . . . . 2.68 110.029 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.02 108.26 19.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.894 -1.15 . . . . 1.23 107.894 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -72.9 -35.46 67.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.514 -1.221 . . . . 2.18 109.805 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.59 108.37 58.19 Favored Pre-proline 0 N--CA 1.423 -1.814 0 N-CA-C 107.243 -1.392 . . . . 2.82 107.243 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.39 129.89 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.475 1.45 . . . . 1.25 109.915 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.405 ' HB ' HG22 ' A' ' 78' ' ' VAL . 17.9 p -126.19 141.11 52.06 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.114 0.483 . . . . 1.22 109.828 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.46 -18.39 48.84 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.144 -0.687 . . . . 2.03 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 76' ' ' THR . 22.3 m -68.7 -12.01 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.238 -0.585 . . . . 1.33 111.491 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.505 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 51.7 m-80 -111.62 25.99 11.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.47 0.652 . . . . 2.19 111.386 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.18 104.37 16.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.304 -0.999 . . . . 1.96 108.304 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.05 26.29 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.039 -0.824 . . . . 0.49 111.039 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -96.17 123.48 39.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.117 0.484 . . . . 2.23 111.361 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 97' ' ' SER . 8.0 m-85 -95.97 121.18 37.44 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.158 0.983 . . . . 0.69 108.978 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 53.7 m -107.77 120.9 43.55 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.582 -0.896 . . . . 0.34 108.582 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 95' ' ' SER . 54.0 tp -96.88 118.75 33.99 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.538 -0.912 . . . . 0.22 108.538 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.85 133.62 49.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.415 -0.957 . . . . 0.36 108.415 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -122.07 119.7 32.16 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.417 -0.957 . . . . 0.31 108.417 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.98 131.38 54.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.42 -0.585 . . . . 0.61 109.42 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 8.0 p30 -151.58 165.31 17.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 107.042 -1.466 . . . . 1.18 107.042 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 Cg_endo -44.69 -40.58 14.33 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.473 2.782 . . . . 1.0 114.337 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.63 -27.28 61.19 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.85 0.685 . . . . 1.1 112.85 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.48 -156.1 27.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.121 -1.038 . . . . 0.59 112.178 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 28.7 tt0 -138.12 126.81 23.65 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.957 0.408 . . . . 1.57 110.674 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.79 157.75 16.74 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.2 p -153.7 142.62 21.14 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 123.255 0.347 . . . . 0.57 110.952 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -147.19 152.32 38.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.439 -1.319 . . . . 0.3 107.439 175.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 37.8 m -128.77 141.16 51.4 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.103 0.411 . . . . 1.26 111.034 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.501 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.33 134.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.407 -0.96 . . . . 0.72 108.407 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.9 ttm -99.42 119.96 38.84 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.929 -0.482 . . . . 1.25 109.782 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.9 116.58 30.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.503 -0.554 . . . . 0.58 109.503 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.49 100.11 11.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.397 -0.964 . . . . 0.84 108.397 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 114.718 -1.128 . . . . 3.86 110.104 -179.19 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.396 -3.15 0 N-CA-C 108.598 -0.889 . . . . 1.58 108.598 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.2 m-85 -86.0 117.71 25.02 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 105.397 -2.075 . . . . 1.19 105.397 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.7 m -83.22 -179.31 7.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.797 -0.816 . . . . 1.32 108.797 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.31 126.01 38.21 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 119.606 -0.837 . . . . 0.45 110.817 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 20.8 t -118.41 131.43 56.29 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.673 -1.232 . . . . 1.19 107.673 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 90.4 t -114.5 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.886 -0.783 . . . . 0.29 108.886 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.82 116.05 27.97 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.665 -1.235 . . . . 2.18 107.665 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 98' ' ' ILE . 38.3 mt -99.48 156.82 16.83 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.511 -0.768 . . . . 0.33 109.924 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -131.6 153.94 49.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.063 -0.517 . . . . 1.03 109.695 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -57.32 133.59 55.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.175 -1.375 . . . . 0.49 110.36 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.59 141.4 58.78 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.649 -0.705 . . . . 0.4 110.311 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -91.37 124.91 44.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.647 0.736 . . . . 0.57 111.535 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.49 111.95 20.46 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.47 -1.241 . . . . 2.52 109.92 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -162.46 0.53 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.215 -1.402 . . . . 0.88 107.215 176.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -60.85 -28.93 69.2 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.618 1.099 . . . . 2.75 112.793 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -120.86 165.16 15.57 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.884 -1.524 . . . . 2.46 106.884 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -118.19 135.83 54.01 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.198 -0.667 . . . . 0.86 109.198 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.76 131.69 35.85 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.552 -0.749 . . . . 0.3 110.002 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.4 HD12 HD23 ' A' ' 70' ' ' LEU . 61.8 mt -104.65 106.24 53.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.383 -1.339 . . . . 0.3 107.383 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.09 137.8 19.77 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.644 2.229 . . . . 0.28 111.35 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 14' ' ' LEU . 55.1 p90 -140.01 146.47 39.1 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.227 0.537 . . . . 0.37 111.853 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.5 p -126.63 118.87 25.67 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 115.137 -0.938 . . . . 0.88 109.31 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -120.12 110.46 28.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.529 -0.915 . . . . 0.27 108.529 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.8 p-10 -108.49 150.94 26.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.395 -0.522 . . . . 1.39 110.504 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.36 144.35 3.91 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 108.493 -1.843 . . . . 0.6 108.493 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.51 -53.25 2.06 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.472 -0.936 . . . . 2.61 108.472 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 23.7 Cg_exo -67.26 120.96 8.04 Favored 'Trans proline' 0 C--N 1.379 2.168 0 N-CA-C 108.978 -1.201 . . . . 0.78 108.978 171.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.95 87.88 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.735 -0.666 . . . . 0.78 112.041 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -90.55 159.78 4.37 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.474 2.116 . . . . 0.56 111.714 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -96.36 120.6 36.95 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.995 -1.483 . . . . 1.37 106.995 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.56 159.08 19.97 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.667 0.27 . . . . 0.5 110.901 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -159.43 138.03 10.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.723 -0.843 . . . . 3.78 108.723 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -105.72 129.89 53.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.215 0.531 . . . . 0.29 111.361 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -109.33 137.35 47.32 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.839 -1.171 . . . . 0.95 107.839 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -124.82 103.89 8.32 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.982 -1.118 . . . . 0.88 107.982 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 64.36 28.0 13.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.093 0.957 . . . . 1.79 110.358 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.8 71.53 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.12 -0.945 . . . . 0.61 112.201 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -93.16 150.08 20.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.897 -0.779 . . . . 1.37 108.897 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.89 115.82 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 116.164 -0.471 . . . . 0.7 109.925 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -85.75 124.22 32.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.483 -1.303 . . . . 0.61 107.483 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -102.15 126.14 49.04 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.625 -0.879 . . . . 2.47 108.625 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 114.41 3.28 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.818 -0.808 . . . . 1.74 108.818 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -130.06 -170.8 2.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.451 -0.795 . . . . 1.57 109.588 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -60.15 -32.72 71.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.173 0.589 . . . . 1.52 112.113 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -84.7 -36.8 21.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.399 0.518 . . . . 1.59 112.399 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.401 HD11 HD21 ' A' ' 79' ' ' ASN . 14.2 mt -132.52 114.63 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.955 -1.128 . . . . 0.5 107.955 -171.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.74 155.54 48.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 118.895 0.771 . . . . 2.89 111.518 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -98.62 110.37 22.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.44 109.87 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.82 120.76 43.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.559 -0.534 . . . . 2.04 109.559 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -97.01 153.56 17.84 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 116.09 -0.505 . . . . 0.87 109.81 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.98 159.86 14.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.126 -1.435 . . . . 1.25 107.126 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 61.6 mm-40 -72.91 115.14 37.21 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 123.576 0.547 . . . . 3.36 110.273 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 3.7 Cg_exo -77.17 153.95 32.28 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.546 2.164 . . . . 1.39 110.551 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.12 146.84 27.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.702 -1.221 . . . . 1.53 107.702 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.84 60.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.073 1.138 . . . . 1.91 114.073 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.18 -0.42 46.89 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.526 -0.469 . . . . 3.49 111.833 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -88.81 138.84 31.05 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.963 0.411 . . . . 1.89 110.693 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -104.45 -2.06 25.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.431 -0.952 . . . . 1.3 108.431 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.0 128.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.351 -0.84 . . . . 0.61 109.399 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.0 ttm-85 -108.88 124.18 50.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.004 -1.11 . . . . 1.84 108.004 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -111.04 146.53 36.56 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.949 0.404 . . . . 1.16 110.097 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.39 32.37 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.614 -0.994 . . . . 0.31 110.614 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 71' ' ' ARG . 4.6 t -138.05 131.67 30.98 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.65 -0.5 . . . . 0.36 109.65 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.4 HD23 HD12 ' A' ' 25' ' ' ILE . 47.2 tp -91.32 94.86 9.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.116 -2.179 . . . . 0.28 105.116 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . 15.5 ptm180 -99.93 126.4 46.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.498 -0.774 . . . . 2.68 110.617 -174.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.91 113.05 25.16 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.948 0.88 . . . . 1.23 109.367 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -61.81 -49.52 76.0 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.18 -1.827 . . . . 2.18 107.593 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -135.29 100.57 11.51 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 107.845 -1.168 . . . . 2.82 107.845 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -83.65 141.96 10.07 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.123 1.882 . . . . 1.25 111.163 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 p -130.31 -178.73 4.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 118.98 -0.533 . . . . 1.22 111.598 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -69.47 -19.6 63.75 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.382 0.992 . . . . 2.03 111.102 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 m -70.69 -10.67 14.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.33 110.639 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.401 HD21 HD11 ' A' ' 52' ' ' ILE . 24.9 m120 -88.15 14.29 9.55 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.625 -0.716 . . . . 2.19 112.844 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.56 93.64 9.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.301 -1.0 . . . . 1.96 108.301 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.19 -173.22 39.39 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.409 -0.9 . . . . 0.49 112.127 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.35 122.8 36.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.17 0.51 . . . . 2.23 111.13 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 98' ' ' ILE . 22.0 m-85 -102.97 130.43 50.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.72 1.208 . . . . 0.69 107.908 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -130.88 128.29 40.27 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.988 -0.445 . . . . 0.34 109.955 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.451 ' CB ' HD11 ' A' ' 14' ' ' LEU . 50.5 tp -100.37 124.54 45.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.59 -0.893 . . . . 0.22 108.59 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.58 138.27 48.33 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.098 -1.075 . . . . 0.36 108.098 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.3 119.5 34.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.818 -1.549 . . . . 0.31 106.818 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.68 125.41 40.24 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.043 -1.095 . . . . 0.61 108.043 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -151.04 144.78 17.46 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.506 -1.664 . . . . 1.18 106.506 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.62 -17.17 27.35 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 123.526 2.817 . . . . 1.0 113.986 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.3 t -89.65 -8.83 51.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 1.1 110.348 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.16 157.02 7.32 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.147 -0.781 . . . . 0.59 111.147 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 31.8 tt0 -90.65 133.66 34.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.088 -0.708 . . . . 1.57 109.088 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.5 150.63 23.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.641 -0.874 . . . . 0.37 108.641 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -151.45 143.21 23.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 123.355 0.409 . . . . 0.57 111.309 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.56 154.29 42.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.28 -1.378 . . . . 0.3 107.28 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.8 t -119.71 132.37 55.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.46 0.648 . . . . 1.26 111.655 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -136.34 119.76 23.07 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 124.267 1.027 . . . . 0.72 109.469 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -106.75 122.04 45.57 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.153 -0.684 . . . . 1.25 109.153 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.05 147.76 38.17 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.663 -0.415 . . . . 0.58 110.34 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.26 120.11 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.409 -1.33 . . . . 0.84 107.409 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 72.0 t80 . . . . . 0 C--N 1.307 -1.245 0 CA-C-N 115.632 -0.713 . . . . 3.86 111.653 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.402 -2.85 0 N-CA-C 109.11 -0.7 . . . . 1.58 109.11 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 97.1 m-85 -89.16 136.35 33.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.706 -1.134 . . . . 1.19 108.55 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.2 t -83.91 169.56 14.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.025 -1.472 . . . . 1.32 107.025 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.92 112.82 24.72 Favored 'General case' 0 CA--C 1.489 -1.404 0 CA-C-O 121.068 0.461 . . . . 0.45 110.63 -173.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.1 t -106.87 131.89 53.45 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.889 -1.152 . . . . 1.19 107.889 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 94' ' ' ALA . 89.2 t -115.08 114.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.735 -0.469 . . . . 0.29 109.735 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -113.14 116.16 29.41 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.501 -0.926 . . . . 2.18 108.501 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 43.9 mt -101.77 150.67 22.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.929 -0.397 . . . . 0.33 109.929 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.64 139.6 49.15 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.523 -0.917 . . . . 1.03 108.523 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -52.44 134.19 34.78 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.035 1.459 . . . . 0.49 110.64 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -58.76 142.47 49.98 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.908 -1.042 . . . . 0.4 111.072 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.51 125.89 44.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.491 0.662 . . . . 0.57 110.418 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 114.43 12.03 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.616 -1.175 . . . . 2.52 111.345 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 23.9 ptt? -165.68 -177.28 4.27 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.635 1.174 . . . . 0.88 107.996 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -71.63 -31.73 67.18 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.193 1.36 . . . . 2.75 114.47 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.495 ' O ' ' HG3' ' A' ' 20' ' ' MET . 90.1 m-70 -112.04 125.71 54.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.564 -2.013 . . . . 2.46 105.564 173.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 75' ' ' PRO . 60.0 m95 -93.12 143.67 26.02 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 113.838 1.051 . . . . 0.86 113.838 -168.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 t -134.66 125.6 27.44 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.001 -1.0 . . . . 0.3 109.876 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.5 mt -106.8 101.19 35.59 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.513 -1.292 . . . . 0.3 107.513 173.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.63 129.66 13.89 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.619 2.213 . . . . 0.28 112.304 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -127.46 143.41 51.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.083 0.468 . . . . 0.37 110.518 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 m -127.18 116.12 20.14 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.551 -0.907 . . . . 0.88 108.551 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.96 121.33 57.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.55 -0.537 . . . . 0.27 109.55 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 p-10 -115.69 148.09 40.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.566 -0.454 . . . . 1.39 109.953 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.37 149.65 6.25 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 108.094 -2.003 . . . . 0.6 108.094 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -75.78 -54.79 2.11 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 118.014 0.907 . . . . 2.61 109.111 -177.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 6.4 Cg_exo -75.99 120.0 5.58 Favored 'Trans proline' 0 C--N 1.369 1.651 0 N-CA-C 107.38 -1.815 . . . . 0.78 107.38 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.93 110.99 3.08 Favored Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 124.055 0.847 . . . . 0.78 110.924 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.7 Cg_endo -74.47 146.05 34.5 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.213 1.942 . . . . 0.56 112.37 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 24.5 t -74.52 111.0 9.27 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.363 -1.347 . . . . 1.37 107.363 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 29' ' ' VAL . 80.3 mt -88.75 125.48 34.9 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.637 -0.711 . . . . 0.5 109.786 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 39' ' ' TRP . 16.4 tpp180 -137.08 137.55 39.43 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.828 -0.434 . . . . 3.78 109.828 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.422 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 91.7 m95 -101.54 140.45 35.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.183 0.516 . . . . 0.29 109.868 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 45' ' ' VAL . 12.3 tp -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.421 -2.066 . . . . 0.95 105.421 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 79' ' ' ASN . 54.6 t80 -116.97 106.99 14.01 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.899 -0.408 . . . . 0.88 109.899 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 58.52 37.96 25.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.206 1.002 . . . . 1.79 110.839 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.72 -17.67 43.65 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.632 -0.713 . . . . 0.61 113.023 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -93.36 135.82 34.22 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.993 -0.743 . . . . 1.37 108.993 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' A' ' 40' ' ' LEU . 5.1 p -67.35 136.52 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 121.373 0.606 . . . . 0.7 111.239 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 46.6 tp -92.2 124.25 36.14 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 116.16 -0.473 . . . . 0.61 110.45 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.41 104.81 13.62 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 103.916 -2.624 . . . . 2.47 103.916 167.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 2.0 pm0 -50.35 137.63 18.26 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.188 0.93 . . . . 1.74 112.504 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -118.48 -166.87 1.28 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.174 -0.921 . . . . 1.57 110.467 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -67.17 -33.59 75.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.014 0.435 . . . . 1.52 111.58 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -88.61 -37.17 15.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.381 -0.372 . . . . 1.59 111.702 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.452 HG23 ' HG ' ' A' ' 72' ' ' LEU . 21.5 mt -110.0 109.45 28.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.787 -1.19 . . . . 0.5 107.787 -174.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -136.26 138.19 41.53 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.689 -0.804 . . . . 2.89 111.608 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -81.61 109.64 16.23 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.457 -0.792 . . . . 0.44 109.518 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -109.63 144.09 38.46 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.901 0.381 . . . . 2.04 110.914 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.13 153.76 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.041 -0.527 . . . . 0.87 109.629 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.45 155.85 38.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.904 -1.517 . . . . 1.25 106.904 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -74.58 121.68 85.8 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 114.534 1.309 . . . . 3.36 114.534 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.92 154.4 22.87 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.823 2.348 . . . . 1.39 109.622 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.64 176.26 9.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.164 -0.68 . . . . 1.53 109.164 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.12 89.9 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 119.043 0.838 . . . . 1.91 112.384 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.78 -20.14 59.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.993 -0.549 . . . . 3.49 110.531 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.0 113.15 19.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 120.376 -0.53 . . . . 1.89 109.974 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 m -92.25 0.47 57.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.487 1.137 . . . . 1.3 108.089 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 t -91.42 129.06 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.532 -1.213 . . . . 0.61 109.797 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB3' HG13 ' A' ' 29' ' ' VAL . 18.6 ttm180 -85.64 121.05 27.76 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.041 -1.837 . . . . 1.84 106.041 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.69 131.24 54.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.095 -0.705 . . . . 1.16 109.095 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.45 -177.52 35.54 Favored Glycine 0 N--CA 1.414 -2.791 0 C-N-CA 119.989 -1.101 . . . . 0.31 111.821 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.9 136.21 20.18 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.307 0.643 . . . . 0.36 109.527 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 56.7 tp -84.58 98.34 10.1 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 104.451 -2.426 . . . . 0.28 104.451 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -97.22 123.42 41.0 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.414 -0.812 . . . . 2.68 110.759 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HG ' HG23 ' A' ' 52' ' ' ILE . 6.5 mp -102.11 109.31 20.99 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.673 -1.232 . . . . 1.23 107.673 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -59.43 -42.77 92.64 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.656 -1.611 . . . . 2.18 109.965 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -133.17 124.98 18.69 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.274 -1.009 . . . . 2.82 108.274 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 23' ' ' TRP . 30.9 Cg_endo -66.02 130.52 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.803 2.336 . . . . 1.25 112.036 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.4 p -109.39 141.84 41.2 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.831 -0.803 . . . . 1.22 108.831 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -80.99 -13.16 59.13 Favored 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 120.589 -0.445 . . . . 2.03 110.038 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.32 -13.02 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 119.325 -0.95 . . . . 1.33 111.83 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.5 m-80 -108.48 23.01 15.15 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.957 1.095 . . . . 2.19 113.957 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -86.26 64.27 8.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.034 0.921 . . . . 1.96 111.761 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.02 -148.12 4.96 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.11 -0.95 . . . . 0.49 111.994 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -102.93 116.76 33.18 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.354 0.597 . . . . 2.23 112.603 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 51.4 m-85 -94.91 140.28 30.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.763 -0.828 . . . . 0.69 108.763 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.0 m -128.8 127.71 42.49 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 108.46 -0.941 . . . . 0.34 108.46 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.9 tp -101.6 122.94 44.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.067 -0.716 . . . . 0.22 109.067 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.13 131.48 55.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.686 -1.227 . . . . 0.36 107.686 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.01 120.11 36.25 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.51 -0.922 . . . . 0.31 108.51 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' SER . . . -96.28 115.51 27.55 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.594 0.559 . . . . 0.61 110.64 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -134.82 150.76 74.25 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-O 117.76 -1.114 . . . . 1.18 108.211 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.09 -42.15 21.2 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.478 2.119 . . . . 1.0 112.243 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.5 t -57.2 -32.69 66.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 1.1 112.01 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.1 178.57 26.93 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 109.867 -1.293 . . . . 0.59 109.867 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -106.36 129.82 54.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.385 -0.598 . . . . 1.57 109.385 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.83 152.86 20.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.005 -0.739 . . . . 0.37 109.005 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 24.8 p -141.05 146.35 37.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.924 0.392 . . . . 0.57 111.251 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.27 43.36 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.738 -1.208 . . . . 0.3 107.738 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 t -122.91 127.81 49.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.7 -0.481 . . . . 1.26 109.7 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.6 123.85 38.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.77 -0.826 . . . . 0.72 108.77 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.0 mtp -101.73 110.62 22.64 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.2 -0.6 . . . . 1.25 110.285 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.89 133.46 38.59 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.779 -0.646 . . . . 0.58 110.513 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.47 100.63 6.33 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.15 -1.056 . . . . 0.84 108.15 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 72' ' ' LEU . 33.0 m-85 . . . . . 0 C--N 1.3 -1.584 0 N-CA-C 107.807 -1.182 . . . . 3.86 107.807 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.381 -3.894 0 CA-C-O 122.582 1.182 . . . . 1.58 113.781 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.27 126.57 52.97 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 112.878 -1.965 . . . . 1.19 105.96 171.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.68 174.17 10.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.753 -1.573 . . . . 1.32 106.753 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.09 129.23 40.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 118.882 -1.127 . . . . 0.45 110.501 -174.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 m -122.03 135.83 54.87 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.798 -1.186 . . . . 1.19 107.798 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.6 t -115.82 123.23 70.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.001 0.429 . . . . 0.29 111.073 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -115.13 139.72 49.66 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.338 -0.986 . . . . 2.18 108.338 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 98' ' ' ILE . 36.1 mt -129.85 156.88 43.64 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.348 -0.612 . . . . 0.33 109.348 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -130.7 143.16 50.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.185 -1.043 . . . . 1.03 108.185 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 134.59 56.14 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.496 1.122 . . . . 0.49 109.693 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.31 139.84 58.81 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 124.003 0.815 . . . . 0.4 110.638 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.32 134.04 31.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.976 0.417 . . . . 0.57 111.542 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 92.26 0.34 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.32 -0.855 . . . . 2.52 112.415 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.8 ptt? -144.93 -177.09 5.35 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -64.1 -41.68 97.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.205 0.817 . . . . 2.75 113.205 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.9 p-80 -112.44 129.24 56.39 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.052 -1.462 . . . . 2.46 107.052 173.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -82.74 147.79 28.23 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 120.849 0.357 . . . . 0.86 111.642 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -137.59 120.26 16.21 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.44 -0.8 . . . . 0.3 110.142 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.4 mt -106.93 97.41 17.61 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.637 -1.245 . . . . 0.3 107.637 173.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.76 131.8 17.69 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 123.125 2.55 . . . . 0.28 112.602 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.62 154.91 39.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.333 0.587 . . . . 0.37 110.844 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 m -140.14 121.83 15.33 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.617 -0.882 . . . . 0.88 108.617 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.3 p -124.07 111.7 29.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.744 -0.835 . . . . 0.27 108.744 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.7 p-10 -106.85 147.25 29.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.026 -0.534 . . . . 1.39 111.309 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 -170.77 32.64 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.06 -1.216 . . . . 0.6 110.06 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -122.55 -51.94 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.456 0.91 . . . . 2.61 113.456 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.01 121.32 9.62 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 107.854 -1.633 . . . . 0.78 107.854 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.43 111.03 6.24 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 123.765 0.666 . . . . 0.78 111.111 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 71.7 Cg_endo -84.47 146.65 10.96 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.841 1.694 . . . . 0.56 111.842 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 22.9 t -79.57 121.96 25.9 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.715 -1.587 . . . . 1.37 106.715 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -96.51 129.72 43.82 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.639 0.587 . . . . 0.5 109.734 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -136.58 134.7 37.71 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.116 -0.493 . . . . 3.78 110.968 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.85 34.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.617 -0.882 . . . . 0.29 108.617 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.86 130.91 52.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.086 -1.45 . . . . 0.95 107.086 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 87.2 t80 -120.8 103.72 9.31 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.049 -0.723 . . . . 0.88 109.049 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 56.86 33.59 23.38 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.662 0.785 . . . . 1.79 111.923 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.83 82.95 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.687 -0.768 . . . . 0.61 112.895 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 t -105.77 146.69 29.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.976 -1.12 . . . . 1.37 107.976 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.88 123.8 36.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.907 -0.775 . . . . 0.7 108.907 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.75 106.53 12.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.263 -0.643 . . . . 0.61 109.263 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.8 131.41 34.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.585 -0.895 . . . . 2.47 108.585 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.01 149.31 47.84 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.273 0.559 . . . . 1.74 111.268 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -145.6 -169.33 3.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 114.938 -1.028 . . . . 1.57 108.768 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 t -72.25 -25.18 61.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.429 0.633 . . . . 1.52 109.987 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 95.9 m-85 -101.52 -12.09 18.79 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.437 0.903 . . . . 1.59 113.437 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' ND2' ' A' ' 79' ' ' ASN . 44.4 mt -135.75 107.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.311 -1.737 . . . . 0.5 106.311 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -141.45 142.33 33.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 112.308 0.485 . . . . 2.89 112.308 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 m -88.79 109.49 20.22 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.644 -0.707 . . . . 0.44 109.499 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.671 ' HG3' ' HE ' ' A' ' 71' ' ' ARG . 6.7 mm-40 -92.98 124.05 36.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.391 0.615 . . . . 2.04 110.883 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.31 120.5 40.03 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.148 -1.427 . . . . 0.87 107.148 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 pp -84.31 155.79 22.22 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 106.836 -1.542 . . . . 1.25 106.836 177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.0 105.97 3.4 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 124.138 0.899 . . . . 3.36 110.407 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 79.4 Cg_endo -88.25 169.68 6.05 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.137 2.558 . . . . 1.39 111.051 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -93.87 139.62 30.67 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.656 -1.238 . . . . 1.53 107.656 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.54 15.11 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.513 0.673 . . . . 1.91 111.413 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.85 -25.62 32.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.069 -0.968 . . . . 3.49 109.829 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.8 pt-20 -97.26 139.4 33.28 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.583 -0.895 . . . . 1.89 108.583 -177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -88.12 13.59 10.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.96 0.886 . . . . 1.3 109.94 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.6 t -119.57 132.05 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.724 -0.671 . . . . 0.61 110.259 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.54 ' HB2' HG13 ' A' ' 29' ' ' VAL . 22.8 mtp180 -95.39 136.23 36.02 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.654 -1.61 . . . . 1.84 106.654 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -125.41 157.74 36.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.163 -0.68 . . . . 1.16 109.163 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.2 -168.24 38.84 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 111.264 -0.734 . . . . 0.31 111.264 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.29 138.41 16.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 123.001 0.52 . . . . 0.36 111.335 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.13 109.83 20.19 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.81 -1.552 . . . . 0.28 106.81 172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.671 ' HE ' ' HG3' ' A' ' 55' ' ' GLU . 76.0 mtm180 -102.28 131.56 48.78 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.795 -0.362 . . . . 2.68 111.574 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.1 mp -119.83 109.56 15.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.777 -0.823 . . . . 1.23 108.777 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.84 -10.61 59.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.759 -0.655 . . . . 2.18 111.184 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 33.3 tt0 -135.09 101.49 11.33 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 108.114 -1.069 . . . . 2.82 108.114 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -88.26 129.59 2.35 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.591 1.528 . . . . 1.25 110.368 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.7 p -136.54 173.15 12.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.842 -0.799 . . . . 1.22 108.842 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -78.79 -5.67 53.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.113 0.412 . . . . 2.03 112.113 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.02 -9.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.611 . . . . 1.33 109.349 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.4 m120 -104.81 22.06 15.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.005 -1.109 . . . . 2.19 108.005 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -114.17 117.44 31.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.799 -0.815 . . . . 1.96 108.799 -175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.27 -153.52 24.68 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.637 -1.268 . . . . 0.49 113.18 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 45.8 m-80 -87.28 120.66 28.79 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.55 -0.325 . . . . 2.23 111.406 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 98' ' ' ILE . 39.4 m-85 -105.56 118.28 36.16 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.311 -0.996 . . . . 0.69 108.311 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 m -122.96 125.02 44.49 Favored 'General case' 0 C--N 1.283 -2.3 0 O-C-N 121.611 -0.681 . . . . 0.34 109.775 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.434 HD23 HG13 ' A' ' 12' ' ' VAL . 59.0 tp -97.39 117.54 31.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.43 133.2 52.29 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.467 -0.938 . . . . 0.36 108.467 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -122.16 120.03 33.03 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.719 -1.215 . . . . 0.31 107.719 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.88 132.53 55.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.962 -0.755 . . . . 0.61 108.962 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 91' ' ' CYS . 8.7 p30 -152.62 170.43 8.1 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-O 118.474 -0.774 . . . . 1.18 109.257 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.48 -39.15 54.92 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.85 2.367 . . . . 1.0 114.465 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.438 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 27.0 t -70.0 -32.06 70.06 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-O 121.224 0.535 . . . . 1.1 111.832 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.19 -146.03 11.75 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 119.864 -1.16 . . . . 0.59 111.969 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.63 138.63 38.03 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.146 -0.687 . . . . 1.57 109.146 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -119.81 146.63 45.52 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.965 -1.124 . . . . 0.37 107.965 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 p -143.74 152.85 41.78 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 121.006 -0.277 . . . . 0.57 110.275 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.58 144.92 26.52 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.86 -1.533 . . . . 0.3 106.86 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -122.44 145.72 48.03 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.472 0.654 . . . . 1.26 112.358 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.755 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -133.64 124.76 48.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 125.475 1.51 . . . . 0.72 108.572 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 tpt -96.34 96.52 8.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.687 -1.227 . . . . 1.25 107.687 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.02 113.16 26.16 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.349 0.595 . . . . 0.58 111.44 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.31 99.62 9.01 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 107.093 -1.447 . . . . 0.84 107.093 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 114.209 1.188 . . . . 3.86 114.209 -178.577 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.411 -2.377 0 CA-C-O 121.478 0.656 . . . . 1.58 109.999 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.431 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.2 m-85 -86.52 127.92 34.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.818 -1.083 . . . . 1.19 109.587 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.2 t -84.68 176.47 8.55 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.557 -1.275 . . . . 1.32 107.557 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.11 114.57 26.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 120.357 -0.537 . . . . 0.45 110.55 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.642 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 34.1 t -117.68 131.31 56.65 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.743 -1.206 . . . . 1.19 107.743 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.53 121.26 67.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.507 -0.315 . . . . 0.29 110.936 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.1 123.42 42.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.569 -0.53 . . . . 2.18 109.569 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 27' ' ' PHE . 43.8 mt -105.87 156.02 18.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.33 109.937 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.53 151.92 51.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 110.455 -0.202 . . . . 1.03 110.455 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -54.05 133.16 43.68 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 124.786 1.304 . . . . 0.49 110.4 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -66.49 145.55 55.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.625 -0.716 . . . . 0.4 110.213 -177.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.68 127.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.518 0.675 . . . . 0.57 112.745 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.74 108.83 4.08 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 114.281 -1.327 . . . . 2.52 110.926 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -170.61 -171.7 1.1 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.93 -1.507 . . . . 0.88 106.93 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -66.52 -50.59 62.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.393 -0.523 . . . . 2.75 111.982 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -92.39 120.13 32.6 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -82.32 120.11 24.99 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.271 0.557 . . . . 0.86 111.023 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.8 121.96 44.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.612 -1.176 . . . . 0.3 109.138 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.4 mt -103.73 103.74 38.45 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 108.054 -1.091 . . . . 0.3 108.054 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.25 130.48 13.06 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.456 2.104 . . . . 0.28 111.85 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.502 ' HB3' HD23 ' A' ' 14' ' ' LEU . 43.1 p90 -135.35 162.2 33.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.318 0.58 . . . . 0.37 110.482 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.0 m -144.62 123.48 12.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.651 -0.704 . . . . 0.88 109.157 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.7 p -123.6 114.69 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.079 -0.964 . . . . 0.27 108.495 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.642 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 4.1 p-10 -102.25 158.49 16.15 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.736 -1.186 . . . . 1.39 109.755 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.98 138.72 2.61 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.795 -1.322 . . . . 0.6 109.795 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -87.32 -49.6 0.45 Allowed Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 119.571 -0.852 . . . . 2.61 110.316 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.6 Cg_exo -64.17 119.48 6.54 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 105.255 -2.633 . . . . 0.78 105.255 164.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.17 117.79 59.78 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 116.138 -0.483 . . . . 0.78 112.296 -171.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -85.89 149.53 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.398 2.065 . . . . 0.56 111.941 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -90.91 138.81 31.31 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.77 -1.196 . . . . 1.37 107.77 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.424 ' HB3' HD11 ' A' ' 85' ' ' LEU . 80.9 mt -98.23 134.06 41.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.938 0.399 . . . . 0.5 111.094 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -130.29 126.22 36.69 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.037 -0.529 . . . . 3.78 110.064 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -96.78 124.33 40.72 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.599 -0.728 . . . . 0.29 109.702 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.97 128.8 55.61 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.492 -0.929 . . . . 0.95 108.492 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -105.01 104.64 14.41 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.169 -1.419 . . . . 0.88 107.169 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.08 30.76 19.65 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.801 0.81 . . . . 1.79 110.961 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.04 64.25 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.39 -0.823 . . . . 0.61 112.392 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -91.45 150.8 21.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.212 -1.032 . . . . 1.37 108.212 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -72.33 121.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.818 -0.628 . . . . 0.7 111.345 -175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -102.66 122.45 44.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.664 -1.235 . . . . 0.61 107.664 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.81 138.32 35.35 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.773 -0.825 . . . . 2.47 108.773 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -75.84 106.15 7.26 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.329 -0.396 . . . . 1.74 110.214 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -88.28 -170.37 2.93 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.852 -0.425 . . . . 1.57 109.852 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -80.12 -13.61 59.14 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.56 -0.713 . . . . 1.52 109.517 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -97.94 -40.1 8.64 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.695 -0.684 . . . . 1.59 110.137 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HG ' ' A' ' 72' ' ' LEU . 37.5 mt -107.12 104.89 17.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.972 -2.232 . . . . 0.5 104.972 174.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -135.09 149.52 50.07 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.378 -0.929 . . . . 2.89 112.078 -173.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.9 m -94.36 109.62 21.45 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.357 -0.979 . . . . 0.44 108.357 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -100.75 123.79 45.46 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.544 -0.91 . . . . 2.04 108.544 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -100.4 146.17 27.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.716 -0.846 . . . . 0.87 108.716 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.15 154.5 32.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.833 -1.173 . . . . 1.25 107.833 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.49 120.43 81.45 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 123.94 0.775 . . . . 3.36 110.203 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.94 169.53 16.26 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.873 2.382 . . . . 1.39 109.936 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.73 141.2 38.06 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.315 -1.735 . . . . 1.53 106.315 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.93 -25.35 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.107 1.521 . . . . 1.91 115.107 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -73.5 -32.05 64.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.087 0.47 . . . . 3.49 110.411 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -75.23 142.36 43.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.251 0.548 . . . . 1.89 110.1 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 m -111.29 18.03 19.66 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.382 -1.71 . . . . 1.3 106.382 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.81 121.36 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 113.819 -1.537 . . . . 0.61 108.45 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 77.6 ttt180 -93.14 111.39 23.01 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.173 -1.417 . . . . 1.84 107.173 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -101.61 155.65 17.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.46 -0.57 . . . . 1.16 109.46 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.28 -174.74 44.83 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.278 -0.963 . . . . 0.31 112.092 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.4 t -145.3 134.85 23.27 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.177 0.591 . . . . 0.36 111.025 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.0 tp -88.63 107.59 19.0 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.103 -2.184 . . . . 0.28 105.103 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -117.91 130.41 56.22 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.432 0.634 . . . . 2.68 111.228 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.8 mp -102.44 114.79 29.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.928 -1.033 . . . . 1.23 110.802 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.33 -39.35 81.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.769 -1.105 . . . . 2.18 109.019 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.34 100.45 49.86 Favored Pre-proline 0 N--CA 1.435 -1.214 0 N-CA-C 107.897 -1.149 . . . . 2.82 107.897 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.6 135.45 24.05 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 122.652 2.234 . . . . 1.25 109.451 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -133.43 149.19 51.79 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.033 0.444 . . . . 1.22 111.514 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -70.14 -4.21 20.31 Favored 'General case' 0 C--O 1.208 -1.085 0 C-N-CA 123.822 0.849 . . . . 2.03 112.117 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.06 -9.78 11.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.416 -0.356 . . . . 1.33 110.178 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.586 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.6 m-80 -115.96 26.48 9.94 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.549 0.944 . . . . 2.19 113.549 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -94.32 72.81 3.88 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.075 0.941 . . . . 1.96 110.011 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.5 -153.11 5.88 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.701 -0.761 . . . . 0.49 113.206 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.35 123.84 43.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.967 -0.383 . . . . 2.23 109.967 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 27.8 m-85 -101.33 116.57 33.1 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.012 -0.736 . . . . 0.69 109.012 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.9 m -110.72 122.32 47.5 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.192 -1.04 . . . . 0.34 108.192 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.4 tp -99.01 119.2 37.4 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.135 -0.484 . . . . 0.22 109.811 -178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 129.38 53.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.554 -0.906 . . . . 0.36 108.554 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.47 120.99 33.61 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.326 -1.361 . . . . 0.31 107.326 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.04 124.8 46.77 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.457 -0.497 . . . . 0.61 111.492 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 43.9 p30 -138.47 171.1 8.8 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.181 -1.414 . . . . 1.18 107.181 174.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 38.9 Cg_exo -45.35 -37.48 14.22 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.043 2.495 . . . . 1.0 114.648 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.04 -49.62 73.84 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.671 0.272 . . . . 1.1 110.824 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.67 -177.65 48.03 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.131 -1.033 . . . . 0.59 111.816 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -108.1 122.58 47.19 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.992 -1.114 . . . . 1.57 107.992 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.88 149.09 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.397 -0.964 . . . . 0.37 108.397 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.1 p -147.42 140.84 25.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 O-C-N 123.464 0.477 . . . . 0.57 110.883 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.17 42.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.318 -1.364 . . . . 0.3 107.318 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.9 p -130.15 146.35 51.78 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.13 0.49 . . . . 1.26 111.842 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -145.57 138.6 21.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.621 -1.622 . . . . 0.72 106.621 178.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -111.12 124.1 51.52 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 1.25 110.336 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.62 115.31 25.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.493 -0.558 . . . . 0.58 109.493 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.43 111.65 23.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.982 -0.554 . . . . 0.84 110.303 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 N--CA 1.432 -1.331 0 CA-C-O 121.555 0.693 . . . . 3.86 111.636 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.417 -2.117 0 CA-C-O 121.784 0.802 . . . . 1.58 109.446 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.34 124.89 24.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.875 -1.057 . . . . 1.19 110.992 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 20.6 t -84.46 160.97 20.45 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.428 -1.693 . . . . 1.32 106.428 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.51 121.24 35.86 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.776 -0.77 . . . . 0.45 111.42 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -112.3 141.88 45.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.454 -1.313 . . . . 1.19 107.454 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.8 t -115.36 114.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 110.056 -0.349 . . . . 0.29 110.056 -176.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -112.35 116.4 30.29 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.379 0.609 . . . . 2.18 109.55 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 98' ' ' ILE . 70.7 mt -104.87 156.81 17.68 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.96 -1.018 . . . . 0.33 109.035 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -131.13 156.52 45.14 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.762 -0.829 . . . . 1.03 108.762 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -65.08 134.76 54.51 Favored 'General case' 0 N--CA 1.423 -1.806 0 O-C-N 124.456 1.097 . . . . 0.49 109.63 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.41 140.9 56.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.25 -0.886 . . . . 0.4 109.684 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.67 132.97 33.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.547 0.689 . . . . 0.57 110.652 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.44 102.39 2.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.427 -1.261 . . . . 2.52 112.465 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -161.37 -179.42 7.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.812 -1.551 . . . . 0.88 106.812 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -64.55 -37.66 88.34 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.468 1.031 . . . . 2.75 113.401 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -107.22 117.91 35.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.906 -1.516 . . . . 2.46 106.906 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.452 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.3 m95 -82.05 125.55 30.96 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.159 -0.616 . . . . 0.86 110.681 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -108.67 121.43 45.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.146 -1.057 . . . . 0.3 108.146 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.3 mt -102.89 98.11 10.77 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 107.693 -1.225 . . . . 0.3 107.693 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.92 132.08 19.33 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.392 2.061 . . . . 0.28 112.056 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -128.69 152.79 48.0 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.327 0.584 . . . . 0.37 110.481 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 48.7 m -142.18 120.63 12.42 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.265 -0.88 . . . . 0.88 108.927 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -124.61 121.16 60.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.335 -0.987 . . . . 0.27 108.335 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 p-10 -111.55 145.49 39.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.737 -0.785 . . . . 1.39 110.204 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.62 4.73 Favored Glycine 0 C--N 1.298 -1.529 0 N-CA-C 107.504 -2.238 . . . . 0.6 107.504 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' HD3' ' A' ' 33' ' ' PRO 0.278 46.1 tt0 -80.87 -57.43 0.58 Allowed Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 118.649 1.224 . . . . 2.61 113.168 -175.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 32.4 Cg_exo -63.69 119.74 6.89 Favored 'Trans proline' 0 C--N 1.367 1.509 0 N-CA-C 106.28 -2.239 . . . . 0.78 106.28 168.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.93 109.84 2.86 Favored Pre-proline 0 C--N 1.315 -0.923 0 O-C-N 123.806 0.691 . . . . 0.78 111.076 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 59.1 Cg_endo -71.16 141.67 40.14 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.162 1.908 . . . . 0.56 112.512 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -71.26 104.24 3.07 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.463 -0.79 . . . . 1.37 108.952 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 29' ' ' VAL . 96.0 mt -81.78 134.03 35.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.352 -0.84 . . . . 0.5 109.813 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -146.39 138.59 25.03 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 123.687 0.795 . . . . 3.78 108.86 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 95.6 m95 -102.78 130.67 49.84 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.378 0.609 . . . . 0.29 110.625 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.9 tp -114.72 126.79 55.26 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.954 -1.869 . . . . 0.95 105.954 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -116.63 98.12 6.36 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 109.077 -0.712 . . . . 0.88 109.077 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 51.92 56.6 7.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.167 0.984 . . . . 1.79 110.23 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.02 -13.95 12.54 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.089 -0.96 . . . . 0.61 113.816 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 m -96.6 140.99 30.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.853 -0.795 . . . . 1.37 108.853 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.92 123.45 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.461 -1.311 . . . . 0.7 107.461 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 47.4 tp -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.58 0.55 . . . . 0.61 109.587 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -82.83 125.83 31.75 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.486 -0.931 . . . . 2.47 108.486 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.36 153.19 35.99 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.222 -0.445 . . . . 1.74 110.031 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.9 t -166.05 -175.28 3.29 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.748 -0.834 . . . . 1.57 108.748 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 m -68.22 -17.67 64.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 119.594 1.088 . . . . 1.52 111.901 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -79.07 -40.17 31.94 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.729 0.3 . . . . 1.59 110.831 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.42 HD11 ' ND2' ' A' ' 79' ' ' ASN . 56.9 mt -136.15 115.66 16.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.929 -0.767 . . . . 0.5 108.929 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 8.8 p90 -142.39 145.69 34.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.107 0.479 . . . . 2.89 112.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 m -82.58 111.19 18.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.466 -0.788 . . . . 0.44 109.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 6.4 mm-40 -89.3 140.39 29.54 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.899 -0.778 . . . . 2.04 108.899 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -122.27 140.67 52.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.749 -0.834 . . . . 0.87 108.749 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.59 151.71 41.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.027 -1.101 . . . . 1.25 108.027 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 32.6 mm-40 -63.46 119.97 58.2 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 123.96 0.788 . . . . 3.36 112.598 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.95 156.13 38.77 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.588 2.192 . . . . 1.39 110.351 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.89 146.91 33.31 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.667 -0.864 . . . . 1.53 108.667 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.69 -13.05 58.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.019 1.118 . . . . 1.91 114.019 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -90.57 -21.47 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.916 0.388 . . . . 3.49 111.424 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.4 pt-20 -99.28 162.47 13.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.689 -0.804 . . . . 1.89 110.957 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -121.49 29.71 7.09 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.966 -1.494 . . . . 1.3 106.966 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 30' ' ' ASP . 21.7 t -107.93 128.76 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.22 -1.355 . . . . 0.61 108.807 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.2 mtp180 -92.59 132.59 36.73 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.003 -1.48 . . . . 1.84 107.003 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -121.97 143.73 49.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.302 -0.629 . . . . 1.16 109.302 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.7 -166.09 24.11 Favored Glycine 0 N--CA 1.416 -2.642 0 C-N-CA 120.512 -0.851 . . . . 0.31 111.035 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.0 t -156.07 137.57 14.06 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.833 0.453 . . . . 0.36 110.183 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 38.3 tp -90.16 107.93 19.43 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.851 -1.907 . . . . 0.28 105.851 171.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 70.6 mtt180 -100.18 120.35 39.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-N 116.502 -0.317 . . . . 2.68 110.873 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 23' ' ' TRP . 73.1 mt -83.7 108.0 16.49 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 105.96 -1.867 . . . . 1.23 105.96 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.408 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 50.4 t30 -66.97 -42.62 84.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.047 -0.979 . . . . 2.18 109.532 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -134.98 100.99 11.63 Favored Pre-proline 0 N--CA 1.412 -2.341 0 N-CA-C 106.533 -1.655 . . . . 2.82 106.533 171.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 14.3 Cg_exo -70.38 131.42 20.33 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.022 1.814 . . . . 1.25 110.367 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 p -130.27 155.74 45.8 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.312 -0.995 . . . . 1.22 108.312 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -65.41 -5.42 7.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.444 1.276 . . . . 2.03 114.444 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.49 -10.44 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 109.638 -0.504 . . . . 1.33 109.638 174.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.42 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.8 m120 -89.18 17.15 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.599 0.76 . . . . 2.19 111.882 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -92.15 121.9 34.13 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.874 -0.788 . . . . 1.96 108.874 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.53 -170.45 36.5 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.39 -1.386 . . . . 0.49 112.641 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.83 101.29 13.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.996 -0.602 . . . . 2.23 110.721 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.49 ' HB2' HG23 ' A' ' 98' ' ' ILE . 45.1 m-85 -83.97 114.13 21.49 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 108.767 -0.827 . . . . 0.69 108.767 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 35.8 m -117.32 132.46 56.6 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 121.452 -0.78 . . . . 0.34 110.683 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 12' ' ' VAL . 44.3 tp -106.18 123.1 47.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.124 -0.695 . . . . 0.22 109.124 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.11 136.07 47.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.254 -1.017 . . . . 0.36 108.254 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -126.84 120.62 29.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.549 -0.908 . . . . 0.31 108.549 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.28 117.19 34.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.796 -0.446 . . . . 0.61 109.796 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 20.4 t-20 -131.31 151.59 79.07 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-O 117.405 -1.283 . . . . 1.18 108.31 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -43.1 -38.42 7.43 Favored 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 122.799 2.332 . . . . 1.0 113.38 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.1 t -64.16 -39.66 94.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.486 0.714 . . . . 1.1 112.137 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.14 30.96 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.149 -0.78 . . . . 0.59 111.149 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 64.5 tt0 -128.83 129.91 46.23 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.729 -0.471 . . . . 1.57 109.729 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.43 150.51 23.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.747 -0.834 . . . . 0.37 108.747 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 p -148.65 123.73 10.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.977 -0.556 . . . . 0.57 110.183 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.41 51.88 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.006 -1.109 . . . . 0.3 108.006 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.4 m -121.17 132.79 55.05 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.699 0.761 . . . . 1.26 112.819 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -109.78 126.55 66.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 125.541 1.536 . . . . 0.72 108.685 175.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' ILE . 16.0 tpt -105.08 111.09 23.73 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 1.25 108.209 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.6 149.7 27.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.218 -0.447 . . . . 0.58 109.961 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.6 127.33 23.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.799 -0.637 . . . . 0.84 110.475 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 75' ' ' PRO . 55.4 t80 . . . . . 0 C--N 1.299 -1.604 0 C-N-CA 124.994 1.317 . . . . 3.86 107.876 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 105.846 -1.909 . . . . 1.58 105.846 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -72.13 131.73 43.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.262 -0.881 . . . . 1.19 110.084 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.36 157.1 21.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.61 -1.256 . . . . 1.32 107.61 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.56 127.2 41.4 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.624 0.601 . . . . 0.45 112.624 -172.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.3 m -123.87 141.05 52.38 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.933 -1.877 . . . . 1.19 105.933 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.7 t -115.0 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.074 0.464 . . . . 0.29 109.755 -174.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -115.81 116.85 28.73 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.001 -0.74 . . . . 2.18 109.001 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 38.8 mt -95.68 156.66 16.23 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.965 -0.561 . . . . 0.33 109.631 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -130.54 142.04 50.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.954 -1.499 . . . . 1.03 106.954 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -62.11 130.1 43.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 124.053 0.846 . . . . 0.49 110.558 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.56 140.63 40.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.451 1.1 . . . . 0.4 112.207 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.7 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.754 -0.657 . . . . 0.57 109.886 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.3 117.27 24.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.991 -1.004 . . . . 2.52 112.394 -171.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.0 ptt? -168.28 -174.27 2.23 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.129 -1.434 . . . . 0.88 107.129 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 8.0 t-80 -65.54 -52.65 50.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.794 0.724 . . . . 2.75 110.639 -176.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.479 ' O ' ' HG3' ' A' ' 20' ' ' MET . 7.8 p-80 -99.35 126.65 45.26 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.625 -0.879 . . . . 2.46 108.625 173.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 82.7 m95 -82.36 148.0 28.51 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.178 0.513 . . . . 0.86 112.224 -171.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 44.0 t -131.55 118.89 20.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.506 -0.924 . . . . 0.3 108.506 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 17' ' ' ALA . 78.3 mt -103.68 99.18 14.84 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.455 -1.313 . . . . 0.3 107.455 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.0 143.58 36.58 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.087 1.858 . . . . 0.28 110.887 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -137.73 154.58 49.61 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.724 -0.39 . . . . 0.37 110.349 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -132.62 114.06 13.77 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.638 -0.71 . . . . 0.88 110.208 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 37' ' ' LEU . 6.4 p -129.57 137.81 55.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.813 -1.551 . . . . 0.27 106.813 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.3 p-10 -132.34 161.88 32.45 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 119.741 -0.784 . . . . 1.39 110.744 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.94 153.74 7.34 Favored Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 109.502 -1.439 . . . . 0.6 109.502 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -81.31 -56.68 0.59 Allowed Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 107.973 -1.121 . . . . 2.61 107.973 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.83 120.85 7.73 Favored 'Trans proline' 0 C--N 1.375 1.928 0 N-CA-C 107.59 -1.734 . . . . 0.78 107.59 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB1' HH21 ' A' ' 66' ' ' ARG . . . -61.78 114.41 11.18 Favored Pre-proline 0 C--N 1.312 -1.023 0 O-C-N 123.742 0.651 . . . . 0.78 111.694 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' ALA . 84.8 Cg_endo -79.1 135.05 12.01 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.572 1.515 . . . . 0.56 112.058 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 p -73.53 116.47 14.14 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 109.023 -0.732 . . . . 1.37 109.023 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.516 HD21 HG11 ' A' ' 29' ' ' VAL . 93.2 mt -87.22 127.53 35.16 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.5 109.647 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -125.7 130.21 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.127 -0.694 . . . . 3.78 109.127 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.5 m95 -95.64 128.87 42.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.277 0.561 . . . . 0.29 109.734 176.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.1 tp -118.59 127.42 53.59 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.703 -1.962 . . . . 0.95 105.703 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -119.91 110.85 17.21 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.587 -0.523 . . . . 0.88 109.587 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.0 28.5 16.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.061 0.945 . . . . 1.79 111.45 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.09 -12.27 69.4 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 121.389 -0.434 . . . . 0.61 112.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.1 p -103.18 151.31 22.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.754 0.311 . . . . 1.37 110.315 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.28 120.76 17.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.667 -0.697 . . . . 0.7 110.436 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.9 tp -94.42 104.44 16.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.05 -0.722 . . . . 0.61 109.05 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -85.74 137.31 32.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.252 -0.647 . . . . 2.47 109.252 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.42 129.18 39.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.956 -0.566 . . . . 1.74 109.536 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 p -126.64 -163.69 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.853 0.861 . . . . 1.57 109.661 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.6 m -87.19 -5.83 58.83 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.359 0.599 . . . . 1.52 109.661 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -103.0 -35.56 8.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.81 -0.632 . . . . 1.59 109.955 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -127.93 106.97 15.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.231 -1.025 . . . . 0.5 108.231 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -138.78 140.22 38.54 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.817 0.341 . . . . 2.89 110.303 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -86.83 113.81 22.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.706 -0.85 . . . . 0.44 108.706 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 71' ' ' ARG . 43.4 mt-10 -105.52 115.06 29.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.397 0.618 . . . . 2.04 110.062 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -96.37 150.63 20.37 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.35 -0.841 . . . . 0.87 109.455 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.0 pp -106.91 165.15 11.55 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.743 -1.947 . . . . 1.25 105.743 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.4 104.74 21.43 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.556 -0.535 . . . . 3.36 109.556 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 86.9 Cg_endo -84.08 165.32 13.15 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.379 2.052 . . . . 1.39 111.145 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.32 137.29 54.54 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.962 -1.125 . . . . 1.53 107.962 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.03 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.012 0.525 . . . . 1.91 111.981 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.49 -26.01 65.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.755 0.788 . . . . 3.49 109.149 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -98.38 140.1 33.15 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.526 -0.761 . . . . 1.89 109.04 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -104.99 28.72 6.94 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.692 0.758 . . . . 1.3 108.993 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 130.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 115.241 -0.89 . . . . 0.61 109.318 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.455 HH21 ' HB1' ' A' ' 34' ' ' ALA . 75.9 mtt180 -82.74 117.54 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.4 -0.963 . . . . 1.84 108.4 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.518 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 96.1 m-70 -104.38 123.74 47.96 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.368 -0.975 . . . . 1.16 108.368 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.9 39.32 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.473 -0.87 . . . . 0.31 111.395 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.4 t -144.16 137.89 27.76 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 122.439 0.296 . . . . 0.36 110.897 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 58.9 tp -84.68 100.38 11.43 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.759 -2.311 . . . . 0.28 104.759 169.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 55' ' ' GLU . 47.8 ttp180 -104.19 120.17 40.54 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 120.238 -0.585 . . . . 2.68 110.049 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 23' ' ' TRP . 75.2 mt -75.55 108.03 8.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.343 -1.725 . . . . 1.23 106.343 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.82 -49.19 66.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.16 -1.382 . . . . 2.18 109.479 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.4 99.8 18.86 Favored Pre-proline 0 N--CA 1.414 -2.234 0 N-CA-C 104.296 -2.483 . . . . 2.82 104.296 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' HG2' ' O ' ' A' ' 21' ' ' HIS . 33.5 Cg_exo -64.06 130.5 27.53 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.388 2.059 . . . . 1.25 111.73 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -135.18 166.02 24.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.56 -0.745 . . . . 1.22 109.383 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -62.54 -5.18 2.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.748 1.759 . . . . 2.03 115.748 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.17 -10.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.035 0.445 . . . . 1.33 109.834 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.7 26.74 0.39 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.113 1.153 . . . . 2.19 114.113 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.14 125.17 53.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.321 -0.992 . . . . 1.96 108.321 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.38 -165.71 30.96 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.21 -0.995 . . . . 0.49 111.744 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -99.96 124.0 44.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 110.024 -0.362 . . . . 2.23 110.024 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -102.67 105.79 16.32 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.622 -0.881 . . . . 0.69 108.622 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.6 m -97.33 129.58 44.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.948 -0.76 . . . . 0.34 108.948 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.2 tp -109.06 120.77 43.53 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.582 -0.525 . . . . 0.22 109.582 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.23 138.95 42.46 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.283 -1.006 . . . . 0.36 108.283 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -125.94 120.66 30.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.306 -0.998 . . . . 0.31 108.306 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -97.97 112.46 24.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.34 0.59 . . . . 0.61 110.97 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -130.61 140.92 40.13 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.13 -1.804 . . . . 1.18 106.13 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.16 -19.57 12.43 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 124.052 3.168 . . . . 1.0 113.947 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.0 t -78.93 -24.29 44.11 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.825 0.345 . . . . 1.1 110.593 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.52 163.61 11.76 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.555 -1.018 . . . . 0.59 110.555 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -98.12 127.65 44.18 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.478 -0.564 . . . . 1.57 109.478 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.27 155.35 18.28 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.05 -0.722 . . . . 0.37 109.05 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 39.6 p -146.02 151.56 37.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 123.232 0.332 . . . . 0.57 110.609 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.44 33.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.662 -1.607 . . . . 0.3 106.662 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 m -135.02 135.47 41.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 117.983 0.356 . . . . 1.26 110.157 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -128.79 134.68 63.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.844 -1.539 . . . . 0.72 106.844 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.9 ttt -108.69 134.27 51.64 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.177 -0.609 . . . . 1.25 110.063 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.54 45.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.018 -1.104 . . . . 0.58 108.018 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.51 121.04 34.64 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.025 0.44 . . . . 0.84 110.351 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.5 t80 . . . . . 0 N--CA 1.402 -2.847 0 N-CA-C 108.577 -0.897 . . . . 3.86 108.577 179.35 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 108.736 -0.839 . . . . 1.58 108.736 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -106.41 127.3 53.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.235 -0.654 . . . . 1.19 109.235 176.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 t -84.64 -177.87 6.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.276 . . . . 1.32 107.553 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.29 120.5 34.62 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.069 -0.652 . . . . 0.45 111.186 -174.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 1.5 m -114.82 131.17 56.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.803 -1.184 . . . . 1.19 107.803 177.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.1 t -119.65 115.01 46.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 110.14 -0.318 . . . . 0.29 110.14 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -120.38 121.96 39.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.335 -0.393 . . . . 2.18 110.033 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 27' ' ' PHE . 17.1 mt -104.16 155.25 18.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.917 -0.583 . . . . 0.33 110.786 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -131.96 151.56 51.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.235 -1.024 . . . . 1.03 108.235 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -64.48 135.8 56.42 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.278 0.986 . . . . 0.49 111.515 -174.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -61.1 128.91 38.73 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.826 -1.079 . . . . 0.4 111.332 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.64 136.81 24.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 116.053 -0.521 . . . . 0.57 110.427 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -87.37 129.73 34.91 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.271 -0.422 . . . . 2.52 111.155 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -176.86 -166.91 0.16 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.918 -1.512 . . . . 0.88 106.918 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -55.18 -38.44 68.34 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.815 0.672 . . . . 2.75 112.815 -178.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.53 132.72 54.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.102 -1.073 . . . . 2.46 108.102 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 64.5 m95 -81.94 119.25 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.575 -0.528 . . . . 0.86 109.575 -179.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.4 t -113.53 119.25 36.9 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.625 -0.716 . . . . 0.3 110.356 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 17' ' ' ALA . 40.8 mt -104.15 96.27 9.39 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.8 -1.556 . . . . 0.3 106.8 171.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.05 141.58 14.89 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.644 2.229 . . . . 0.28 112.723 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 14' ' ' LEU . 51.4 p90 -145.85 156.78 43.79 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.067 -0.515 . . . . 0.37 111.416 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -129.07 123.53 32.51 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 115.036 -0.984 . . . . 0.88 108.758 175.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ARG . 1.5 p -122.01 110.47 27.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.271 -0.877 . . . . 0.27 109.015 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 p30 -106.8 152.94 23.19 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.879 -0.601 . . . . 1.39 111.353 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.5 158.47 9.92 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 109.315 -1.514 . . . . 0.6 109.315 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 23.8 tm0? -84.79 -51.02 0.56 Allowed Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 117.74 0.77 . . . . 2.61 109.972 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 12.1 Cg_exo -73.57 134.81 21.0 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 N-CA-C 107.589 -1.735 . . . . 0.78 107.589 168.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.0 117.05 61.08 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 110.251 -0.277 . . . . 0.78 110.251 -177.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' A' ' 89' ' ' ASN . 73.1 Cg_endo -82.97 154.62 14.9 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.442 2.095 . . . . 0.56 112.727 -177.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -83.35 125.14 31.34 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.779 -1.193 . . . . 1.37 107.779 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 29' ' ' VAL . 97.0 mt -94.13 130.95 40.13 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 120.873 0.368 . . . . 0.5 110.044 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -135.61 135.23 40.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.421 -0.808 . . . . 3.78 109.633 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.6 m95 -96.01 132.05 41.75 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.237 0.542 . . . . 0.29 110.528 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.8 tp -119.47 126.86 52.32 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.444 -1.687 . . . . 0.95 106.444 176.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -115.89 107.5 15.09 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.277 -1.008 . . . . 0.88 108.277 -177.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 62.24 19.91 11.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.616 0.766 . . . . 1.79 112.727 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.1 -8.96 50.09 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.263 -0.97 . . . . 0.61 112.213 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 m -105.97 137.88 43.12 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.384 -0.599 . . . . 1.37 109.384 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.3 127.87 28.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.178 0.513 . . . . 0.7 110.345 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.56 106.69 18.22 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.374 -0.973 . . . . 0.61 108.374 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -87.68 121.35 30.01 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.306 -1.368 . . . . 2.47 107.306 178.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.77 142.13 24.63 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.662 1.226 . . . . 1.74 112.386 -177.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 p -128.11 -172.15 2.62 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.67 -0.695 . . . . 1.57 109.982 -177.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 m -76.07 -12.81 60.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.667 0.27 . . . . 1.52 111.286 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.97 -40.84 7.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.918 0.389 . . . . 1.59 110.549 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.3 mt -115.89 106.41 20.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.046 -1.465 . . . . 0.5 107.046 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -147.46 152.57 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.179 0.514 . . . . 2.89 112.057 -175.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 m -96.07 118.7 33.18 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.045 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.13 143.1 33.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.327 -0.99 . . . . 2.04 108.327 173.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.49 135.8 51.55 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.2 -0.296 . . . . 0.87 110.2 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.47 165.44 13.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.747 -1.205 . . . . 1.25 107.747 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -64.23 112.64 8.05 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 113.389 0.885 . . . . 3.36 113.389 -170.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.4 132.26 7.94 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.601 2.201 . . . . 1.39 110.188 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.42 146.24 24.31 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.819 -0.752 . . . . 1.53 109.492 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.37 11.69 2.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.452 0.644 . . . . 1.91 110.809 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -105.8 2.24 27.63 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.466 1.106 . . . . 3.49 109.34 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.95 157.41 44.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.826 -1.176 . . . . 1.89 107.826 -178.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 p -111.4 36.24 3.3 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.213 1.006 . . . . 1.3 109.259 175.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.66 128.69 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.445 -1.252 . . . . 0.61 109.095 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HB3' HG13 ' A' ' 29' ' ' VAL . 77.3 ttt180 -99.71 133.94 43.32 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.0 -1.482 . . . . 1.84 107.0 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -126.62 132.58 51.22 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.982 -0.377 . . . . 1.16 109.982 -174.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.81 27.84 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 119.953 -1.118 . . . . 0.31 111.674 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 14.2 t -149.78 134.67 17.83 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.569 0.223 . . . . 0.36 110.773 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 38.3 tp -83.24 108.46 16.49 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.22 -1.77 . . . . 0.28 106.22 173.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.596 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 35.7 mtp85 -109.61 102.73 11.54 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.864 -0.607 . . . . 2.68 111.905 -173.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.4 109.98 17.77 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.746 -0.661 . . . . 1.23 109.986 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -69.61 -29.01 66.42 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.585 -1.189 . . . . 2.18 110.219 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -125.62 108.72 25.98 Favored Pre-proline 0 N--CA 1.425 -1.712 0 N-CA-C 108.444 -0.947 . . . . 2.82 108.444 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.65 129.76 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.253 1.302 . . . . 1.25 109.36 176.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -125.99 141.55 51.91 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.329 -0.619 . . . . 1.22 109.329 -175.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -77.83 -18.9 55.79 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 116.163 -0.471 . . . . 2.03 110.715 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.78 -23.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.41 -0.359 . . . . 1.33 111.19 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 55.5 m-80 -97.84 26.75 4.89 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.852 1.427 . . . . 2.19 114.852 -176.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -83.77 122.73 29.05 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.4 -1.333 . . . . 1.96 107.4 174.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.27 -160.19 32.89 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.622 -1.275 . . . . 0.49 113.215 -177.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.55 111.69 23.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.008 0.523 . . . . 2.23 110.929 -175.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.581 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 34.5 m-85 -94.74 115.37 27.43 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.948 -0.569 . . . . 0.69 109.896 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 83.5 m -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 109.304 -0.628 . . . . 0.34 109.304 177.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' SER . 57.3 tp -96.83 121.13 38.35 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.678 -0.86 . . . . 0.22 108.678 179.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' LEU . 2.8 mm? -104.94 134.38 48.15 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.806 -0.813 . . . . 0.36 108.806 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.98 119.52 34.53 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.313 -1.366 . . . . 0.31 107.313 170.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.54 112.7 24.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.614 -0.884 . . . . 0.61 108.614 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 21.0 t-20 -132.94 146.46 61.38 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.761 -1.2 . . . . 1.18 107.761 -175.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.97 -16.43 38.8 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.433 2.756 . . . . 1.0 113.419 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 t -80.79 -38.69 28.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.872 0.368 . . . . 1.1 110.267 175.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 169.75 170.13 33.84 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.267 -1.533 . . . . 0.59 109.267 -177.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -110.27 121.21 44.74 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.034 0.445 . . . . 1.57 110.245 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.89 147.54 26.78 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.849 -0.614 . . . . 0.37 109.844 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 46.9 p -140.46 144.82 36.28 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.216 0.323 . . . . 0.57 110.344 177.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.3 46.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.484 . . . . 0.3 106.992 175.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -129.87 130.36 45.11 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 118.286 0.493 . . . . 1.26 111.073 -174.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 128.1 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.369 -1.345 . . . . 0.72 107.369 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.77 114.98 26.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.985 -1.116 . . . . 1.25 107.985 -178.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.43 113.84 26.23 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.448 0.642 . . . . 0.58 111.028 -175.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.01 102.78 14.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.281 -0.872 . . . . 0.84 109.154 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.317 -0.833 0 CA-C-N 115.409 -0.814 . . . . 3.86 110.841 179.704 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.379 -3.987 0 CA-C-O 122.143 0.973 . . . . 1.58 109.889 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -83.38 129.83 35.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.892 -1.151 . . . . 1.19 107.892 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 27.7 m -84.49 167.03 16.76 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.983 -1.118 . . . . 1.32 107.983 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.66 129.83 41.38 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.565 0.698 . . . . 0.45 112.413 -170.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 t -124.32 136.08 53.83 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.043 -1.836 . . . . 1.19 106.043 175.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.31 126.99 73.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.227 0.537 . . . . 0.29 111.155 -175.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -121.14 120.47 35.36 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.809 -1.087 . . . . 2.18 109.062 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD13 HG22 ' A' ' 98' ' ' ILE . 44.2 mt -111.58 145.55 38.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.842 -0.799 . . . . 0.33 108.842 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -132.19 154.21 49.79 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.913 0.387 . . . . 1.03 110.958 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 m -58.99 134.49 57.03 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.708 -1.133 . . . . 0.49 111.684 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.6 145.53 48.59 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.286 1.034 . . . . 0.4 111.929 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -92.27 138.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.201 -0.454 . . . . 0.57 109.996 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -82.61 108.44 16.0 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.388 0.613 . . . . 2.52 112.618 -176.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -157.97 -178.78 7.56 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.212 -1.773 . . . . 0.88 106.212 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -63.25 -39.45 94.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 119.375 0.989 . . . . 2.75 112.867 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.32 122.42 44.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.485 -1.302 . . . . 2.46 107.485 176.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.24 126.76 32.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.112 0.482 . . . . 0.86 111.593 -173.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -120.35 117.45 27.79 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.3 109.989 -177.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 17' ' ' ALA . 75.7 mt -99.41 105.04 30.7 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.682 -1.229 . . . . 0.3 107.682 173.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.88 136.74 19.03 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 122.261 1.974 . . . . 0.28 111.687 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 14' ' ' LEU . 49.8 p90 -137.56 159.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.187 0.518 . . . . 0.37 110.018 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -141.97 119.55 11.72 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.636 -0.711 . . . . 0.88 109.77 176.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.93 125.95 67.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.044 -1.465 . . . . 0.27 107.044 176.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.4 p-10 -115.36 155.71 26.86 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.246 -0.982 . . . . 1.39 110.592 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 140.77 3.06 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.506 -1.437 . . . . 0.6 109.506 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -75.77 -54.6 2.17 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 108.169 -1.049 . . . . 2.61 108.169 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HG2' HD21 ' A' ' 89' ' ' ASN . 18.7 Cg_endo -65.76 122.8 10.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 N-CA-C 108.644 -1.329 . . . . 0.78 108.644 170.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.96 121.22 80.81 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 116.383 -0.371 . . . . 0.78 111.693 -175.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.76 155.54 11.77 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.898 1.732 . . . . 0.56 111.988 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -82.66 109.98 17.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.903 -0.777 . . . . 1.37 108.903 176.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.97 119.2 25.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.108 0.48 . . . . 0.5 110.472 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -126.65 126.12 43.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.602 -0.726 . . . . 3.78 110.324 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -91.81 119.67 31.83 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.181 -0.918 . . . . 0.29 109.662 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -109.92 127.71 54.91 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 0.95 105.7 173.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -118.81 106.09 12.18 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 110.298 -0.26 . . . . 0.88 110.298 -174.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 59.07 30.95 20.88 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.544 1.164 . . . . 1.79 110.603 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.08 82.61 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.521 -0.763 . . . . 0.61 113.092 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 p -104.78 140.97 37.31 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.338 -0.507 . . . . 1.37 109.872 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.61 114.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.7 111.031 -176.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.9 tp -90.21 112.22 23.67 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.337 -0.986 . . . . 0.61 108.337 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -93.49 136.98 33.24 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.682 -0.858 . . . . 2.47 108.682 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.14 100.46 0.61 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.368 0.667 . . . . 1.74 109.924 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.8 p -93.49 -167.1 1.64 Allowed 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.009 0.524 . . . . 1.57 111.397 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -77.09 -20.93 55.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.181 0.515 . . . . 1.52 110.563 175.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 99.6 m-85 -95.8 -36.51 11.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.03 0.443 . . . . 1.59 110.641 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 mt -112.41 105.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.213 -1.403 . . . . 0.5 107.213 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -134.61 155.42 50.49 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.098 0.475 . . . . 2.89 111.538 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -107.29 114.48 28.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.587 -0.523 . . . . 0.44 109.587 -178.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.11 132.4 34.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.358 -0.608 . . . . 2.04 109.358 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -122.13 149.49 43.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.779 -0.452 . . . . 0.87 109.779 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.01 163.43 20.47 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.804 -1.184 . . . . 1.25 107.804 173.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 10.8 mm-40 -81.54 116.63 64.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 123.58 0.55 . . . . 3.36 111.191 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 14.9 Cg_exo -69.39 141.28 46.27 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.626 2.217 . . . . 1.39 110.35 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.76 145.12 55.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.78 -0.822 . . . . 1.53 108.78 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.17 -10.22 39.29 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.228 0.825 . . . . 1.91 113.228 -174.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -92.58 1.34 57.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.691 0.282 . . . . 3.49 110.875 178.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.23 170.69 15.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.356 -0.609 . . . . 1.89 109.356 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.7 p -132.45 26.8 4.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.401 0.62 . . . . 1.3 111.113 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.55 127.85 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.226 -0.657 . . . . 0.61 109.226 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB3' HG13 ' A' ' 29' ' ' VAL . 25.3 ttm180 -88.67 115.16 26.0 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.352 -1.351 . . . . 1.84 107.352 177.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -99.67 136.86 38.96 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.42 -0.955 . . . . 1.16 108.42 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.11 -178.26 43.91 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 119.941 -1.123 . . . . 0.31 112.22 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -148.99 136.6 20.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.69 0.396 . . . . 0.36 110.774 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.8 tp -85.6 103.7 14.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 105.035 -2.209 . . . . 0.28 105.035 171.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -111.44 127.4 55.67 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 119.955 -0.698 . . . . 2.68 110.39 -173.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.9 mp -108.85 109.78 20.98 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.937 -1.505 . . . . 1.23 106.937 178.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.52 -43.39 90.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.604 -0.725 . . . . 2.18 109.267 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -135.59 112.02 10.7 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 107.419 -1.326 . . . . 2.82 107.419 172.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.48 137.41 20.65 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.599 1.533 . . . . 1.25 111.654 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.8 p -83.48 148.52 27.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.553 -1.647 . . . . 1.22 106.553 174.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -58.39 -20.35 43.49 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.564 0.95 . . . . 2.03 113.564 -172.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.69 -10.53 13.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 O-C-N 123.202 0.314 . . . . 1.33 111.433 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.63 26.22 0.24 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.041 1.126 . . . . 2.19 114.041 -174.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -106.85 87.76 2.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.676 -1.231 . . . . 1.96 107.676 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.72 -161.72 24.34 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.634 -0.793 . . . . 0.49 112.053 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 99' ' ' MET . 52.4 t-20 -97.16 125.2 41.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.764 0.316 . . . . 2.23 110.557 -177.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -98.46 106.55 18.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.317 -0.994 . . . . 0.69 108.317 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -97.85 114.9 27.08 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.486 -0.931 . . . . 0.34 108.486 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.6 tp -95.43 116.86 29.38 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.273 -0.64 . . . . 0.22 109.273 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.37 127.75 52.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.27 -1.011 . . . . 0.36 108.27 177.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.46 120.1 37.08 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.994 -1.113 . . . . 0.31 107.994 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.24 112.65 25.42 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.967 -0.753 . . . . 0.61 108.967 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 26.8 t-20 -120.5 147.06 44.53 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 106.48 -1.674 . . . . 1.18 106.48 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.07 -19.64 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.894 2.396 . . . . 1.0 113.623 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.3 -29.2 23.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.818 0.342 . . . . 1.1 110.239 178.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 170.64 179.37 41.94 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 110.916 -0.874 . . . . 0.59 110.916 -179.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -112.55 139.99 47.68 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 109.448 -0.575 . . . . 1.57 109.448 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -120.53 153.05 37.24 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 178.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 48.5 p -150.35 155.39 39.53 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.377 0.423 . . . . 0.57 110.194 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.36 165.53 34.71 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.476 -1.676 . . . . 0.3 106.476 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.41 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 35.7 m -143.38 125.85 15.78 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 117.972 0.351 . . . . 1.26 110.625 -177.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.502 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -123.75 122.93 65.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.611 -1.255 . . . . 0.72 107.611 178.486 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 22.3 ttt -107.41 111.61 24.01 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.046 0.451 . . . . 1.25 110.08 -176.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.11 154.22 36.44 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.013 -0.539 . . . . 0.58 111.6 -174.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.76 123.67 28.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.994 -1.484 . . . . 0.84 106.994 176.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 116.291 -0.413 . . . . 3.86 111.959 -176.312 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.419 -1.995 0 CA-C-O 121.928 0.87 . . . . 1.58 110.136 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.41 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 46.4 m-85 -104.72 133.8 48.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.695 -1.139 . . . . 1.19 108.075 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 m -84.86 -165.6 1.24 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.942 -0.762 . . . . 1.32 108.942 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -94.12 124.62 38.25 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.251 -0.98 . . . . 0.45 111.06 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 t -128.12 129.89 47.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.444 -1.317 . . . . 1.19 107.444 175.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 94' ' ' ALA . 87.7 t -119.97 132.56 69.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.673 -0.239 . . . . 0.29 110.664 -174.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -130.38 122.07 27.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.376 0.608 . . . . 2.18 109.711 173.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 48.8 mt -104.68 148.83 26.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.651 -0.704 . . . . 0.33 110.212 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -131.76 150.57 52.11 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.161 -0.681 . . . . 1.03 109.161 -176.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.5 m -49.39 135.23 17.87 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.605 1.562 . . . . 0.49 111.899 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 137.87 50.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.918 -1.037 . . . . 0.4 108.776 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.02 131.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.439 0.638 . . . . 0.57 110.064 -175.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -74.31 91.81 2.22 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.57 -1.196 . . . . 2.52 110.533 -177.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.7 mtm -130.98 -171.61 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.816 -0.439 . . . . 0.88 109.816 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.06 -25.38 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 2.75 109.691 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -119.84 143.82 47.69 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.456 -0.793 . . . . 2.46 109.83 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.78 124.11 29.96 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.574 0.702 . . . . 0.86 112.044 -177.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.7 121.59 19.88 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.556 -1.202 . . . . 0.3 109.131 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -107.16 100.96 35.76 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 107.738 -1.208 . . . . 0.3 107.738 174.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.14 129.07 11.88 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.545 2.163 . . . . 0.28 112.575 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -126.29 153.38 44.89 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.058 -0.519 . . . . 0.37 110.584 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.1 m -134.93 127.09 29.94 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.94 -0.763 . . . . 0.88 108.94 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.1 p -127.29 124.99 65.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.39 -0.967 . . . . 0.27 108.39 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 65' ' ' VAL . 5.2 p-10 -115.49 149.89 37.39 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.83 -0.348 . . . . 1.39 111.821 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 -171.83 33.6 Favored Glycine 0 N--CA 1.428 -1.896 0 O-C-N 124.622 1.201 . . . . 0.6 110.851 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -119.0 -57.29 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-O 118.583 -0.722 . . . . 2.61 112.674 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.3 Cg_exo -59.97 120.53 8.37 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 108.553 -1.364 . . . . 0.78 108.553 171.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 116.23 16.19 Favored Pre-proline 0 N--CA 1.448 -0.549 0 O-C-N 123.871 0.732 . . . . 0.78 111.53 -175.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 93.4 Cg_endo -85.62 152.9 10.28 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 121.848 1.698 . . . . 0.56 111.842 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 p -82.8 106.07 14.33 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.881 -0.785 . . . . 1.37 108.881 174.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.69 119.75 23.7 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 109.405 -0.591 . . . . 0.5 109.405 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -137.82 131.52 31.26 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.696 -0.683 . . . . 3.78 110.679 -177.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.414 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 85.3 m95 -94.81 129.01 41.95 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.569 -0.741 . . . . 0.29 109.713 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.97 129.06 54.96 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 106.639 -1.615 . . . . 0.95 106.639 176.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -112.72 98.05 6.96 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.007 0.432 . . . . 0.88 110.28 -178.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.0 47.68 24.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.554 1.141 . . . . 1.79 111.294 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -22.22 36.59 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.367 -0.833 . . . . 0.61 113.57 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -96.37 143.57 27.3 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 1.37 109.332 -176.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.98 118.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.548 -0.751 . . . . 0.7 109.994 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 tp -82.45 120.67 25.76 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.491 -1.299 . . . . 0.61 107.491 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -107.77 140.09 41.36 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.298 -1.001 . . . . 2.47 108.298 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.89 92.93 0.52 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.662 0.744 . . . . 1.74 109.714 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -88.91 178.97 6.28 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.01 -0.996 . . . . 1.57 108.918 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 t -48.6 -36.91 16.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.171 0.988 . . . . 1.52 112.992 -176.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -110.72 5.59 20.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.113 0.783 . . . . 1.59 113.113 -173.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.428 HG12 HD23 ' A' ' 72' ' ' LEU . 54.5 mt -124.15 106.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.472 -1.677 . . . . 0.5 106.472 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -126.72 137.84 53.31 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.414 -0.357 . . . . 2.89 110.439 -171.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 m -92.69 109.39 20.81 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.265 -1.383 . . . . 0.44 107.265 176.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.74 136.9 42.56 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.384 -0.598 . . . . 2.04 109.384 -174.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.01 152.49 36.31 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.9 0.381 . . . . 0.87 110.013 -177.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 67' ' ' HIS . 4.5 pp -110.51 165.2 11.99 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.402 -1.703 . . . . 1.25 106.402 175.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.38 109.73 11.39 Favored Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 123.169 0.293 . . . . 3.36 110.264 -178.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.72 140.09 20.58 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.221 1.948 . . . . 1.39 110.651 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 31.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.236 -1.024 . . . . 1.53 108.236 177.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.73 -13.21 62.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.458 0.646 . . . . 1.91 110.877 -178.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.4 -26.39 65.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.855 -1.066 . . . . 3.49 110.551 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.08 143.42 33.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.114 0.483 . . . . 1.89 110.071 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.7 p -98.32 18.05 17.32 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.762 -1.199 . . . . 1.3 107.762 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 30' ' ' ASP . 16.5 t -114.17 129.08 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 114.383 -1.28 . . . . 0.61 109.211 -177.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.537 ' HB3' HG13 ' A' ' 29' ' ' VAL . 15.5 ttm180 -95.11 132.46 40.01 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.76 -1.57 . . . . 1.84 106.76 177.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 57' ' ' LEU . 87.9 m-70 -119.6 141.83 48.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.102 -0.333 . . . . 1.16 110.102 -176.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.0 -173.94 34.18 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.409 -1.076 . . . . 0.31 110.409 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.416 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 26.8 t -148.27 135.45 20.32 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.064 0.459 . . . . 0.36 111.107 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.3 tp -83.58 114.35 21.46 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.28 106.52 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 96.7 mtt180 -114.92 125.05 53.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.506 0.67 . . . . 2.68 111.584 -175.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 52' ' ' ILE . 4.5 mp -111.62 109.84 19.94 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.765 -1.107 . . . . 1.23 108.782 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.46 -35.42 80.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.046 -0.979 . . . . 2.18 111.107 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -128.18 119.76 20.98 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.963 -0.755 . . . . 2.82 108.963 178.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.63 136.95 29.25 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 121.441 1.427 . . . . 1.25 109.068 175.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -128.99 161.04 30.84 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.33 -0.989 . . . . 1.22 108.33 -178.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -68.7 -5.03 17.99 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.472 0.916 . . . . 2.03 113.472 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.62 -9.02 10.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-O 121.069 0.461 . . . . 1.33 110.301 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.815 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.4 m120 -83.4 27.92 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.292 0.637 . . . . 2.19 112.355 -176.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.4 m-20 -124.67 103.06 7.91 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -159.12 30.61 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.684 -0.967 . . . . 0.49 110.684 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 23.4 t-20 -103.41 122.71 45.42 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 120.736 0.303 . . . . 2.23 110.379 -177.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.815 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 51.3 m-85 -100.49 115.2 29.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.439 -0.578 . . . . 0.69 109.439 178.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -103.31 127.59 50.6 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.496 -0.32 . . . . 0.34 110.183 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 ' CB ' HD11 ' A' ' 14' ' ' LEU . 59.9 tp -100.89 120.41 40.11 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.951 -0.759 . . . . 0.22 108.951 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.96 139.09 38.97 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.089 -1.078 . . . . 0.36 108.089 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -135.07 120.63 19.32 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.164 -1.421 . . . . 0.31 107.164 173.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.53 133.56 53.28 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.754 -0.378 . . . . 0.61 110.996 -178.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -142.76 171.29 7.29 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-O 117.23 -1.367 . . . . 1.18 107.541 175.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.24 -25.16 29.16 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.168 1.912 . . . . 1.0 114.753 -175.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.16 -23.23 38.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.994 0.368 . . . . 1.1 111.994 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.58 -175.63 35.62 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.518 -1.325 . . . . 0.59 113.092 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -124.43 131.19 53.5 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.819 -0.437 . . . . 1.57 109.819 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.62 148.46 28.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.454 -0.943 . . . . 0.37 108.454 176.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.4 p -142.57 122.83 13.84 Favored 'General case' 0 N--CA 1.425 -1.705 0 O-C-N 123.401 0.438 . . . . 0.57 110.442 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.81 155.5 43.99 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.799 -1.186 . . . . 0.3 107.799 177.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 50.9 m -130.26 144.22 51.24 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.84 0.352 . . . . 1.26 110.845 -178.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -130.24 126.53 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.853 -1.166 . . . . 0.72 107.853 176.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 tpt -87.06 114.1 23.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.61 -0.885 . . . . 1.25 108.61 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.11 132.13 53.62 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.87 0.367 . . . . 0.58 110.779 -175.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -140.23 101.44 4.14 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.154 -1.054 . . . . 0.84 108.154 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 . . . . . 0 C--N 1.302 -1.492 0 CA-C-N 115.991 -0.55 . . . . 3.86 111.865 -179.034 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.408 -2.554 0 N-CA-C 108.085 -1.08 . . . . 1.58 108.085 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.497 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 97.2 m-85 -89.94 134.47 34.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.022 -1.473 . . . . 1.19 107.022 176.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.0 m -83.26 177.0 8.72 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.879 -1.156 . . . . 1.32 107.879 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -93.25 124.22 37.08 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 119.37 -0.932 . . . . 0.45 111.17 -170.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -123.86 133.08 53.84 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 106.905 -1.517 . . . . 1.19 106.905 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 94' ' ' ALA . 88.3 t -115.28 118.35 58.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.735 0.303 . . . . 0.29 110.266 -175.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -116.74 116.24 27.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.768 -0.827 . . . . 2.18 108.768 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 98' ' ' ILE . 41.3 mt -96.51 156.99 16.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.651 -0.704 . . . . 0.33 110.72 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -129.93 144.65 51.43 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.876 -1.157 . . . . 1.03 107.876 -174.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -57.55 133.49 55.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.953 1.408 . . . . 0.49 110.652 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -70.28 141.35 52.4 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.074 -0.966 . . . . 0.4 110.3 -176.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -92.65 127.59 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 113.26 0.837 . . . . 0.57 113.26 -177.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -83.97 88.33 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.891 -1.049 . . . . 2.52 108.796 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.03 -169.67 3.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.545 -1.28 . . . . 0.88 107.545 175.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -48.57 -38.18 19.9 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.103 1.149 . . . . 2.75 114.103 -171.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -133.25 139.57 47.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.417 -0.957 . . . . 2.46 108.417 175.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' HD12 ' A' ' 72' ' ' LEU . 73.5 m95 -81.34 127.1 32.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.294 0.569 . . . . 0.86 110.442 -175.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -120.81 121.58 38.46 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 114.563 -1.199 . . . . 0.3 108.144 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 17' ' ' ALA . 52.3 mt -108.27 96.05 17.46 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.139 -1.43 . . . . 0.3 107.139 175.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.69 128.52 13.49 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.333 2.022 . . . . 0.28 111.8 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -120.05 146.68 45.67 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 116.03 -0.532 . . . . 0.37 109.853 178.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -132.59 106.81 8.04 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 108.689 -0.856 . . . . 0.88 108.689 176.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -110.56 111.25 35.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.169 -0.923 . . . . 0.27 108.766 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 p30 -101.3 137.53 39.53 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.396 -0.82 . . . . 1.39 110.148 -178.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.05 146.64 4.61 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 108.699 -1.761 . . . . 0.6 108.699 -176.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.45 -59.79 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 CA-C-O 117.947 -1.025 . . . . 2.61 110.199 -176.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 7.8 Cg_endo -54.81 119.43 6.46 Favored 'Trans proline' 0 C--N 1.393 2.88 0 N-CA-C 107.72 -1.685 . . . . 0.78 107.72 171.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.69 114.68 17.01 Favored Pre-proline 0 C--N 1.291 -1.936 0 CA-C-N 114.567 -1.197 . . . . 0.78 112.746 -171.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.67 150.05 11.35 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 122.134 1.89 . . . . 0.56 112.454 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -84.57 127.04 33.85 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.208 -1.405 . . . . 1.37 107.208 174.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.91 122.69 43.23 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.856 0.36 . . . . 0.5 111.714 -176.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -130.22 128.28 41.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.607 -0.724 . . . . 3.78 110.52 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 94.1 m95 -90.82 141.2 29.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.924 -0.769 . . . . 0.29 108.924 175.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.32 127.4 41.03 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.206 -1.405 . . . . 0.95 107.206 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -103.13 98.13 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.024 -0.732 . . . . 0.88 109.024 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.67 29.63 7.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.015 0.926 . . . . 1.79 113.311 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.56 -20.57 24.92 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.828 -0.701 . . . . 0.61 113.263 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 m -89.84 137.96 31.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.16 0.48 . . . . 1.37 110.735 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.41 108.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.994 -1.003 . . . . 0.7 111.16 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.8 tp -87.62 114.92 24.68 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.053 -1.091 . . . . 0.61 108.053 178.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.01 140.59 40.95 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.476 -1.305 . . . . 2.47 107.476 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.11 107.87 2.06 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.873 0.869 . . . . 1.74 110.998 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -99.37 -166.13 1.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.191 -0.459 . . . . 1.57 110.122 -178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.5 t -82.02 -13.21 57.71 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.1 -0.704 . . . . 1.52 109.1 176.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -102.03 -38.89 7.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.809 -0.632 . . . . 1.59 110.565 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.8 108.21 24.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.293 -1.373 . . . . 0.5 107.293 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -135.06 137.7 43.15 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.4 -0.92 . . . . 2.89 112.252 -174.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -81.44 111.04 17.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.665 -0.698 . . . . 0.44 110.163 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.28 111.27 23.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.211 0.529 . . . . 2.04 111.051 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -84.09 141.88 30.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.928 -0.578 . . . . 0.87 109.808 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -119.1 160.66 21.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.238 -1.023 . . . . 1.25 108.238 -179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -77.33 119.24 76.68 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 113.368 0.877 . . . . 3.36 113.368 -176.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.1 170.06 8.51 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 123.482 2.788 . . . . 1.39 109.241 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.68 143.02 34.99 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.286 -1.376 . . . . 1.53 107.286 177.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.28 14.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.716 1.747 . . . . 1.91 115.716 -170.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -93.73 -9.98 35.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.61 -0.836 . . . . 3.49 110.831 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.16 126.1 30.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.097 0.475 . . . . 1.89 110.525 178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -95.64 30.75 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.927 1.346 . . . . 1.3 108.372 171.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 33.4 t -116.11 135.48 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.771 -1.558 . . . . 0.61 107.363 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.6 ttm180 -99.44 122.16 42.15 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.361 -1.348 . . . . 1.84 107.361 177.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -108.55 141.13 40.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.485 -0.931 . . . . 1.16 108.485 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.81 -177.34 39.62 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.314 -0.946 . . . . 0.31 110.977 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.2 t -145.14 132.68 20.84 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.556 0.209 . . . . 0.36 110.575 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.9 tp -82.62 111.63 18.77 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.965 -2.235 . . . . 0.28 104.965 170.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -107.23 119.09 38.45 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.96 -0.564 . . . . 2.68 110.195 -172.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 23' ' ' TRP . 77.8 mt -81.05 108.01 14.35 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.695 -1.595 . . . . 1.23 106.695 173.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -69.99 -45.15 67.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.97 -1.014 . . . . 2.18 108.602 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -129.88 101.2 18.47 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.676 -1.602 . . . . 2.82 106.676 172.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -69.03 130.77 20.86 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.37 2.047 . . . . 1.25 111.297 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -128.65 168.85 15.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.361 -0.836 . . . . 1.22 108.983 -177.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.254 14.8 p-80 -68.47 -3.2 10.6 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 113.894 1.072 . . . . 2.03 113.894 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.88 -10.38 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.482 0.658 . . . . 1.33 109.937 174.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.696 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.7 m120 -85.69 28.09 0.8 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.261 1.025 . . . . 2.19 113.237 -175.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 35.8 p-10 -126.2 99.1 5.74 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.977 0.894 . . . . 1.96 111.735 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . 170.76 -158.18 29.68 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.298 -0.864 . . . . 0.49 111.269 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -97.33 105.69 17.89 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 122.654 0.382 . . . . 2.23 110.343 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.696 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 59.0 m-85 -93.0 106.32 18.29 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.244 -0.65 . . . . 0.69 109.244 175.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 38.3 m -92.87 131.99 37.41 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 0.34 109.855 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 12' ' ' VAL . 53.2 tp -104.2 117.37 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.148 -0.686 . . . . 0.22 109.148 177.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.14 129.67 51.87 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.315 -0.994 . . . . 0.36 108.315 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.21 121.03 32.95 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.256 -1.016 . . . . 0.31 108.256 176.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.33 126.05 46.15 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.691 -0.403 . . . . 0.61 111.496 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -134.37 169.85 12.81 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 117.448 -1.263 . . . . 1.18 107.695 176.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.9 Cg_endo -43.25 -32.24 3.1 Favored 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 123.539 2.826 . . . . 1.0 115.248 178.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -77.08 -34.91 56.94 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 122.028 -0.42 . . . . 1.1 111.682 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.04 -166.59 38.79 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 120.405 -0.902 . . . . 0.59 112.044 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 27.6 tt0 -124.77 132.97 53.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.993 0.425 . . . . 1.57 110.338 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -108.25 152.26 24.84 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.147 -0.686 . . . . 0.37 109.147 178.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 p -141.54 148.88 40.07 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 123.482 0.489 . . . . 0.57 111.144 -179.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.78 144.22 14.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.318 -1.364 . . . . 0.3 107.318 174.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 49.1 m -121.23 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.992 0.425 . . . . 1.26 110.684 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.494 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.11 126.27 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.725 -1.213 . . . . 0.72 107.725 178.48 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.4 ttm -92.59 103.86 16.21 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.335 -0.546 . . . . 1.25 110.649 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -95.4 135.0 37.58 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.478 -1.675 . . . . 0.58 106.478 174.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.82 101.52 5.3 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.248 -0.649 . . . . 0.84 109.248 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 34.9 t80 . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.387 -0.824 . . . . 3.86 111.085 179.916 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.421 -1.89 0 N-CA-C 109.136 -0.69 . . . . 1.58 109.136 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.603 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 54.9 m-85 -102.33 122.45 44.28 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.387 -1.338 . . . . 1.19 107.387 174.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.25 -179.19 7.15 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.774 -0.648 . . . . 1.32 109.768 -176.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.43 128.56 39.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 119.51 -0.876 . . . . 0.45 112.373 -168.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -121.57 128.22 51.76 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.815 -1.55 . . . . 1.19 106.815 175.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 94' ' ' ALA . 98.0 t -115.25 120.02 63.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.819 0.342 . . . . 0.29 110.466 -175.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -119.47 136.03 54.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.816 -0.629 . . . . 2.18 109.764 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 98' ' ' ILE . 36.7 mt -123.06 149.63 44.17 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.386 0.613 . . . . 0.33 110.897 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -131.07 145.48 52.02 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.975 -1.12 . . . . 1.03 107.975 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 m -64.79 139.22 58.74 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.988 -1.006 . . . . 0.49 110.715 -175.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -52.96 139.31 28.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.638 -1.165 . . . . 0.4 111.951 -178.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -92.07 142.74 12.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.788 -0.642 . . . . 0.57 109.914 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.41 111.61 20.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.57 0.582 . . . . 2.52 112.57 -173.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.1 ptt? -162.39 -173.24 3.5 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.48 -0.933 . . . . 0.88 108.48 175.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 118.634 0.652 . . . . 2.75 112.367 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 20' ' ' MET . 81.9 m-70 -110.8 124.82 52.76 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.645 -1.983 . . . . 2.46 105.645 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -82.6 133.48 35.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.295 0.569 . . . . 0.86 111.568 -173.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.7 t -126.56 120.49 29.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.021 -0.99 . . . . 0.3 110.053 -175.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.5 mt -101.84 101.98 20.98 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.931 -1.137 . . . . 0.3 107.931 174.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.05 131.87 16.04 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.524 2.15 . . . . 0.28 112.504 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.53 160.22 34.8 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.053 0.454 . . . . 0.37 110.374 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -143.99 111.07 5.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.985 -0.746 . . . . 0.88 108.985 176.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -114.06 122.86 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.78 -0.645 . . . . 0.27 109.952 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 28.9 t70 -101.94 141.59 34.55 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.013 -0.54 . . . . 1.39 109.99 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.51 148.13 5.62 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.273 -1.131 . . . . 0.6 110.273 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -85.9 -55.68 0.39 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.993 -1.114 . . . . 2.61 107.993 178.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.3 Cg_endo -73.28 119.61 6.09 Favored 'Trans proline' 0 C--N 1.382 2.296 0 N-CA-C 107.275 -1.856 . . . . 0.78 107.275 167.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.94 112.85 11.81 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 123.753 0.658 . . . . 0.78 112.512 -172.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 42.1 Cg_endo -70.7 141.49 41.54 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.679 2.253 . . . . 0.56 112.694 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -76.32 112.32 12.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.065 -1.457 . . . . 1.37 107.065 174.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.21 131.15 35.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.165 -0.47 . . . . 0.5 111.301 -177.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -132.28 131.95 42.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.283 -0.636 . . . . 3.78 109.283 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 92.0 m95 -98.02 135.39 39.78 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.916 0.389 . . . . 0.29 110.002 177.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.3 tp -116.56 134.44 54.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.246 -1.761 . . . . 0.95 106.246 176.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -121.29 112.52 18.7 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.572 -0.529 . . . . 0.88 109.572 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 57.26 24.82 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.853 0.861 . . . . 1.79 112.464 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.04 4.41 71.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.826 -0.702 . . . . 0.61 112.694 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -113.1 151.85 30.29 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.886 -0.783 . . . . 1.37 108.886 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.31 117.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.157 -0.683 . . . . 0.7 109.157 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.1 tp -82.04 111.33 18.1 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.886 -0.597 . . . . 0.61 109.401 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.66 117.39 23.75 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.147 -1.057 . . . . 2.47 108.147 176.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.96 122.58 18.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.345 -0.389 . . . . 1.74 110.153 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.7 p -105.78 -171.05 1.83 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.389 -0.369 . . . . 1.57 110.047 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -69.35 -21.03 63.85 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.29 0.567 . . . . 1.52 109.828 173.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 58.0 m-85 -91.53 -40.69 11.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.342 -0.39 . . . . 1.59 110.379 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.49 106.47 20.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.628 -1.249 . . . . 0.5 107.628 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.22 145.52 41.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.16 0.505 . . . . 2.89 112.276 -176.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.5 m -84.38 114.06 21.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.63 -0.878 . . . . 0.44 108.63 176.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.4 127.14 54.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.725 -0.843 . . . . 2.04 108.725 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.92 151.17 21.62 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.74 -0.467 . . . . 0.87 109.74 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -119.87 146.61 45.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 178.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 58' ' ' GLU . 4.2 mp0 -47.64 105.95 0.54 Allowed Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 125.744 1.618 . . . . 3.36 114.623 -172.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.54 136.0 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.187 2.592 . . . . 1.39 110.32 174.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.54 159.11 29.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.366 -0.605 . . . . 1.53 109.366 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.62 -3.37 21.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.524 0.564 . . . . 1.91 112.524 -175.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -103.5 9.36 37.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.12 0.486 . . . . 3.49 109.913 175.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.06 131.75 56.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 120.779 -0.369 . . . . 1.89 111.178 -179.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.9 p -96.99 2.05 51.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.875 -1.157 . . . . 1.3 107.875 170.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 19.6 t -94.26 128.54 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.17 -1.377 . . . . 0.61 108.578 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 67.1 mtp180 -99.88 121.24 41.02 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.644 -1.613 . . . . 1.84 106.644 178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -103.8 141.28 36.38 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.758 -0.83 . . . . 1.16 108.758 -175.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.51 -173.7 35.89 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 119.613 -1.28 . . . . 0.31 111.967 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 t -151.07 134.33 16.1 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 123.308 0.643 . . . . 0.36 110.332 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 55.3 tp -84.43 104.19 14.23 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 104.291 -2.485 . . . . 0.28 104.291 169.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -109.34 127.23 54.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.373 -0.531 . . . . 2.68 110.963 -171.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 6.6 mp -103.79 111.36 23.84 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.135 -0.939 . . . . 1.23 109.1 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -64.04 -42.84 96.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.47 -1.241 . . . . 2.18 109.027 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -128.63 113.04 19.23 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.726 -0.842 . . . . 2.82 108.726 176.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.79 130.39 8.62 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.111 1.874 . . . . 1.25 111.885 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 p -107.73 141.4 39.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.263 -1.014 . . . . 1.22 108.263 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -68.38 -14.76 63.22 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 120.965 0.412 . . . . 2.03 111.025 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.95 -15.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.91 -0.587 . . . . 1.33 111.06 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 47.3 m-80 -102.95 25.84 8.87 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 112.98 0.733 . . . . 2.19 112.98 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.701 -1.592 . . . . 1.96 106.701 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.45 -154.12 6.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.084 -1.055 . . . . 0.49 113.549 -175.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -105.53 120.16 40.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.066 0.46 . . . . 2.23 111.498 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 16.3 m-85 -101.24 133.79 45.28 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.117 -0.947 . . . . 0.69 108.788 178.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.8 m -122.78 129.16 51.4 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.909 -1.145 . . . . 0.34 107.909 176.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.5 tp -100.83 120.47 40.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.017 -0.734 . . . . 0.22 109.017 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.15 136.28 49.63 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.931 -1.137 . . . . 0.36 107.931 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.07 121.28 27.52 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.469 -0.937 . . . . 0.31 108.469 178.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.03 122.51 46.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.046 -0.262 . . . . 0.61 110.409 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 p-10 -137.22 177.24 2.26 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 107.102 -1.444 . . . . 1.18 107.102 177.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.28 -26.98 28.87 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.523 2.149 . . . . 1.0 114.589 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 92.6 m -76.94 -17.85 58.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.883 0.327 . . . . 1.1 111.883 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -158.74 22.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.463 -0.875 . . . . 0.59 111.653 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -107.6 138.23 44.2 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.899 0.381 . . . . 1.57 109.977 -176.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -117.48 158.26 24.83 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.385 -1.339 . . . . 0.37 107.385 174.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 42.7 p -153.84 159.11 41.71 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 112.442 0.534 . . . . 0.57 112.442 -177.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.17 153.98 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.833 -1.543 . . . . 0.3 106.833 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 p -123.48 151.45 42.74 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 118.075 0.398 . . . . 1.26 111.138 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -148.8 128.4 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.72 107.661 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.5 110.99 23.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.066 -1.457 . . . . 1.25 107.066 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.65 112.76 25.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.749 0.785 . . . . 0.58 111.659 -174.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.46 101.2 10.88 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.77 -1.105 . . . . 0.84 108.027 176.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.308 -1.22 0 CA-C-N 115.727 -0.67 . . . . 3.86 109.722 179.681 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.893 0.378 . . . . 7.93 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.77 126.23 51.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.948 0.404 . . . . 6.17 109.918 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -108.79 -27.77 9.57 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.1 0.952 . . . . 5.43 109.359 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -134.86 97.97 3.9 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.468 -1.242 . . . . 3.87 107.804 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -85.41 -26.51 26.35 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.633 -0.712 . . . . 2.55 109.571 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 16.9 m -65.9 102.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.72 -1.127 . . . . 2.08 112.036 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -107.24 97.99 7.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 108.314 -0.995 . . . . 1.58 108.314 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.538 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-85 -97.69 124.26 41.94 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.917 -1.142 . . . . 1.19 107.917 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.99 173.93 10.75 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.712 -1.218 . . . . 1.32 107.712 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.43 127.14 41.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.318 -0.553 . . . . 0.45 111.978 -173.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 50.3 m -118.17 140.82 49.22 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.346 -1.353 . . . . 1.19 107.346 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 94' ' ' ALA . 95.5 t -115.93 121.22 66.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 121.378 0.608 . . . . 0.29 112.025 -174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 79.3 mt-30 -108.13 130.63 55.1 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.864 -1.161 . . . . 2.18 107.864 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.742 HD13 HG22 ' A' ' 98' ' ' ILE . 28.4 mt -122.96 156.2 35.21 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 109.232 -0.655 . . . . 0.33 109.232 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -132.11 151.01 52.01 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 109.549 -0.538 . . . . 1.03 109.549 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -60.04 132.47 54.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 124.551 1.157 . . . . 0.49 110.058 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -59.42 135.06 57.54 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 124.473 1.108 . . . . 0.4 109.722 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -91.44 127.91 43.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 109.694 -0.484 . . . . 0.57 109.694 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.3 mt-10 -77.86 109.96 12.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.126 -0.943 . . . . 2.52 112.058 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -168.9 162.39 11.25 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 104.807 -2.294 . . . . 0.88 104.807 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -55.63 -36.67 67.26 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.967 1.258 . . . . 2.75 113.42 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -95.5 99.22 11.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.893 -1.521 . . . . 2.46 106.893 172.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 53.3 m95 -81.0 137.59 36.07 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.226 -0.443 . . . . 0.86 110.203 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.07 124.04 31.88 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.765 -0.652 . . . . 0.3 110.222 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.3 mt -107.27 95.57 13.63 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 107.12 -1.437 . . . . 0.3 107.12 172.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.06 134.92 26.25 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.655 2.237 . . . . 0.28 111.912 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -129.74 155.49 45.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.112 0.482 . . . . 0.37 111.171 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 23.0 m -138.72 117.7 12.49 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.349 -0.982 . . . . 0.88 108.349 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -126.08 123.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.27 -1.011 . . . . 0.27 108.27 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 6.1 p-10 -108.96 156.33 19.84 Favored 'General case' 0 C--N 1.289 -2.051 0 C-N-CA 119.868 -0.733 . . . . 1.39 111.013 -175.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.57 147.25 4.57 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 110.652 -0.979 . . . . 0.6 110.652 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -86.31 -50.28 0.49 Allowed Pre-proline 0 C--N 1.311 -1.078 0 CA-C-O 119.126 -0.464 . . . . 2.61 111.253 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.5 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 C--N 1.366 1.453 0 N-CA-C 107.398 -1.808 . . . . 0.78 107.398 167.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.67 117.48 45.02 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 115.773 -0.649 . . . . 0.78 111.75 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -85.27 145.71 9.67 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.85 1.7 . . . . 0.56 111.642 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 m -78.32 120.17 22.71 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.122 -1.066 . . . . 1.37 108.122 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 56' ' ' PHE . 97.2 mt -93.17 123.3 36.35 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.891 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -134.66 131.82 38.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.029 -0.532 . . . . 3.78 110.848 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 87.6 m95 -93.02 135.07 34.52 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.359 -0.837 . . . . 0.29 109.495 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -113.11 134.51 54.51 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 105.894 -1.891 . . . . 0.95 105.894 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 81.0 t80 -125.34 111.42 15.16 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.489 -0.56 . . . . 0.88 109.489 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 57.61 34.59 24.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.165 0.986 . . . . 1.79 111.048 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.73 -1.6 85.64 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 116.142 -0.481 . . . . 0.61 112.974 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -108.33 153.6 23.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.753 -0.832 . . . . 1.37 108.753 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.25 115.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.759 . . . . 0.7 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -89.34 122.62 32.75 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.247 -1.02 . . . . 0.61 108.247 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.57 129.92 55.54 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.374 -1.343 . . . . 2.47 107.374 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 123.235 0.614 . . . . 1.74 111.194 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 p -126.26 -165.69 1.47 Allowed 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.044 -0.724 . . . . 1.57 109.044 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 m -78.62 -22.45 46.95 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 118.414 0.552 . . . . 1.52 110.597 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 23.2 m-85 -87.21 -40.39 14.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.745 -0.382 . . . . 1.59 110.386 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -112.49 106.71 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.701 -1.222 . . . . 0.5 107.701 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -130.88 139.71 50.15 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.179 0.807 . . . . 2.89 113.179 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -84.68 119.96 25.84 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 115.263 -0.88 . . . . 0.44 109.749 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -94.09 125.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 116.44 -0.346 . . . . 2.04 110.441 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 37' ' ' LEU . 66.8 m-85 -106.78 106.74 17.41 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.582 -1.636 . . . . 0.87 106.582 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 67' ' ' HIS . 3.5 pp -95.0 154.63 17.08 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.397 -0.921 . . . . 1.25 108.956 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 8.5 mm-40 -70.26 113.0 14.58 Favored Pre-proline 0 C--N 1.305 -1.343 0 C-N-CA 123.479 0.711 . . . . 3.36 111.574 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.1 Cg_exo -78.81 161.15 27.45 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.727 2.285 . . . . 1.39 110.552 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.82 142.06 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.82 -6.19 20.22 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.136 0.574 . . . . 1.91 112.243 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -104.0 -0.7 28.54 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.142 -0.481 . . . . 3.49 111.332 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.5 pt-20 -115.04 146.15 41.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.691 -1.226 . . . . 1.89 107.691 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -94.12 2.91 55.92 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.134 -0.691 . . . . 1.3 109.134 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 16.8 t -99.94 129.03 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.617 -0.72 . . . . 0.61 111.609 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB3' HG13 ' A' ' 29' ' ' VAL . 14.3 ttm180 -94.55 134.97 36.53 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.148 -1.797 . . . . 1.84 106.148 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.502 ' HB2' HD11 ' A' ' 57' ' ' LEU . 47.7 m-70 -121.16 161.79 21.23 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.612 -0.435 . . . . 1.16 110.266 -175.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.29 -165.38 35.24 Favored Glycine 0 N--CA 1.419 -2.493 0 C-N-CA 120.674 -0.774 . . . . 0.31 111.334 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 t -156.16 141.87 17.87 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.502 -0.555 . . . . 0.36 109.502 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 50.3 tp -91.02 100.93 13.7 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.618 -2.364 . . . . 0.28 104.618 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -103.27 129.27 50.21 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.218 -0.593 . . . . 2.68 110.63 -173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 5.7 mp -108.73 109.18 20.27 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.617 -0.883 . . . . 1.23 108.617 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -72.15 -43.09 65.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.599 -1.182 . . . . 2.18 109.95 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.27 101.0 31.9 Favored Pre-proline 0 N--CA 1.429 -1.501 0 N-CA-C 105.641 -1.985 . . . . 2.82 105.641 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.05 147.11 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.617 2.211 . . . . 1.25 112.372 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 p -130.06 141.29 50.73 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 122.039 -0.413 . . . . 1.22 110.406 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 41.8 p-80 -58.54 -6.4 0.7 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.118 1.525 . . . . 2.03 115.118 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.79 -17.06 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.152 -0.684 . . . . 1.33 109.152 173.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.603 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 17.5 m120 -83.34 -1.2 52.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.241 1.016 . . . . 2.19 109.625 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 39.5 t30 -77.11 81.22 3.63 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.28 -0.873 . . . . 1.96 108.883 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.88 -155.86 8.99 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.201 -0.909 . . . . 0.49 111.669 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 26.3 t-20 -98.43 128.97 45.04 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.841 0.682 . . . . 2.23 112.841 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 76.9 m-85 -108.25 141.57 39.83 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 124.969 1.308 . . . . 0.69 108.021 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.1 m -142.57 134.44 27.0 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.631 -0.668 . . . . 0.34 109.353 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.8 tp -104.89 122.45 45.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.77 -0.456 . . . . 0.22 109.77 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.91 125.25 52.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.204 -1.036 . . . . 0.36 108.204 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -120.65 120.8 36.78 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.19 -1.041 . . . . 0.31 108.19 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.69 121.6 35.94 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.83 -0.348 . . . . 0.61 111.425 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.9 p30 -128.59 170.97 9.39 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 107.576 -1.268 . . . . 1.18 107.576 173.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.9 Cg_exo -48.06 -41.26 33.74 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.602 2.201 . . . . 1.0 114.432 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -67.29 -45.65 75.91 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 120.509 -0.476 . . . . 1.1 112.207 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.01 178.09 47.54 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 119.103 -1.523 . . . . 0.59 113.594 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -119.86 133.53 55.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 123.202 0.601 . . . . 1.57 109.742 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -113.9 155.28 26.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.138 -0.69 . . . . 0.37 109.138 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.7 p -144.8 148.03 33.57 Favored 'General case' 0 N--CA 1.418 -2.068 0 O-C-N 123.52 0.513 . . . . 0.57 110.26 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.82 146.38 29.1 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.057 -1.831 . . . . 0.3 106.057 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -118.48 144.31 46.1 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.473 -0.491 . . . . 1.26 110.318 -175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.742 HG22 HD13 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -134.67 122.16 37.76 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 C-N-CA 124.807 1.243 . . . . 0.72 109.505 -179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.19 108.6 16.82 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.777 -1.564 . . . . 1.25 106.777 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 155.84 25.22 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.313 -0.403 . . . . 0.58 110.924 -174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.38 100.65 10.07 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.385 0.612 . . . . 0.84 111.373 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 86.0 m-85 -100.07 78.43 2.08 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.146 -1.057 . . . . 3.86 108.146 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.7 mtt -101.81 113.9 27.5 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.016 -0.538 . . . . 4.72 110.572 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 77' ' ' HIS . 76.2 m-20 -98.06 159.42 14.95 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 121.516 0.674 . . . . 5.33 111.255 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -120.75 99.83 46.99 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.423 -2.066 . . . . 5.34 105.423 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.83 140.01 10.23 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.469 2.779 . . . . 5.07 113.449 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 125.223 1.409 . . . . 9.52 109.789 -175.706 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 CA--C 1.501 -0.942 0 N-CA-C 107.926 -1.139 . . . . 7.93 107.926 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 53.3 34.01 16.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.416 0.687 . . . . 6.17 110.147 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.37 52.0 1.29 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 114.212 1.19 . . . . 5.43 114.212 -171.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t70 38.6 54.89 1.92 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.217 2.207 . . . . 3.87 113.544 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -98.05 -50.49 4.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.391 -0.966 . . . . 2.55 108.391 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 m -94.24 98.92 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-O 122.155 0.979 . . . . 2.08 109.0 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 p -89.18 98.72 11.92 Favored 'General case' 0 N--CA 1.403 -2.791 0 CA-C-N 115.291 -0.868 . . . . 1.58 109.374 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.612 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.9 m-85 -75.09 115.68 14.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.093 -1.447 . . . . 1.19 107.093 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -83.2 178.14 8.23 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.937 -0.764 . . . . 1.32 108.937 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 126.92 40.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 C-N-CA 119.745 -0.782 . . . . 0.45 111.257 -173.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 m -122.93 143.23 50.04 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.142 -1.429 . . . . 1.19 107.142 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 85.4 t -115.81 121.14 66.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.132 0.491 . . . . 0.29 110.901 -174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 118.83 37.77 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.301 -0.863 . . . . 2.18 108.858 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 98' ' ' ILE . 34.0 mt -115.44 144.64 43.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.943 0.401 . . . . 0.33 109.984 176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.95 151.27 51.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.968 -0.753 . . . . 1.03 108.968 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 m -57.49 135.1 56.58 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 124.455 1.097 . . . . 0.49 110.411 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -56.2 130.86 46.09 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.393 1.058 . . . . 0.4 110.66 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.9 136.14 25.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.335 0.588 . . . . 0.57 110.094 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -75.93 106.94 7.79 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.331 -1.304 . . . . 2.52 110.54 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 55.4 mtm -141.93 -163.16 1.53 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.953 -1.499 . . . . 0.88 106.953 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -67.89 -45.03 75.61 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.99 -0.744 . . . . 2.75 108.99 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -111.85 138.84 47.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 106.393 -1.706 . . . . 2.46 106.393 171.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 72.4 m95 -81.76 133.54 35.35 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 109.506 -0.553 . . . . 0.86 109.506 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 42.1 t -120.26 116.09 24.89 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.3 -0.864 . . . . 0.3 110.093 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 69.9 mt -100.08 99.37 9.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 107.144 -1.428 . . . . 0.3 107.144 172.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 2.9 Cg_exo -75.3 125.89 9.41 Favored 'Trans proline' 0 C--O 1.252 1.207 0 C-N-CA 122.502 2.135 . . . . 0.28 111.804 -177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -120.98 153.57 37.14 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.092 -0.707 . . . . 0.37 109.092 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.5 m -140.54 114.3 8.87 Favored 'General case' 0 C--N 1.267 -3.02 0 N-CA-C 108.715 -0.846 . . . . 0.88 108.715 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -110.43 116.31 52.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.596 -0.89 . . . . 0.27 108.596 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 8.5 t70 -101.22 137.06 40.07 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.634 -0.876 . . . . 1.39 108.634 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.46 145.17 4.27 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 110.326 -1.11 . . . . 0.6 110.326 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -84.05 -55.53 0.46 Allowed Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 109.739 -0.467 . . . . 2.61 109.739 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.1 Cg_endo -62.4 120.78 8.48 Favored 'Trans proline' 0 C--N 1.387 2.56 0 N-CA-C 108.643 -1.329 . . . . 0.78 108.643 170.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.1 111.59 8.99 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 116.15 -0.477 . . . . 0.78 111.531 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -83.97 162.13 13.79 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 122.547 2.165 . . . . 0.56 112.344 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 7.9 p -94.37 130.01 40.86 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.516 -0.92 . . . . 1.37 108.516 174.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.441 ' HB3' HD11 ' A' ' 85' ' ' LEU . 88.2 mt -98.54 140.67 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.995 -0.372 . . . . 0.5 109.995 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -143.88 133.71 23.89 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.162 -0.681 . . . . 3.78 109.162 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.456 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.3 m95 -96.64 117.46 31.04 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.047 0.451 . . . . 0.29 109.862 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 tp -100.72 127.23 47.21 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.336 -1.727 . . . . 0.95 106.336 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.5 ' HZ ' ' O ' ' A' ' 78' ' ' VAL . 88.7 t80 -122.97 108.05 12.51 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 109.213 -0.662 . . . . 0.88 109.213 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.58 17.7 6.39 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.679 0.791 . . . . 1.79 112.835 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.1 -12.16 40.7 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.973 -0.632 . . . . 0.61 112.685 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 m -108.62 151.99 25.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.851 -0.796 . . . . 1.37 108.851 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.41 123.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 116.379 -0.373 . . . . 0.7 110.017 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.2 tp -82.65 113.38 20.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.845 -0.616 . . . . 0.61 109.552 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -85.01 140.78 30.78 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.374 -0.602 . . . . 2.47 109.374 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.77 137.59 36.25 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.785 -0.643 . . . . 1.74 110.084 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.3 p -127.16 -165.97 1.54 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.773 0.829 . . . . 1.57 110.068 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.9 m -75.64 -31.91 60.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.023 0.44 . . . . 1.52 110.546 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -89.84 -28.41 19.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.071 0.397 . . . . 1.59 112.071 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.43 HG23 HD23 ' A' ' 72' ' ' LEU . 55.9 mt -125.53 106.64 16.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.091 -0.707 . . . . 0.5 109.091 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HE1' HD21 ' A' ' 73' ' ' ASN . 53.0 p90 -145.91 156.27 43.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.61 -0.436 . . . . 2.89 110.547 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -85.23 109.79 18.58 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.666 -0.864 . . . . 0.44 108.666 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.54 108.77 21.55 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 108.37 -0.974 . . . . 2.04 108.37 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -85.95 145.74 27.0 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.53 -0.915 . . . . 0.87 108.53 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.2 pp -109.42 157.96 18.41 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.376 -1.713 . . . . 1.25 106.376 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.07 109.0 5.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 O-C-N 123.485 0.491 . . . . 3.36 110.15 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.63 140.92 19.22 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.393 2.062 . . . . 1.39 111.705 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.61 134.66 51.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.069 -1.085 . . . . 1.53 108.069 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.17 -18.28 63.31 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.832 0.678 . . . . 1.91 112.832 -173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -73.65 -23.2 59.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.256 -0.429 . . . . 3.49 110.478 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.83 152.31 18.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.515 -0.55 . . . . 1.89 109.515 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.57 11.12 38.26 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.496 -1.298 . . . . 1.3 107.496 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.5 t -104.74 127.88 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.037 -0.983 . . . . 0.61 110.617 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HB2' HG13 ' A' ' 29' ' ' VAL . 66.5 mtp180 -92.43 115.06 27.75 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.574 -1.639 . . . . 1.84 106.574 176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.439 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 90.5 m-70 -101.97 142.73 32.8 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.263 -0.643 . . . . 1.16 109.263 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.78 -178.79 38.4 Favored Glycine 0 N--CA 1.423 -2.205 0 C-N-CA 120.21 -0.995 . . . . 0.31 111.327 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 t -144.33 132.81 22.09 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 120.547 0.213 . . . . 0.36 111.278 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 54.4 tp -87.16 114.01 23.4 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.433 -2.062 . . . . 0.28 105.433 170.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 16.4 ptm180 -106.76 119.58 39.71 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 112.338 0.495 . . . . 2.68 112.338 -174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.43 HD23 HG23 ' A' ' 52' ' ' ILE . 15.6 mt -92.85 108.2 19.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.75 -2.315 . . . . 1.23 104.75 171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.405 HD21 ' HE1' ' A' ' 53' ' ' PHE . 86.8 m-20 -74.35 -52.53 11.93 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 108.982 -0.747 . . . . 2.18 108.982 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -128.26 100.23 23.44 Favored Pre-proline 0 N--CA 1.397 -3.111 0 N-CA-C 105.843 -1.91 . . . . 2.82 105.843 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 25.2 Cg_exo -67.09 150.39 82.36 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.11 1.873 . . . . 1.25 109.897 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.9 p -112.62 178.14 4.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 116.577 -0.283 . . . . 1.22 111.073 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -52.63 -37.02 57.69 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.469 0.708 . . . . 2.03 112.626 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.5 ' O ' ' HZ ' ' A' ' 41' ' ' PHE . 14.6 m -77.17 -10.44 13.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 112.825 0.676 . . . . 1.33 112.825 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -78.58 26.97 0.22 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.701 1.0 . . . . 2.19 113.701 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.6 m-20 -110.86 53.47 0.7 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.755 -1.943 . . . . 1.96 105.755 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -133.78 -168.23 11.78 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.38 -1.39 . . . . 0.49 114.061 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 15.0 m120 -102.43 114.59 28.91 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.517 0.727 . . . . 2.23 109.989 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.09 116.2 31.56 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.738 -0.838 . . . . 0.69 108.738 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 77.8 m -116.62 122.75 45.53 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.694 -0.484 . . . . 0.34 109.694 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.1 tp -96.84 118.32 33.02 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.765 -0.457 . . . . 0.22 109.765 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.6 136.33 41.63 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.748 -0.834 . . . . 0.36 108.748 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 36' ' ' SER . . . -128.49 120.42 26.77 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.86 -1.163 . . . . 0.31 107.86 173.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.07 134.4 54.55 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 123.16 0.288 . . . . 0.61 110.599 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -153.2 171.93 6.24 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.67 -1.233 . . . . 1.18 107.67 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -55.94 -39.32 91.9 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.284 1.989 . . . . 1.0 113.408 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.55 -15.74 61.77 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.045 0.387 . . . . 1.1 112.045 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.27 -161.46 29.72 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 119.02 -1.562 . . . . 0.59 113.252 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -134.72 124.29 25.0 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.814 -0.81 . . . . 1.57 108.814 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.38 151.15 22.6 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.66 -0.867 . . . . 0.37 108.66 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 6.4 p -152.23 135.31 15.72 Favored 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 123.719 0.637 . . . . 0.57 110.775 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.02 155.44 47.08 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.175 -1.417 . . . . 0.3 107.175 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -129.54 145.24 51.49 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.875 0.369 . . . . 1.26 111.318 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.516 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -143.98 126.37 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 N-CA-C 107.947 -1.131 . . . . 0.72 107.947 178.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -106.67 137.19 45.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.221 -0.659 . . . . 1.25 109.221 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.46 145.86 47.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.765 -0.828 . . . . 0.58 108.765 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -127.64 104.08 7.67 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.272 0.558 . . . . 0.84 110.433 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 58.2 t80 -72.88 -54.45 8.72 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 114.389 1.255 . . . . 3.86 114.389 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.7 ptm -145.36 -178.48 6.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.603 -0.517 . . . . 4.72 109.603 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 120.5 31.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.312 -1.736 . . . . 5.33 106.312 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.27 130.84 87.34 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 112.223 0.453 . . . . 5.34 112.223 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.69 117.08 4.81 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 121.917 1.745 . . . . 5.07 109.221 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.217 -0.897 . . . . 9.52 111.211 -178.414 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 112.084 0.402 . . . . 7.93 112.084 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -93.74 -72.3 0.62 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.551 0.614 . . . . 6.17 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -68.9 -38.22 79.48 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 122.659 1.219 . . . . 5.43 107.753 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.0 66.69 5.57 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.773 -1.558 . . . . 3.87 108.68 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -92.42 -31.68 15.21 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.44 -1.319 . . . . 2.55 107.44 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.8 m -50.04 99.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 C-N-CA 126.078 1.751 . . . . 2.08 110.973 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.6 m -104.99 97.74 7.55 Favored 'General case' 0 N--CA 1.379 -3.976 0 CA-C-N 114.411 -1.268 . . . . 1.58 110.259 -175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 95.1 m-85 -96.61 127.26 42.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.323 -1.732 . . . . 1.19 106.323 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.2 m -92.4 -159.39 0.66 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 119.145 -0.455 . . . . 1.32 110.227 -177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.58 106.84 18.78 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 119.369 0.986 . . . . 0.45 112.123 -169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.482 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 39.4 m -112.81 126.68 55.7 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.399 -0.819 . . . . 1.19 108.882 175.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 94' ' ' ALA . 62.1 t -115.55 124.86 72.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 120.926 0.393 . . . . 0.29 112.0 -173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -124.83 121.13 33.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.092 -1.077 . . . . 2.18 108.092 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 98' ' ' ILE . 43.3 mt -105.0 156.12 18.33 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.982 0.42 . . . . 0.33 111.494 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -130.91 144.28 51.35 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.453 -1.314 . . . . 1.03 107.453 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -65.25 136.99 57.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 123.718 0.807 . . . . 0.49 110.089 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -51.58 138.63 22.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.403 1.064 . . . . 0.4 110.926 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.62 143.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 116.036 -0.529 . . . . 0.57 110.234 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.86 98.53 2.02 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.796 -1.093 . . . . 2.52 111.685 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -141.21 -169.59 2.88 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.395 -1.335 . . . . 0.88 107.395 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -78.93 -39.67 34.02 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.995 -0.743 . . . . 2.75 108.995 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -101.55 127.08 48.42 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.858 -1.905 . . . . 2.46 105.858 174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.5 m95 -82.78 126.83 32.85 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.099 0.476 . . . . 0.86 110.991 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 43.7 t -117.73 118.13 31.23 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.51 -0.768 . . . . 0.3 109.435 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 17' ' ' ALA . 72.6 mt -101.75 97.43 7.94 Favored Pre-proline 0 C--O 1.247 0.952 0 N-CA-C 107.599 -1.26 . . . . 0.3 107.599 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 9.7 Cg_exo -74.25 136.0 21.43 Favored 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.507 2.138 . . . . 0.28 111.427 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -124.41 161.32 26.25 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.283 0.563 . . . . 0.37 110.818 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -140.8 110.51 6.43 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.792 -0.818 . . . . 0.88 108.792 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 66' ' ' ARG . 4.0 p -123.33 117.49 51.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.059 -1.089 . . . . 0.27 108.059 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.7 p-10 -103.1 165.94 10.73 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 118.526 -1.27 . . . . 1.39 110.715 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.58 165.54 12.5 Favored Glycine 0 N--CA 1.409 -3.111 0 O-C-N 124.823 1.327 . . . . 0.6 109.935 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.402 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 23.8 mm-40 -101.96 -55.22 0.13 Allowed Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.788 -0.449 . . . . 2.61 109.788 175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 18.2 Cg_endo -66.05 119.78 6.85 Favored 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.08 -1.931 . . . . 0.78 107.08 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.83 115.07 27.31 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 115.969 -0.56 . . . . 0.78 111.508 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 92.7 Cg_endo -81.01 134.59 9.45 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 121.516 1.477 . . . . 0.56 111.356 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -70.61 132.75 45.93 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.519 -1.289 . . . . 1.37 107.519 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 85' ' ' LEU . 72.1 mt -100.04 120.45 39.85 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.968 0.414 . . . . 0.5 110.432 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.428 HH12 ' HG3' ' A' ' 48' ' ' GLU . 9.2 tpp180 -122.1 128.05 50.87 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.532 -0.758 . . . . 3.78 109.819 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -93.9 155.37 17.2 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.082 -0.508 . . . . 0.29 110.627 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 11.5 tp -137.83 141.1 40.8 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.185 -1.413 . . . . 0.95 107.185 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -119.12 101.96 8.39 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.348 0.659 . . . . 0.88 109.43 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 57.69 31.38 20.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.96 0.904 . . . . 1.79 111.063 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.51 -19.04 55.33 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.707 -0.759 . . . . 0.61 112.74 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.7 t -88.68 140.98 28.9 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.44 -0.578 . . . . 1.37 109.44 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.21 117.1 2.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.741 -0.663 . . . . 0.7 111.007 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.7 tp -91.13 126.46 36.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.011 -0.737 . . . . 0.61 109.011 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -93.99 137.39 33.25 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.898 -0.592 . . . . 2.47 109.441 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' HH12 ' A' ' 38' ' ' ARG . 34.9 mt-10 -79.76 83.31 5.73 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.754 -0.832 . . . . 1.74 108.754 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -84.48 -178.41 6.89 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.198 -0.91 . . . . 1.57 110.706 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -58.96 -34.82 72.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.213 0.53 . . . . 1.52 111.67 -177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -87.43 -13.99 41.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.643 0.609 . . . . 1.59 112.643 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.19 105.07 5.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 107.304 -1.369 . . . . 0.5 107.304 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -135.94 145.95 46.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.509 -0.877 . . . . 2.89 112.025 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 m -89.7 110.21 21.12 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.912 -1.144 . . . . 0.44 107.912 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.33 113.38 26.63 Favored 'General case' 0 N--CA 1.418 -2.025 0 C-N-CA 119.325 -0.95 . . . . 2.04 109.047 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' CE1' HD12 ' A' ' 37' ' ' LEU . 70.5 m-85 -87.74 133.84 33.78 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.831 -1.544 . . . . 0.87 106.831 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.16 164.19 19.31 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.234 -0.986 . . . . 1.25 108.949 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -59.82 120.5 50.36 Favored Pre-proline 0 C--N 1.316 -0.873 0 N-CA-C 108.779 -0.823 . . . . 3.36 108.779 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.12 128.34 30.11 Favored 'Trans proline' 0 CA--C 1.497 -1.348 0 C-N-CA 122.635 2.223 . . . . 1.39 111.253 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.91 125.45 29.32 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 115.282 -0.872 . . . . 1.53 108.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.22 -27.81 62.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.0 -1.0 . . . . 1.91 113.006 -173.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.3 -9.16 42.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.047 0.388 . . . . 3.49 112.047 -177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -102.3 150.28 23.48 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.693 0.759 . . . . 1.89 112.248 -173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.5 p -105.07 7.99 34.11 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.991 -1.004 . . . . 1.3 108.701 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 18.1 t -112.0 133.26 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 114.922 -1.035 . . . . 0.61 109.668 -176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HB2' HG13 ' A' ' 29' ' ' VAL . 64.8 mtp180 -87.56 134.86 33.55 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.685 -1.598 . . . . 1.84 106.685 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -124.3 155.68 38.25 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.009 0.433 . . . . 1.16 109.891 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.03 -171.63 43.03 Favored Glycine 0 N--CA 1.411 -3.028 0 N-CA-C 109.516 -1.434 . . . . 0.31 109.516 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.422 ' SG ' ' HG2' ' A' ' 71' ' ' ARG . 39.3 t -148.03 141.26 25.12 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.004 0.43 . . . . 0.36 110.793 -178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.0 tp -88.65 102.23 14.76 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.282 -2.118 . . . . 0.28 105.282 171.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HG2' ' SG ' ' A' ' 69' ' ' CYS . 85.2 mtm-85 -102.37 129.2 48.77 Favored 'General case' 0 CA--C 1.48 -1.745 0 C-N-CA 119.203 -0.999 . . . . 2.68 110.857 -177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 23' ' ' TRP . 62.8 mt -86.24 108.47 18.39 Favored 'General case' 0 N--CA 1.406 -2.625 0 N-CA-C 106.561 -1.644 . . . . 1.23 106.561 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -67.64 -47.07 70.61 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 114.691 -1.141 . . . . 2.18 109.011 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -128.12 110.07 19.87 Favored Pre-proline 0 N--CA 1.421 -1.882 0 N-CA-C 106.439 -1.689 . . . . 2.82 106.439 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 35.1 Cg_endo -68.83 130.54 20.69 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 121.607 1.538 . . . . 1.25 111.275 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.6 p -123.96 171.99 9.29 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.57 -0.741 . . . . 1.22 109.632 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -72.46 -8.54 55.59 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 112.452 0.538 . . . . 2.03 112.452 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.89 -9.54 11.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.824 0 CA-C-O 121.394 0.616 . . . . 1.33 110.422 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.657 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.1 m120 -90.12 27.12 1.69 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.711 0.767 . . . . 2.19 110.467 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -126.57 64.96 1.26 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.016 -1.105 . . . . 1.96 108.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.06 -158.55 11.52 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.525 -0.845 . . . . 0.49 112.234 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -96.55 129.22 43.98 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 110.377 -0.231 . . . . 2.23 110.377 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 52.6 m-85 -116.64 117.75 30.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.035 0.445 . . . . 0.69 110.427 175.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.1 m -100.47 136.07 40.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.238 -0.653 . . . . 0.34 109.238 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 95' ' ' SER . 49.3 tp -103.29 114.21 28.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.187 -0.672 . . . . 0.22 109.187 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.8 mm? -100.63 116.41 32.48 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.145 -1.057 . . . . 0.36 108.145 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -113.72 120.98 42.71 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.948 -1.13 . . . . 0.31 107.948 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.64 50.67 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.872 -0.331 . . . . 0.61 111.549 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 42.7 p30 -141.12 175.25 3.18 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.34 -1.355 . . . . 1.18 107.34 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 52.9 Cg_exo -47.08 -29.77 9.23 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.851 2.368 . . . . 1.0 115.035 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 77.6 m -71.6 -41.23 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.073 0.463 . . . . 1.1 111.769 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.21 -162.76 35.05 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.571 -0.824 . . . . 0.59 111.051 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 62.4 tt0 -132.47 131.32 41.57 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.857 -0.423 . . . . 1.57 109.857 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -107.76 150.19 27.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.0 p -142.8 120.78 12.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 120.771 0.32 . . . . 0.57 111.831 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -121.34 147.92 45.04 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.542 -1.281 . . . . 0.3 107.542 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -118.46 123.88 46.25 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 118.002 0.364 . . . . 1.26 111.164 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.485 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -118.92 120.22 63.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.974 -1.121 . . . . 0.72 107.974 178.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.53 128.74 39.79 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.288 -1.004 . . . . 1.25 108.288 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.75 116.91 30.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.875 0.369 . . . . 0.58 110.583 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.11 101.4 12.86 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.355 0.598 . . . . 0.84 109.414 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 20.3 t80 -82.18 -68.03 0.73 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.29 -0.868 . . . . 3.86 112.501 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -150.6 -177.88 6.23 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.556 -1.276 . . . . 4.72 107.556 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.57 116.47 22.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.814 -1.18 . . . . 5.33 107.814 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -96.95 114.23 64.28 Favored Pre-proline 0 C--N 1.29 -2.001 0 N-CA-C 108.766 -0.827 . . . . 5.34 108.766 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.44 116.56 4.29 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 121.728 1.619 . . . . 5.07 112.203 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 124.567 1.147 . . . . 9.52 112.789 178.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.882 0.849 . . . . 7.93 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 6' ' ' VAL . 3.8 m-20 -101.27 8.32 42.52 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.658 -1.238 . . . . 6.17 107.658 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.08 -19.56 63.25 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.905 -1.498 . . . . 5.43 114.011 -168.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -89.66 -32.27 17.13 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.764 -0.774 . . . . 3.87 109.751 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -74.67 -44.19 51.51 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.204 -0.907 . . . . 2.55 111.422 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 2' ' ' ASP . 14.4 m -84.37 98.58 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-O 122.331 1.062 . . . . 2.08 108.699 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -108.49 98.2 7.75 Favored 'General case' 0 N--CA 1.397 -3.077 0 CA-C-O 122.2 1.0 . . . . 1.58 109.515 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.488 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 67.1 m-85 -81.48 109.96 16.43 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 105.775 -1.935 . . . . 1.19 105.775 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.3 t -84.0 175.59 9.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.228 -1.027 . . . . 1.32 108.228 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.71 126.37 39.97 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 112.852 0.686 . . . . 0.45 112.852 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 m -123.82 139.13 54.28 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.515 -1.291 . . . . 1.19 107.515 171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 94' ' ' ALA . 82.7 t -115.36 114.41 46.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 109.583 -0.525 . . . . 0.29 109.583 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -111.42 116.72 31.4 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.967 -0.56 . . . . 2.18 110.791 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.477 HD13 HG22 ' A' ' 98' ' ' ILE . 42.7 mt -102.71 156.34 17.7 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.277 -0.874 . . . . 0.33 109.16 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -131.82 153.01 50.59 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.344 -0.613 . . . . 1.03 109.344 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m -58.85 137.38 57.8 Favored 'General case' 0 N--CA 1.425 -1.724 0 O-C-N 124.909 1.38 . . . . 0.49 108.728 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 143.03 56.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.19 -0.67 . . . . 0.4 109.19 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.62 129.85 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.52 0.676 . . . . 0.57 110.146 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -78.73 91.75 4.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.724 -1.125 . . . . 2.52 112.514 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -154.43 -178.32 7.07 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.084 -1.821 . . . . 0.88 106.084 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -71.93 -28.64 63.61 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 120.554 1.525 . . . . 2.75 110.499 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -88.43 100.96 13.44 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -81.89 99.55 9.12 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.837 0.827 . . . . 0.86 110.22 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.6 t -103.05 123.05 45.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.717 -1.583 . . . . 0.3 109.123 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 62.6 mt -105.87 99.97 25.23 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.426 -1.324 . . . . 0.3 107.426 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.29 132.72 18.23 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.361 2.041 . . . . 0.28 112.58 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HB3' HD23 ' A' ' 14' ' ' LEU . 46.9 p90 -128.35 149.9 50.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.232 0.539 . . . . 0.37 109.869 176.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.7 m -136.61 112.68 9.7 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.229 -1.026 . . . . 0.88 108.229 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.7 p -110.83 119.23 59.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.825 -0.805 . . . . 0.27 108.825 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 25.0 t70 -101.0 132.05 46.59 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.243 -1.021 . . . . 1.39 108.243 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.83 131.66 1.28 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 109.387 -1.485 . . . . 0.6 109.387 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.448 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 25.4 tt0 -75.64 -54.77 2.19 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.629 -0.508 . . . . 2.61 109.629 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 19.7 Cg_endo -63.11 120.42 7.89 Favored 'Trans proline' 0 C--N 1.379 2.163 0 N-CA-C 107.384 -1.814 . . . . 0.78 107.384 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.0 12.52 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.193 -0.458 . . . . 0.78 111.807 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.503 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 87.4 Cg_endo -76.64 149.69 30.49 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.11 1.874 . . . . 0.56 111.698 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -76.13 109.37 9.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.567 -0.901 . . . . 1.37 108.567 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 29' ' ' VAL . 90.8 mt -87.36 125.68 34.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.876 0.37 . . . . 0.5 110.953 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -135.52 130.95 35.39 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 116.223 -0.444 . . . . 3.78 110.11 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -90.97 131.56 36.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.749 -0.659 . . . . 0.29 109.734 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -104.88 127.03 52.55 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 105.247 -2.131 . . . . 0.95 105.247 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.29 109.54 16.97 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 122.662 0.385 . . . . 0.88 110.254 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.8 t30 51.35 52.36 14.96 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 124.344 1.028 . . . . 1.79 110.58 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.73 51.01 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 114.541 -1.209 . . . . 0.61 114.179 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -122.7 161.27 24.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.862 -0.792 . . . . 1.37 108.862 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.78 117.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 115.338 -0.846 . . . . 0.7 110.416 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.6 tp -82.64 98.53 9.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.076 -0.65 . . . . 0.61 110.085 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -84.62 95.64 8.94 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 103.951 -2.611 . . . . 2.47 103.951 167.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -56.99 125.54 23.08 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.267 -0.879 . . . . 1.74 112.875 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.5 p -103.9 -165.44 1.15 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.14 -0.936 . . . . 1.57 111.852 -172.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -84.49 -9.93 57.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.906 0.86 . . . . 1.52 108.876 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -89.02 -39.7 13.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.417 -0.81 . . . . 1.59 109.094 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.408 HG23 HD23 ' A' ' 72' ' ' LEU . 40.5 mt -127.48 106.38 15.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.755 -1.572 . . . . 0.5 106.755 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 32.3 p90 -131.39 150.37 52.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 119.608 -0.837 . . . . 2.89 112.728 -177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 m -92.55 110.51 21.94 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.716 -1.129 . . . . 0.44 110.105 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -88.48 113.11 23.73 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.693 -0.854 . . . . 2.04 108.693 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.54 138.03 31.81 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.544 0.687 . . . . 0.87 110.687 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' HIS . 11.0 mt -100.71 136.67 40.21 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.055 -0.975 . . . . 1.25 109.606 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -68.52 112.84 12.36 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 124.802 1.314 . . . . 3.36 111.983 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -88.33 155.06 6.71 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.197 2.598 . . . . 1.39 110.172 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.08 168.09 19.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 119.097 -0.478 . . . . 1.53 109.74 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.52 -39.03 85.09 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 118.724 0.693 . . . . 1.91 112.695 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -85.07 -2.67 58.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.173 1.175 . . . . 3.49 114.173 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -101.17 157.59 16.66 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.592 -0.843 . . . . 1.89 108.825 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 p -112.4 15.93 20.08 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 120.834 0.349 . . . . 1.3 111.697 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.12 124.57 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 119.967 -0.693 . . . . 0.61 110.363 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.0 mtp180 -95.73 116.59 29.1 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 105.665 -1.976 . . . . 1.84 105.665 175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 57' ' ' LEU . 55.7 m-70 -98.73 149.5 22.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.181 -1.044 . . . . 1.16 108.181 -174.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.01 174.96 46.01 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 119.338 -1.41 . . . . 0.31 112.388 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -144.76 132.66 21.3 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.471 0.708 . . . . 0.36 109.929 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 42.2 tp -88.44 113.18 23.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 105.644 -1.984 . . . . 0.28 105.644 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -107.34 123.37 48.24 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.131 0.491 . . . . 2.68 111.596 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 HG23 ' A' ' 52' ' ' ILE . 49.5 mt -84.79 108.37 17.44 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 106.567 -1.642 . . . . 1.23 106.567 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 39.3 t30 -73.4 -52.94 12.0 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.071 -0.968 . . . . 2.18 109.059 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.0 101.23 51.25 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.56 -1.274 . . . . 2.82 107.56 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.04 129.47 18.41 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.688 1.592 . . . . 1.25 110.331 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 p -138.62 168.88 18.83 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.138 -1.06 . . . . 1.22 108.138 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -76.13 -6.01 49.24 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 122.243 -0.286 . . . . 2.03 111.479 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.44 -21.41 10.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 109.212 -0.662 . . . . 1.33 109.212 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.27 -10.6 59.73 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.657 0.741 . . . . 2.19 109.799 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 11.2 t30 -83.57 75.97 9.99 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.23 -1.396 . . . . 1.96 107.23 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.55 -171.58 27.78 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.21 -0.905 . . . . 0.49 111.533 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.29 128.23 38.06 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.42 0.526 . . . . 2.23 112.42 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -114.47 123.09 48.54 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.224 -1.028 . . . . 0.69 108.224 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 61.7 m -115.42 128.99 56.43 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.19 -0.671 . . . . 0.34 109.19 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.1 tp -99.61 114.59 27.73 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.1 -0.704 . . . . 0.22 109.1 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.14 131.01 50.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.157 -1.053 . . . . 0.36 108.157 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -121.14 119.04 31.23 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.916 -1.142 . . . . 0.31 107.916 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.16 130.4 46.29 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 116.235 -0.439 . . . . 0.61 110.045 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 42.9 t-20 -155.63 136.36 8.92 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.411 -1.329 . . . . 1.18 107.411 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.12 -17.11 23.81 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.968 3.112 . . . . 1.0 113.352 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.87 -22.49 45.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.581 0.705 . . . . 1.1 109.537 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.46 146.9 4.51 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.971 -1.252 . . . . 0.59 109.971 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -90.94 135.34 33.8 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.639 -0.504 . . . . 1.57 109.639 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -114.85 151.67 33.5 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.06 -1.089 . . . . 0.37 108.06 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.9 p -160.33 148.96 16.9 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.103 0.478 . . . . 0.57 111.824 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.04 156.97 44.23 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.365 -1.346 . . . . 0.3 107.365 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -133.4 132.38 41.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.175 -0.676 . . . . 1.26 109.175 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.477 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.78 133.14 41.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.808 -0.812 . . . . 0.72 108.808 -176.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 48.2 ttm -108.95 125.78 52.39 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.877 -0.514 . . . . 1.25 109.7 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -98.05 113.67 25.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.524 -0.917 . . . . 0.58 108.524 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.26 100.16 12.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.014 -0.735 . . . . 0.84 109.014 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -74.48 -49.46 22.14 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.828 -1.078 . . . . 3.86 111.831 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.9 ptp -153.86 154.32 33.69 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.658 -1.238 . . . . 4.72 107.658 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.86 110.73 11.71 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.056 -1.831 . . . . 5.33 106.056 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -56.33 113.29 5.61 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 114.479 -1.237 . . . . 5.34 113.685 -168.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -78.82 177.85 8.23 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.693 2.262 . . . . 5.07 112.48 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--N 1.304 -1.394 0 CA-C-N 115.551 -0.75 . . . . 9.52 111.374 -177.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 107.342 -1.355 . . . . 7.93 107.342 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -112.98 155.77 24.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.207 0.527 . . . . 6.17 111.159 -173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -87.87 46.73 1.41 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.198 0.999 . . . . 5.43 110.661 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.09 40.8 3.65 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.268 -0.878 . . . . 3.87 109.924 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.97 -50.85 18.09 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.669 -0.412 . . . . 2.55 110.349 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 m -98.15 98.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 122.483 1.135 . . . . 2.08 109.701 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -102.02 99.17 9.31 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 115.267 -0.879 . . . . 1.58 109.257 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -87.13 129.2 35.03 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.272 -1.01 . . . . 1.19 108.272 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.9 m -83.84 -179.94 7.41 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.322 -0.992 . . . . 1.32 108.322 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.22 117.64 30.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 CA-C-O 121.217 0.532 . . . . 0.45 110.345 -171.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -118.44 134.48 55.03 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 107.039 -1.467 . . . . 1.19 107.039 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 94' ' ' ALA . 68.4 t -122.99 119.16 57.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 120.939 -0.305 . . . . 0.29 110.906 -173.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -119.15 117.74 29.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.547 0.689 . . . . 2.18 110.505 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.797 HD13 HG22 ' A' ' 98' ' ' ILE . 40.8 mt -100.37 157.15 16.83 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.048 -0.978 . . . . 0.33 111.053 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -130.93 144.52 51.53 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.178 -1.045 . . . . 1.03 108.178 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.5 m -67.91 137.77 55.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.631 -0.878 . . . . 0.49 108.631 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 24' ' ' CYS . . . -47.25 137.82 7.78 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.27 1.028 . . . . 0.4 111.884 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.65 138.35 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.574 -0.739 . . . . 0.57 111.06 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.54 89.43 0.36 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.205 -1.362 . . . . 2.52 112.316 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -150.17 178.52 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.376 -1.342 . . . . 0.88 107.376 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -66.19 -46.46 77.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 119.028 0.831 . . . . 2.75 111.091 -173.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -91.7 128.84 37.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -82.6 120.37 25.45 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.918 0.866 . . . . 0.86 112.545 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 40.5 t -120.51 121.4 38.37 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.263 -1.335 . . . . 0.3 109.684 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 68.5 mt -102.43 97.64 9.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 107.844 -1.169 . . . . 0.3 107.844 174.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 24' ' ' CYS . 15.2 Cg_exo -69.04 135.54 32.44 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 122.345 2.03 . . . . 0.28 111.913 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -128.7 149.34 50.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.311 0.577 . . . . 0.37 110.575 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.0 m -131.49 112.21 12.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.318 -0.856 . . . . 0.88 108.76 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.9 124.74 71.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.837 -0.62 . . . . 0.27 109.721 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t0 -101.17 144.07 30.49 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.22 -1.029 . . . . 1.39 108.22 -176.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 158.52 8.67 Favored Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 111.43 -0.668 . . . . 0.6 111.43 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.407 ' H ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 mm-40 -99.94 -58.02 0.13 Allowed Pre-proline 0 C--N 1.307 -1.28 0 CA-C-O 118.916 -0.564 . . . . 2.61 110.902 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.1 Cg_endo -58.0 125.07 17.48 Favored 'Trans proline' 0 C--N 1.366 1.49 0 N-CA-C 108.064 -1.552 . . . . 0.78 108.064 169.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 115.69 19.73 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-O 120.988 0.423 . . . . 0.78 111.768 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.474 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 91.4 Cg_endo -83.63 142.45 10.34 Favored 'Trans proline' 0 N--CA 1.424 -2.585 0 C-N-CA 121.515 1.477 . . . . 0.56 110.748 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 m -75.28 105.39 6.28 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.919 -1.141 . . . . 1.37 107.919 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.5 mt -78.06 116.92 18.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.327 0.584 . . . . 0.5 110.019 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' A' ' 45' ' ' VAL . 8.4 tpp180 -129.3 130.2 45.85 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.222 -0.899 . . . . 3.78 109.735 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 90.3 m95 -100.09 140.29 34.53 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.091 -0.707 . . . . 0.29 109.091 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.2 tp -119.56 127.72 53.26 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 105.957 -1.868 . . . . 0.95 105.957 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -121.82 109.41 14.63 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 109.983 -0.377 . . . . 0.88 109.983 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.08 29.62 17.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.005 0.907 . . . . 1.79 109.967 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.41 60.14 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.309 -0.859 . . . . 0.61 112.62 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.0 t -93.18 142.59 27.13 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.969 -0.752 . . . . 1.37 108.969 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG13 ' HD2' ' A' ' 38' ' ' ARG . 53.9 t -67.45 111.01 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.685 -0.688 . . . . 0.7 110.3 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.42 97.53 9.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.374 -0.83 . . . . 0.61 109.23 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -84.59 127.43 34.06 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.174 -1.417 . . . . 2.47 107.174 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.3 mp0 -61.32 120.45 10.45 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 123.923 0.764 . . . . 1.74 110.659 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.0 p -106.67 -167.39 1.28 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.878 -0.601 . . . . 1.57 109.827 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -80.96 -16.86 52.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.789 -0.819 . . . . 1.52 108.789 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.75 -41.7 11.11 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.102 -0.499 . . . . 1.59 110.438 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -124.41 106.29 16.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 106.382 -1.71 . . . . 0.5 106.382 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -130.39 141.93 50.53 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.901 -0.72 . . . . 2.89 111.248 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -83.31 109.97 17.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.896 -0.779 . . . . 0.44 108.896 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 71' ' ' ARG . 42.3 mt-10 -109.9 155.33 21.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.3 0.571 . . . . 2.04 110.222 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -121.88 151.31 40.82 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 107.749 -1.204 . . . . 0.87 107.749 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -108.82 166.15 11.03 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.251 -1.759 . . . . 1.25 106.251 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -50.94 102.88 0.33 Allowed Pre-proline 0 N--CA 1.473 0.725 0 O-C-N 123.957 0.785 . . . . 3.36 110.367 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.04 129.45 2.01 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 122.571 2.181 . . . . 1.39 113.411 -173.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 121.11 15.26 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.347 -0.842 . . . . 1.53 109.828 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.08 -4.83 59.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.061 0.457 . . . . 1.91 109.896 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -63.72 -39.33 94.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.697 -1.224 . . . . 3.49 107.697 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -102.99 163.74 12.03 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.84 -1.073 . . . . 1.89 108.375 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.2 p -94.96 23.63 5.43 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 120.655 0.264 . . . . 1.3 111.383 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 24.1 t -116.88 129.47 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-O 121.178 0.514 . . . . 0.61 110.749 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -91.74 132.4 36.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.906 -1.516 . . . . 1.84 106.906 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -113.19 128.05 56.36 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.451 -0.574 . . . . 1.16 109.451 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.58 -169.06 17.45 Favored Glycine 0 N--CA 1.417 -2.598 0 N-CA-C 111.068 -0.813 . . . . 0.31 111.068 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.1 t -152.0 133.3 14.48 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 120.92 0.391 . . . . 0.36 110.81 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 46.3 tp -84.61 90.78 7.75 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 104.747 -2.316 . . . . 0.28 104.747 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 55' ' ' GLU . 50.1 ttp180 -95.87 120.94 37.03 Favored 'General case' 0 N--CA 1.411 -2.425 0 CA-C-N 115.595 -0.729 . . . . 2.68 109.734 -176.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.35 108.6 17.9 Favored 'General case' 0 N--CA 1.4 -2.958 0 N-CA-C 106.862 -1.532 . . . . 1.23 106.862 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.74 -40.18 91.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.759 -1.564 . . . . 2.18 110.64 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -128.69 101.42 20.69 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.813 -0.81 . . . . 2.82 108.813 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.59 130.41 14.81 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.357 2.038 . . . . 1.25 112.458 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 p -139.39 165.13 28.03 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.958 -1.127 . . . . 1.22 107.958 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 103' ' ' MET . 16.5 p-80 -76.82 -5.66 49.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.285 0.846 . . . . 2.03 113.285 -173.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.54 -11.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.089 0.471 . . . . 1.33 109.791 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -92.52 26.49 2.62 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.571 0.701 . . . . 2.19 110.038 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 101' ' ' ALA . 17.6 t30 -117.51 114.8 23.99 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.344 -0.984 . . . . 1.96 108.344 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.76 -159.2 32.19 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.521 -0.847 . . . . 0.49 112.378 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -88.3 118.01 27.61 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.671 0.388 . . . . 2.23 111.657 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.564 ' HB2' HG23 ' A' ' 98' ' ' ILE . 57.0 m-85 -106.8 137.56 44.6 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.588 -0.893 . . . . 0.69 108.588 176.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.2 m -137.72 133.89 34.7 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.792 -0.818 . . . . 0.34 108.792 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' CE2' ' A' ' 39' ' ' TRP . 53.0 tp -106.11 120.68 42.42 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 109.736 -0.468 . . . . 0.22 109.736 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.42 133.41 51.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.339 -0.986 . . . . 0.36 108.339 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.66 121.18 25.09 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.999 -1.111 . . . . 0.31 107.999 174.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.59 132.53 53.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.024 0.202 . . . . 0.61 110.507 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 31.9 p30 -148.33 173.61 4.07 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-O 117.965 -1.017 . . . . 1.18 108.722 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 17.3 Cg_exo -41.57 -32.29 1.4 Allowed 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.742 2.961 . . . . 1.0 116.318 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.8 t -81.85 -33.41 30.67 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.698 -0.626 . . . . 1.1 111.735 -176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.15 -161.94 35.75 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 119.563 -1.303 . . . . 0.59 112.825 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -129.25 133.38 47.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.805 -0.813 . . . . 1.57 108.805 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.27 154.35 29.25 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.656 -0.868 . . . . 0.37 108.656 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 13.4 p -149.5 123.77 9.57 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 123.72 0.637 . . . . 0.57 111.256 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.22 149.8 48.8 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.229 -1.397 . . . . 0.3 107.229 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.8 p -118.63 147.99 43.18 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.439 0.638 . . . . 1.26 112.598 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.797 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -140.59 118.88 10.28 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 C-N-CA 124.767 1.227 . . . . 0.72 109.041 177.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.88 100.75 11.1 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.389 -1.708 . . . . 1.25 106.389 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.77 113.47 26.68 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.656 0.741 . . . . 0.58 111.007 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -105.13 104.98 14.82 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.566 -1.197 . . . . 0.84 108.611 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -103.47 -87.46 0.43 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 120.304 -0.558 . . . . 3.86 110.791 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.479 ' HB2' ' HA ' ' A' ' 77' ' ' HIS . 65.4 mtt -101.37 139.28 37.26 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.381 -0.97 . . . . 4.72 108.381 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.503 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 7.0 p-10 -76.96 148.6 36.22 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.879 -0.6 . . . . 5.33 110.695 -175.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.434 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 7.8 t30 -96.96 104.38 18.48 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 109.163 -0.68 . . . . 5.34 109.163 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 107' ' ' PHE . 48.1 Cg_exo -65.52 115.7 3.51 Favored 'Trans proline' 0 C--O 1.254 1.293 0 C-N-CA 121.706 1.604 . . . . 5.07 111.552 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 44.0 t80 . . . . . 0 C--O 1.245 0.863 0 O-C-N 125.201 1.563 . . . . 9.52 107.896 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 CA--C 1.495 -1.142 0 N-CA-C 108.821 -0.807 . . . . 7.93 108.821 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -166.07 -61.2 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.816 -0.629 . . . . 6.17 110.214 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -87.82 51.75 2.29 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.318 -1.364 . . . . 5.43 107.318 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' HA ' HE22 ' A' ' 32' ' ' GLN . 5.0 m-20 -127.94 37.75 4.13 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.878 -1.51 . . . . 3.87 108.724 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.06 -50.69 70.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.205 -0.907 . . . . 2.55 109.03 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.02 102.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 114.928 -1.033 . . . . 2.08 108.636 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 t -80.02 99.55 7.72 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 108.49 -0.929 . . . . 1.58 108.49 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 27.6 m-85 -75.06 121.4 21.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.3 -1.371 . . . . 1.19 107.3 176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.1 m -83.95 -174.16 5.13 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.154 -1.054 . . . . 1.32 108.154 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.36 118.35 30.83 Favored 'General case' 0 CA--C 1.474 -1.942 0 C-N-CA 119.128 -1.029 . . . . 0.45 109.652 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.1 m -116.67 130.66 56.86 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.789 -1.096 . . . . 1.19 108.569 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 85' ' ' LEU . 77.8 t -116.68 119.5 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 116.331 -0.395 . . . . 0.29 111.379 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -115.11 120.41 39.71 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.162 -0.681 . . . . 2.18 109.162 173.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 27' ' ' PHE . 33.5 mt -98.41 155.13 17.39 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 109.589 -0.522 . . . . 0.33 109.589 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.67 147.18 52.49 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.917 -1.142 . . . . 1.03 107.917 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 m -60.96 131.72 51.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 124.118 0.886 . . . . 0.49 109.41 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.36 139.27 19.74 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.403 1.064 . . . . 0.4 111.44 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.9 140.98 15.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.515 0.674 . . . . 0.57 110.137 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -82.72 102.33 11.46 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.346 -1.297 . . . . 2.52 111.731 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 70.7 mtm -145.12 -167.47 2.68 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.106 -1.442 . . . . 0.88 107.106 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -77.93 -49.46 14.12 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 106.843 -1.54 . . . . 2.75 106.843 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -89.82 120.13 30.8 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.554 -1.276 . . . . 2.46 107.554 172.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.62 134.25 35.17 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.106 0.479 . . . . 0.86 111.05 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.7 t -125.99 126.07 43.71 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.214 -0.903 . . . . 0.3 110.555 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 71.9 mt -101.33 102.75 22.64 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.149 -1.426 . . . . 0.3 107.149 173.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.14 138.8 23.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.251 1.967 . . . . 0.28 111.558 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.476 ' HB3' HD23 ' A' ' 14' ' ' LEU . 50.3 p90 -133.29 144.27 49.6 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.871 0.367 . . . . 0.37 110.731 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -121.59 106.24 11.18 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 108.447 -0.945 . . . . 0.88 108.447 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.0 p -114.33 117.86 56.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.684 -0.858 . . . . 0.27 108.684 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -117.79 156.92 27.49 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.301 -0.56 . . . . 1.39 109.491 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.78 149.38 5.31 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 108.323 -1.911 . . . . 0.6 108.323 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.449 HE22 ' HA ' ' A' ' 4' ' ' ASP . 12.3 tt0 -86.47 -53.54 0.42 Allowed Pre-proline 0 C--N 1.311 -1.095 0 C-N-CA 118.857 -1.137 . . . . 2.61 110.857 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 14.2 Cg_endo -62.75 119.31 6.34 Favored 'Trans proline' 0 C--N 1.373 1.824 0 N-CA-C 107.439 -1.793 . . . . 0.78 107.439 167.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.11 118.7 61.28 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 115.475 -0.784 . . . . 0.78 112.156 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -86.84 160.33 8.98 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.108 1.872 . . . . 0.56 112.398 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -96.99 138.19 34.9 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.235 -1.024 . . . . 1.37 108.235 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD21 HG11 ' A' ' 29' ' ' VAL . 95.1 mt -101.33 134.63 44.1 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.185 0.517 . . . . 0.5 111.526 -175.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -136.75 131.34 33.3 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.483 -0.781 . . . . 3.78 110.248 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -97.34 138.54 34.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.873 -0.603 . . . . 0.29 110.647 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 21.0 tp -129.8 137.04 50.28 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.716 -1.957 . . . . 0.95 105.716 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.45 119.68 20.94 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.962 -0.385 . . . . 0.88 109.962 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 60.06 26.34 15.67 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.24 1.019 . . . . 1.79 110.885 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.28 82.15 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.61 112.252 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 p -108.26 150.86 26.72 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.012 0.434 . . . . 1.37 110.391 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.9 t -69.45 114.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.436 -0.802 . . . . 0.7 112.148 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -90.38 122.1 32.95 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.936 -1.135 . . . . 0.61 107.936 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.41 137.11 40.18 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.01 -0.541 . . . . 2.47 110.029 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.52 121.03 12.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.362 -1.718 . . . . 1.74 106.362 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -138.09 -163.99 1.55 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 120.455 -0.498 . . . . 1.57 110.715 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -64.56 -49.89 69.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.631 0.604 . . . . 1.52 112.631 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -84.87 -31.76 23.58 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 1.59 112.013 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 HD21 ' A' ' 79' ' ' ASN . 21.0 mt -114.42 106.66 21.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 106.705 -1.591 . . . . 0.5 106.705 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.23 154.21 50.22 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.542 0.687 . . . . 2.89 111.369 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -95.14 129.3 42.29 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.311 -0.859 . . . . 0.44 109.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -123.13 129.39 51.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.032 -1.47 . . . . 2.04 107.032 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.58 120.84 37.63 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 109.625 -0.509 . . . . 0.87 109.625 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.15 153.84 27.03 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 106.822 -1.548 . . . . 1.25 106.822 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.56 102.05 0.29 Allowed Pre-proline 0 C--N 1.313 -0.998 0 C-N-CA 125.901 1.68 . . . . 3.36 114.0 -172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -88.91 146.71 5.62 Favored 'Trans proline' 0 C--O 1.264 1.79 0 C-N-CA 122.135 1.89 . . . . 1.39 110.383 174.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.501 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -84.97 155.08 21.76 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.255 -1.017 . . . . 1.53 108.255 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.54 -22.1 61.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-N 115.417 -0.811 . . . . 1.91 112.448 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -97.17 -2.29 43.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.425 0.528 . . . . 3.49 112.425 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 54.8 mt-10 -83.04 136.84 34.35 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 109.112 -0.699 . . . . 1.89 109.112 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 m -103.72 27.83 7.13 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 122.827 1.298 . . . . 1.3 108.157 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 t -122.5 129.42 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.2 -1.364 . . . . 0.61 108.087 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.648 ' HB3' HG13 ' A' ' 29' ' ' VAL . 37.2 ttm180 -93.86 119.12 32.38 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 106.934 -1.506 . . . . 1.84 106.934 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -98.39 115.41 28.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.345 -0.983 . . . . 1.16 108.345 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 27' ' ' PHE . . . -133.22 166.0 23.88 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.157 -1.497 . . . . 0.31 113.517 -177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.9 t -139.88 131.93 27.91 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.541 0.736 . . . . 0.36 109.748 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.0 tp -96.39 103.44 15.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 105.518 -2.03 . . . . 0.28 105.518 171.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -108.12 127.91 54.22 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.783 0.801 . . . . 2.68 111.539 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.5 mp -103.67 109.43 21.12 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.462 -1.245 . . . . 1.23 108.744 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -66.42 -36.39 82.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.554 -1.203 . . . . 2.18 109.677 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -134.48 101.35 12.09 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 108.021 -1.103 . . . . 2.82 108.021 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.21 130.75 11.32 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.257 1.971 . . . . 1.25 110.329 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -117.56 169.94 9.15 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.684 -0.487 . . . . 1.22 109.684 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -76.27 -7.01 53.98 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.655 0.613 . . . . 2.03 112.655 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 m -82.59 -9.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.503 -0.555 . . . . 1.33 109.503 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.479 HD21 HD11 ' A' ' 52' ' ' ILE . 10.8 m120 -99.59 26.85 5.77 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.401 0.68 . . . . 2.19 110.105 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -111.42 100.21 8.84 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.785 -0.82 . . . . 1.96 108.785 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.81 -157.61 30.17 Favored Glycine 0 N--CA 1.429 -1.83 0 C-N-CA 119.335 -1.412 . . . . 0.49 113.85 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.53 118.73 30.21 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.355 0.662 . . . . 2.23 112.293 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.13 127.29 46.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.828 -1.078 . . . . 0.69 108.316 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 29.4 m -117.69 127.22 53.72 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 108.886 -0.783 . . . . 0.34 108.886 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.2 tp -103.39 125.71 50.14 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.645 -0.502 . . . . 0.22 109.645 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 95' ' ' SER . 2.7 mm? -108.45 129.34 55.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 124.178 0.924 . . . . 0.36 108.794 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.78 121.6 35.07 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.288 -1.375 . . . . 0.31 107.288 173.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.25 128.49 54.73 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 112.508 0.558 . . . . 0.61 112.508 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -141.25 162.96 44.87 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 106.986 -1.487 . . . . 1.18 106.986 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -47.55 -29.68 10.84 Favored 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 122.716 2.278 . . . . 1.0 114.775 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.63 -29.26 64.45 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.008 -0.432 . . . . 1.1 111.804 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 163.93 165.88 21.86 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.787 -1.197 . . . . 0.59 112.557 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.34 122.5 47.12 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.713 -1.217 . . . . 1.57 107.713 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.64 145.94 28.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.944 -0.762 . . . . 0.37 108.944 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 35.0 p -138.05 138.82 39.17 Favored 'General case' 0 N--CA 1.416 -2.161 0 O-C-N 123.669 0.606 . . . . 0.57 109.837 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.34 155.7 47.51 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.246 -1.391 . . . . 0.3 107.246 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 p -127.75 143.1 51.15 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.654 0.264 . . . . 1.26 111.686 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.461 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -139.58 131.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 105.804 -1.924 . . . . 0.72 105.804 176.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 ttt -112.32 107.5 16.35 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.81 -0.756 . . . . 1.25 109.202 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.37 126.48 55.41 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.292 0.568 . . . . 0.58 111.575 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.05 103.39 15.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.188 -0.915 . . . . 0.84 108.689 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -93.68 -79.12 0.42 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.381 -0.528 . . . . 3.86 110.795 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 mmt -109.25 129.61 55.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.196 -1.039 . . . . 4.72 108.196 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.03 140.57 42.01 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 122.408 0.283 . . . . 5.33 110.384 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -74.59 121.06 84.4 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.524 -0.307 . . . . 5.34 110.37 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.18 141.31 56.74 Favored 'Trans proline' 0 C--O 1.244 0.815 0 C-N-CA 122.855 2.37 . . . . 5.07 112.804 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.685 1.241 . . . . 9.52 111.265 177.702 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 109.315 -0.624 . . . . 7.93 109.315 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.3 t70 58.53 79.97 0.2 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.189 1.396 . . . . 6.17 110.642 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -75.81 52.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.379 0.672 . . . . 5.43 110.674 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -157.61 -51.57 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.245 -0.889 . . . . 3.87 109.941 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.12 -49.67 69.01 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.326 0.391 . . . . 2.55 109.98 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.3 m -88.47 98.93 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-O 122.291 1.043 . . . . 2.08 109.474 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 p -88.95 98.61 11.85 Favored 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 107.037 -1.468 . . . . 1.58 107.037 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 65.2 m-85 -68.1 134.52 50.71 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.67 -1.233 . . . . 1.19 107.67 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.58 -174.81 5.5 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.572 -1.27 . . . . 1.32 107.572 -174.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.17 121.89 34.99 Favored 'General case' 0 CA--C 1.484 -1.561 0 C-N-CA 119.788 -0.765 . . . . 0.45 109.462 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -125.13 135.05 52.28 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.764 -1.199 . . . . 1.19 107.764 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 94' ' ' ALA . 52.2 t -122.54 119.11 57.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 120.94 0.4 . . . . 0.29 111.435 -173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -118.08 116.56 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.952 -0.759 . . . . 2.18 108.952 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 98' ' ' ILE . 32.7 mt -98.13 155.95 16.9 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.263 -0.643 . . . . 0.33 109.263 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -130.86 153.92 48.61 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.783 -1.192 . . . . 1.03 107.783 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.0 m -59.32 133.64 56.28 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 124.729 1.268 . . . . 0.49 110.62 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -69.9 151.78 45.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.417 -0.81 . . . . 0.4 109.152 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.98 126.73 44.53 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.689 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' CZ3' ' A' ' 23' ' ' TRP . 28.0 mm-40 -72.24 88.83 1.16 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.998 -1.001 . . . . 2.52 110.565 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -153.28 -178.86 7.24 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.674 -0.862 . . . . 0.88 108.674 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -61.82 -42.52 99.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.577 0.626 . . . . 2.75 112.067 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.08 109.11 21.21 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.992 -1.114 . . . . 2.46 107.992 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 92.1 m95 -82.27 106.97 14.59 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.306 0.574 . . . . 0.86 111.602 -174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.0 t -104.48 116.97 33.03 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.574 -1.194 . . . . 0.3 109.023 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.1 mt -102.84 100.14 15.75 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 107.858 -1.164 . . . . 0.3 107.858 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -73.41 130.02 14.53 Favored 'Trans proline' 0 C--O 1.244 0.824 0 C-N-CA 122.258 1.972 . . . . 0.28 111.738 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -122.3 155.75 35.28 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.209 0.528 . . . . 0.37 110.522 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.5 m -138.24 106.98 5.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.462 -0.94 . . . . 0.88 108.462 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.3 p -113.28 117.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.059 0.457 . . . . 0.27 110.008 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 29.9 t70 -101.91 136.97 40.83 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.946 -0.57 . . . . 1.39 110.461 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.08 150.6 7.95 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.363 -1.095 . . . . 0.6 110.363 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -82.88 -58.79 0.41 Allowed Pre-proline 0 C--N 1.313 -1.002 0 N-CA-C 107.322 -1.362 . . . . 2.61 107.322 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 38.0 Cg_endo -71.97 120.98 7.19 Favored 'Trans proline' 0 C--N 1.369 1.607 0 N-CA-C 108.173 -1.51 . . . . 0.78 108.173 168.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.7 113.63 8.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 0.78 111.065 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.48 142.43 14.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.452 2.101 . . . . 0.56 111.734 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.1 p -69.47 127.77 34.18 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.631 -0.713 . . . . 1.37 110.019 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.3 mt -98.94 126.16 44.55 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.88 -0.6 . . . . 0.5 111.069 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -131.85 127.59 36.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.88 -0.6 . . . . 3.78 110.176 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.0 m95 -92.91 126.95 38.24 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.29 110.312 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.1 tp -115.94 126.92 54.52 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.677 -1.601 . . . . 0.95 106.677 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -115.74 102.97 10.21 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.177 -0.675 . . . . 0.88 109.177 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 54.15 40.42 31.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.055 0.942 . . . . 1.79 112.101 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.1 84.84 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 115.671 -0.695 . . . . 0.61 113.689 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 m -114.04 136.94 52.36 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 117.449 0.624 . . . . 1.37 109.716 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.0 t -64.77 121.06 13.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.217 -0.447 . . . . 0.7 110.266 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 tp -82.27 137.82 34.75 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.451 -1.315 . . . . 0.61 107.451 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -109.21 121.22 44.69 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 123.354 0.409 . . . . 2.47 110.229 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.22 119.64 13.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.868 -0.79 . . . . 1.74 108.868 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 t -150.06 -174.03 4.61 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.828 -0.804 . . . . 1.57 108.828 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 t -70.73 3.68 3.02 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 112.932 0.715 . . . . 1.52 112.932 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.16 -28.39 9.52 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.871 -0.518 . . . . 1.59 109.921 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.7 mt -149.02 108.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.894 -1.15 . . . . 0.5 107.894 -172.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -135.59 156.28 49.12 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 112.785 0.661 . . . . 2.89 112.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.0 m -100.31 110.43 22.66 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.293 -0.867 . . . . 0.44 110.421 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.34 146.26 24.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.78 -0.822 . . . . 2.04 108.78 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.07 156.88 32.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.314 -0.624 . . . . 0.87 109.314 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -125.26 160.35 29.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.422 -1.325 . . . . 1.25 107.422 172.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 34.6 mm-40 -71.68 120.28 79.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 113.916 1.08 . . . . 3.36 113.916 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.53 145.1 29.31 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 123.198 2.599 . . . . 1.39 111.071 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.54 162.0 16.65 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.485 -0.932 . . . . 1.53 108.485 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.75 -11.38 60.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.931 0.715 . . . . 1.91 112.931 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -91.19 3.31 55.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.167 0.984 . . . . 3.49 108.517 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 151.7 48.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.062 -0.972 . . . . 1.89 108.956 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -120.29 23.88 10.69 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.498 -1.667 . . . . 1.3 106.498 165.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 15.1 t -99.76 123.48 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 113.303 -1.771 . . . . 0.61 109.526 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.512 ' HB2' HG13 ' A' ' 29' ' ' VAL . 62.1 mtp180 -89.01 116.32 27.21 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.173 -1.788 . . . . 1.84 106.173 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -101.2 137.88 38.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.329 -0.989 . . . . 1.16 108.329 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.45 -170.39 30.33 Favored Glycine 0 N--CA 1.419 -2.435 0 C-N-CA 120.19 -1.005 . . . . 0.31 111.046 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.9 t -150.41 132.48 15.29 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 120.874 0.368 . . . . 0.36 110.841 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.6 tp -90.13 111.82 23.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.301 -2.111 . . . . 0.28 105.301 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 10.1 ptp180 -114.09 128.91 56.59 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.046 -1.062 . . . . 2.68 112.49 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.84 107.09 18.79 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 105.455 -2.054 . . . . 1.23 105.455 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -80.81 -35.26 33.25 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.234 -0.439 . . . . 2.18 110.524 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.47 99.79 51.48 Favored Pre-proline 0 N--CA 1.421 -1.909 0 N-CA-C 108.172 -1.048 . . . . 2.82 108.172 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -84.13 143.09 10.1 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 122.229 1.953 . . . . 1.25 111.411 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -136.82 160.93 37.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.108 -1.071 . . . . 1.22 108.108 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.71 -6.89 2.89 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.963 1.097 . . . . 2.03 113.963 -173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.86 -9.93 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.797 0.332 . . . . 1.33 110.572 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -77.86 8.92 3.98 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.643 0.979 . . . . 2.19 113.643 -175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -91.4 88.56 6.88 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.393 -1.706 . . . . 1.96 106.393 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.65 -171.29 27.51 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.458 -1.83 . . . . 0.49 114.536 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -98.88 103.79 15.78 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.051 0.94 . . . . 2.23 110.611 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -93.3 105.96 17.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.865 -0.791 . . . . 0.69 108.865 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.0 m -103.93 125.94 50.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.239 -0.652 . . . . 0.34 109.239 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' SER . 55.5 tp -100.6 118.28 36.45 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.009 -0.737 . . . . 0.22 109.009 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.15 130.38 47.21 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.46 -0.941 . . . . 0.36 108.46 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 121.11 28.74 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.557 -1.275 . . . . 0.31 107.557 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.47 130.78 44.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 123.399 0.437 . . . . 0.61 110.504 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.1 p30 -134.9 171.27 9.28 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.415 -1.328 . . . . 1.18 107.415 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 80.3 Cg_exo -49.41 -30.11 19.76 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.448 2.099 . . . . 1.0 114.145 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.83 -50.99 37.41 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 111.747 0.277 . . . . 1.1 111.747 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.92 45.22 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.452 -1.356 . . . . 0.59 112.933 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -123.55 133.09 54.04 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.928 0.428 . . . . 1.57 110.345 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.244 -1.021 . . . . 0.37 108.244 176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 31.9 p -144.96 138.84 27.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 109.583 -0.525 . . . . 0.57 109.583 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.72 152.36 47.92 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.384 -1.339 . . . . 0.3 107.384 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 m -131.48 141.32 49.75 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.597 -0.441 . . . . 1.26 111.134 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.465 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.34 123.96 39.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 106.441 -1.689 . . . . 0.72 106.441 176.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -103.88 98.87 8.65 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.243 -0.651 . . . . 1.25 109.243 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.03 142.89 27.28 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.416 -0.811 . . . . 0.58 110.645 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.17 143.33 42.08 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.935 -1.135 . . . . 0.84 107.935 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 75' ' ' PRO . 19.3 t80 -111.77 -78.93 0.58 Allowed 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 112.662 0.616 . . . . 3.86 112.662 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 88.1 mtp -134.45 177.26 7.91 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.151 -0.685 . . . . 4.72 109.151 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.57 135.14 36.02 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.796 -1.187 . . . . 5.33 107.796 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -95.32 111.72 56.15 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 109.203 -0.666 . . . . 5.34 109.203 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -57.75 129.02 31.4 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 122.907 2.405 . . . . 5.07 111.832 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.817 -1.087 . . . . 9.52 111.551 178.705 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 110.106 -0.331 . . . . 7.93 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 48.43 57.36 6.31 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 113.708 1.003 . . . . 6.17 113.708 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -67.47 -40.12 85.29 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 106.201 -1.777 . . . . 5.43 106.201 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 59.98 14.14 4.15 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.505 1.922 . . . . 3.87 113.748 167.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.92 -32.9 65.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.462 0.648 . . . . 2.55 110.104 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 m -70.61 98.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-O 122.948 1.356 . . . . 2.08 108.995 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.3 m -110.67 101.0 9.68 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 114.277 -1.329 . . . . 1.58 111.038 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.467 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.7 p90 -130.38 134.54 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.721 -1.127 . . . . 1.19 108.993 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 73.0 m -84.17 -166.19 1.36 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.57 -0.741 . . . . 1.32 111.93 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 131.72 39.74 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.69 0.757 . . . . 0.45 112.018 -172.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 29.4 t -111.72 137.48 49.57 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.954 -1.499 . . . . 1.19 106.954 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 94' ' ' ALA . 86.0 t -115.6 114.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.116 -0.698 . . . . 0.29 109.116 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 96.0 mt-30 -108.44 116.03 31.2 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.033 -0.728 . . . . 2.18 109.033 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 98' ' ' ILE . 23.9 mt -98.97 151.22 21.15 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 109.539 -0.541 . . . . 0.33 109.539 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -131.32 148.8 52.72 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.43 -0.952 . . . . 1.03 108.43 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -56.59 136.39 54.54 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 125.224 1.41 . . . . 0.49 109.617 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -62.96 143.2 57.94 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.952 0.783 . . . . 0.4 110.61 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.81 127.58 44.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 109.485 -0.561 . . . . 0.57 109.485 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.73 116.48 16.48 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.522 -0.763 . . . . 2.52 110.567 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.2 ptt? -168.2 -177.06 3.14 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.966 -1.494 . . . . 0.88 106.966 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -71.34 -39.46 71.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 119.517 1.053 . . . . 2.75 112.208 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.429 ' O ' ' HG3' ' A' ' 20' ' ' MET . 37.5 m80 -98.59 115.14 27.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.42 -1.326 . . . . 2.46 107.42 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' HD12 ' A' ' 72' ' ' LEU . 84.0 m95 -81.77 137.94 35.25 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 0.86 111.953 -172.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.81 120.62 21.83 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.46 -1.245 . . . . 0.3 109.144 -177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 17' ' ' ALA . 54.9 mt -102.9 100.0 15.46 Favored Pre-proline 0 C--O 1.247 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.3 106.88 172.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.54 135.57 20.19 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.338 2.026 . . . . 0.28 112.084 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.7 p90 -127.33 155.85 42.91 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.16 -0.473 . . . . 0.37 109.833 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 10.4 m -132.58 106.32 7.75 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.768 -1.197 . . . . 0.88 107.768 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.4 p -110.74 119.28 59.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.67 -0.863 . . . . 0.27 108.67 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 21.8 t70 -121.22 128.15 52.15 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.624 -0.716 . . . . 1.39 111.303 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.71 147.85 9.35 Favored Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.776 -1.73 . . . . 0.6 108.776 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.16 -55.96 1.69 Allowed Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 109.091 -0.707 . . . . 2.61 109.091 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.545 ' HB2' HD21 ' A' ' 89' ' ' ASN . 25.2 Cg_endo -63.77 122.01 9.93 Favored 'Trans proline' 0 C--N 1.376 2.0 0 N-CA-C 108.283 -1.468 . . . . 0.78 108.283 169.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.35 121.76 84.31 Favored Pre-proline 0 C--N 1.298 -1.652 0 CA-C-N 115.818 -0.628 . . . . 0.78 112.166 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -90.97 167.77 3.7 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.713 2.276 . . . . 0.56 112.464 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -105.62 126.73 52.48 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.12 -1.067 . . . . 1.37 108.12 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.99 143.92 26.36 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.883 0.373 . . . . 0.5 111.843 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -144.54 137.99 27.21 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 124.595 1.158 . . . . 3.78 109.221 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -102.93 146.0 28.99 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.67 0.748 . . . . 0.29 110.871 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 19.2 tp -131.59 127.75 37.75 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.667 -1.605 . . . . 0.95 106.667 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -111.95 106.16 14.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 110.228 -0.286 . . . . 0.88 110.228 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 57.0 30.02 17.44 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.514 0.725 . . . . 1.79 111.883 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.3 -14.34 64.52 Favored Glycine 0 C--N 1.312 -0.792 0 C-N-CA 120.741 -0.742 . . . . 0.61 112.086 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 m -90.48 129.85 36.6 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.629 -0.508 . . . . 1.37 109.629 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.37 117.22 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.572 -0.74 . . . . 0.7 110.342 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.0 tp -97.58 101.3 12.79 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 115.409 -0.814 . . . . 0.61 109.744 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -84.31 130.71 34.78 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.898 -1.519 . . . . 2.47 106.898 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.09 138.22 56.25 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.614 0.765 . . . . 1.74 111.808 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -108.21 -163.84 0.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.654 -0.703 . . . . 1.57 109.391 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -85.76 -34.65 21.13 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.849 -0.797 . . . . 1.52 108.849 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -85.2 -28.98 25.08 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.52 -0.309 . . . . 1.59 111.67 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.7 mt -117.93 106.46 19.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.911 -1.144 . . . . 0.5 107.911 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.186 0.517 . . . . 2.89 110.983 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 m -84.54 112.53 20.49 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.91 127.01 46.13 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.354 -0.98 . . . . 2.04 108.354 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.01 137.14 44.44 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.87 107.821 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 4.4 pp -96.47 165.79 12.01 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.675 -1.232 . . . . 1.25 107.675 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -69.61 107.67 2.48 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 117.783 0.265 . . . . 3.36 111.383 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 44.1 Cg_endo -89.41 169.39 4.91 Favored 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.662 2.908 . . . . 1.39 111.238 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 63' ' ' GLU . . . -92.95 139.48 30.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.274 -1.38 . . . . 1.53 107.274 175.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.77 -18.94 65.51 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.532 0.733 . . . . 1.91 111.824 -176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -76.07 -13.17 60.22 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.55 -0.295 . . . . 3.49 111.763 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 42.2 mt-10 -93.77 134.78 35.75 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.807 0.336 . . . . 1.89 110.826 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 p -95.03 -2.94 49.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.073 0.94 . . . . 1.3 108.83 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -86.01 129.65 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 107.64 -1.244 . . . . 0.61 107.64 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HB2' HG13 ' A' ' 29' ' ' VAL . 60.1 mtp85 -97.22 117.13 30.74 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.154 -1.425 . . . . 1.84 107.154 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.7 112.31 24.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.516 -0.766 . . . . 1.16 110.312 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 178.96 31.62 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 111.083 -0.807 . . . . 0.31 111.083 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 t -150.43 145.19 25.9 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 110.127 -0.323 . . . . 0.36 110.127 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 51.2 tp -80.66 109.93 15.66 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.43 -1.693 . . . . 0.28 106.43 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -97.86 122.81 41.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.76 -0.655 . . . . 2.68 110.986 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 23' ' ' TRP . 37.4 mt -99.19 108.45 21.05 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.159 -1.422 . . . . 1.23 107.159 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -72.4 -54.99 7.78 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.165 -0.925 . . . . 2.18 109.329 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -110.43 106.17 57.72 Favored Pre-proline 0 N--CA 1.427 -1.61 0 N-CA-C 108.307 -0.998 . . . . 2.82 108.307 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.4 135.76 55.49 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.265 2.643 . . . . 1.25 111.343 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 p -142.02 155.34 45.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.939 -0.393 . . . . 1.22 109.939 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -72.88 -5.08 35.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 112.563 0.579 . . . . 2.03 112.563 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -78.66 -9.72 12.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 CA-C-O 120.981 0.42 . . . . 1.33 110.285 171.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.795 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 16.1 m120 -87.81 26.53 1.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.195 0.997 . . . . 2.19 109.407 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -120.68 87.83 2.82 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.273 -1.38 . . . . 1.96 107.273 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.24 -167.41 39.8 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.219 -0.991 . . . . 0.49 112.013 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.78 106.45 18.52 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.94 0.4 . . . . 2.23 111.201 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.795 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 69.7 m-85 -95.42 117.14 29.83 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.078 -1.082 . . . . 0.69 108.078 174.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 88.1 m -106.83 131.35 54.03 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.512 -0.551 . . . . 0.34 109.512 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD23 HG13 ' A' ' 12' ' ' VAL . 55.6 tp -102.41 120.53 40.66 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.961 -0.755 . . . . 0.22 108.961 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.52 136.28 44.38 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.537 -1.283 . . . . 0.36 107.537 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.09 119.37 30.11 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.679 -1.601 . . . . 0.31 106.679 171.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.12 127.28 47.73 Favored 'General case' 0 C--N 1.292 -1.915 0 O-C-N 123.378 0.424 . . . . 0.61 109.896 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.545 HD21 ' HB2' ' A' ' 33' ' ' PRO . 25.5 t-20 -150.98 136.95 10.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.16 -1.422 . . . . 1.18 107.16 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -43.13 -34.84 4.43 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 125.252 3.968 . . . . 1.0 115.532 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.0 p -91.33 -33.69 15.2 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.678 -0.809 . . . . 1.1 111.526 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.86 131.55 2.58 Favored Glycine 0 C--N 1.299 -1.493 0 C-N-CA 120.075 -1.06 . . . . 0.59 112.526 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -103.92 126.58 51.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.903 -0.777 . . . . 1.57 108.903 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -105.4 152.89 22.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.098 -0.501 . . . . 0.37 109.813 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.7 p -151.2 120.76 6.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.246 -0.433 . . . . 0.57 110.362 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.89 144.32 49.83 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.763 -0.829 . . . . 0.3 108.763 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m -113.89 140.18 48.58 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.084 -0.339 . . . . 1.26 110.084 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.506 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -141.85 118.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 108.247 -1.019 . . . . 0.72 108.247 176.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.5 ttm -95.25 108.77 20.93 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.241 -0.583 . . . . 1.25 109.493 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 113.59 25.68 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.287 -0.87 . . . . 0.58 108.759 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.68 101.06 13.29 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.338 -1.356 . . . . 0.84 107.338 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -65.54 -71.76 0.18 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.073 -1.421 . . . . 3.86 111.39 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 68.3 mtt -158.74 -178.82 7.53 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.954 -1.869 . . . . 4.72 105.954 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.14 141.13 50.76 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.916 -0.772 . . . . 5.33 108.916 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 10.6 t30 -95.22 117.08 66.81 Favored Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 109.126 -0.694 . . . . 5.34 109.126 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 31.9 Cg_exo -59.25 142.39 99.11 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.861 2.374 . . . . 5.07 112.296 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 76.0 t80 . . . . . 0 C--O 1.245 0.845 0 C-N-CA 124.873 1.269 . . . . 9.52 110.097 -178.266 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 108.75 -0.833 . . . . 7.93 108.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 5' ' ' ASP . 3.7 m-20 68.89 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.592 1.157 . . . . 6.17 113.069 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -85.25 -28.18 25.54 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.341 -0.845 . . . . 5.43 109.197 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -89.58 5.4 45.8 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 122.125 0.964 . . . . 3.87 110.23 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 2' ' ' ASP . 24.1 t70 -66.35 -27.49 67.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.838 -0.619 . . . . 2.55 111.309 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 12.9 m -79.47 98.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.509 1.147 . . . . 2.08 109.065 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m -111.23 98.96 7.88 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.884 -1.053 . . . . 1.58 110.783 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.468 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 98.8 m-85 -98.84 134.02 42.31 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.997 -0.547 . . . . 1.19 109.83 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.3 m -84.09 176.33 8.89 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.52 -0.918 . . . . 1.32 108.52 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.8 130.49 39.8 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.487 -0.485 . . . . 0.45 110.57 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.475 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 5.7 m -126.98 144.4 51.03 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.674 -1.602 . . . . 1.19 106.674 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 94' ' ' ALA . 61.9 t -127.79 116.47 43.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.29 111.673 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -110.31 126.4 54.17 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.229 -0.656 . . . . 2.18 109.229 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD13 HG22 ' A' ' 98' ' ' ILE . 28.6 mt -111.78 156.32 22.14 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.225 -0.657 . . . . 0.33 109.225 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -131.57 145.76 51.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.053 -0.721 . . . . 1.03 109.053 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -52.98 133.54 38.23 Favored 'General case' 0 C--O 1.249 1.038 0 O-C-N 124.914 1.384 . . . . 0.49 110.075 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.22 141.53 58.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.214 -0.903 . . . . 0.4 110.004 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.21 130.75 39.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 120.508 -0.477 . . . . 0.57 110.907 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.01 96.46 2.15 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.946 -1.024 . . . . 2.52 112.845 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -167.13 150.73 6.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.848 -1.908 . . . . 0.88 105.848 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -52.33 -30.85 30.53 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.726 1.266 . . . . 2.75 114.068 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -98.73 100.65 11.89 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.212 -1.774 . . . . 2.46 106.212 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -80.63 141.05 35.35 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.547 0.689 . . . . 0.86 111.672 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.0 t -135.59 124.54 24.17 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.669 -1.15 . . . . 0.3 109.614 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.2 mt -111.02 99.39 42.74 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 107.556 -1.275 . . . . 0.3 107.556 174.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.86 135.76 24.03 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.411 2.074 . . . . 0.28 111.647 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.34 157.17 40.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.808 0.337 . . . . 0.37 110.305 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -142.85 106.74 4.68 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.571 0.701 . . . . 0.88 109.37 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -113.82 131.61 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 115.486 -0.779 . . . . 0.27 109.028 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.2 p30 -122.62 150.74 42.25 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.591 -0.444 . . . . 1.39 111.142 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.17 169.84 30.3 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 108.697 -1.761 . . . . 0.6 108.697 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 6' ' ' VAL . 21.8 tm0? -93.99 -56.87 0.22 Allowed Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 118.491 1.145 . . . . 2.61 108.52 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.7 Cg_endo -70.4 121.55 8.1 Favored 'Trans proline' 0 C--N 1.368 1.562 0 N-CA-C 107.681 -1.7 . . . . 0.78 107.681 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.63 114.34 9.98 Favored Pre-proline 0 C--N 1.32 -0.69 0 O-C-N 123.546 0.529 . . . . 0.78 109.941 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 90.4 Cg_endo -77.22 141.53 20.67 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.203 1.935 . . . . 0.56 111.923 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -71.5 110.95 6.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.807 -0.633 . . . . 1.37 109.609 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.7 130.8 34.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.648 -0.705 . . . . 0.5 111.082 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -138.28 136.79 36.84 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.849 -0.797 . . . . 3.78 108.849 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -100.49 118.77 37.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.097 0.475 . . . . 0.29 109.921 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.01 126.14 50.91 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 105.376 -2.083 . . . . 0.95 105.376 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -109.92 98.8 8.03 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-O 121.082 0.467 . . . . 0.88 110.276 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 60.17 25.53 14.89 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.872 1.269 . . . . 1.79 111.221 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.54 -15.17 32.39 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.825 -0.702 . . . . 0.61 113.387 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.1 t -109.52 142.44 40.56 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.667 -0.864 . . . . 1.37 108.667 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.4 t -67.12 122.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.517 -0.549 . . . . 0.7 109.517 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.4 tp -77.09 121.4 23.52 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.717 -0.846 . . . . 0.61 108.717 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -93.49 124.11 37.26 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.166 -1.05 . . . . 2.47 108.166 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 129.54 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.701 -0.481 . . . . 1.74 109.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.2 p -120.77 -166.96 1.4 Allowed 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.883 -0.598 . . . . 1.57 111.035 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.0 m -81.82 -12.83 58.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.923 -0.769 . . . . 1.52 108.923 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -103.29 -40.77 6.27 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.949 -0.568 . . . . 1.59 110.938 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG23 ' HG ' ' A' ' 72' ' ' LEU . 35.3 mt -113.59 106.79 21.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 106.959 -1.497 . . . . 0.5 106.959 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -139.04 143.52 38.43 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.086 0.47 . . . . 2.89 112.194 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.3 m -84.97 113.05 21.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.982 -0.554 . . . . 0.44 109.822 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 14.8 mm-40 -87.49 136.67 32.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.076 -0.511 . . . . 2.04 109.635 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.59 144.0 49.39 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.992 -0.744 . . . . 0.87 108.992 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.45 166.85 15.28 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.087 -0.709 . . . . 1.25 109.087 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -47.54 124.79 9.7 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 114.234 1.198 . . . . 3.36 114.234 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.81 128.42 2.4 Favored 'Trans proline' 0 N--CA 1.431 -2.152 0 C-N-CA 121.714 1.609 . . . . 1.39 108.927 169.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.071 -1.085 . . . . 1.53 108.071 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.95 -14.22 61.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.497 0.665 . . . . 1.91 110.284 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -76.11 -14.82 60.18 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.56 -1.2 . . . . 3.49 110.056 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.21 161.04 21.03 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.464 -0.939 . . . . 1.89 108.464 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' ASP . 3.3 p -112.12 8.13 19.89 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.514 -0.921 . . . . 1.3 108.514 172.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 30' ' ' ASP . 38.1 t -95.96 129.72 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 114.511 -1.222 . . . . 0.61 110.366 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 29' ' ' VAL . 77.4 mtp180 -89.68 140.4 29.61 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.309 -2.108 . . . . 1.84 105.309 174.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -115.87 133.18 56.29 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.015 -0.735 . . . . 1.16 109.015 -172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.17 179.83 44.33 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 119.439 -1.363 . . . . 0.31 113.461 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.29 136.71 15.83 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 123.652 0.781 . . . . 0.36 110.285 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 tp -84.88 110.63 18.99 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.682 -1.599 . . . . 0.28 106.682 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 80.3 mtt180 -102.06 132.99 47.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.967 0.413 . . . . 2.68 111.813 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -112.51 109.55 19.19 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 107.453 -1.314 . . . . 1.23 107.453 172.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -59.09 -37.7 77.75 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.218 -1.356 . . . . 2.18 110.851 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -128.27 135.22 27.21 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 107.929 -1.137 . . . . 2.82 107.929 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -74.26 130.25 13.89 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 121.473 1.449 . . . . 1.25 109.672 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -115.19 139.97 49.48 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.355 -0.609 . . . . 1.22 109.355 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' MET . 5.4 p80 -75.61 -14.48 60.38 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 112.233 0.457 . . . . 2.03 112.233 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.56 -10.53 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 119.68 -0.808 . . . . 1.33 113.088 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.263 20.2 m-80 -92.19 26.95 2.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 116.17 1.915 . . . . 2.19 116.17 -171.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 103' ' ' MET . 87.3 m-20 -80.87 74.25 7.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.998 -0.741 . . . . 1.96 108.998 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.09 -174.9 15.03 Favored Glycine 0 N--CA 1.429 -1.815 0 C-N-CA 120.134 -1.032 . . . . 0.49 112.42 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -93.97 112.04 23.83 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.525 -0.337 . . . . 2.23 110.997 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -86.52 108.09 18.4 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.414 -0.958 . . . . 0.69 108.414 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.5 m -102.16 117.99 35.95 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.725 -0.842 . . . . 0.34 108.725 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.8 tp -94.73 118.91 32.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.712 -0.848 . . . . 0.22 108.712 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.0 134.5 46.34 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.917 . . . . 0.36 108.523 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -134.85 120.98 19.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.552 -0.907 . . . . 0.31 108.552 176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.38 135.34 49.41 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 123.218 0.324 . . . . 0.61 110.4 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 40.7 p30 -143.91 169.74 9.75 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-O 117.432 -1.27 . . . . 1.18 107.663 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 24.4 Cg_exo -42.77 -30.99 1.92 Allowed 'Trans proline' 0 CA--C 1.552 1.407 0 C-N-CA 123.317 2.678 . . . . 1.0 115.966 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.0 t -74.97 -47.46 29.23 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 120.33 -0.548 . . . . 1.1 111.649 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -178.2 -164.45 31.36 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.825 -1.178 . . . . 0.59 112.48 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.96 129.31 43.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.093 0.473 . . . . 1.57 109.796 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -115.6 159.33 21.44 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.424 -0.954 . . . . 0.37 108.424 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 30.8 p -155.93 153.21 29.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.977 -0.556 . . . . 0.57 110.328 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 158.71 43.52 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.713 -1.588 . . . . 0.3 106.713 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 m -133.72 127.12 32.17 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 120.944 0.402 . . . . 1.26 110.615 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.524 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -129.67 118.49 45.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.697 -1.223 . . . . 0.72 107.697 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.0 ttm -96.75 114.79 26.46 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.933 -0.707 . . . . 1.25 109.659 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.73 29.72 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.331 -0.618 . . . . 0.58 109.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.83 123.03 36.4 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 108.667 -0.864 . . . . 0.84 108.667 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -156.99 73.95 0.77 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 122.003 0.906 . . . . 3.86 110.873 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.513 ' HB3' HD21 ' A' ' 80' ' ' ASN . 23.7 ptt? -100.32 96.71 7.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.898 1.332 . . . . 4.72 111.253 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -97.44 126.13 42.51 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.629 -1.623 . . . . 5.33 107.893 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -98.36 114.47 65.28 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 108.742 -0.836 . . . . 5.34 108.742 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.69 134.89 67.35 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 122.889 2.393 . . . . 5.07 111.229 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 C--O 1.241 0.63 0 C-N-CA 124.993 1.317 . . . . 9.52 110.92 -177.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.497 -1.087 0 N-CA-C 108.787 -0.819 . . . . 7.93 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -127.49 -49.82 1.4 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 120.744 0.307 . . . . 6.17 111.462 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.86 -40.76 79.13 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.331 0.586 . . . . 5.43 110.414 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.35 127.72 9.94 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.068 -1.456 . . . . 3.87 107.068 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.87 -28.59 7.34 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.399 -0.52 . . . . 2.55 110.466 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.61 96.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 CA-C-O 122.611 1.196 . . . . 2.08 108.902 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -93.64 96.83 10.07 Favored 'General case' 0 N--CA 1.388 -3.567 0 N-CA-C 106.192 -1.781 . . . . 1.58 106.192 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.502 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 46.6 m-85 -74.31 142.78 45.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.95 -1.023 . . . . 1.19 110.341 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.28 173.42 11.61 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.42 -1.326 . . . . 1.32 107.42 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.24 116.06 28.65 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-O 121.234 0.54 . . . . 0.45 110.192 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 t -117.02 132.03 56.8 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 107.283 -1.377 . . . . 1.19 107.283 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 48.5 t -115.86 115.77 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 110.242 -0.281 . . . . 0.29 110.242 -173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -112.31 117.9 33.78 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.597 -0.52 . . . . 2.18 109.597 175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD13 HG22 ' A' ' 98' ' ' ILE . 31.2 mt -100.41 151.53 21.41 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 108.654 -0.869 . . . . 0.33 108.654 173.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -131.24 146.13 52.19 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.238 -1.393 . . . . 1.03 107.238 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.47 132.68 54.22 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 124.087 0.867 . . . . 0.49 110.498 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.88 139.51 39.94 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 124.596 1.185 . . . . 0.4 111.165 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -91.92 131.21 39.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.961 -0.563 . . . . 0.57 110.076 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.08 120.4 21.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.268 -0.878 . . . . 2.52 111.053 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -169.7 -169.84 0.96 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.185 -1.413 . . . . 0.88 107.185 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -72.88 -39.26 66.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 119.286 0.948 . . . . 2.75 111.968 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -104.89 121.45 43.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.518 -1.66 . . . . 2.46 106.518 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -82.06 129.48 34.81 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.188 0.518 . . . . 0.86 110.988 -173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -121.11 118.59 30.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.076 -0.966 . . . . 0.3 110.013 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 17' ' ' ALA . 62.7 mt -101.38 102.23 20.56 Favored Pre-proline 0 C--O 1.244 0.775 0 N-CA-C 107.476 -1.305 . . . . 0.3 107.476 173.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.89 138.15 18.35 Favored 'Trans proline' 0 C--O 1.249 1.027 0 C-N-CA 122.459 2.106 . . . . 0.28 111.976 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.28 149.01 51.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.323 0.582 . . . . 0.37 110.677 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 m -133.28 106.66 7.67 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.973 -1.121 . . . . 0.88 107.973 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG13 ' HB3' ' A' ' 66' ' ' ARG . 3.6 p -110.93 119.33 59.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 120.933 0.397 . . . . 0.27 109.953 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -101.59 140.54 35.74 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.838 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.1 134.84 1.74 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 108.79 -1.724 . . . . 0.6 108.79 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.502 ' H ' ' HB2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -71.73 -57.23 4.31 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 106.846 -1.539 . . . . 2.61 106.846 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.51 120.45 7.75 Favored 'Trans proline' 0 C--N 1.373 1.829 0 N-CA-C 108.316 -1.455 . . . . 0.78 108.316 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.4 119.73 59.06 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.407 -0.815 . . . . 0.78 110.947 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.04 149.46 9.46 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 122.344 2.029 . . . . 0.56 112.992 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.3 t -80.97 132.41 35.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.858 -1.534 . . . . 1.37 106.858 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 82.2 mt -103.2 148.24 26.03 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.065 0.46 . . . . 0.5 111.19 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 1.6 tpm_? -141.72 141.4 33.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.174 -0.676 . . . . 3.78 109.174 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -106.91 125.59 51.21 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-O 121.158 0.504 . . . . 0.29 109.952 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 22.4 tp -121.97 128.92 52.04 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 107.227 -1.398 . . . . 0.95 107.227 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -118.4 106.56 12.85 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.17 -0.678 . . . . 0.88 109.17 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.06 31.77 20.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.121 0.969 . . . . 1.79 111.446 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.93 85.49 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.853 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -107.43 150.53 26.66 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.008 -0.738 . . . . 1.37 109.008 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.3 120.29 24.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 116.373 -0.376 . . . . 0.7 110.756 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.9 tp -87.23 128.88 35.15 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.82 -1.178 . . . . 0.61 107.82 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -104.09 123.96 48.21 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 110.221 -0.289 . . . . 2.47 110.221 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.94 120.96 19.28 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.996 -1.113 . . . . 1.74 107.996 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -136.89 -163.94 1.5 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.889 -0.596 . . . . 1.57 110.117 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 t -58.86 -44.8 91.11 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.505 1.122 . . . . 1.52 111.98 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 74' ' ' GLN . 72.4 m-85 -92.26 -23.1 19.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.874 0.694 . . . . 1.59 112.874 -174.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.405 HG23 ' HG ' ' A' ' 72' ' ' LEU . 45.7 mt -124.74 106.3 16.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.974 -1.491 . . . . 0.5 106.974 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -132.9 148.31 52.29 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.309 0.485 . . . . 2.89 112.309 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 m -101.22 116.96 34.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.442 -0.947 . . . . 0.44 108.442 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 71' ' ' ARG . 42.4 mt-10 -96.21 119.85 35.44 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.458 -0.497 . . . . 2.04 110.513 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -103.38 112.74 25.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.581 -0.736 . . . . 0.87 109.409 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.46 165.57 18.01 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.723 -0.843 . . . . 1.25 108.723 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.4 115.84 43.19 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.945 -0.761 . . . . 3.36 108.945 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.26 134.32 28.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.794 1.663 . . . . 1.39 110.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 124.33 23.09 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.712 -1.218 . . . . 1.53 107.712 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -23.52 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.256 1.022 . . . . 1.91 113.453 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -77.99 -24.99 47.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.828 0.347 . . . . 3.49 111.213 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -96.48 152.25 18.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.227 -1.027 . . . . 1.89 108.227 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 p -108.44 16.1 23.35 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.977 0.894 . . . . 1.3 109.399 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 t -109.52 127.22 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.735 -1.121 . . . . 0.61 109.86 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.608 ' HB3' HG13 ' A' ' 29' ' ' VAL . 21.5 ttm180 -89.59 118.01 28.9 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.165 -1.42 . . . . 1.84 107.165 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -103.85 152.29 22.09 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.426 -0.953 . . . . 1.16 108.426 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.67 -178.72 48.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.661 -1.376 . . . . 0.31 109.661 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 35.4 t -146.16 142.34 28.37 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 120.939 0.4 . . . . 0.36 111.297 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -92.25 100.99 13.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.936 -1.876 . . . . 0.28 105.936 171.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.667 ' HD2' ' OE2' ' A' ' 55' ' ' GLU . 70.8 mtt85 -99.83 131.7 45.64 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.563 0.697 . . . . 2.68 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 52' ' ' ILE . 3.6 mp -111.0 109.66 19.88 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 107.749 -1.204 . . . . 1.23 107.749 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -65.63 -45.35 83.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.775 -1.102 . . . . 2.18 108.539 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 12.9 mm-40 -130.16 100.85 18.29 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 114.969 -1.014 . . . . 2.82 109.18 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.16 154.25 12.71 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.07 1.847 . . . . 1.25 108.352 173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 78' ' ' VAL . 21.5 p -125.38 -177.85 4.02 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 118.862 -0.589 . . . . 1.22 109.769 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 105' ' ' ASN . 13.1 p80 -67.0 -18.18 65.26 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.32 0.963 . . . . 2.03 110.812 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG22 ' OG1' ' A' ' 76' ' ' THR . 13.0 m -72.77 -10.89 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.791 -0.641 . . . . 1.33 109.913 -177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -96.58 26.1 4.68 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 113.223 0.823 . . . . 2.19 113.223 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -113.6 98.27 6.95 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.46 -0.941 . . . . 1.96 108.46 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.1 -161.95 29.18 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 120.392 -0.909 . . . . 0.49 112.247 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.84 116.78 23.49 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 110.418 -0.216 . . . . 2.23 110.418 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' SER . 53.6 m-85 -97.1 105.73 17.93 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.239 -0.652 . . . . 0.69 109.239 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 90.1 m -101.76 124.8 48.0 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.587 -0.733 . . . . 0.34 110.365 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -106.56 123.72 48.53 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.655 -0.869 . . . . 0.22 108.655 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 1.9 mm? -105.48 141.98 36.02 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.997 -1.112 . . . . 0.36 107.997 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -135.54 121.24 19.58 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.024 -0.732 . . . . 0.31 109.024 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.47 124.14 42.91 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.309 0.485 . . . . 0.61 112.309 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -138.65 177.04 2.25 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 116.87 -1.538 . . . . 1.18 107.366 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 18.3 Cg_exo -42.64 -26.25 0.6 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.53 2.82 . . . . 1.0 116.271 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.63 -34.54 58.32 Favored 'General case' 0 C--N 1.317 -0.82 0 O-C-N 121.865 -0.522 . . . . 1.1 110.998 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.25 -167.26 29.02 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.951 -0.86 . . . . 0.59 110.951 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 61.8 tt0 -115.36 127.34 55.33 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 122.939 0.496 . . . . 1.57 110.265 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.81 161.77 13.47 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.182 -0.673 . . . . 0.37 109.182 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.7 p -143.69 136.72 27.61 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.602 -0.518 . . . . 0.57 109.602 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -136.6 155.03 50.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.954 -1.498 . . . . 0.3 106.954 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 46.0 m -140.07 126.8 20.52 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.09 0.471 . . . . 1.26 111.452 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -112.42 130.71 65.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 107.532 -1.284 . . . . 0.72 107.532 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 tpt -90.5 106.57 18.59 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 109.633 -0.506 . . . . 1.25 109.633 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.93 132.72 55.61 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.341 0.591 . . . . 0.58 110.686 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.17 119.7 19.16 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.023 -1.473 . . . . 0.84 107.023 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -99.29 -84.05 0.41 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.384 -0.526 . . . . 3.86 112.315 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.6 ptp -104.21 160.76 14.6 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.265 -0.272 . . . . 4.72 110.265 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -57.76 131.73 51.2 Favored 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 124.344 1.027 . . . . 5.33 112.638 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 77' ' ' HIS . 7.1 p30 -112.24 136.08 21.37 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 108.946 -0.761 . . . . 5.34 108.946 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 12.0 Cg_exo -71.39 178.6 5.38 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.68 2.253 . . . . 5.07 111.013 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.6 t80 . . . . . 0 C--O 1.252 1.208 0 C-N-CA 124.419 1.087 . . . . 9.52 108.326 -176.573 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.205 -0.665 . . . . 7.93 109.205 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -86.53 24.38 1.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.67 0.788 . . . . 6.17 109.936 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -94.63 -12.21 27.83 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.081 -0.963 . . . . 5.43 109.999 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.497 ' OD2' HG22 ' A' ' 6' ' ' VAL . 11.1 t70 -106.2 140.25 39.45 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.441 -0.948 . . . . 3.87 108.441 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.23 -34.9 78.66 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 124.964 1.305 . . . . 2.55 114.262 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG22 ' OD2' ' A' ' 4' ' ' ASP . 18.0 m -79.99 103.77 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-O 122.59 1.186 . . . . 2.08 113.602 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.6 t -108.15 97.88 7.51 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 114.69 -1.141 . . . . 1.58 108.403 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 92.9 m-85 -92.88 130.65 38.41 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.074 -0.713 . . . . 1.19 109.074 174.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -84.64 167.26 16.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.79 -1.096 . . . . 1.32 109.045 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.45 127.16 40.19 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 120.75 0.31 . . . . 0.45 111.436 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 m -120.74 135.88 55.02 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.834 -1.913 . . . . 1.19 105.834 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 85' ' ' LEU . 96.0 t -115.22 114.71 47.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 120.927 0.394 . . . . 0.29 110.342 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -116.98 123.71 47.6 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.505 -0.924 . . . . 2.18 108.505 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD13 HG22 ' A' ' 98' ' ' ILE . 72.9 mt -104.05 155.95 18.26 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.887 -0.412 . . . . 0.33 109.887 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -132.08 142.95 49.7 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.018 -0.734 . . . . 1.03 109.018 -175.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 m -53.82 135.89 41.11 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 125.119 1.368 . . . . 0.49 110.858 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.87 57.2 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.4 110.789 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -91.33 139.07 18.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-O 121.223 0.535 . . . . 0.57 109.776 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.71 113.34 23.29 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.079 -0.964 . . . . 2.52 111.829 -171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -170.3 -177.65 2.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.191 -2.151 . . . . 0.88 105.191 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -66.72 -38.45 86.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 120.193 1.361 . . . . 2.75 113.755 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -94.29 115.74 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.465 -0.939 . . . . 2.46 108.465 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 72' ' ' LEU . 94.0 m95 -82.1 117.52 22.34 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.594 0.711 . . . . 0.86 109.932 -176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.5 t -110.84 122.54 48.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.3 109.305 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 70' ' ' LEU . 66.3 mt -106.95 101.71 38.94 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.383 -0.969 . . . . 0.3 108.383 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.59 132.15 15.65 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.416 2.077 . . . . 0.28 111.918 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -122.71 155.34 36.67 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.117 0.484 . . . . 0.37 110.326 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -136.81 107.7 6.66 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 115.862 -0.608 . . . . 0.88 109.428 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.6 p -119.82 121.49 66.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.827 -0.805 . . . . 0.27 108.827 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.6 p-10 -104.91 161.19 14.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.644 -0.822 . . . . 1.39 110.797 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.77 177.94 24.28 Favored Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 110.396 -1.082 . . . . 0.6 110.396 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HA ' ' NE2' ' A' ' 32' ' ' GLN 0.303 17.2 mm-40 -109.85 -54.82 0.05 OUTLIER Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.626 0.602 . . . . 2.61 112.626 175.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -68.93 119.17 6.18 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 N-CA-C 105.819 -2.416 . . . . 0.78 105.819 168.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 109.4 2.47 Favored Pre-proline 0 C--N 1.32 -0.695 0 O-C-N 123.826 0.704 . . . . 0.78 110.727 -174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.9 Cg_endo -72.46 135.03 23.58 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.642 1.561 . . . . 0.56 111.15 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 p -65.0 108.71 1.89 Allowed 'General case' 0 N--CA 1.433 -1.318 0 O-C-N 123.865 0.728 . . . . 1.37 109.98 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 29' ' ' VAL . 87.8 mt -85.57 126.25 33.73 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.288 -0.869 . . . . 0.5 110.128 -176.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -136.77 127.2 26.68 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.049 -0.523 . . . . 3.78 109.726 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 85.3 m95 -90.77 134.58 34.32 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.623 -0.717 . . . . 0.29 109.756 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 tp -113.7 126.86 55.71 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 105.447 -2.057 . . . . 0.95 105.447 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -119.8 103.5 9.41 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 109.45 -0.574 . . . . 0.88 109.45 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 61.39 32.88 19.0 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.208 -0.906 . . . . 1.79 110.783 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.97 -14.48 64.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.081 -0.581 . . . . 0.61 112.807 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 m -98.88 138.63 35.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.223 -0.658 . . . . 1.37 109.223 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -70.07 123.79 24.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.941 -0.572 . . . . 0.7 110.395 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 62.2 tp -80.04 120.38 24.13 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.237 -1.023 . . . . 0.61 108.237 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.79 127.62 45.93 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.833 -1.914 . . . . 2.47 105.833 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -57.79 126.73 28.67 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.705 0.628 . . . . 1.74 109.89 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.5 p -128.63 173.77 10.0 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.74 -0.837 . . . . 1.57 108.74 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -77.1 -1.29 28.38 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.738 0.78 . . . . 1.52 110.36 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -105.19 -40.68 5.78 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.305 -0.861 . . . . 1.59 109.002 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.6 mt -128.58 109.22 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 107.835 -1.172 . . . . 0.5 107.835 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -143.81 147.07 33.6 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.464 0.65 . . . . 2.89 111.446 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -77.49 109.73 11.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.74 -1.118 . . . . 0.44 108.983 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -104.56 108.8 20.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.526 -1.287 . . . . 2.04 107.526 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.02 147.54 24.94 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.937 0.398 . . . . 0.87 111.513 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -117.81 165.55 13.52 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.428 -1.323 . . . . 1.25 107.428 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -81.58 126.36 76.16 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 113.638 0.977 . . . . 3.36 113.638 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.92 140.4 16.08 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.7 2.267 . . . . 1.39 111.124 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.15 161.15 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.029 -1.1 . . . . 1.53 108.029 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.39 -15.29 63.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.997 0.74 . . . . 1.91 112.997 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.54 -7.73 49.49 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.381 -0.6 . . . . 3.49 109.381 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.2 134.27 46.89 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.718 -0.475 . . . . 1.89 109.718 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -106.1 20.68 18.57 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.851 -1.537 . . . . 1.3 106.851 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 21.9 t -112.88 132.57 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 114.466 -1.243 . . . . 0.61 110.402 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.543 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.1 mtp180 -84.11 122.86 29.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.985 -1.857 . . . . 1.84 105.985 175.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -108.56 139.09 43.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 110.049 -0.352 . . . . 1.16 110.049 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.81 176.21 41.3 Favored Glycine 0 N--CA 1.412 -2.937 0 N-CA-C 110.707 -0.957 . . . . 0.31 110.707 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 t -138.36 132.66 31.85 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 109.671 -0.492 . . . . 0.36 109.671 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 53.3 tp -80.26 105.15 11.3 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 104.593 -2.373 . . . . 0.28 104.593 170.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -99.57 116.16 31.06 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.885 -0.598 . . . . 2.68 110.521 -171.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 23' ' ' TRP . 53.9 mt -83.23 107.54 15.84 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 106.651 -1.611 . . . . 1.23 106.651 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -72.85 -49.43 30.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.329 -1.305 . . . . 2.18 109.912 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -122.2 101.46 41.27 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 107.004 -1.48 . . . . 2.82 107.004 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.46 129.87 29.72 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 121.989 1.793 . . . . 1.25 110.593 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -129.63 157.08 43.08 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.257 -0.883 . . . . 1.22 108.665 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.38 -5.09 17.03 Favored 'General case' 0 C--O 1.208 -1.084 0 N-CA-C 113.639 0.978 . . . . 2.03 113.639 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.4 m -82.91 -10.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.406 0.146 . . . . 1.33 110.943 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -78.03 26.87 0.19 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.396 1.258 . . . . 2.19 114.396 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.9 p30 -113.62 123.56 50.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.069 -1.086 . . . . 1.96 108.069 175.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -170.81 33.0 Favored Glycine 0 C--N 1.289 -2.072 0 C-N-CA 119.458 -1.353 . . . . 0.49 111.745 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.05 104.91 16.98 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.616 0.245 . . . . 2.23 110.697 -175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -85.95 110.78 19.69 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.549 -0.908 . . . . 0.69 108.549 176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' TRP . 24.5 m -102.11 133.24 47.26 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.527 -0.546 . . . . 0.34 109.527 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 95' ' ' SER . 47.5 tp -107.99 115.47 30.19 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.828 -0.434 . . . . 0.22 109.828 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 131.65 45.83 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.088 -1.079 . . . . 0.36 108.088 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -130.23 124.06 31.61 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 132.3 53.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.967 -0.293 . . . . 0.61 111.236 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 35.0 p30 -149.89 176.91 2.03 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.775 -1.565 . . . . 1.18 106.775 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 40.7 Cg_exo -45.19 -30.31 4.98 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.197 2.598 . . . . 1.0 115.803 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.14 -21.16 59.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.538 0.57 . . . . 1.1 112.538 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -161.14 23.57 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 119.988 -1.101 . . . . 0.59 112.383 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -100.31 133.78 44.22 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.196 0.598 . . . . 1.57 111.173 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.45 42.77 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.625 -1.621 . . . . 0.37 106.625 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 49.7 p -162.06 141.38 9.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.208 0.528 . . . . 0.57 111.751 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.78 164.65 32.12 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.282 -1.747 . . . . 0.3 106.282 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.7 p -135.42 139.97 44.55 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.454 -0.499 . . . . 1.26 111.152 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.586 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.13 127.22 70.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.559 -1.274 . . . . 0.72 107.559 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.0 ttt -100.71 128.4 46.77 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.808 -0.757 . . . . 1.25 110.248 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -117.88 135.93 53.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.083 -1.451 . . . . 0.58 107.083 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.44 100.95 9.44 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.26 0.552 . . . . 0.84 110.666 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -130.65 82.72 2.07 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 121.939 0.876 . . . . 3.86 108.782 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.84 95.64 5.94 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.08 0.943 . . . . 4.72 109.003 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.17 152.84 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.627 -1.169 . . . . 5.33 108.983 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -107.07 99.93 29.49 Favored Pre-proline 0 C--N 1.294 -1.817 0 N-CA-C 108.195 -1.039 . . . . 5.34 108.195 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.36 124.24 11.05 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.778 2.319 . . . . 5.07 112.145 -175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 C--O 1.239 0.538 0 C-N-CA 124.723 1.209 . . . . 9.52 110.817 177.273 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.241 -0.281 . . . . 7.93 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -135.29 -51.13 0.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.988 0.423 . . . . 6.17 111.224 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.91 -31.37 71.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.762 0.792 . . . . 5.43 111.226 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.583 ' HA ' HE22 ' A' ' 32' ' ' GLN . 16.8 p-10 -84.1 1.78 42.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.465 -0.789 . . . . 3.87 112.393 -176.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.87 -44.76 69.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.38 0.61 . . . . 2.55 109.802 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -82.0 98.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 122.276 1.036 . . . . 2.08 110.075 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 t -86.83 99.89 12.14 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-N 114.73 -1.123 . . . . 1.58 108.674 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.533 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 19.3 m-85 -78.56 124.73 28.46 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.085 -1.82 . . . . 1.19 106.085 174.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.9 m -83.54 -171.34 3.53 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.082 -0.71 . . . . 1.32 109.082 -175.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -92.68 119.67 32.32 Favored 'General case' 0 CA--C 1.481 -1.678 0 C-N-CA 119.093 -1.043 . . . . 0.45 109.746 -172.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 15.5 m -118.14 128.74 55.02 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.069 -1.086 . . . . 1.19 108.069 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.92 119.53 62.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 116.546 -0.297 . . . . 0.29 110.261 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -113.62 116.85 30.13 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.255 -0.646 . . . . 2.18 109.255 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 98' ' ' ILE . 37.1 mt -104.46 146.56 28.68 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.156 -0.475 . . . . 0.33 109.769 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -131.25 145.85 52.07 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.612 -0.884 . . . . 1.03 108.612 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 m -56.3 132.95 52.25 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 124.589 1.181 . . . . 0.49 111.674 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -57.71 140.57 51.04 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 114.814 -1.085 . . . . 0.4 110.949 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.9 131.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.668 -0.493 . . . . 0.57 109.668 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.464 ' HG2' ' CZ3' ' A' ' 23' ' ' TRP . 43.1 mt-10 -84.78 104.04 14.4 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.703 -0.681 . . . . 2.52 111.904 -175.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -155.3 -168.51 2.87 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.497 -1.668 . . . . 0.88 106.497 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -68.5 -40.29 80.91 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.292 0.951 . . . . 2.75 111.124 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -97.89 113.86 25.8 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.21 -1.404 . . . . 2.46 107.21 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CZ3' ' HG2' ' A' ' 19' ' ' GLU . 54.6 m95 -81.45 124.6 29.58 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.227 -0.657 . . . . 0.86 109.227 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.82 124.73 42.73 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.639 -0.71 . . . . 0.3 110.72 -174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.556 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.7 mt -106.68 103.15 45.46 Favored Pre-proline 0 C--O 1.242 0.676 0 N-CA-C 108.365 -0.976 . . . . 0.3 108.365 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.79 131.24 14.33 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.608 2.205 . . . . 0.28 111.789 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' HB3' HD23 ' A' ' 14' ' ' LEU . 47.9 p90 -135.66 155.05 51.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.107 0.48 . . . . 0.37 110.289 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.0 m -142.45 114.98 8.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.653 0.739 . . . . 0.88 109.536 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -112.78 125.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.821 -1.081 . . . . 0.27 108.502 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -121.16 151.06 40.35 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.717 -0.793 . . . . 1.39 110.338 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.21 138.73 2.59 Favored Glycine 0 N--CA 1.42 -2.431 0 N-CA-C 108.274 -1.93 . . . . 0.6 108.274 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.583 HE22 ' HA ' ' A' ' 4' ' ' ASP . 24.0 tt0 -79.91 -50.97 1.17 Allowed Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.776 -0.77 . . . . 2.61 109.936 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.7 Cg_exo -61.72 120.0 7.41 Favored 'Trans proline' 0 C--N 1.375 1.923 0 N-CA-C 106.273 -2.241 . . . . 0.78 106.273 162.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB1' ' NH2' ' A' ' 66' ' ' ARG . . . -65.43 116.29 29.75 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.349 -0.841 . . . . 0.78 111.114 -174.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -87.21 159.56 8.41 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 121.928 1.752 . . . . 0.56 112.703 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 p -102.11 131.84 48.35 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.249 -1.019 . . . . 1.37 108.249 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 80.4 mt -97.97 154.05 17.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.788 0.327 . . . . 0.5 110.999 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -155.07 135.64 13.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.798 -0.816 . . . . 3.78 108.798 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.4 m95 -96.82 121.9 39.19 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.754 -0.461 . . . . 0.29 109.754 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.7 tp -109.88 127.47 54.74 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 106.791 -1.559 . . . . 0.95 106.791 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -118.29 98.98 6.56 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 109.625 -0.509 . . . . 0.88 109.625 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.7 m120 48.86 43.41 21.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.752 1.221 . . . . 1.79 113.284 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.38 -14.9 61.87 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.53 -0.843 . . . . 0.61 113.742 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 t -107.54 144.85 33.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.004 -1.11 . . . . 1.37 108.004 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -78.86 129.15 37.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.573 -0.899 . . . . 0.7 108.573 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 50.4 tp -80.66 120.02 24.03 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.992 -0.744 . . . . 0.61 108.992 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -95.57 126.05 40.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.031 -0.729 . . . . 2.47 109.031 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -58.72 122.63 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.968 0.793 . . . . 1.74 109.292 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.6 p -124.73 -172.03 2.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 109.85 -0.426 . . . . 1.57 109.85 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.9 t -74.95 -30.69 61.3 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.393 -0.965 . . . . 1.52 108.393 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 43.1 m-85 -82.98 -41.49 18.69 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.302 -0.863 . . . . 1.59 110.362 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.467 HG23 ' HG ' ' A' ' 72' ' ' LEU . 33.7 mt -124.94 106.9 17.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.287 -1.005 . . . . 0.5 108.287 -176.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -146.04 156.13 43.26 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 118.255 0.48 . . . . 2.89 110.413 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.9 m -92.27 121.41 33.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.629 -0.714 . . . . 0.44 110.792 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.0 134.05 40.88 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.301 -1.37 . . . . 2.04 107.301 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -118.78 144.27 46.4 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.84 0.352 . . . . 0.87 111.648 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.94 165.68 11.16 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 105.341 -2.096 . . . . 1.25 105.341 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.58 128.11 28.11 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 113.399 0.889 . . . . 3.36 113.399 -172.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 159.78 27.23 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 123.185 2.59 . . . . 1.39 110.494 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.51 176.16 6.65 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.124 -0.695 . . . . 1.53 109.124 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.24 -38.86 77.71 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.59 0.589 . . . . 1.91 112.59 -173.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -95.74 19.2 11.62 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.14 0.495 . . . . 3.49 112.067 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -111.21 113.08 25.32 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.407 -1.331 . . . . 1.89 107.407 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.3 p -93.76 2.62 56.2 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.8 0.81 . . . . 1.3 108.961 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.41 127.03 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 114.677 -1.147 . . . . 0.61 109.473 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' NH2' ' HB1' ' A' ' 34' ' ' ALA . 48.1 mtt180 -103.53 139.31 39.03 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.755 -1.572 . . . . 1.84 106.755 176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.9 145.41 49.84 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.896 -1.149 . . . . 1.16 107.896 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.49 -167.98 33.97 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 120.032 -1.08 . . . . 0.31 111.447 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 10.0 t -150.81 132.34 14.77 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 122.069 0.148 . . . . 0.36 110.969 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 60.0 tp -84.36 112.32 20.23 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 104.606 -2.368 . . . . 0.28 104.606 169.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 23' ' ' TRP . 38.1 ttm180 -116.69 125.97 52.49 Favored 'General case' 0 N--CA 1.418 -2.061 0 C-N-CA 119.652 -0.819 . . . . 2.68 112.262 -171.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.467 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.6 mp -107.11 109.62 21.51 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.567 -1.197 . . . . 1.23 108.616 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -70.72 -40.01 73.04 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.962 -1.017 . . . . 2.18 110.094 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -135.09 102.1 11.1 Favored Pre-proline 0 N--CA 1.419 -2.005 0 N-CA-C 107.341 -1.355 . . . . 2.82 107.341 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 23' ' ' TRP . 73.9 Cg_endo -74.98 141.45 26.71 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.14 1.893 . . . . 1.25 111.21 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.7 p -104.25 171.58 7.26 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.299 -0.63 . . . . 1.22 109.299 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -68.93 -37.35 78.84 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.011 -1.075 . . . . 2.03 111.699 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.24 -10.36 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 113.46 0.911 . . . . 1.33 113.46 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.15 -8.7 58.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.052 0.76 . . . . 2.19 113.052 -171.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 17.7 p30 -77.65 77.25 4.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.883 0.849 . . . . 1.96 111.804 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . -152.34 -153.03 6.13 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 115.134 -0.939 . . . . 0.49 111.499 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -106.17 118.66 37.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 122.977 0.511 . . . . 2.23 111.154 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -96.88 112.64 24.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.562 -0.903 . . . . 0.69 108.562 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 60.9 m -102.93 123.41 46.51 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.917 -0.771 . . . . 0.34 108.917 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 12' ' ' VAL . 54.2 tp -98.49 119.24 36.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.947 -0.76 . . . . 0.22 108.947 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 2.9 mm? -102.18 131.72 48.54 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.431 -0.804 . . . . 0.36 109.104 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.74 120.61 31.09 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.706 -1.22 . . . . 0.31 107.706 173.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.21 132.04 55.89 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 123.448 0.468 . . . . 0.61 111.526 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 37.5 p30 -145.06 174.03 3.81 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 107.8 -1.185 . . . . 1.18 107.8 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 56.8 Cg_exo -48.05 -32.98 19.66 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.979 2.453 . . . . 1.0 115.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.38 -36.47 63.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.796 0.331 . . . . 1.1 111.1 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.17 -166.42 38.26 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 119.761 -1.209 . . . . 0.59 112.253 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 60.8 tt0 -128.41 135.59 49.73 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 108.707 -0.849 . . . . 1.57 108.707 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.04 154.87 20.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.5 p -146.84 119.48 8.55 Favored 'General case' 0 N--CA 1.426 -1.649 0 O-C-N 123.618 0.574 . . . . 0.57 111.149 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -126.03 148.34 49.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.416 -1.327 . . . . 0.3 107.416 177.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.2 m -127.83 139.77 52.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 117.934 0.334 . . . . 1.26 111.465 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.51 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -133.64 123.9 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 109.149 -0.686 . . . . 0.72 109.149 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 51.0 ttm -98.17 123.31 42.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.622 -0.51 . . . . 1.25 109.622 177.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -120.42 125.84 48.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.699 0.285 . . . . 0.58 110.972 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 113.11 24.51 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.703 -0.851 . . . . 0.84 108.703 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -92.64 -78.56 0.41 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.308 -0.406 . . . . 3.86 111.471 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -138.22 163.01 32.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.338 -0.616 . . . . 4.72 109.338 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 3.9 p-10 -61.61 153.37 28.03 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.128 0.892 . . . . 5.33 111.732 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -94.43 109.62 44.0 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.309 -0.859 . . . . 5.34 111.4 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 104' ' ' ASP . 4.8 Cg_exo -78.94 137.49 13.92 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 121.792 1.661 . . . . 5.07 108.991 172.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 C--O 1.243 0.727 0 C-N-CA 124.415 1.086 . . . . 9.52 111.131 -179.399 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 . . . . . 0 CA--C 1.51 -0.589 0 CA-C-O 122.863 1.316 . . . . 7.93 108.69 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.19 -48.43 1.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 113.892 -1.504 . . . . 6.17 108.725 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -91.73 19.41 6.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.282 1.039 . . . . 5.43 108.632 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 58.72 43.94 17.93 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.734 -1.58 . . . . 3.87 106.734 -172.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.94 -50.58 18.67 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 111.693 -2.503 . . . . 2.55 113.526 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 15.4 m -73.45 98.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 122.271 1.034 . . . . 2.08 112.214 -175.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 108.121 -1.066 . . . . 1.58 108.121 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 70.4 m-85 -104.27 132.59 50.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.118 -1.067 . . . . 1.19 108.118 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.3 m -83.76 175.48 9.63 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.138 -1.06 . . . . 1.32 108.138 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.44 124.19 38.31 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.869 -0.732 . . . . 0.45 111.404 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 67.5 m -121.57 135.61 54.99 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.456 -1.313 . . . . 1.19 107.456 172.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 94' ' ' ALA . 93.7 t -115.44 118.23 58.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.028 0.442 . . . . 0.29 110.695 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -113.09 116.46 29.91 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.651 -1.24 . . . . 2.18 107.651 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 98' ' ' ILE . 29.1 mt -100.39 156.63 17.15 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.16 0.505 . . . . 0.33 111.841 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -131.31 144.49 51.31 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.693 -1.225 . . . . 1.03 107.693 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -63.73 139.3 58.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 124.241 0.963 . . . . 0.49 108.97 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -54.42 141.78 29.41 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 124.045 0.841 . . . . 0.4 111.072 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -91.04 130.69 39.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.542 0.687 . . . . 0.57 109.978 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -76.89 111.19 12.17 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.433 -1.258 . . . . 2.52 112.385 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 24.0 ptt? -166.72 -172.89 2.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.538 -1.282 . . . . 0.88 107.538 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -75.78 -32.86 60.08 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 119.661 1.119 . . . . 2.75 111.063 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.438 ' O ' ' HG3' ' A' ' 20' ' ' MET . 61.3 m80 -99.0 122.07 41.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.448 -1.316 . . . . 2.46 107.448 176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -86.97 126.26 34.6 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.425 -0.91 . . . . 0.86 113.365 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -126.65 121.66 32.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.17 -1.377 . . . . 0.3 109.617 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 17' ' ' ALA . 53.8 mt -106.18 97.95 17.6 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.467 -1.308 . . . . 0.3 107.467 173.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.3 138.66 27.9 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.631 2.221 . . . . 0.28 112.141 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -134.29 159.14 41.89 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.964 0.411 . . . . 0.37 110.595 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 p -139.86 116.71 10.95 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.36 -0.836 . . . . 0.88 109.265 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.4 p -126.39 122.75 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.428 -0.953 . . . . 0.27 108.428 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.2 p-10 -105.63 158.7 16.51 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 118.951 -1.1 . . . . 1.39 111.13 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.11 165.64 13.34 Favored Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.752 -1.113 . . . . 0.6 110.471 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.489 ' H ' ' HD2' ' A' ' 33' ' ' PRO 0.261 20.9 mm-40 -107.34 -52.1 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 118.942 -0.551 . . . . 2.61 111.877 175.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 32' ' ' GLN . 10.2 Cg_endo -61.55 120.47 8.12 Favored 'Trans proline' 0 C--N 1.367 1.51 0 N-CA-C 106.703 -2.076 . . . . 0.78 106.703 165.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.19 114.18 11.85 Favored Pre-proline 0 C--N 1.313 -1.014 0 O-C-N 123.55 0.531 . . . . 0.78 112.115 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 86.6 Cg_endo -81.18 142.79 13.71 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.413 1.409 . . . . 0.56 111.731 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 4.3 p -77.28 120.97 23.06 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 108.935 -0.765 . . . . 1.37 108.935 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD21 HG11 ' A' ' 29' ' ' VAL . 93.6 mt -95.8 117.08 29.87 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.466 0.651 . . . . 0.5 110.477 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -125.95 134.81 51.41 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.926 -1.034 . . . . 3.78 109.577 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -98.64 115.86 29.61 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.627 -0.508 . . . . 0.29 109.627 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 20.8 tp -101.87 126.89 48.86 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 105.001 -2.222 . . . . 0.95 105.001 174.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -122.78 108.88 13.53 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 108.995 -0.743 . . . . 0.88 108.995 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.97 34.44 21.53 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 123.94 0.775 . . . . 1.79 111.466 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.3 6.9 88.97 Favored Glycine 0 C--O 1.219 -0.796 0 CA-C-N 115.849 -0.614 . . . . 0.61 112.586 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -116.24 147.15 41.77 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.024 -1.102 . . . . 1.37 108.024 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.5 t -76.89 114.75 17.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.142 -1.058 . . . . 0.7 108.142 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.96 118.24 18.53 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.702 -0.851 . . . . 0.61 108.702 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.08 115.04 20.33 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.442 -0.577 . . . . 2.47 109.442 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -72.26 108.01 5.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.51 -0.922 . . . . 1.74 108.51 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.2 p -104.13 -162.89 0.93 Allowed 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.553 -1.203 . . . . 1.57 109.655 -175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -81.41 -26.59 35.27 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.857 -0.794 . . . . 1.52 108.857 173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -79.04 -40.31 31.66 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.884 -0.598 . . . . 1.59 110.268 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.457 HG23 ' HG ' ' A' ' 72' ' ' LEU . 56.6 mt -120.26 105.77 17.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.79 -1.93 . . . . 0.5 105.79 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -139.29 140.51 37.64 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.328 -0.549 . . . . 2.89 111.435 -172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.0 m -86.82 112.2 21.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.285 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -110.75 152.52 26.5 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.993 -0.743 . . . . 2.04 108.993 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -118.64 163.13 17.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 120.768 0.318 . . . . 0.87 110.815 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.92 140.9 52.52 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.873 -1.899 . . . . 1.25 105.873 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.21 116.75 30.29 Favored Pre-proline 0 C--N 1.296 -1.752 0 O-C-N 124.026 0.829 . . . . 3.36 111.394 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.87 169.04 16.91 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.573 2.182 . . . . 1.39 110.609 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.81 142.31 33.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.176 -1.046 . . . . 1.53 108.176 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.76 -15.24 61.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.559 0.577 . . . . 1.91 112.559 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -98.49 8.11 45.31 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.27 -0.423 . . . . 3.49 111.324 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.8 pt-20 -117.92 155.47 30.13 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.347 -0.983 . . . . 1.89 108.347 176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 p -106.51 8.35 31.36 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.201 0.524 . . . . 1.3 110.887 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 26.9 t -100.08 134.62 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.456 -0.793 . . . . 0.61 109.824 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 29' ' ' VAL . 80.4 mtp180 -93.67 141.96 27.9 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.286 -1.376 . . . . 1.84 107.286 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -124.29 139.58 53.78 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.927 -0.398 . . . . 1.16 109.927 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.41 -179.44 42.49 Favored Glycine 0 N--CA 1.425 -2.079 0 C-N-CA 120.498 -0.858 . . . . 0.31 111.516 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 t -149.66 138.07 20.7 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.927 0.394 . . . . 0.36 110.897 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.7 tp -80.32 106.91 12.69 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.25 -1.759 . . . . 0.28 106.25 172.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -94.18 103.96 15.99 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.535 -0.757 . . . . 2.68 109.809 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' HG23 ' A' ' 52' ' ' ILE . 4.9 mp -94.64 109.51 21.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.601 -1.259 . . . . 1.23 107.601 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -77.66 -51.16 11.06 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.67 -1.15 . . . . 2.18 109.469 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.64 101.84 52.01 Favored Pre-proline 0 N--CA 1.423 -1.778 0 N-CA-C 107.477 -1.305 . . . . 2.82 107.477 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.9 130.65 6.71 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.288 1.992 . . . . 1.25 109.917 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -110.53 154.64 23.42 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.796 -1.187 . . . . 1.22 107.796 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -74.07 -5.4 41.38 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.694 -0.629 . . . . 2.03 112.118 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.7 -10.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 1.33 110.24 173.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.612 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 16.6 m120 -83.77 -1.62 54.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.891 0.876 . . . . 2.19 109.545 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -79.45 83.35 5.47 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.799 -1.186 . . . . 1.96 107.799 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.33 -150.64 6.7 Favored Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.924 -0.58 . . . . 0.49 111.816 -176.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -107.72 124.13 49.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.701 0.286 . . . . 2.23 111.45 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 63.4 m-85 -100.27 113.39 26.06 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.742 -0.836 . . . . 0.69 108.742 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 16.4 m -103.5 121.97 43.96 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.928 -1.138 . . . . 0.34 107.928 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.5 tp -99.9 119.9 38.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.734 -0.469 . . . . 0.22 109.734 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.56 136.16 44.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.388 -0.967 . . . . 0.36 108.388 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.4 120.73 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.438 -1.319 . . . . 0.31 107.438 174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.74 114.05 20.55 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.322 0.582 . . . . 0.61 112.507 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 39.5 p30 -127.0 161.7 52.19 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 106.538 -1.652 . . . . 1.18 106.538 172.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 4.5 Cg_exo -40.68 -38.65 2.72 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.895 3.063 . . . . 1.0 115.349 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.63 -34.35 75.6 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 112.488 0.551 . . . . 1.1 112.488 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.21 170.95 36.67 Favored Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.816 -1.183 . . . . 0.59 112.508 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -110.67 126.91 55.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.52 -0.918 . . . . 1.57 108.52 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.64 155.27 18.41 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.449 -0.575 . . . . 0.37 109.449 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 p -150.95 128.69 11.58 Favored 'General case' 0 N--CA 1.426 -1.655 0 O-C-N 123.651 0.594 . . . . 0.57 110.68 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.77 159.88 41.31 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.586 -1.635 . . . . 0.3 106.586 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.4 p -136.69 146.75 46.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.586 0.708 . . . . 1.26 112.653 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.519 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -134.97 122.15 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.713 -1.217 . . . . 0.72 107.713 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.0 ttt -100.61 123.41 44.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.94 -0.763 . . . . 1.25 108.94 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.93 140.92 51.45 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.189 -0.3 . . . . 0.58 110.189 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.15 142.69 28.77 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.741 -0.663 . . . . 0.84 109.668 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.52 118.69 12.7 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.411 -0.588 . . . . 3.86 109.411 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.9 ptp -105.84 97.13 6.99 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.939 0.876 . . . . 4.72 110.369 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -98.1 129.2 44.92 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.285 -0.87 . . . . 5.33 109.276 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -70.45 118.29 63.07 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 123.764 0.665 . . . . 5.34 109.545 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.74 166.53 19.88 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.733 2.288 . . . . 5.07 113.305 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--N 1.293 -1.878 0 CA-C-N 114.954 -1.021 . . . . 9.52 109.407 179.51 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.664 0.745 . . . . 7.93 109.886 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -118.03 140.04 50.33 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.737 -0.838 . . . . 6.17 108.737 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.79 -19.6 61.98 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.645 0.591 . . . . 5.43 110.311 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.11 140.31 36.57 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.853 -0.612 . . . . 3.87 109.711 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -98.25 -17.57 18.87 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.644 0.735 . . . . 2.55 110.322 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 m -86.73 98.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-O 122.811 1.291 . . . . 2.08 112.131 -173.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.2 m -99.21 98.81 9.75 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 113.997 -1.456 . . . . 1.58 107.704 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.435 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 40.3 m-85 -85.31 135.09 34.05 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.183 -0.917 . . . . 1.19 109.39 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.7 m -84.71 176.65 8.42 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.97 -1.492 . . . . 1.32 106.97 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.38 128.41 40.89 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.728 -0.789 . . . . 0.45 111.408 -173.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 23.3 t -115.33 136.58 52.94 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 106.464 -1.68 . . . . 1.19 106.464 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 94' ' ' ALA . 99.5 t -115.69 116.14 51.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.025 0.44 . . . . 0.29 110.129 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -117.0 116.29 27.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.656 -0.868 . . . . 2.18 108.656 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.501 HD13 HG22 ' A' ' 98' ' ' ILE . 31.9 mt -97.41 156.18 16.58 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.725 -0.472 . . . . 0.33 109.725 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -131.91 146.39 52.08 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 106.758 -1.571 . . . . 1.03 106.758 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 m -63.33 132.21 50.83 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 123.812 0.695 . . . . 0.49 109.615 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.33 142.74 30.91 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.648 -1.16 . . . . 0.4 112.107 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.21 130.4 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.543 -0.753 . . . . 0.57 110.117 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' CH2' ' A' ' 23' ' ' TRP . 36.2 mt-10 -80.64 107.17 13.22 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.837 -1.074 . . . . 2.52 110.263 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 22' ' ' HIS . 59.8 mtm -134.76 -165.81 1.72 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.41 -1.7 . . . . 0.88 106.41 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -66.02 -39.01 89.86 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.254 -1.017 . . . . 2.75 108.254 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 20' ' ' MET . 66.9 m170 -117.56 153.55 33.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.452 -1.684 . . . . 2.46 106.452 176.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.453 ' CH2' ' HG2' ' A' ' 19' ' ' GLU . 68.6 m95 -98.63 144.85 27.47 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 113.017 0.747 . . . . 0.86 113.017 -171.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.4 t -136.23 121.01 18.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.788 -1.096 . . . . 0.3 109.384 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 17' ' ' ALA . 58.8 mt -103.38 100.31 17.94 Favored Pre-proline 0 C--O 1.24 0.562 0 N-CA-C 108.468 -0.938 . . . . 0.3 108.468 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.66 132.91 16.45 Favored 'Trans proline' 0 C--O 1.244 0.784 0 C-N-CA 122.324 2.016 . . . . 0.28 111.85 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' HB3' HD23 ' A' ' 14' ' ' LEU . 53.8 p90 -128.47 152.26 48.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.993 0.425 . . . . 0.37 111.094 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 m -127.31 114.3 17.41 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.372 -0.973 . . . . 0.88 108.372 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 66' ' ' ARG . 3.2 p -125.29 112.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.308 -0.627 . . . . 0.27 109.308 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.2 p-10 -112.02 144.79 40.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.995 -0.682 . . . . 1.39 110.316 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.24 165.48 32.57 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 108.637 -1.785 . . . . 0.6 108.637 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 19.5 tm0? -91.4 -53.31 0.28 Allowed Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 117.519 0.659 . . . . 2.61 109.999 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 3.2 Cg_exo -80.36 120.63 4.09 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 107.6 -1.731 . . . . 0.78 107.6 170.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.5 115.67 10.72 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 123.779 0.674 . . . . 0.78 111.763 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 87.7 Cg_endo -81.51 153.2 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.749 2.299 . . . . 0.56 113.204 -177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 m -79.56 119.31 22.35 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.531 -1.285 . . . . 1.37 107.531 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 127.41 39.04 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.927 0.394 . . . . 0.5 110.053 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -123.79 130.67 52.98 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.941 -0.763 . . . . 3.78 108.941 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.2 m95 -94.57 119.86 33.89 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.127 0.489 . . . . 0.29 109.948 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 26.3 tp -110.66 126.91 55.0 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.169 -1.419 . . . . 0.95 107.169 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -116.48 106.9 14.11 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 110.204 -0.295 . . . . 0.88 110.204 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 56.39 35.2 25.51 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.227 1.011 . . . . 1.79 111.18 174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.49 -18.17 57.96 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.777 -0.647 . . . . 0.61 113.25 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.5 p -106.02 139.71 40.15 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.179 -0.6 . . . . 1.37 110.375 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.14 128.12 28.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.904 -0.589 . . . . 0.7 109.785 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.4 tp -91.1 111.65 23.21 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.684 -0.689 . . . . 0.61 109.269 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -85.04 135.13 34.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.115 -1.069 . . . . 2.47 108.115 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -72.61 141.08 48.35 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.8 -0.445 . . . . 1.74 109.8 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -123.87 -163.79 1.17 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.284 -0.635 . . . . 1.57 109.284 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -81.98 -17.44 46.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.831 -0.433 . . . . 1.52 109.831 175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.11 -31.46 9.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.409 -0.36 . . . . 1.59 111.405 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.3 mt -113.84 106.73 21.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 106.511 -1.663 . . . . 0.5 106.511 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.42 145.91 33.02 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.273 0.558 . . . . 2.89 111.813 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -85.92 112.95 21.64 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.422 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -96.83 112.54 24.25 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.858 -0.61 . . . . 2.04 110.947 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.52 142.6 27.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.203 -1.036 . . . . 0.87 108.203 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -118.31 161.68 19.54 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.408 -1.33 . . . . 1.25 107.408 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 47.7 mt-10 -67.13 113.67 14.68 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 113.973 1.101 . . . . 3.36 113.973 -173.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 4.7 Cg_exo -80.56 157.72 21.98 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.085 2.524 . . . . 1.39 109.61 174.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -80.6 145.57 31.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.737 -0.838 . . . . 1.53 108.737 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.03 0.76 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.689 0.756 . . . . 1.91 111.236 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -123.01 9.55 9.36 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.307 -0.86 . . . . 3.49 109.034 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 15.6 pt-20 -135.56 160.77 37.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 107.268 -1.382 . . . . 1.89 107.268 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 p -118.71 34.71 5.09 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.936 0.875 . . . . 1.3 109.778 175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.44 ' HB ' ' OE1' ' A' ' 63' ' ' GLU . 18.7 t -109.43 127.18 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.196 -0.911 . . . . 0.61 109.401 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB2' HG13 ' A' ' 29' ' ' VAL . 74.2 mtp180 -91.32 129.17 37.34 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.6 -1.629 . . . . 1.84 106.6 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -114.06 134.99 54.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.386 -0.968 . . . . 1.16 108.386 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -160.62 179.08 36.34 Favored Glycine 0 N--CA 1.408 -3.176 0 C-N-CA 119.73 -1.224 . . . . 0.31 111.714 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 4.7 t -144.61 132.79 21.66 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.83 0.852 . . . . 0.36 109.932 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.1 tp -84.45 105.66 15.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 105.224 -2.139 . . . . 0.28 105.224 170.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -100.46 123.83 45.19 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.045 -0.525 . . . . 2.68 110.029 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.02 108.26 19.69 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.894 -1.15 . . . . 1.23 107.894 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -72.9 -35.46 67.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.514 -1.221 . . . . 2.18 109.805 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -110.59 108.37 58.19 Favored Pre-proline 0 N--CA 1.423 -1.814 0 N-CA-C 107.243 -1.392 . . . . 2.82 107.243 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.39 129.89 16.55 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.475 1.45 . . . . 1.25 109.915 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.405 ' HB ' HG22 ' A' ' 78' ' ' VAL . 17.9 p -126.19 141.11 52.06 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.114 0.483 . . . . 1.22 109.828 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -80.46 -18.39 48.84 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.144 -0.687 . . . . 2.03 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 76' ' ' THR . 22.3 m -68.7 -12.01 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.238 -0.585 . . . . 1.33 111.491 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.505 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 51.7 m-80 -111.62 25.99 11.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.47 0.652 . . . . 2.19 111.386 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.18 104.37 16.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.304 -0.999 . . . . 1.96 108.304 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.05 26.29 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.039 -0.824 . . . . 0.49 111.039 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -96.17 123.48 39.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.117 0.484 . . . . 2.23 111.361 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 97' ' ' SER . 8.0 m-85 -95.97 121.18 37.44 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.158 0.983 . . . . 0.69 108.978 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' ALA . 53.7 m -107.77 120.9 43.55 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.582 -0.896 . . . . 0.34 108.582 177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 95' ' ' SER . 54.0 tp -96.88 118.75 33.99 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.538 -0.912 . . . . 0.22 108.538 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.85 133.62 49.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.415 -0.957 . . . . 0.36 108.415 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -122.07 119.7 32.16 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.417 -0.957 . . . . 0.31 108.417 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.98 131.38 54.62 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.42 -0.585 . . . . 0.61 109.42 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 8.0 p30 -151.58 165.31 17.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 107.042 -1.466 . . . . 1.18 107.042 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.1 Cg_endo -44.69 -40.58 14.33 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.473 2.782 . . . . 1.0 114.337 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.63 -27.28 61.19 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.85 0.685 . . . . 1.1 112.85 -175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.48 -156.1 27.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.121 -1.038 . . . . 0.59 112.178 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 28.7 tt0 -138.12 126.81 23.65 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.957 0.408 . . . . 1.57 110.674 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.545 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.79 157.75 16.74 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.862 -0.792 . . . . 0.37 108.862 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 23.2 p -153.7 142.62 21.14 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 123.255 0.347 . . . . 0.57 110.952 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' THR . . . -147.19 152.32 38.2 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.439 -1.319 . . . . 0.3 107.439 175.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 83' ' ' TYR . 37.8 m -128.77 141.16 51.4 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 118.103 0.411 . . . . 1.26 111.034 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.501 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -138.33 134.36 43.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.407 -0.96 . . . . 0.72 108.407 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.9 ttm -99.42 119.96 38.84 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.929 -0.482 . . . . 1.25 109.782 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.9 116.58 30.23 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 109.503 -0.554 . . . . 0.58 109.503 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.49 100.11 11.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.397 -0.964 . . . . 0.84 108.397 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -75.64 -68.94 0.52 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.718 -1.128 . . . . 3.86 110.104 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 66.7 mtt -132.41 151.25 51.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.198 -1.408 . . . . 4.72 107.198 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.51 160.37 17.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.801 -0.815 . . . . 5.33 108.801 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.62 111.3 56.74 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 116.093 -0.503 . . . . 5.34 110.606 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.64 134.9 14.06 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.058 1.839 . . . . 5.07 109.639 174.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 123.855 0.862 . . . . 9.52 110.857 -178.247 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 108.105 -1.072 . . . . 7.93 108.105 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.522 ' O ' HG22 ' A' ' 6' ' ' VAL . 5.2 m-20 -111.34 -10.35 14.23 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 122.168 -0.332 . . . . 6.17 111.878 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.04 -39.81 28.8 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 116.029 1.863 . . . . 5.43 116.029 -168.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -79.14 -30.38 43.58 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.88 -0.513 . . . . 3.87 111.262 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.83 -37.92 18.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.394 -0.366 . . . . 2.55 111.831 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 2' ' ' ASP . 13.1 m -71.05 99.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 CA-C-O 122.564 1.173 . . . . 2.08 110.465 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t -87.57 98.01 11.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 CA-C-N 115.054 -0.975 . . . . 1.58 108.598 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 23.2 m-85 -86.0 117.71 25.02 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 105.397 -2.075 . . . . 1.19 105.397 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.7 m -83.22 -179.31 7.37 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.797 -0.816 . . . . 1.32 108.797 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.31 126.01 38.21 Favored 'General case' 0 CA--C 1.484 -1.573 0 C-N-CA 119.606 -0.837 . . . . 0.45 110.817 -170.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 20.8 t -118.41 131.43 56.29 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.673 -1.232 . . . . 1.19 107.673 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 90.4 t -114.5 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.886 -0.783 . . . . 0.29 108.886 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.82 116.05 27.97 Favored 'General case' 0 N--CA 1.413 -2.282 0 N-CA-C 107.665 -1.235 . . . . 2.18 107.665 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.711 HD13 HG22 ' A' ' 98' ' ' ILE . 38.3 mt -99.48 156.82 16.83 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.511 -0.768 . . . . 0.33 109.924 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -131.6 153.94 49.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.063 -0.517 . . . . 1.03 109.695 -176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -57.32 133.59 55.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.175 -1.375 . . . . 0.49 110.36 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.59 141.4 58.78 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.649 -0.705 . . . . 0.4 110.311 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -91.37 124.91 44.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.647 0.736 . . . . 0.57 111.535 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -85.49 111.95 20.46 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.47 -1.241 . . . . 2.52 109.92 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.26 -162.46 0.53 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.215 -1.402 . . . . 0.88 107.215 176.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -60.85 -28.93 69.2 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.618 1.099 . . . . 2.75 112.793 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -120.86 165.16 15.57 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.884 -1.524 . . . . 2.46 106.884 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -118.19 135.83 54.01 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 109.198 -0.667 . . . . 0.86 109.198 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 t -135.76 131.69 35.85 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.552 -0.749 . . . . 0.3 110.002 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.4 HD12 HD23 ' A' ' 70' ' ' LEU . 61.8 mt -104.65 106.24 53.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.383 -1.339 . . . . 0.3 107.383 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.09 137.8 19.77 Favored 'Trans proline' 0 C--O 1.245 0.858 0 C-N-CA 122.644 2.229 . . . . 0.28 111.35 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' HB3' HD23 ' A' ' 14' ' ' LEU . 55.1 p90 -140.01 146.47 39.1 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.227 0.537 . . . . 0.37 111.853 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.5 p -126.63 118.87 25.67 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 115.137 -0.938 . . . . 0.88 109.31 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' SER . 2.5 p -120.12 110.46 28.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.529 -0.915 . . . . 0.27 108.529 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 3.8 p-10 -108.49 150.94 26.74 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.395 -0.522 . . . . 1.39 110.504 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.36 144.35 3.91 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 108.493 -1.843 . . . . 0.6 108.493 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.51 -53.25 2.06 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.472 -0.936 . . . . 2.61 108.472 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 23.7 Cg_exo -67.26 120.96 8.04 Favored 'Trans proline' 0 C--N 1.379 2.168 0 N-CA-C 108.978 -1.201 . . . . 0.78 108.978 171.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.95 87.88 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 115.735 -0.666 . . . . 0.78 112.041 -174.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -90.55 159.78 4.37 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.474 2.116 . . . . 0.56 111.714 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -96.36 120.6 36.95 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.995 -1.483 . . . . 1.37 106.995 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.56 159.08 19.97 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.667 0.27 . . . . 0.5 110.901 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -159.43 138.03 10.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.723 -0.843 . . . . 3.78 108.723 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -105.72 129.89 53.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.215 0.531 . . . . 0.29 111.361 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -109.33 137.35 47.32 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 107.839 -1.171 . . . . 0.95 107.839 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -124.82 103.89 8.32 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.982 -1.118 . . . . 0.88 107.982 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 64.36 28.0 13.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.093 0.957 . . . . 1.79 110.358 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.8 71.53 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.12 -0.945 . . . . 0.61 112.201 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.3 m -93.16 150.08 20.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.897 -0.779 . . . . 1.37 108.897 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.89 115.82 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 116.164 -0.471 . . . . 0.7 109.925 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -85.75 124.22 32.02 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.483 -1.303 . . . . 0.61 107.483 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -102.15 126.14 49.04 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.625 -0.879 . . . . 2.47 108.625 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.7 114.41 3.28 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.818 -0.808 . . . . 1.74 108.818 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -130.06 -170.8 2.38 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.451 -0.795 . . . . 1.57 109.588 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -60.15 -32.72 71.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.173 0.589 . . . . 1.52 112.113 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -84.7 -36.8 21.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.399 0.518 . . . . 1.59 112.399 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.401 HD11 HD21 ' A' ' 79' ' ' ASN . 14.2 mt -132.52 114.63 23.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.955 -1.128 . . . . 0.5 107.955 -171.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -138.74 155.54 48.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 118.895 0.771 . . . . 2.89 111.518 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -98.62 110.37 22.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.44 109.87 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -109.82 120.76 43.47 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.559 -0.534 . . . . 2.04 109.559 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -97.01 153.56 17.84 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 116.09 -0.505 . . . . 0.87 109.81 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -98.98 159.86 14.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.126 -1.435 . . . . 1.25 107.126 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 61.6 mm-40 -72.91 115.14 37.21 Favored Pre-proline 0 C--N 1.307 -1.271 0 O-C-N 123.576 0.547 . . . . 3.36 110.273 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 3.7 Cg_exo -77.17 153.95 32.28 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.546 2.164 . . . . 1.39 110.551 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.12 146.84 27.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.702 -1.221 . . . . 1.53 107.702 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.64 -25.84 60.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.073 1.138 . . . . 1.91 114.073 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.18 -0.42 46.89 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 120.526 -0.469 . . . . 3.49 111.833 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -88.81 138.84 31.05 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.963 0.411 . . . . 1.89 110.693 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -104.45 -2.06 25.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.431 -0.952 . . . . 1.3 108.431 173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.1 t -98.0 128.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.351 -0.84 . . . . 0.61 109.399 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.0 ttm-85 -108.88 124.18 50.25 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.004 -1.11 . . . . 1.84 108.004 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -111.04 146.53 36.56 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.949 0.404 . . . . 1.16 110.097 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.49 179.39 32.37 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 110.614 -0.994 . . . . 0.31 110.614 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 71' ' ' ARG . 4.6 t -138.05 131.67 30.98 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.65 -0.5 . . . . 0.36 109.65 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.4 HD23 HD12 ' A' ' 25' ' ' ILE . 47.2 tp -91.32 94.86 9.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.116 -2.179 . . . . 0.28 105.116 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.524 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . 15.5 ptm180 -99.93 126.4 46.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.498 -0.774 . . . . 2.68 110.617 -174.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -90.91 113.05 25.16 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.948 0.88 . . . . 1.23 109.367 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -61.81 -49.52 76.0 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.18 -1.827 . . . . 2.18 107.593 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -135.29 100.57 11.51 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 107.845 -1.168 . . . . 2.82 107.845 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HB2' ' CE1' ' A' ' 102' ' ' PHE . 1.3 Cg_endo -83.65 141.96 10.07 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.123 1.882 . . . . 1.25 111.163 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 p -130.31 -178.73 4.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 118.98 -0.533 . . . . 1.22 111.598 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -69.47 -19.6 63.75 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.382 0.992 . . . . 2.03 111.102 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 m -70.69 -10.67 14.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.33 110.639 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.401 HD21 HD11 ' A' ' 52' ' ' ILE . 24.9 m120 -88.15 14.29 9.55 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.625 -0.716 . . . . 2.19 112.844 -175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -90.56 93.64 9.37 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.301 -1.0 . . . . 1.96 108.301 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.19 -173.22 39.39 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 120.409 -0.9 . . . . 0.49 112.127 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -93.35 122.8 36.13 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.17 0.51 . . . . 2.23 111.13 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG23 ' A' ' 98' ' ' ILE . 22.0 m-85 -102.97 130.43 50.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.72 1.208 . . . . 0.69 107.908 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.1 m -130.88 128.29 40.27 Favored 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.988 -0.445 . . . . 0.34 109.955 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.451 ' CB ' HD11 ' A' ' 14' ' ' LEU . 50.5 tp -100.37 124.54 45.99 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.59 -0.893 . . . . 0.22 108.59 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.58 138.27 48.33 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.098 -1.075 . . . . 0.36 108.098 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.3 119.5 34.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.818 -1.549 . . . . 0.31 106.818 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.68 125.41 40.24 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.043 -1.095 . . . . 0.61 108.043 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -151.04 144.78 17.46 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.506 -1.664 . . . . 1.18 106.506 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.62 -17.17 27.35 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 123.526 2.817 . . . . 1.0 113.986 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.3 t -89.65 -8.83 51.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.036 0.446 . . . . 1.1 110.348 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.16 157.02 7.32 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.147 -0.781 . . . . 0.59 111.147 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 31.8 tt0 -90.65 133.66 34.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.088 -0.708 . . . . 1.57 109.088 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.5 150.63 23.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.641 -0.874 . . . . 0.37 108.641 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -151.45 143.21 23.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 O-C-N 123.355 0.409 . . . . 0.57 111.309 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.56 154.29 42.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.28 -1.378 . . . . 0.3 107.28 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.8 t -119.71 132.37 55.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.46 0.648 . . . . 1.26 111.655 -173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 HD13 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -136.34 119.76 23.07 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.873 0 C-N-CA 124.267 1.027 . . . . 0.72 109.469 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -106.75 122.04 45.57 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 109.153 -0.684 . . . . 1.25 109.153 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.05 147.76 38.17 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.663 -0.415 . . . . 0.58 110.34 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.26 120.11 18.49 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.409 -1.33 . . . . 0.84 107.409 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 75' ' ' PRO . 72.0 t80 -84.37 -72.8 0.45 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.632 -0.713 . . . . 3.86 111.653 -177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.4 ptm -136.75 -177.25 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.587 -0.894 . . . . 4.72 108.587 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -74.57 138.83 43.3 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.245 0.545 . . . . 5.33 110.366 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -91.72 132.43 33.14 Favored Pre-proline 0 C--N 1.306 -1.3 0 CA-C-N 115.919 -0.582 . . . . 5.34 110.953 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -65.95 117.95 5.08 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.77 2.313 . . . . 5.07 110.066 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 . . . . . 0 N--CA 1.417 -2.118 0 CA-C-O 118.388 -0.815 . . . . 9.52 109.038 -174.22 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 108.913 -0.773 . . . . 7.93 108.913 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -160.91 128.72 4.35 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.887 -0.783 . . . . 6.17 108.887 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.39 -0.82 8.7 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.087 -0.506 . . . . 5.43 110.933 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 58.38 24.69 11.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.554 0.741 . . . . 3.87 110.688 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -82.01 2.34 31.4 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.693 0.797 . . . . 2.55 110.762 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 m -97.9 98.22 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.254 0 CA-C-O 122.389 1.09 . . . . 2.08 108.599 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.1 m -110.54 98.52 7.7 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 115.079 -0.964 . . . . 1.58 109.11 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' H ' ' HB2' ' A' ' 32' ' ' GLN . 97.1 m-85 -89.16 136.35 33.07 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.706 -1.134 . . . . 1.19 108.55 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.2 t -83.91 169.56 14.94 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.025 -1.472 . . . . 1.32 107.025 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.92 112.82 24.72 Favored 'General case' 0 CA--C 1.489 -1.404 0 CA-C-O 121.068 0.461 . . . . 0.45 110.63 -173.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.1 t -106.87 131.89 53.45 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.889 -1.152 . . . . 1.19 107.889 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 94' ' ' ALA . 89.2 t -115.08 114.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.735 -0.469 . . . . 0.29 109.735 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -113.14 116.16 29.41 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.501 -0.926 . . . . 2.18 108.501 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 43.9 mt -101.77 150.67 22.91 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.929 -0.397 . . . . 0.33 109.929 176.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.64 139.6 49.15 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.523 -0.917 . . . . 1.03 108.523 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -52.44 134.19 34.78 Favored 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 125.035 1.459 . . . . 0.49 110.64 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -58.76 142.47 49.98 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.908 -1.042 . . . . 0.4 111.072 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.51 125.89 44.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.491 0.662 . . . . 0.57 110.418 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.76 114.43 12.03 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.616 -1.175 . . . . 2.52 111.345 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 23.9 ptt? -165.68 -177.28 4.27 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.635 1.174 . . . . 0.88 107.996 175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -71.63 -31.73 67.18 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.193 1.36 . . . . 2.75 114.47 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.495 ' O ' ' HG3' ' A' ' 20' ' ' MET . 90.1 m-70 -112.04 125.71 54.38 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.564 -2.013 . . . . 2.46 105.564 173.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 75' ' ' PRO . 60.0 m95 -93.12 143.67 26.02 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 113.838 1.051 . . . . 0.86 113.838 -168.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 t -134.66 125.6 27.44 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.001 -1.0 . . . . 0.3 109.876 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 17' ' ' ALA . 63.5 mt -106.8 101.19 35.59 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.513 -1.292 . . . . 0.3 107.513 173.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -73.63 129.66 13.89 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.619 2.213 . . . . 0.28 112.304 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -127.46 143.41 51.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.083 0.468 . . . . 0.37 110.518 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.4 m -127.18 116.12 20.14 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 108.551 -0.907 . . . . 0.88 108.551 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.585 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.96 121.33 57.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.55 -0.537 . . . . 0.27 109.55 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 p-10 -115.69 148.09 40.13 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.566 -0.454 . . . . 1.39 109.953 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.37 149.65 6.25 Favored Glycine 0 N--CA 1.428 -1.858 0 N-CA-C 108.094 -2.003 . . . . 0.6 108.094 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -75.78 -54.79 2.11 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 118.014 0.907 . . . . 2.61 109.111 -177.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 6.4 Cg_exo -75.99 120.0 5.58 Favored 'Trans proline' 0 C--N 1.369 1.651 0 N-CA-C 107.38 -1.815 . . . . 0.78 107.38 172.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.93 110.99 3.08 Favored Pre-proline 0 C--N 1.318 -0.768 0 O-C-N 124.055 0.847 . . . . 0.78 110.924 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.443 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 73.7 Cg_endo -74.47 146.05 34.5 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.213 1.942 . . . . 0.56 112.37 -176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 24.5 t -74.52 111.0 9.27 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.363 -1.347 . . . . 1.37 107.363 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 29' ' ' VAL . 80.3 mt -88.75 125.48 34.9 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.637 -0.711 . . . . 0.5 109.786 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 39' ' ' TRP . 16.4 tpp180 -137.08 137.55 39.43 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.828 -0.434 . . . . 3.78 109.828 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.422 ' H ' ' HD3' ' A' ' 38' ' ' ARG . 91.7 m95 -101.54 140.45 35.81 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.183 0.516 . . . . 0.29 109.868 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 45' ' ' VAL . 12.3 tp -120.72 127.32 51.9 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.421 -2.066 . . . . 0.95 105.421 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 79' ' ' ASN . 54.6 t80 -116.97 106.99 14.01 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.899 -0.408 . . . . 0.88 109.899 -178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 58.52 37.96 25.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.206 1.002 . . . . 1.79 110.839 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.72 -17.67 43.65 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.632 -0.713 . . . . 0.61 113.023 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 m -93.36 135.82 34.22 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.993 -0.743 . . . . 1.37 108.993 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' A' ' 40' ' ' LEU . 5.1 p -67.35 136.52 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 CA-C-O 121.373 0.606 . . . . 0.7 111.239 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 46.6 tp -92.2 124.25 36.14 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 116.16 -0.473 . . . . 0.61 110.45 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.41 104.81 13.62 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 103.916 -2.624 . . . . 2.47 103.916 167.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 2.0 pm0 -50.35 137.63 18.26 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.188 0.93 . . . . 1.74 112.504 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -118.48 -166.87 1.28 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.174 -0.921 . . . . 1.57 110.467 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -67.17 -33.59 75.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.014 0.435 . . . . 1.52 111.58 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -88.61 -37.17 15.85 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.381 -0.372 . . . . 1.59 111.702 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.452 HG23 ' HG ' ' A' ' 72' ' ' LEU . 21.5 mt -110.0 109.45 28.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.787 -1.19 . . . . 0.5 107.787 -174.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -136.26 138.19 41.53 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.689 -0.804 . . . . 2.89 111.608 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 m -81.61 109.64 16.23 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.457 -0.792 . . . . 0.44 109.518 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -109.63 144.09 38.46 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 120.901 0.381 . . . . 2.04 110.914 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -122.13 153.76 38.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.041 -0.527 . . . . 0.87 109.629 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.45 155.85 38.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.904 -1.517 . . . . 1.25 106.904 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -74.58 121.68 85.8 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 114.534 1.309 . . . . 3.36 114.534 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -79.92 154.4 22.87 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.823 2.348 . . . . 1.39 109.622 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.64 176.26 9.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.164 -0.68 . . . . 1.53 109.164 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.62 -38.12 89.9 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 119.043 0.838 . . . . 1.91 112.384 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -74.78 -20.14 59.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.993 -0.549 . . . . 3.49 110.531 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.0 113.15 19.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 120.376 -0.53 . . . . 1.89 109.974 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 m -92.25 0.47 57.45 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.487 1.137 . . . . 1.3 108.089 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 t -91.42 129.06 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 114.532 -1.213 . . . . 0.61 109.797 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HB3' HG13 ' A' ' 29' ' ' VAL . 18.6 ttm180 -85.64 121.05 27.76 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.041 -1.837 . . . . 1.84 106.041 172.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -106.69 131.24 54.05 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.095 -0.705 . . . . 1.16 109.095 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.45 -177.52 35.54 Favored Glycine 0 N--CA 1.414 -2.791 0 C-N-CA 119.989 -1.101 . . . . 0.31 111.821 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.9 136.21 20.18 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.307 0.643 . . . . 0.36 109.527 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 56.7 tp -84.58 98.34 10.1 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 104.451 -2.426 . . . . 0.28 104.451 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -97.22 123.42 41.0 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.414 -0.812 . . . . 2.68 110.759 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HG ' HG23 ' A' ' 52' ' ' ILE . 6.5 mp -102.11 109.31 20.99 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.673 -1.232 . . . . 1.23 107.673 174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -59.43 -42.77 92.64 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.656 -1.611 . . . . 2.18 109.965 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -133.17 124.98 18.69 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.274 -1.009 . . . . 2.82 108.274 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 23' ' ' TRP . 30.9 Cg_endo -66.02 130.52 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.803 2.336 . . . . 1.25 112.036 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.4 p -109.39 141.84 41.2 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.831 -0.803 . . . . 1.22 108.831 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -80.99 -13.16 59.13 Favored 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 120.589 -0.445 . . . . 2.03 110.038 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.32 -13.02 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 119.325 -0.95 . . . . 1.33 111.83 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.5 m-80 -108.48 23.01 15.15 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.957 1.095 . . . . 2.19 113.957 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.45 HD21 ' HB3' ' A' ' 105' ' ' ASN . 19.0 p30 -86.26 64.27 8.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 122.034 0.921 . . . . 1.96 111.761 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.02 -148.12 4.96 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.11 -0.95 . . . . 0.49 111.994 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -102.93 116.76 33.18 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.354 0.597 . . . . 2.23 112.603 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 51.4 m-85 -94.91 140.28 30.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.763 -0.828 . . . . 0.69 108.763 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.0 m -128.8 127.71 42.49 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 108.46 -0.941 . . . . 0.34 108.46 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' SER . 51.9 tp -101.6 122.94 44.78 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.067 -0.716 . . . . 0.22 109.067 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -109.13 131.48 55.03 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.686 -1.227 . . . . 0.36 107.686 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -119.01 120.11 36.25 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.51 -0.922 . . . . 0.31 108.51 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 36' ' ' SER . . . -96.28 115.51 27.55 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.594 0.559 . . . . 0.61 110.64 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -134.82 150.76 74.25 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-O 117.76 -1.114 . . . . 1.18 108.211 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.09 -42.15 21.2 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.478 2.119 . . . . 1.0 112.243 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.5 t -57.2 -32.69 66.73 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.947 0.899 . . . . 1.1 112.01 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.1 178.57 26.93 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 109.867 -1.293 . . . . 0.59 109.867 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 29.8 tt0 -106.36 129.82 54.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.385 -0.598 . . . . 1.57 109.385 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.83 152.86 20.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.005 -0.739 . . . . 0.37 109.005 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 24.8 p -141.05 146.35 37.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.924 0.392 . . . . 0.57 111.251 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.27 43.36 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.738 -1.208 . . . . 0.3 107.738 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 t -122.91 127.81 49.44 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.7 -0.481 . . . . 1.26 109.7 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -135.6 123.85 38.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.77 -0.826 . . . . 0.72 108.77 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 74.0 mtp -101.73 110.62 22.64 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.2 -0.6 . . . . 1.25 110.285 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.89 133.46 38.59 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.779 -0.646 . . . . 0.58 110.513 -177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -126.47 100.63 6.33 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.15 -1.056 . . . . 0.84 108.15 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.405 ' CZ ' HD22 ' A' ' 72' ' ' LEU . 33.0 m-85 -78.02 -70.87 0.45 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.807 -1.182 . . . . 3.86 107.807 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 20.1 ptp -127.68 136.06 51.06 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 104.415 -2.439 . . . . 4.72 104.415 170.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.52 141.63 58.4 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 123.525 0.516 . . . . 5.33 110.103 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.45 ' HB3' HD21 ' A' ' 80' ' ' ASN . 5.8 p30 -72.27 113.2 18.59 Favored Pre-proline 0 CA--C 1.51 -0.559 0 O-C-N 123.906 0.754 . . . . 5.34 112.332 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -82.14 178.14 6.62 Favored 'Trans proline' 0 N--CA 1.424 -2.59 0 C-N-CA 121.748 1.632 . . . . 5.07 111.42 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 114.985 -1.007 . . . . 9.52 108.348 -176.612 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 CA--C 1.497 -1.09 0 N-CA-C 108.779 -0.823 . . . . 7.93 108.779 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.6 t70 68.65 17.57 8.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.395 1.478 . . . . 6.17 110.235 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 6' ' ' VAL . 15.2 m-20 -80.19 -19.09 47.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.976 -1.466 . . . . 5.43 107.461 177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.29 -15.47 61.41 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.043 -1.435 . . . . 3.87 111.083 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.9 -19.72 64.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.591 0.589 . . . . 2.55 112.591 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 3' ' ' ASP . 31.1 m -68.34 99.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 123.299 1.523 . . . . 2.08 108.541 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.2 m -97.77 98.67 10.04 Favored 'General case' 0 N--CA 1.381 -3.894 0 CA-C-N 113.882 -1.508 . . . . 1.58 113.781 -168.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -108.27 126.57 52.97 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 112.878 -1.965 . . . . 1.19 105.96 171.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.4 t -83.68 174.17 10.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.753 -1.573 . . . . 1.32 106.753 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.09 129.23 40.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 118.882 -1.127 . . . . 0.45 110.501 -174.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 m -122.03 135.83 54.87 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.798 -1.186 . . . . 1.19 107.798 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.6 t -115.82 123.23 70.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.001 0.429 . . . . 0.29 111.073 -174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -115.13 139.72 49.66 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.338 -0.986 . . . . 2.18 108.338 176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.755 HD13 HG22 ' A' ' 98' ' ' ILE . 36.1 mt -129.85 156.88 43.64 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.348 -0.612 . . . . 0.33 109.348 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -130.7 143.16 50.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.185 -1.043 . . . . 1.03 108.185 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.8 m -57.36 134.59 56.14 Favored 'General case' 0 C--O 1.25 1.083 0 O-C-N 124.496 1.122 . . . . 0.49 109.693 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -64.31 139.84 58.81 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 124.003 0.815 . . . . 0.4 110.638 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.32 134.04 31.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.976 0.417 . . . . 0.57 111.542 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 92.26 0.34 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.32 -0.855 . . . . 2.52 112.415 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.8 ptt? -144.93 -177.09 5.35 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 109.092 -0.707 . . . . 0.88 109.092 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -64.1 -41.68 97.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.205 0.817 . . . . 2.75 113.205 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.9 p-80 -112.44 129.24 56.39 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.052 -1.462 . . . . 2.46 107.052 173.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -82.74 147.79 28.23 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 120.849 0.357 . . . . 0.86 111.642 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.9 t -137.59 120.26 16.21 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.44 -0.8 . . . . 0.3 110.142 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.4 mt -106.93 97.41 17.61 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.637 -1.245 . . . . 0.3 107.637 173.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.76 131.8 17.69 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 123.125 2.55 . . . . 0.28 112.602 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.62 154.91 39.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.333 0.587 . . . . 0.37 110.844 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 m -140.14 121.83 15.33 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.617 -0.882 . . . . 0.88 108.617 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.3 p -124.07 111.7 29.82 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 108.744 -0.835 . . . . 0.27 108.744 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.7 p-10 -106.85 147.25 29.96 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.026 -0.534 . . . . 1.39 111.309 -177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.02 -170.77 32.64 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 110.06 -1.216 . . . . 0.6 110.06 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -122.55 -51.94 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.456 0.91 . . . . 2.61 113.456 178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.01 121.32 9.62 Favored 'Trans proline' 0 C--N 1.37 1.675 0 N-CA-C 107.854 -1.633 . . . . 0.78 107.854 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.43 111.03 6.24 Favored Pre-proline 0 C--N 1.316 -0.857 0 O-C-N 123.765 0.666 . . . . 0.78 111.111 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 71.7 Cg_endo -84.47 146.65 10.96 Favored 'Trans proline' 0 N--CA 1.435 -1.936 0 C-N-CA 121.841 1.694 . . . . 0.56 111.842 -178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' ALA . 22.9 t -79.57 121.96 25.9 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.715 -1.587 . . . . 1.37 106.715 174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.1 mt -96.51 129.72 43.82 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.639 0.587 . . . . 0.5 109.734 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -136.58 134.7 37.71 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.116 -0.493 . . . . 3.78 110.968 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -95.29 119.85 34.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.617 -0.882 . . . . 0.29 108.617 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.86 130.91 52.91 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.086 -1.45 . . . . 0.95 107.086 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 82' ' ' ASN . 87.2 t80 -120.8 103.72 9.31 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 109.049 -0.723 . . . . 0.88 109.049 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 56.86 33.59 23.38 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.662 0.785 . . . . 1.79 111.923 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.83 82.95 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.687 -0.768 . . . . 0.61 112.895 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 t -105.77 146.69 29.51 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.976 -1.12 . . . . 1.37 107.976 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -78.88 123.8 36.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.907 -0.775 . . . . 0.7 108.907 -177.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -80.75 106.53 12.82 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.263 -0.643 . . . . 0.61 109.263 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -87.8 131.41 34.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.585 -0.895 . . . . 2.47 108.585 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.01 149.31 47.84 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.273 0.559 . . . . 1.74 111.268 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -145.6 -169.33 3.2 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 114.938 -1.028 . . . . 1.57 108.768 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 t -72.25 -25.18 61.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.429 0.633 . . . . 1.52 109.987 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 95.9 m-85 -101.52 -12.09 18.79 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.437 0.903 . . . . 1.59 113.437 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' ND2' ' A' ' 79' ' ' ASN . 44.4 mt -135.75 107.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.311 -1.737 . . . . 0.5 106.311 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -141.45 142.33 33.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 112.308 0.485 . . . . 2.89 112.308 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 m -88.79 109.49 20.22 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.644 -0.707 . . . . 0.44 109.499 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.671 ' HG3' ' HE ' ' A' ' 71' ' ' ARG . 6.7 mm-40 -92.98 124.05 36.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.391 0.615 . . . . 2.04 110.883 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.31 120.5 40.03 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 107.148 -1.427 . . . . 0.87 107.148 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 3.9 pp -84.31 155.79 22.22 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 106.836 -1.542 . . . . 1.25 106.836 177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.0 105.97 3.4 Favored Pre-proline 0 C--N 1.294 -1.806 0 O-C-N 124.138 0.899 . . . . 3.36 110.407 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 79.4 Cg_endo -88.25 169.68 6.05 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.137 2.558 . . . . 1.39 111.051 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -93.87 139.62 30.67 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.656 -1.238 . . . . 1.53 107.656 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.54 15.11 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.513 0.673 . . . . 1.91 111.413 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -82.85 -25.62 32.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.069 -0.968 . . . . 3.49 109.829 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 14.8 pt-20 -97.26 139.4 33.28 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.583 -0.895 . . . . 1.89 108.583 -177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -88.12 13.59 10.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.96 0.886 . . . . 1.3 109.94 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 11.6 t -119.57 132.05 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 115.724 -0.671 . . . . 0.61 110.259 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.54 ' HB2' HG13 ' A' ' 29' ' ' VAL . 22.8 mtp180 -95.39 136.23 36.02 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.654 -1.61 . . . . 1.84 106.654 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -125.41 157.74 36.1 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.163 -0.68 . . . . 1.16 109.163 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.2 -168.24 38.84 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 111.264 -0.734 . . . . 0.31 111.264 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.29 138.41 16.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 123.001 0.52 . . . . 0.36 111.335 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.13 109.83 20.19 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.81 -1.552 . . . . 0.28 106.81 172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.671 ' HE ' ' HG3' ' A' ' 55' ' ' GLU . 76.0 mtm180 -102.28 131.56 48.78 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.795 -0.362 . . . . 2.68 111.574 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.1 mp -119.83 109.56 15.72 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.777 -0.823 . . . . 1.23 108.777 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.84 -10.61 59.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.759 -0.655 . . . . 2.18 111.184 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 33.3 tt0 -135.09 101.49 11.33 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 108.114 -1.069 . . . . 2.82 108.114 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -88.26 129.59 2.35 Favored 'Trans proline' 0 N--CA 1.435 -1.96 0 C-N-CA 121.591 1.528 . . . . 1.25 110.368 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.7 p -136.54 173.15 12.02 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.842 -0.799 . . . . 1.22 108.842 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -78.79 -5.67 53.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.113 0.412 . . . . 2.03 112.113 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -88.02 -9.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.349 -0.611 . . . . 1.33 109.349 170.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.4 m120 -104.81 22.06 15.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.005 -1.109 . . . . 2.19 108.005 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -114.17 117.44 31.21 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.799 -0.815 . . . . 1.96 108.799 -175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.27 -153.52 24.68 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 119.637 -1.268 . . . . 0.49 113.18 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 45.8 m-80 -87.28 120.66 28.79 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 115.55 -0.325 . . . . 2.23 111.406 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 98' ' ' ILE . 39.4 m-85 -105.56 118.28 36.16 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.311 -0.996 . . . . 0.69 108.311 176.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 m -122.96 125.02 44.49 Favored 'General case' 0 C--N 1.283 -2.3 0 O-C-N 121.611 -0.681 . . . . 0.34 109.775 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.434 HD23 HG13 ' A' ' 12' ' ' VAL . 59.0 tp -97.39 117.54 31.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.43 133.2 52.29 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.467 -0.938 . . . . 0.36 108.467 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -122.16 120.03 33.03 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.719 -1.215 . . . . 0.31 107.719 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.88 132.53 55.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.962 -0.755 . . . . 0.61 108.962 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 91' ' ' CYS . 8.7 p30 -152.62 170.43 8.1 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-O 118.474 -0.774 . . . . 1.18 109.257 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.48 -39.15 54.92 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.85 2.367 . . . . 1.0 114.465 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.438 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 27.0 t -70.0 -32.06 70.06 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-O 121.224 0.535 . . . . 1.1 111.832 -177.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.19 -146.03 11.75 Favored Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 119.864 -1.16 . . . . 0.59 111.969 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -138.63 138.63 38.03 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.146 -0.687 . . . . 1.57 109.146 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -119.81 146.63 45.52 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.965 -1.124 . . . . 0.37 107.965 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 p -143.74 152.85 41.78 Favored 'General case' 0 N--CA 1.417 -2.076 0 C-N-CA 121.006 -0.277 . . . . 0.57 110.275 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.58 144.92 26.52 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.86 -1.533 . . . . 0.3 106.86 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -122.44 145.72 48.03 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.472 0.654 . . . . 1.26 112.358 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.755 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -133.64 124.76 48.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 125.475 1.51 . . . . 0.72 108.572 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 tpt -96.34 96.52 8.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.687 -1.227 . . . . 1.25 107.687 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.02 113.16 26.16 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.349 0.595 . . . . 0.58 111.44 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.31 99.62 9.01 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 107.093 -1.447 . . . . 0.84 107.093 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -79.92 -24.65 40.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.209 1.188 . . . . 3.86 114.209 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 87.2 mmm -137.98 143.91 40.89 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.848 -1.538 . . . . 4.72 106.848 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.21 110.01 12.82 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.68 -1.6 . . . . 5.33 106.68 172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -81.37 113.02 38.46 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 115.191 -0.913 . . . . 5.34 112.083 -172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.44 124.4 9.36 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.092 1.862 . . . . 5.07 109.354 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 C--N 1.314 -0.953 0 C-N-CA 124.709 1.204 . . . . 9.52 110.528 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.5 -0.963 0 CA-C-O 121.033 0.444 . . . . 7.93 110.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -131.62 99.54 4.83 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.956 -0.757 . . . . 6.17 108.956 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.87 -29.56 32.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.556 -1.276 . . . . 5.43 107.556 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.64 123.67 25.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.401 -1.272 . . . . 3.87 109.181 175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.6 -15.94 53.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.868 0.842 . . . . 2.55 109.546 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 m -71.98 99.88 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.945 -1.025 . . . . 2.08 111.223 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.4 p -97.73 107.73 20.29 Favored 'General case' 0 N--CA 1.411 -2.377 0 CA-C-N 115.335 -0.848 . . . . 1.58 109.999 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.431 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 24.2 m-85 -86.52 127.92 34.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.818 -1.083 . . . . 1.19 109.587 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.2 t -84.68 176.47 8.55 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.557 -1.275 . . . . 1.32 107.557 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.11 114.57 26.74 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 120.357 -0.537 . . . . 0.45 110.55 -175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.642 ' HB3' ' OD1' ' A' ' 30' ' ' ASP . 34.1 t -117.68 131.31 56.65 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.743 -1.206 . . . . 1.19 107.743 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.53 121.26 67.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.507 -0.315 . . . . 0.29 110.936 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.1 123.42 42.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.569 -0.53 . . . . 2.18 109.569 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 27' ' ' PHE . 43.8 mt -105.87 156.02 18.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.882 -0.599 . . . . 0.33 109.937 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -132.53 151.92 51.75 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 110.455 -0.202 . . . . 1.03 110.455 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -54.05 133.16 43.68 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 124.786 1.304 . . . . 0.49 110.4 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -66.49 145.55 55.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.625 -0.716 . . . . 0.4 110.213 -177.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -91.68 127.83 43.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-O 121.518 0.675 . . . . 0.57 112.745 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.74 108.83 4.08 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 114.281 -1.327 . . . . 2.52 110.926 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -170.61 -171.7 1.1 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.93 -1.507 . . . . 0.88 106.93 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -66.52 -50.59 62.69 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.393 -0.523 . . . . 2.75 111.982 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -92.39 120.13 32.6 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -82.32 120.11 24.99 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.271 0.557 . . . . 0.86 111.023 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.4 t -114.8 121.96 44.9 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.612 -1.176 . . . . 0.3 109.138 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 17' ' ' ALA . 61.4 mt -103.73 103.74 38.45 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 108.054 -1.091 . . . . 0.3 108.054 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.25 130.48 13.06 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 122.456 2.104 . . . . 0.28 111.85 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.502 ' HB3' HD23 ' A' ' 14' ' ' LEU . 43.1 p90 -135.35 162.2 33.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.318 0.58 . . . . 0.37 110.482 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.0 m -144.62 123.48 12.68 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.651 -0.704 . . . . 0.88 109.157 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.7 p -123.6 114.69 42.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.079 -0.964 . . . . 0.27 108.495 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.642 ' OD1' ' HB3' ' A' ' 11' ' ' SER . 4.1 p-10 -102.25 158.49 16.15 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.736 -1.186 . . . . 1.39 109.755 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.98 138.72 2.61 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 109.795 -1.322 . . . . 0.6 109.795 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -87.32 -49.6 0.45 Allowed Pre-proline 0 N--CA 1.437 -1.095 0 C-N-CA 119.571 -0.852 . . . . 2.61 110.316 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 33.6 Cg_exo -64.17 119.48 6.54 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 105.255 -2.633 . . . . 0.78 105.255 164.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.17 117.79 59.78 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 116.138 -0.483 . . . . 0.78 112.296 -171.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -85.89 149.53 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.398 2.065 . . . . 0.56 111.941 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -90.91 138.81 31.31 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.77 -1.196 . . . . 1.37 107.77 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.424 ' HB3' HD11 ' A' ' 85' ' ' LEU . 80.9 mt -98.23 134.06 41.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.938 0.399 . . . . 0.5 111.094 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -130.29 126.22 36.69 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.037 -0.529 . . . . 3.78 110.064 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -96.78 124.33 40.72 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.599 -0.728 . . . . 0.29 109.702 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.97 128.8 55.61 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.492 -0.929 . . . . 0.95 108.492 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -105.01 104.64 14.41 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.169 -1.419 . . . . 0.88 107.169 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 61.08 30.76 19.65 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.801 0.81 . . . . 1.79 110.961 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.04 64.25 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.39 -0.823 . . . . 0.61 112.392 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -91.45 150.8 21.07 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.212 -1.032 . . . . 1.37 108.212 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.2 t -72.33 121.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.818 -0.628 . . . . 0.7 111.345 -175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.9 tp -102.66 122.45 44.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.664 -1.235 . . . . 0.61 107.664 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -97.81 138.32 35.35 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.773 -0.825 . . . . 2.47 108.773 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -75.84 106.15 7.26 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.329 -0.396 . . . . 1.74 110.214 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.7 p -88.28 -170.37 2.93 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.852 -0.425 . . . . 1.57 109.852 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -80.12 -13.61 59.14 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.56 -0.713 . . . . 1.52 109.517 174.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -97.94 -40.1 8.64 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.695 -0.684 . . . . 1.59 110.137 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HG ' ' A' ' 72' ' ' LEU . 37.5 mt -107.12 104.89 17.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.972 -2.232 . . . . 0.5 104.972 174.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -135.09 149.52 50.07 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.378 -0.929 . . . . 2.89 112.078 -173.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.9 m -94.36 109.62 21.45 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.357 -0.979 . . . . 0.44 108.357 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -100.75 123.79 45.46 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.544 -0.91 . . . . 2.04 108.544 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -100.4 146.17 27.32 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.716 -0.846 . . . . 0.87 108.716 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -118.15 154.5 32.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.833 -1.173 . . . . 1.25 107.833 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.49 120.43 81.45 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 123.94 0.775 . . . . 3.36 110.203 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.94 169.53 16.26 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 122.873 2.382 . . . . 1.39 109.936 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.73 141.2 38.06 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.315 -1.735 . . . . 1.53 106.315 175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -50.93 -25.35 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.107 1.521 . . . . 1.91 115.107 -172.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -73.5 -32.05 64.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.087 0.47 . . . . 3.49 110.411 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -75.23 142.36 43.41 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.251 0.548 . . . . 1.89 110.1 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 m -111.29 18.03 19.66 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.382 -1.71 . . . . 1.3 106.382 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.81 121.36 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 113.819 -1.537 . . . . 0.61 108.45 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 77.6 ttt180 -93.14 111.39 23.01 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 107.173 -1.417 . . . . 1.84 107.173 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -101.61 155.65 17.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.46 -0.57 . . . . 1.16 109.46 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.28 -174.74 44.83 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.278 -0.963 . . . . 0.31 112.092 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.4 t -145.3 134.85 23.27 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.177 0.591 . . . . 0.36 111.025 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.0 tp -88.63 107.59 19.0 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.103 -2.184 . . . . 0.28 105.103 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -117.91 130.41 56.22 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.432 0.634 . . . . 2.68 111.228 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 52' ' ' ILE . 5.8 mp -102.44 114.79 29.28 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.928 -1.033 . . . . 1.23 110.802 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.33 -39.35 81.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.769 -1.105 . . . . 2.18 109.019 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -119.34 100.45 49.86 Favored Pre-proline 0 N--CA 1.435 -1.214 0 N-CA-C 107.897 -1.149 . . . . 2.82 107.897 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.6 135.45 24.05 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 122.652 2.234 . . . . 1.25 109.451 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 p -133.43 149.19 51.79 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.033 0.444 . . . . 1.22 111.514 -175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -70.14 -4.21 20.31 Favored 'General case' 0 C--O 1.208 -1.085 0 C-N-CA 123.822 0.849 . . . . 2.03 112.117 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -85.06 -9.78 11.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 116.416 -0.356 . . . . 1.33 110.178 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.586 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 44.6 m-80 -115.96 26.48 9.94 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 113.549 0.944 . . . . 2.19 113.549 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -94.32 72.81 3.88 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.075 0.941 . . . . 1.96 110.011 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.5 -153.11 5.88 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 120.701 -0.761 . . . . 0.49 113.206 -175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -99.35 123.84 43.97 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.967 -0.383 . . . . 2.23 109.967 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 27.8 m-85 -101.33 116.57 33.1 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.012 -0.736 . . . . 0.69 109.012 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.9 m -110.72 122.32 47.5 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.192 -1.04 . . . . 0.34 108.192 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.4 tp -99.01 119.2 37.4 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.135 -0.484 . . . . 0.22 109.811 -178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 129.38 53.88 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.554 -0.906 . . . . 0.36 108.554 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.47 120.99 33.61 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.326 -1.361 . . . . 0.31 107.326 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.04 124.8 46.77 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.457 -0.497 . . . . 0.61 111.492 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 43.9 p30 -138.47 171.1 8.8 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 107.181 -1.414 . . . . 1.18 107.181 174.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 38.9 Cg_exo -45.35 -37.48 14.22 Favored 'Trans proline' 0 C--N 1.365 1.428 0 C-N-CA 123.043 2.495 . . . . 1.0 114.648 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.7 t -63.04 -49.62 73.84 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 120.671 0.272 . . . . 1.1 110.824 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.67 -177.65 48.03 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 120.131 -1.033 . . . . 0.59 111.816 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -108.1 122.58 47.19 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.992 -1.114 . . . . 1.57 107.992 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -101.88 149.09 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.397 -0.964 . . . . 0.37 108.397 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 12.1 p -147.42 140.84 25.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 O-C-N 123.464 0.477 . . . . 0.57 110.883 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.17 42.5 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.318 -1.364 . . . . 0.3 107.318 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.9 p -130.15 146.35 51.78 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.13 0.49 . . . . 1.26 111.842 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.492 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -145.57 138.6 21.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.621 -1.622 . . . . 0.72 106.621 178.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.2 ttt -111.12 124.1 51.52 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 1.25 110.336 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.62 115.31 25.47 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.493 -0.558 . . . . 0.58 109.493 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.43 111.65 23.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.982 -0.554 . . . . 0.84 110.303 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -149.24 121.08 8.14 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.555 0.693 . . . . 3.86 111.636 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.6 mtt -103.03 132.94 48.93 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 4.72 108.117 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -97.44 143.53 28.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.589 -1.263 . . . . 5.33 107.589 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -117.89 99.82 52.12 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 106.77 -1.567 . . . . 5.34 106.77 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.73 172.33 10.74 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.051 1.834 . . . . 5.07 114.228 -175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 N--CA 1.409 -2.508 0 CA-C-N 114.051 -1.431 . . . . 9.52 108.631 -173.332 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.648 0.261 . . . . 7.93 110.471 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -97.59 62.36 1.68 Allowed 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.846 -1.168 . . . . 6.17 107.846 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -103.8 30.55 5.02 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.413 -0.812 . . . . 5.43 112.937 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.24 121.72 31.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.313 -1.366 . . . . 3.87 107.313 169.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -65.97 -15.58 63.12 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.515 -0.766 . . . . 2.55 111.579 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.07 98.84 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 107.633 -1.247 . . . . 2.08 107.633 169.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.1 p -81.44 99.4 8.71 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.424 -0.807 . . . . 1.58 109.446 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.34 124.89 24.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.875 -1.057 . . . . 1.19 110.992 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 20.6 t -84.46 160.97 20.45 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.428 -1.693 . . . . 1.32 106.428 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.51 121.24 35.86 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 119.776 -0.77 . . . . 0.45 111.42 -174.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.9 m -112.3 141.88 45.48 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.454 -1.313 . . . . 1.19 107.454 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.8 t -115.36 114.75 47.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 110.056 -0.349 . . . . 0.29 110.056 -176.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -112.35 116.4 30.29 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.379 0.609 . . . . 2.18 109.55 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 98' ' ' ILE . 70.7 mt -104.87 156.81 17.68 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.96 -1.018 . . . . 0.33 109.035 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -131.13 156.52 45.14 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.762 -0.829 . . . . 1.03 108.762 -175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.2 m -65.08 134.76 54.51 Favored 'General case' 0 N--CA 1.423 -1.806 0 O-C-N 124.456 1.097 . . . . 0.49 109.63 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.41 140.9 56.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.25 -0.886 . . . . 0.4 109.684 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.67 132.97 33.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.547 0.689 . . . . 0.57 110.652 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.44 102.39 2.65 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.427 -1.261 . . . . 2.52 112.465 -175.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -161.37 -179.42 7.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.812 -1.551 . . . . 0.88 106.812 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -64.55 -37.66 88.34 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.468 1.031 . . . . 2.75 113.401 -175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -107.22 117.91 35.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.906 -1.516 . . . . 2.46 106.906 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.452 ' HB2' HD12 ' A' ' 72' ' ' LEU . 78.3 m95 -82.05 125.55 30.96 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.159 -0.616 . . . . 0.86 110.681 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -108.67 121.43 45.0 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.146 -1.057 . . . . 0.3 108.146 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 17' ' ' ALA . 60.3 mt -102.89 98.11 10.77 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 107.693 -1.225 . . . . 0.3 107.693 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.92 132.08 19.33 Favored 'Trans proline' 0 C--O 1.245 0.862 0 C-N-CA 122.392 2.061 . . . . 0.28 112.056 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -128.69 152.79 48.0 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.327 0.584 . . . . 0.37 110.481 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 48.7 m -142.18 120.63 12.42 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.265 -0.88 . . . . 0.88 108.927 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.9 p -124.61 121.16 60.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.335 -0.987 . . . . 0.27 108.335 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 p-10 -111.55 145.49 39.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.737 -0.785 . . . . 1.39 110.204 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.62 4.73 Favored Glycine 0 C--N 1.298 -1.529 0 N-CA-C 107.504 -2.238 . . . . 0.6 107.504 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.462 ' HB3' ' HD3' ' A' ' 33' ' ' PRO 0.278 46.1 tt0 -80.87 -57.43 0.58 Allowed Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 118.649 1.224 . . . . 2.61 113.168 -175.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 32.4 Cg_exo -63.69 119.74 6.89 Favored 'Trans proline' 0 C--N 1.367 1.509 0 N-CA-C 106.28 -2.239 . . . . 0.78 106.28 168.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.93 109.84 2.86 Favored Pre-proline 0 C--N 1.315 -0.923 0 O-C-N 123.806 0.691 . . . . 0.78 111.076 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 59.1 Cg_endo -71.16 141.67 40.14 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.162 1.908 . . . . 0.56 112.512 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -71.26 104.24 3.07 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.463 -0.79 . . . . 1.37 108.952 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 29' ' ' VAL . 96.0 mt -81.78 134.03 35.4 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.352 -0.84 . . . . 0.5 109.813 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -146.39 138.59 25.03 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 123.687 0.795 . . . . 3.78 108.86 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 46' ' ' LEU . 95.6 m95 -102.78 130.67 49.84 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.378 0.609 . . . . 0.29 110.625 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.9 tp -114.72 126.79 55.26 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 105.954 -1.869 . . . . 0.95 105.954 175.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -116.63 98.12 6.36 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 109.077 -0.712 . . . . 0.88 109.077 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 51.92 56.6 7.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.167 0.984 . . . . 1.79 110.23 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.02 -13.95 12.54 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 115.089 -0.96 . . . . 0.61 113.816 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 m -96.6 140.99 30.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.853 -0.795 . . . . 1.37 108.853 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.92 123.45 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.461 -1.311 . . . . 0.7 107.461 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 39' ' ' TRP . 47.4 tp -77.15 107.21 9.37 Favored 'General case' 0 N--CA 1.434 -1.267 0 O-C-N 123.58 0.55 . . . . 0.61 109.587 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -82.83 125.83 31.75 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.486 -0.931 . . . . 2.47 108.486 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.36 153.19 35.99 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.222 -0.445 . . . . 1.74 110.031 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.9 t -166.05 -175.28 3.29 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.748 -0.834 . . . . 1.57 108.748 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 m -68.22 -17.67 64.37 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 119.594 1.088 . . . . 1.52 111.901 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -79.07 -40.17 31.94 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.729 0.3 . . . . 1.59 110.831 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.42 HD11 ' ND2' ' A' ' 79' ' ' ASN . 56.9 mt -136.15 115.66 16.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.929 -0.767 . . . . 0.5 108.929 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 73' ' ' ASN . 8.8 p90 -142.39 145.69 34.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.107 0.479 . . . . 2.89 112.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 m -82.58 111.19 18.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.466 -0.788 . . . . 0.44 109.883 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HG3' ' HD2' ' A' ' 71' ' ' ARG . 6.4 mm-40 -89.3 140.39 29.54 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.899 -0.778 . . . . 2.04 108.899 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -122.27 140.67 52.35 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.749 -0.834 . . . . 0.87 108.749 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.59 151.71 41.15 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.027 -1.101 . . . . 1.25 108.027 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 32.6 mm-40 -63.46 119.97 58.2 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 123.96 0.788 . . . . 3.36 112.598 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 7.4 Cg_exo -75.95 156.13 38.77 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.588 2.192 . . . . 1.39 110.351 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . . . -78.89 146.91 33.31 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.667 -0.864 . . . . 1.53 108.667 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.69 -13.05 58.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 114.019 1.118 . . . . 1.91 114.019 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -90.57 -21.47 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.916 0.388 . . . . 3.49 111.424 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 60' ' ' ALA . 16.4 pt-20 -99.28 162.47 13.03 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.689 -0.804 . . . . 1.89 110.957 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -121.49 29.71 7.09 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.966 -1.494 . . . . 1.3 106.966 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 30' ' ' ASP . 21.7 t -107.93 128.76 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 114.22 -1.355 . . . . 0.61 108.807 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.51 ' HB2' HG13 ' A' ' 29' ' ' VAL . 78.2 mtp180 -92.59 132.59 36.73 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.003 -1.48 . . . . 1.84 107.003 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -121.97 143.73 49.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.302 -0.629 . . . . 1.16 109.302 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.7 -166.09 24.11 Favored Glycine 0 N--CA 1.416 -2.642 0 C-N-CA 120.512 -0.851 . . . . 0.31 111.035 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.0 t -156.07 137.57 14.06 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.833 0.453 . . . . 0.36 110.183 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 38.3 tp -90.16 107.93 19.43 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 105.851 -1.907 . . . . 0.28 105.851 171.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' GLU . 70.6 mtt180 -100.18 120.35 39.75 Favored 'General case' 0 CA--C 1.482 -1.662 0 CA-C-N 116.502 -0.317 . . . . 2.68 110.873 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 23' ' ' TRP . 73.1 mt -83.7 108.0 16.49 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 105.96 -1.867 . . . . 1.23 105.96 171.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.408 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 50.4 t30 -66.97 -42.62 84.84 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.047 -0.979 . . . . 2.18 109.532 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -134.98 100.99 11.63 Favored Pre-proline 0 N--CA 1.412 -2.341 0 N-CA-C 106.533 -1.655 . . . . 2.82 106.533 171.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 14.3 Cg_exo -70.38 131.42 20.33 Favored 'Trans proline' 0 N--CA 1.443 -1.469 0 C-N-CA 122.022 1.814 . . . . 1.25 110.367 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.1 p -130.27 155.74 45.8 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.312 -0.995 . . . . 1.22 108.312 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -65.41 -5.42 7.56 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.444 1.276 . . . . 2.03 114.444 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -81.49 -10.44 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 109.638 -0.504 . . . . 1.33 109.638 174.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.42 ' ND2' HD11 ' A' ' 52' ' ' ILE . 13.8 m120 -89.18 17.15 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.599 0.76 . . . . 2.19 111.882 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -92.15 121.9 34.13 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.874 -0.788 . . . . 1.96 108.874 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.53 -170.45 36.5 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.39 -1.386 . . . . 0.49 112.641 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.83 101.29 13.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.996 -0.602 . . . . 2.23 110.721 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.49 ' HB2' HG23 ' A' ' 98' ' ' ILE . 45.1 m-85 -83.97 114.13 21.49 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 108.767 -0.827 . . . . 0.69 108.767 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 35.8 m -117.32 132.46 56.6 Favored 'General case' 0 C--N 1.28 -2.454 0 O-C-N 121.452 -0.78 . . . . 0.34 110.683 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 12' ' ' VAL . 44.3 tp -106.18 123.1 47.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 109.124 -0.695 . . . . 0.22 109.124 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.11 136.07 47.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.254 -1.017 . . . . 0.36 108.254 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -126.84 120.62 29.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.549 -0.908 . . . . 0.31 108.549 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.28 117.19 34.23 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.796 -0.446 . . . . 0.61 109.796 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 20.4 t-20 -131.31 151.59 79.07 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-O 117.405 -1.283 . . . . 1.18 108.31 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -43.1 -38.42 7.43 Favored 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 122.799 2.332 . . . . 1.0 113.38 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.1 t -64.16 -39.66 94.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.486 0.714 . . . . 1.1 112.137 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.91 -158.14 30.96 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 111.149 -0.78 . . . . 0.59 111.149 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 64.5 tt0 -128.83 129.91 46.23 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.729 -0.471 . . . . 1.57 109.729 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.43 150.51 23.29 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.747 -0.834 . . . . 0.37 108.747 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 p -148.65 123.73 10.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.977 -0.556 . . . . 0.57 110.183 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.33 148.41 51.88 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.006 -1.109 . . . . 0.3 108.006 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.4 m -121.17 132.79 55.05 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.699 0.761 . . . . 1.26 112.819 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -109.78 126.55 66.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 125.541 1.536 . . . . 0.72 108.685 175.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.463 ' N ' HD12 ' A' ' 98' ' ' ILE . 16.0 tpt -105.08 111.09 23.73 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 1.25 108.209 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.6 149.7 27.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.218 -0.447 . . . . 0.58 109.961 -177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.6 127.33 23.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.799 -0.637 . . . . 0.84 110.475 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 75' ' ' PRO . 55.4 t80 -161.33 92.75 0.91 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 124.994 1.317 . . . . 3.86 107.876 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.77 96.55 7.15 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.221 -0.591 . . . . 4.72 109.877 -177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.56 137.62 33.2 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.027 -1.101 . . . . 5.33 108.027 174.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -113.01 127.57 26.67 Favored Pre-proline 0 C--N 1.283 -2.306 0 N-CA-C 108.924 -0.769 . . . . 5.34 108.924 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.76 117.61 4.18 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.482 2.121 . . . . 5.07 110.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.0 t80 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.241 1.416 . . . . 9.52 108.802 -175.215 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 t70 . . . . . 0 C--O 1.244 0.772 0 N-CA-C 107.003 -1.48 . . . . 7.93 107.003 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -150.67 77.81 1.29 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.659 0.742 . . . . 6.17 109.402 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -94.5 -26.3 16.5 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.3 -0.864 . . . . 5.43 110.405 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.0 132.65 39.63 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 3.87 109.32 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -96.32 -50.19 4.89 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 122.682 0.393 . . . . 2.55 111.613 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 m -90.52 98.33 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 113.958 1.096 . . . . 2.08 113.958 -173.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.5 t -104.26 98.1 7.95 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 105.846 -1.909 . . . . 1.58 105.846 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -72.13 131.73 43.22 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.262 -0.881 . . . . 1.19 110.084 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.36 157.1 21.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.61 -1.256 . . . . 1.32 107.61 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -95.56 127.2 41.4 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.624 0.601 . . . . 0.45 112.624 -172.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.3 m -123.87 141.05 52.38 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.933 -1.877 . . . . 1.19 105.933 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 94' ' ' ALA . 97.7 t -115.0 116.59 53.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.074 0.464 . . . . 0.29 109.755 -174.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -115.81 116.85 28.73 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.001 -0.74 . . . . 2.18 109.001 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.472 HD13 HG22 ' A' ' 98' ' ' ILE . 38.8 mt -95.68 156.66 16.23 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.965 -0.561 . . . . 0.33 109.631 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -130.54 142.04 50.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.954 -1.499 . . . . 1.03 106.954 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 m -62.11 130.1 43.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 O-C-N 124.053 0.846 . . . . 0.49 110.558 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -55.56 140.63 40.15 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.451 1.1 . . . . 0.4 112.207 -177.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.7 139.56 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.754 -0.657 . . . . 0.57 109.886 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -85.3 117.27 24.13 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.991 -1.004 . . . . 2.52 112.394 -171.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.0 ptt? -168.28 -174.27 2.23 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.129 -1.434 . . . . 0.88 107.129 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 8.0 t-80 -65.54 -52.65 50.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.794 0.724 . . . . 2.75 110.639 -176.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.479 ' O ' ' HG3' ' A' ' 20' ' ' MET . 7.8 p-80 -99.35 126.65 45.26 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.625 -0.879 . . . . 2.46 108.625 173.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.432 ' HB2' HD12 ' A' ' 72' ' ' LEU . 82.7 m95 -82.36 148.0 28.51 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.178 0.513 . . . . 0.86 112.224 -171.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 44.0 t -131.55 118.89 20.74 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.506 -0.924 . . . . 0.3 108.506 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 17' ' ' ALA . 78.3 mt -103.68 99.18 14.84 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.455 -1.313 . . . . 0.3 107.455 175.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.0 143.58 36.58 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.087 1.858 . . . . 0.28 110.887 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -137.73 154.58 49.61 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.724 -0.39 . . . . 0.37 110.349 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -132.62 114.06 13.77 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.638 -0.71 . . . . 0.88 110.208 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 37' ' ' LEU . 6.4 p -129.57 137.81 55.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 106.813 -1.551 . . . . 0.27 106.813 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.3 p-10 -132.34 161.88 32.45 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 119.741 -0.784 . . . . 1.39 110.744 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.94 153.74 7.34 Favored Glycine 0 N--CA 1.418 -2.5 0 N-CA-C 109.502 -1.439 . . . . 0.6 109.502 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -81.31 -56.68 0.59 Allowed Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 107.973 -1.121 . . . . 2.61 107.973 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.83 120.85 7.73 Favored 'Trans proline' 0 C--N 1.375 1.928 0 N-CA-C 107.59 -1.734 . . . . 0.78 107.59 168.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.455 ' HB1' HH21 ' A' ' 66' ' ' ARG . . . -61.78 114.41 11.18 Favored Pre-proline 0 C--N 1.312 -1.023 0 O-C-N 123.742 0.651 . . . . 0.78 111.694 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' ALA . 84.8 Cg_endo -79.1 135.05 12.01 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.572 1.515 . . . . 0.56 112.058 -178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.4 p -73.53 116.47 14.14 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 109.023 -0.732 . . . . 1.37 109.023 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.516 HD21 HG11 ' A' ' 29' ' ' VAL . 93.2 mt -87.22 127.53 35.16 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.5 109.647 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -125.7 130.21 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.127 -0.694 . . . . 3.78 109.127 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 97.5 m95 -95.64 128.87 42.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.277 0.561 . . . . 0.29 109.734 176.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 18.1 tp -118.59 127.42 53.59 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 105.703 -1.962 . . . . 0.95 105.703 176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -119.91 110.85 17.21 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.587 -0.523 . . . . 0.88 109.587 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.0 28.5 16.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.061 0.945 . . . . 1.79 111.45 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.09 -12.27 69.4 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 121.389 -0.434 . . . . 0.61 112.856 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.1 p -103.18 151.31 22.77 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.754 0.311 . . . . 1.37 110.315 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.28 120.76 17.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.667 -0.697 . . . . 0.7 110.436 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.9 tp -94.42 104.44 16.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.05 -0.722 . . . . 0.61 109.05 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -85.74 137.31 32.9 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.252 -0.647 . . . . 2.47 109.252 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.42 129.18 39.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.956 -0.566 . . . . 1.74 109.536 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.7 p -126.64 -163.69 1.26 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 123.853 0.861 . . . . 1.57 109.661 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.6 m -87.19 -5.83 58.83 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.359 0.599 . . . . 1.52 109.661 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -103.0 -35.56 8.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.81 -0.632 . . . . 1.59 109.955 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -127.93 106.97 15.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.231 -1.025 . . . . 0.5 108.231 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -138.78 140.22 38.54 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.817 0.341 . . . . 2.89 110.303 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -86.83 113.81 22.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.706 -0.85 . . . . 0.44 108.706 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' CD ' HH21 ' A' ' 71' ' ' ARG . 43.4 mt-10 -105.52 115.06 29.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.397 0.618 . . . . 2.04 110.062 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -96.37 150.63 20.37 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.35 -0.841 . . . . 0.87 109.455 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 67' ' ' HIS . 4.0 pp -106.91 165.15 11.55 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 105.743 -1.947 . . . . 1.25 105.743 172.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.4 104.74 21.43 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.556 -0.535 . . . . 3.36 109.556 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 57' ' ' LEU . 86.9 Cg_endo -84.08 165.32 13.15 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.379 2.052 . . . . 1.39 111.145 -176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.32 137.29 54.54 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.962 -1.125 . . . . 1.53 107.962 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.03 27.2 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.012 0.525 . . . . 1.91 111.981 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.49 -26.01 65.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.755 0.788 . . . . 3.49 109.149 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -98.38 140.1 33.15 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 115.526 -0.761 . . . . 1.89 109.04 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -104.99 28.72 6.94 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.692 0.758 . . . . 1.3 108.993 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.35 130.39 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 115.241 -0.89 . . . . 0.61 109.318 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.455 HH21 ' HB1' ' A' ' 34' ' ' ALA . 75.9 mtt180 -82.74 117.54 22.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.4 -0.963 . . . . 1.84 108.4 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.518 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 96.1 m-70 -104.38 123.74 47.96 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.368 -0.975 . . . . 1.16 108.368 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.8 -176.9 39.32 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.473 -0.87 . . . . 0.31 111.395 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.4 t -144.16 137.89 27.76 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 122.439 0.296 . . . . 0.36 110.897 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 58.9 tp -84.68 100.38 11.43 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.759 -2.311 . . . . 0.28 104.759 169.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 55' ' ' GLU . 47.8 ttp180 -104.19 120.17 40.54 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 120.238 -0.585 . . . . 2.68 110.049 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 23' ' ' TRP . 75.2 mt -75.55 108.03 8.09 Favored 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.343 -1.725 . . . . 1.23 106.343 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -66.82 -49.19 66.56 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.16 -1.382 . . . . 2.18 109.479 -171.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.4 99.8 18.86 Favored Pre-proline 0 N--CA 1.414 -2.234 0 N-CA-C 104.296 -2.483 . . . . 2.82 104.296 175.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' HG2' ' O ' ' A' ' 21' ' ' HIS . 33.5 Cg_exo -64.06 130.5 27.53 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.388 2.059 . . . . 1.25 111.73 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -135.18 166.02 24.06 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.56 -0.745 . . . . 1.22 109.383 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 103' ' ' MET . 50.0 p-80 -62.54 -5.18 2.38 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 115.748 1.759 . . . . 2.03 115.748 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.17 -10.2 11.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.035 0.445 . . . . 1.33 109.834 175.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.7 26.74 0.39 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.113 1.153 . . . . 2.19 114.113 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -115.14 125.17 53.13 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.321 -0.992 . . . . 1.96 108.321 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.38 -165.71 30.96 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.21 -0.995 . . . . 0.49 111.744 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -99.96 124.0 44.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 110.024 -0.362 . . . . 2.23 110.024 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -102.67 105.79 16.32 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.622 -0.881 . . . . 0.69 108.622 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.6 m -97.33 129.58 44.59 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.948 -0.76 . . . . 0.34 108.948 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' SER . 52.2 tp -109.06 120.77 43.53 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.582 -0.525 . . . . 0.22 109.582 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.23 138.95 42.46 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.283 -1.006 . . . . 0.36 108.283 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -125.94 120.66 30.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.306 -0.998 . . . . 0.31 108.306 175.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PRO . . . -97.97 112.46 24.38 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.34 0.59 . . . . 0.61 110.97 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -130.61 140.92 40.13 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.13 -1.804 . . . . 1.18 106.13 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -53.16 -19.57 12.43 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 124.052 3.168 . . . . 1.0 113.947 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 40.0 t -78.93 -24.29 44.11 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.825 0.345 . . . . 1.1 110.593 176.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.52 163.61 11.76 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.555 -1.018 . . . . 0.59 110.555 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -98.12 127.65 44.18 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.478 -0.564 . . . . 1.57 109.478 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -102.27 155.35 18.28 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.05 -0.722 . . . . 0.37 109.05 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 39.6 p -146.02 151.56 37.95 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 123.232 0.332 . . . . 0.57 110.609 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.44 33.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.662 -1.607 . . . . 0.3 106.662 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 m -135.02 135.47 41.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 117.983 0.356 . . . . 1.26 110.157 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -128.79 134.68 63.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.844 -1.539 . . . . 0.72 106.844 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.9 ttt -108.69 134.27 51.64 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.177 -0.609 . . . . 1.25 110.063 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.54 45.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.018 -1.104 . . . . 0.58 108.018 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -123.51 121.04 34.64 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.025 0.44 . . . . 0.84 110.351 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -151.2 118.09 5.84 Favored 'General case' 0 N--CA 1.402 -2.847 0 N-CA-C 108.577 -0.897 . . . . 3.86 108.577 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 16.3 ptp -115.45 111.8 21.32 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.762 -0.653 . . . . 4.72 110.639 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.95 126.6 31.08 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.718 -1.586 . . . . 5.33 106.718 174.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -120.42 103.98 43.55 Favored Pre-proline 0 C--N 1.285 -2.213 0 CA-C-N 116.344 -0.389 . . . . 5.34 111.732 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -91.46 178.94 1.63 Allowed 'Trans proline' 0 N--CA 1.429 -2.318 0 C-N-CA 121.934 1.756 . . . . 5.07 110.854 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 C--N 1.275 -2.639 0 N-CA-C 106.478 -1.675 . . . . 9.52 106.478 173.932 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.529 0.566 . . . . 7.93 112.529 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -100.08 -25.71 14.2 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.104 -0.702 . . . . 6.17 109.104 177.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -61.11 -35.04 75.96 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.498 -1.228 . . . . 5.43 109.263 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -157.7 132.81 8.77 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 102.955 -2.98 . . . . 3.87 102.955 174.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.12 -43.49 17.72 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 114.233 1.197 . . . . 2.55 114.233 -168.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 8' ' ' PHE . 12.6 m -86.94 99.5 8.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 122.114 0.959 . . . . 2.08 112.858 -171.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -90.32 98.97 12.09 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.242 -0.89 . . . . 1.58 108.736 -178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE1' ' HB ' ' A' ' 6' ' ' VAL . 53.9 m-85 -106.41 127.3 53.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.235 -0.654 . . . . 1.19 109.235 176.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 t -84.64 -177.87 6.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.276 . . . . 1.32 107.553 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.29 120.5 34.62 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.069 -0.652 . . . . 0.45 111.186 -174.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.462 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . 1.5 m -114.82 131.17 56.91 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.803 -1.184 . . . . 1.19 107.803 177.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.1 t -119.65 115.01 46.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 110.14 -0.318 . . . . 0.29 110.14 -177.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -120.38 121.96 39.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.335 -0.393 . . . . 2.18 110.033 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 27' ' ' PHE . 17.1 mt -104.16 155.25 18.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.917 -0.583 . . . . 0.33 110.786 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -131.96 151.56 51.65 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.235 -1.024 . . . . 1.03 108.235 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m -64.48 135.8 56.42 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 124.278 0.986 . . . . 0.49 111.515 -174.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -61.1 128.91 38.73 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.826 -1.079 . . . . 0.4 111.332 -179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.64 136.81 24.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 116.053 -0.521 . . . . 0.57 110.427 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -87.37 129.73 34.91 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.271 -0.422 . . . . 2.52 111.155 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -176.86 -166.91 0.16 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.918 -1.512 . . . . 0.88 106.918 179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -55.18 -38.44 68.34 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.815 0.672 . . . . 2.75 112.815 -178.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -121.53 132.72 54.86 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.102 -1.073 . . . . 2.46 108.102 174.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ARG . 64.5 m95 -81.94 119.25 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.575 -0.528 . . . . 0.86 109.575 -179.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.4 t -113.53 119.25 36.9 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.625 -0.716 . . . . 0.3 110.356 -176.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 17' ' ' ALA . 40.8 mt -104.15 96.27 9.39 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.8 -1.556 . . . . 0.3 106.8 171.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.05 141.58 14.89 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.644 2.229 . . . . 0.28 112.723 -176.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 14' ' ' LEU . 51.4 p90 -145.85 156.78 43.79 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.067 -0.515 . . . . 0.37 111.416 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -129.07 123.53 32.51 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-N 115.036 -0.984 . . . . 0.88 108.758 175.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 66' ' ' ARG . 1.5 p -122.01 110.47 27.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 CA-C-N 115.271 -0.877 . . . . 0.27 109.015 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 p30 -106.8 152.94 23.19 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.879 -0.601 . . . . 1.39 111.353 -177.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.5 158.47 9.92 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 109.315 -1.514 . . . . 0.6 109.315 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 23.8 tm0? -84.79 -51.02 0.56 Allowed Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 117.74 0.77 . . . . 2.61 109.972 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 32' ' ' GLN . 12.1 Cg_exo -73.57 134.81 21.0 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 N-CA-C 107.589 -1.735 . . . . 0.78 107.589 168.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.0 117.05 61.08 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 110.251 -0.277 . . . . 0.78 110.251 -177.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.456 ' HB3' ' HB2' ' A' ' 89' ' ' ASN . 73.1 Cg_endo -82.97 154.62 14.9 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.442 2.095 . . . . 0.56 112.727 -177.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -83.35 125.14 31.34 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.779 -1.193 . . . . 1.37 107.779 176.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 29' ' ' VAL . 97.0 mt -94.13 130.95 40.13 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 120.873 0.368 . . . . 0.5 110.044 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -135.61 135.23 40.07 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.421 -0.808 . . . . 3.78 109.633 -179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.439 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 99.6 m95 -96.01 132.05 41.75 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.237 0.542 . . . . 0.29 110.528 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.8 tp -119.47 126.86 52.32 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.444 -1.687 . . . . 0.95 106.444 176.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -115.89 107.5 15.09 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.277 -1.008 . . . . 0.88 108.277 -177.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 62.24 19.91 11.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.616 0.766 . . . . 1.79 112.727 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.1 -8.96 50.09 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.263 -0.97 . . . . 0.61 112.213 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.6 m -105.97 137.88 43.12 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.384 -0.599 . . . . 1.37 109.384 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.8 t -66.3 127.87 28.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.178 0.513 . . . . 0.7 110.345 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.56 106.69 18.22 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.374 -0.973 . . . . 0.61 108.374 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -87.68 121.35 30.01 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.306 -1.368 . . . . 2.47 107.306 178.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -53.77 142.13 24.63 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.662 1.226 . . . . 1.74 112.386 -177.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.4 p -128.11 -172.15 2.62 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.67 -0.695 . . . . 1.57 109.982 -177.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 m -76.07 -12.81 60.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.667 0.27 . . . . 1.52 111.286 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.97 -40.84 7.86 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 120.918 0.389 . . . . 1.59 110.549 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.3 mt -115.89 106.41 20.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.046 -1.465 . . . . 0.5 107.046 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -147.46 152.57 38.29 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.179 0.514 . . . . 2.89 112.057 -175.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 m -96.07 118.7 33.18 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.264 -0.88 . . . . 0.44 111.045 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.13 143.1 33.05 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.327 -0.99 . . . . 2.04 108.327 173.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -111.49 135.8 51.55 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.2 -0.296 . . . . 0.87 110.2 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -90.47 165.44 13.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.747 -1.205 . . . . 1.25 107.747 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -64.23 112.64 8.05 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 113.389 0.885 . . . . 3.36 113.389 -170.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.4 132.26 7.94 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.601 2.201 . . . . 1.39 110.188 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.42 146.24 24.31 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 119.819 -0.752 . . . . 1.53 109.492 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.37 11.69 2.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.452 0.644 . . . . 1.91 110.809 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -105.8 2.24 27.63 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.466 1.106 . . . . 3.49 109.34 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.95 157.41 44.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.826 -1.176 . . . . 1.89 107.826 -178.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 p -111.4 36.24 3.3 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.213 1.006 . . . . 1.3 109.259 175.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.66 128.69 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 114.445 -1.252 . . . . 0.61 109.095 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HB3' HG13 ' A' ' 29' ' ' VAL . 77.3 ttt180 -99.71 133.94 43.32 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 107.0 -1.482 . . . . 1.84 107.0 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -126.62 132.58 51.22 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.982 -0.377 . . . . 1.16 109.982 -174.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.81 27.84 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 119.953 -1.118 . . . . 0.31 111.674 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 14.2 t -149.78 134.67 17.83 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.569 0.223 . . . . 0.36 110.773 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 38.3 tp -83.24 108.46 16.49 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.22 -1.77 . . . . 0.28 106.22 173.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.596 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 35.7 mtp85 -109.61 102.73 11.54 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.864 -0.607 . . . . 2.68 111.905 -173.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -83.4 109.98 17.77 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.746 -0.661 . . . . 1.23 109.986 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -69.61 -29.01 66.42 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.585 -1.189 . . . . 2.18 110.219 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -125.62 108.72 25.98 Favored Pre-proline 0 N--CA 1.425 -1.712 0 N-CA-C 108.444 -0.947 . . . . 2.82 108.444 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.65 129.76 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.253 1.302 . . . . 1.25 109.36 176.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -125.99 141.55 51.91 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.329 -0.619 . . . . 1.22 109.329 -175.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -77.83 -18.9 55.79 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 116.163 -0.471 . . . . 2.03 110.715 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.78 -23.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.41 -0.359 . . . . 1.33 111.19 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.581 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 55.5 m-80 -97.84 26.75 4.89 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.852 1.427 . . . . 2.19 114.852 -176.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -83.77 122.73 29.05 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.4 -1.333 . . . . 1.96 107.4 174.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.27 -160.19 32.89 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.622 -1.275 . . . . 0.49 113.215 -177.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.55 111.69 23.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.008 0.523 . . . . 2.23 110.929 -175.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.581 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 34.5 m-85 -94.74 115.37 27.43 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.948 -0.569 . . . . 0.69 109.896 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 83.5 m -110.59 125.73 53.7 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 109.304 -0.628 . . . . 0.34 109.304 177.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' SER . 57.3 tp -96.83 121.13 38.35 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.678 -0.86 . . . . 0.22 108.678 179.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' LEU . 2.8 mm? -104.94 134.38 48.15 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.806 -0.813 . . . . 0.36 108.806 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.98 119.52 34.53 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.313 -1.366 . . . . 0.31 107.313 170.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.54 112.7 24.65 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.614 -0.884 . . . . 0.61 108.614 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' PRO . 21.0 t-20 -132.94 146.46 61.38 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 107.761 -1.2 . . . . 1.18 107.761 -175.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.97 -16.43 38.8 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 123.433 2.756 . . . . 1.0 113.419 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.2 t -80.79 -38.69 28.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.872 0.368 . . . . 1.1 110.267 175.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 169.75 170.13 33.84 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.267 -1.533 . . . . 0.59 109.267 -177.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -110.27 121.21 44.74 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.034 0.445 . . . . 1.57 110.245 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.89 147.54 26.78 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.849 -0.614 . . . . 0.37 109.844 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 46.9 p -140.46 144.82 36.28 Favored 'General case' 0 N--CA 1.419 -2.001 0 O-C-N 123.216 0.323 . . . . 0.57 110.344 177.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -138.94 151.3 46.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.992 -1.484 . . . . 0.3 106.992 175.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -129.87 130.36 45.11 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 118.286 0.493 . . . . 1.26 111.073 -174.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 128.1 72.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.369 -1.345 . . . . 0.72 107.369 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.77 114.98 26.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.985 -1.116 . . . . 1.25 107.985 -178.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.43 113.84 26.23 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.448 0.642 . . . . 0.58 111.028 -175.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.01 102.78 14.62 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.281 -0.872 . . . . 0.84 109.154 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -84.97 -76.88 0.3 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.409 -0.814 . . . . 3.86 110.841 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.9 mtt -138.83 153.77 48.39 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.274 -1.38 . . . . 4.72 107.274 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -93.46 162.09 14.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.744 -0.836 . . . . 5.33 108.744 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.22 115.45 62.03 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.699 0.285 . . . . 5.34 110.806 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -86.08 179.61 3.6 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 C-N-CA 122.233 1.955 . . . . 5.07 110.897 175.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 C--N 1.28 -2.448 0 CA-C-O 118.511 -0.757 . . . . 9.52 109.104 179.814 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.239 0.519 0 N-CA-C 108.539 -0.911 . . . . 7.93 108.539 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.1 t70 57.79 57.52 4.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.892 1.277 . . . . 6.17 109.601 -173.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 6' ' ' VAL . 6.8 m-20 -131.16 23.73 4.87 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 105.978 -1.86 . . . . 5.43 105.978 178.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.91 -12.59 60.39 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.103 -0.953 . . . . 3.87 112.717 -168.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.14 1.63 55.35 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.361 -0.381 . . . . 2.55 111.469 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 3' ' ' ASP . 31.0 m -68.18 121.51 17.56 Favored 'Isoleucine or valine' 0 C--O 1.251 1.137 0 CA-C-O 122.235 1.017 . . . . 2.08 110.247 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 p -107.89 98.19 7.8 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-O 122.143 0.973 . . . . 1.58 109.889 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -83.38 129.83 35.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.892 -1.151 . . . . 1.19 107.892 174.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 27.7 m -84.49 167.03 16.76 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.983 -1.118 . . . . 1.32 107.983 -177.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -94.66 129.83 41.38 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.565 0.698 . . . . 0.45 112.413 -170.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 t -124.32 136.08 53.83 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.043 -1.836 . . . . 1.19 106.043 175.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 94' ' ' ALA . 84.1 t -115.31 126.99 73.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.227 0.537 . . . . 0.29 111.155 -175.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -121.14 120.47 35.36 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.809 -1.087 . . . . 2.18 109.062 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD13 HG22 ' A' ' 98' ' ' ILE . 44.2 mt -111.58 145.55 38.95 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.842 -0.799 . . . . 0.33 108.842 176.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -132.19 154.21 49.79 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.913 0.387 . . . . 1.03 110.958 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.1 m -58.99 134.49 57.03 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.708 -1.133 . . . . 0.49 111.684 -177.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -60.6 145.53 48.59 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.286 1.034 . . . . 0.4 111.929 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -92.27 138.69 19.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 116.201 -0.454 . . . . 0.57 109.996 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -82.61 108.44 16.0 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.388 0.613 . . . . 2.52 112.618 -176.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -157.97 -178.78 7.56 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.212 -1.773 . . . . 0.88 106.212 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -63.25 -39.45 94.62 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 119.375 0.989 . . . . 2.75 112.867 -176.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.32 122.42 44.77 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.485 -1.302 . . . . 2.46 107.485 176.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.24 126.76 32.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.112 0.482 . . . . 0.86 111.593 -173.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -120.35 117.45 27.79 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.523 -0.762 . . . . 0.3 109.989 -177.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 17' ' ' ALA . 75.7 mt -99.41 105.04 30.7 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 107.682 -1.229 . . . . 0.3 107.682 173.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.88 136.74 19.03 Favored 'Trans proline' 0 C--O 1.251 1.152 0 C-N-CA 122.261 1.974 . . . . 0.28 111.687 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 14' ' ' LEU . 49.8 p90 -137.56 159.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 121.187 0.518 . . . . 0.37 110.018 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.8 m -141.97 119.55 11.72 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.636 -0.711 . . . . 0.88 109.77 176.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.7 p -126.93 125.95 67.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.044 -1.465 . . . . 0.27 107.044 176.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.4 p-10 -115.36 155.71 26.86 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 119.246 -0.982 . . . . 1.39 110.592 -179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 140.77 3.06 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.506 -1.437 . . . . 0.6 109.506 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -75.77 -54.6 2.17 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 108.169 -1.049 . . . . 2.61 108.169 178.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HG2' HD21 ' A' ' 89' ' ' ASN . 18.7 Cg_endo -65.76 122.8 10.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 N-CA-C 108.644 -1.329 . . . . 0.78 108.644 170.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.96 121.22 80.81 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 116.383 -0.371 . . . . 0.78 111.693 -175.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.76 155.54 11.77 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 121.898 1.732 . . . . 0.56 111.988 177.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 m -82.66 109.98 17.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.903 -0.777 . . . . 1.37 108.903 176.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.97 119.2 25.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.108 0.48 . . . . 0.5 110.472 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -126.65 126.12 43.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.602 -0.726 . . . . 3.78 110.324 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -91.81 119.67 31.83 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.181 -0.918 . . . . 0.29 109.662 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.5 tp -109.92 127.71 54.91 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 0.95 105.7 173.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -118.81 106.09 12.18 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 110.298 -0.26 . . . . 0.88 110.298 -174.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 59.07 30.95 20.88 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 122.544 1.164 . . . . 1.79 110.603 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.23 -7.08 82.61 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.521 -0.763 . . . . 0.61 113.092 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 p -104.78 140.97 37.31 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 122.338 -0.507 . . . . 1.37 109.872 178.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -69.61 114.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.7 111.031 -176.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.9 tp -90.21 112.22 23.67 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.337 -0.986 . . . . 0.61 108.337 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -93.49 136.98 33.24 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.682 -0.858 . . . . 2.47 108.682 178.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.14 100.46 0.61 Allowed 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 123.368 0.667 . . . . 1.74 109.924 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.8 p -93.49 -167.1 1.64 Allowed 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.009 0.524 . . . . 1.57 111.397 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -77.09 -20.93 55.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.181 0.515 . . . . 1.52 110.563 175.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 99.6 m-85 -95.8 -36.51 11.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.03 0.443 . . . . 1.59 110.641 -178.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 mt -112.41 105.52 18.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.213 -1.403 . . . . 0.5 107.213 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -134.61 155.42 50.49 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.098 0.475 . . . . 2.89 111.538 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 m -107.29 114.48 28.54 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.587 -0.523 . . . . 0.44 109.587 -178.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.11 132.4 34.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.358 -0.608 . . . . 2.04 109.358 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -122.13 149.49 43.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.779 -0.452 . . . . 0.87 109.779 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -123.01 163.43 20.47 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.804 -1.184 . . . . 1.25 107.804 173.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 10.8 mm-40 -81.54 116.63 64.2 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 123.58 0.55 . . . . 3.36 111.191 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 58' ' ' GLU . 14.9 Cg_exo -69.39 141.28 46.27 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.626 2.217 . . . . 1.39 110.35 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.76 145.12 55.02 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.78 -0.822 . . . . 1.53 108.78 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.17 -10.22 39.29 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.228 0.825 . . . . 1.91 113.228 -174.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -92.58 1.34 57.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.691 0.282 . . . . 3.49 110.875 178.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -141.23 170.69 15.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.356 -0.609 . . . . 1.89 109.356 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.7 p -132.45 26.8 4.44 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.401 0.62 . . . . 1.3 111.113 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 t -97.55 127.85 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.226 -0.657 . . . . 0.61 109.226 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB3' HG13 ' A' ' 29' ' ' VAL . 25.3 ttm180 -88.67 115.16 26.0 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.352 -1.351 . . . . 1.84 107.352 177.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -99.67 136.86 38.96 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.42 -0.955 . . . . 1.16 108.42 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.11 -178.26 43.91 Favored Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 119.941 -1.123 . . . . 0.31 112.22 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -148.99 136.6 20.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.69 0.396 . . . . 0.36 110.774 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 49.8 tp -85.6 103.7 14.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 105.035 -2.209 . . . . 0.28 105.035 171.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -111.44 127.4 55.67 Favored 'General case' 0 N--CA 1.416 -2.147 0 C-N-CA 119.955 -0.698 . . . . 2.68 110.39 -173.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 4.9 mp -108.85 109.78 20.98 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 106.937 -1.505 . . . . 1.23 106.937 178.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -65.52 -43.39 90.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.604 -0.725 . . . . 2.18 109.267 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -135.59 112.02 10.7 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 107.419 -1.326 . . . . 2.82 107.419 172.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.48 137.41 20.65 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.599 1.533 . . . . 1.25 111.654 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.8 p -83.48 148.52 27.19 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.553 -1.647 . . . . 1.22 106.553 174.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' HD2' ' OD1' ' A' ' 105' ' ' ASN . 55.6 p-80 -58.39 -20.35 43.49 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.564 0.95 . . . . 2.03 113.564 -172.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.69 -10.53 13.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 O-C-N 123.202 0.314 . . . . 1.33 111.433 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.63 26.22 0.24 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.041 1.126 . . . . 2.19 114.041 -174.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -106.85 87.76 2.59 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.676 -1.231 . . . . 1.96 107.676 177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.72 -161.72 24.34 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.634 -0.793 . . . . 0.49 112.053 -177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 99' ' ' MET . 52.4 t-20 -97.16 125.2 41.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.764 0.316 . . . . 2.23 110.557 -177.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -98.46 106.55 18.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.317 -0.994 . . . . 0.69 108.317 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 m -97.85 114.9 27.08 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 108.486 -0.931 . . . . 0.34 108.486 179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.6 tp -95.43 116.86 29.38 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.273 -0.64 . . . . 0.22 109.273 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.37 127.75 52.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.27 -1.011 . . . . 0.36 108.27 177.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.46 120.1 37.08 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.994 -1.113 . . . . 0.31 107.994 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.24 112.65 25.42 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.967 -0.753 . . . . 0.61 108.967 178.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 26.8 t-20 -120.5 147.06 44.53 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 106.48 -1.674 . . . . 1.18 106.48 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.07 -19.64 49.82 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.894 2.396 . . . . 1.0 113.623 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.9 t -86.3 -29.2 23.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.818 0.342 . . . . 1.1 110.239 178.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 89' ' ' ASN . . . 170.64 179.37 41.94 Favored Glycine 0 N--CA 1.438 -1.217 0 N-CA-C 110.916 -0.874 . . . . 0.59 110.916 -179.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -112.55 139.99 47.68 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 109.448 -0.575 . . . . 1.57 109.448 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -120.53 153.05 37.24 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 178.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 48.5 p -150.35 155.39 39.53 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.377 0.423 . . . . 0.57 110.194 178.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.36 165.53 34.71 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.476 -1.676 . . . . 0.3 106.476 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.41 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 35.7 m -143.38 125.85 15.78 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 117.972 0.351 . . . . 1.26 110.625 -177.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.502 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -123.75 122.93 65.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.611 -1.255 . . . . 0.72 107.611 178.486 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 22.3 ttt -107.41 111.61 24.01 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.046 0.451 . . . . 1.25 110.08 -176.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.11 154.22 36.44 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.013 -0.539 . . . . 0.58 111.6 -174.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -131.76 123.67 28.15 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.994 -1.484 . . . . 0.84 106.994 176.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -101.01 -77.05 0.55 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.291 -0.413 . . . . 3.86 111.959 -176.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -127.34 137.61 52.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.212 -0.662 . . . . 4.72 109.212 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.05 127.71 30.31 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.943 1.297 . . . . 5.33 112.128 -177.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.4 ' OD1' ' HD2' ' A' ' 77' ' ' HIS . 31.2 m-80 -55.29 109.15 1.43 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.802 1.241 . . . . 5.34 113.108 -178.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.562 ' O ' ' HB2' ' A' ' 107' ' ' PHE . 6.5 Cg_exo -84.34 115.72 1.96 Allowed 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.201 1.934 . . . . 5.07 111.346 174.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 26.8 t80 . . . . . 0 CA--C 1.505 -0.764 0 O-C-N 124.82 1.325 . . . . 9.52 107.776 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.514 -0.422 0 N-CA-C 112.95 0.722 . . . . 7.93 112.95 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -104.34 -86.08 0.46 Allowed 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.517 -0.873 . . . . 6.17 110.997 -174.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.14 -15.39 27.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.648 1.213 . . . . 5.43 108.456 178.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -93.89 138.33 32.15 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.45 -1.705 . . . . 3.87 109.536 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -120.47 -50.41 2.22 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.276 -0.639 . . . . 2.55 109.276 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.61 101.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.064 -0.971 . . . . 2.08 110.656 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -93.63 98.52 11.2 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.928 0.87 . . . . 1.58 110.136 -174.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.41 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 46.4 m-85 -104.72 133.8 48.94 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.695 -1.139 . . . . 1.19 108.075 176.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 m -84.86 -165.6 1.24 Allowed 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.942 -0.762 . . . . 1.32 108.942 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -94.12 124.62 38.25 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.251 -0.98 . . . . 0.45 111.06 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 t -128.12 129.89 47.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 107.444 -1.317 . . . . 1.19 107.444 175.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG23 ' HB3' ' A' ' 94' ' ' ALA . 87.7 t -119.97 132.56 69.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 116.673 -0.239 . . . . 0.29 110.664 -174.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -130.38 122.07 27.15 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.376 0.608 . . . . 2.18 109.711 173.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 48.8 mt -104.68 148.83 26.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.651 -0.704 . . . . 0.33 110.212 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -131.76 150.57 52.11 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.161 -0.681 . . . . 1.03 109.161 -176.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.5 m -49.39 135.23 17.87 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 125.605 1.562 . . . . 0.49 111.899 -177.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 137.87 50.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.918 -1.037 . . . . 0.4 108.776 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.7 m -91.02 131.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.439 0.638 . . . . 0.57 110.064 -175.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -74.31 91.81 2.22 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.57 -1.196 . . . . 2.52 110.533 -177.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.7 mtm -130.98 -171.61 2.62 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.816 -0.439 . . . . 0.88 109.816 176.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.06 -25.38 63.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 2.75 109.691 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -119.84 143.82 47.69 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.456 -0.793 . . . . 2.46 109.83 174.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -82.78 124.11 29.96 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.574 0.702 . . . . 0.86 112.044 -177.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.7 121.59 19.88 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.556 -1.202 . . . . 0.3 109.131 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -107.16 100.96 35.76 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 107.738 -1.208 . . . . 0.3 107.738 174.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.14 129.07 11.88 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.545 2.163 . . . . 0.28 112.575 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -126.29 153.38 44.89 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.058 -0.519 . . . . 0.37 110.584 179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.1 m -134.93 127.09 29.94 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.94 -0.763 . . . . 0.88 108.94 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.1 p -127.29 124.99 65.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.39 -0.967 . . . . 0.27 108.39 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 65' ' ' VAL . 5.2 p-10 -115.49 149.89 37.39 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 120.83 -0.348 . . . . 1.39 111.821 -176.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.51 -171.83 33.6 Favored Glycine 0 N--CA 1.428 -1.896 0 O-C-N 124.622 1.201 . . . . 0.6 110.851 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -119.0 -57.29 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.106 0 CA-C-O 118.583 -0.722 . . . . 2.61 112.674 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 52.3 Cg_exo -59.97 120.53 8.37 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 108.553 -1.364 . . . . 0.78 108.553 171.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.9 116.23 16.19 Favored Pre-proline 0 N--CA 1.448 -0.549 0 O-C-N 123.871 0.732 . . . . 0.78 111.53 -175.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 93.4 Cg_endo -85.62 152.9 10.28 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 121.848 1.698 . . . . 0.56 111.842 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 p -82.8 106.07 14.33 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.881 -0.785 . . . . 1.37 108.881 174.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.69 119.75 23.7 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 109.405 -0.591 . . . . 0.5 109.405 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -137.82 131.52 31.26 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.696 -0.683 . . . . 3.78 110.679 -177.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.414 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 85.3 m95 -94.81 129.01 41.95 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.569 -0.741 . . . . 0.29 109.713 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -118.97 129.06 54.96 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 106.639 -1.615 . . . . 0.95 106.639 176.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -112.72 98.05 6.96 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.007 0.432 . . . . 0.88 110.28 -178.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.0 47.68 24.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.554 1.141 . . . . 1.79 111.294 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 -22.22 36.59 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.367 -0.833 . . . . 0.61 113.57 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -96.37 143.57 27.3 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.332 -0.618 . . . . 1.37 109.332 -176.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.98 118.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.548 -0.751 . . . . 0.7 109.994 -177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.2 tp -82.45 120.67 25.76 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.491 -1.299 . . . . 0.61 107.491 177.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -107.77 140.09 41.36 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.298 -1.001 . . . . 2.47 108.298 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -68.89 92.93 0.52 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.662 0.744 . . . . 1.74 109.714 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -88.91 178.97 6.28 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.01 -0.996 . . . . 1.57 108.918 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.4 t -48.6 -36.91 16.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.171 0.988 . . . . 1.52 112.992 -176.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -110.72 5.59 20.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.113 0.783 . . . . 1.59 113.113 -173.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.428 HG12 HD23 ' A' ' 72' ' ' LEU . 54.5 mt -124.15 106.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.472 -1.677 . . . . 0.5 106.472 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -126.72 137.84 53.31 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.414 -0.357 . . . . 2.89 110.439 -171.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 m -92.69 109.39 20.81 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.265 -1.383 . . . . 0.44 107.265 176.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.74 136.9 42.56 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.384 -0.598 . . . . 2.04 109.384 -174.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.01 152.49 36.31 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.9 0.381 . . . . 0.87 110.013 -177.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 67' ' ' HIS . 4.5 pp -110.51 165.2 11.99 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.402 -1.703 . . . . 1.25 106.402 175.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.38 109.73 11.39 Favored Pre-proline 0 C--N 1.307 -1.25 0 O-C-N 123.169 0.293 . . . . 3.36 110.264 -178.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.72 140.09 20.58 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 122.221 1.948 . . . . 1.39 110.651 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.54 148.13 31.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.236 -1.024 . . . . 1.53 108.236 177.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.73 -13.21 62.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.458 0.646 . . . . 1.91 110.877 -178.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.4 -26.39 65.52 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.855 -1.066 . . . . 3.49 110.551 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.08 143.42 33.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.114 0.483 . . . . 1.89 110.071 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.7 p -98.32 18.05 17.32 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.762 -1.199 . . . . 1.3 107.762 171.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 30' ' ' ASP . 16.5 t -114.17 129.08 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 114.383 -1.28 . . . . 0.61 109.211 -177.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.537 ' HB3' HG13 ' A' ' 29' ' ' VAL . 15.5 ttm180 -95.11 132.46 40.01 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 106.76 -1.57 . . . . 1.84 106.76 177.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 57' ' ' LEU . 87.9 m-70 -119.6 141.83 48.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.102 -0.333 . . . . 1.16 110.102 -176.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.0 -173.94 34.18 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 110.409 -1.076 . . . . 0.31 110.409 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.416 ' SG ' ' HG3' ' A' ' 71' ' ' ARG . 26.8 t -148.27 135.45 20.32 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.064 0.459 . . . . 0.36 111.107 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 57.3 tp -83.58 114.35 21.46 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.52 -1.659 . . . . 0.28 106.52 173.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HG3' ' SG ' ' A' ' 69' ' ' CYS . 96.7 mtt180 -114.92 125.05 53.19 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.506 0.67 . . . . 2.68 111.584 -175.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 52' ' ' ILE . 4.5 mp -111.62 109.84 19.94 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.765 -1.107 . . . . 1.23 108.782 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.46 -35.42 80.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.046 -0.979 . . . . 2.18 111.107 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -128.18 119.76 20.98 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.963 -0.755 . . . . 2.82 108.963 178.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.63 136.95 29.25 Favored 'Trans proline' 0 N--CA 1.436 -1.88 0 C-N-CA 121.441 1.427 . . . . 1.25 109.068 175.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -128.99 161.04 30.84 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.33 -0.989 . . . . 1.22 108.33 -178.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -68.7 -5.03 17.99 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.472 0.916 . . . . 2.03 113.472 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.62 -9.02 10.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-O 121.069 0.461 . . . . 1.33 110.301 175.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.815 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.4 m120 -83.4 27.92 0.57 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.292 0.637 . . . . 2.19 112.355 -176.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 74.4 m-20 -124.67 103.06 7.91 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.355 -0.98 . . . . 1.96 108.355 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.56 -159.12 30.61 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.684 -0.967 . . . . 0.49 110.684 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 97' ' ' SER . 23.4 t-20 -103.41 122.71 45.42 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 120.736 0.303 . . . . 2.23 110.379 -177.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.815 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 51.3 m-85 -100.49 115.2 29.54 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.439 -0.578 . . . . 0.69 109.439 178.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.4 m -103.31 127.59 50.6 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.496 -0.32 . . . . 0.34 110.183 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 ' CB ' HD11 ' A' ' 14' ' ' LEU . 59.9 tp -100.89 120.41 40.11 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.951 -0.759 . . . . 0.22 108.951 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.96 139.09 38.97 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.089 -1.078 . . . . 0.36 108.089 177.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -135.07 120.63 19.32 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.164 -1.421 . . . . 0.31 107.164 173.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.53 133.56 53.28 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.754 -0.378 . . . . 0.61 110.996 -178.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -142.76 171.29 7.29 Favored Pre-proline 0 C--N 1.3 -1.576 0 CA-C-O 117.23 -1.367 . . . . 1.18 107.541 175.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.24 -25.16 29.16 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.168 1.912 . . . . 1.0 114.753 -175.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.16 -23.23 38.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.994 0.368 . . . . 1.1 111.994 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.58 -175.63 35.62 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.518 -1.325 . . . . 0.59 113.092 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -124.43 131.19 53.5 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.819 -0.437 . . . . 1.57 109.819 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -106.62 148.46 28.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.454 -0.943 . . . . 0.37 108.454 176.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.4 p -142.57 122.83 13.84 Favored 'General case' 0 N--CA 1.425 -1.705 0 O-C-N 123.401 0.438 . . . . 0.57 110.442 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.81 155.5 43.99 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.799 -1.186 . . . . 0.3 107.799 177.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.441 ' HB3' ' OD1' ' A' ' 82' ' ' ASN . 50.9 m -130.26 144.22 51.24 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.84 0.352 . . . . 1.26 110.845 -178.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -130.24 126.53 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.853 -1.166 . . . . 0.72 107.853 176.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.7 tpt -87.06 114.1 23.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.61 -0.885 . . . . 1.25 108.61 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.11 132.13 53.62 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 120.87 0.367 . . . . 0.58 110.779 -175.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . . . -140.23 101.44 4.14 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.154 -1.054 . . . . 0.84 108.154 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -81.27 -66.31 0.9 Allowed 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.991 -0.55 . . . . 3.86 111.865 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -148.7 126.69 11.98 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 108.937 -0.764 . . . . 4.72 108.937 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.407 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . 19.7 t0 -71.05 163.47 27.51 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.205 0.602 . . . . 5.33 111.555 -178.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 72.8 m-20 -51.26 126.86 28.75 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.626 1.17 . . . . 5.34 112.522 -174.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 11.7 Cg_endo -90.07 179.41 2.02 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.803 2.335 . . . . 5.07 110.369 172.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 . . . . . 0 C--N 1.289 -2.063 0 N-CA-C 107.8 -1.185 . . . . 9.52 107.8 174.131 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 CA--C 1.486 -1.484 0 CA-C-O 120.446 0.165 . . . . 7.93 111.065 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.34 69.03 9.92 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 105.921 -1.881 . . . . 6.17 105.921 175.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.19 53.01 1.66 Allowed 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.899 1.333 . . . . 5.43 113.399 -173.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -135.5 38.35 2.89 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 105.424 -2.065 . . . . 3.87 105.424 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -69.68 -51.29 35.89 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 114.67 -1.15 . . . . 2.55 109.761 -177.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 m -79.3 99.24 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 CA-C-O 122.464 1.126 . . . . 2.08 110.254 177.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -110.41 98.82 7.95 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.085 -1.08 . . . . 1.58 108.085 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.497 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 97.2 m-85 -89.94 134.47 34.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.022 -1.473 . . . . 1.19 107.022 176.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.0 m -83.26 177.0 8.72 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.879 -1.156 . . . . 1.32 107.879 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 94' ' ' ALA . . . -93.25 124.22 37.08 Favored 'General case' 0 CA--C 1.483 -1.605 0 C-N-CA 119.37 -0.932 . . . . 0.45 111.17 -170.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -123.86 133.08 53.84 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 106.905 -1.517 . . . . 1.19 106.905 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 94' ' ' ALA . 88.3 t -115.28 118.35 58.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.735 0.303 . . . . 0.29 110.266 -175.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -116.74 116.24 27.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.768 -0.827 . . . . 2.18 108.768 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 98' ' ' ILE . 41.3 mt -96.51 156.99 16.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.651 -0.704 . . . . 0.33 110.72 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -129.93 144.65 51.43 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.876 -1.157 . . . . 1.03 107.876 -174.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.1 m -57.55 133.49 55.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 O-C-N 124.953 1.408 . . . . 0.49 110.652 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -70.28 141.35 52.4 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.074 -0.966 . . . . 0.4 110.3 -176.192 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -92.65 127.59 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 113.26 0.837 . . . . 0.57 113.26 -177.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -83.97 88.33 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.891 -1.049 . . . . 2.52 108.796 176.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.03 -169.67 3.35 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.545 -1.28 . . . . 0.88 107.545 175.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -48.57 -38.18 19.9 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 114.103 1.149 . . . . 2.75 114.103 -171.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -133.25 139.57 47.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.417 -0.957 . . . . 2.46 108.417 175.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HB2' HD12 ' A' ' 72' ' ' LEU . 73.5 m95 -81.34 127.1 32.38 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.294 0.569 . . . . 0.86 110.442 -175.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.8 t -120.81 121.58 38.46 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-N 114.563 -1.199 . . . . 0.3 108.144 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 17' ' ' ALA . 52.3 mt -108.27 96.05 17.46 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.139 -1.43 . . . . 0.3 107.139 175.388 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.69 128.52 13.49 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.333 2.022 . . . . 0.28 111.8 -177.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -120.05 146.68 45.67 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 116.03 -0.532 . . . . 0.37 109.853 178.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 m -132.59 106.81 8.04 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 108.689 -0.856 . . . . 0.88 108.689 176.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HB3' ' A' ' 66' ' ' ARG . 2.6 p -110.56 111.25 35.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.169 -0.923 . . . . 0.27 108.766 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.3 p30 -101.3 137.53 39.53 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.396 -0.82 . . . . 1.39 110.148 -178.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.05 146.64 4.61 Favored Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 108.699 -1.761 . . . . 0.6 108.699 -176.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.45 -59.79 0.24 Allowed Pre-proline 0 C--N 1.3 -1.574 0 CA-C-O 117.947 -1.025 . . . . 2.61 110.199 -176.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 7.8 Cg_endo -54.81 119.43 6.46 Favored 'Trans proline' 0 C--N 1.393 2.88 0 N-CA-C 107.72 -1.685 . . . . 0.78 107.72 171.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.69 114.68 17.01 Favored Pre-proline 0 C--N 1.291 -1.936 0 CA-C-N 114.567 -1.197 . . . . 0.78 112.746 -171.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.67 150.05 11.35 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 122.134 1.89 . . . . 0.56 112.454 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -84.57 127.04 33.85 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 107.208 -1.405 . . . . 1.37 107.208 174.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.1 mt -99.91 122.69 43.23 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.856 0.36 . . . . 0.5 111.714 -176.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -130.22 128.28 41.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.607 -0.724 . . . . 3.78 110.52 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 94.1 m95 -90.82 141.2 29.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.924 -0.769 . . . . 0.29 108.924 175.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 tp -129.32 127.4 41.03 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.206 -1.405 . . . . 0.95 107.206 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -103.13 98.13 8.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.024 -0.732 . . . . 0.88 109.024 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.67 29.63 7.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.015 0.926 . . . . 1.79 113.311 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.56 -20.57 24.92 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.828 -0.701 . . . . 0.61 113.263 -179.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 m -89.84 137.96 31.89 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 117.16 0.48 . . . . 1.37 110.735 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.1 t -65.41 108.68 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.994 -1.003 . . . . 0.7 111.16 -178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 32.8 tp -87.62 114.92 24.68 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.053 -1.091 . . . . 0.61 108.053 178.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -108.01 140.59 40.95 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.476 -1.305 . . . . 2.47 107.476 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.11 107.87 2.06 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 123.873 0.869 . . . . 1.74 110.998 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -99.37 -166.13 1.31 Allowed 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 116.191 -0.459 . . . . 1.57 110.122 -178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.5 t -82.02 -13.21 57.71 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.1 -0.704 . . . . 1.52 109.1 176.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -102.03 -38.89 7.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.809 -0.632 . . . . 1.59 110.565 -176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.5 mt -117.8 108.21 24.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.293 -1.373 . . . . 0.5 107.293 179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -135.06 137.7 43.15 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.4 -0.92 . . . . 2.89 112.252 -174.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -81.44 111.04 17.41 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.665 -0.698 . . . . 0.44 110.163 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -103.28 111.27 23.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.211 0.529 . . . . 2.04 111.051 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -84.09 141.88 30.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.928 -0.578 . . . . 0.87 109.808 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -119.1 160.66 21.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.238 -1.023 . . . . 1.25 108.238 -179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -77.33 119.24 76.68 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 113.368 0.877 . . . . 3.36 113.368 -176.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.1 170.06 8.51 Favored 'Trans proline' 0 C--O 1.254 1.317 0 C-N-CA 123.482 2.788 . . . . 1.39 109.241 175.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.68 143.02 34.99 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.286 -1.376 . . . . 1.53 107.286 177.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.28 14.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.716 1.747 . . . . 1.91 115.716 -170.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -93.73 -9.98 35.87 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.61 -0.836 . . . . 3.49 110.831 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.16 126.1 30.37 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.097 0.475 . . . . 1.89 110.525 178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -95.64 30.75 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.927 1.346 . . . . 1.3 108.372 171.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 33.4 t -116.11 135.48 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.771 -1.558 . . . . 0.61 107.363 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HB3' HG13 ' A' ' 29' ' ' VAL . 31.6 ttm180 -99.44 122.16 42.15 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.361 -1.348 . . . . 1.84 107.361 177.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -108.55 141.13 40.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.485 -0.931 . . . . 1.16 108.485 -179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.81 -177.34 39.62 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.314 -0.946 . . . . 0.31 110.977 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.2 t -145.14 132.68 20.84 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 123.556 0.209 . . . . 0.36 110.575 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 59.9 tp -82.62 111.63 18.77 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 104.965 -2.235 . . . . 0.28 104.965 170.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -107.23 119.09 38.45 Favored 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.96 -0.564 . . . . 2.68 110.195 -172.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 23' ' ' TRP . 77.8 mt -81.05 108.01 14.35 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 106.695 -1.595 . . . . 1.23 106.695 173.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -69.99 -45.15 67.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.97 -1.014 . . . . 2.18 108.602 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -129.88 101.2 18.47 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 106.676 -1.602 . . . . 2.82 106.676 172.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -69.03 130.77 20.86 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.37 2.047 . . . . 1.25 111.297 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 p -128.65 168.85 15.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.361 -0.836 . . . . 1.22 108.983 -177.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.254 14.8 p-80 -68.47 -3.2 10.6 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 113.894 1.072 . . . . 2.03 113.894 -175.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.6 m -84.88 -10.38 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.482 0.658 . . . . 1.33 109.937 174.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.696 ' HA ' ' OH ' ' A' ' 83' ' ' TYR . 15.7 m120 -85.69 28.09 0.8 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.261 1.025 . . . . 2.19 113.237 -175.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 35.8 p-10 -126.2 99.1 5.74 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.977 0.894 . . . . 1.96 111.735 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' MET . . . 170.76 -158.18 29.68 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.298 -0.864 . . . . 0.49 111.269 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -97.33 105.69 17.89 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 122.654 0.382 . . . . 2.23 110.343 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.696 ' OH ' ' HA ' ' A' ' 79' ' ' ASN . 59.0 m-85 -93.0 106.32 18.29 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.244 -0.65 . . . . 0.69 109.244 175.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 38.3 m -92.87 131.99 37.41 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 0.34 109.855 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 12' ' ' VAL . 53.2 tp -104.2 117.37 34.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.148 -0.686 . . . . 0.22 109.148 177.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.14 129.67 51.87 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.315 -0.994 . . . . 0.36 108.315 177.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 93' ' ' GLN . . . -125.21 121.03 32.95 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.256 -1.016 . . . . 0.31 108.256 176.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.33 126.05 46.15 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.691 -0.403 . . . . 0.61 111.496 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.565 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 41.6 p30 -134.37 169.85 12.81 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 117.448 -1.263 . . . . 1.18 107.695 176.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 89' ' ' ASN . 1.9 Cg_endo -43.25 -32.24 3.1 Favored 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 123.539 2.826 . . . . 1.0 115.248 178.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.8 t -77.08 -34.91 56.94 Favored 'General case' 0 C--O 1.241 0.657 0 O-C-N 122.028 -0.42 . . . . 1.1 111.682 -176.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.04 -166.59 38.79 Favored Glycine 0 C--O 1.247 0.93 0 C-N-CA 120.405 -0.902 . . . . 0.59 112.044 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 27.6 tt0 -124.77 132.97 53.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.993 0.425 . . . . 1.57 110.338 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -108.25 152.26 24.84 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.147 -0.686 . . . . 0.37 109.147 178.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 p -141.54 148.88 40.07 Favored 'General case' 0 N--CA 1.428 -1.53 0 O-C-N 123.482 0.489 . . . . 0.57 111.144 -179.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.78 144.22 14.88 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.318 -1.364 . . . . 0.3 107.318 174.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 84' ' ' THR . 49.1 m -121.23 136.12 55.02 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 120.992 0.425 . . . . 1.26 110.684 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.494 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.11 126.27 69.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.725 -1.213 . . . . 0.72 107.725 178.48 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.4 ttm -92.59 103.86 16.21 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.335 -0.546 . . . . 1.25 110.649 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 80' ' ' ASN . . . -95.4 135.0 37.58 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.478 -1.675 . . . . 0.58 106.478 174.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.82 101.52 5.3 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.248 -0.649 . . . . 0.84 109.248 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -67.97 -71.26 0.22 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.387 -0.824 . . . . 3.86 111.085 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 63.8 mtt -149.42 148.77 29.86 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.443 -1.317 . . . . 4.72 107.443 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.79 127.35 32.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 124.194 0.934 . . . . 5.33 109.173 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -80.03 117.19 66.25 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 123.891 0.744 . . . . 5.34 112.938 -173.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -72.55 116.88 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.557 2.171 . . . . 5.07 111.149 174.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.427 -1.612 0 CA-C-O 118.34 -0.838 . . . . 9.52 109.242 178.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 120.187 0.041 . . . . 7.93 111.058 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -99.95 131.42 45.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.133 -1.062 . . . . 6.17 108.133 176.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -113.28 40.85 2.25 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.585 0.707 . . . . 5.43 111.313 -175.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -106.01 -27.78 10.95 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 121.908 -0.495 . . . . 3.87 111.653 -178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.47 -38.94 65.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.106 -0.701 . . . . 2.55 109.106 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 m -73.43 105.54 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.939 0.876 . . . . 2.08 110.708 174.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.4 t -108.51 99.45 8.83 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.334 -0.848 . . . . 1.58 109.136 -178.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.603 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 54.9 m-85 -102.33 122.45 44.28 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.387 -1.338 . . . . 1.19 107.387 174.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.25 -179.19 7.15 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.774 -0.648 . . . . 1.32 109.768 -176.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 30' ' ' ASP . . . -93.43 128.56 39.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 119.51 -0.876 . . . . 0.45 112.373 -168.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -121.57 128.22 51.76 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.815 -1.55 . . . . 1.19 106.815 175.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 94' ' ' ALA . 98.0 t -115.25 120.02 63.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 120.819 0.342 . . . . 0.29 110.466 -175.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -119.47 136.03 54.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.816 -0.629 . . . . 2.18 109.764 176.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 98' ' ' ILE . 36.7 mt -123.06 149.63 44.17 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.386 0.613 . . . . 0.33 110.897 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -131.07 145.48 52.02 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.975 -1.12 . . . . 1.03 107.975 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 m -64.79 139.22 58.74 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 114.988 -1.006 . . . . 0.49 110.715 -175.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 25' ' ' ILE . . . -52.96 139.31 28.01 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 114.638 -1.165 . . . . 0.4 111.951 -178.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -92.07 142.74 12.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.788 -0.642 . . . . 0.57 109.914 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.41 111.61 20.68 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.57 0.582 . . . . 2.52 112.57 -173.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 22' ' ' HIS . 22.1 ptt? -162.39 -173.24 3.5 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.48 -0.933 . . . . 0.88 108.48 175.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 118.634 0.652 . . . . 2.75 112.367 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 20' ' ' MET . 81.9 m-70 -110.8 124.82 52.76 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 105.645 -1.983 . . . . 2.46 105.645 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -82.6 133.48 35.18 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.295 0.569 . . . . 0.86 111.568 -173.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 45.7 t -126.56 120.49 29.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.021 -0.99 . . . . 0.3 110.053 -175.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 17' ' ' ALA . 66.5 mt -101.84 101.98 20.98 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 107.931 -1.137 . . . . 0.3 107.931 174.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.05 131.87 16.04 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.524 2.15 . . . . 0.28 112.504 -178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -130.53 160.22 34.8 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.053 0.454 . . . . 0.37 110.374 178.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -143.99 111.07 5.77 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.985 -0.746 . . . . 0.88 108.985 176.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 66' ' ' ARG . 2.6 p -114.06 122.86 69.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.78 -0.645 . . . . 0.27 109.952 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 28.9 t70 -101.94 141.59 34.55 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.013 -0.54 . . . . 1.39 109.99 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.51 148.13 5.62 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.273 -1.131 . . . . 0.6 110.273 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' HB2' ' H ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -85.9 -55.68 0.39 Allowed Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 107.993 -1.114 . . . . 2.61 107.993 178.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 8' ' ' PHE . 36.3 Cg_endo -73.28 119.61 6.09 Favored 'Trans proline' 0 C--N 1.382 2.296 0 N-CA-C 107.275 -1.856 . . . . 0.78 107.275 167.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.94 112.85 11.81 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 123.753 0.658 . . . . 0.78 112.512 -172.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' HB3' ' HB3' ' A' ' 89' ' ' ASN . 42.1 Cg_endo -70.7 141.49 41.54 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.679 2.253 . . . . 0.56 112.694 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.5 t -76.32 112.32 12.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.065 -1.457 . . . . 1.37 107.065 174.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.21 131.15 35.28 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.165 -0.47 . . . . 0.5 111.301 -177.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -132.28 131.95 42.53 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.283 -0.636 . . . . 3.78 109.283 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 70' ' ' LEU . 92.0 m95 -98.02 135.39 39.78 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.916 0.389 . . . . 0.29 110.002 177.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 84' ' ' THR . 15.3 tp -116.56 134.44 54.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.246 -1.761 . . . . 0.95 106.246 176.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -121.29 112.52 18.7 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.572 -0.529 . . . . 0.88 109.572 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 57.26 24.82 10.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.853 0.861 . . . . 1.79 112.464 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.04 4.41 71.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.826 -0.702 . . . . 0.61 112.694 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.8 m -113.1 151.85 30.29 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.886 -0.783 . . . . 1.37 108.886 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.31 117.71 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.157 -0.683 . . . . 0.7 109.157 -178.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.1 tp -82.04 111.33 18.1 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.886 -0.597 . . . . 0.61 109.401 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -84.66 117.39 23.75 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.147 -1.057 . . . . 2.47 108.147 176.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.96 122.58 18.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.345 -0.389 . . . . 1.74 110.153 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.7 p -105.78 -171.05 1.83 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.389 -0.369 . . . . 1.57 110.047 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -69.35 -21.03 63.85 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.29 0.567 . . . . 1.52 109.828 173.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 58.0 m-85 -91.53 -40.69 11.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.342 -0.39 . . . . 1.59 110.379 -177.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.9 mt -109.49 106.47 20.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.628 -1.249 . . . . 0.5 107.628 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.22 145.52 41.5 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.16 0.505 . . . . 2.89 112.276 -176.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.5 m -84.38 114.06 21.61 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.63 -0.878 . . . . 0.44 108.63 176.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.4 127.14 54.95 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.725 -0.843 . . . . 2.04 108.725 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.92 151.17 21.62 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.74 -0.467 . . . . 0.87 109.74 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -119.87 146.61 45.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.65 -1.241 . . . . 1.25 107.65 178.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 58' ' ' GLU . 4.2 mp0 -47.64 105.95 0.54 Allowed Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 125.744 1.618 . . . . 3.36 114.623 -172.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.54 136.0 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.187 2.592 . . . . 1.39 110.32 174.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -77.54 159.11 29.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.366 -0.605 . . . . 1.53 109.366 -177.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.62 -3.37 21.21 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.524 0.564 . . . . 1.91 112.524 -175.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -103.5 9.36 37.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.12 0.486 . . . . 3.49 109.913 175.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.06 131.75 56.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 120.779 -0.369 . . . . 1.89 111.178 -179.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.9 p -96.99 2.05 51.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.875 -1.157 . . . . 1.3 107.875 170.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . 19.6 t -94.26 128.54 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.17 -1.377 . . . . 0.61 108.578 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 29' ' ' VAL . 67.1 mtp180 -99.88 121.24 41.02 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.644 -1.613 . . . . 1.84 106.644 178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -103.8 141.28 36.38 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.758 -0.83 . . . . 1.16 108.758 -175.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.51 -173.7 35.89 Favored Glycine 0 N--CA 1.424 -2.125 0 C-N-CA 119.613 -1.28 . . . . 0.31 111.967 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.5 t -151.07 134.33 16.1 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 123.308 0.643 . . . . 0.36 110.332 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . 55.3 tp -84.43 104.19 14.23 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 104.291 -2.485 . . . . 0.28 104.291 169.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -109.34 127.23 54.16 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.373 -0.531 . . . . 2.68 110.963 -171.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 6.6 mp -103.79 111.36 23.84 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.135 -0.939 . . . . 1.23 109.1 177.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -64.04 -42.84 96.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.47 -1.241 . . . . 2.18 109.027 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -128.63 113.04 19.23 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.726 -0.842 . . . . 2.82 108.726 176.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.79 130.39 8.62 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.111 1.874 . . . . 1.25 111.885 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 p -107.73 141.4 39.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.263 -1.014 . . . . 1.22 108.263 177.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -68.38 -14.76 63.22 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 120.965 0.412 . . . . 2.03 111.025 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -73.95 -15.39 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.91 -0.587 . . . . 1.33 111.06 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.542 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 47.3 m-80 -102.95 25.84 8.87 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 112.98 0.733 . . . . 2.19 112.98 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.701 -1.592 . . . . 1.96 106.701 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.45 -154.12 6.97 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.084 -1.055 . . . . 0.49 113.549 -175.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -105.53 120.16 40.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.066 0.46 . . . . 2.23 111.498 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB3' ' A' ' 79' ' ' ASN . 16.3 m-85 -101.24 133.79 45.28 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.117 -0.947 . . . . 0.69 108.788 178.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 27.8 m -122.78 129.16 51.4 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.909 -1.145 . . . . 0.34 107.909 176.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' SER . 53.5 tp -100.83 120.47 40.18 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.017 -0.734 . . . . 0.22 109.017 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.15 136.28 49.63 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.931 -1.137 . . . . 0.36 107.931 178.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 35' ' ' PRO . . . -129.07 121.28 27.52 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.469 -0.937 . . . . 0.31 108.469 178.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.03 122.51 46.43 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.046 -0.262 . . . . 0.61 110.409 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 p-10 -137.22 177.24 2.26 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 107.102 -1.444 . . . . 1.18 107.102 177.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.28 -26.98 28.87 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.523 2.149 . . . . 1.0 114.589 -177.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 92.6 m -76.94 -17.85 58.64 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.883 0.327 . . . . 1.1 111.883 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.66 -158.74 22.95 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.463 -0.875 . . . . 0.59 111.653 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -107.6 138.23 44.2 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.899 0.381 . . . . 1.57 109.977 -176.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -117.48 158.26 24.83 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.385 -1.339 . . . . 0.37 107.385 174.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 85' ' ' LEU . 42.7 p -153.84 159.11 41.71 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 112.442 0.534 . . . . 0.57 112.442 -177.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.17 153.98 24.71 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 106.833 -1.543 . . . . 0.3 106.833 174.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 p -123.48 151.45 42.74 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 118.075 0.398 . . . . 1.26 111.138 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -148.8 128.4 3.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.661 -1.237 . . . . 0.72 107.661 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.5 110.99 23.44 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.066 -1.457 . . . . 1.25 107.066 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.65 112.76 25.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.749 0.785 . . . . 0.58 111.659 -174.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.46 101.2 10.88 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.77 -1.105 . . . . 0.84 108.027 176.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.3 -69.9 0.45 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.727 -0.67 . . . . 3.86 109.722 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -142.07 145.47 34.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.169 -1.049 . . . . 4.72 108.169 178.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.97 135.79 40.03 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 123.834 0.854 . . . . 5.33 111.052 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.0 t30 -56.54 115.81 11.15 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 124.475 1.11 . . . . 5.34 112.495 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 4.0 Cg_exo -78.18 149.28 25.03 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.202 1.935 . . . . 5.07 109.798 173.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 117.51 -1.233 . . . . 9.52 111.511 -178.694 . . . . . . . . 0 0 . 1 stop_ save_